"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34172911","10.1038/s41432-021-0181-3","COVID-19, social media use and anxiety: more complex than it might appear?","Design Cross-sectional questionnaire survey of 403 dental healthcare workers.Sample selection Snowball sampling via social media.Data analysis Descriptive analysis of sample. Bivariate analysis of the relationship between demographic variables, social media use and anxiety. Binary logistic regression analysis predicting: 1) use of social media; and 2) general anxiety.Results 1) Social media use was predicted by moderate/severe anxiety level; 2) general anxiety level was predicted by being female","2021","06","30","Evid Based Dent","Evidence-based dentistry","Anxiety; COVID-19; Cross-Sectional Studies; Female; Humans; SARS-CoV-2; Social Media","Newton","Tim","King's College London, London, UK",NA
"2","34172910","10.1038/s41432-021-0179-x","Is periodontitis associated with the severity of COVID-19?","Data sources The national electronic health records of the Hamad Medical Corporation (HMC) in the State of Qatar.Data extraction and synthesis This case-control study included 568 patients from the HMC electronic database for data eliciting from 27 February 2020 to 31 July 2020. Patients with coronavirus disease 2019 (COVID-19) complications were considered as cases. Controls were defined as COVID-19 patients without major complications (discharged). Multivariate logistic regression was performe","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Case-Control Studies; Humans; Periodontitis; Qatar; Risk Factors; SARS-CoV-2","Shamsoddin","Erfan","National Institute for Medical Research Development (NIMAD), Tehran, Iran",NA
"3","34172909","10.1038/s41432-021-0182-2","Should we test asymptomatic children for SARS-CoV-2?","Design Cross-sectional study.Sample selection This study included 921 children (471 male, 450 female) due to receive either routine dental care involving aerosol generating procedures or comprehensive dental care under general anaesthetic. Data was collected at a paediatric dental clinic associated with the University of Illinois, Chicago. Patients were screened by a telephone questionnaire assessing for coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS","2021","06","30","Evid Based Dent","Evidence-based dentistry","Adolescent; Aged; COVID-19; Chicago; Child; Cross-Sectional Studies; Female; Humans; Male; SARS-CoV-2","Cowan","Kirsty","Dental Core Trainee, Aberdeen Dental Hospital, Department of Restorative Dentistry, UK",NA
"4","34172909","10.1038/s41432-021-0182-2","Should we test asymptomatic children for SARS-CoV-2?","Design Cross-sectional study.Sample selection This study included 921 children (471 male, 450 female) due to receive either routine dental care involving aerosol generating procedures or comprehensive dental care under general anaesthetic. Data was collected at a paediatric dental clinic associated with the University of Illinois, Chicago. Patients were screened by a telephone questionnaire assessing for coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS","2021","06","30","Evid Based Dent","Evidence-based dentistry","Adolescent; Aged; COVID-19; Chicago; Child; Cross-Sectional Studies; Female; Humans; Male; SARS-CoV-2","Keys","William","Consultant, Aberdeen Dental Hospital, Department of Restorative Dentistry, UK",NA
"5","34172908","10.1038/s41432-021-0183-1","Dental professionals' role in the fight against COVID-19: current evidence.","Data sources Five databases were used to search for articles: PubMed, Embase, Scopus, Web of Science and Cochrane.Study selection All articles with the relevant topics related to COVID-19 and limited to Italian and English Language (with available English abstract) were screened. Additionally, included articles were screened for relevant references.Date extraction and synthesis Two of the authors reviewed the titles and abstracts obtained from the search and screened for relevance. Databases wer","2021","06","30","Evid Based Dent","Evidence-based dentistry","Aerosols; COVID-19; Dentists; Hand Hygiene; Humans; SARS-CoV-2","Crowder","Lauren","Paediatric Department, Glasgow Dental Hospital, Glasgow, UK",NA
"6","34172907","10.1038/s41432-021-0184-0","Is SARS-CoV-2 present in the periodontium? A post-mortem study.","Aims To investigate the presence of SARS-CoV-2, the virus responsible for COVID-19 infection, in the periodontal tissues of deceased individuals with a positive SARS-CoV-2 nasopharyngeal swab test.Sample selection Seven deceased individuals, who were admitted to the intensive care unit of the Hospital das Clínicas of the Medicine School of Sao Paulo University for invasive mechanical ventilation following a positive nasopharyngeal COVID-19 test result, underwent a post-mortem examination. Indivi","2021","06","30","Evid Based Dent","Evidence-based dentistry","Adolescent; Adult; Aged; Brazil; COVID-19; Child; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Periodontium; SARS-CoV-2; Young Adult","Adam","Mohammed","University of Liverpool, Liverpool, UK",NA
"7","34172906","10.1038/s41432-021-0185-z","Exploring the relationship between COVID-19 and oral health by radiographic examination.","Design Analytical retrospective study aimed at revealing the relationship between dental damage stage (DD Stg) and the severity of COVID-19 disease. This study was conducted over four months between 10 March 2020 and 15 July 2020 at the University of Health Sciences department at the Abdulhamid Han Training and Research Hospital Dental Services in Turkey.Sample selection A total of 137 patients were included in this study taken from a cohort of 1,516 patients with a positive polymerase chain rea","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Humans; Oral Health; Retrospective Studies; SARS-CoV-2; Turkey","Kalsi","Hasneet K","Dental Core Trainee, Newcastle Dental Hospital, UK",NA
"8","34172906","10.1038/s41432-021-0185-z","Exploring the relationship between COVID-19 and oral health by radiographic examination.","Design Analytical retrospective study aimed at revealing the relationship between dental damage stage (DD Stg) and the severity of COVID-19 disease. This study was conducted over four months between 10 March 2020 and 15 July 2020 at the University of Health Sciences department at the Abdulhamid Han Training and Research Hospital Dental Services in Turkey.Sample selection A total of 137 patients were included in this study taken from a cohort of 1,516 patients with a positive polymerase chain rea","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Humans; Oral Health; Retrospective Studies; SARS-CoV-2; Turkey","Carr","Andrew","Clinical Teaching Fellow, School of Dental Sciences, Newcastle University, UK",NA
"9","34172904","10.1038/s41432-021-0168-0","COVID-19: dental aerosol contamination in open plan dental clinics and future implications.","Study design An experimental study design was used to investigate the spread of splatter/aerosol during simulated dental procedures on a mannequin in open plan clinic and dental clinical teaching laboratory settings. All experiments were based on crown preparation of an artificial maxillary central incisor using a high-speed air turbine over a ten-minute period. Fluorescein dye was introduced into the irrigation system of the handpiece (model 1) and the mannequin's mouth was used to simulate sal","2021","06","30","Evid Based Dent","Evidence-based dentistry","Aerosols; COVID-19; Dental Clinics; Humans; SARS-CoV-2; Suction","Ali","Kamran","University of Plymouth Peninsula Dental School, Plymouth, UK",NA
"10","34172904","10.1038/s41432-021-0168-0","COVID-19: dental aerosol contamination in open plan dental clinics and future implications.","Study design An experimental study design was used to investigate the spread of splatter/aerosol during simulated dental procedures on a mannequin in open plan clinic and dental clinical teaching laboratory settings. All experiments were based on crown preparation of an artificial maxillary central incisor using a high-speed air turbine over a ten-minute period. Fluorescein dye was introduced into the irrigation system of the handpiece (model 1) and the mannequin's mouth was used to simulate sal","2021","06","30","Evid Based Dent","Evidence-based dentistry","Aerosols; COVID-19; Dental Clinics; Humans; SARS-CoV-2; Suction","Raja","Mahwish","Newcastle University, Newcastle upon Tyne, UK",NA
"11","34172903","10.1038/s41432-021-0170-6","Should photographic triage become common practice?","Design Cross-sectional, exploratory study collecting photographic referral data over three months.Sample selection Paediatric referrals to the orthodontic and maxillofacial department at Alder Hey Hospital during the COVID-19 pandemic.Data analysis Photographic referrals were analysed using Microsoft Excel to determine treatment outcomes, including 'not to see', 'plan to see' and 'need to see'. Demographic information collected and analysed were patient age, gender, referral source and presentin","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Child; Cross-Sectional Studies; Humans; Pandemics; Referral and Consultation; SARS-CoV-2; Triage","Thomas","Nicole","Faculty of Health, University of Plymouth, Plymouth, UK",NA
"12","34172902","10.1038/s41432-021-0171-5","Do aspirating systems have a role in preventing COVID-19 transmission among dental healthcare workers?","Aim The aim of this retrospective cohort study was to determine and compare the seropositivity rates of SARS-CoV-2 among dental healthcare workers (HCWs) working in three different clinics using different types of aspirating systems. The study took place in Ekaterinburg (Russian Federation).Methods A total of 157 HCWs from three different clinics (56, 60 and 41 HCWs, respectively) who worked during the COVID-19 pandemic period (May to August 2020) constituted the cohort. All of the three chosen ","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Health Personnel; Humans; Pandemics; Retrospective Studies; Russia; SARS-CoV-2; Seroepidemiologic Studies","Gugnani","Neeraj","Department of Paedodontics and Preventive Dentistry, DAV (C) Dental College Yamunanagar, Haryana, India",NA
"13","34172902","10.1038/s41432-021-0171-5","Do aspirating systems have a role in preventing COVID-19 transmission among dental healthcare workers?","Aim The aim of this retrospective cohort study was to determine and compare the seropositivity rates of SARS-CoV-2 among dental healthcare workers (HCWs) working in three different clinics using different types of aspirating systems. The study took place in Ekaterinburg (Russian Federation).Methods A total of 157 HCWs from three different clinics (56, 60 and 41 HCWs, respectively) who worked during the COVID-19 pandemic period (May to August 2020) constituted the cohort. All of the three chosen ","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Health Personnel; Humans; Pandemics; Retrospective Studies; Russia; SARS-CoV-2; Seroepidemiologic Studies","Gugnani","Shalini","Department of Periodontics and Oral Implantology, DAV (C) Dental College Yamunanagar, Haryana, India",NA
"14","34172901","10.1038/s41432-021-0169-z","Could dentists be the first to diagnose COVID-19 due to oral manifestations?","Data sources A search of electronic databases (PubMed and Google Scholar) was carried out, with publication being set from 2019 to October 2020.Study selection Titles and abstracts from the original search were reviewed by two reviewers independently. Overall, 17 studies were included in the final analysis.Data extraction and synthesis Data extraction was conducted independently by two reviewers. Studies that were chosen were examined and the following data parameters were included: age and gend","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; COVID-19 Testing; Dentists; False Negative Reactions; Humans; SARS-CoV-2","Coll","Yasmine","DCT2, Oral and Maxillofacial Surgery, Crosshouse Hospital, Kilmarnock, UK",NA
"15","34172901","10.1038/s41432-021-0169-z","Could dentists be the first to diagnose COVID-19 due to oral manifestations?","Data sources A search of electronic databases (PubMed and Google Scholar) was carried out, with publication being set from 2019 to October 2020.Study selection Titles and abstracts from the original search were reviewed by two reviewers independently. Overall, 17 studies were included in the final analysis.Data extraction and synthesis Data extraction was conducted independently by two reviewers. Studies that were chosen were examined and the following data parameters were included: age and gend","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; COVID-19 Testing; Dentists; False Negative Reactions; Humans; SARS-CoV-2","Elmahgoub","Fatima","DCT3, Oral and Maxillofacial Surgery, Crosshouse Hospital, Kilmarnock, UK",NA
"16","34172868","10.1038/s41415-021-3176-8","Dental education during the pandemic - how effective?",NA,"2021","07","09","Br Dent J","British dental journal","COVID-19; Education, Dental; Humans; Pandemics","Wadia","Reena","Specialist Periodontist at RW Perio and Associate Specialist at King's College Dental Hospital, London, UK",NA
"17","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Lombardi","Andrea","Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy. andrea.lombardi@policlinico.mi","andrea.lombardi@policlinico.mi.it"
"18","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Duiella","Silvia","Unit of Obstetric, Dept of Woman Child and Neonate, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Mangiagalli Centre, University of Milan, Milan, Italy",NA
"19","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Piani","Letizia Li","Unit of Obstetric, Dept of Woman Child and Neonate, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Mangiagalli Centre, University of Milan, Milan, Italy",NA
"20","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Comelli","Agnese","Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy",NA
"21","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Ceriotti","Ferruccio","Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"22","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Oggioni","Massimo","Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"23","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Muscatello","Antonio","Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy",NA
"24","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Bandera","Alessandra","Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy",NA
"25","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Gori","Andrea","Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy",NA
"26","34172816","10.1038/s41598-021-92885-7","Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease affecting also obstetric patients and uncertainties exist about the prognostic role of inflammatory biomarkers and hemocytometry values in patients with this infection. To clarify that, we have assessed the values of several inflammatory biomarkers and hemocytometry variables in a cohort of obstetric patients hospitalized with COVID-19 and we have correlated the values at admission with the need of oxygen supplementation during the ","2021","07","07","Sci Rep","Scientific reports","Adult; Biomarkers; C-Reactive Protein; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Lymphocytes; Pregnancy; Retrospective Studies","Ferrazzi","Enrico","Unit of Obstetric, Dept of Woman Child and Neonate, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Mangiagalli Centre, University of Milan, Milan, Italy",NA
"27","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Magomedov","Abakar","Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany",NA
"28","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Zickler","Daniel","Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany",NA
"29","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Karaivanov","Stoyan","Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany",NA
"30","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Kurreck","Annika","Department of Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany",NA
"31","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Münch","Frédéric H","Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany",NA
"32","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Kamhieh-Milz","Julian","Department of Transfusion Medince, Universitätsmedizin Berlin, Berlin, Germany",NA
"33","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Ferse","Caroline","Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany",NA
"34","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Kahl","Andreas","Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany",NA
"35","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Piper","Sophie K","Institute of Biometry and Clinical Epidemiology, Charité-Universitätmedizin Berlin, Berlin, Germany",NA
"36","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Eckardt","Kai-Uwe","Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany",NA
"37","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Dörner","Thomas","Department of Rheumatology und Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany",NA
"38","34172793","10.1038/s41598-021-92683-1","Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19.","COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used viscoelastic rotational thrombelastometry (ROTEM) in a single center cohort of 13 critical ill patients and performed follow up examinations three months after discharge from ICU. We found clear signs of a hypercoagulable state due to severe hypofibrinolysis ","2021","07","07","Sci Rep","Scientific reports","Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thrombelastography; Thromboembolism; Venous Thrombosis","Kruse","Jan Matthias","Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. jan-matthias.kruse@charite","matthias.kruse@charite.de"
"39","34172790","10.1038/s41598-021-92734-7","Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.","Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described. However, angiotensin-converting enzyme 2 (ACE2), responsible for host entry of the novel coronavirus (SARS-CoV-2) leading to COVID-19, is postulated to be upregulated in patients taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Here, we evaluated the occurrence of pulmonary ad","2021","07","07","Sci Rep","Scientific reports","Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Comorbidity; Hospital Mortality; Humans; Hypertension; Indoles; Quinapril; Retrospective Studies","Jaberi-Douraki","Majid","DATA Consortium, Manhattan, USA. jaberi@k-state",NA
"40","34172790","10.1038/s41598-021-92734-7","Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.","Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described. However, angiotensin-converting enzyme 2 (ACE2), responsible for host entry of the novel coronavirus (SARS-CoV-2) leading to COVID-19, is postulated to be upregulated in patients taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Here, we evaluated the occurrence of pulmonary ad","2021","07","07","Sci Rep","Scientific reports","Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Comorbidity; Hospital Mortality; Humans; Hypertension; Indoles; Quinapril; Retrospective Studies","Meyer","Emma","DATA Consortium, Manhattan, USA",NA
"41","34172790","10.1038/s41598-021-92734-7","Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.","Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described. However, angiotensin-converting enzyme 2 (ACE2), responsible for host entry of the novel coronavirus (SARS-CoV-2) leading to COVID-19, is postulated to be upregulated in patients taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Here, we evaluated the occurrence of pulmonary ad","2021","07","07","Sci Rep","Scientific reports","Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Comorbidity; Hospital Mortality; Humans; Hypertension; Indoles; Quinapril; Retrospective Studies","Riviere","Jim","DATA Consortium, Manhattan, USA",NA
"42","34172790","10.1038/s41598-021-92734-7","Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.","Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described. However, angiotensin-converting enzyme 2 (ACE2), responsible for host entry of the novel coronavirus (SARS-CoV-2) leading to COVID-19, is postulated to be upregulated in patients taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Here, we evaluated the occurrence of pulmonary ad","2021","07","07","Sci Rep","Scientific reports","Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Comorbidity; Hospital Mortality; Humans; Hypertension; Indoles; Quinapril; Retrospective Studies","Gedara","Nuwan Indika Millagaha","DATA Consortium, Manhattan, USA",NA
"43","34172790","10.1038/s41598-021-92734-7","Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.","Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described. However, angiotensin-converting enzyme 2 (ACE2), responsible for host entry of the novel coronavirus (SARS-CoV-2) leading to COVID-19, is postulated to be upregulated in patients taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Here, we evaluated the occurrence of pulmonary ad","2021","07","07","Sci Rep","Scientific reports","Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Comorbidity; Hospital Mortality; Humans; Hypertension; Indoles; Quinapril; Retrospective Studies","Kawakami","Jessica","DATA Consortium, Manhattan, USA",NA
"44","34172790","10.1038/s41598-021-92734-7","Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.","Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described. However, angiotensin-converting enzyme 2 (ACE2), responsible for host entry of the novel coronavirus (SARS-CoV-2) leading to COVID-19, is postulated to be upregulated in patients taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Here, we evaluated the occurrence of pulmonary ad","2021","07","07","Sci Rep","Scientific reports","Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Comorbidity; Hospital Mortality; Humans; Hypertension; Indoles; Quinapril; Retrospective Studies","Wyckoff","Gerald J","DATA Consortium, Manhattan, USA",NA
"45","34172790","10.1038/s41598-021-92734-7","Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.","Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described. However, angiotensin-converting enzyme 2 (ACE2), responsible for host entry of the novel coronavirus (SARS-CoV-2) leading to COVID-19, is postulated to be upregulated in patients taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Here, we evaluated the occurrence of pulmonary ad","2021","07","07","Sci Rep","Scientific reports","Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Comorbidity; Hospital Mortality; Humans; Hypertension; Indoles; Quinapril; Retrospective Studies","Xu","Xuan","DATA Consortium, Manhattan, USA",NA
"46","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Britton","Graham J","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"47","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Chen-Liaw","Alice","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"48","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Cossarini","Francesca","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"49","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Livanos","Alexandra E","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"50","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Spindler","Matthew P","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"51","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Plitt","Tamar","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"52","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Eggers","Joseph","Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"53","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Mogno","Ilaria","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"54","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Gonzalez-Reiche","Ana S","Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"55","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Siu","Sophia","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"56","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Tankelevich","Michael","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"57","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Grinspan","Lauren Tal","The Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"58","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Dixon","Rebekah E","The Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"59","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Jha","Divya","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"60","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","van de Guchte","Adriana","Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"61","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Khan","Zenab","Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"62","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Martinez-Delgado","Gustavo","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"63","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Amanat","Fatima","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"64","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Hoagland","Daisy A","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"65","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","tenOever","Benjamin R","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"66","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Dubinsky","Marla C","The Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"67","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Merad","Miriam","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"68","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","van Bakel","Harm","Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"69","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Krammer","Florian","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"70","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Bongers","Gerold","Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA",NA
"71","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Mehandru","Saurabh","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. saurabh.mehandru@mssm","saurabh.mehandru@mssm.edu"
"72","34172783","10.1038/s41598-021-92740-9","Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.","Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of obtaining biopsy specimens from infected individuals. In lieu of tissue samples, we measured cytokines, inflammatory markers, viral RNA, microbiome composition, and antibody responses in stool samples from a cohort of 44 hospitalized COVID-19 patients. SARS-CoV-2 RNA was detected in stool of 41% of patients and more freque","2021","07","07","Sci Rep","Scientific reports","Aged; Biomarkers; COVID-19; Cohort Studies; Cytokines; Feces; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Male; Middle Aged; Nasopharynx; New York City; RNA, Viral; SARS-CoV-2","Faith","Jeremiah J","Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. jeremiah.faith@mssm","jeremiah.faith@mssm.edu"
"73","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Lu","Furong","The Key Laboratory of Sepsis Translational Medicine, The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Minyou Road 12, Xiashan District, Zhanjiang City, 524001, Guangdong Province, People's Republic of China",NA
"74","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Chen","Hongpeng","The Department of Chemotherapy, Jieyang Affiliated Hospital, SunYat-Sen University, Jieyang, Guangdong, People's Republic of China",NA
"75","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Hong","Yuan","The Key Laboratory of Sepsis Translational Medicine, The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Minyou Road 12, Xiashan District, Zhanjiang City, 524001, Guangdong Province, People's Republic of China",NA
"76","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Lin","Yao","The Clinical Medicine Research Laboratory, The Intensive Care Unit, Jieyang Affiliated Hospital, SunYat-Sen University, Tianfu Road 107, Rongcheng District, Jieyang City, 522000, Guangdong Province, People's Republic of China",NA
"77","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Liu","Lizhen","The Key Laboratory of Sepsis Translational Medicine, The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Minyou Road 12, Xiashan District, Zhanjiang City, 524001, Guangdong Province, People's Republic of China",NA
"78","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Wei","Ning","The Key Laboratory of Sepsis Translational Medicine, The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Minyou Road 12, Xiashan District, Zhanjiang City, 524001, Guangdong Province, People's Republic of China",NA
"79","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Wu","Qinyan","The Key Laboratory of Sepsis Translational Medicine, The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Minyou Road 12, Xiashan District, Zhanjiang City, 524001, Guangdong Province, People's Republic of China",NA
"80","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Liao","Shuanglin","The Key Laboratory of Sepsis Translational Medicine, The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Minyou Road 12, Xiashan District, Zhanjiang City, 524001, Guangdong Province, People's Republic of China",NA
"81","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Yang","Shuai","The Key Laboratory of Sepsis Translational Medicine, The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Minyou Road 12, Xiashan District, Zhanjiang City, 524001, Guangdong Province, People's Republic of China",NA
"82","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","He","Junbing","The Clinical Medicine Research Laboratory, The Intensive Care Unit, Jieyang Affiliated Hospital, SunYat-Sen University, Tianfu Road 107, Rongcheng District, Jieyang City, 522000, Guangdong Province, People's Republic of China. junbinghe_gmc@163","gmc@163.com"
"83","34172780","10.1038/s41598-021-92547-8","A gain-of-function NLRP3 3'-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression.","Nucleotide-binding domain and leucine-rich repeat (LRR)-containing family protein 3 (NLRP3) regulated the maturation of inflammation-related cytokines by forming NLRP3 inflammasome, which plays pivotal roles in sepsis pathogenesis. In this study, we evaluated the genetic association of NLRP3 polymorphisms with sepsis (640 patients and 769 controls) and characterized the impact of NLRP3 polymorphisms on NLRP3 expression and inflammatory responses. No significant differences were observed in genot","2021","07","07","Sci Rep","Scientific reports","China; Cytokines; Disease Progression; Disease Susceptibility; Female; Gain of Function Mutation; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Male; MicroRNAs; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Polymorphism, Genetic; Sepsis; THP-1 Cells","Shao","Yiming","The Key Laboratory of Sepsis Translational Medicine, The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Minyou Road 12, Xiashan District, Zhanjiang City, 524001, Guangdong Province, People's Republic of China. sym@gdmu.edu","sym@gdmu.edu.cn"
"84","34172764","10.1038/s41598-021-92253-5","Inter-provincial disparity of COVID-19 transmission and control in Nepal.","Despite the global efforts to mitigate the ongoing COVID-19 pandemic, the disease transmission and the effective controls still remain uncertain as the outcome of the epidemic varies from place to place. In this regard, the province-wise data from Nepal provides a unique opportunity to study the effective control strategies. This is because (a) some provinces of Nepal share an open-border with India, resulting in a significantly high inflow of COVID-19 cases from India; (b) despite the inflow of","2021","07","07","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Government Programs; Humans; Nepal; Pandemics","Pantha","Buddhi","Department of Science and Mathematics, Abraham Baldwin Agricultural College, Tifton, GA, 31793, USA",NA
"85","34172764","10.1038/s41598-021-92253-5","Inter-provincial disparity of COVID-19 transmission and control in Nepal.","Despite the global efforts to mitigate the ongoing COVID-19 pandemic, the disease transmission and the effective controls still remain uncertain as the outcome of the epidemic varies from place to place. In this regard, the province-wise data from Nepal provides a unique opportunity to study the effective control strategies. This is because (a) some provinces of Nepal share an open-border with India, resulting in a significantly high inflow of COVID-19 cases from India; (b) despite the inflow of","2021","07","07","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Government Programs; Humans; Nepal; Pandemics","Acharya","Subas","Department of Mathematical Sciences, University of Texas at Dallas, Dallas, TX, USA",NA
"86","34172764","10.1038/s41598-021-92253-5","Inter-provincial disparity of COVID-19 transmission and control in Nepal.","Despite the global efforts to mitigate the ongoing COVID-19 pandemic, the disease transmission and the effective controls still remain uncertain as the outcome of the epidemic varies from place to place. In this regard, the province-wise data from Nepal provides a unique opportunity to study the effective control strategies. This is because (a) some provinces of Nepal share an open-border with India, resulting in a significantly high inflow of COVID-19 cases from India; (b) despite the inflow of","2021","07","07","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Government Programs; Humans; Nepal; Pandemics","Joshi","Hem Raj","Department of Mathematics, Xavier University, Cincinnati, OH, USA",NA
"87","34172764","10.1038/s41598-021-92253-5","Inter-provincial disparity of COVID-19 transmission and control in Nepal.","Despite the global efforts to mitigate the ongoing COVID-19 pandemic, the disease transmission and the effective controls still remain uncertain as the outcome of the epidemic varies from place to place. In this regard, the province-wise data from Nepal provides a unique opportunity to study the effective control strategies. This is because (a) some provinces of Nepal share an open-border with India, resulting in a significantly high inflow of COVID-19 cases from India; (b) despite the inflow of","2021","07","07","Sci Rep","Scientific reports","Basic Reproduction Number; COVID-19; Government Programs; Humans; Nepal; Pandemics","Vaidya","Naveen K","Department of Mathematics and Statistics, San Diego State University, San Diego, CA, USA. nvaidya@sdsu","nvaidya@sdsu.edu"
"88","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Adetifa","Ifedayo M O","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. IAdetifa@kemri-wellcome",NA
"89","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Uyoga","Sophie","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. SUyoga@kemri-wellcome",NA
"90","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Gitonga","John N","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"91","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Mugo","Daisy","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"92","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Otiende","Mark","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"93","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Nyagwange","James","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"94","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Karanja","Henry K","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"95","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Tuju","James","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"96","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Wanjiku","Perpetual","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"97","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Aman","Rashid","Ministry of Health, Government of Kenya, Nairobi, Kenya",NA
"98","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Mwangangi","Mercy","Ministry of Health, Government of Kenya, Nairobi, Kenya",NA
"99","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Amoth","Patrick","Ministry of Health, Government of Kenya, Nairobi, Kenya",NA
"100","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Kasera","Kadondi","Ministry of Health, Government of Kenya, Nairobi, Kenya",NA
"101","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Ng'ang'a","Wangari","Presidential Policy &amp",NA
"102","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Rombo","Charles","Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya",NA
"103","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Yegon","Christine","Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya",NA
"104","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Kithi","Khamisi","Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya",NA
"105","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Odhiambo","Elizabeth","Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya",NA
"106","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Rotich","Thomas","Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya",NA
"107","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Orgut","Irene","Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya",NA
"108","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Kihara","Sammy","Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya",NA
"109","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Bottomley","Christian","Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom",NA
"110","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Kagucia","Eunice W","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"111","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Gallagher","Katherine E","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"112","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Etyang","Anthony","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"113","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Voller","Shirine","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"114","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Lambe","Teresa","Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom",NA
"115","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Wright","Daniel","Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom",NA
"116","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Barasa","Edwine","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"117","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Tsofa","Benjamin","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"118","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Bejon","Philip","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"119","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Ochola-Oyier","Lynette I","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"120","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Agweyu","Ambrose","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"121","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Scott","J Anthony G","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"122","34172732","10.1038/s41467-021-24062-3","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with appa","2021","07","19","Nat Commun","Nature communications","Adolescent; Adult; Antibodies, Viral; Bayes Theorem; COVID-19; Enzyme-Linked Immunosorbent Assay; Epidemics; Female; Humans; Immunoglobulin G; Kenya; Male; Middle Aged; Prevalence; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Warimwe","George M","KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",NA
"123","34172713","10.47665/tb.38.2.060","In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.","Corona virus SARS-CoV-2-induced viral disease (COVID-19) is a zoonotic disease that was initially transmitted from animals to humans. The virus surfaced towards the end of December 2019 in Wuhan, China where earlier SARS (Severe Acute Respiratory Syndrome) had also surfaced in 2003. Unlike SARS, SARS-CoV-2 (a close relative of the SARS virus) created a pandemic, and as of February 24 2021, caused 112,778,672 infections and 2,499,252 deaths world-wide. Despite the best efforts of scientists, no d","2021","07","06","Trop Biomed","Tropical biomedicine","Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus 3C Proteases; Humans; Molecular Docking Simulation; Onions; Phytochemicals; Protein Binding; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Bondhon","T A","Department of Biotechnology and Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka-1207, Bangladesh",NA
"124","34172713","10.47665/tb.38.2.060","In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.","Corona virus SARS-CoV-2-induced viral disease (COVID-19) is a zoonotic disease that was initially transmitted from animals to humans. The virus surfaced towards the end of December 2019 in Wuhan, China where earlier SARS (Severe Acute Respiratory Syndrome) had also surfaced in 2003. Unlike SARS, SARS-CoV-2 (a close relative of the SARS virus) created a pandemic, and as of February 24 2021, caused 112,778,672 infections and 2,499,252 deaths world-wide. Despite the best efforts of scientists, no d","2021","07","06","Trop Biomed","Tropical biomedicine","Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus 3C Proteases; Humans; Molecular Docking Simulation; Onions; Phytochemicals; Protein Binding; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Fatima","A","Quest International University Perak, Ipoh, Malaysia",NA
"125","34172713","10.47665/tb.38.2.060","In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.","Corona virus SARS-CoV-2-induced viral disease (COVID-19) is a zoonotic disease that was initially transmitted from animals to humans. The virus surfaced towards the end of December 2019 in Wuhan, China where earlier SARS (Severe Acute Respiratory Syndrome) had also surfaced in 2003. Unlike SARS, SARS-CoV-2 (a close relative of the SARS virus) created a pandemic, and as of February 24 2021, caused 112,778,672 infections and 2,499,252 deaths world-wide. Despite the best efforts of scientists, no d","2021","07","06","Trop Biomed","Tropical biomedicine","Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus 3C Proteases; Humans; Molecular Docking Simulation; Onions; Phytochemicals; Protein Binding; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Jannat","K","Department of Biotechnology and Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka-1207, Bangladesh",NA
"126","34172713","10.47665/tb.38.2.060","In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.","Corona virus SARS-CoV-2-induced viral disease (COVID-19) is a zoonotic disease that was initially transmitted from animals to humans. The virus surfaced towards the end of December 2019 in Wuhan, China where earlier SARS (Severe Acute Respiratory Syndrome) had also surfaced in 2003. Unlike SARS, SARS-CoV-2 (a close relative of the SARS virus) created a pandemic, and as of February 24 2021, caused 112,778,672 infections and 2,499,252 deaths world-wide. Despite the best efforts of scientists, no d","2021","07","06","Trop Biomed","Tropical biomedicine","Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus 3C Proteases; Humans; Molecular Docking Simulation; Onions; Phytochemicals; Protein Binding; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Hasan","A","Department of Biotechnology and Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka-1207, Bangladesh",NA
"127","34172713","10.47665/tb.38.2.060","In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.","Corona virus SARS-CoV-2-induced viral disease (COVID-19) is a zoonotic disease that was initially transmitted from animals to humans. The virus surfaced towards the end of December 2019 in Wuhan, China where earlier SARS (Severe Acute Respiratory Syndrome) had also surfaced in 2003. Unlike SARS, SARS-CoV-2 (a close relative of the SARS virus) created a pandemic, and as of February 24 2021, caused 112,778,672 infections and 2,499,252 deaths world-wide. Despite the best efforts of scientists, no d","2021","07","06","Trop Biomed","Tropical biomedicine","Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus 3C Proteases; Humans; Molecular Docking Simulation; Onions; Phytochemicals; Protein Binding; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Jahan","R","Department of Biotechnology and Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka-1207, Bangladesh",NA
"128","34172713","10.47665/tb.38.2.060","In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.","Corona virus SARS-CoV-2-induced viral disease (COVID-19) is a zoonotic disease that was initially transmitted from animals to humans. The virus surfaced towards the end of December 2019 in Wuhan, China where earlier SARS (Severe Acute Respiratory Syndrome) had also surfaced in 2003. Unlike SARS, SARS-CoV-2 (a close relative of the SARS virus) created a pandemic, and as of February 24 2021, caused 112,778,672 infections and 2,499,252 deaths world-wide. Despite the best efforts of scientists, no d","2021","07","06","Trop Biomed","Tropical biomedicine","Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus 3C Proteases; Humans; Molecular Docking Simulation; Onions; Phytochemicals; Protein Binding; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Nissapatorn","V","chool of Allied Health Sciences, World Union for Herbal Drug Discovery (WUHeDD), and Research Excellence Center for Innovation and Health Products (RECIHP), Walailak University, Nakhon Si Thammarat, Thailand",NA
"129","34172713","10.47665/tb.38.2.060","In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.","Corona virus SARS-CoV-2-induced viral disease (COVID-19) is a zoonotic disease that was initially transmitted from animals to humans. The virus surfaced towards the end of December 2019 in Wuhan, China where earlier SARS (Severe Acute Respiratory Syndrome) had also surfaced in 2003. Unlike SARS, SARS-CoV-2 (a close relative of the SARS virus) created a pandemic, and as of February 24 2021, caused 112,778,672 infections and 2,499,252 deaths world-wide. Despite the best efforts of scientists, no d","2021","07","06","Trop Biomed","Tropical biomedicine","Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus 3C Proteases; Humans; Molecular Docking Simulation; Onions; Phytochemicals; Protein Binding; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Wiart","C","School of Pharmacy, University of Nottingham Malaysia Campus, Selangor, Malaysia",NA
"130","34172713","10.47665/tb.38.2.060","In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.","Corona virus SARS-CoV-2-induced viral disease (COVID-19) is a zoonotic disease that was initially transmitted from animals to humans. The virus surfaced towards the end of December 2019 in Wuhan, China where earlier SARS (Severe Acute Respiratory Syndrome) had also surfaced in 2003. Unlike SARS, SARS-CoV-2 (a close relative of the SARS virus) created a pandemic, and as of February 24 2021, caused 112,778,672 infections and 2,499,252 deaths world-wide. Despite the best efforts of scientists, no d","2021","07","06","Trop Biomed","Tropical biomedicine","Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus 3C Proteases; Humans; Molecular Docking Simulation; Onions; Phytochemicals; Protein Binding; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Pereira","M L","CICECO-Aveiro Institute of Materials and Department of Medical Sciences, University of Aveiro, Aveiro, Portugal",NA
"131","34172713","10.47665/tb.38.2.060","In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.","Corona virus SARS-CoV-2-induced viral disease (COVID-19) is a zoonotic disease that was initially transmitted from animals to humans. The virus surfaced towards the end of December 2019 in Wuhan, China where earlier SARS (Severe Acute Respiratory Syndrome) had also surfaced in 2003. Unlike SARS, SARS-CoV-2 (a close relative of the SARS virus) created a pandemic, and as of February 24 2021, caused 112,778,672 infections and 2,499,252 deaths world-wide. Despite the best efforts of scientists, no d","2021","07","06","Trop Biomed","Tropical biomedicine","Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus 3C Proteases; Humans; Molecular Docking Simulation; Onions; Phytochemicals; Protein Binding; Receptors, Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Rahmatullah","M","Department of Biotechnology and Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka-1207, Bangladesh",NA
"132","34172701","10.47665/tb.38.2.048","Potential severe pediatric SARS-CoV-2-induced multisystem inflammatory syndrome resembles dengue infection.","We describe a child with acute fever and abdominal pain who developed rash and edema of extremities. Blood test revealed thrombocytopenia, lymphopenia, positive dengue-IgM, and hypoalbuminemia with elevated procalcitonin. Right pleural effusion revealed from chest x-ray. Diagnosed as dengue hemorrhagic fever (DHF) grade 1, however, at 7<sup>th</sup> day of illness, altered mental status, respiratory and circulatory failure occurred. Laboratory examination showed marked thrombocytopenia, transami","2021","07","06","Trop Biomed","Tropical biomedicine","COVID-19; Child; Critical Care; Dengue Virus; Diagnosis, Differential; Diagnostic Errors; Female; Humans; SARS-CoV-2; Severe Dengue; Systemic Inflammatory Response Syndrome","Yuliarto","S","Department of Pediatrics, Saiful Anwar General Hospital, Universitas Brawijaya Malang, Indonesia",NA
"133","34172701","10.47665/tb.38.2.048","Potential severe pediatric SARS-CoV-2-induced multisystem inflammatory syndrome resembles dengue infection.","We describe a child with acute fever and abdominal pain who developed rash and edema of extremities. Blood test revealed thrombocytopenia, lymphopenia, positive dengue-IgM, and hypoalbuminemia with elevated procalcitonin. Right pleural effusion revealed from chest x-ray. Diagnosed as dengue hemorrhagic fever (DHF) grade 1, however, at 7<sup>th</sup> day of illness, altered mental status, respiratory and circulatory failure occurred. Laboratory examination showed marked thrombocytopenia, transami","2021","07","06","Trop Biomed","Tropical biomedicine","COVID-19; Child; Critical Care; Dengue Virus; Diagnosis, Differential; Diagnostic Errors; Female; Humans; SARS-CoV-2; Severe Dengue; Systemic Inflammatory Response Syndrome","Susanto","W P","Department of Pediatrics, Saiful Anwar General Hospital, Universitas Brawijaya Malang, Indonesia",NA
"134","34172701","10.47665/tb.38.2.048","Potential severe pediatric SARS-CoV-2-induced multisystem inflammatory syndrome resembles dengue infection.","We describe a child with acute fever and abdominal pain who developed rash and edema of extremities. Blood test revealed thrombocytopenia, lymphopenia, positive dengue-IgM, and hypoalbuminemia with elevated procalcitonin. Right pleural effusion revealed from chest x-ray. Diagnosed as dengue hemorrhagic fever (DHF) grade 1, however, at 7<sup>th</sup> day of illness, altered mental status, respiratory and circulatory failure occurred. Laboratory examination showed marked thrombocytopenia, transami","2021","07","06","Trop Biomed","Tropical biomedicine","COVID-19; Child; Critical Care; Dengue Virus; Diagnosis, Differential; Diagnostic Errors; Female; Humans; SARS-CoV-2; Severe Dengue; Systemic Inflammatory Response Syndrome","Kadafi","K T","Department of Pediatrics, Saiful Anwar General Hospital, Universitas Brawijaya Malang, Indonesia",NA
"135","34172701","10.47665/tb.38.2.048","Potential severe pediatric SARS-CoV-2-induced multisystem inflammatory syndrome resembles dengue infection.","We describe a child with acute fever and abdominal pain who developed rash and edema of extremities. Blood test revealed thrombocytopenia, lymphopenia, positive dengue-IgM, and hypoalbuminemia with elevated procalcitonin. Right pleural effusion revealed from chest x-ray. Diagnosed as dengue hemorrhagic fever (DHF) grade 1, however, at 7<sup>th</sup> day of illness, altered mental status, respiratory and circulatory failure occurred. Laboratory examination showed marked thrombocytopenia, transami","2021","07","06","Trop Biomed","Tropical biomedicine","COVID-19; Child; Critical Care; Dengue Virus; Diagnosis, Differential; Diagnostic Errors; Female; Humans; SARS-CoV-2; Severe Dengue; Systemic Inflammatory Response Syndrome","Ratridewi","I","Department of Pediatrics, Saiful Anwar General Hospital, Universitas Brawijaya Malang, Indonesia",NA
"136","34172701","10.47665/tb.38.2.048","Potential severe pediatric SARS-CoV-2-induced multisystem inflammatory syndrome resembles dengue infection.","We describe a child with acute fever and abdominal pain who developed rash and edema of extremities. Blood test revealed thrombocytopenia, lymphopenia, positive dengue-IgM, and hypoalbuminemia with elevated procalcitonin. Right pleural effusion revealed from chest x-ray. Diagnosed as dengue hemorrhagic fever (DHF) grade 1, however, at 7<sup>th</sup> day of illness, altered mental status, respiratory and circulatory failure occurred. Laboratory examination showed marked thrombocytopenia, transami","2021","07","06","Trop Biomed","Tropical biomedicine","COVID-19; Child; Critical Care; Dengue Virus; Diagnosis, Differential; Diagnostic Errors; Female; Humans; SARS-CoV-2; Severe Dengue; Systemic Inflammatory Response Syndrome","Olivianto","E","Department of Pediatrics, Saiful Anwar General Hospital, Universitas Brawijaya Malang, Indonesia",NA
"137","34172696","10.47665/tb.38.2.038","Shift in parasitic infections during the Corona pandemic: a hospital-based retrospective study.","The Corona pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) calls on the Saudi government to take action to control the infection. The government closed borders, prohibited travel, limited outdoor movements, and told primary and secondary care facilities to reduce all regular non-urgent health services. It is not known whether these measures have impacted the prevalence of parasitic intestinal infections. This study has therefore been carried out to investigate ","2021","07","06","Trop Biomed","Tropical biomedicine","Adolescent; Animals; COVID-19; Child; Child, Preschool; Communicable Disease Control; Feces; Female; Helminthiasis; Helminths; Humans; Intestinal Diseases, Parasitic; Male; Protozoan Infections; Retrospective Studies; SARS-CoV-2; Saudi Arabia","Hawash","Y","Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia",NA
"138","34172696","10.47665/tb.38.2.038","Shift in parasitic infections during the Corona pandemic: a hospital-based retrospective study.","The Corona pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) calls on the Saudi government to take action to control the infection. The government closed borders, prohibited travel, limited outdoor movements, and told primary and secondary care facilities to reduce all regular non-urgent health services. It is not known whether these measures have impacted the prevalence of parasitic intestinal infections. This study has therefore been carried out to investigate ","2021","07","06","Trop Biomed","Tropical biomedicine","Adolescent; Animals; COVID-19; Child; Child, Preschool; Communicable Disease Control; Feces; Female; Helminthiasis; Helminths; Humans; Intestinal Diseases, Parasitic; Male; Protozoan Infections; Retrospective Studies; SARS-CoV-2; Saudi Arabia","Ismail","K H","Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia",NA
"139","34172696","10.47665/tb.38.2.038","Shift in parasitic infections during the Corona pandemic: a hospital-based retrospective study.","The Corona pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) calls on the Saudi government to take action to control the infection. The government closed borders, prohibited travel, limited outdoor movements, and told primary and secondary care facilities to reduce all regular non-urgent health services. It is not known whether these measures have impacted the prevalence of parasitic intestinal infections. This study has therefore been carried out to investigate ","2021","07","06","Trop Biomed","Tropical biomedicine","Adolescent; Animals; COVID-19; Child; Child, Preschool; Communicable Disease Control; Feces; Female; Helminthiasis; Helminths; Humans; Intestinal Diseases, Parasitic; Male; Protozoan Infections; Retrospective Studies; SARS-CoV-2; Saudi Arabia","Abdel-Wahab","M","Department of Medical Microbiology, King Faisal Medical Complex, Taif, KSA",NA
"140","34172647","10.1097/TP.0000000000003875","Successful Liver Transplantation From a Donation After Brain Death Donor With Cerebral Venous Sinus and Hepatic Veins Thrombosis Occurred After ChAdOx1 nCov-19 Vaccination.",NA,"2021","06","26","Transplantation","Transplantation",NA,"Centonze","Leonardo","Department of General Surgery and Transplantation, Niguarda Ca' Granda Hospital, Milan, Italy School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy",NA
"141","34172647","10.1097/TP.0000000000003875","Successful Liver Transplantation From a Donation After Brain Death Donor With Cerebral Venous Sinus and Hepatic Veins Thrombosis Occurred After ChAdOx1 nCov-19 Vaccination.",NA,"2021","06","26","Transplantation","Transplantation",NA,"Lauterio","Andrea","Department of General Surgery and Transplantation, Niguarda Ca' Granda Hospital, Milan, Italy School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy",NA
"142","34172647","10.1097/TP.0000000000003875","Successful Liver Transplantation From a Donation After Brain Death Donor With Cerebral Venous Sinus and Hepatic Veins Thrombosis Occurred After ChAdOx1 nCov-19 Vaccination.",NA,"2021","06","26","Transplantation","Transplantation",NA,"De Carlis","Riccardo","Department of General Surgery and Transplantation, Niguarda Ca' Granda Hospital, Milan, Italy School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy",NA
"143","34172647","10.1097/TP.0000000000003875","Successful Liver Transplantation From a Donation After Brain Death Donor With Cerebral Venous Sinus and Hepatic Veins Thrombosis Occurred After ChAdOx1 nCov-19 Vaccination.",NA,"2021","06","26","Transplantation","Transplantation",NA,"Ferla","Fabio","Department of General Surgery and Transplantation, Niguarda Ca' Granda Hospital, Milan, Italy School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy",NA
"144","34172647","10.1097/TP.0000000000003875","Successful Liver Transplantation From a Donation After Brain Death Donor With Cerebral Venous Sinus and Hepatic Veins Thrombosis Occurred After ChAdOx1 nCov-19 Vaccination.",NA,"2021","06","26","Transplantation","Transplantation",NA,"De Carlis","Luciano","Department of General Surgery and Transplantation, Niguarda Ca' Granda Hospital, Milan, Italy School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy",NA
"145","34172625","10.1097/ADM.0000000000000874","During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio.","During the COVID-19 pandemic, states have had to confront a drug overdose problem associated with the pandemic. The objective of this study was to identify the impact of the COVID-19 pandemic on the opioid epidemic in the state of Ohio by describing the changes in the quarterly opioid overdose deaths (OOD) over the last 10 years. This longitudinal study included OOD data from death records obtained through the Ohio Department of Health. Temporal trend analysis and visualizations were performed o","2021","06","26","J Addict Med","Journal of addiction medicine",NA,"Vieson","Jamie","The Ohio Attorney General's Office, Columbus, OH (JV, JES)",NA
"146","34172625","10.1097/ADM.0000000000000874","During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio.","During the COVID-19 pandemic, states have had to confront a drug overdose problem associated with the pandemic. The objective of this study was to identify the impact of the COVID-19 pandemic on the opioid epidemic in the state of Ohio by describing the changes in the quarterly opioid overdose deaths (OOD) over the last 10 years. This longitudinal study included OOD data from death records obtained through the Ohio Department of Health. Temporal trend analysis and visualizations were performed o","2021","06","26","J Addict Med","Journal of addiction medicine",NA,"Yeh","Arthur B","The Ohio Attorney General's Office, Columbus, OH (JV, JES)",NA
"147","34172625","10.1097/ADM.0000000000000874","During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio.","During the COVID-19 pandemic, states have had to confront a drug overdose problem associated with the pandemic. The objective of this study was to identify the impact of the COVID-19 pandemic on the opioid epidemic in the state of Ohio by describing the changes in the quarterly opioid overdose deaths (OOD) over the last 10 years. This longitudinal study included OOD data from death records obtained through the Ohio Department of Health. Temporal trend analysis and visualizations were performed o","2021","06","26","J Addict Med","Journal of addiction medicine",NA,"Lan","Qizhen","The Ohio Attorney General's Office, Columbus, OH (JV, JES)",NA
"148","34172625","10.1097/ADM.0000000000000874","During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio.","During the COVID-19 pandemic, states have had to confront a drug overdose problem associated with the pandemic. The objective of this study was to identify the impact of the COVID-19 pandemic on the opioid epidemic in the state of Ohio by describing the changes in the quarterly opioid overdose deaths (OOD) over the last 10 years. This longitudinal study included OOD data from death records obtained through the Ohio Department of Health. Temporal trend analysis and visualizations were performed o","2021","06","26","J Addict Med","Journal of addiction medicine",NA,"Sprague","Jon E","The Ohio Attorney General's Office, Columbus, OH (JV, JES)",NA
"149","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Fernández","Sara","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"150","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Moreno-Castaño","Ana B","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"151","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Palomo","Marta","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"152","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Martinez-Sanchez","Julia","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"153","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Torramadé-Moix","Sergi","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"154","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Téllez","Adrián","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"155","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Ventosa","Helena","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"156","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Seguí","Ferran","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"157","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Escolar","Ginés","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"158","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Carreras","Enric","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"159","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Nicolás","Josep M","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"160","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Richardson","Edward","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"161","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"García-Bernal","David","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"162","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Carlo-Stella","Carmelo","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"163","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Moraleda","José M","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"164","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Richardson","Paul G","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"165","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Díaz-Ricart","Maribel","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"166","34172614","10.1097/SHK.0000000000001823","Distinctive Biomarker Features in The Endotheliopathy of COVID-19 and Septic Syndromes.","Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. To characterize circulating biomarkers of endothelial damage in different COVID-19 clinical disease stages compared with sepsis syndrome and normal volunteers. Patients with COVID-19 pneumonia (n = 49) were classified into moderate, severe, or critical (life-threatening) disease. Plasma s","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Castro","Pedro","Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain Barcelona Endothelium Team, Barcelona, Spain IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain School of Medicine, University of Barcelona, Barcelona, Spain Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut Department of Surgery, Yale University School of Medicine, New Haven, Connecticut Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts",NA
"167","34172612","10.1097/SHK.0000000000001825","Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights from Thrombosis and Hemostasis.","The pathomechanisms of hypoxemia and treatment strategies for type H and type L acute respiratory distress syndrome (ARDS) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 (COVID-19) have not been elucidated. SARS-CoV-2 mainly targets the lungs and blood, leading to ARDS, and systemic thrombosis or bleeding. Angiotensin II-induced coagulopathy, SARS-CoV-2-induced hyperfibrin(ogen)olysis, and pulmonary and/or disseminated intravascular coagulation d","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Gando","Satoshi","Acute and Critical Center, Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan",NA
"168","34172612","10.1097/SHK.0000000000001825","Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights from Thrombosis and Hemostasis.","The pathomechanisms of hypoxemia and treatment strategies for type H and type L acute respiratory distress syndrome (ARDS) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 (COVID-19) have not been elucidated. SARS-CoV-2 mainly targets the lungs and blood, leading to ARDS, and systemic thrombosis or bleeding. Angiotensin II-induced coagulopathy, SARS-CoV-2-induced hyperfibrin(ogen)olysis, and pulmonary and/or disseminated intravascular coagulation d","2021","06","26","Shock","Shock (Augusta, Ga.)",NA,"Wada","Takeshi","Acute and Critical Center, Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan",NA
"169","34172581","10.1073/pnas.2023947118","Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.","Globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 59 million people and killed more than 1.39 million. Designing and monitoring interventions to slow and stop the spread of the virus require knowledge of how many people have been and are currently infected, where they live, and how they interact. The first step is an accurate assessment of the population prevalence of past infections. There are very few population-representative prevalence studies of S","2021","07","05","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; SARS-CoV-2; coronavirus; imperfect diagnostic tests; seroprevalence survey; Adolescent; Adult; Aged; Bayes Theorem; COVID-19; COVID-19 Serological Testing; Female; Humans; Male; Middle Aged; Ohio; Prevalence; SARS-CoV-2; Seroepidemiologic Studies","Kline","David","Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH 43210","david.kline@osumc.edu"
"170","34172581","10.1073/pnas.2023947118","Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.","Globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 59 million people and killed more than 1.39 million. Designing and monitoring interventions to slow and stop the spread of the virus require knowledge of how many people have been and are currently infected, where they live, and how they interact. The first step is an accurate assessment of the population prevalence of past infections. There are very few population-representative prevalence studies of S","2021","07","05","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; SARS-CoV-2; coronavirus; imperfect diagnostic tests; seroprevalence survey; Adolescent; Adult; Aged; Bayes Theorem; COVID-19; COVID-19 Serological Testing; Female; Humans; Male; Middle Aged; Ohio; Prevalence; SARS-CoV-2; Seroepidemiologic Studies","Li","Zehang","Department of Statistics, University of California, Santa Cruz, CA 95064",NA
"171","34172581","10.1073/pnas.2023947118","Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.","Globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 59 million people and killed more than 1.39 million. Designing and monitoring interventions to slow and stop the spread of the virus require knowledge of how many people have been and are currently infected, where they live, and how they interact. The first step is an accurate assessment of the population prevalence of past infections. There are very few population-representative prevalence studies of S","2021","07","05","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; SARS-CoV-2; coronavirus; imperfect diagnostic tests; seroprevalence survey; Adolescent; Adult; Aged; Bayes Theorem; COVID-19; COVID-19 Serological Testing; Female; Humans; Male; Middle Aged; Ohio; Prevalence; SARS-CoV-2; Seroepidemiologic Studies","Chu","Yue","Department of Sociology, The Ohio State University, Columbus, OH 43210",NA
"172","34172581","10.1073/pnas.2023947118","Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.","Globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 59 million people and killed more than 1.39 million. Designing and monitoring interventions to slow and stop the spread of the virus require knowledge of how many people have been and are currently infected, where they live, and how they interact. The first step is an accurate assessment of the population prevalence of past infections. There are very few population-representative prevalence studies of S","2021","07","05","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; SARS-CoV-2; coronavirus; imperfect diagnostic tests; seroprevalence survey; Adolescent; Adult; Aged; Bayes Theorem; COVID-19; COVID-19 Serological Testing; Female; Humans; Male; Middle Aged; Ohio; Prevalence; SARS-CoV-2; Seroepidemiologic Studies","Wakefield","Jon","Department of Statistics, University of Washington, Seattle, WA 98195",NA
"173","34172581","10.1073/pnas.2023947118","Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.","Globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 59 million people and killed more than 1.39 million. Designing and monitoring interventions to slow and stop the spread of the virus require knowledge of how many people have been and are currently infected, where they live, and how they interact. The first step is an accurate assessment of the population prevalence of past infections. There are very few population-representative prevalence studies of S","2021","07","05","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; SARS-CoV-2; coronavirus; imperfect diagnostic tests; seroprevalence survey; Adolescent; Adult; Aged; Bayes Theorem; COVID-19; COVID-19 Serological Testing; Female; Humans; Male; Middle Aged; Ohio; Prevalence; SARS-CoV-2; Seroepidemiologic Studies","Miller","William C","Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH 43210",NA
"174","34172581","10.1073/pnas.2023947118","Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.","Globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 59 million people and killed more than 1.39 million. Designing and monitoring interventions to slow and stop the spread of the virus require knowledge of how many people have been and are currently infected, where they live, and how they interact. The first step is an accurate assessment of the population prevalence of past infections. There are very few population-representative prevalence studies of S","2021","07","05","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; SARS-CoV-2; coronavirus; imperfect diagnostic tests; seroprevalence survey; Adolescent; Adult; Aged; Bayes Theorem; COVID-19; COVID-19 Serological Testing; Female; Humans; Male; Middle Aged; Ohio; Prevalence; SARS-CoV-2; Seroepidemiologic Studies","Norris Turner","Abigail","Division of Infectious Diseases, College of Medicine, The Ohio State University, Columbus, OH 43210",NA
"175","34172581","10.1073/pnas.2023947118","Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.","Globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 59 million people and killed more than 1.39 million. Designing and monitoring interventions to slow and stop the spread of the virus require knowledge of how many people have been and are currently infected, where they live, and how they interact. The first step is an accurate assessment of the population prevalence of past infections. There are very few population-representative prevalence studies of S","2021","07","05","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; SARS-CoV-2; coronavirus; imperfect diagnostic tests; seroprevalence survey; Adolescent; Adult; Aged; Bayes Theorem; COVID-19; COVID-19 Serological Testing; Female; Humans; Male; Middle Aged; Ohio; Prevalence; SARS-CoV-2; Seroepidemiologic Studies","Clark","Samuel J","Department of Sociology, The Ohio State University, Columbus, OH 43210","david.kline@osumc.edu"
"176","34172551","10.1136/bmjopen-2021-049405","Discrimination as a predictor of poor mental health among LGBTQ+ people during the COVID-19 pandemic: cross-sectional analysis of the online Queerantine study.","To assess the mental health and experiences of discrimination among lesbian, gay, bisexual, transgender, queer (LGBTQ) people at the start of the COVID-19 pandemic. Data come from a cross-sectional online survey targeted at LGBTQ+ people, which collected data on mental health, experiences of discrimination and a number of other pandemic-related experiences. To examine the association between sexual orientation and gender and mental health and experiences of discrimination, we conducted regressio","2021","06","30","BMJ Open","BMJ open","COVID-19; mental health; social medicine; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Sexual and Gender Minorities","Kneale","Dylan","EPPI-Centre, UCL Social Research Institute, University College London, London, UK D.Kneale@ucl.ac","D.Kneale@ucl.ac.uk"
"177","34172551","10.1136/bmjopen-2021-049405","Discrimination as a predictor of poor mental health among LGBTQ+ people during the COVID-19 pandemic: cross-sectional analysis of the online Queerantine study.","To assess the mental health and experiences of discrimination among lesbian, gay, bisexual, transgender, queer (LGBTQ) people at the start of the COVID-19 pandemic. Data come from a cross-sectional online survey targeted at LGBTQ+ people, which collected data on mental health, experiences of discrimination and a number of other pandemic-related experiences. To examine the association between sexual orientation and gender and mental health and experiences of discrimination, we conducted regressio","2021","06","30","BMJ Open","BMJ open","COVID-19; mental health; social medicine; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Sexual and Gender Minorities","Bécares","Laia","Social Work and Social Care, University of Sussex, Falmer, Sussex, UK",NA
"178","34172549","10.1136/bmjopen-2020-047561","Hypertension is the major predictor of poor outcomes among inpatients with COVID-19 infection in the UK: a retrospective cohort study.","To assess the impact of diabetes, hypertension and cardiovascular diseases on inpatient mortality from COVID-19, and its relationship to ethnicity and social deprivation. Retrospective, single-centre observational study SETTING: Birmingham, UK. 907 hospitalised patients with laboratory-confirmed COVID-19 from a multi-ethnic community, admitted between 1 March 2020 and 31 May 2020. The primary analysis was an evaluation of cardiovascular conditions and diabetes in relation to ethnicity and social","2021","06","30","BMJ Open","BMJ open","COVID-19; epidemiology; general diabetes; hypertension; Aged; COVID-19; Comorbidity; Hospital Mortality; Hospitalization; Humans; Hypertension; Inpatients; Male; Retrospective Studies; Risk Factors; SARS-CoV-2; United Kingdom","Basu","Ansu","Diabetes, Endocrinology and Lipid Metabolism, Sandwell and West Birmingham NHS Trust, Birmingham, UK ansu.basu@nhs","ansu.basu@nhs.net"
"179","34172549","10.1136/bmjopen-2020-047561","Hypertension is the major predictor of poor outcomes among inpatients with COVID-19 infection in the UK: a retrospective cohort study.","To assess the impact of diabetes, hypertension and cardiovascular diseases on inpatient mortality from COVID-19, and its relationship to ethnicity and social deprivation. Retrospective, single-centre observational study SETTING: Birmingham, UK. 907 hospitalised patients with laboratory-confirmed COVID-19 from a multi-ethnic community, admitted between 1 March 2020 and 31 May 2020. The primary analysis was an evaluation of cardiovascular conditions and diabetes in relation to ethnicity and social","2021","06","30","BMJ Open","BMJ open","COVID-19; epidemiology; general diabetes; hypertension; Aged; COVID-19; Comorbidity; Hospital Mortality; Hospitalization; Humans; Hypertension; Inpatients; Male; Retrospective Studies; Risk Factors; SARS-CoV-2; United Kingdom","Agwu","Juliana Chizo","Paediatrics, Sandwell and West Birmingham NHS Trust, Birmingham, UK",NA
"180","34172549","10.1136/bmjopen-2020-047561","Hypertension is the major predictor of poor outcomes among inpatients with COVID-19 infection in the UK: a retrospective cohort study.","To assess the impact of diabetes, hypertension and cardiovascular diseases on inpatient mortality from COVID-19, and its relationship to ethnicity and social deprivation. Retrospective, single-centre observational study SETTING: Birmingham, UK. 907 hospitalised patients with laboratory-confirmed COVID-19 from a multi-ethnic community, admitted between 1 March 2020 and 31 May 2020. The primary analysis was an evaluation of cardiovascular conditions and diabetes in relation to ethnicity and social","2021","06","30","BMJ Open","BMJ open","COVID-19; epidemiology; general diabetes; hypertension; Aged; COVID-19; Comorbidity; Hospital Mortality; Hospitalization; Humans; Hypertension; Inpatients; Male; Retrospective Studies; Risk Factors; SARS-CoV-2; United Kingdom","Barlow","Nicola","Black Country Pathology Services, Sandwell and West Birmingham NHS Trust, Birmingham, UK",NA
"181","34172549","10.1136/bmjopen-2020-047561","Hypertension is the major predictor of poor outcomes among inpatients with COVID-19 infection in the UK: a retrospective cohort study.","To assess the impact of diabetes, hypertension and cardiovascular diseases on inpatient mortality from COVID-19, and its relationship to ethnicity and social deprivation. Retrospective, single-centre observational study SETTING: Birmingham, UK. 907 hospitalised patients with laboratory-confirmed COVID-19 from a multi-ethnic community, admitted between 1 March 2020 and 31 May 2020. The primary analysis was an evaluation of cardiovascular conditions and diabetes in relation to ethnicity and social","2021","06","30","BMJ Open","BMJ open","COVID-19; epidemiology; general diabetes; hypertension; Aged; COVID-19; Comorbidity; Hospital Mortality; Hospitalization; Humans; Hypertension; Inpatients; Male; Retrospective Studies; Risk Factors; SARS-CoV-2; United Kingdom","Lee","Brian","Diabetes, Endocrinology and Lipid Metabolism, Sandwell and West Birmingham NHS Trust, Birmingham, UK",NA
"182","34172526","10.1136/medethics-2021-107297","Ethics of genomic passports: should the genetically resistant be exempted from lockdowns and quarantines?","Lockdowns and quarantines have been implemented widely in response to the COVID-19 pandemic. This has been accompanied by a rise in interest in the ethics of 'passport' systems that allow low-risk individuals greater freedoms during lockdowns and exemptions to quarantines. Immunity and vaccination passports have been suggested to facilitate the greater movement of those with acquired immunity and who have been vaccinated. Another group of individuals who pose a low risk to others during pandemic","2021","06","26","J Med Ethics","Journal of medical ethics","COVID-19; genetic information; history of health ethics/bioethics; public health ethics","Gyngell","Christopher","Biomedical Ethics Research Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia christopher.gyngell@mcri.edu","christopher.gyngell@mcri.edu.au"
"183","34172526","10.1136/medethics-2021-107297","Ethics of genomic passports: should the genetically resistant be exempted from lockdowns and quarantines?","Lockdowns and quarantines have been implemented widely in response to the COVID-19 pandemic. This has been accompanied by a rise in interest in the ethics of 'passport' systems that allow low-risk individuals greater freedoms during lockdowns and exemptions to quarantines. Immunity and vaccination passports have been suggested to facilitate the greater movement of those with acquired immunity and who have been vaccinated. Another group of individuals who pose a low risk to others during pandemic","2021","06","26","J Med Ethics","Journal of medical ethics","COVID-19; genetic information; history of health ethics/bioethics; public health ethics","Savulescu","Julian","Biomedical Ethics Research Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia",NA
"184","34172525","10.1136/medethics-2021-107248","Who will receive the last ventilator: why COVID-19 policies should not prioritise healthcare workers.","Policies promoted and adopted for allocating ventilators during the COVID-19 pandemic have often prioritised healthcare workers or other essential workers. While the need for such policies has so far been largely averted, renewed stress on health systems from continuing surges, as well as the experience of allocating another scarce resource-vaccination-counsel revisiting the justifications for such prioritisation. Prioritising healthcare workers may have intuitive appeal, but the ethical justifi","2021","07","02","J Med Ethics","Journal of medical ethics","COVID-19; allocation of health care resources; distributive justice; interests of health personnel/institutions; public health ethics","Chen","Donna T","Center for Health Humanities and Ethics, University of Virginia School of Medicine, Charlottesville, Virginia, USA",NA
"185","34172525","10.1136/medethics-2021-107248","Who will receive the last ventilator: why COVID-19 policies should not prioritise healthcare workers.","Policies promoted and adopted for allocating ventilators during the COVID-19 pandemic have often prioritised healthcare workers or other essential workers. While the need for such policies has so far been largely averted, renewed stress on health systems from continuing surges, as well as the experience of allocating another scarce resource-vaccination-counsel revisiting the justifications for such prioritisation. Prioritising healthcare workers may have intuitive appeal, but the ethical justifi","2021","07","02","J Med Ethics","Journal of medical ethics","COVID-19; allocation of health care resources; distributive justice; interests of health personnel/institutions; public health ethics","Shepherd","Lois","Center for Health Humanities and Ethics, University of Virginia School of Medicine, Charlottesville, Virginia, USA lls4b@virginia","lls4b@virginia.edu"
"186","34172525","10.1136/medethics-2021-107248","Who will receive the last ventilator: why COVID-19 policies should not prioritise healthcare workers.","Policies promoted and adopted for allocating ventilators during the COVID-19 pandemic have often prioritised healthcare workers or other essential workers. While the need for such policies has so far been largely averted, renewed stress on health systems from continuing surges, as well as the experience of allocating another scarce resource-vaccination-counsel revisiting the justifications for such prioritisation. Prioritising healthcare workers may have intuitive appeal, but the ethical justifi","2021","07","02","J Med Ethics","Journal of medical ethics","COVID-19; allocation of health care resources; distributive justice; interests of health personnel/institutions; public health ethics","Taylor","Jordan","Center for Health Humanities and Ethics, University of Virginia School of Medicine, Charlottesville, Virginia, USA",NA
"187","34172525","10.1136/medethics-2021-107248","Who will receive the last ventilator: why COVID-19 policies should not prioritise healthcare workers.","Policies promoted and adopted for allocating ventilators during the COVID-19 pandemic have often prioritised healthcare workers or other essential workers. While the need for such policies has so far been largely averted, renewed stress on health systems from continuing surges, as well as the experience of allocating another scarce resource-vaccination-counsel revisiting the justifications for such prioritisation. Prioritising healthcare workers may have intuitive appeal, but the ethical justifi","2021","07","02","J Med Ethics","Journal of medical ethics","COVID-19; allocation of health care resources; distributive justice; interests of health personnel/institutions; public health ethics","Marshall","Mary Faith","Center for Health Humanities and Ethics, University of Virginia School of Medicine, Charlottesville, Virginia, USA",NA
"188","34172507","10.1136/bmjspcare-2021-003250","Dimethyl fumarate for COVID-19.",NA,"2021","06","26","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; hospital care; neurological conditions; pharmacology; respiratory conditions","Pathania","Yashdeep Singh","Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences, Jodhpur, 342005, India yashdeepsinghpathania@gmail","yashdeepsinghpathania@gmail.com"
"189","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Bugatti","Serena","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy serena.bugatti@unipv","serena.bugatti@unipv.it"
"190","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","De Stefano","Ludovico","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"191","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Balduzzi","Silvia","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"192","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Greco","Maria Immacolata","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"193","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Luvaro","Terenzj","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"194","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Cassaniti","Irene","Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"195","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Bogliolo","Laura","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"196","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Mazzucchelli","Iolanda","Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy",NA
"197","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","D'Onofrio","Bernardo","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"198","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","di Lernia","Michele","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"199","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Mauric","Eleonora","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"200","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Lilleri","Daniele","Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"201","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Baldanti","Fausto","Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"202","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Manzo","Antonio","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"203","34172502","10.1136/annrheumdis-2021-220862","Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.",NA,"2021","06","26","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination","Montecucco","Carlomaurizio","Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"204","34172497","10.1136/bmj.n1640","Covid-19: US doctors suggest new ways to target vaccine hesitancy.",NA,"2021","06","28","BMJ","BMJ (Clinical research ed.)",NA,"Tanne","Janice Hopkins","New York",NA
"205","34172491","10.1136/bmj.n1643","Covid-19: Hunger spreads and food prices soar amid pandemic, warns UN food agency.",NA,"2021","06","28","BMJ","BMJ (Clinical research ed.)",NA,"Dyer","Owen","Montreal, Canada",NA
"206","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Lum","Alvin","Deputy Director, Family Physician, Institute of Mental Health, Singapore, Singapore alvin_lum@imh.com","lum@imh.com.sg"
"207","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Goh","Yen-Li","Director, Senior Consultant, Institute of Mental Health, Singapore, Singapore",NA
"208","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Wong","Kai Sheng","Executive, Institute of Mental Health, Singapore, Singapore",NA
"209","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Seah","Junie","Senior Case Manager, Institute of Mental Health, Singapore, Singapore",NA
"210","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Teo","Gina","Senior Executive, Institute of Mental Health, Singapore, Singapore",NA
"211","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Ng","Jun Qiang","Executive, Institute of Mental Health, Singapore, Singapore",NA
"212","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Abdin","Edimansyah","Principal Biostatistician, Institute of Mental Health, Singapore, Singapore",NA
"213","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Hendricks","Margaret Mary","Senior Principal Case Manager, Institute of Mental Health, Singapore, Singapore",NA
"214","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Tham","Josephine","Senior Case Manager, Institute of Mental Health, Singapore, Singapore",NA
"215","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Nan","Wang","Medical Officer, Institute of Mental Health, Singapore, Singapore",NA
"216","34172477","10.3399/BJGPO.2021.0072","Impact of COVID-19 on the mental health of Singaporean GPs: a cross-sectional study.","COVID-19 has stressed healthcare systems and workers worldwide. GPs, as first points of contact between suspected cases and the healthcare system, have assumed frontline roles in this crisis. While the prevalence of mental health problems and illnesses arising in healthcare workers (HCWs) from tertiary care settings during the COVID-19 pandemic is well-examined,<sup>1</sup> the impact on GPs remains understudied. To describe the prevalence and predictors of anxiety, burnout, depression, and post","2021","07","21","BJGP Open","BJGP open","COVID-19; anxiety; burnout, psychological; cross-sectional studies; depression; general practitioners; mental health; primary health care; stress disorders, post-traumatic","Fung","Daniel","Chief Executive Officer, Senior Consultant, Institute of Mental Health, Singapore, Singapore",NA
"217","34172468","10.1183/13993003.00360-2021","The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort.",NA,"2021","07","23","Eur Respir J","The European respiratory journal","COVID-19; Cohort Studies; Humans; RNA, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Waudby-West","Rupert","Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK",NA
"218","34172468","10.1183/13993003.00360-2021","The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort.",NA,"2021","07","23","Eur Respir J","The European respiratory journal","COVID-19; Cohort Studies; Humans; RNA, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Parcell","Benjamin J","Dept of Medical Microbiology, Ninewells Hospital and Medical School, Dundee, UK",NA
"219","34172468","10.1183/13993003.00360-2021","The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort.",NA,"2021","07","23","Eur Respir J","The European respiratory journal","COVID-19; Cohort Studies; Humans; RNA, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Palmer","Colin N A","Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK",NA
"220","34172468","10.1183/13993003.00360-2021","The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort.",NA,"2021","07","23","Eur Respir J","The European respiratory journal","COVID-19; Cohort Studies; Humans; RNA, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Bell","Samira","Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK",NA
"221","34172468","10.1183/13993003.00360-2021","The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort.",NA,"2021","07","23","Eur Respir J","The European respiratory journal","COVID-19; Cohort Studies; Humans; RNA, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Chalmers","James D","Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK",NA
"222","34172468","10.1183/13993003.00360-2021","The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort.",NA,"2021","07","23","Eur Respir J","The European respiratory journal","COVID-19; Cohort Studies; Humans; RNA, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Siddiqui","Moneeza K","Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK",NA
"223","34172467","10.1183/13993003.02964-2020","Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis.","The individual prognostic factors for COVID-19 are unclear. For this reason, we aimed to present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients. We systematically reviewed PubMed from January 1, 2020 to July 26, 2020 to identify non-overlapping studies examining the association of any prognostic factor with any adverse outcome in patients with COVID-19. Random-effects meta-analysis was performed, and between-study hetero","2021","06","26","Eur Respir J","The European respiratory journal",NA,"Bellou","Vanesa","Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece",NA
"224","34172467","10.1183/13993003.02964-2020","Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis.","The individual prognostic factors for COVID-19 are unclear. For this reason, we aimed to present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients. We systematically reviewed PubMed from January 1, 2020 to July 26, 2020 to identify non-overlapping studies examining the association of any prognostic factor with any adverse outcome in patients with COVID-19. Random-effects meta-analysis was performed, and between-study hetero","2021","06","26","Eur Respir J","The European respiratory journal",NA,"Tzoulaki","Ioanna","Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece",NA
"225","34172467","10.1183/13993003.02964-2020","Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis.","The individual prognostic factors for COVID-19 are unclear. For this reason, we aimed to present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients. We systematically reviewed PubMed from January 1, 2020 to July 26, 2020 to identify non-overlapping studies examining the association of any prognostic factor with any adverse outcome in patients with COVID-19. Random-effects meta-analysis was performed, and between-study hetero","2021","06","26","Eur Respir J","The European respiratory journal",NA,"van Smeden","Maarten","Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands",NA
"226","34172467","10.1183/13993003.02964-2020","Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis.","The individual prognostic factors for COVID-19 are unclear. For this reason, we aimed to present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients. We systematically reviewed PubMed from January 1, 2020 to July 26, 2020 to identify non-overlapping studies examining the association of any prognostic factor with any adverse outcome in patients with COVID-19. Random-effects meta-analysis was performed, and between-study hetero","2021","06","26","Eur Respir J","The European respiratory journal",NA,"Moons","Karel G M","Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands",NA
"227","34172467","10.1183/13993003.02964-2020","Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis.","The individual prognostic factors for COVID-19 are unclear. For this reason, we aimed to present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients. We systematically reviewed PubMed from January 1, 2020 to July 26, 2020 to identify non-overlapping studies examining the association of any prognostic factor with any adverse outcome in patients with COVID-19. Random-effects meta-analysis was performed, and between-study hetero","2021","06","26","Eur Respir J","The European respiratory journal",NA,"Evangelou","Evangelos","Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece",NA
"228","34172467","10.1183/13993003.02964-2020","Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis.","The individual prognostic factors for COVID-19 are unclear. For this reason, we aimed to present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients. We systematically reviewed PubMed from January 1, 2020 to July 26, 2020 to identify non-overlapping studies examining the association of any prognostic factor with any adverse outcome in patients with COVID-19. Random-effects meta-analysis was performed, and between-study hetero","2021","06","26","Eur Respir J","The European respiratory journal",NA,"Belbasis","Lazaros","Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece",NA
"229","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Jung","Christian","Medical Faculty, Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany christian.jung@med.uni-duesseldorf","christian.jung@med.uni"
"230","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Wernly","Bernhard","Department of Anaesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria",NA
"231","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Fjølner","Jesper","Department of Intensive Care, Aarhus University Hospital, Aarhus, Denmark",NA
"232","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Bruno","Raphael Romano","Medical Faculty, Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany",NA
"233","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Dudzinski","David","Cardiac Intensive Care Unit, Massachusetts General Hospital, Boston, USA",NA
"234","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Artigas","Antonio","Department of Intensive Care Medicine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain",NA
"235","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Pinto","Bernardo Bollen","Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland",NA
"236","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Schefold","Joerg C","Department of Intensive Care Medicine, Inselspital, Universitätsspital, University of Bern, Bern, Switzerland",NA
"237","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Wolff","Georg","Medical Faculty, Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany",NA
"238","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Kelm","Malte","Medical Faculty, Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany",NA
"239","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Beil","Michael","Department of Medical Intensive Care, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel",NA
"240","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Sigal","Sviri","Department of Medical Intensive Care, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel",NA
"241","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"van Heerden","Peter Vernon","Department of Anesthesia, Intensive Care and Pain Medicine, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel",NA
"242","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Szczeklik","Wojciech","Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland",NA
"243","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Czuczwar","Miroslaw","nd Department of Anesthesiology and Intensive Care, Medical University of Lublin, , Lublin, Poland",NA
"244","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Elhadi","Muhammed","Faculty of Medicine, University of Tripoli, Tripoli, Libya",NA
"245","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Joannidis","Michael","Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria",NA
"246","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Oeyen","Sandra","Department of Intensive Care 1K12IC, Ghent University Hospital, Ghent, Belgium",NA
"247","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Zafeiridis","Tilemachos","Intensive Care Unit General Hospital of Larissa, Larissa, Greece",NA
"248","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Marsh","Brian","Mater Misericordiae University Hospital, Dublin, Ireland",NA
"249","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Andersen","Finn H","Dep. Of Anaesthesia and Intensive Care, Ålesund Hospital, Ålesund, Norway",NA
"250","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Moreno","Rui","Faculdade de Ciências Médicas de Lisboa, Unidade de Cuidados Intensivos Neurocríticos e Trauma. Hospital de São José, Centro Hospitalar Universitário de Lisboa Central, Nova Médical School, Lisbon, Portugal",NA
"251","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Cecconi","Maurizio","Department of Anaesthesia IRCCS, Instituto Clínico Humanitas, Humanitas University, Milan, Italy",NA
"252","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Leaver","Susannah","General Intensive care, St Georgés University Hospitals NHS Foundation trust, London, United Kingdom",NA
"253","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Boumendil","Ariane","Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe: épidémiologie hospitalière qualité et organisation des soins, Paris, France",NA
"254","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"De Lange","Dylan W","Department of Intensive Care Medicine, University Medical Center, University Utrecht, the Netherlands",NA
"255","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Guidet","Bertrand","Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe: épidémiologie hospitalière qualité et organisation des soins, Paris, France",NA
"256","34172464","10.1183/13993003.00979-2021","Steroid use in elderly critically ill COVID-19 patients.",NA,"2021","07","03","Eur Respir J","The European respiratory journal",NA,"Flaatten","Hans","Department of Clinical Medicine, University of Bergen, Bergen, Norway",NA
"257","34172460","10.1136/bmj.n1544","Beyond the numbers: understanding the diversity of covid-19 epidemiology and response in South Asia.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","Asia; COVID-19; Communicable Disease Control; Female; Humans; Life Expectancy; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2","Bhutta","Zulfiqar A","Institute for Global Health and Development, Aga Khan University, Karachi, Pakistan zulfiqar.bhutta@aku","zulfiqar.bhutta@aku.edu"
"258","34172460","10.1136/bmj.n1544","Beyond the numbers: understanding the diversity of covid-19 epidemiology and response in South Asia.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","Asia; COVID-19; Communicable Disease Control; Female; Humans; Life Expectancy; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2","Siddiqi","Sameen","Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan",NA
"259","34172460","10.1136/bmj.n1544","Beyond the numbers: understanding the diversity of covid-19 epidemiology and response in South Asia.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","Asia; COVID-19; Communicable Disease Control; Female; Humans; Life Expectancy; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2","Hafeez","Assad","Health Services Academy University, Islamabad, Pakistan",NA
"260","34172460","10.1136/bmj.n1544","Beyond the numbers: understanding the diversity of covid-19 epidemiology and response in South Asia.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","Asia; COVID-19; Communicable Disease Control; Female; Humans; Life Expectancy; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2","Islam","Muhammad","Centre for Global Child Health, Hospital for Sick Children, Toronto, Canada",NA
"261","34172460","10.1136/bmj.n1544","Beyond the numbers: understanding the diversity of covid-19 epidemiology and response in South Asia.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","Asia; COVID-19; Communicable Disease Control; Female; Humans; Life Expectancy; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2","Nundy","Samiran","Department of Surgical Gastroenterology and Liver Transplantation, Sir Ganga Ram Hospital, New Delhi, India",NA
"262","34172460","10.1136/bmj.n1544","Beyond the numbers: understanding the diversity of covid-19 epidemiology and response in South Asia.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","Asia; COVID-19; Communicable Disease Control; Female; Humans; Life Expectancy; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2","Qadri","Firdausi","International Centre for Diarrheal Diseases Research, Dhaka, Bangladesh",NA
"263","34172460","10.1136/bmj.n1544","Beyond the numbers: understanding the diversity of covid-19 epidemiology and response in South Asia.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","Asia; COVID-19; Communicable Disease Control; Female; Humans; Life Expectancy; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2","Sultan","Faisal","Ministry of Health Services, Regulation and Coordination, Islamabad, Pakistan",NA
"264","34172459","10.1136/bmj.n1613","Covid-19: the last incompetently managed pandemic?",NA,"2021","06","30","BMJ","BMJ (Clinical research ed.)","COVID-19; Humans; Pandemics; SARS-CoV-2","Ford","Steven","Hexham, UK",NA
"265","34172456","10.1136/bmj.n1608","Vaccinating undocumented migrants against covid-19.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","COVID-19; COVID-19 Vaccines; Health Services Accessibility; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transients and Migrants","Teerawattananon","Yot","Health Intervention and Technology Assessment Program (HITAP), Department of Health, Muang, Nonthaburi 11000, Thailand",NA
"266","34172456","10.1136/bmj.n1608","Vaccinating undocumented migrants against covid-19.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","COVID-19; COVID-19 Vaccines; Health Services Accessibility; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transients and Migrants","Teo","Yik Ying","Saw Swee Hock School of Public Health, National University of Singapore, Singapore",NA
"267","34172456","10.1136/bmj.n1608","Vaccinating undocumented migrants against covid-19.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","COVID-19; COVID-19 Vaccines; Health Services Accessibility; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transients and Migrants","Lim","Jeremy Fung Yen","Saw Swee Hock School of Public Health, National University of Singapore, Singapore",NA
"268","34172456","10.1136/bmj.n1608","Vaccinating undocumented migrants against covid-19.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","COVID-19; COVID-19 Vaccines; Health Services Accessibility; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transients and Migrants","Hsu","Li Yang","Saw Swee Hock School of Public Health, National University of Singapore, Singapore",NA
"269","34172456","10.1136/bmj.n1608","Vaccinating undocumented migrants against covid-19.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)","COVID-19; COVID-19 Vaccines; Health Services Accessibility; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transients and Migrants","Dabak","Saudamini","Health Intervention and Technology Assessment Program (HITAP), Department of Health, Muang, Nonthaburi 11000, Thailand saudamini.d@hitap","saudamini.d@hitap.net"
"270","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Heggestad","Jacob T","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"271","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Kinnamon","David S","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"272","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Olson","Lyra B","Duke Medical Scientist Training Program, Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, USA",NA
"273","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Liu","Jason","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"274","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Kelly","Garrett","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"275","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Wall","Simone A","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"276","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Oshabaheebwa","Solomon","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"277","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Quinn","Zachary","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"278","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Fontes","Cassio M","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"279","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Joh","Daniel Y","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"280","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Hucknall","Angus M","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"281","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Pieper","Carl","Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC 27708, USA",NA
"282","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Anderson","Jack G","Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University, Durham, NC 27710, USA",NA
"283","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Naqvi","Ibtehaj A","Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA",NA
"284","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Chen","Lingye","Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA",NA
"285","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Que","Loretta G","Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA",NA
"286","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Oguin","Thomas","Department of Medicine and Duke Human Vaccine Institute, School of Medicine, Duke University, Durham, NC 27710, USA",NA
"287","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Nair","Smita K","Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA",NA
"288","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Sullenger","Bruce A","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA",NA
"289","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Woods","Christopher W","Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University, Durham, NC 27710, USA",NA
"290","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Burke","Thomas W","Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University, Durham, NC 27710, USA",NA
"291","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Sempowski","Gregory D","Department of Medicine and Duke Human Vaccine Institute, School of Medicine, Duke University, Durham, NC 27710, USA",NA
"292","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Kraft","Bryan D","Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA",NA
"293","34172447","10.1126/sciadv.abg4901","Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.","Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disease 2019 (COVID-19). Here, we report on a microfluidic POC test that can profile the antibody response against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens-spike S1 (S1), nucleocapsid (N), and the receptor binding domain (RBD)-simultaneously from 60 µl of blood, plasma, or serum. We assessed the levels of antibodies in plasma samples from 31 ind","2021","07","19","Sci Adv","Science advances","Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Humans; Point-of-Care Testing; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus","Chilkoti","Ashutosh","Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA. chilkoti@duke","chilkoti@duke.edu"
"294","34172430","10.1016/j.rceng.2021.01.007","Usefulness and acceptance of telephone monitoring by a virtual assistant for patients with COVID-19 following discharge.","COVID-19 has placed a significant burden on the healthcare system, making it necessary to implement new tools that allow patients to be monitored remotely and guarantee quality and continuity of care. The usefulness and acceptance by patients of a virtual caregiver designed for follow-up in the month following hospital discharge for COVID-19 are evaluated. The virtual assistant, based on voice and artificial intelligence technology, made telephone calls at 48 h, seven days, 15 days, and 30 days ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Artificial intelligence; Asistente virtual; COVID-19; Cuidador virtual; Follow-up after discharge; Inteligencia artificial; Seguimiento tras el alta; Virtual assistant; Virtual caregiver","García Bermúdez","I","Servicio de Medicina Interna, Hospital Universitario de La Princesa, Madrid, Spain",NA
"295","34172430","10.1016/j.rceng.2021.01.007","Usefulness and acceptance of telephone monitoring by a virtual assistant for patients with COVID-19 following discharge.","COVID-19 has placed a significant burden on the healthcare system, making it necessary to implement new tools that allow patients to be monitored remotely and guarantee quality and continuity of care. The usefulness and acceptance by patients of a virtual caregiver designed for follow-up in the month following hospital discharge for COVID-19 are evaluated. The virtual assistant, based on voice and artificial intelligence technology, made telephone calls at 48 h, seven days, 15 days, and 30 days ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Artificial intelligence; Asistente virtual; COVID-19; Cuidador virtual; Follow-up after discharge; Inteligencia artificial; Seguimiento tras el alta; Virtual assistant; Virtual caregiver","González Manso","M","Tucuvi Care S.L., Madrid, Spain",NA
"296","34172430","10.1016/j.rceng.2021.01.007","Usefulness and acceptance of telephone monitoring by a virtual assistant for patients with COVID-19 following discharge.","COVID-19 has placed a significant burden on the healthcare system, making it necessary to implement new tools that allow patients to be monitored remotely and guarantee quality and continuity of care. The usefulness and acceptance by patients of a virtual caregiver designed for follow-up in the month following hospital discharge for COVID-19 are evaluated. The virtual assistant, based on voice and artificial intelligence technology, made telephone calls at 48 h, seven days, 15 days, and 30 days ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Artificial intelligence; Asistente virtual; COVID-19; Cuidador virtual; Follow-up after discharge; Inteligencia artificial; Seguimiento tras el alta; Virtual assistant; Virtual caregiver","Sánchez Sánchez","E","Servicio de Medicina Interna, Hospital Universitario de La Princesa, Madrid, Spain",NA
"297","34172430","10.1016/j.rceng.2021.01.007","Usefulness and acceptance of telephone monitoring by a virtual assistant for patients with COVID-19 following discharge.","COVID-19 has placed a significant burden on the healthcare system, making it necessary to implement new tools that allow patients to be monitored remotely and guarantee quality and continuity of care. The usefulness and acceptance by patients of a virtual caregiver designed for follow-up in the month following hospital discharge for COVID-19 are evaluated. The virtual assistant, based on voice and artificial intelligence technology, made telephone calls at 48 h, seven days, 15 days, and 30 days ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Artificial intelligence; Asistente virtual; COVID-19; Cuidador virtual; Follow-up after discharge; Inteligencia artificial; Seguimiento tras el alta; Virtual assistant; Virtual caregiver","Rodríguez Hita","A","Unidad de Apoyo a la Innovación, nodo de La Plataforma ITEMAS, Hospital Universitario de La Princesa, Madrid, Spain",NA
"298","34172430","10.1016/j.rceng.2021.01.007","Usefulness and acceptance of telephone monitoring by a virtual assistant for patients with COVID-19 following discharge.","COVID-19 has placed a significant burden on the healthcare system, making it necessary to implement new tools that allow patients to be monitored remotely and guarantee quality and continuity of care. The usefulness and acceptance by patients of a virtual caregiver designed for follow-up in the month following hospital discharge for COVID-19 are evaluated. The virtual assistant, based on voice and artificial intelligence technology, made telephone calls at 48 h, seven days, 15 days, and 30 days ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Artificial intelligence; Asistente virtual; COVID-19; Cuidador virtual; Follow-up after discharge; Inteligencia artificial; Seguimiento tras el alta; Virtual assistant; Virtual caregiver","Rubio Rubio","M","Tucuvi Care S.L., Madrid, Spain",NA
"299","34172430","10.1016/j.rceng.2021.01.007","Usefulness and acceptance of telephone monitoring by a virtual assistant for patients with COVID-19 following discharge.","COVID-19 has placed a significant burden on the healthcare system, making it necessary to implement new tools that allow patients to be monitored remotely and guarantee quality and continuity of care. The usefulness and acceptance by patients of a virtual caregiver designed for follow-up in the month following hospital discharge for COVID-19 are evaluated. The virtual assistant, based on voice and artificial intelligence technology, made telephone calls at 48 h, seven days, 15 days, and 30 days ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Artificial intelligence; Asistente virtual; COVID-19; Cuidador virtual; Follow-up after discharge; Inteligencia artificial; Seguimiento tras el alta; Virtual assistant; Virtual caregiver","Suárez Fernández","C","Servicio de Medicina Interna, Hospital Universitario de La Princesa, Madrid, Spain. Electronic address: csuarezf@salud.madrid","csuarezf@salud.madrid.org"
"300","34172426","10.1016/j.pcd.2021.06.007","COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population.","The complete lockdown caused by the COVID-19 pandemic had imposed a new behavior and lifestyle especially in terms of diet, physical activity, and the management of patients with chronic diseases. The present study aimed to analyze the impact of lockdown on the monitoring and care of type 2 diabetes mellitus (T2DM) patients in a Moroccan population from the Doukkala region. We conducted a retrospective observational study including 121 T2DM patients recruited from the Diabetes Diagnosis and Trea","2021","07","01","Prim Care Diabetes","Primary care diabetes","COVID-19; Complications; Impact; Lockdown; Morocco; SARS-CoV-2; Type 2 diabetes mellitus","Farhane","Hamid","Equipe des Sciences Anthropogénétiques et Biotechnologies, Département de Biologie, Faculté des Sciences, Université Chouaïb Doukkali, El Jadida, Morocco",NA
"301","34172426","10.1016/j.pcd.2021.06.007","COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population.","The complete lockdown caused by the COVID-19 pandemic had imposed a new behavior and lifestyle especially in terms of diet, physical activity, and the management of patients with chronic diseases. The present study aimed to analyze the impact of lockdown on the monitoring and care of type 2 diabetes mellitus (T2DM) patients in a Moroccan population from the Doukkala region. We conducted a retrospective observational study including 121 T2DM patients recruited from the Diabetes Diagnosis and Trea","2021","07","01","Prim Care Diabetes","Primary care diabetes","COVID-19; Complications; Impact; Lockdown; Morocco; SARS-CoV-2; Type 2 diabetes mellitus","Motrane","Majida","Equipe des Sciences Anthropogénétiques et Biotechnologies, Département de Biologie, Faculté des Sciences, Université Chouaïb Doukkali, El Jadida, Morocco",NA
"302","34172426","10.1016/j.pcd.2021.06.007","COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population.","The complete lockdown caused by the COVID-19 pandemic had imposed a new behavior and lifestyle especially in terms of diet, physical activity, and the management of patients with chronic diseases. The present study aimed to analyze the impact of lockdown on the monitoring and care of type 2 diabetes mellitus (T2DM) patients in a Moroccan population from the Doukkala region. We conducted a retrospective observational study including 121 T2DM patients recruited from the Diabetes Diagnosis and Trea","2021","07","01","Prim Care Diabetes","Primary care diabetes","COVID-19; Complications; Impact; Lockdown; Morocco; SARS-CoV-2; Type 2 diabetes mellitus","Anaibar","Fatima-Ezzahra","Equipe des Sciences Anthropogénétiques et Biotechnologies, Département de Biologie, Faculté des Sciences, Université Chouaïb Doukkali, El Jadida, Morocco",NA
"303","34172426","10.1016/j.pcd.2021.06.007","COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population.","The complete lockdown caused by the COVID-19 pandemic had imposed a new behavior and lifestyle especially in terms of diet, physical activity, and the management of patients with chronic diseases. The present study aimed to analyze the impact of lockdown on the monitoring and care of type 2 diabetes mellitus (T2DM) patients in a Moroccan population from the Doukkala region. We conducted a retrospective observational study including 121 T2DM patients recruited from the Diabetes Diagnosis and Trea","2021","07","01","Prim Care Diabetes","Primary care diabetes","COVID-19; Complications; Impact; Lockdown; Morocco; SARS-CoV-2; Type 2 diabetes mellitus","Motrane","Aïcha","Centre de Diagnostic et de Traitement de Diabète, Délégation Provinciale de la Santé Publique d'El Jadida, El Jadida, Morocco",NA
"304","34172426","10.1016/j.pcd.2021.06.007","COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population.","The complete lockdown caused by the COVID-19 pandemic had imposed a new behavior and lifestyle especially in terms of diet, physical activity, and the management of patients with chronic diseases. The present study aimed to analyze the impact of lockdown on the monitoring and care of type 2 diabetes mellitus (T2DM) patients in a Moroccan population from the Doukkala region. We conducted a retrospective observational study including 121 T2DM patients recruited from the Diabetes Diagnosis and Trea","2021","07","01","Prim Care Diabetes","Primary care diabetes","COVID-19; Complications; Impact; Lockdown; Morocco; SARS-CoV-2; Type 2 diabetes mellitus","Abeid","Said Nassor","Equipe des Sciences Anthropogénétiques et Biotechnologies, Département de Biologie, Faculté des Sciences, Université Chouaïb Doukkali, El Jadida, Morocco",NA
"305","34172426","10.1016/j.pcd.2021.06.007","COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population.","The complete lockdown caused by the COVID-19 pandemic had imposed a new behavior and lifestyle especially in terms of diet, physical activity, and the management of patients with chronic diseases. The present study aimed to analyze the impact of lockdown on the monitoring and care of type 2 diabetes mellitus (T2DM) patients in a Moroccan population from the Doukkala region. We conducted a retrospective observational study including 121 T2DM patients recruited from the Diabetes Diagnosis and Trea","2021","07","01","Prim Care Diabetes","Primary care diabetes","COVID-19; Complications; Impact; Lockdown; Morocco; SARS-CoV-2; Type 2 diabetes mellitus","Harich","Nourdin","Equipe des Sciences Anthropogénétiques et Biotechnologies, Département de Biologie, Faculté des Sciences, Université Chouaïb Doukkali, El Jadida, Morocco. Electronic address: harichanthropo@gmail","harichanthropo@gmail.com"
"306","34172424","10.1016/j.jmir.2021.05.017","Follow-up regarding the article ""Get comfortable with being uncomfortable: Experiences from diagnostic radiographers a year into the COVID-19 pandemic"".",NA,"2021","07","01","J Med Imaging Radiat Sci","Journal of medical imaging and radiation sciences",NA,"Tay","Yi Xiang","Radiography Department, Division of Radiological Sciences, Singapore General Hospital, Singapore. Electronic address: tay.yi.xiang@sgh.com","tay.yi.xiang@sgh.com.sg"
"307","34172420","10.1016/j.resinv.2021.05.013","Increase in humidifier lung cases owing to coronavirus disease 2019.",NA,"2021","07","01","Respir Investig","Respiratory investigation",NA,"Shimoda","Masafumi","Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), 3-1-24 Matsuyama, Kiyose City, Tokyo, 204-8522, Japan. Electronic address: shimodam@fukujuji","shimodam@fukujuji.org"
"308","34172420","10.1016/j.resinv.2021.05.013","Increase in humidifier lung cases owing to coronavirus disease 2019.",NA,"2021","07","01","Respir Investig","Respiratory investigation",NA,"Morimoto","Kozo","Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), 3-1-24 Matsuyama, Kiyose City, Tokyo, 204-8522, Japan",NA
"309","34172420","10.1016/j.resinv.2021.05.013","Increase in humidifier lung cases owing to coronavirus disease 2019.",NA,"2021","07","01","Respir Investig","Respiratory investigation",NA,"Tanaka","Yoshiaki","Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), 3-1-24 Matsuyama, Kiyose City, Tokyo, 204-8522, Japan",NA
"310","34172420","10.1016/j.resinv.2021.05.013","Increase in humidifier lung cases owing to coronavirus disease 2019.",NA,"2021","07","01","Respir Investig","Respiratory investigation",NA,"Kokutou","Hiroyuki","Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), 3-1-24 Matsuyama, Kiyose City, Tokyo, 204-8522, Japan",NA
"311","34172420","10.1016/j.resinv.2021.05.013","Increase in humidifier lung cases owing to coronavirus disease 2019.",NA,"2021","07","01","Respir Investig","Respiratory investigation",NA,"Uchiyama","Takashi","Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), 3-1-24 Matsuyama, Kiyose City, Tokyo, 204-8522, Japan",NA
"312","34172420","10.1016/j.resinv.2021.05.013","Increase in humidifier lung cases owing to coronavirus disease 2019.",NA,"2021","07","01","Respir Investig","Respiratory investigation",NA,"Yoshimori","Kozo","Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), 3-1-24 Matsuyama, Kiyose City, Tokyo, 204-8522, Japan",NA
"313","34172420","10.1016/j.resinv.2021.05.013","Increase in humidifier lung cases owing to coronavirus disease 2019.",NA,"2021","07","01","Respir Investig","Respiratory investigation",NA,"Ohta","Ken","Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), 3-1-24 Matsuyama, Kiyose City, Tokyo, 204-8522, Japan",NA
"314","34172414","10.1016/j.cireng.2021.06.003","Cholecystitis enfisematous suspected SARS-CoV-2 infection.",NA,"2021","07","01","Cir Esp (Engl Ed)","Cirugia espanola",NA,"Bernabeu García","Ana","Hospital de Mataró, Servicio Cirugía General y Digestiva, Unidad hepatobiliopancreática, Barcelona, Spain. Electronic address: ana_bg_22@hotmail",NA
"315","34172414","10.1016/j.cireng.2021.06.003","Cholecystitis enfisematous suspected SARS-CoV-2 infection.",NA,"2021","07","01","Cir Esp (Engl Ed)","Cirugia espanola",NA,"De la Cruz Verdun","Joan","Hospital de Mataró, Servicio Cirugía General y Digestiva, Unidad hepatobiliopancreática, Barcelona, Spain",NA
"316","34172414","10.1016/j.cireng.2021.06.003","Cholecystitis enfisematous suspected SARS-CoV-2 infection.",NA,"2021","07","01","Cir Esp (Engl Ed)","Cirugia espanola",NA,"Suñol Sala","Xavier","Hospital de Mataró, Servicio Cirugía General y Digestiva, Unidad hepatobiliopancreática, Barcelona, Spain",NA
"317","34172412","10.1016/j.jiph.2021.06.006","What were the changes during the COVID-19 pandemic era concerning occupational risks among health care workers?","Accidental exposure to percutaneous needle stick and sharp injuries (NSSIs) and blood and other body fluids is the unintended contact with risky medical instruments or patient secretions during a medical intervention. During the COVID-19 pandemic, the significance of occupational injuries in healthcare professionals was revealed once again. To assess the occupational injuries, we compared rates, distribution and type of exposure to blood and body fluids and NSSIs of health care workers for 2019 ","2021","06","26","J Infect Public Health","Journal of infection and public health","Blood and other body fluids; COVID-19; Health care workers; Needlestick and sharp injuries","Diktas","Husrev","Department of Infectious Diseases and Clinical Microbiology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey. Electronic address: drhusrevdiktas@gmail","drhusrevdiktas@gmail.com"
"318","34172412","10.1016/j.jiph.2021.06.006","What were the changes during the COVID-19 pandemic era concerning occupational risks among health care workers?","Accidental exposure to percutaneous needle stick and sharp injuries (NSSIs) and blood and other body fluids is the unintended contact with risky medical instruments or patient secretions during a medical intervention. During the COVID-19 pandemic, the significance of occupational injuries in healthcare professionals was revealed once again. To assess the occupational injuries, we compared rates, distribution and type of exposure to blood and body fluids and NSSIs of health care workers for 2019 ","2021","06","26","J Infect Public Health","Journal of infection and public health","Blood and other body fluids; COVID-19; Health care workers; Needlestick and sharp injuries","Oncul","Ahsen","Department of Infectious Diseases and Clinical Microbiology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",NA
"319","34172412","10.1016/j.jiph.2021.06.006","What were the changes during the COVID-19 pandemic era concerning occupational risks among health care workers?","Accidental exposure to percutaneous needle stick and sharp injuries (NSSIs) and blood and other body fluids is the unintended contact with risky medical instruments or patient secretions during a medical intervention. During the COVID-19 pandemic, the significance of occupational injuries in healthcare professionals was revealed once again. To assess the occupational injuries, we compared rates, distribution and type of exposure to blood and body fluids and NSSIs of health care workers for 2019 ","2021","06","26","J Infect Public Health","Journal of infection and public health","Blood and other body fluids; COVID-19; Health care workers; Needlestick and sharp injuries","Tahtasakal","Ceren Atasoy","Department of Infectious Diseases and Clinical Microbiology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",NA
"320","34172412","10.1016/j.jiph.2021.06.006","What were the changes during the COVID-19 pandemic era concerning occupational risks among health care workers?","Accidental exposure to percutaneous needle stick and sharp injuries (NSSIs) and blood and other body fluids is the unintended contact with risky medical instruments or patient secretions during a medical intervention. During the COVID-19 pandemic, the significance of occupational injuries in healthcare professionals was revealed once again. To assess the occupational injuries, we compared rates, distribution and type of exposure to blood and body fluids and NSSIs of health care workers for 2019 ","2021","06","26","J Infect Public Health","Journal of infection and public health","Blood and other body fluids; COVID-19; Health care workers; Needlestick and sharp injuries","Sevgi","Dilek Yildiz","Department of Infectious Diseases and Clinical Microbiology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",NA
"321","34172412","10.1016/j.jiph.2021.06.006","What were the changes during the COVID-19 pandemic era concerning occupational risks among health care workers?","Accidental exposure to percutaneous needle stick and sharp injuries (NSSIs) and blood and other body fluids is the unintended contact with risky medical instruments or patient secretions during a medical intervention. During the COVID-19 pandemic, the significance of occupational injuries in healthcare professionals was revealed once again. To assess the occupational injuries, we compared rates, distribution and type of exposure to blood and body fluids and NSSIs of health care workers for 2019 ","2021","06","26","J Infect Public Health","Journal of infection and public health","Blood and other body fluids; COVID-19; Health care workers; Needlestick and sharp injuries","Kaya","Ozlem","Hospital Infection Control Committee, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",NA
"322","34172412","10.1016/j.jiph.2021.06.006","What were the changes during the COVID-19 pandemic era concerning occupational risks among health care workers?","Accidental exposure to percutaneous needle stick and sharp injuries (NSSIs) and blood and other body fluids is the unintended contact with risky medical instruments or patient secretions during a medical intervention. During the COVID-19 pandemic, the significance of occupational injuries in healthcare professionals was revealed once again. To assess the occupational injuries, we compared rates, distribution and type of exposure to blood and body fluids and NSSIs of health care workers for 2019 ","2021","06","26","J Infect Public Health","Journal of infection and public health","Blood and other body fluids; COVID-19; Health care workers; Needlestick and sharp injuries","Cimenci","Nese","Hospital Infection Control Committee, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",NA
"323","34172412","10.1016/j.jiph.2021.06.006","What were the changes during the COVID-19 pandemic era concerning occupational risks among health care workers?","Accidental exposure to percutaneous needle stick and sharp injuries (NSSIs) and blood and other body fluids is the unintended contact with risky medical instruments or patient secretions during a medical intervention. During the COVID-19 pandemic, the significance of occupational injuries in healthcare professionals was revealed once again. To assess the occupational injuries, we compared rates, distribution and type of exposure to blood and body fluids and NSSIs of health care workers for 2019 ","2021","06","26","J Infect Public Health","Journal of infection and public health","Blood and other body fluids; COVID-19; Health care workers; Needlestick and sharp injuries","Uzun","Nuray","Department of Infectious Diseases and Clinical Microbiology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",NA
"324","34172412","10.1016/j.jiph.2021.06.006","What were the changes during the COVID-19 pandemic era concerning occupational risks among health care workers?","Accidental exposure to percutaneous needle stick and sharp injuries (NSSIs) and blood and other body fluids is the unintended contact with risky medical instruments or patient secretions during a medical intervention. During the COVID-19 pandemic, the significance of occupational injuries in healthcare professionals was revealed once again. To assess the occupational injuries, we compared rates, distribution and type of exposure to blood and body fluids and NSSIs of health care workers for 2019 ","2021","06","26","J Infect Public Health","Journal of infection and public health","Blood and other body fluids; COVID-19; Health care workers; Needlestick and sharp injuries","Dokmetas","Ilyas","Department of Infectious Diseases and Clinical Microbiology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",NA
"325","34172389","10.1016/j.molmed.2021.06.003","Uprooting race-based assumptions in biomedical journal articles.","Coronavirus disease 2019 (COVID-19) has exacerbated the structural inequities in healthcare and the challenges of translating research into public discourse. This article highlights key antiracist considerations, presents previously noted core challenges, and provides recommendations for writing and reporting. Importantly, this article contributes to combating racialized science in the biomedical community.","2021","07","01","Trends Mol Med","Trends in molecular medicine","biomedical reporting; guidelines; racialized science","Aifah","Angela","Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA",NA
"326","34172389","10.1016/j.molmed.2021.06.003","Uprooting race-based assumptions in biomedical journal articles.","Coronavirus disease 2019 (COVID-19) has exacerbated the structural inequities in healthcare and the challenges of translating research into public discourse. This article highlights key antiracist considerations, presents previously noted core challenges, and provides recommendations for writing and reporting. Importantly, this article contributes to combating racialized science in the biomedical community.","2021","07","01","Trends Mol Med","Trends in molecular medicine","biomedical reporting; guidelines; racialized science","Onakomaiya","Deborah","Vilcek Institute of Graduate Biomedical Sciences, New York University Grossman School of Medicine, New York, NY, USA",NA
"327","34172389","10.1016/j.molmed.2021.06.003","Uprooting race-based assumptions in biomedical journal articles.","Coronavirus disease 2019 (COVID-19) has exacerbated the structural inequities in healthcare and the challenges of translating research into public discourse. This article highlights key antiracist considerations, presents previously noted core challenges, and provides recommendations for writing and reporting. Importantly, this article contributes to combating racialized science in the biomedical community.","2021","07","01","Trends Mol Med","Trends in molecular medicine","biomedical reporting; guidelines; racialized science","Rakhra","Ashlin","Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA",NA
"328","34172389","10.1016/j.molmed.2021.06.003","Uprooting race-based assumptions in biomedical journal articles.","Coronavirus disease 2019 (COVID-19) has exacerbated the structural inequities in healthcare and the challenges of translating research into public discourse. This article highlights key antiracist considerations, presents previously noted core challenges, and provides recommendations for writing and reporting. Importantly, this article contributes to combating racialized science in the biomedical community.","2021","07","01","Trends Mol Med","Trends in molecular medicine","biomedical reporting; guidelines; racialized science","Ogedegbe","Gbenga","Institute for Excellence in Health Equity, New York University Langone Health, New York, NY, USA. Electronic address: Olugbenga.Ogedegbe@nyulangone","Olugbenga.Ogedegbe@nyulangone.org"
"329","34172388","10.1016/j.jaim.2021.04.003","Combating the psychological impact of COVID-19 pandemic through yoga: Recommendation from an overview.","Globally, the psychological health of the people is being affected due to the COVID-19 pandemic. Given the fact that numerous systematic reviews already exist on yoga and mental health, it becomes vital to undertake an overview on the same. The objective of the overview was to summarise the evidence from different systematic reviews of distinct yoga interventions used to improve mental health and recommend yoga practices for the same. The protocol was registered on PROSPERO (CRD42020185221). MED","2021","06","26","J Ayurveda Integr Med","Journal of Ayurveda and integrative medicine","Anxiety; COVID-19; Mental health; Overview; Yoga","Kulkarni","Medha Sanjay","Department of Swasthvritta, All India Institute of Ayurveda, New Delhi, India",NA
"330","34172388","10.1016/j.jaim.2021.04.003","Combating the psychological impact of COVID-19 pandemic through yoga: Recommendation from an overview.","Globally, the psychological health of the people is being affected due to the COVID-19 pandemic. Given the fact that numerous systematic reviews already exist on yoga and mental health, it becomes vital to undertake an overview on the same. The objective of the overview was to summarise the evidence from different systematic reviews of distinct yoga interventions used to improve mental health and recommend yoga practices for the same. The protocol was registered on PROSPERO (CRD42020185221). MED","2021","06","26","J Ayurveda Integr Med","Journal of Ayurveda and integrative medicine","Anxiety; COVID-19; Mental health; Overview; Yoga","Kakodkar","Pradnya","Dr D Y Patil Vidyapeeth, Pimpri, Pune, India. Electronic address: Pradnya.kakodkar@gmail","Pradnya.kakodkar@gmail.com"
"331","34172388","10.1016/j.jaim.2021.04.003","Combating the psychological impact of COVID-19 pandemic through yoga: Recommendation from an overview.","Globally, the psychological health of the people is being affected due to the COVID-19 pandemic. Given the fact that numerous systematic reviews already exist on yoga and mental health, it becomes vital to undertake an overview on the same. The objective of the overview was to summarise the evidence from different systematic reviews of distinct yoga interventions used to improve mental health and recommend yoga practices for the same. The protocol was registered on PROSPERO (CRD42020185221). MED","2021","06","26","J Ayurveda Integr Med","Journal of Ayurveda and integrative medicine","Anxiety; COVID-19; Mental health; Overview; Yoga","Nesari","Tanuja M","All India Institute of Ayurveda, New Delhi, India",NA
"332","34172388","10.1016/j.jaim.2021.04.003","Combating the psychological impact of COVID-19 pandemic through yoga: Recommendation from an overview.","Globally, the psychological health of the people is being affected due to the COVID-19 pandemic. Given the fact that numerous systematic reviews already exist on yoga and mental health, it becomes vital to undertake an overview on the same. The objective of the overview was to summarise the evidence from different systematic reviews of distinct yoga interventions used to improve mental health and recommend yoga practices for the same. The protocol was registered on PROSPERO (CRD42020185221). MED","2021","06","26","J Ayurveda Integr Med","Journal of Ayurveda and integrative medicine","Anxiety; COVID-19; Mental health; Overview; Yoga","Dubewar","Arati P","Department of Rasashastra, Dr. D Y Patil Vidyapeeth, Pimpri, Pune, India",NA
"333","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Mohanka","Manish R","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"334","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Mahan","Luke D","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"335","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Joerns","John","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"336","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Lawrence","Adrian","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"337","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Bollineni","Srinivas","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"338","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Kaza","Vaidehi","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"339","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","La Hoz","Ricardo M","Infectious Disease and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"340","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Kershaw","Corey D","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"341","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Terada","Lance S","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"342","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Torres","Fernando","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas",NA
"343","34172387","10.1016/j.healun.2021.05.003","Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.","There are limited data on management strategies and outcomes among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). We implemented management protocols based on the best available evidence and consensus among multidisciplinary teams. The current study reports our experience and outcomes using this protocol-based management strategy. We included single or bilateral LT patients who tested positive for SARS-CoV-2 on nasopharyngeal swab between March 1, 2020, to December 15, 2","2021","07","01","J Heart Lung Transplant","The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation","SARS-CoV-2; allograft dysfunction; chronic kidney disease; survival","Banga","Amit","Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: amit.banga@utsouthwestern","amit.banga@utsouthwestern.edu"
"344","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Yamamoto","Kei","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: kyamamoto@hosp.ncgm.go","kyamamoto@hosp.ncgm.go.jp"
"345","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Suzuki","Michiyo","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan",NA
"346","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Yamada","Gen","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan",NA
"347","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Sudo","Tsutomu","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan",NA
"348","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Nomoto","Hidetoshi","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan",NA
"349","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Kinoshita","Noriko","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan",NA
"350","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Nakamura","Keiji","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan",NA
"351","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Tsujimoto","Yoshie","Department of Respirology, National Center for Global Health and Medicine, Tokyo, Japan",NA
"352","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Kusaba","Yusaku","Department of Respirology, National Center for Global Health and Medicine, Tokyo, Japan",NA
"353","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Morita","Chie","Department of Respirology, National Center for Global Health and Medicine, Tokyo, Japan",NA
"354","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Moriya","Ataru","Clinical Laboratory, National Center for Global Health and Medicine, Tokyo, Japan",NA
"355","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Maeda","Kenji","Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan",NA
"356","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Yagi","Shintaro","Fujirebio Inc., Tokyo, Japan",NA
"357","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Kimura","Motoi","Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan",NA
"358","34172380","10.1016/j.ijid.2021.06.009","Corrigendum to ""Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"" [Int J Infect Dis 104 (2021) 65-72].",NA,"2021","07","01","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Ohmagari","Norio","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan",NA
"359","34172379","10.1016/j.tracli.2021.06.001","COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.",NA,"2021","07","01","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine",NA,"Vuk","T","Croatian Institute of Transfusion Medicine, Zagreb, Croatia. Electronic address: tomislav.vuk@hztm","tomislav.vuk@hztm.hr"
"360","34172379","10.1016/j.tracli.2021.06.001","COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.",NA,"2021","07","01","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine",NA,"Hecimovic","A","Croatian Institute of Transfusion Medicine, Zagreb, Croatia",NA
"361","34172379","10.1016/j.tracli.2021.06.001","COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.",NA,"2021","07","01","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine",NA,"Jukic","I","Croatian Institute of Transfusion Medicine, Zagreb, Croatia",NA
"362","34172379","10.1016/j.tracli.2021.06.001","COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.",NA,"2021","07","01","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine",NA,"Ravlic","S","University of Zagreb, Centre for Research and Knowledge Transfer in Biotechnology, Rockefellerova 10, 10000 Zagreb, Croatia",NA
"363","34172379","10.1016/j.tracli.2021.06.001","COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.",NA,"2021","07","01","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine",NA,"Kurtovic","T","University of Zagreb, Centre for Research and Knowledge Transfer in Biotechnology, Rockefellerova 10, 10000 Zagreb, Croatia",NA
"364","34172379","10.1016/j.tracli.2021.06.001","COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.",NA,"2021","07","01","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine",NA,"Rnjak","D","Special Hospital for Pulmonary Diseases, Rockefellerova 3, 10000 Zagreb, Croatia",NA
"365","34172379","10.1016/j.tracli.2021.06.001","COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.",NA,"2021","07","01","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine",NA,"Halassy","B","University of Zagreb, Centre for Research and Knowledge Transfer in Biotechnology, Rockefellerova 10, 10000 Zagreb, Croatia","bhalassy@unizg.hr"
"366","34172361","10.1016/j.jvoice.2021.04.017","Adjustment of Health-Care Service Delivery Among Phoniatricians and ENT Specialists During the COVID-19 Pandemic, A UEP Survey.","Applying measures that prioritize staff safety, while protecting patient safety and care, represents a challenge during the current pandemic. Many documents of recommendations toward safe practice have been developed for this purpose. To assess adjustments that have been undertaken by phoniatricians and otolaryngologists in the delivery of health-care services during the pandemic in order to reduce staff exposure to COVID-19 and improve safety. Cross-sectional. An online self-administered survey","2021","06","26","J Voice","Journal of voice : official journal of the Voice Foundation","COVID-19; Otolaryngologists; Phoniatricians; Service delivery","Shadi","Mariam S","Department of Otorhinolaryngology, Phoniatrics Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: mariamshadi@med.asu.edu","mariamshadi@med.asu.edu.eg"
"367","34172361","10.1016/j.jvoice.2021.04.017","Adjustment of Health-Care Service Delivery Among Phoniatricians and ENT Specialists During the COVID-19 Pandemic, A UEP Survey.","Applying measures that prioritize staff safety, while protecting patient safety and care, represents a challenge during the current pandemic. Many documents of recommendations toward safe practice have been developed for this purpose. To assess adjustments that have been undertaken by phoniatricians and otolaryngologists in the delivery of health-care services during the pandemic in order to reduce staff exposure to COVID-19 and improve safety. Cross-sectional. An online self-administered survey","2021","06","26","J Voice","Journal of voice : official journal of the Voice Foundation","COVID-19; Otolaryngologists; Phoniatricians; Service delivery","Rubin","John S","Consultant ENT Surgeon, University College Hospitals London NHS Trust. Honorary Consultant ENT Surgeon, National Hospital for Neurology and Neurosurgery. Honorary Associate Professor, Department of Targeted Intervention, University College London. Honorary Visiting Professor, Department of Health Science, City University of London",NA
"368","34172361","10.1016/j.jvoice.2021.04.017","Adjustment of Health-Care Service Delivery Among Phoniatricians and ENT Specialists During the COVID-19 Pandemic, A UEP Survey.","Applying measures that prioritize staff safety, while protecting patient safety and care, represents a challenge during the current pandemic. Many documents of recommendations toward safe practice have been developed for this purpose. To assess adjustments that have been undertaken by phoniatricians and otolaryngologists in the delivery of health-care services during the pandemic in order to reduce staff exposure to COVID-19 and improve safety. Cross-sectional. An online self-administered survey","2021","06","26","J Voice","Journal of voice : official journal of the Voice Foundation","COVID-19; Otolaryngologists; Phoniatricians; Service delivery","Geneid","Ahmed","Department of Otorhinolaryngology and Phoniatrics - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"369","34172361","10.1016/j.jvoice.2021.04.017","Adjustment of Health-Care Service Delivery Among Phoniatricians and ENT Specialists During the COVID-19 Pandemic, A UEP Survey.","Applying measures that prioritize staff safety, while protecting patient safety and care, represents a challenge during the current pandemic. Many documents of recommendations toward safe practice have been developed for this purpose. To assess adjustments that have been undertaken by phoniatricians and otolaryngologists in the delivery of health-care services during the pandemic in order to reduce staff exposure to COVID-19 and improve safety. Cross-sectional. An online self-administered survey","2021","06","26","J Voice","Journal of voice : official journal of the Voice Foundation","COVID-19; Otolaryngologists; Phoniatricians; Service delivery","Magdy","Elham","Department of Otorhinolaryngology, Phoniatrics Unit, Zagazig University, Zagazig, Egypt",NA
"370","34172361","10.1016/j.jvoice.2021.04.017","Adjustment of Health-Care Service Delivery Among Phoniatricians and ENT Specialists During the COVID-19 Pandemic, A UEP Survey.","Applying measures that prioritize staff safety, while protecting patient safety and care, represents a challenge during the current pandemic. Many documents of recommendations toward safe practice have been developed for this purpose. To assess adjustments that have been undertaken by phoniatricians and otolaryngologists in the delivery of health-care services during the pandemic in order to reduce staff exposure to COVID-19 and improve safety. Cross-sectional. An online self-administered survey","2021","06","26","J Voice","Journal of voice : official journal of the Voice Foundation","COVID-19; Otolaryngologists; Phoniatricians; Service delivery","Ibrahim","Reham Abdelwakil","Department of Otorhinolaryngology, Phoniatrics Unit, Assuit University, Assuit, Egypt",NA
"371","34172354","10.1016/j.pedhc.2021.01.007","Telemedicine and Health Equity During COVID-19 in Pediatric Gastroenterology.","Telehealth (TH) services rapidly expanded during the COVID-19 pandemic. This rapid deployment precluded the opportunity for initial planning of implementation strategies. The purpose of the quality improvement project was to understand the needs of nurse practitioners and examine TH procedures and interventions designed to promote high-quality, equitable health care for pediatric patients with gastrointestinal concerns. The Plan-Do-Study-Act model was used. Survey data from providers and familie","2021","06","26","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","Telehealth; health equity; nurse practitioner; pediatrics; quality improvement","Serino-Cipoletta","Jessica",NA,NA
"372","34172354","10.1016/j.pedhc.2021.01.007","Telemedicine and Health Equity During COVID-19 in Pediatric Gastroenterology.","Telehealth (TH) services rapidly expanded during the COVID-19 pandemic. This rapid deployment precluded the opportunity for initial planning of implementation strategies. The purpose of the quality improvement project was to understand the needs of nurse practitioners and examine TH procedures and interventions designed to promote high-quality, equitable health care for pediatric patients with gastrointestinal concerns. The Plan-Do-Study-Act model was used. Survey data from providers and familie","2021","06","26","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","Telehealth; health equity; nurse practitioner; pediatrics; quality improvement","Dempsey","Catherine",NA,NA
"373","34172354","10.1016/j.pedhc.2021.01.007","Telemedicine and Health Equity During COVID-19 in Pediatric Gastroenterology.","Telehealth (TH) services rapidly expanded during the COVID-19 pandemic. This rapid deployment precluded the opportunity for initial planning of implementation strategies. The purpose of the quality improvement project was to understand the needs of nurse practitioners and examine TH procedures and interventions designed to promote high-quality, equitable health care for pediatric patients with gastrointestinal concerns. The Plan-Do-Study-Act model was used. Survey data from providers and familie","2021","06","26","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","Telehealth; health equity; nurse practitioner; pediatrics; quality improvement","Goldberg","Nancy",NA,NA
"374","34172354","10.1016/j.pedhc.2021.01.007","Telemedicine and Health Equity During COVID-19 in Pediatric Gastroenterology.","Telehealth (TH) services rapidly expanded during the COVID-19 pandemic. This rapid deployment precluded the opportunity for initial planning of implementation strategies. The purpose of the quality improvement project was to understand the needs of nurse practitioners and examine TH procedures and interventions designed to promote high-quality, equitable health care for pediatric patients with gastrointestinal concerns. The Plan-Do-Study-Act model was used. Survey data from providers and familie","2021","06","26","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","Telehealth; health equity; nurse practitioner; pediatrics; quality improvement","Marinaccio","Barbara",NA,NA
"375","34172354","10.1016/j.pedhc.2021.01.007","Telemedicine and Health Equity During COVID-19 in Pediatric Gastroenterology.","Telehealth (TH) services rapidly expanded during the COVID-19 pandemic. This rapid deployment precluded the opportunity for initial planning of implementation strategies. The purpose of the quality improvement project was to understand the needs of nurse practitioners and examine TH procedures and interventions designed to promote high-quality, equitable health care for pediatric patients with gastrointestinal concerns. The Plan-Do-Study-Act model was used. Survey data from providers and familie","2021","06","26","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","Telehealth; health equity; nurse practitioner; pediatrics; quality improvement","O'Malley","Kimberli",NA,NA
"376","34172354","10.1016/j.pedhc.2021.01.007","Telemedicine and Health Equity During COVID-19 in Pediatric Gastroenterology.","Telehealth (TH) services rapidly expanded during the COVID-19 pandemic. This rapid deployment precluded the opportunity for initial planning of implementation strategies. The purpose of the quality improvement project was to understand the needs of nurse practitioners and examine TH procedures and interventions designed to promote high-quality, equitable health care for pediatric patients with gastrointestinal concerns. The Plan-Do-Study-Act model was used. Survey data from providers and familie","2021","06","26","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","Telehealth; health equity; nurse practitioner; pediatrics; quality improvement","Dolan","Caitlin",NA,NA
"377","34172354","10.1016/j.pedhc.2021.01.007","Telemedicine and Health Equity During COVID-19 in Pediatric Gastroenterology.","Telehealth (TH) services rapidly expanded during the COVID-19 pandemic. This rapid deployment precluded the opportunity for initial planning of implementation strategies. The purpose of the quality improvement project was to understand the needs of nurse practitioners and examine TH procedures and interventions designed to promote high-quality, equitable health care for pediatric patients with gastrointestinal concerns. The Plan-Do-Study-Act model was used. Survey data from providers and familie","2021","06","26","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","Telehealth; health equity; nurse practitioner; pediatrics; quality improvement","Parker-Hartigan","Lori",NA,NA
"378","34172354","10.1016/j.pedhc.2021.01.007","Telemedicine and Health Equity During COVID-19 in Pediatric Gastroenterology.","Telehealth (TH) services rapidly expanded during the COVID-19 pandemic. This rapid deployment precluded the opportunity for initial planning of implementation strategies. The purpose of the quality improvement project was to understand the needs of nurse practitioners and examine TH procedures and interventions designed to promote high-quality, equitable health care for pediatric patients with gastrointestinal concerns. The Plan-Do-Study-Act model was used. Survey data from providers and familie","2021","06","26","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","Telehealth; health equity; nurse practitioner; pediatrics; quality improvement","Williams","Lucinda",NA,NA
"379","34172354","10.1016/j.pedhc.2021.01.007","Telemedicine and Health Equity During COVID-19 in Pediatric Gastroenterology.","Telehealth (TH) services rapidly expanded during the COVID-19 pandemic. This rapid deployment precluded the opportunity for initial planning of implementation strategies. The purpose of the quality improvement project was to understand the needs of nurse practitioners and examine TH procedures and interventions designed to promote high-quality, equitable health care for pediatric patients with gastrointestinal concerns. The Plan-Do-Study-Act model was used. Survey data from providers and familie","2021","06","26","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","Telehealth; health equity; nurse practitioner; pediatrics; quality improvement","Vessey","Judith A",NA,NA
"380","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Kimura","Yurika","Department of Otolaryngology, Ebara Hospital, Tokyo Metropolitan Health and Hospitals Corporation, Japan",NA
"381","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Nogami","Kenichiro","Japan Otorhinolaryngologist Association, Japan",NA
"382","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Watanabe","Kazuo","Japan Otorhinolaryngologist Association, Japan",NA
"383","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Yoshimura","Tadashi","Japan Otorhinolaryngologist Association, Japan",NA
"384","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Asai","Hideyo","Japan Otorhinolaryngologist Association, Japan",NA
"385","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Fujioka","Osamu","Japan Otorhinolaryngologist Association, Japan",NA
"386","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Kawasaki","Yoshiaki","Japan Otorhinolaryngologist Association, Japan",NA
"387","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Igarashi","Mitsuru","Committee of Community healthcare, The Oto-Rhino-Laryngological Society of Japan, Japan",NA
"388","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Inamura","Naoki","Committee of Community healthcare, The Oto-Rhino-Laryngological Society of Japan, Japan",NA
"389","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Kawashima","Kayoko","Committee of Community healthcare, The Oto-Rhino-Laryngological Society of Japan, Japan",NA
"390","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Nishino","Hiroshi","Committee of Community healthcare, The Oto-Rhino-Laryngological Society of Japan, Japan",NA
"391","34172351","10.1016/j.anl.2021.05.010","COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.","In Japan, many otolaryngologists provide primary care for patients with coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the characteristics of otorhinolaryngological findings in order to improve COVID-19 diagnostic systems in a primary care setting. A total of 351 patients (mean age, 36.0 ± 15.4 years) diagnosed with COVID-19 by otolaryngologists who belong to the Japan Otorhinolaryngologists Association were included in the study. A web-based questionnaire was used","2021","07","01","Auris Nasus Larynx","Auris, nasus, larynx","COVID-19; Centor score; Olfactory disturbances; Otolaryngological findings","Fukuyo","Kazumasa","Japan Otorhinolaryngologist Association, Japan",NA
"392","34172334","10.1016/j.jemermed.2021.04.019","Ethnic Disparities in COVID-19 Among Older Adults Presenting to the Geriatric Emergency Department.","There is a dearth of epidemiological data on ethnic disparities among older patients with COVID-19. The objective of this study was to characterize ethnic differences in clinical presentation and outcomes from COVID-19 among older U.S. adults. This was a retrospective cohort study within two geriatric emergency departments (GEDs) at a large academic health system. One hundred patients 65 years or older who visited a GED between March 10, 2020 and August 9, 2020 and tested positive for COVID-19 w","2021","07","01","J Emerg Med","The Journal of emergency medicine","COVID-19; Hispanic; disparities; ethnicity; geriatric emergency department","Shadyab","Aladdin H","Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla, California",NA
"393","34172334","10.1016/j.jemermed.2021.04.019","Ethnic Disparities in COVID-19 Among Older Adults Presenting to the Geriatric Emergency Department.","There is a dearth of epidemiological data on ethnic disparities among older patients with COVID-19. The objective of this study was to characterize ethnic differences in clinical presentation and outcomes from COVID-19 among older U.S. adults. This was a retrospective cohort study within two geriatric emergency departments (GEDs) at a large academic health system. One hundred patients 65 years or older who visited a GED between March 10, 2020 and August 9, 2020 and tested positive for COVID-19 w","2021","07","01","J Emerg Med","The Journal of emergency medicine","COVID-19; Hispanic; disparities; ethnicity; geriatric emergency department","Tolia","Vaishal M","Department of Emergency Medicine, University of California, San Diego, La Jolla, California",NA
"394","34172334","10.1016/j.jemermed.2021.04.019","Ethnic Disparities in COVID-19 Among Older Adults Presenting to the Geriatric Emergency Department.","There is a dearth of epidemiological data on ethnic disparities among older patients with COVID-19. The objective of this study was to characterize ethnic differences in clinical presentation and outcomes from COVID-19 among older U.S. adults. This was a retrospective cohort study within two geriatric emergency departments (GEDs) at a large academic health system. One hundred patients 65 years or older who visited a GED between March 10, 2020 and August 9, 2020 and tested positive for COVID-19 w","2021","07","01","J Emerg Med","The Journal of emergency medicine","COVID-19; Hispanic; disparities; ethnicity; geriatric emergency department","Brennan","Jesse J","Department of Emergency Medicine, University of California, San Diego, La Jolla, California",NA
"395","34172334","10.1016/j.jemermed.2021.04.019","Ethnic Disparities in COVID-19 Among Older Adults Presenting to the Geriatric Emergency Department.","There is a dearth of epidemiological data on ethnic disparities among older patients with COVID-19. The objective of this study was to characterize ethnic differences in clinical presentation and outcomes from COVID-19 among older U.S. adults. This was a retrospective cohort study within two geriatric emergency departments (GEDs) at a large academic health system. One hundred patients 65 years or older who visited a GED between March 10, 2020 and August 9, 2020 and tested positive for COVID-19 w","2021","07","01","J Emerg Med","The Journal of emergency medicine","COVID-19; Hispanic; disparities; ethnicity; geriatric emergency department","Chan","Theodore C","Department of Emergency Medicine, University of California, San Diego, La Jolla, California",NA
"396","34172334","10.1016/j.jemermed.2021.04.019","Ethnic Disparities in COVID-19 Among Older Adults Presenting to the Geriatric Emergency Department.","There is a dearth of epidemiological data on ethnic disparities among older patients with COVID-19. The objective of this study was to characterize ethnic differences in clinical presentation and outcomes from COVID-19 among older U.S. adults. This was a retrospective cohort study within two geriatric emergency departments (GEDs) at a large academic health system. One hundred patients 65 years or older who visited a GED between March 10, 2020 and August 9, 2020 and tested positive for COVID-19 w","2021","07","01","J Emerg Med","The Journal of emergency medicine","COVID-19; Hispanic; disparities; ethnicity; geriatric emergency department","Castillo","Edward M","Department of Emergency Medicine, University of California, San Diego, La Jolla, California",NA
"397","34172330","10.1016/j.vaccine.2021.06.041","Early influenza vaccination rates decline in children during the COVID-19 pandemic.","This investigation sought to determine whether early season rates of pediatric influenza vaccination changed in a season when there was a concurrent COVID-19 pandemic. This study used cohort and cross sectional data from an academic primary care division in Southcentral Pennsylvania that serves approximately 17,500 patients across 4 practice sites. Early season (prior to November 1) vaccination rates in 2018, 2019 and 2020 were recorded for children, age 6 months to 17 years. To explore the impa","2021","07","09","Vaccine","Vaccine","COVID-19; Child; Cross-Sectional Studies; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Pennsylvania; SARS-CoV-2; Vaccination","Fogel","Benjamin","Department of Pediatrics, Penn State College of Medicine, United States. Electronic address: bfogel@pennstatehealth.psu","bfogel@pennstatehealth.psu.edu"
"398","34172330","10.1016/j.vaccine.2021.06.041","Early influenza vaccination rates decline in children during the COVID-19 pandemic.","This investigation sought to determine whether early season rates of pediatric influenza vaccination changed in a season when there was a concurrent COVID-19 pandemic. This study used cohort and cross sectional data from an academic primary care division in Southcentral Pennsylvania that serves approximately 17,500 patients across 4 practice sites. Early season (prior to November 1) vaccination rates in 2018, 2019 and 2020 were recorded for children, age 6 months to 17 years. To explore the impa","2021","07","09","Vaccine","Vaccine","COVID-19; Child; Cross-Sectional Studies; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Pennsylvania; SARS-CoV-2; Vaccination","Schaefer","Eric W","Department of Public Health Sciences, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, United States. Electronic address: ESchaefer@phs.psu","ESchaefer@phs.psu.edu"
"399","34172330","10.1016/j.vaccine.2021.06.041","Early influenza vaccination rates decline in children during the COVID-19 pandemic.","This investigation sought to determine whether early season rates of pediatric influenza vaccination changed in a season when there was a concurrent COVID-19 pandemic. This study used cohort and cross sectional data from an academic primary care division in Southcentral Pennsylvania that serves approximately 17,500 patients across 4 practice sites. Early season (prior to November 1) vaccination rates in 2018, 2019 and 2020 were recorded for children, age 6 months to 17 years. To explore the impa","2021","07","09","Vaccine","Vaccine","COVID-19; Child; Cross-Sectional Studies; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Pennsylvania; SARS-CoV-2; Vaccination","Hicks","Steven D","Department of Pediatrics, Penn State College of Medicine, United States. Electronic address: shicks1@pennstatehealth.psu","shicks1@pennstatehealth.psu.edu"
"400","34172329","10.1016/j.vaccine.2021.06.027","Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines.","Many persons with religious convictions report hesitancy about COVID-19 vaccines, in part due to ethical concerns that fetal cell lines are used in the development of certain vaccines. The issue of abortion is contentious and, given the potential impact on COVID-19 vaccination, it is important for clinicians to be aware of this issue, whatever their personal beliefs. I provide four responses that clinicians may offer their patients: 1) Ethical analyses of moral complicity and COVID vaccines. 2) ","2021","07","09","Vaccine","Vaccine","COVID-19 vaccines; Fetal cell line ethics; Vaccine ethics; COVID-19; COVID-19 Vaccines; Cell Line; Female; Humans; Pregnancy; SARS-CoV-2; Vaccination; Vaccines","Zimmerman","Richard K","University of Pittsburgh, School of Medicine, Department of Family Medicine, USA","zimmer@pitt.edu"
"401","34172324","10.1016/j.ijmmb.2021.06.006","Antimicrobial resistance and the COVID -19 pandemic: A double threat.",NA,"2021","07","01","Indian J Med Microbiol","Indian journal of medical microbiology",NA,"Kanungo","Reba","Department of of Microbiology, Pondicherry Institute of Medical Sciences, Kalathumettupathai, Ganapathichettikulam Village No.20, Kalapet, Puducherry 605014, India. Electronic address: reba.kanungo@gmail","reba.kanungo@gmail.com"
"402","34172316","10.1016/j.cpcardiol.2021.100905","Presentation and Outcome of Congenital Heart Disease During Covid-19 Pandemic: A Review.","Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-COV2) infection is a rapid evolving pandemic with multiple peaks of outbreak and substantial mortality worldwide. It has been proposed that infants are more vulnerable to SARS-COV-2 infection. On the other hand, children with COVID-19 have generally milder disease compared to infected adults and more often presented with gastrointestinal symptoms compared to respiratory ones. Multisystem inflammatory syndrome in children (MIS-c) i","2021","07","01","Curr Probl Cardiol","Current problems in cardiology",NA,"Soleimani","Azam","Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran","asoleimanii@gmail.com"
"403","34172316","10.1016/j.cpcardiol.2021.100905","Presentation and Outcome of Congenital Heart Disease During Covid-19 Pandemic: A Review.","Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-COV2) infection is a rapid evolving pandemic with multiple peaks of outbreak and substantial mortality worldwide. It has been proposed that infants are more vulnerable to SARS-COV-2 infection. On the other hand, children with COVID-19 have generally milder disease compared to infected adults and more often presented with gastrointestinal symptoms compared to respiratory ones. Multisystem inflammatory syndrome in children (MIS-c) i","2021","07","01","Curr Probl Cardiol","Current problems in cardiology",NA,"Soleimani","Zahra","Perinatologist, Nephrology and Urology research center, Baqiyatallah University of Medical Sciences, Tehran, Iran",NA
"404","34172313","10.1016/j.regg.2021.05.009","[Single dose of SARS-CoV-2 mRNA vaccine in post-COVID-19 elderly people].",NA,"2021","07","01","Rev Esp Geriatr Gerontol","Revista espanola de geriatria y gerontologia",NA,"Nieto Colino","Sonia","Servicio de Geriatría, Hospital Universitario de Móstoles, Móstoles, Madrid, España. Electronic address: sonia.nieto@salud.madrid","sonia.nieto@salud.madrid.org"
"405","34172313","10.1016/j.regg.2021.05.009","[Single dose of SARS-CoV-2 mRNA vaccine in post-COVID-19 elderly people].",NA,"2021","07","01","Rev Esp Geriatr Gerontol","Revista espanola de geriatria y gerontologia",NA,"Cid Abasolo","Francisco Javier","Servicio de Geriatría, Hospital Universitario de Móstoles, Móstoles, Madrid, España",NA
"406","34172313","10.1016/j.regg.2021.05.009","[Single dose of SARS-CoV-2 mRNA vaccine in post-COVID-19 elderly people].",NA,"2021","07","01","Rev Esp Geriatr Gerontol","Revista espanola de geriatria y gerontologia",NA,"Martínez Hernández","Juan","Servicio de Medicina Preventiva, Hospital Universitario de Móstoles, Móstoles, Madrid, España",NA
"407","34172309","10.1016/j.medcli.2021.05.010","Declaration of COVID-19 as an occupational disease in healthcare workers: challenges and reality.",NA,"2021","07","01","Med Clin (Barc)","Medicina clinica",NA,"Gil-Blanco","Laura","Grupo Consolidado de Investigación GIIS- 063, Instituto de Investigación Sanitaria de Aragón (ISS-Aragón), Aragón, España",NA
"408","34172309","10.1016/j.medcli.2021.05.010","Declaration of COVID-19 as an occupational disease in healthcare workers: challenges and reality.",NA,"2021","07","01","Med Clin (Barc)","Medicina clinica",NA,"Martínez-Jarreta","Begoña","Grupo Consolidado de Investigación GIIS- 063, Instituto de Investigación Sanitaria de Aragón (ISS-Aragón), Aragón, España","mjarreta@unizar.es"
"409","34172305","10.1016/j.puhe.2021.05.018","Reinfections with SARS-CoV-2 or second COVID-19 episodes?",NA,"2021","07","01","Public Health","Public health",NA,"Cabrera-Gaytán","David Alejandro","Mexican Institute of Social Security, Mexico City, Mexico. Electronic address: david.cabrerag@imss.gob","david.cabrerag@imss.gob.mx"
"410","34172305","10.1016/j.puhe.2021.05.018","Reinfections with SARS-CoV-2 or second COVID-19 episodes?",NA,"2021","07","01","Public Health","Public health",NA,"Santiago-Espinosa","Oscar","Mexican Institute of Social Security, Quintana Roo, Mexico. Electronic address: oscar.santiagoe@imss.gob","oscar.santiagoe@imss.gob.mx"
"411","34172305","10.1016/j.puhe.2021.05.018","Reinfections with SARS-CoV-2 or second COVID-19 episodes?",NA,"2021","07","01","Public Health","Public health",NA,"Prieto Torres","María Erandhi","Mexican Institute of Social Security, Quintana Roo, Mexico. Electronic address: erandhi.prieto@imss.gob","erandhi.prieto@imss.gob.mx"
"412","34172292","10.1016/j.neurol.2021.05.001","Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection.","To analyze the humoral response after COVID-19 vaccination in patients with multiple sclerosis (MS) according to disease-modifying treatments (DMTs) and in comparison with the humoral response after SARS-CoV-2 infection. We included 28 MS patients with serological results after COVID-19 vaccination (Pfizer-BioNTech or Moderna ARNm) and 61 MS patients with serological results after COVID-19 (COVID-19 group) among patients followed up at the MS Center of Strasbourg, France, between January and Apr","2021","07","01","Rev Neurol (Paris)","Revue neurologique","Antibody; COVID-19; Humoral response; Multiple sclerosis; Vaccine","Bigaut","K","Department of Neurology, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg, France",NA
"413","34172292","10.1016/j.neurol.2021.05.001","Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection.","To analyze the humoral response after COVID-19 vaccination in patients with multiple sclerosis (MS) according to disease-modifying treatments (DMTs) and in comparison with the humoral response after SARS-CoV-2 infection. We included 28 MS patients with serological results after COVID-19 vaccination (Pfizer-BioNTech or Moderna ARNm) and 61 MS patients with serological results after COVID-19 (COVID-19 group) among patients followed up at the MS Center of Strasbourg, France, between January and Apr","2021","07","01","Rev Neurol (Paris)","Revue neurologique","Antibody; COVID-19; Humoral response; Multiple sclerosis; Vaccine","Kremer","L","Department of Neurology, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg, France",NA
"414","34172292","10.1016/j.neurol.2021.05.001","Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection.","To analyze the humoral response after COVID-19 vaccination in patients with multiple sclerosis (MS) according to disease-modifying treatments (DMTs) and in comparison with the humoral response after SARS-CoV-2 infection. We included 28 MS patients with serological results after COVID-19 vaccination (Pfizer-BioNTech or Moderna ARNm) and 61 MS patients with serological results after COVID-19 (COVID-19 group) among patients followed up at the MS Center of Strasbourg, France, between January and Apr","2021","07","01","Rev Neurol (Paris)","Revue neurologique","Antibody; COVID-19; Humoral response; Multiple sclerosis; Vaccine","Fleury","M","Department of Neurology, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg, France",NA
"415","34172292","10.1016/j.neurol.2021.05.001","Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection.","To analyze the humoral response after COVID-19 vaccination in patients with multiple sclerosis (MS) according to disease-modifying treatments (DMTs) and in comparison with the humoral response after SARS-CoV-2 infection. We included 28 MS patients with serological results after COVID-19 vaccination (Pfizer-BioNTech or Moderna ARNm) and 61 MS patients with serological results after COVID-19 (COVID-19 group) among patients followed up at the MS Center of Strasbourg, France, between January and Apr","2021","07","01","Rev Neurol (Paris)","Revue neurologique","Antibody; COVID-19; Humoral response; Multiple sclerosis; Vaccine","Lanotte","L","Department of Neurology, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg, France",NA
"416","34172292","10.1016/j.neurol.2021.05.001","Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection.","To analyze the humoral response after COVID-19 vaccination in patients with multiple sclerosis (MS) according to disease-modifying treatments (DMTs) and in comparison with the humoral response after SARS-CoV-2 infection. We included 28 MS patients with serological results after COVID-19 vaccination (Pfizer-BioNTech or Moderna ARNm) and 61 MS patients with serological results after COVID-19 (COVID-19 group) among patients followed up at the MS Center of Strasbourg, France, between January and Apr","2021","07","01","Rev Neurol (Paris)","Revue neurologique","Antibody; COVID-19; Humoral response; Multiple sclerosis; Vaccine","Collongues","N","Department of Neurology, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg, France",NA
"417","34172292","10.1016/j.neurol.2021.05.001","Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection.","To analyze the humoral response after COVID-19 vaccination in patients with multiple sclerosis (MS) according to disease-modifying treatments (DMTs) and in comparison with the humoral response after SARS-CoV-2 infection. We included 28 MS patients with serological results after COVID-19 vaccination (Pfizer-BioNTech or Moderna ARNm) and 61 MS patients with serological results after COVID-19 (COVID-19 group) among patients followed up at the MS Center of Strasbourg, France, between January and Apr","2021","07","01","Rev Neurol (Paris)","Revue neurologique","Antibody; COVID-19; Humoral response; Multiple sclerosis; Vaccine","de Seze","J","Department of Neurology, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg, France",NA
"418","34172261","10.1016/j.identj.2021.05.002","Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment.","The objective of the present study was to investigate the presence of SARS-CoV-2 in aerosol and COVID-19 contamination distance asssociated with ultrasonic scaling and tooth preparation. Twenty-four patients with COVID-19 were included in this study. Removal of supragingival plaque with ultrasonic instruments for 10 minutes and high-speed air-turbine using for the simulation of cutting the maxillary right canine tooth with a round diamond bur for 5 minutes were performed. Patients were randomly ","2021","07","01","Int Dent J","International dental journal","Aerosol; Covid-19; PCR test; Scaling; Suction","Akin","Hakan","Department of Prosthodontics, Faculty of Dentistry, Sakarya University, Sakarya, Turkey. Electronic address: drhknkn@hotmail","drhknkn@hotmail.com"
"419","34172261","10.1016/j.identj.2021.05.002","Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment.","The objective of the present study was to investigate the presence of SARS-CoV-2 in aerosol and COVID-19 contamination distance asssociated with ultrasonic scaling and tooth preparation. Twenty-four patients with COVID-19 were included in this study. Removal of supragingival plaque with ultrasonic instruments for 10 minutes and high-speed air-turbine using for the simulation of cutting the maxillary right canine tooth with a round diamond bur for 5 minutes were performed. Patients were randomly ","2021","07","01","Int Dent J","International dental journal","Aerosol; Covid-19; PCR test; Scaling; Suction","Karabay","Oguz","Department of Infectious Diseases, Faculty of Medicine, Sakarya University, Sakarya, Turkey",NA
"420","34172261","10.1016/j.identj.2021.05.002","Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment.","The objective of the present study was to investigate the presence of SARS-CoV-2 in aerosol and COVID-19 contamination distance asssociated with ultrasonic scaling and tooth preparation. Twenty-four patients with COVID-19 were included in this study. Removal of supragingival plaque with ultrasonic instruments for 10 minutes and high-speed air-turbine using for the simulation of cutting the maxillary right canine tooth with a round diamond bur for 5 minutes were performed. Patients were randomly ","2021","07","01","Int Dent J","International dental journal","Aerosol; Covid-19; PCR test; Scaling; Suction","Toptan","Hande","Department of Microbiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey",NA
"421","34172261","10.1016/j.identj.2021.05.002","Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment.","The objective of the present study was to investigate the presence of SARS-CoV-2 in aerosol and COVID-19 contamination distance asssociated with ultrasonic scaling and tooth preparation. Twenty-four patients with COVID-19 were included in this study. Removal of supragingival plaque with ultrasonic instruments for 10 minutes and high-speed air-turbine using for the simulation of cutting the maxillary right canine tooth with a round diamond bur for 5 minutes were performed. Patients were randomly ","2021","07","01","Int Dent J","International dental journal","Aerosol; Covid-19; PCR test; Scaling; Suction","Furuncuoglu","Halit","Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Sakarya University, Sakarya, Turkey",NA
"422","34172261","10.1016/j.identj.2021.05.002","Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment.","The objective of the present study was to investigate the presence of SARS-CoV-2 in aerosol and COVID-19 contamination distance asssociated with ultrasonic scaling and tooth preparation. Twenty-four patients with COVID-19 were included in this study. Removal of supragingival plaque with ultrasonic instruments for 10 minutes and high-speed air-turbine using for the simulation of cutting the maxillary right canine tooth with a round diamond bur for 5 minutes were performed. Patients were randomly ","2021","07","01","Int Dent J","International dental journal","Aerosol; Covid-19; PCR test; Scaling; Suction","Kaya","Gurkan","Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Sakarya University, Sakarya, Turkey",NA
"423","34172261","10.1016/j.identj.2021.05.002","Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment.","The objective of the present study was to investigate the presence of SARS-CoV-2 in aerosol and COVID-19 contamination distance asssociated with ultrasonic scaling and tooth preparation. Twenty-four patients with COVID-19 were included in this study. Removal of supragingival plaque with ultrasonic instruments for 10 minutes and high-speed air-turbine using for the simulation of cutting the maxillary right canine tooth with a round diamond bur for 5 minutes were performed. Patients were randomly ","2021","07","01","Int Dent J","International dental journal","Aerosol; Covid-19; PCR test; Scaling; Suction","Akin","Emine Gulsah","Department of Restorative Dentistry, Faculty of Dentistry, Sakarya University, Sakarya, Turkey",NA
"424","34172261","10.1016/j.identj.2021.05.002","Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment.","The objective of the present study was to investigate the presence of SARS-CoV-2 in aerosol and COVID-19 contamination distance asssociated with ultrasonic scaling and tooth preparation. Twenty-four patients with COVID-19 were included in this study. Removal of supragingival plaque with ultrasonic instruments for 10 minutes and high-speed air-turbine using for the simulation of cutting the maxillary right canine tooth with a round diamond bur for 5 minutes were performed. Patients were randomly ","2021","07","01","Int Dent J","International dental journal","Aerosol; Covid-19; PCR test; Scaling; Suction","Koroglu","Mehmet","Department of Microbiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey",NA
"425","34172241","10.1016/j.amj.2021.04.005","Helicopter Emergency Medical Services During Coronavirus Disease 2019 in Nepal.","Virtually every country in the world has been affected by coronavirus disease 2019 (COVID-19). Nepal is a landlocked country located in Southern Asia. Nepal's population has suffered greatly due to a shortage of critical care facilities, resources, and trained personnel. For appropriate care, patients need access to hospitals mostly in the centrally located capital city of Kathmandu. Unfortunately, Nepal's resources and personnel dedicated to transferring COVID-19 patients are scarce. Road and t","2021","07","13","Air Med J","Air medical journal","Air Ambulances; COVID-19; Humans; Nepal; Rural Health Services","Karki","Sanjaya","Department of ER/EMS/HEMS, Nepal Mediciti Hospital, Kathmandu, Nepal. Electronic address: sanjaya.karki@nepalmediciti","sanjaya.karki@nepalmediciti.com"
"426","34172241","10.1016/j.amj.2021.04.005","Helicopter Emergency Medical Services During Coronavirus Disease 2019 in Nepal.","Virtually every country in the world has been affected by coronavirus disease 2019 (COVID-19). Nepal is a landlocked country located in Southern Asia. Nepal's population has suffered greatly due to a shortage of critical care facilities, resources, and trained personnel. For appropriate care, patients need access to hospitals mostly in the centrally located capital city of Kathmandu. Unfortunately, Nepal's resources and personnel dedicated to transferring COVID-19 patients are scarce. Road and t","2021","07","13","Air Med J","Air medical journal","Air Ambulances; COVID-19; Humans; Nepal; Rural Health Services","Sprinkle","Daniel J","Med-Trans Corporation Air Care program in Alabama, USA",NA
"427","34172240","10.1016/j.amj.2021.03.014","Overseas Air Medical Repatriation of National Soccer Players Infected With Coronavirus Disease 2019 and Contacted Staff From Austria to South Korea.","Korea rarely has a system to transport patients from abroad. However, single-patient transfers are steadily being performed, and there was an experience of transferring a large number of personnel regardless of whether they were confirmed or not due to coronavirus disease 2019. Recently, a national soccer game was held abroad, and a total of 8 players and staff were infected. A total of 15 people were transported through a charter fully equipped with quarantine equipment by a medical response te","2021","07","13","Air Med J","Air medical journal","Air Ambulances; Athletes; Austria; COVID-19; Humans; Quarantine; Republic of Korea; Soccer; Travel-Related Illness","Choi","Hyo-Jeong","Department of Emergency Medical trainee, Sunmoon University, Asan, Republic of Korea",NA
"428","34172240","10.1016/j.amj.2021.03.014","Overseas Air Medical Repatriation of National Soccer Players Infected With Coronavirus Disease 2019 and Contacted Staff From Austria to South Korea.","Korea rarely has a system to transport patients from abroad. However, single-patient transfers are steadily being performed, and there was an experience of transferring a large number of personnel regardless of whether they were confirmed or not due to coronavirus disease 2019. Recently, a national soccer game was held abroad, and a total of 8 players and staff were infected. A total of 15 people were transported through a charter fully equipped with quarantine equipment by a medical response te","2021","07","13","Air Med J","Air medical journal","Air Ambulances; Athletes; Austria; COVID-19; Humans; Quarantine; Republic of Korea; Soccer; Travel-Related Illness","Kim","Ho-Jung","Department of Emergency Medicine, Bucheon hospital of Soonchunhyang University, Bucheon, Republic of Korea. Electronic address: lovelydr@schmc.ac","lovelydr@schmc.ac.kr"
"429","34172240","10.1016/j.amj.2021.03.014","Overseas Air Medical Repatriation of National Soccer Players Infected With Coronavirus Disease 2019 and Contacted Staff From Austria to South Korea.","Korea rarely has a system to transport patients from abroad. However, single-patient transfers are steadily being performed, and there was an experience of transferring a large number of personnel regardless of whether they were confirmed or not due to coronavirus disease 2019. Recently, a national soccer game was held abroad, and a total of 8 players and staff were infected. A total of 15 people were transported through a charter fully equipped with quarantine equipment by a medical response te","2021","07","13","Air Med J","Air medical journal","Air Ambulances; Athletes; Austria; COVID-19; Humans; Quarantine; Republic of Korea; Soccer; Travel-Related Illness","Seo","Gon","Department of Emergency Medicine, Gyeonggi Provincial Medical Center, Ansung Hospital, Ansung, Republic of Korea",NA
"430","34172228","10.1016/j.amj.2021.04.001","Decision Making and Interventions During Interfacility Transport of High-Acuity Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","There are limited data regarding the typical characteristics of coronavirus disease 2019 (COVID-19) patients requiring interfacility transport or the clinical capabilities of the out-of-hospital transport clinicians required to provide safe transport. The objective of this study is to provide epidemiologic data and highlight the clinical skill set and decision making needed to transport critically ill COVID-19 patients. A retrospective chart review of persons under investigation for COVID-19 tra","2021","07","13","Air Med J","Air medical journal","Adult; Aged; Aged, 80 and over; COVID-19; Clinical Competence; Clinical Decision-Making; Combined Modality Therapy; Critical Care; Critical Illness; Female; Humans; Male; Maryland; Middle Aged; Patient Acuity; Patient Transfer; Retrospective Studies; Transportation of Patients","Troncoso","Ruben D","Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD","rtronco1@jhmi.edu"
"431","34172228","10.1016/j.amj.2021.04.001","Decision Making and Interventions During Interfacility Transport of High-Acuity Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","There are limited data regarding the typical characteristics of coronavirus disease 2019 (COVID-19) patients requiring interfacility transport or the clinical capabilities of the out-of-hospital transport clinicians required to provide safe transport. The objective of this study is to provide epidemiologic data and highlight the clinical skill set and decision making needed to transport critically ill COVID-19 patients. A retrospective chart review of persons under investigation for COVID-19 tra","2021","07","13","Air Med J","Air medical journal","Adult; Aged; Aged, 80 and over; COVID-19; Clinical Competence; Clinical Decision-Making; Combined Modality Therapy; Critical Care; Critical Illness; Female; Humans; Male; Maryland; Middle Aged; Patient Acuity; Patient Transfer; Retrospective Studies; Transportation of Patients","Garfinkel","Eric M","Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"432","34172228","10.1016/j.amj.2021.04.001","Decision Making and Interventions During Interfacility Transport of High-Acuity Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","There are limited data regarding the typical characteristics of coronavirus disease 2019 (COVID-19) patients requiring interfacility transport or the clinical capabilities of the out-of-hospital transport clinicians required to provide safe transport. The objective of this study is to provide epidemiologic data and highlight the clinical skill set and decision making needed to transport critically ill COVID-19 patients. A retrospective chart review of persons under investigation for COVID-19 tra","2021","07","13","Air Med J","Air medical journal","Adult; Aged; Aged, 80 and over; COVID-19; Clinical Competence; Clinical Decision-Making; Combined Modality Therapy; Critical Care; Critical Illness; Female; Humans; Male; Maryland; Middle Aged; Patient Acuity; Patient Transfer; Retrospective Studies; Transportation of Patients","Leon","David","Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"433","34172228","10.1016/j.amj.2021.04.001","Decision Making and Interventions During Interfacility Transport of High-Acuity Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","There are limited data regarding the typical characteristics of coronavirus disease 2019 (COVID-19) patients requiring interfacility transport or the clinical capabilities of the out-of-hospital transport clinicians required to provide safe transport. The objective of this study is to provide epidemiologic data and highlight the clinical skill set and decision making needed to transport critically ill COVID-19 patients. A retrospective chart review of persons under investigation for COVID-19 tra","2021","07","13","Air Med J","Air medical journal","Adult; Aged; Aged, 80 and over; COVID-19; Clinical Competence; Clinical Decision-Making; Combined Modality Therapy; Critical Care; Critical Illness; Female; Humans; Male; Maryland; Middle Aged; Patient Acuity; Patient Transfer; Retrospective Studies; Transportation of Patients","Lopez","Sandra M","Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"434","34172228","10.1016/j.amj.2021.04.001","Decision Making and Interventions During Interfacility Transport of High-Acuity Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","There are limited data regarding the typical characteristics of coronavirus disease 2019 (COVID-19) patients requiring interfacility transport or the clinical capabilities of the out-of-hospital transport clinicians required to provide safe transport. The objective of this study is to provide epidemiologic data and highlight the clinical skill set and decision making needed to transport critically ill COVID-19 patients. A retrospective chart review of persons under investigation for COVID-19 tra","2021","07","13","Air Med J","Air medical journal","Adult; Aged; Aged, 80 and over; COVID-19; Clinical Competence; Clinical Decision-Making; Combined Modality Therapy; Critical Care; Critical Illness; Female; Humans; Male; Maryland; Middle Aged; Patient Acuity; Patient Transfer; Retrospective Studies; Transportation of Patients","Lin","Andrew","Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"435","34172228","10.1016/j.amj.2021.04.001","Decision Making and Interventions During Interfacility Transport of High-Acuity Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","There are limited data regarding the typical characteristics of coronavirus disease 2019 (COVID-19) patients requiring interfacility transport or the clinical capabilities of the out-of-hospital transport clinicians required to provide safe transport. The objective of this study is to provide epidemiologic data and highlight the clinical skill set and decision making needed to transport critically ill COVID-19 patients. A retrospective chart review of persons under investigation for COVID-19 tra","2021","07","13","Air Med J","Air medical journal","Adult; Aged; Aged, 80 and over; COVID-19; Clinical Competence; Clinical Decision-Making; Combined Modality Therapy; Critical Care; Critical Illness; Female; Humans; Male; Maryland; Middle Aged; Patient Acuity; Patient Transfer; Retrospective Studies; Transportation of Patients","Jones","Dennis","Johns Hopkins Lifeline Critical Care Transportation Program, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"436","34172228","10.1016/j.amj.2021.04.001","Decision Making and Interventions During Interfacility Transport of High-Acuity Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","There are limited data regarding the typical characteristics of coronavirus disease 2019 (COVID-19) patients requiring interfacility transport or the clinical capabilities of the out-of-hospital transport clinicians required to provide safe transport. The objective of this study is to provide epidemiologic data and highlight the clinical skill set and decision making needed to transport critically ill COVID-19 patients. A retrospective chart review of persons under investigation for COVID-19 tra","2021","07","13","Air Med J","Air medical journal","Adult; Aged; Aged, 80 and over; COVID-19; Clinical Competence; Clinical Decision-Making; Combined Modality Therapy; Critical Care; Critical Illness; Female; Humans; Male; Maryland; Middle Aged; Patient Acuity; Patient Transfer; Retrospective Studies; Transportation of Patients","Trautman","Shawn","Johns Hopkins Lifeline Critical Care Transportation Program, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"437","34172228","10.1016/j.amj.2021.04.001","Decision Making and Interventions During Interfacility Transport of High-Acuity Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","There are limited data regarding the typical characteristics of coronavirus disease 2019 (COVID-19) patients requiring interfacility transport or the clinical capabilities of the out-of-hospital transport clinicians required to provide safe transport. The objective of this study is to provide epidemiologic data and highlight the clinical skill set and decision making needed to transport critically ill COVID-19 patients. A retrospective chart review of persons under investigation for COVID-19 tra","2021","07","13","Air Med J","Air medical journal","Adult; Aged; Aged, 80 and over; COVID-19; Clinical Competence; Clinical Decision-Making; Combined Modality Therapy; Critical Care; Critical Illness; Female; Humans; Male; Maryland; Middle Aged; Patient Acuity; Patient Transfer; Retrospective Studies; Transportation of Patients","Levy","Matthew J","Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"438","34172228","10.1016/j.amj.2021.04.001","Decision Making and Interventions During Interfacility Transport of High-Acuity Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","There are limited data regarding the typical characteristics of coronavirus disease 2019 (COVID-19) patients requiring interfacility transport or the clinical capabilities of the out-of-hospital transport clinicians required to provide safe transport. The objective of this study is to provide epidemiologic data and highlight the clinical skill set and decision making needed to transport critically ill COVID-19 patients. A retrospective chart review of persons under investigation for COVID-19 tra","2021","07","13","Air Med J","Air medical journal","Adult; Aged; Aged, 80 and over; COVID-19; Clinical Competence; Clinical Decision-Making; Combined Modality Therapy; Critical Care; Critical Illness; Female; Humans; Male; Maryland; Middle Aged; Patient Acuity; Patient Transfer; Retrospective Studies; Transportation of Patients","Margolis","Asa M","Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"439","34172226","10.1016/j.amj.2021.04.003","Analysis of European Air Medical Evacuation Flights of Coronavirus Disease 2019 Patients.","As part of the humanitarian response to the coronavirus disease 2019 (COVID-19) pandemic, the German and French Armed Forces provided air transport for patients from overwhelmed regional hospitals in Italy and France. The objective of this study was to analyze the characteristics of the missions and the medical conditions of COVID-19 patients transported during an air medical evacuation on fixed wing aircraft in March and April 2020. This was a retrospective analysis of transport records as well","2021","07","13","Air Med J","Air medical journal","Aged; Air Ambulances; COVID-19; Comorbidity; Critical Care; Europe; Female; Humans; Male; Middle Aged; Pandemics; Patient Transfer; Retrospective Studies; Severity of Illness Index","Sammito","Stefan","Department of Research, Science and Testing, German Air Force Centre for Aerospace Medicine, Cologne, Germany","stefansammito@bundeswehr.org"
"440","34172226","10.1016/j.amj.2021.04.003","Analysis of European Air Medical Evacuation Flights of Coronavirus Disease 2019 Patients.","As part of the humanitarian response to the coronavirus disease 2019 (COVID-19) pandemic, the German and French Armed Forces provided air transport for patients from overwhelmed regional hospitals in Italy and France. The objective of this study was to analyze the characteristics of the missions and the medical conditions of COVID-19 patients transported during an air medical evacuation on fixed wing aircraft in March and April 2020. This was a retrospective analysis of transport records as well","2021","07","13","Air Med J","Air medical journal","Aged; Air Ambulances; COVID-19; Comorbidity; Critical Care; Europe; Female; Humans; Male; Middle Aged; Pandemics; Patient Transfer; Retrospective Studies; Severity of Illness Index","Turc","Jean","Intensive Care Unit Anaesthesiology Department, Military Teaching Hospital Desgenettes, Lyon, France",NA
"441","34172226","10.1016/j.amj.2021.04.003","Analysis of European Air Medical Evacuation Flights of Coronavirus Disease 2019 Patients.","As part of the humanitarian response to the coronavirus disease 2019 (COVID-19) pandemic, the German and French Armed Forces provided air transport for patients from overwhelmed regional hospitals in Italy and France. The objective of this study was to analyze the characteristics of the missions and the medical conditions of COVID-19 patients transported during an air medical evacuation on fixed wing aircraft in March and April 2020. This was a retrospective analysis of transport records as well","2021","07","13","Air Med J","Air medical journal","Aged; Air Ambulances; COVID-19; Comorbidity; Critical Care; Europe; Female; Humans; Male; Middle Aged; Pandemics; Patient Transfer; Retrospective Studies; Severity of Illness Index","Post","Janina","Department of Occupational Medicine, Medical Faculty, Otto von Guericke University, Magdeburg, Germany",NA
"442","34172226","10.1016/j.amj.2021.04.003","Analysis of European Air Medical Evacuation Flights of Coronavirus Disease 2019 Patients.","As part of the humanitarian response to the coronavirus disease 2019 (COVID-19) pandemic, the German and French Armed Forces provided air transport for patients from overwhelmed regional hospitals in Italy and France. The objective of this study was to analyze the characteristics of the missions and the medical conditions of COVID-19 patients transported during an air medical evacuation on fixed wing aircraft in March and April 2020. This was a retrospective analysis of transport records as well","2021","07","13","Air Med J","Air medical journal","Aged; Air Ambulances; COVID-19; Comorbidity; Critical Care; Europe; Female; Humans; Male; Middle Aged; Pandemics; Patient Transfer; Retrospective Studies; Severity of Illness Index","Beaussac","Madeleine","0th Military Medical Unit, Route du Camp d'Aviation, Istres, France",NA
"443","34172226","10.1016/j.amj.2021.04.003","Analysis of European Air Medical Evacuation Flights of Coronavirus Disease 2019 Patients.","As part of the humanitarian response to the coronavirus disease 2019 (COVID-19) pandemic, the German and French Armed Forces provided air transport for patients from overwhelmed regional hospitals in Italy and France. The objective of this study was to analyze the characteristics of the missions and the medical conditions of COVID-19 patients transported during an air medical evacuation on fixed wing aircraft in March and April 2020. This was a retrospective analysis of transport records as well","2021","07","13","Air Med J","Air medical journal","Aged; Air Ambulances; COVID-19; Comorbidity; Critical Care; Europe; Female; Humans; Male; Middle Aged; Pandemics; Patient Transfer; Retrospective Studies; Severity of Illness Index","Hossfeld","Björn","Department X - Anaesthesiology, Intensive Care, Emergency Medicine and Pain Therapy, Bundeswehr Hospital Ulm, Ulm, Germany",NA
"444","34172226","10.1016/j.amj.2021.04.003","Analysis of European Air Medical Evacuation Flights of Coronavirus Disease 2019 Patients.","As part of the humanitarian response to the coronavirus disease 2019 (COVID-19) pandemic, the German and French Armed Forces provided air transport for patients from overwhelmed regional hospitals in Italy and France. The objective of this study was to analyze the characteristics of the missions and the medical conditions of COVID-19 patients transported during an air medical evacuation on fixed wing aircraft in March and April 2020. This was a retrospective analysis of transport records as well","2021","07","13","Air Med J","Air medical journal","Aged; Air Ambulances; COVID-19; Comorbidity; Critical Care; Europe; Female; Humans; Male; Middle Aged; Pandemics; Patient Transfer; Retrospective Studies; Severity of Illness Index","Boutonnet","Mathieu","Intensive Care Unit Anaesthesiology Department, Military Teaching Hospital Percy, Clamart, France",NA
"445","34172174","10.1016/j.ajodo.2021.01.017","Incorrect and clinically compromising cross-infection control advice given to orthodontists managing patients in the coronavirus disease 2019 pandemic.",NA,"2021","06","30","Am J Orthod Dentofacial Orthop","American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics","COVID-19; Humans; Infection Control; Orthodontists; Pandemics; SARS-CoV-2","Chate","Robert A C","Colchester, England",NA
"446","34172140","10.1016/j.jadohealth.2021.04.005","COVID-19 and Adolescent Mental Health in the United Kingdom.","This study examines the mental health impact of the COVID-19 pandemic on adolescents in the United Kingdom as well as social, demographic, and economic variations in the impact. Nationally representative longitudinal panel data from the Understanding Society COVID-19 survey were analyzed. The analytical sample comprises 886 adolescents aged 10-16 years surveyed both before and during the pandemic. The Strengths and Difficulties Questionnaire was used to measure adolescents' mental health. The re","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Inequality; Mental health; The United Kingdom; Adolescent; Adult; COVID-19; Child; Female; Humans; Male; Mental Disorders; Mental Health; Pandemics; SARS-CoV-2; United Kingdom","Hu","Yang","Department of Sociology, Lancaster University, United Kingdom. Electronic address: yang.hu@lancaster.ac","yang.hu@lancaster.ac.uk"
"447","34172140","10.1016/j.jadohealth.2021.04.005","COVID-19 and Adolescent Mental Health in the United Kingdom.","This study examines the mental health impact of the COVID-19 pandemic on adolescents in the United Kingdom as well as social, demographic, and economic variations in the impact. Nationally representative longitudinal panel data from the Understanding Society COVID-19 survey were analyzed. The analytical sample comprises 886 adolescents aged 10-16 years surveyed both before and during the pandemic. The Strengths and Difficulties Questionnaire was used to measure adolescents' mental health. The re","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Inequality; Mental health; The United Kingdom; Adolescent; Adult; COVID-19; Child; Female; Humans; Male; Mental Disorders; Mental Health; Pandemics; SARS-CoV-2; United Kingdom","Qian","Yue","Department of Sociology, University of British Columbia, Vancouver, BC Canada",NA
"448","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Miller","Maureen J","Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia","yax6@cdc.gov"
"449","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Dasgupta","Sharoda","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"450","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Ruffin","Jasmine","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"451","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Colton","Kevin","Children's Medical Group, Atlanta, Georgia",NA
"452","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","King","David","Children's Medical Group, Atlanta, Georgia",NA
"453","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Tate","Jacqueline E","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"454","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Kirking","Hannah L","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"455","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Bryant","Bobbi","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"456","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Hennesy","Nora","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"457","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Plata","Zuwena","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"458","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Nakayama","Jasmine Y","Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"459","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Tanner","Mary R","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"460","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Koyuncu","Aybüke","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"461","34172138","10.1016/j.jadohealth.2021.04.010","Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged &lt;18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.","The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged &lt;18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24-December 5, 2020. Among 4,995 ","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Adolescents; COVID-19; Children; Coronavirus; Adolescent; COVID-19; COVID-19 Testing; Child; Georgia; Humans; Outpatients; SARS-CoV-2","Rabold","Elizabeth","CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"462","34172137","10.1016/j.jadohealth.2021.04.035","Spatial Clustering of Adolescent Bereavement in the United States During the COVID-19 Pandemic.","Few studies have examined grief and bereavement in the context of a pandemic, particularly among young people during the ongoing COVID-19 pandemic. The objective of this study is to examine spatiotemporal clustering of bereavement using data from Crisis Text Line, an SMS-based intervention with widespread usage among youth and adolescents in the United States from January 2017 to September 2020. Results found significant spatial clustering of bereavement during the pandemic period in the late su","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Bereavement; COVID-19; Cluster detection; Crisis response; Geographic information systems; Help-seeking; Adolescent; Bereavement; COVID-19; Cluster Analysis; Grief; Humans; Pandemics; SARS-CoV-2; United States","Harden","Stella R","Department of Geography and Planning, Appalachian State University, Boone, North Carolina",NA
"463","34172137","10.1016/j.jadohealth.2021.04.035","Spatial Clustering of Adolescent Bereavement in the United States During the COVID-19 Pandemic.","Few studies have examined grief and bereavement in the context of a pandemic, particularly among young people during the ongoing COVID-19 pandemic. The objective of this study is to examine spatiotemporal clustering of bereavement using data from Crisis Text Line, an SMS-based intervention with widespread usage among youth and adolescents in the United States from January 2017 to September 2020. Results found significant spatial clustering of bereavement during the pandemic period in the late su","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Bereavement; COVID-19; Cluster detection; Crisis response; Geographic information systems; Help-seeking; Adolescent; Bereavement; COVID-19; Cluster Analysis; Grief; Humans; Pandemics; SARS-CoV-2; United States","Runkle","Jennifer D","North Carolina Institute For Climate Studies, North Carolina State University, Asheville, North Carolina",NA
"464","34172137","10.1016/j.jadohealth.2021.04.035","Spatial Clustering of Adolescent Bereavement in the United States During the COVID-19 Pandemic.","Few studies have examined grief and bereavement in the context of a pandemic, particularly among young people during the ongoing COVID-19 pandemic. The objective of this study is to examine spatiotemporal clustering of bereavement using data from Crisis Text Line, an SMS-based intervention with widespread usage among youth and adolescents in the United States from January 2017 to September 2020. Results found significant spatial clustering of bereavement during the pandemic period in the late su","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Bereavement; COVID-19; Cluster detection; Crisis response; Geographic information systems; Help-seeking; Adolescent; Bereavement; COVID-19; Cluster Analysis; Grief; Humans; Pandemics; SARS-CoV-2; United States","Weiser","Jaclyn","Data Team, Crisis Text Line, New York City, New York",NA
"465","34172137","10.1016/j.jadohealth.2021.04.035","Spatial Clustering of Adolescent Bereavement in the United States During the COVID-19 Pandemic.","Few studies have examined grief and bereavement in the context of a pandemic, particularly among young people during the ongoing COVID-19 pandemic. The objective of this study is to examine spatiotemporal clustering of bereavement using data from Crisis Text Line, an SMS-based intervention with widespread usage among youth and adolescents in the United States from January 2017 to September 2020. Results found significant spatial clustering of bereavement during the pandemic period in the late su","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Bereavement; COVID-19; Cluster detection; Crisis response; Geographic information systems; Help-seeking; Adolescent; Bereavement; COVID-19; Cluster Analysis; Grief; Humans; Pandemics; SARS-CoV-2; United States","Green","Shannon","Data Team, Crisis Text Line, New York City, New York",NA
"466","34172137","10.1016/j.jadohealth.2021.04.035","Spatial Clustering of Adolescent Bereavement in the United States During the COVID-19 Pandemic.","Few studies have examined grief and bereavement in the context of a pandemic, particularly among young people during the ongoing COVID-19 pandemic. The objective of this study is to examine spatiotemporal clustering of bereavement using data from Crisis Text Line, an SMS-based intervention with widespread usage among youth and adolescents in the United States from January 2017 to September 2020. Results found significant spatial clustering of bereavement during the pandemic period in the late su","2021","06","30","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","Bereavement; COVID-19; Cluster detection; Crisis response; Geographic information systems; Help-seeking; Adolescent; Bereavement; COVID-19; Cluster Analysis; Grief; Humans; Pandemics; SARS-CoV-2; United States","Sugg","Margaret M","Department of Geography and Planning, Appalachian State University, Boone, North Carolina. Electronic address: kovachmm@appstate","kovachmm@appstate.edu"
"467","34172106","10.30802/AALAS-JAALAS-20-000130","Reuse of Disposable Isolation Gowns in Rodent Facilities during a Pandemic.","Reuse of disposable personal protective equipment is traditionally discouraged, yet in times of heightened medical applications such as the SARS CoV-2 pandemic, it can be difficult to obtain. In this article we examine the reuse of disposable gowns with respect to still providing personnel protection. XR7, a fluorescent powder, was used to track contamination of gowns after manipulation of rodent cages. Mouse cages were treated with XR7 prior to manipulations. Disposable gowns were labeled for s","2021","07","23","J Am Assoc Lab Anim Sci","Journal of the American Association for Laboratory Animal Science : JAALAS","Animal Technicians; Animals; Animals, Laboratory; Disposable Equipment; Health Personnel; Housing, Animal; Humans; Mice; Pandemics; Personal Protective Equipment; Protective Clothing","Collins","Toi A","University Laboratory Animal Resources, Ohio State University, Columbus, Ohio",NA
"468","34172106","10.30802/AALAS-JAALAS-20-000130","Reuse of Disposable Isolation Gowns in Rodent Facilities during a Pandemic.","Reuse of disposable personal protective equipment is traditionally discouraged, yet in times of heightened medical applications such as the SARS CoV-2 pandemic, it can be difficult to obtain. In this article we examine the reuse of disposable gowns with respect to still providing personnel protection. XR7, a fluorescent powder, was used to track contamination of gowns after manipulation of rodent cages. Mouse cages were treated with XR7 prior to manipulations. Disposable gowns were labeled for s","2021","07","23","J Am Assoc Lab Anim Sci","Journal of the American Association for Laboratory Animal Science : JAALAS","Animal Technicians; Animals; Animals, Laboratory; Disposable Equipment; Health Personnel; Housing, Animal; Humans; Mice; Pandemics; Personal Protective Equipment; Protective Clothing","Sparks","Amanda E","University Laboratory Animal Resources, Ohio State University, Columbus, Ohio",NA
"469","34172106","10.30802/AALAS-JAALAS-20-000130","Reuse of Disposable Isolation Gowns in Rodent Facilities during a Pandemic.","Reuse of disposable personal protective equipment is traditionally discouraged, yet in times of heightened medical applications such as the SARS CoV-2 pandemic, it can be difficult to obtain. In this article we examine the reuse of disposable gowns with respect to still providing personnel protection. XR7, a fluorescent powder, was used to track contamination of gowns after manipulation of rodent cages. Mouse cages were treated with XR7 prior to manipulations. Disposable gowns were labeled for s","2021","07","23","J Am Assoc Lab Anim Sci","Journal of the American Association for Laboratory Animal Science : JAALAS","Animal Technicians; Animals; Animals, Laboratory; Disposable Equipment; Health Personnel; Housing, Animal; Humans; Mice; Pandemics; Personal Protective Equipment; Protective Clothing","Walker","Mary M","University Laboratory Animal Resources, Ohio State University, Columbus, Ohio",NA
"470","34172106","10.30802/AALAS-JAALAS-20-000130","Reuse of Disposable Isolation Gowns in Rodent Facilities during a Pandemic.","Reuse of disposable personal protective equipment is traditionally discouraged, yet in times of heightened medical applications such as the SARS CoV-2 pandemic, it can be difficult to obtain. In this article we examine the reuse of disposable gowns with respect to still providing personnel protection. XR7, a fluorescent powder, was used to track contamination of gowns after manipulation of rodent cages. Mouse cages were treated with XR7 prior to manipulations. Disposable gowns were labeled for s","2021","07","23","J Am Assoc Lab Anim Sci","Journal of the American Association for Laboratory Animal Science : JAALAS","Animal Technicians; Animals; Animals, Laboratory; Disposable Equipment; Health Personnel; Housing, Animal; Humans; Mice; Pandemics; Personal Protective Equipment; Protective Clothing","Kendall","Lon V","Department of Laboratory Animal Resources, Colorado State University, Fort Collins, Colorado",NA
"471","34172106","10.30802/AALAS-JAALAS-20-000130","Reuse of Disposable Isolation Gowns in Rodent Facilities during a Pandemic.","Reuse of disposable personal protective equipment is traditionally discouraged, yet in times of heightened medical applications such as the SARS CoV-2 pandemic, it can be difficult to obtain. In this article we examine the reuse of disposable gowns with respect to still providing personnel protection. XR7, a fluorescent powder, was used to track contamination of gowns after manipulation of rodent cages. Mouse cages were treated with XR7 prior to manipulations. Disposable gowns were labeled for s","2021","07","23","J Am Assoc Lab Anim Sci","Journal of the American Association for Laboratory Animal Science : JAALAS","Animal Technicians; Animals; Animals, Laboratory; Disposable Equipment; Health Personnel; Housing, Animal; Humans; Mice; Pandemics; Personal Protective Equipment; Protective Clothing","Dobos","Karen M","Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado",NA
"472","34172106","10.30802/AALAS-JAALAS-20-000130","Reuse of Disposable Isolation Gowns in Rodent Facilities during a Pandemic.","Reuse of disposable personal protective equipment is traditionally discouraged, yet in times of heightened medical applications such as the SARS CoV-2 pandemic, it can be difficult to obtain. In this article we examine the reuse of disposable gowns with respect to still providing personnel protection. XR7, a fluorescent powder, was used to track contamination of gowns after manipulation of rodent cages. Mouse cages were treated with XR7 prior to manipulations. Disposable gowns were labeled for s","2021","07","23","J Am Assoc Lab Anim Sci","Journal of the American Association for Laboratory Animal Science : JAALAS","Animal Technicians; Animals; Animals, Laboratory; Disposable Equipment; Health Personnel; Housing, Animal; Humans; Mice; Pandemics; Personal Protective Equipment; Protective Clothing","Bergdall","Valerie K","University Laboratory Animal Resources, Ohio State University, Columbus, Ohio",NA
"473","34172106","10.30802/AALAS-JAALAS-20-000130","Reuse of Disposable Isolation Gowns in Rodent Facilities during a Pandemic.","Reuse of disposable personal protective equipment is traditionally discouraged, yet in times of heightened medical applications such as the SARS CoV-2 pandemic, it can be difficult to obtain. In this article we examine the reuse of disposable gowns with respect to still providing personnel protection. XR7, a fluorescent powder, was used to track contamination of gowns after manipulation of rodent cages. Mouse cages were treated with XR7 prior to manipulations. Disposable gowns were labeled for s","2021","07","23","J Am Assoc Lab Anim Sci","Journal of the American Association for Laboratory Animal Science : JAALAS","Animal Technicians; Animals; Animals, Laboratory; Disposable Equipment; Health Personnel; Housing, Animal; Humans; Mice; Pandemics; Personal Protective Equipment; Protective Clothing","Hickman-Davis","Judy M","University Laboratory Animal Resources, Ohio State University, Columbus, Ohio","davis.2@osu.edu"
"474","34172071","10.1186/s13063-021-05353-y","The Retornus-2 study: impact of respiratory muscle training in subacute stroke patients with dysphagia, study protocol of a double-blind randomized controlled trial.","Stroke can lead to varying degrees of oropharyngeal dysphagia, respiratory muscle dysfunction and even increase medical complications such as aspiration, malnutrition and death. Recent studies suggest that inspiratory and expiratory respiratory muscle training (IEMT) can improve swallowing efficacy and may reduce aspiration events. The main purpose of this study is to examine whether an 8-week IEMT programme can improve respiratory muscle strength and swallow dysfunction severity in subacute str","2021","06","29","Trials","Trials","Dysphagia; Randomized clinical trial; Rehabilitation; Respiratory muscle training; Stroke; Breathing Exercises; COVID-19; Deglutition Disorders; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Stroke; Treatment Outcome","Guillen-Sola","A","Department of Physical Medicine and Rehabilitation, Parc de Salut Mar (Hospital del Mar-Hospital de l'Esperança), Barcelona, Spain. aguillen@parcdesalutmar","aguillen@parcdesalutmar.cat"
"475","34172071","10.1186/s13063-021-05353-y","The Retornus-2 study: impact of respiratory muscle training in subacute stroke patients with dysphagia, study protocol of a double-blind randomized controlled trial.","Stroke can lead to varying degrees of oropharyngeal dysphagia, respiratory muscle dysfunction and even increase medical complications such as aspiration, malnutrition and death. Recent studies suggest that inspiratory and expiratory respiratory muscle training (IEMT) can improve swallowing efficacy and may reduce aspiration events. The main purpose of this study is to examine whether an 8-week IEMT programme can improve respiratory muscle strength and swallow dysfunction severity in subacute str","2021","06","29","Trials","Trials","Dysphagia; Randomized clinical trial; Rehabilitation; Respiratory muscle training; Stroke; Breathing Exercises; COVID-19; Deglutition Disorders; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Stroke; Treatment Outcome","Messaggi-Sartor","M","Department of Physical Medicine and Rehabilitation, Parc de Salut Mar (Hospital del Mar-Hospital de l'Esperança), Barcelona, Spain",NA
"476","34172071","10.1186/s13063-021-05353-y","The Retornus-2 study: impact of respiratory muscle training in subacute stroke patients with dysphagia, study protocol of a double-blind randomized controlled trial.","Stroke can lead to varying degrees of oropharyngeal dysphagia, respiratory muscle dysfunction and even increase medical complications such as aspiration, malnutrition and death. Recent studies suggest that inspiratory and expiratory respiratory muscle training (IEMT) can improve swallowing efficacy and may reduce aspiration events. The main purpose of this study is to examine whether an 8-week IEMT programme can improve respiratory muscle strength and swallow dysfunction severity in subacute str","2021","06","29","Trials","Trials","Dysphagia; Randomized clinical trial; Rehabilitation; Respiratory muscle training; Stroke; Breathing Exercises; COVID-19; Deglutition Disorders; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Stroke; Treatment Outcome","Ramírez-Fuentes","C","Department of Physical Medicine and Rehabilitation, Parc de Salut Mar (Hospital del Mar-Hospital de l'Esperança), Barcelona, Spain",NA
"477","34172071","10.1186/s13063-021-05353-y","The Retornus-2 study: impact of respiratory muscle training in subacute stroke patients with dysphagia, study protocol of a double-blind randomized controlled trial.","Stroke can lead to varying degrees of oropharyngeal dysphagia, respiratory muscle dysfunction and even increase medical complications such as aspiration, malnutrition and death. Recent studies suggest that inspiratory and expiratory respiratory muscle training (IEMT) can improve swallowing efficacy and may reduce aspiration events. The main purpose of this study is to examine whether an 8-week IEMT programme can improve respiratory muscle strength and swallow dysfunction severity in subacute str","2021","06","29","Trials","Trials","Dysphagia; Randomized clinical trial; Rehabilitation; Respiratory muscle training; Stroke; Breathing Exercises; COVID-19; Deglutition Disorders; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Stroke; Treatment Outcome","Marco","E","Department of Physical Medicine and Rehabilitation, Parc de Salut Mar (Hospital del Mar-Hospital de l'Esperança), Barcelona, Spain",NA
"478","34172071","10.1186/s13063-021-05353-y","The Retornus-2 study: impact of respiratory muscle training in subacute stroke patients with dysphagia, study protocol of a double-blind randomized controlled trial.","Stroke can lead to varying degrees of oropharyngeal dysphagia, respiratory muscle dysfunction and even increase medical complications such as aspiration, malnutrition and death. Recent studies suggest that inspiratory and expiratory respiratory muscle training (IEMT) can improve swallowing efficacy and may reduce aspiration events. The main purpose of this study is to examine whether an 8-week IEMT programme can improve respiratory muscle strength and swallow dysfunction severity in subacute str","2021","06","29","Trials","Trials","Dysphagia; Randomized clinical trial; Rehabilitation; Respiratory muscle training; Stroke; Breathing Exercises; COVID-19; Deglutition Disorders; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Stroke; Treatment Outcome","Duarte","E","Department of Physical Medicine and Rehabilitation, Parc de Salut Mar (Hospital del Mar-Hospital de l'Esperança), Barcelona, Spain",NA
"479","34172055","10.1186/s12911-021-01563-1","Usefulness of smartphone use among surgeons in clinical practice during the pandemic of COVID-19: a cross-sectional study.","With the magnitude and severity of the COVID-19 pandemic, the usual face-to-face consultation within a clinical setting is no longer feasible. Thus, this led to the need for alternate means to provide adequate patient care for surgical patients. This is where the role of smartphones comes into play, in which it is thus of paramount importance. This research study aimed to assess the usefulness of smartphones in surgical practice during COVID-19 pandemic. This cross-sectional study is based on a ","2021","06","30","BMC Med Inform Decis Mak","BMC medical informatics and decision making","Benefits; Clinical practice; Smartphone; Surgeons; Adult; COVID-19; Cross-Sectional Studies; Humans; Kuwait; Male; Pandemics; SARS-CoV-2; Smartphone; Surgeons; Surveys and Questionnaires","Buabbas","Ali Jasem","Department of Community Medicine and Behavioural Sciences, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110,, Jabriya, Kuwait. ali.buabbas@hsc.edu","ali.buabbas@hsc.edu.kw"
"480","34172055","10.1186/s12911-021-01563-1","Usefulness of smartphone use among surgeons in clinical practice during the pandemic of COVID-19: a cross-sectional study.","With the magnitude and severity of the COVID-19 pandemic, the usual face-to-face consultation within a clinical setting is no longer feasible. Thus, this led to the need for alternate means to provide adequate patient care for surgical patients. This is where the role of smartphones comes into play, in which it is thus of paramount importance. This research study aimed to assess the usefulness of smartphones in surgical practice during COVID-19 pandemic. This cross-sectional study is based on a ","2021","06","30","BMC Med Inform Decis Mak","BMC medical informatics and decision making","Benefits; Clinical practice; Smartphone; Surgeons; Adult; COVID-19; Cross-Sectional Studies; Humans; Kuwait; Male; Pandemics; SARS-CoV-2; Smartphone; Surgeons; Surveys and Questionnaires","Aldousari","Saad","Department of Surgery, Faculty of Medicine, Kuwait University, Jabriya, Kuwait",NA
"481","34172055","10.1186/s12911-021-01563-1","Usefulness of smartphone use among surgeons in clinical practice during the pandemic of COVID-19: a cross-sectional study.","With the magnitude and severity of the COVID-19 pandemic, the usual face-to-face consultation within a clinical setting is no longer feasible. Thus, this led to the need for alternate means to provide adequate patient care for surgical patients. This is where the role of smartphones comes into play, in which it is thus of paramount importance. This research study aimed to assess the usefulness of smartphones in surgical practice during COVID-19 pandemic. This cross-sectional study is based on a ","2021","06","30","BMC Med Inform Decis Mak","BMC medical informatics and decision making","Benefits; Clinical practice; Smartphone; Surgeons; Adult; COVID-19; Cross-Sectional Studies; Humans; Kuwait; Male; Pandemics; SARS-CoV-2; Smartphone; Surgeons; Surveys and Questionnaires","Ayed","Adel K","Department of Surgery, Faculty of Medicine, Kuwait University, Jabriya, Kuwait",NA
"482","34172055","10.1186/s12911-021-01563-1","Usefulness of smartphone use among surgeons in clinical practice during the pandemic of COVID-19: a cross-sectional study.","With the magnitude and severity of the COVID-19 pandemic, the usual face-to-face consultation within a clinical setting is no longer feasible. Thus, this led to the need for alternate means to provide adequate patient care for surgical patients. This is where the role of smartphones comes into play, in which it is thus of paramount importance. This research study aimed to assess the usefulness of smartphones in surgical practice during COVID-19 pandemic. This cross-sectional study is based on a ","2021","06","30","BMC Med Inform Decis Mak","BMC medical informatics and decision making","Benefits; Clinical practice; Smartphone; Surgeons; Adult; COVID-19; Cross-Sectional Studies; Humans; Kuwait; Male; Pandemics; SARS-CoV-2; Smartphone; Surgeons; Surveys and Questionnaires","Safar","Maryam","Health Sciences Center, Faculty of Dentistry, Kuwait University, Jabriya, Kuwait",NA
"483","34172055","10.1186/s12911-021-01563-1","Usefulness of smartphone use among surgeons in clinical practice during the pandemic of COVID-19: a cross-sectional study.","With the magnitude and severity of the COVID-19 pandemic, the usual face-to-face consultation within a clinical setting is no longer feasible. Thus, this led to the need for alternate means to provide adequate patient care for surgical patients. This is where the role of smartphones comes into play, in which it is thus of paramount importance. This research study aimed to assess the usefulness of smartphones in surgical practice during COVID-19 pandemic. This cross-sectional study is based on a ","2021","06","30","BMC Med Inform Decis Mak","BMC medical informatics and decision making","Benefits; Clinical practice; Smartphone; Surgeons; Adult; COVID-19; Cross-Sectional Studies; Humans; Kuwait; Male; Pandemics; SARS-CoV-2; Smartphone; Surgeons; Surveys and Questionnaires","Alkandari","Omar","Kuwait Institute for Medical Specializations, Yousif Al Roumi Street, Kuwait City, Kuwait",NA
"484","34172045","10.1186/s12913-021-06515-z","Access to water, sanitation and hygiene services in health facilities in sub-Saharan Africa 2013-2018: Results of health facility surveys and implications for COVID-19 transmission.","The COVID-19 pandemic has highlighted important needs in water, sanitation and hygiene (WASH) services and standard practices for infection prevention and control in sub-Saharan Africa. We assessed the availability of WASH and standard precautions for infection prevention in health facilities across 18 countries in sub-Saharan Africa, as well as inequalities by location (rural/urban) and managing authority (public/private). Data from health facility surveys conducted between 2013 and 2018 in 18 ","2021","06","29","BMC Health Serv Res","BMC health services research","Coronavirus disease (COVID-19); Health care facilities; Inequalities; Sub-Saharan Africa; Water, Sanitation and hygiene; Africa South of the Sahara; COVID-19; Health Facilities; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water; Water Supply","Kanyangarara","Mufaro","Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, SC, 29201, Columbia, USA. mufaro@mailbox.sc","mufaro@mailbox.sc.edu"
"485","34172045","10.1186/s12913-021-06515-z","Access to water, sanitation and hygiene services in health facilities in sub-Saharan Africa 2013-2018: Results of health facility surveys and implications for COVID-19 transmission.","The COVID-19 pandemic has highlighted important needs in water, sanitation and hygiene (WASH) services and standard practices for infection prevention and control in sub-Saharan Africa. We assessed the availability of WASH and standard precautions for infection prevention in health facilities across 18 countries in sub-Saharan Africa, as well as inequalities by location (rural/urban) and managing authority (public/private). Data from health facility surveys conducted between 2013 and 2018 in 18 ","2021","06","29","BMC Health Serv Res","BMC health services research","Coronavirus disease (COVID-19); Health care facilities; Inequalities; Sub-Saharan Africa; Water, Sanitation and hygiene; Africa South of the Sahara; COVID-19; Health Facilities; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water; Water Supply","Allen","Savannah","Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, SC, 29201, Columbia, USA",NA
"486","34172045","10.1186/s12913-021-06515-z","Access to water, sanitation and hygiene services in health facilities in sub-Saharan Africa 2013-2018: Results of health facility surveys and implications for COVID-19 transmission.","The COVID-19 pandemic has highlighted important needs in water, sanitation and hygiene (WASH) services and standard practices for infection prevention and control in sub-Saharan Africa. We assessed the availability of WASH and standard precautions for infection prevention in health facilities across 18 countries in sub-Saharan Africa, as well as inequalities by location (rural/urban) and managing authority (public/private). Data from health facility surveys conducted between 2013 and 2018 in 18 ","2021","06","29","BMC Health Serv Res","BMC health services research","Coronavirus disease (COVID-19); Health care facilities; Inequalities; Sub-Saharan Africa; Water, Sanitation and hygiene; Africa South of the Sahara; COVID-19; Health Facilities; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water; Water Supply","Jiwani","Safia S","Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"487","34172045","10.1186/s12913-021-06515-z","Access to water, sanitation and hygiene services in health facilities in sub-Saharan Africa 2013-2018: Results of health facility surveys and implications for COVID-19 transmission.","The COVID-19 pandemic has highlighted important needs in water, sanitation and hygiene (WASH) services and standard practices for infection prevention and control in sub-Saharan Africa. We assessed the availability of WASH and standard precautions for infection prevention in health facilities across 18 countries in sub-Saharan Africa, as well as inequalities by location (rural/urban) and managing authority (public/private). Data from health facility surveys conducted between 2013 and 2018 in 18 ","2021","06","29","BMC Health Serv Res","BMC health services research","Coronavirus disease (COVID-19); Health care facilities; Inequalities; Sub-Saharan Africa; Water, Sanitation and hygiene; Africa South of the Sahara; COVID-19; Health Facilities; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water; Water Supply","Fuente","David","School of Earth, Ocean and the Environment, University of South Carolina, Columbia, SC, USA",NA
"488","34172042","10.1186/s12889-021-11264-z","Lifestyle changes during the first wave of the COVID-19 pandemic: a cross-sectional survey in the Netherlands.","During the Covid-19 pandemic the Dutch government implemented its so-called 'intelligent lockdown' in which people were urged to leave their homes as little as possible and work from home. This life changing event may have caused changes in lifestyle behaviour, an important factor in the onset and course of diseases. The overarching aim of this study is to determine life-style related changes during the first wave of the COVID-19 pandemic among a representative sample of the adult population in ","2021","06","30","BMC Public Health","BMC public health","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Life Style; Male; Middle Aged; Netherlands; Pandemics; SARS-CoV-2; Young Adult","van der Werf","Esther T","Louis Bolk Institute, Bunnik, The Netherlands. e.vanderwerf@louisbolk","e.vanderwerf@louisbolk.nl"
"489","34172042","10.1186/s12889-021-11264-z","Lifestyle changes during the first wave of the COVID-19 pandemic: a cross-sectional survey in the Netherlands.","During the Covid-19 pandemic the Dutch government implemented its so-called 'intelligent lockdown' in which people were urged to leave their homes as little as possible and work from home. This life changing event may have caused changes in lifestyle behaviour, an important factor in the onset and course of diseases. The overarching aim of this study is to determine life-style related changes during the first wave of the COVID-19 pandemic among a representative sample of the adult population in ","2021","06","30","BMC Public Health","BMC public health","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Life Style; Male; Middle Aged; Netherlands; Pandemics; SARS-CoV-2; Young Adult","Busch","Martine","Dutch Consortium for Integrative Medicine and Health (CIZG), Utrecht, The Netherlands",NA
"490","34172042","10.1186/s12889-021-11264-z","Lifestyle changes during the first wave of the COVID-19 pandemic: a cross-sectional survey in the Netherlands.","During the Covid-19 pandemic the Dutch government implemented its so-called 'intelligent lockdown' in which people were urged to leave their homes as little as possible and work from home. This life changing event may have caused changes in lifestyle behaviour, an important factor in the onset and course of diseases. The overarching aim of this study is to determine life-style related changes during the first wave of the COVID-19 pandemic among a representative sample of the adult population in ","2021","06","30","BMC Public Health","BMC public health","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Life Style; Male; Middle Aged; Netherlands; Pandemics; SARS-CoV-2; Young Adult","Jong","Miek C","National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway",NA
"491","34172042","10.1186/s12889-021-11264-z","Lifestyle changes during the first wave of the COVID-19 pandemic: a cross-sectional survey in the Netherlands.","During the Covid-19 pandemic the Dutch government implemented its so-called 'intelligent lockdown' in which people were urged to leave their homes as little as possible and work from home. This life changing event may have caused changes in lifestyle behaviour, an important factor in the onset and course of diseases. The overarching aim of this study is to determine life-style related changes during the first wave of the COVID-19 pandemic among a representative sample of the adult population in ","2021","06","30","BMC Public Health","BMC public health","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Life Style; Male; Middle Aged; Netherlands; Pandemics; SARS-CoV-2; Young Adult","Hoenders","H J Rogier","Dutch Consortium for Integrative Medicine and Health (CIZG), Utrecht, The Netherlands",NA
"492","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Xie","Zongyu","Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, 233004, Anhui, China",NA
"493","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Sun","Haitao","Shanghai Institute of Medical Imaging, and Department of Interventional Radiology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China",NA
"494","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Wang","Jian","Department of Radiology, Tongde Hospital of Zhejiang Province, No.234, Gucui Road, Hangzhou, 310012, Zhejiang Province, China",NA
"495","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Xu","He","Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, 233004, Anhui, China",NA
"496","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Li","Shuhua","Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, 233004, Anhui, China",NA
"497","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Zhao","Cancan","Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, 233004, Anhui, China",NA
"498","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Gao","Yuqing","Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, 233004, Anhui, China",NA
"499","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Wang","Xiaolei","Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, 233004, Anhui, China",NA
"500","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Zhao","Tongtong","Department of Radiology, Fuyang Second People's Hospital, No. 450 Linquan Road, Fuyang, 236000, Anhui, China",NA
"501","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Duan","Shaofeng","GE Healthcare China, Pudong new town, No1, Huatuo road, Shanghai, 210000, China",NA
"502","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Hu","Chunhong","Department of Radiology, The First Affiliated Hospital of Soochow University, No. 188, Street of Shizi, Suzhou, 200000, China. sdhuchunhong@sina","sdhuchunhong@sina.com"
"503","34171991","10.1186/s12879-021-06331-0","A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia.","Convenient and precise assessment of the severity in coronavirus disease 2019 (COVID-19) contributes to the timely patient treatment and prognosis improvement. We aimed to evaluate the ability of CT-based radiomics nomogram in discriminating the severity of patients with COVID-19 Pneumonia. A total of 150 patients (training cohort n = 105; test cohort n = 45) with COVID-19 confirmed by reverse transcription polymerase chain reaction (RT-PCR) test were enrolled. Two feature selection methods, Max","2021","06","29","BMC Infect Dis","BMC infectious diseases","COVID-19; Nomogram; Radiomics; Tomography; X-ray computed; Adult; COVID-19; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nomograms; Prognosis; SARS-CoV-2; Tomography, X-Ray Computed","Ao","Weiqun","Department of Radiology, Tongde Hospital of Zhejiang Province, No.234, Gucui Road, Hangzhou, 310012, Zhejiang Province, China. 78123858@qq",NA
"504","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Valverde-López","Francisco","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"505","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Tendero-Peinado","Cristina","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"506","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Lecuona-Muñoz","Marta","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"507","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Heredia-Carrasco","Clara","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"508","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Abellán-Alfocea","Patricia","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"509","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Ortega-Suazo","Eva Julissa","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"510","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Martín-Rodríguez","Maria Del Mar","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"511","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Sánchez-Capilla","Antonio Damián","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"512","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Sotorrío-Simó","Virginia","Department of Internal Medicine, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"513","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Jiménez-Rosales","Rita","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"514","34171981","10.1080/00325481.2021.1949200","A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis.","COVID19 pandemic has forced physicians from different specialties to assist cases overload. Our aim is to assess gastroenterologist's assistance in COVID-19 by assessing mortality, ICU admission, and length of stay, and seek for risk factors for in-hospital mortality and longer hospital stay. A total of 41 COVID-19 patients assisted by gastroenterologist (GI cohort) and 137 assisted by pulmonologist, internal medicine practitioners, and infectious disease specialists (COVID expert cohort) during","2021","07","21","Postgrad Med","Postgraduate medicine","COVID-19; SARS COV2; gastroenterology; length of stay; mortality","Redondo-Cerezo","Eduardo","Department of Gastroenterology and Hepatology, University Hospital Virgen De Las Nieves, Granada, Spain",NA
"515","34171980","10.1177/00031348211029868","The COVID-19 Pandemic and Virtual Interviews in the 2020-2021 Resident Match.",NA,"2021","06","26","Am Surg","The American surgeon",NA,"Elkbuli","Adel","Department of Surgery, Division of Trauma and Surgical Critical Care, 14506Kendall Regional Medical Center, Miami, FL, USA",NA
"516","34171980","10.1177/00031348211029868","The COVID-19 Pandemic and Virtual Interviews in the 2020-2021 Resident Match.",NA,"2021","06","26","Am Surg","The American surgeon",NA,"Ehrlich","Haley","Department of Surgery, Division of Trauma and Surgical Critical Care, 14506Kendall Regional Medical Center, Miami, FL, USA",NA
"517","34171980","10.1177/00031348211029868","The COVID-19 Pandemic and Virtual Interviews in the 2020-2021 Resident Match.",NA,"2021","06","26","Am Surg","The American surgeon",NA,"McKenney","Mark","Department of Surgery, Division of Trauma and Surgical Critical Care, 14506Kendall Regional Medical Center, Miami, FL, USA",NA
"518","34171980","10.1177/00031348211029868","The COVID-19 Pandemic and Virtual Interviews in the 2020-2021 Resident Match.",NA,"2021","06","26","Am Surg","The American surgeon",NA,"Nakayama","Don","Department of Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA",NA
"519","34171975","10.1177/13591045211028169","The COVID-19 pandemic and obsessive-compulsive disorder in young people: Systematic review.","The COVID-19 pandemic has impacted the world since the first cases were reported in China in January 2020. The secondary mental health impacts of the pandemic are thought to be significant. Obsessive-compulsive disorder is a condition defined by recurrent obsessions and compulsions. It has been hypothesised that the focus on hygiene and contamination during the pandemic could exacerbate obsessive-compulsive symptoms in young people. A systematic literature review was conducted. Papers were sough","2021","06","26","Clin Child Psychol Psychiatry","Clinical child psychology and psychiatry","COVID-19; Obsessivecompulsive disorder; adolescent health; child health; obsessivecompulsive symptoms; pandemic","Cunning","Catherine","Division of Psychiatry, Faculty of Medicine, Imperial College London, London, UK",NA
"520","34171975","10.1177/13591045211028169","The COVID-19 pandemic and obsessive-compulsive disorder in young people: Systematic review.","The COVID-19 pandemic has impacted the world since the first cases were reported in China in January 2020. The secondary mental health impacts of the pandemic are thought to be significant. Obsessive-compulsive disorder is a condition defined by recurrent obsessions and compulsions. It has been hypothesised that the focus on hygiene and contamination during the pandemic could exacerbate obsessive-compulsive symptoms in young people. A systematic literature review was conducted. Papers were sough","2021","06","26","Clin Child Psychol Psychiatry","Clinical child psychology and psychiatry","COVID-19; Obsessivecompulsive disorder; adolescent health; child health; obsessivecompulsive symptoms; pandemic","Hodes","Matthew","Division of Psychiatry, Faculty of Medicine, Imperial College London, London, UK",NA
"521","34171971","10.1089/bfm.2021.0079","Maternal and Child Symptoms Following COVID-19 Vaccination Among Breastfeeding Mothers.","Background: The impact of COVID-19 vaccination on breastfeeding is unknown. The primary aim of this study was to determine whether vaccine-related side effects following COVID-19 vaccination were associated with an adverse impact on breastfeeding. Secondarily, we sought to determine perceived symptoms in breastfed children and maternal opinion about COVID-19 vaccination. Materials and Methods: We conducted a cross-sectional survey of breastfeeding mothers who underwen","2021","06","26","Breastfeed Med","Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine","COVID-19 vaccine; breastfeeding; immunization; lactation","McLaurin-Jiang","Skyler","Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, USA",NA
"522","34171971","10.1089/bfm.2021.0079","Maternal and Child Symptoms Following COVID-19 Vaccination Among Breastfeeding Mothers.","Background: The impact of COVID-19 vaccination on breastfeeding is unknown. The primary aim of this study was to determine whether vaccine-related side effects following COVID-19 vaccination were associated with an adverse impact on breastfeeding. Secondarily, we sought to determine perceived symptoms in breastfed children and maternal opinion about COVID-19 vaccination. Materials and Methods: We conducted a cross-sectional survey of breastfeeding mothers who underwen","2021","06","26","Breastfeed Med","Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine","COVID-19 vaccine; breastfeeding; immunization; lactation","Garner","Christine D","Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, USA",NA
"523","34171971","10.1089/bfm.2021.0079","Maternal and Child Symptoms Following COVID-19 Vaccination Among Breastfeeding Mothers.","Background: The impact of COVID-19 vaccination on breastfeeding is unknown. The primary aim of this study was to determine whether vaccine-related side effects following COVID-19 vaccination were associated with an adverse impact on breastfeeding. Secondarily, we sought to determine perceived symptoms in breastfed children and maternal opinion about COVID-19 vaccination. Materials and Methods: We conducted a cross-sectional survey of breastfeeding mothers who underwen","2021","06","26","Breastfeed Med","Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine","COVID-19 vaccine; breastfeeding; immunization; lactation","Krutsch","Kaytlin","InfantRisk Center, Texas Tech University Health Sciences Center, Amarillo, Texas, USA",NA
"524","34171971","10.1089/bfm.2021.0079","Maternal and Child Symptoms Following COVID-19 Vaccination Among Breastfeeding Mothers.","Background: The impact of COVID-19 vaccination on breastfeeding is unknown. The primary aim of this study was to determine whether vaccine-related side effects following COVID-19 vaccination were associated with an adverse impact on breastfeeding. Secondarily, we sought to determine perceived symptoms in breastfed children and maternal opinion about COVID-19 vaccination. Materials and Methods: We conducted a cross-sectional survey of breastfeeding mothers who underwen","2021","06","26","Breastfeed Med","Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine","COVID-19 vaccine; breastfeeding; immunization; lactation","Hale","Thomas W","Department of Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, USA",NA
"525","34171961","10.1089/cmb.2020.0112.retract","<i>Retraction of:</i> A Study of Potential SARS-CoV-2 Antiviral Drugs and Preliminary Research of Their Molecular Mechanism, Based on Anti-SARS-CoV Drug Screening and Molecular Dynamics Simulation (doi: 10.1089/cmb.2020.0112).",NA,"2021","07","24","J Comput Biol","Journal of computational biology : a journal of computational molecular cell biology",NA,NA,NA,NA,NA
"526","34171950","","COVID-19 patient care experience in the United Kingdom.","In response to the COVID-19 pandemic many health care systems have attempted to reorganize healthcare workforce. Many doctors and nurses have been redeployed to acute care wards. In order to ensure the best quality of care it is essential for health professionals to stay updated on clinical studies and novel therapeutical approaches. Most patients with COVID-19 who become seriously unwell have an acute respiratory illness and about 14 % will require non-invasive respiratory support. This article","2021","06","29","Vnitr Lek","Vnitrni lekarstvi","COVID-19; dexamethasone; non-invasive ventilation; oxygen therapy; oxygenotherapy; remdesivir; tocilizumab.; COVID-19; Critical Care; Humans; Pandemics; SARS-CoV-2; Treatment Outcome; United Kingdom","Aldhoon","Bashar",NA,NA
"527","34171940","10.1515/jpem-2021-0153","Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes.","Our study aims to assess the impact of lockdown during the coronavirus disease 2019 pandemic on glycemic control and psychological well-being in youths with type 1 diabetes. We compared glycemic metrics during lockdown with the same period of 2019. The psychological impact was evaluated with the Test of Anxiety and Depression. We analyzed metrics of 117 adolescents (87% on Multiple Daily Injections and 100% were flash glucose monitoring/continuous glucose monitoring users). During the lockdown, ","2021","06","25","J Pediatr Endocrinol Metab","Journal of pediatric endocrinology &amp; metabolism : JPEM","Covid-19; adolescents; anxiety; depression; type 1 diabetes","Cusinato","Maria","Pediatric Diabetes Unit, Department of Women's and Children's Health, Azienda Ospedale Università di Padova, Padua, Italy",NA
"528","34171940","10.1515/jpem-2021-0153","Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes.","Our study aims to assess the impact of lockdown during the coronavirus disease 2019 pandemic on glycemic control and psychological well-being in youths with type 1 diabetes. We compared glycemic metrics during lockdown with the same period of 2019. The psychological impact was evaluated with the Test of Anxiety and Depression. We analyzed metrics of 117 adolescents (87% on Multiple Daily Injections and 100% were flash glucose monitoring/continuous glucose monitoring users). During the lockdown, ","2021","06","25","J Pediatr Endocrinol Metab","Journal of pediatric endocrinology &amp; metabolism : JPEM","Covid-19; adolescents; anxiety; depression; type 1 diabetes","Martino","Mariangela","Pediatric Diabetes Unit, Department of Women's and Children's Health, Azienda Ospedale Università di Padova, Padua, Italy",NA
"529","34171940","10.1515/jpem-2021-0153","Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes.","Our study aims to assess the impact of lockdown during the coronavirus disease 2019 pandemic on glycemic control and psychological well-being in youths with type 1 diabetes. We compared glycemic metrics during lockdown with the same period of 2019. The psychological impact was evaluated with the Test of Anxiety and Depression. We analyzed metrics of 117 adolescents (87% on Multiple Daily Injections and 100% were flash glucose monitoring/continuous glucose monitoring users). During the lockdown, ","2021","06","25","J Pediatr Endocrinol Metab","Journal of pediatric endocrinology &amp; metabolism : JPEM","Covid-19; adolescents; anxiety; depression; type 1 diabetes","Sartori","Alex","Pediatric Diabetes Unit, Department of Women's and Children's Health, Azienda Ospedale Università di Padova, Padua, Italy",NA
"530","34171940","10.1515/jpem-2021-0153","Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes.","Our study aims to assess the impact of lockdown during the coronavirus disease 2019 pandemic on glycemic control and psychological well-being in youths with type 1 diabetes. We compared glycemic metrics during lockdown with the same period of 2019. The psychological impact was evaluated with the Test of Anxiety and Depression. We analyzed metrics of 117 adolescents (87% on Multiple Daily Injections and 100% were flash glucose monitoring/continuous glucose monitoring users). During the lockdown, ","2021","06","25","J Pediatr Endocrinol Metab","Journal of pediatric endocrinology &amp; metabolism : JPEM","Covid-19; adolescents; anxiety; depression; type 1 diabetes","Gabrielli","Claudia","Pediatric Diabetes Unit, Department of Women's and Children's Health, Azienda Ospedale Università di Padova, Padua, Italy",NA
"531","34171940","10.1515/jpem-2021-0153","Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes.","Our study aims to assess the impact of lockdown during the coronavirus disease 2019 pandemic on glycemic control and psychological well-being in youths with type 1 diabetes. We compared glycemic metrics during lockdown with the same period of 2019. The psychological impact was evaluated with the Test of Anxiety and Depression. We analyzed metrics of 117 adolescents (87% on Multiple Daily Injections and 100% were flash glucose monitoring/continuous glucose monitoring users). During the lockdown, ","2021","06","25","J Pediatr Endocrinol Metab","Journal of pediatric endocrinology &amp; metabolism : JPEM","Covid-19; adolescents; anxiety; depression; type 1 diabetes","Tassara","Laura","Pediatric Diabetes Unit, Department of Women's and Children's Health, Azienda Ospedale Università di Padova, Padua, Italy",NA
"532","34171940","10.1515/jpem-2021-0153","Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes.","Our study aims to assess the impact of lockdown during the coronavirus disease 2019 pandemic on glycemic control and psychological well-being in youths with type 1 diabetes. We compared glycemic metrics during lockdown with the same period of 2019. The psychological impact was evaluated with the Test of Anxiety and Depression. We analyzed metrics of 117 adolescents (87% on Multiple Daily Injections and 100% were flash glucose monitoring/continuous glucose monitoring users). During the lockdown, ","2021","06","25","J Pediatr Endocrinol Metab","Journal of pediatric endocrinology &amp; metabolism : JPEM","Covid-19; adolescents; anxiety; depression; type 1 diabetes","Debertolis","Giulia","Pediatric Diabetes Unit, Department of Women's and Children's Health, Azienda Ospedale Università di Padova, Padua, Italy",NA
"533","34171940","10.1515/jpem-2021-0153","Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes.","Our study aims to assess the impact of lockdown during the coronavirus disease 2019 pandemic on glycemic control and psychological well-being in youths with type 1 diabetes. We compared glycemic metrics during lockdown with the same period of 2019. The psychological impact was evaluated with the Test of Anxiety and Depression. We analyzed metrics of 117 adolescents (87% on Multiple Daily Injections and 100% were flash glucose monitoring/continuous glucose monitoring users). During the lockdown, ","2021","06","25","J Pediatr Endocrinol Metab","Journal of pediatric endocrinology &amp; metabolism : JPEM","Covid-19; adolescents; anxiety; depression; type 1 diabetes","Righetto","Elena","Pediatric Diabetes Unit, Department of Women's and Children's Health, Azienda Ospedale Università di Padova, Padua, Italy",NA
"534","34171940","10.1515/jpem-2021-0153","Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes.","Our study aims to assess the impact of lockdown during the coronavirus disease 2019 pandemic on glycemic control and psychological well-being in youths with type 1 diabetes. We compared glycemic metrics during lockdown with the same period of 2019. The psychological impact was evaluated with the Test of Anxiety and Depression. We analyzed metrics of 117 adolescents (87% on Multiple Daily Injections and 100% were flash glucose monitoring/continuous glucose monitoring users). During the lockdown, ","2021","06","25","J Pediatr Endocrinol Metab","Journal of pediatric endocrinology &amp; metabolism : JPEM","Covid-19; adolescents; anxiety; depression; type 1 diabetes","Moretti","Carlo","Pediatric Diabetes Unit, Department of Women's and Children's Health, Azienda Ospedale Università di Padova, Padua, Italy",NA
"535","34171927","10.1055/a-1492-3293","Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases.","The SARS-CoV-2 pandemic with psychiatric comorbidities leads to a scenario in which the use of psychotropic drugs may be required. This requires the support of evidence-based medicine to take into account possible interactions between antidepressants, mood stabilizers, benzodiazepines, and coronavirus infection treatments. Three databases were consulted: (a) Lexicomp Drug Interactions, (b) Micromedex Solutions Drugs Interactions, (c)Liverpool Drug Interaction Group for COVID-19 therapies. The Cr","2021","06","25","Pharmacopsychiatry","Pharmacopsychiatry",NA,"Plasencia-García","Beatriz Oda","Department of Psychiatry, University Hospital Virgen del Rocio Spain",NA
"536","34171927","10.1055/a-1492-3293","Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases.","The SARS-CoV-2 pandemic with psychiatric comorbidities leads to a scenario in which the use of psychotropic drugs may be required. This requires the support of evidence-based medicine to take into account possible interactions between antidepressants, mood stabilizers, benzodiazepines, and coronavirus infection treatments. Three databases were consulted: (a) Lexicomp Drug Interactions, (b) Micromedex Solutions Drugs Interactions, (c)Liverpool Drug Interaction Group for COVID-19 therapies. The Cr","2021","06","25","Pharmacopsychiatry","Pharmacopsychiatry",NA,"Rico-Rangel","María Isabel","Department of Psychiatry, University Hospital Virgen del Rocio Spain",NA
"537","34171927","10.1055/a-1492-3293","Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases.","The SARS-CoV-2 pandemic with psychiatric comorbidities leads to a scenario in which the use of psychotropic drugs may be required. This requires the support of evidence-based medicine to take into account possible interactions between antidepressants, mood stabilizers, benzodiazepines, and coronavirus infection treatments. Three databases were consulted: (a) Lexicomp Drug Interactions, (b) Micromedex Solutions Drugs Interactions, (c)Liverpool Drug Interaction Group for COVID-19 therapies. The Cr","2021","06","25","Pharmacopsychiatry","Pharmacopsychiatry",NA,"Rodríguez-Menéndez","Gonzalo","Department of Psychiatry, University Hospital Virgen del Rocio Spain",NA
"538","34171927","10.1055/a-1492-3293","Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases.","The SARS-CoV-2 pandemic with psychiatric comorbidities leads to a scenario in which the use of psychotropic drugs may be required. This requires the support of evidence-based medicine to take into account possible interactions between antidepressants, mood stabilizers, benzodiazepines, and coronavirus infection treatments. Three databases were consulted: (a) Lexicomp Drug Interactions, (b) Micromedex Solutions Drugs Interactions, (c)Liverpool Drug Interaction Group for COVID-19 therapies. The Cr","2021","06","25","Pharmacopsychiatry","Pharmacopsychiatry",NA,"Rubio-García","Ana","Department of Psychiatry, University Hospital Virgen del Rocio Spain",NA
"539","34171927","10.1055/a-1492-3293","Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases.","The SARS-CoV-2 pandemic with psychiatric comorbidities leads to a scenario in which the use of psychotropic drugs may be required. This requires the support of evidence-based medicine to take into account possible interactions between antidepressants, mood stabilizers, benzodiazepines, and coronavirus infection treatments. Three databases were consulted: (a) Lexicomp Drug Interactions, (b) Micromedex Solutions Drugs Interactions, (c)Liverpool Drug Interaction Group for COVID-19 therapies. The Cr","2021","06","25","Pharmacopsychiatry","Pharmacopsychiatry",NA,"Torelló-Iserte","Jaime","Department of Clinical Pharmacology, University Hospital Virgen del Rocio Spain",NA
"540","34171927","10.1055/a-1492-3293","Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases.","The SARS-CoV-2 pandemic with psychiatric comorbidities leads to a scenario in which the use of psychotropic drugs may be required. This requires the support of evidence-based medicine to take into account possible interactions between antidepressants, mood stabilizers, benzodiazepines, and coronavirus infection treatments. Three databases were consulted: (a) Lexicomp Drug Interactions, (b) Micromedex Solutions Drugs Interactions, (c)Liverpool Drug Interaction Group for COVID-19 therapies. The Cr","2021","06","25","Pharmacopsychiatry","Pharmacopsychiatry",NA,"Crespo-Facorro","Benedicto","Department of Psychiatry, University Hospital Virgen del Rocio Spain",NA
"541","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Gibbard","Marissa","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"542","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Ponton","Ethan","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"543","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Sidhu","Bernita V","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"544","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Farrell","Sarah","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"545","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Bone","Jeffrey N","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"546","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Wu","Luke A","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"547","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Schaeffer","Emily","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"548","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Cooper","Anthony","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"549","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Aroojis","Alaric","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"550","34171889","10.1097/BPO.0000000000001887","Survey of the Impact of COVID-19 on Pediatric Orthopaedic Surgeons Globally.","The coronavirus disease 2019 (COVID-19) pandemic required rapid, global health care shifts to prioritize urgent or pandemic-related care and minimize transmission. Little is known about impacts on pediatric orthopaedic surgeons during this time. We aimed to investigate COVID-19-related changes in practice, training, and research among pediatric orthopaedic surgeons globally. An online survey was administered to orthopaedic surgeons with interest in pediatrics in April 2020 and a follow-up was ad","2021","06","25","J Pediatr Orthop","Journal of pediatric orthopedics",NA,"Mulpuri","Kishore","Departments of Orthopaedics Obstetrics and Gynaecology Office of Pediatric Surgical Evaluation and Innovation, BC Children's Hospital, University of British Columbia BC Children's Hospital Research Institute Department of Orthopaedic Surgery, BC Children's Hospital, Vancouver, BC, Canada Department of Orthopaedics, Queensland Children's Hospital, South Brisbane, QLD, Australia Department of Paediatric Orthopaedics, Bai Jerbai Wadia Hospital for Children Lilavati Hospital and Research Centre, Mumbai, India",NA
"551","34171881","10.1097/SPV.0000000000001085","Adapting to Challenging Circumstances: Pessary Care in a Racially Diverse Urban Population Within a U.S. Epicenter of the COVID-19 Pandemic.","The aim of the study was to describe time intervals between pessary maintenance visits in racially diverse women receiving care in a U.S. epicenter of the COVID-19 pandemic. We secondarily aimed to determine whether time interval between pessary changes is associated with adverse outcomes and to identify factors associated with adverse pessary outcomes. We performed a retrospective study of women undergoing pessary care after the COVID-19 pandemic began. Time between the most recent visit before","2021","06","25","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Halani","Priyanka Kadam","From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics &amp",NA
"552","34171881","10.1097/SPV.0000000000001085","Adapting to Challenging Circumstances: Pessary Care in a Racially Diverse Urban Population Within a U.S. Epicenter of the COVID-19 Pandemic.","The aim of the study was to describe time intervals between pessary maintenance visits in racially diverse women receiving care in a U.S. epicenter of the COVID-19 pandemic. We secondarily aimed to determine whether time interval between pessary changes is associated with adverse outcomes and to identify factors associated with adverse pessary outcomes. We performed a retrospective study of women undergoing pessary care after the COVID-19 pandemic began. Time between the most recent visit before","2021","06","25","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Gelman","Eden","From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics &amp",NA
"553","34171881","10.1097/SPV.0000000000001085","Adapting to Challenging Circumstances: Pessary Care in a Racially Diverse Urban Population Within a U.S. Epicenter of the COVID-19 Pandemic.","The aim of the study was to describe time intervals between pessary maintenance visits in racially diverse women receiving care in a U.S. epicenter of the COVID-19 pandemic. We secondarily aimed to determine whether time interval between pessary changes is associated with adverse outcomes and to identify factors associated with adverse pessary outcomes. We performed a retrospective study of women undergoing pessary care after the COVID-19 pandemic began. Time between the most recent visit before","2021","06","25","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Duchein","Yvette","From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics &amp",NA
"554","34171881","10.1097/SPV.0000000000001085","Adapting to Challenging Circumstances: Pessary Care in a Racially Diverse Urban Population Within a U.S. Epicenter of the COVID-19 Pandemic.","The aim of the study was to describe time intervals between pessary maintenance visits in racially diverse women receiving care in a U.S. epicenter of the COVID-19 pandemic. We secondarily aimed to determine whether time interval between pessary changes is associated with adverse outcomes and to identify factors associated with adverse pessary outcomes. We performed a retrospective study of women undergoing pessary care after the COVID-19 pandemic began. Time between the most recent visit before","2021","06","25","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Roselli","Nicole","From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics &amp",NA
"555","34171881","10.1097/SPV.0000000000001085","Adapting to Challenging Circumstances: Pessary Care in a Racially Diverse Urban Population Within a U.S. Epicenter of the COVID-19 Pandemic.","The aim of the study was to describe time intervals between pessary maintenance visits in racially diverse women receiving care in a U.S. epicenter of the COVID-19 pandemic. We secondarily aimed to determine whether time interval between pessary changes is associated with adverse outcomes and to identify factors associated with adverse pessary outcomes. We performed a retrospective study of women undergoing pessary care after the COVID-19 pandemic began. Time between the most recent visit before","2021","06","25","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Leegant","Ava","From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics &amp",NA
"556","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Park","Keon Min","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"557","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Rashidian","Nikdokht","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"558","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Anderson","Chelsie","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"559","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Brian","Riley","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"560","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Calthorpe","Lucia M","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"561","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Gee","Denise","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"562","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Hernandez","Sophia","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"563","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Lau","James","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"564","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Nepomnayshy","Dmitry","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"565","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Patel","Nell Maloney","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"566","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Pei","Kevin","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"567","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Reddy","Rishindra M","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"568","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Roman","Sânziana A","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"569","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Scott","Daniel J","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"570","34171862","10.1097/SLA.0000000000005014","Evidence-based Guidelines on the Use of Virtual Surgical Education Pertaining to the Domains of Cognition and Curriculum, Psychomotor Skills Training, and Faculty Development and Mentorship.","The Association for Surgical Education formed an ad-hoc research group to evaluate the quality and methodology of the current literature on virtual surgical education. Using SIGN methodology, evidence-based guidelines were developed for utilizing virtual surgical education within the cognitive and curricula, psychomotor, and faculty development domains. To identify, categorize, and evaluate the quality of literature, and to provide evidence-based guidelines on virtual surgical education within t","2021","06","25","Ann Surg","Annals of surgery",NA,"Alseidi","Adnan","Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Human Structure and Repair, Ghent University, Ghent, Belgium School of Medicine, University of California San Francisco, San Francisco, CA. USA Department of Surgery, University of California San Francisco, San Francisco, CA. USA Department of Surgery, Massachusetts General hospital, Boston, MA. USA Department of Surgery, Loyola University Medical Center, Chicago, IL. USA Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA. USA Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ. USA Department of Graduate Medical Education, Parkview Health, Fort Wayne, IN. USA Department of Surgery, University of Michigan, Ann Arbor, MI. USA Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX",NA
"571","34171861","10.1097/SLA.0000000000005020","Comment on ""The Relationship Between Surgeon Gender and Stress During the Covid-19 Pandemic"" Mavrouidis C L et al.",NA,"2021","06","25","Ann Surg","Annals of surgery",NA,"Sterpetti","Antonio V","University of Rome Sapienza",NA
"572","34171857","10.1097/BOR.0000000000000812","Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease.","Although the literature to date on COVID-19 outcomes in those with immune-mediated inflammatory disease has been largely reassuring there remain many unanswered questions. These include the impact of specific medications on outcomes and the antibody response after COVID-19 vaccination. We summarized the current literature related to COVID-19 outcomes in immune-mediated inflammatory diseases in rheumatology, gastroenterology, dermatology, and neurology. Overall, we found either no difference or m","2021","06","25","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Sparks","Jeffrey A","Brigham and Women's Hospital and Harvard Medical School Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA University of Queensland School of Clinical Medicine, Faculty of Medicine Royal Brisbane &amp",NA
"573","34171857","10.1097/BOR.0000000000000812","Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease.","Although the literature to date on COVID-19 outcomes in those with immune-mediated inflammatory disease has been largely reassuring there remain many unanswered questions. These include the impact of specific medications on outcomes and the antibody response after COVID-19 vaccination. We summarized the current literature related to COVID-19 outcomes in immune-mediated inflammatory diseases in rheumatology, gastroenterology, dermatology, and neurology. Overall, we found either no difference or m","2021","06","25","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Wallace","Zachary S","Brigham and Women's Hospital and Harvard Medical School Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA University of Queensland School of Clinical Medicine, Faculty of Medicine Royal Brisbane &amp",NA
"574","34171857","10.1097/BOR.0000000000000812","Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease.","Although the literature to date on COVID-19 outcomes in those with immune-mediated inflammatory disease has been largely reassuring there remain many unanswered questions. These include the impact of specific medications on outcomes and the antibody response after COVID-19 vaccination. We summarized the current literature related to COVID-19 outcomes in immune-mediated inflammatory diseases in rheumatology, gastroenterology, dermatology, and neurology. Overall, we found either no difference or m","2021","06","25","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Robinson","Philip C","Brigham and Women's Hospital and Harvard Medical School Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA University of Queensland School of Clinical Medicine, Faculty of Medicine Royal Brisbane &amp",NA
"575","34171844","10.1163/15718093-bja10050","Curtailing Covid Casualties, From Hospital Room to Courtroom: An Analysis of Ireland's Deficient Liability Regime During Public Health Emergencies.","This article considers the liability of healthcare professionals during public health crises in Ireland. It argues that Covid-19 has shown that Irish law lacks protective measures for healthcare practitioners who elect to value high-capacity care over best possible treatment to smaller numbers of patients. Such a prohibition, it is contended, has the potential to be fatal to the management of public health emergencies and can lead to defensive clinical practices which serve to slow or halt progr","2021","06","25","Eur J Health Law","European journal of health law",NA,"O'Leary","Diarmuid","The Honorable Society of King's Inns Henrietta Street, Dublin 1 Ireland",NA
"576","34171825","10.1016/j.drugalcdep.2021.108818","Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans.","There have been reports of increased alcohol consumption during the COVID-19 pandemic in the general population. However, little is known about the impact of the pandemic on the prevalence of alcohol use disorder (AUD), especially in high-risk samples such as U.S. military veterans. Data were analyzed from the 2019-2020 National Health and Resilience in Veterans Study, which surveyed a nationally representative, prospective cohort of 3078 U.S. veterans. Pre-pandemic and 1-year peri-pandemic risk","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Alcohol; Alcohol use disorder; COVID-19; Veterans; Adult; Aged; Aged, 80 and over; Alcoholism; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Prevalence; Prospective Studies; Protective Factors; Risk Factors; United States; Veterans; Young Adult","Na","Peter J","Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. Electronic address: peter.na@yale","peter.na@yale.edu"
"577","34171825","10.1016/j.drugalcdep.2021.108818","Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans.","There have been reports of increased alcohol consumption during the COVID-19 pandemic in the general population. However, little is known about the impact of the pandemic on the prevalence of alcohol use disorder (AUD), especially in high-risk samples such as U.S. military veterans. Data were analyzed from the 2019-2020 National Health and Resilience in Veterans Study, which surveyed a nationally representative, prospective cohort of 3078 U.S. veterans. Pre-pandemic and 1-year peri-pandemic risk","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Alcohol; Alcohol use disorder; COVID-19; Veterans; Adult; Aged; Aged, 80 and over; Alcoholism; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Prevalence; Prospective Studies; Protective Factors; Risk Factors; United States; Veterans; Young Adult","Norman","Sonya B","National Center for PTSD, White River Junction, VT, USA",NA
"578","34171825","10.1016/j.drugalcdep.2021.108818","Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans.","There have been reports of increased alcohol consumption during the COVID-19 pandemic in the general population. However, little is known about the impact of the pandemic on the prevalence of alcohol use disorder (AUD), especially in high-risk samples such as U.S. military veterans. Data were analyzed from the 2019-2020 National Health and Resilience in Veterans Study, which surveyed a nationally representative, prospective cohort of 3078 U.S. veterans. Pre-pandemic and 1-year peri-pandemic risk","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Alcohol; Alcohol use disorder; COVID-19; Veterans; Adult; Aged; Aged, 80 and over; Alcoholism; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Prevalence; Prospective Studies; Protective Factors; Risk Factors; United States; Veterans; Young Adult","Nichter","Brandon","Department of Psychiatry, University of California, San Diego, CA, USA",NA
"579","34171825","10.1016/j.drugalcdep.2021.108818","Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans.","There have been reports of increased alcohol consumption during the COVID-19 pandemic in the general population. However, little is known about the impact of the pandemic on the prevalence of alcohol use disorder (AUD), especially in high-risk samples such as U.S. military veterans. Data were analyzed from the 2019-2020 National Health and Resilience in Veterans Study, which surveyed a nationally representative, prospective cohort of 3078 U.S. veterans. Pre-pandemic and 1-year peri-pandemic risk","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Alcohol; Alcohol use disorder; COVID-19; Veterans; Adult; Aged; Aged, 80 and over; Alcoholism; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Prevalence; Prospective Studies; Protective Factors; Risk Factors; United States; Veterans; Young Adult","Hill","Melanie L","VA San Diego Healthcare System, San Diego, CA, USA",NA
"580","34171825","10.1016/j.drugalcdep.2021.108818","Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans.","There have been reports of increased alcohol consumption during the COVID-19 pandemic in the general population. However, little is known about the impact of the pandemic on the prevalence of alcohol use disorder (AUD), especially in high-risk samples such as U.S. military veterans. Data were analyzed from the 2019-2020 National Health and Resilience in Veterans Study, which surveyed a nationally representative, prospective cohort of 3078 U.S. veterans. Pre-pandemic and 1-year peri-pandemic risk","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Alcohol; Alcohol use disorder; COVID-19; Veterans; Adult; Aged; Aged, 80 and over; Alcoholism; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Prevalence; Prospective Studies; Protective Factors; Risk Factors; United States; Veterans; Young Adult","Rosen","Marc I","Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA",NA
"581","34171825","10.1016/j.drugalcdep.2021.108818","Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans.","There have been reports of increased alcohol consumption during the COVID-19 pandemic in the general population. However, little is known about the impact of the pandemic on the prevalence of alcohol use disorder (AUD), especially in high-risk samples such as U.S. military veterans. Data were analyzed from the 2019-2020 National Health and Resilience in Veterans Study, which surveyed a nationally representative, prospective cohort of 3078 U.S. veterans. Pre-pandemic and 1-year peri-pandemic risk","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Alcohol; Alcohol use disorder; COVID-19; Veterans; Adult; Aged; Aged, 80 and over; Alcoholism; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Prevalence; Prospective Studies; Protective Factors; Risk Factors; United States; Veterans; Young Adult","Petrakis","Ismene L","Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA",NA
"582","34171825","10.1016/j.drugalcdep.2021.108818","Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans.","There have been reports of increased alcohol consumption during the COVID-19 pandemic in the general population. However, little is known about the impact of the pandemic on the prevalence of alcohol use disorder (AUD), especially in high-risk samples such as U.S. military veterans. Data were analyzed from the 2019-2020 National Health and Resilience in Veterans Study, which surveyed a nationally representative, prospective cohort of 3078 U.S. veterans. Pre-pandemic and 1-year peri-pandemic risk","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Alcohol; Alcohol use disorder; COVID-19; Veterans; Adult; Aged; Aged, 80 and over; Alcoholism; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Prevalence; Prospective Studies; Protective Factors; Risk Factors; United States; Veterans; Young Adult","Pietrzak","Robert H","Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA",NA
"583","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Chen","Fan-En","Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA",NA
"584","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Lee","Pei-Wei","Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA",NA
"585","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Trick","Alexander Y","Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA",NA
"586","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Park","Joon Soo","Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA",NA
"587","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Chen","Liben","Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA",NA
"588","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Shah","Kushagra","Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA",NA
"589","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Mostafa","Heba","Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD, 21287, USA",NA
"590","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Carroll","Karen C","Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD, 21287, USA",NA
"591","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Hsieh","Kuangwen","Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA. Electronic address: khsieh4@jhu","khsieh4@jhu.edu"
"592","34171821","10.1016/j.bios.2021.113390","Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.","In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays are viewed as transformative solutions for POC diagnostic testing, but their lack of streamlined sample preparation and full integration within an automated and portable device hamper their potential ","2021","07","22","Biosens Bioelectron","Biosensors &amp; bioelectronics","CRISPR; Point-of-Care; Sensors; Viruses; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Point-of-Care Systems; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Wang","Tza-Huei","Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA","thwang@jhu.edu"
"593","34171768","10.1016/j.jpsychores.2021.110552","Impact of COVID-19 on mental health according to prior depression status: A mental health survey of community prospective cohort data.","We aimed to investigate the mental health impact of COVID-19 on a demographically well-characterized population cohort by gender and previous depression status. Among people who participated in a community cohort study between 2013 and 2018 with previous depression measurement, a total of 1928 people without quarantine experience (680 men and 1249 women) were included after responding to an online survey in March 2020. In the 2020 survey, people were queried about daily needs supply, social supp","2021","07","23","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Epidemic; Gender; Mental health; PTSD","Jung","Sun Jae","Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea","sunjaejung@yuhs.ac"
"594","34171768","10.1016/j.jpsychores.2021.110552","Impact of COVID-19 on mental health according to prior depression status: A mental health survey of community prospective cohort data.","We aimed to investigate the mental health impact of COVID-19 on a demographically well-characterized population cohort by gender and previous depression status. Among people who participated in a community cohort study between 2013 and 2018 with previous depression measurement, a total of 1928 people without quarantine experience (680 men and 1249 women) were included after responding to an online survey in March 2020. In the 2020 survey, people were queried about daily needs supply, social supp","2021","07","23","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Epidemic; Gender; Mental health; PTSD","Jeon","Ye Jin","Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: jeonye1028@yuhs","jeonye1028@yuhs.ac"
"595","34171768","10.1016/j.jpsychores.2021.110552","Impact of COVID-19 on mental health according to prior depression status: A mental health survey of community prospective cohort data.","We aimed to investigate the mental health impact of COVID-19 on a demographically well-characterized population cohort by gender and previous depression status. Among people who participated in a community cohort study between 2013 and 2018 with previous depression measurement, a total of 1928 people without quarantine experience (680 men and 1249 women) were included after responding to an online survey in March 2020. In the 2020 survey, people were queried about daily needs supply, social supp","2021","07","23","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Epidemic; Gender; Mental health; PTSD","Yang","Ji Su","Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: yangjisu28@yuhs","yangjisu28@yuhs.ac"
"596","34171768","10.1016/j.jpsychores.2021.110552","Impact of COVID-19 on mental health according to prior depression status: A mental health survey of community prospective cohort data.","We aimed to investigate the mental health impact of COVID-19 on a demographically well-characterized population cohort by gender and previous depression status. Among people who participated in a community cohort study between 2013 and 2018 with previous depression measurement, a total of 1928 people without quarantine experience (680 men and 1249 women) were included after responding to an online survey in March 2020. In the 2020 survey, people were queried about daily needs supply, social supp","2021","07","23","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Epidemic; Gender; Mental health; PTSD","Park","Minseo","Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: minseo9137@yuhs","minseo9137@yuhs.ac"
"597","34171768","10.1016/j.jpsychores.2021.110552","Impact of COVID-19 on mental health according to prior depression status: A mental health survey of community prospective cohort data.","We aimed to investigate the mental health impact of COVID-19 on a demographically well-characterized population cohort by gender and previous depression status. Among people who participated in a community cohort study between 2013 and 2018 with previous depression measurement, a total of 1928 people without quarantine experience (680 men and 1249 women) were included after responding to an online survey in March 2020. In the 2020 survey, people were queried about daily needs supply, social supp","2021","07","23","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Epidemic; Gender; Mental health; PTSD","Kim","Kwanghyun","Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: SKNKUH10@yuhs","SKNKUH10@yuhs.ac"
"598","34171768","10.1016/j.jpsychores.2021.110552","Impact of COVID-19 on mental health according to prior depression status: A mental health survey of community prospective cohort data.","We aimed to investigate the mental health impact of COVID-19 on a demographically well-characterized population cohort by gender and previous depression status. Among people who participated in a community cohort study between 2013 and 2018 with previous depression measurement, a total of 1928 people without quarantine experience (680 men and 1249 women) were included after responding to an online survey in March 2020. In the 2020 survey, people were queried about daily needs supply, social supp","2021","07","23","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Epidemic; Gender; Mental health; PTSD","Chibnik","Lori B","Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA","lchibnik@partners.org"
"599","34171768","10.1016/j.jpsychores.2021.110552","Impact of COVID-19 on mental health according to prior depression status: A mental health survey of community prospective cohort data.","We aimed to investigate the mental health impact of COVID-19 on a demographically well-characterized population cohort by gender and previous depression status. Among people who participated in a community cohort study between 2013 and 2018 with previous depression measurement, a total of 1928 people without quarantine experience (680 men and 1249 women) were included after responding to an online survey in March 2020. In the 2020 survey, people were queried about daily needs supply, social supp","2021","07","23","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Epidemic; Gender; Mental health; PTSD","Kim","Hyeon Chang","Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: hckim@yuhs","hckim@yuhs.ac"
"600","34171768","10.1016/j.jpsychores.2021.110552","Impact of COVID-19 on mental health according to prior depression status: A mental health survey of community prospective cohort data.","We aimed to investigate the mental health impact of COVID-19 on a demographically well-characterized population cohort by gender and previous depression status. Among people who participated in a community cohort study between 2013 and 2018 with previous depression measurement, a total of 1928 people without quarantine experience (680 men and 1249 women) were included after responding to an online survey in March 2020. In the 2020 survey, people were queried about daily needs supply, social supp","2021","07","23","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Epidemic; Gender; Mental health; PTSD","Koenen","Karestan C","Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA","kkoenen@hsph.harvard.edu"
"601","34171720","10.1016/j.ajem.2021.06.020","Effectiveness of the rapid emergency medicine score and the rapid acute physiology score in prognosticating mortality in patients presenting to the emergency department with COVID-19 symptoms.","We investigated the effectiveness of the Rapid Emergency Medicine Score and the Rapid Acute Physiology Score in identifying critical patients among those presenting to the emergency department with COVID-19 symptoms. This prospective, observational, cohort study included patients with COVID-19 symptoms presenting to the emergency department over a two-month period. Demographics, clinical characteristics, and the data of all-cause mortality within 30 days after admission were noted, and the Rapid","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","COVID-19; Coronavirus infections; Early warning scores; Rapid acute physiology score; Rapid emergency medicine score; Triage","Özdemir","Serdar","Department of Emergency Medicine, University of Health Sciences Umraniye Training and Research Hospital, Istanbul, Turkey. Electronic address: dr.serdar55@hotmail","dr.serdar55@hotmail.com"
"602","34171720","10.1016/j.ajem.2021.06.020","Effectiveness of the rapid emergency medicine score and the rapid acute physiology score in prognosticating mortality in patients presenting to the emergency department with COVID-19 symptoms.","We investigated the effectiveness of the Rapid Emergency Medicine Score and the Rapid Acute Physiology Score in identifying critical patients among those presenting to the emergency department with COVID-19 symptoms. This prospective, observational, cohort study included patients with COVID-19 symptoms presenting to the emergency department over a two-month period. Demographics, clinical characteristics, and the data of all-cause mortality within 30 days after admission were noted, and the Rapid","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","COVID-19; Coronavirus infections; Early warning scores; Rapid acute physiology score; Rapid emergency medicine score; Triage","Akça","Hatice Seyma","Department of Emergency Medicine, University of Health Sciences Umraniye Training and Research Hospital, Istanbul, Turkey",NA
"603","34171720","10.1016/j.ajem.2021.06.020","Effectiveness of the rapid emergency medicine score and the rapid acute physiology score in prognosticating mortality in patients presenting to the emergency department with COVID-19 symptoms.","We investigated the effectiveness of the Rapid Emergency Medicine Score and the Rapid Acute Physiology Score in identifying critical patients among those presenting to the emergency department with COVID-19 symptoms. This prospective, observational, cohort study included patients with COVID-19 symptoms presenting to the emergency department over a two-month period. Demographics, clinical characteristics, and the data of all-cause mortality within 30 days after admission were noted, and the Rapid","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","COVID-19; Coronavirus infections; Early warning scores; Rapid acute physiology score; Rapid emergency medicine score; Triage","Algin","Abdullah","Department of Emergency Medicine, University of Health Sciences Umraniye Training and Research Hospital, Istanbul, Turkey",NA
"604","34171720","10.1016/j.ajem.2021.06.020","Effectiveness of the rapid emergency medicine score and the rapid acute physiology score in prognosticating mortality in patients presenting to the emergency department with COVID-19 symptoms.","We investigated the effectiveness of the Rapid Emergency Medicine Score and the Rapid Acute Physiology Score in identifying critical patients among those presenting to the emergency department with COVID-19 symptoms. This prospective, observational, cohort study included patients with COVID-19 symptoms presenting to the emergency department over a two-month period. Demographics, clinical characteristics, and the data of all-cause mortality within 30 days after admission were noted, and the Rapid","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","COVID-19; Coronavirus infections; Early warning scores; Rapid acute physiology score; Rapid emergency medicine score; Triage","Altunok","Ibrahim","Department of Emergency Medicine, University of Health Sciences Umraniye Training and Research Hospital, Istanbul, Turkey",NA
"605","34171720","10.1016/j.ajem.2021.06.020","Effectiveness of the rapid emergency medicine score and the rapid acute physiology score in prognosticating mortality in patients presenting to the emergency department with COVID-19 symptoms.","We investigated the effectiveness of the Rapid Emergency Medicine Score and the Rapid Acute Physiology Score in identifying critical patients among those presenting to the emergency department with COVID-19 symptoms. This prospective, observational, cohort study included patients with COVID-19 symptoms presenting to the emergency department over a two-month period. Demographics, clinical characteristics, and the data of all-cause mortality within 30 days after admission were noted, and the Rapid","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","COVID-19; Coronavirus infections; Early warning scores; Rapid acute physiology score; Rapid emergency medicine score; Triage","Eroglu","Serkan Emre","Department of Emergency Medicine, University of Health Sciences Umraniye Training and Research Hospital, Istanbul, Turkey",NA
"606","34171663","10.1016/j.ijmedinf.2021.104526","Novel application of telemedicine and an alternate EHR environment for virtual clinical education: A new model for primary care education during the SARS-CoV-2 pandemic.","Restrictions to direct patient contact resulting from the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic left some medical students near graduation in need of a required critical care medicine (CCM) sub-internship. A group of educators deployed a virtual curriculum utilizing telemedicine and electronic health record (EHR) technologies. Nine students participated in a formal curriculum of high-value critical care medicine topics designed to meet the learning objectives of t","2021","07","01","Int J Med Inform","International journal of medical informatics","Professional training&lt;Education; Remote monitoring&lt;Clinical documentation and communications&lt;Specific types&lt;Clinical information systems; Telemedicine and telehealth&lt;Clinical documentation and communications&lt;Specific types&lt;Clinical information systems; Training and education requirements&lt;Clinical Informatics","Shoemaker","Margrit M","Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA. Electronic address: MShoemaker@som.geisinger","MShoemaker@som.geisinger.edu"
"607","34171663","10.1016/j.ijmedinf.2021.104526","Novel application of telemedicine and an alternate EHR environment for virtual clinical education: A new model for primary care education during the SARS-CoV-2 pandemic.","Restrictions to direct patient contact resulting from the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic left some medical students near graduation in need of a required critical care medicine (CCM) sub-internship. A group of educators deployed a virtual curriculum utilizing telemedicine and electronic health record (EHR) technologies. Nine students participated in a formal curriculum of high-value critical care medicine topics designed to meet the learning objectives of t","2021","07","01","Int J Med Inform","International journal of medical informatics","Professional training&lt;Education; Remote monitoring&lt;Clinical documentation and communications&lt;Specific types&lt;Clinical information systems; Telemedicine and telehealth&lt;Clinical documentation and communications&lt;Specific types&lt;Clinical information systems; Training and education requirements&lt;Clinical Informatics","Lippold","Cassiopia","Adult Multidisciplinary Critical Care, Geisinger Medical Center, Danville, PA, USA. Electronic address: clippold@geisinger","clippold@geisinger.edu"
"608","34171663","10.1016/j.ijmedinf.2021.104526","Novel application of telemedicine and an alternate EHR environment for virtual clinical education: A new model for primary care education during the SARS-CoV-2 pandemic.","Restrictions to direct patient contact resulting from the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic left some medical students near graduation in need of a required critical care medicine (CCM) sub-internship. A group of educators deployed a virtual curriculum utilizing telemedicine and electronic health record (EHR) technologies. Nine students participated in a formal curriculum of high-value critical care medicine topics designed to meet the learning objectives of t","2021","07","01","Int J Med Inform","International journal of medical informatics","Professional training&lt;Education; Remote monitoring&lt;Clinical documentation and communications&lt;Specific types&lt;Clinical information systems; Telemedicine and telehealth&lt;Clinical documentation and communications&lt;Specific types&lt;Clinical information systems; Training and education requirements&lt;Clinical Informatics","Schreiber","Richard","Department of Medical Education, Geisinger Commonwealth School of Medicine, 431 North 21st Street, Suite 101, Camp Hill, PA, 17011, USA","rschreiber@pennstatehealth.psu.edu"
"609","34171663","10.1016/j.ijmedinf.2021.104526","Novel application of telemedicine and an alternate EHR environment for virtual clinical education: A new model for primary care education during the SARS-CoV-2 pandemic.","Restrictions to direct patient contact resulting from the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic left some medical students near graduation in need of a required critical care medicine (CCM) sub-internship. A group of educators deployed a virtual curriculum utilizing telemedicine and electronic health record (EHR) technologies. Nine students participated in a formal curriculum of high-value critical care medicine topics designed to meet the learning objectives of t","2021","07","01","Int J Med Inform","International journal of medical informatics","Professional training&lt;Education; Remote monitoring&lt;Clinical documentation and communications&lt;Specific types&lt;Clinical information systems; Telemedicine and telehealth&lt;Clinical documentation and communications&lt;Specific types&lt;Clinical information systems; Training and education requirements&lt;Clinical Informatics","Levy","Bruce","Department of Medical Education, Geisinger Commonwealth School of Medicine, USA","blevy2@geisinger.edu"
"610","34171649","10.1016/j.jstrokecerebrovasdis.2021.105938","Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine.","Coronavirus is a novel human pathogen causing fulminant respiratory syndrome (COVID-19). Although COVID-19 is primarily a disease of the lungs with florid respiratory manifestations, there are increasing reports of cardiovascular, musculoskeletal, gastrointestinal, and thromboembolic complications. Developing an effective and reliable vaccine was emergently pursued to control the catastrophic spread of the global pandemic. We report a fatal case of vaccine-induced immune thrombotic thrombocytope","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Cerebral Venous Sinus Thrombosis; Death; Disseminated Intravascular Coagulation; Vaccine; Vaccine-induced Immune Thrombotic Thrombocytopenia","Aladdin","Yasser","King Abdulaziz Medical City, Jeddah, Saudi Arabia","yaladdin@ymail.com"
"611","34171649","10.1016/j.jstrokecerebrovasdis.2021.105938","Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine.","Coronavirus is a novel human pathogen causing fulminant respiratory syndrome (COVID-19). Although COVID-19 is primarily a disease of the lungs with florid respiratory manifestations, there are increasing reports of cardiovascular, musculoskeletal, gastrointestinal, and thromboembolic complications. Developing an effective and reliable vaccine was emergently pursued to control the catastrophic spread of the global pandemic. We report a fatal case of vaccine-induced immune thrombotic thrombocytope","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Cerebral Venous Sinus Thrombosis; Death; Disseminated Intravascular Coagulation; Vaccine; Vaccine-induced Immune Thrombotic Thrombocytopenia","Algahtani","Hussein","King Abdulaziz Medical City, Jeddah, Saudi Arabia","halgahtani@hotmail.com"
"612","34171649","10.1016/j.jstrokecerebrovasdis.2021.105938","Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine.","Coronavirus is a novel human pathogen causing fulminant respiratory syndrome (COVID-19). Although COVID-19 is primarily a disease of the lungs with florid respiratory manifestations, there are increasing reports of cardiovascular, musculoskeletal, gastrointestinal, and thromboembolic complications. Developing an effective and reliable vaccine was emergently pursued to control the catastrophic spread of the global pandemic. We report a fatal case of vaccine-induced immune thrombotic thrombocytope","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Cerebral Venous Sinus Thrombosis; Death; Disseminated Intravascular Coagulation; Vaccine; Vaccine-induced Immune Thrombotic Thrombocytopenia","Shirah","Bader","King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia",NA
"613","34171641","10.1016/j.compbiomed.2021.104579","Scat-NET: COVID-19 diagnosis with a CNN model using scattergram images.","The acute respiratory syndrome COVID-19 disease, which is caused by SARS-CoV-2, has infected many people over a short time and caused the death of more than 2 million people. The gold standard in detecting COVID-19 is to apply the reverse transcription polymerase chain reaction (RT-PCR) test. This test has low sensitivity and produces false results of approximately 15%-20%. Computer tomography (CT) images were checked as a result of suspicious RT-PCR tests. If the virus is not infected in the lu","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computer tomography; Convolutional neural network; Reverse transcription polymerase chain reaction; Scattergram","Tuncer","Seda Arslan","Firat University Department of Software Engineering, 23119, Elazig, Turkey. Electronic address: satuncer@firat.edu","satuncer@firat.edu.tr"
"614","34171641","10.1016/j.compbiomed.2021.104579","Scat-NET: COVID-19 diagnosis with a CNN model using scattergram images.","The acute respiratory syndrome COVID-19 disease, which is caused by SARS-CoV-2, has infected many people over a short time and caused the death of more than 2 million people. The gold standard in detecting COVID-19 is to apply the reverse transcription polymerase chain reaction (RT-PCR) test. This test has low sensitivity and produces false results of approximately 15%-20%. Computer tomography (CT) images were checked as a result of suspicious RT-PCR tests. If the virus is not infected in the lu","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computer tomography; Convolutional neural network; Reverse transcription polymerase chain reaction; Scattergram","Ayyildiz","Hakan","Fethi Sekin Central Hosspital, 23280, Elazig, Turkey. Electronic address: hakan.ayyildiz1@saglik.gov","hakan.ayyildiz1@saglik.gov.tr"
"615","34171641","10.1016/j.compbiomed.2021.104579","Scat-NET: COVID-19 diagnosis with a CNN model using scattergram images.","The acute respiratory syndrome COVID-19 disease, which is caused by SARS-CoV-2, has infected many people over a short time and caused the death of more than 2 million people. The gold standard in detecting COVID-19 is to apply the reverse transcription polymerase chain reaction (RT-PCR) test. This test has low sensitivity and produces false results of approximately 15%-20%. Computer tomography (CT) images were checked as a result of suspicious RT-PCR tests. If the virus is not infected in the lu","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computer tomography; Convolutional neural network; Reverse transcription polymerase chain reaction; Scattergram","Kalayci","Mehmet","Fethi Sekin Central Hosspital, 23280, Elazig, Turkey. Electronic address: dr_mehmetkalayci@msn","mehmetkalayci@msn.com"
"616","34171641","10.1016/j.compbiomed.2021.104579","Scat-NET: COVID-19 diagnosis with a CNN model using scattergram images.","The acute respiratory syndrome COVID-19 disease, which is caused by SARS-CoV-2, has infected many people over a short time and caused the death of more than 2 million people. The gold standard in detecting COVID-19 is to apply the reverse transcription polymerase chain reaction (RT-PCR) test. This test has low sensitivity and produces false results of approximately 15%-20%. Computer tomography (CT) images were checked as a result of suspicious RT-PCR tests. If the virus is not infected in the lu","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computer tomography; Convolutional neural network; Reverse transcription polymerase chain reaction; Scattergram","Tuncer","Taner","Firat University, Department of Computer Engineering, 23119, Elazig, Turkey. Electronic address: ttuncer@firat.edu","ttuncer@firat.edu.tr"
"617","34171635","10.1016/j.ejogrb.2021.06.002","Screening for infections in pregnancy - An overview of where we are today.","Although most infections in pregnancy have very little impact, some affect either the mother or fetus or both. Screening must target those infections with consequences and furthermore, must be cost-beneficial. The introduction of any screening test for infections should take into consideration the prevalence of the condition, its consequences (health impact), the accuracy of the test and whether there are remedial steps including primary and secondary prevention to take with a positive or negati","2021","07","20","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology","Cost-benefit analysis; Infections in pregnancy; Screening; Sensitivity and specificity","Ahmed","Badredeen","Feto Maternal Centre, Doha, Qatar",NA
"618","34171635","10.1016/j.ejogrb.2021.06.002","Screening for infections in pregnancy - An overview of where we are today.","Although most infections in pregnancy have very little impact, some affect either the mother or fetus or both. Screening must target those infections with consequences and furthermore, must be cost-beneficial. The introduction of any screening test for infections should take into consideration the prevalence of the condition, its consequences (health impact), the accuracy of the test and whether there are remedial steps including primary and secondary prevention to take with a positive or negati","2021","07","20","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology","Cost-benefit analysis; Infections in pregnancy; Screening; Sensitivity and specificity","Konje","Justin C","Department of Health Sciences, University of Leicester, UK. Electronic address: jck4@leicester.ac","jck4@leicester.ac.uk"
"619","34171616","10.1016/j.puhe.2021.05.009","Factors associated with reported likelihood to get vaccinated for COVID-19 in a nationally representative US survey.","Although general principles related to vaccination hesitancy have been well researched, reports on reluctance to be vaccinated for coronavirus disease 2019 (COVID-19) in the United States are somewhat surprising, given the disease's substantive disruption of everyday life. However, the landscape in which people are making COVID-19 vaccination decisions has recently evolved with releases of encouraging vaccine-related data and changes to official messaging about the virus. Therefore, this study s","2021","07","21","Public Health","Public health","COVID-19; Prevention; Trust in science; Vaccination","Agley","J","Prevention Insights, Department of Applied Health Science, School of Public Health Bloomington, Indiana University Bloomington, Bloomington, IN, USA. Electronic address: jagley@indiana","jagley@indiana.edu"
"620","34171616","10.1016/j.puhe.2021.05.009","Factors associated with reported likelihood to get vaccinated for COVID-19 in a nationally representative US survey.","Although general principles related to vaccination hesitancy have been well researched, reports on reluctance to be vaccinated for coronavirus disease 2019 (COVID-19) in the United States are somewhat surprising, given the disease's substantive disruption of everyday life. However, the landscape in which people are making COVID-19 vaccination decisions has recently evolved with releases of encouraging vaccine-related data and changes to official messaging about the virus. Therefore, this study s","2021","07","21","Public Health","Public health","COVID-19; Prevention; Trust in science; Vaccination","Xiao","Y","School of Social Work, Indiana University Bloomington, Bloomington, IN, USA",NA
"621","34171616","10.1016/j.puhe.2021.05.009","Factors associated with reported likelihood to get vaccinated for COVID-19 in a nationally representative US survey.","Although general principles related to vaccination hesitancy have been well researched, reports on reluctance to be vaccinated for coronavirus disease 2019 (COVID-19) in the United States are somewhat surprising, given the disease's substantive disruption of everyday life. However, the landscape in which people are making COVID-19 vaccination decisions has recently evolved with releases of encouraging vaccine-related data and changes to official messaging about the virus. Therefore, this study s","2021","07","21","Public Health","Public health","COVID-19; Prevention; Trust in science; Vaccination","Thompson","E E","Media School, Indiana University Bloomington, Bloomington, IN, USA",NA
"622","34171616","10.1016/j.puhe.2021.05.009","Factors associated with reported likelihood to get vaccinated for COVID-19 in a nationally representative US survey.","Although general principles related to vaccination hesitancy have been well researched, reports on reluctance to be vaccinated for coronavirus disease 2019 (COVID-19) in the United States are somewhat surprising, given the disease's substantive disruption of everyday life. However, the landscape in which people are making COVID-19 vaccination decisions has recently evolved with releases of encouraging vaccine-related data and changes to official messaging about the virus. Therefore, this study s","2021","07","21","Public Health","Public health","COVID-19; Prevention; Trust in science; Vaccination","Golzarri-Arroyo","L","Biostatistics Consulting Center, School of Public Health Bloomington, Indiana University Bloomington, Bloomington, IN, USA",NA
"623","34171615","10.1016/j.puhe.2021.04.015","Home participation, support and barriers among children with attention-deficit/hyperactivity disorder before and during the COVID-19 pandemic.","Few studies have focused on the participation of children with attention-deficit/hyperactivity disorder (ADHD) in daily routine and leisure activities. This study aimed to compare the participation, support and barriers for children with ADHD at home pre-COVID-19 and during the COVID-19 outbreak. The study included 55 children with ADHD aged 6-11 years. Participation frequency, involvement, desire for change, supports and barriers at home were assessed using the Participation and Environment Mea","2021","07","21","Public Health","Public health","Attention-deficit/hyperactivity disorder (ADHD); Environment; Home; Participation","Kaya Kara","Ozgun","Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Akdeniz University, Antalya, Turkey. Electronic address: ozgun_kaya@yahoo","kaya@yahoo.com"
"624","34171615","10.1016/j.puhe.2021.04.015","Home participation, support and barriers among children with attention-deficit/hyperactivity disorder before and during the COVID-19 pandemic.","Few studies have focused on the participation of children with attention-deficit/hyperactivity disorder (ADHD) in daily routine and leisure activities. This study aimed to compare the participation, support and barriers for children with ADHD at home pre-COVID-19 and during the COVID-19 outbreak. The study included 55 children with ADHD aged 6-11 years. Participation frequency, involvement, desire for change, supports and barriers at home were assessed using the Participation and Environment Mea","2021","07","21","Public Health","Public health","Attention-deficit/hyperactivity disorder (ADHD); Environment; Home; Participation","Tonak","Hasan Atacan","Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Akdeniz University, Antalya, Turkey",NA
"625","34171615","10.1016/j.puhe.2021.04.015","Home participation, support and barriers among children with attention-deficit/hyperactivity disorder before and during the COVID-19 pandemic.","Few studies have focused on the participation of children with attention-deficit/hyperactivity disorder (ADHD) in daily routine and leisure activities. This study aimed to compare the participation, support and barriers for children with ADHD at home pre-COVID-19 and during the COVID-19 outbreak. The study included 55 children with ADHD aged 6-11 years. Participation frequency, involvement, desire for change, supports and barriers at home were assessed using the Participation and Environment Mea","2021","07","21","Public Health","Public health","Attention-deficit/hyperactivity disorder (ADHD); Environment; Home; Participation","Kara","Koray","Department of Child and Adolescent Psychiatry, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey",NA
"626","34171615","10.1016/j.puhe.2021.04.015","Home participation, support and barriers among children with attention-deficit/hyperactivity disorder before and during the COVID-19 pandemic.","Few studies have focused on the participation of children with attention-deficit/hyperactivity disorder (ADHD) in daily routine and leisure activities. This study aimed to compare the participation, support and barriers for children with ADHD at home pre-COVID-19 and during the COVID-19 outbreak. The study included 55 children with ADHD aged 6-11 years. Participation frequency, involvement, desire for change, supports and barriers at home were assessed using the Participation and Environment Mea","2021","07","21","Public Health","Public health","Attention-deficit/hyperactivity disorder (ADHD); Environment; Home; Participation","Sonbahar Ulu","Hazal","Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Akdeniz University, Antalya, Turkey",NA
"627","34171615","10.1016/j.puhe.2021.04.015","Home participation, support and barriers among children with attention-deficit/hyperactivity disorder before and during the COVID-19 pandemic.","Few studies have focused on the participation of children with attention-deficit/hyperactivity disorder (ADHD) in daily routine and leisure activities. This study aimed to compare the participation, support and barriers for children with ADHD at home pre-COVID-19 and during the COVID-19 outbreak. The study included 55 children with ADHD aged 6-11 years. Participation frequency, involvement, desire for change, supports and barriers at home were assessed using the Participation and Environment Mea","2021","07","21","Public Health","Public health","Attention-deficit/hyperactivity disorder (ADHD); Environment; Home; Participation","Kose","Barkin","Department of Occupational Therapy, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey",NA
"628","34171615","10.1016/j.puhe.2021.04.015","Home participation, support and barriers among children with attention-deficit/hyperactivity disorder before and during the COVID-19 pandemic.","Few studies have focused on the participation of children with attention-deficit/hyperactivity disorder (ADHD) in daily routine and leisure activities. This study aimed to compare the participation, support and barriers for children with ADHD at home pre-COVID-19 and during the COVID-19 outbreak. The study included 55 children with ADHD aged 6-11 years. Participation frequency, involvement, desire for change, supports and barriers at home were assessed using the Participation and Environment Mea","2021","07","21","Public Health","Public health","Attention-deficit/hyperactivity disorder (ADHD); Environment; Home; Participation","Sahin","Sedef","Department of Occupational Therapy, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey",NA
"629","34171615","10.1016/j.puhe.2021.04.015","Home participation, support and barriers among children with attention-deficit/hyperactivity disorder before and during the COVID-19 pandemic.","Few studies have focused on the participation of children with attention-deficit/hyperactivity disorder (ADHD) in daily routine and leisure activities. This study aimed to compare the participation, support and barriers for children with ADHD at home pre-COVID-19 and during the COVID-19 outbreak. The study included 55 children with ADHD aged 6-11 years. Participation frequency, involvement, desire for change, supports and barriers at home were assessed using the Participation and Environment Mea","2021","07","21","Public Health","Public health","Attention-deficit/hyperactivity disorder (ADHD); Environment; Home; Participation","Kara","Mahmut Zabit","Department of Child and Adolescent Psychiatry, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey",NA
"630","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Naidoo","Pragalathan","Department of Biological Sciences, School of Life Sciences, College of Agriculture, Engineering and Science, Westville Campus, University of KwaZulu-Natal, Westville, Durban 3629, South Africa","naidoop5@ukzn.ac.za"
"631","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Ghazi","Terisha","Department of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, Howard College, University of KwaZulu-Natal, Glenwood, Durban 4041, South Africa",NA
"632","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Chuturgoon","Anil A","Department of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, Howard College, University of KwaZulu-Natal, Glenwood, Durban 4041, South Africa",NA
"633","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Naidoo","Rajen N","Discipline of Occupational and Environmental Health, School of Nursing and Public Health, College of Health Sciences, Howard College, University of KwaZulu-Natal, Glenwood, Durban 4041, South Africa",NA
"634","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Ramsuran","Veron","School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa",NA
"635","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Mpaka-Mbatha","Miranda N","Department of Biological Sciences, School of Life Sciences, College of Agriculture, Engineering and Science, Westville Campus, University of KwaZulu-Natal, Westville, Durban 3629, South Africa",NA
"636","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Bhengu","Khethiwe N","Department of Biological Sciences, School of Life Sciences, College of Agriculture, Engineering and Science, Westville Campus, University of KwaZulu-Natal, Westville, Durban 3629, South Africa",NA
"637","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Nembe","Nomzamo","Department of Biological Sciences, School of Life Sciences, College of Agriculture, Engineering and Science, Westville Campus, University of KwaZulu-Natal, Westville, Durban 3629, South Africa",NA
"638","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Duma","Zamathombeni","Department of Biological Sciences, School of Life Sciences, College of Agriculture, Engineering and Science, Westville Campus, University of KwaZulu-Natal, Westville, Durban 3629, South Africa",NA
"639","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Pillay","Roxanne","Department of Biological Sciences, School of Life Sciences, College of Agriculture, Engineering and Science, Westville Campus, University of KwaZulu-Natal, Westville, Durban 3629, South Africa",NA
"640","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Singh","Ravesh","Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, Howard College, University of KwaZulu-Natal, Glenwood, Durban 4041, South Africa",NA
"641","34171587","10.1016/j.envint.2021.106695","SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.","Soil-transmitted helminths infect billions of people globally, particularly those residing in low- and middle-income regions with poor environmental sanitation and high levels of air and water pollution. Helminths display potent immunomodulatory activity by activating T helper type 2 (Th2) anti-inflammatory and Th3 regulatory immune responses. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (COVID-19), can exacerbate Th1/Th17 pro-i","2021","07","21","Environ Int","Environment international","Cytokine storm; Environmental pollution; Helminth-induced Th2/Th3 anti-inflammatory immune response; Immunomodulatory activity of helminths; SARS-CoV-2/ COVID-19; Th1/Th17-induced pro-inflammatory immune response","Mkhize-Kwitshana","Zilungile L","Department of Biological Sciences, School of Life Sciences, College of Agriculture, Engineering and Science, Westville Campus, University of KwaZulu-Natal, Westville, Durban 3629, South Africa",NA
"642","34171563","10.1016/j.jss.2021.05.019","Recognizing the Benefit of Telemedicine Before and After COVID-19: A Survey of Pediatric Surgery Providers.","Prior to the COVID-19 pandemic, the use of telemedicine to evaluate pediatric surgery patients was uncommon. Due in part to restrictions imposed to mitigate the spread of the virus, the use of telemedicine within pediatric surgery has significantly expanded. Prior to the use of telemedicine within surgery divisions at our institution, pediatric surgeons were surveyed to determine their perspectives on the use of telemedicine. Following the expanded use of telemedicine in response to the COVID-19","2021","07","19","J Surg Res","The Journal of surgical research","COVID-19; Pediatric surgery; Pediatrics; Telehealth; Telemedicine","Metzger","Gregory A","The Center for Surgical Outcomes Research, Nationwide Children's Hospital, Columbus, Ohio",NA
"643","34171563","10.1016/j.jss.2021.05.019","Recognizing the Benefit of Telemedicine Before and After COVID-19: A Survey of Pediatric Surgery Providers.","Prior to the COVID-19 pandemic, the use of telemedicine to evaluate pediatric surgery patients was uncommon. Due in part to restrictions imposed to mitigate the spread of the virus, the use of telemedicine within pediatric surgery has significantly expanded. Prior to the use of telemedicine within surgery divisions at our institution, pediatric surgeons were surveyed to determine their perspectives on the use of telemedicine. Following the expanded use of telemedicine in response to the COVID-19","2021","07","19","J Surg Res","The Journal of surgical research","COVID-19; Pediatric surgery; Pediatrics; Telehealth; Telemedicine","Cooper","Jennifer","The Center for Surgical Outcomes Research, Nationwide Children's Hospital, Columbus, Ohio",NA
"644","34171563","10.1016/j.jss.2021.05.019","Recognizing the Benefit of Telemedicine Before and After COVID-19: A Survey of Pediatric Surgery Providers.","Prior to the COVID-19 pandemic, the use of telemedicine to evaluate pediatric surgery patients was uncommon. Due in part to restrictions imposed to mitigate the spread of the virus, the use of telemedicine within pediatric surgery has significantly expanded. Prior to the use of telemedicine within surgery divisions at our institution, pediatric surgeons were surveyed to determine their perspectives on the use of telemedicine. Following the expanded use of telemedicine in response to the COVID-19","2021","07","19","J Surg Res","The Journal of surgical research","COVID-19; Pediatric surgery; Pediatrics; Telehealth; Telemedicine","Lutz","Carley","The Center for Surgical Outcomes Research, Nationwide Children's Hospital, Columbus, Ohio",NA
"645","34171563","10.1016/j.jss.2021.05.019","Recognizing the Benefit of Telemedicine Before and After COVID-19: A Survey of Pediatric Surgery Providers.","Prior to the COVID-19 pandemic, the use of telemedicine to evaluate pediatric surgery patients was uncommon. Due in part to restrictions imposed to mitigate the spread of the virus, the use of telemedicine within pediatric surgery has significantly expanded. Prior to the use of telemedicine within surgery divisions at our institution, pediatric surgeons were surveyed to determine their perspectives on the use of telemedicine. Following the expanded use of telemedicine in response to the COVID-19","2021","07","19","J Surg Res","The Journal of surgical research","COVID-19; Pediatric surgery; Pediatrics; Telehealth; Telemedicine","Jatana","Kris R","Department of Pediatric Otolaryngology, Nationwide Children's Hospital, Columbus, Ohio",NA
"646","34171563","10.1016/j.jss.2021.05.019","Recognizing the Benefit of Telemedicine Before and After COVID-19: A Survey of Pediatric Surgery Providers.","Prior to the COVID-19 pandemic, the use of telemedicine to evaluate pediatric surgery patients was uncommon. Due in part to restrictions imposed to mitigate the spread of the virus, the use of telemedicine within pediatric surgery has significantly expanded. Prior to the use of telemedicine within surgery divisions at our institution, pediatric surgeons were surveyed to determine their perspectives on the use of telemedicine. Following the expanded use of telemedicine in response to the COVID-19","2021","07","19","J Surg Res","The Journal of surgical research","COVID-19; Pediatric surgery; Pediatrics; Telehealth; Telemedicine","Nishimura","Leah","The Center for Surgical Outcomes Research, Nationwide Children's Hospital, Columbus, Ohio",NA
"647","34171563","10.1016/j.jss.2021.05.019","Recognizing the Benefit of Telemedicine Before and After COVID-19: A Survey of Pediatric Surgery Providers.","Prior to the COVID-19 pandemic, the use of telemedicine to evaluate pediatric surgery patients was uncommon. Due in part to restrictions imposed to mitigate the spread of the virus, the use of telemedicine within pediatric surgery has significantly expanded. Prior to the use of telemedicine within surgery divisions at our institution, pediatric surgeons were surveyed to determine their perspectives on the use of telemedicine. Following the expanded use of telemedicine in response to the COVID-19","2021","07","19","J Surg Res","The Journal of surgical research","COVID-19; Pediatric surgery; Pediatrics; Telehealth; Telemedicine","Deans","Katherine J","Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, Ohio",NA
"648","34171563","10.1016/j.jss.2021.05.019","Recognizing the Benefit of Telemedicine Before and After COVID-19: A Survey of Pediatric Surgery Providers.","Prior to the COVID-19 pandemic, the use of telemedicine to evaluate pediatric surgery patients was uncommon. Due in part to restrictions imposed to mitigate the spread of the virus, the use of telemedicine within pediatric surgery has significantly expanded. Prior to the use of telemedicine within surgery divisions at our institution, pediatric surgeons were surveyed to determine their perspectives on the use of telemedicine. Following the expanded use of telemedicine in response to the COVID-19","2021","07","19","J Surg Res","The Journal of surgical research","COVID-19; Pediatric surgery; Pediatrics; Telehealth; Telemedicine","Minneci","Peter C","Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, Ohio",NA
"649","34171563","10.1016/j.jss.2021.05.019","Recognizing the Benefit of Telemedicine Before and After COVID-19: A Survey of Pediatric Surgery Providers.","Prior to the COVID-19 pandemic, the use of telemedicine to evaluate pediatric surgery patients was uncommon. Due in part to restrictions imposed to mitigate the spread of the virus, the use of telemedicine within pediatric surgery has significantly expanded. Prior to the use of telemedicine within surgery divisions at our institution, pediatric surgeons were surveyed to determine their perspectives on the use of telemedicine. Following the expanded use of telemedicine in response to the COVID-19","2021","07","19","J Surg Res","The Journal of surgical research","COVID-19; Pediatric surgery; Pediatrics; Telehealth; Telemedicine","Halaweish","Ihab","Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: ihab.halaweish@nationwidechildrens","ihab.halaweish@nationwidechildrens.org"
"650","34171559","10.1016/j.ctarc.2021.100425","COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.","Malignancy is one of the prime global causes of mortality. Cancer Patients suffering from SARS-CoV-2 have demonstrated higher rates of severe complications exacerbating towards death. Possible genetic and epigenetic alterations may exist in cancer patients which have the potential to contribute towards their increased vulnerability towards COVID-19. An exhaustive literature search using 'COVID-19', 'SARS-CoV-2', 'Cancer', 'Malignancy', 'Relationships', Interlinks', 'Genetic', 'Epigenetic', 'Epid","2021","07","21","Cancer Treat Res Commun","Cancer treatment and research communications","ACE2; Cancer; Epigenetic; Genetic; IL-6; SARS-CoV-2; TMPRSS2; Vaccine","Sayed","Shomoita","Department of Biochemistry and Molecular Biology, Jagannath University. 9-10 Chittaranjan Ave, Dhaka 1100, Bangladesh. Electronic address: shomoita.s@gmail","shomoita.s@gmail.com"
"651","34171548","10.1016/j.jcv.2021.104900","A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.","More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a high viral load specimen that repeatedly tested negative by this antigen test. Whole","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Antigen; False negative; Nucleocapsid; Quidel; Sars-cov-2; Sofia 2; Variant","Bourassa","Lori","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA",NA
"652","34171548","10.1016/j.jcv.2021.104900","A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.","More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a high viral load specimen that repeatedly tested negative by this antigen test. Whole","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Antigen; False negative; Nucleocapsid; Quidel; Sars-cov-2; Sofia 2; Variant","Perchetti","Garrett A","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA",NA
"653","34171548","10.1016/j.jcv.2021.104900","A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.","More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a high viral load specimen that repeatedly tested negative by this antigen test. Whole","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Antigen; False negative; Nucleocapsid; Quidel; Sars-cov-2; Sofia 2; Variant","Phung","Quynh","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA",NA
"654","34171548","10.1016/j.jcv.2021.104900","A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.","More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a high viral load specimen that repeatedly tested negative by this antigen test. Whole","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Antigen; False negative; Nucleocapsid; Quidel; Sars-cov-2; Sofia 2; Variant","Lin","Michelle J","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA",NA
"655","34171548","10.1016/j.jcv.2021.104900","A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.","More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a high viral load specimen that repeatedly tested negative by this antigen test. Whole","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Antigen; False negative; Nucleocapsid; Quidel; Sars-cov-2; Sofia 2; Variant","Mills","Margaret G","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA",NA
"656","34171548","10.1016/j.jcv.2021.104900","A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.","More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a high viral load specimen that repeatedly tested negative by this antigen test. Whole","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Antigen; False negative; Nucleocapsid; Quidel; Sars-cov-2; Sofia 2; Variant","Roychoudhury","Pavitra","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA",NA
"657","34171548","10.1016/j.jcv.2021.104900","A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.","More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a high viral load specimen that repeatedly tested negative by this antigen test. Whole","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Antigen; False negative; Nucleocapsid; Quidel; Sars-cov-2; Sofia 2; Variant","Harmon","Kimberly G","Department of Family Medicine, for Stanley Herring Department of Physical Medicine and Rehabilitation, University of Washington, Seattle, Washington, USA",NA
"658","34171548","10.1016/j.jcv.2021.104900","A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.","More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a high viral load specimen that repeatedly tested negative by this antigen test. Whole","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Antigen; False negative; Nucleocapsid; Quidel; Sars-cov-2; Sofia 2; Variant","Reed","Jonathan C","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA",NA
"659","34171548","10.1016/j.jcv.2021.104900","A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.","More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a high viral load specimen that repeatedly tested negative by this antigen test. Whole","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Antigen; False negative; Nucleocapsid; Quidel; Sars-cov-2; Sofia 2; Variant","Greninger","Alexander L","Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA",NA
"660","34171538","10.1016/j.accpm.2021.100912","COVID-19 in Africa: Current difficulties and future challenges considering the ACCCOS study.",NA,"2021","07","17","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Africa: outcomes; COVID-19; qSOFA","Hasanin","Ahmed","Department of Anaesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: ahmedmohamedhasanin@gmail","ahmedmohamedhasanin@gmail.com"
"661","34171538","10.1016/j.accpm.2021.100912","COVID-19 in Africa: Current difficulties and future challenges considering the ACCCOS study.",NA,"2021","07","17","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Africa: outcomes; COVID-19; qSOFA","de Vasconcellos","Kim","Department of Critical Care, King Edward VIII Hospital, Durban, South Africa",NA
"662","34171538","10.1016/j.accpm.2021.100912","COVID-19 in Africa: Current difficulties and future challenges considering the ACCCOS study.",NA,"2021","07","17","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Africa: outcomes; COVID-19; qSOFA","Abdulatif","Mohamed","Department of Anaesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"663","34171532","10.1016/j.jvsv.2021.06.011","The clinical significance of ultra-high D-dimer levels.","Plasma D-dimer levels &gt;5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less clear for patients diagnosed with COVID-19 with a baseline elevation in plasma D-dimer levels. In the present study, we reviewed the occurrence of plasma D-dimer levels &gt;5000 ng/mL and investigated the clinic","2021","07","14","J Vasc Surg Venous Lymphat Disord","Journal of vascular surgery. Venous and lymphatic disorders","Cancer; Coronavirus; D-dimer; Screening; Thrombosis","Schafer","Kristin","University of Toledo College of Medicine, Toledo, Ohio",NA
"664","34171532","10.1016/j.jvsv.2021.06.011","The clinical significance of ultra-high D-dimer levels.","Plasma D-dimer levels &gt;5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less clear for patients diagnosed with COVID-19 with a baseline elevation in plasma D-dimer levels. In the present study, we reviewed the occurrence of plasma D-dimer levels &gt;5000 ng/mL and investigated the clinic","2021","07","14","J Vasc Surg Venous Lymphat Disord","Journal of vascular surgery. Venous and lymphatic disorders","Cancer; Coronavirus; D-dimer; Screening; Thrombosis","Goldschmidt","Eric","University of Toledo College of Medicine, Toledo, Ohio",NA
"665","34171532","10.1016/j.jvsv.2021.06.011","The clinical significance of ultra-high D-dimer levels.","Plasma D-dimer levels &gt;5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less clear for patients diagnosed with COVID-19 with a baseline elevation in plasma D-dimer levels. In the present study, we reviewed the occurrence of plasma D-dimer levels &gt;5000 ng/mL and investigated the clinic","2021","07","14","J Vasc Surg Venous Lymphat Disord","Journal of vascular surgery. Venous and lymphatic disorders","Cancer; Coronavirus; D-dimer; Screening; Thrombosis","Oostra","Drew","Jobst Vascular Institute, Toledo, Ohio",NA
"666","34171532","10.1016/j.jvsv.2021.06.011","The clinical significance of ultra-high D-dimer levels.","Plasma D-dimer levels &gt;5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less clear for patients diagnosed with COVID-19 with a baseline elevation in plasma D-dimer levels. In the present study, we reviewed the occurrence of plasma D-dimer levels &gt;5000 ng/mL and investigated the clinic","2021","07","14","J Vasc Surg Venous Lymphat Disord","Journal of vascular surgery. Venous and lymphatic disorders","Cancer; Coronavirus; D-dimer; Screening; Thrombosis","Fish","John","Jobst Vascular Institute, Toledo, Ohio",NA
"667","34171532","10.1016/j.jvsv.2021.06.011","The clinical significance of ultra-high D-dimer levels.","Plasma D-dimer levels &gt;5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less clear for patients diagnosed with COVID-19 with a baseline elevation in plasma D-dimer levels. In the present study, we reviewed the occurrence of plasma D-dimer levels &gt;5000 ng/mL and investigated the clinic","2021","07","14","J Vasc Surg Venous Lymphat Disord","Journal of vascular surgery. Venous and lymphatic disorders","Cancer; Coronavirus; D-dimer; Screening; Thrombosis","Russell","Todd","Jobst Vascular Institute, Toledo, Ohio",NA
"668","34171532","10.1016/j.jvsv.2021.06.011","The clinical significance of ultra-high D-dimer levels.","Plasma D-dimer levels &gt;5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less clear for patients diagnosed with COVID-19 with a baseline elevation in plasma D-dimer levels. In the present study, we reviewed the occurrence of plasma D-dimer levels &gt;5000 ng/mL and investigated the clinic","2021","07","14","J Vasc Surg Venous Lymphat Disord","Journal of vascular surgery. Venous and lymphatic disorders","Cancer; Coronavirus; D-dimer; Screening; Thrombosis","Lurie","Fedor","Jobst Vascular Institute, Toledo, Ohio. Electronic address: fedor.lurie@promedica","fedor.lurie@promedica.org"
"669","34171517","10.1016/j.pedn.2021.06.005","Impact of COVID-19 on Pediatric Clinical Research.","Many public institutions and settings have taken action to limit exposure to and slow the spread of the novel coronavirus (COVID-19). We sought to characterize the impact of stay-at-home orders on our study of cerebral autoregulation and its association with developmental delays in infants with congenital heart disease compared with healthy controls. We calculated the number of participants recruited (i.e., not enrolled in the study) and assessed (i.e., currently enrolled) before March 2020 (pre","2021","07","01","J Pediatr Nurs","Journal of pediatric nursing","COVID-19; Clinical research; Congenital heart disease; Pediatrics; Stay-at-home order","Tran","Nhu N","Keck School of Medicine of University of Southern California (KSOM USC), Department of Surgery and Children's Hospital, Los Angeles (CHLA), United States of America. Electronic address: ntran@chla.usc","ntran@chla.usc.edu"
"670","34171517","10.1016/j.pedn.2021.06.005","Impact of COVID-19 on Pediatric Clinical Research.","Many public institutions and settings have taken action to limit exposure to and slow the spread of the novel coronavirus (COVID-19). We sought to characterize the impact of stay-at-home orders on our study of cerebral autoregulation and its association with developmental delays in infants with congenital heart disease compared with healthy controls. We calculated the number of participants recruited (i.e., not enrolled in the study) and assessed (i.e., currently enrolled) before March 2020 (pre","2021","07","01","J Pediatr Nurs","Journal of pediatric nursing","COVID-19; Clinical research; Congenital heart disease; Pediatrics; Stay-at-home order","Tran","Michelle","Department of Preventive Medicine, KSOM USC and Division of Research on Children, Youth, and Families, The Saban Research Institute, CHLA, United States of America",NA
"671","34171517","10.1016/j.pedn.2021.06.005","Impact of COVID-19 on Pediatric Clinical Research.","Many public institutions and settings have taken action to limit exposure to and slow the spread of the novel coronavirus (COVID-19). We sought to characterize the impact of stay-at-home orders on our study of cerebral autoregulation and its association with developmental delays in infants with congenital heart disease compared with healthy controls. We calculated the number of participants recruited (i.e., not enrolled in the study) and assessed (i.e., currently enrolled) before March 2020 (pre","2021","07","01","J Pediatr Nurs","Journal of pediatric nursing","COVID-19; Clinical research; Congenital heart disease; Pediatrics; Stay-at-home order","Lopez","Jeraldine","Division of Research on Children, Youth, and Families, The Saban Research Institute, CHLA, United States of America",NA
"672","34171517","10.1016/j.pedn.2021.06.005","Impact of COVID-19 on Pediatric Clinical Research.","Many public institutions and settings have taken action to limit exposure to and slow the spread of the novel coronavirus (COVID-19). We sought to characterize the impact of stay-at-home orders on our study of cerebral autoregulation and its association with developmental delays in infants with congenital heart disease compared with healthy controls. We calculated the number of participants recruited (i.e., not enrolled in the study) and assessed (i.e., currently enrolled) before March 2020 (pre","2021","07","01","J Pediatr Nurs","Journal of pediatric nursing","COVID-19; Clinical research; Congenital heart disease; Pediatrics; Stay-at-home order","Woon","Jessica","Department of Biological Sciences, USC Dornsife College of Letters, Arts, and Sciences and Division of Research on Children, Youth, and Families, The Saban Research Institute, CHLA, United States of America",NA
"673","34171517","10.1016/j.pedn.2021.06.005","Impact of COVID-19 on Pediatric Clinical Research.","Many public institutions and settings have taken action to limit exposure to and slow the spread of the novel coronavirus (COVID-19). We sought to characterize the impact of stay-at-home orders on our study of cerebral autoregulation and its association with developmental delays in infants with congenital heart disease compared with healthy controls. We calculated the number of participants recruited (i.e., not enrolled in the study) and assessed (i.e., currently enrolled) before March 2020 (pre","2021","07","01","J Pediatr Nurs","Journal of pediatric nursing","COVID-19; Clinical research; Congenital heart disease; Pediatrics; Stay-at-home order","Nguyen","Jennifer","Department of Biological Sciences, USC Dornsife College of Letters, Arts, and Sciences and Division of Research on Children, Youth, and Families, The Saban Research Institute, CHLA, United States of America",NA
"674","34171517","10.1016/j.pedn.2021.06.005","Impact of COVID-19 on Pediatric Clinical Research.","Many public institutions and settings have taken action to limit exposure to and slow the spread of the novel coronavirus (COVID-19). We sought to characterize the impact of stay-at-home orders on our study of cerebral autoregulation and its association with developmental delays in infants with congenital heart disease compared with healthy controls. We calculated the number of participants recruited (i.e., not enrolled in the study) and assessed (i.e., currently enrolled) before March 2020 (pre","2021","07","01","J Pediatr Nurs","Journal of pediatric nursing","COVID-19; Clinical research; Congenital heart disease; Pediatrics; Stay-at-home order","Brecht","Mary-Lynn","University of California, Los Angeles, School of Nursing, United States of America",NA
"675","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Kiti","Moses C","Emory University, Atlanta, GA, USA. Electronic address: mkiti@emory","mkiti@emory.edu"
"676","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Aguolu","Obianuju G","Yale University, CT, USA",NA
"677","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Liu","Carol Y","Emory University, Atlanta, GA, USA",NA
"678","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Mesa","Ana R","Emory University, Atlanta, GA, USA",NA
"679","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Regina","Rachel","Emory University, Atlanta, GA, USA",NA
"680","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Woody","Meaghan","Emory University, Atlanta, GA, USA",NA
"681","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Willebrand","Kathryn","Yale University, CT, USA",NA
"682","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Couzens","Chandra","Yale University, CT, USA",NA
"683","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Bartelsmeyer","Tilman","Yale University, CT, USA",NA
"684","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Nelson","Kristin N","Emory University, Atlanta, GA, USA",NA
"685","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Jenness","Samuel","Emory University, Atlanta, GA, USA",NA
"686","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Riley","Steven","Imperial College London, London, UK",NA
"687","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Melegaro","Alessia","Bocconi University, Milan, Italy",NA
"688","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Ahmed","Faruque","Centers for Disease Control and Prevention, Atlanta, GA, USA",NA
"689","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Malik","Fauzia","Yale University, CT, USA",NA
"690","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Lopman","Ben A","Emory University, Atlanta, GA, USA",NA
"691","34171510","10.1016/j.epidem.2021.100481","Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.","We measured contact patterns using online diaries for 304 employees of 3 U.S. companies working remotely. The median number of daily contacts was 2 (IQR 1-4); majority were conversation (55 %), occurred at home (64 %) and lasted &gt;4 h (38 %). These data are crucial for modeling outbreak control among the workforces.","2021","07","21","Epidemics","Epidemics","Infectious diseases; Social contact patterns; Social contact surveys; Social mixing","Omer","Saad B","Yale University, CT, USA",NA
"692","34171509","10.1016/j.epidem.2021.100477","Quantifying heterogeneity in SARS-CoV-2 transmission during the lockdown in India.","The novel SARS-CoV-2 virus, as it manifested in India in April 2020, showed marked heterogeneity in its transmission. Here, we used data collected from contact tracing during the lockdown in response to the first wave of COVID-19 in Punjab, a major state in India, to quantify this heterogeneity, and to examine implications for transmission dynamics. We found evidence of heterogeneity acting at multiple levels: in the number of potentially infectious contacts per index case, and in the per-contac","2021","07","21","Epidemics","Epidemics","COVID-19; Heterogeneity; SARS-CoV-2; Transmission dynamics","Arinaminpathy","Nimalan","MRC Centre for Global Infectious Disease Analysis, Imperial College, United Kingdom. Electronic address: nim.pathy@imperial.ac","nim.pathy@imperial.ac.uk"
"693","34171509","10.1016/j.epidem.2021.100477","Quantifying heterogeneity in SARS-CoV-2 transmission during the lockdown in India.","The novel SARS-CoV-2 virus, as it manifested in India in April 2020, showed marked heterogeneity in its transmission. Here, we used data collected from contact tracing during the lockdown in response to the first wave of COVID-19 in Punjab, a major state in India, to quantify this heterogeneity, and to examine implications for transmission dynamics. We found evidence of heterogeneity acting at multiple levels: in the number of potentially infectious contacts per index case, and in the per-contac","2021","07","21","Epidemics","Epidemics","COVID-19; Heterogeneity; SARS-CoV-2; Transmission dynamics","Das","Jishnu","McCourt School of Public Policy and the Walsh School of Foreign Service, Georgetown University, United States",NA
"694","34171509","10.1016/j.epidem.2021.100477","Quantifying heterogeneity in SARS-CoV-2 transmission during the lockdown in India.","The novel SARS-CoV-2 virus, as it manifested in India in April 2020, showed marked heterogeneity in its transmission. Here, we used data collected from contact tracing during the lockdown in response to the first wave of COVID-19 in Punjab, a major state in India, to quantify this heterogeneity, and to examine implications for transmission dynamics. We found evidence of heterogeneity acting at multiple levels: in the number of potentially infectious contacts per index case, and in the per-contac","2021","07","21","Epidemics","Epidemics","COVID-19; Heterogeneity; SARS-CoV-2; Transmission dynamics","McCormick","Tyler H","Departments of Statistics and Sociology, University of Washington, United States",NA
"695","34171509","10.1016/j.epidem.2021.100477","Quantifying heterogeneity in SARS-CoV-2 transmission during the lockdown in India.","The novel SARS-CoV-2 virus, as it manifested in India in April 2020, showed marked heterogeneity in its transmission. Here, we used data collected from contact tracing during the lockdown in response to the first wave of COVID-19 in Punjab, a major state in India, to quantify this heterogeneity, and to examine implications for transmission dynamics. We found evidence of heterogeneity acting at multiple levels: in the number of potentially infectious contacts per index case, and in the per-contac","2021","07","21","Epidemics","Epidemics","COVID-19; Heterogeneity; SARS-CoV-2; Transmission dynamics","Mukhopadhyay","Partha","Centre for Policy Research, New Delhi, India",NA
"696","34171509","10.1016/j.epidem.2021.100477","Quantifying heterogeneity in SARS-CoV-2 transmission during the lockdown in India.","The novel SARS-CoV-2 virus, as it manifested in India in April 2020, showed marked heterogeneity in its transmission. Here, we used data collected from contact tracing during the lockdown in response to the first wave of COVID-19 in Punjab, a major state in India, to quantify this heterogeneity, and to examine implications for transmission dynamics. We found evidence of heterogeneity acting at multiple levels: in the number of potentially infectious contacts per index case, and in the per-contac","2021","07","21","Epidemics","Epidemics","COVID-19; Heterogeneity; SARS-CoV-2; Transmission dynamics","Sircar","Neelanjan","Centre for Policy Research, New Delhi, India",NA
"697","34171504","10.1016/j.compbiolchem.2021.107532","A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19).","Zoonotic Novel coronavirus disease 2019 (COVID-19) is highly pathogenic and transmissible considered as emerging pandemic disease. The virus belongs from a large virus Coronaviridae family affect respiratory tract of animal and human likely originated from bat and homology to SARA-CoV and MERS-CoV. The virus consists of single-stranded positive genomic RNA coated by nucleocapsid protein. The rate of mutation in any virulence gene may influence the phenomenon of host radiation. We have studied th","2021","07","19","Comput Biol Chem","Computational biology and chemistry","Adaptive molecular evolution; COVID-19; Hemagglutinin; Likelihood ratio test; Markov model; Positive selection; RdRP; Zoonotic","Kumari","Priya","Department of Bioengineering, Birla Institute of Technology-Mesra, Ranchi, JH 835 215, India",NA
"698","34171504","10.1016/j.compbiolchem.2021.107532","A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19).","Zoonotic Novel coronavirus disease 2019 (COVID-19) is highly pathogenic and transmissible considered as emerging pandemic disease. The virus belongs from a large virus Coronaviridae family affect respiratory tract of animal and human likely originated from bat and homology to SARA-CoV and MERS-CoV. The virus consists of single-stranded positive genomic RNA coated by nucleocapsid protein. The rate of mutation in any virulence gene may influence the phenomenon of host radiation. We have studied th","2021","07","19","Comput Biol Chem","Computational biology and chemistry","Adaptive molecular evolution; COVID-19; Hemagglutinin; Likelihood ratio test; Markov model; Positive selection; RdRP; Zoonotic","Poddar","Raju","Department of Bioengineering, Birla Institute of Technology-Mesra, Ranchi, JH 835 215, India. Electronic address: rpoddar@bitmesra.ac","rpoddar@bitmesra.ac.in"
"699","34171493","10.1016/j.ajp.2021.102735","Parent training intervention for autism symptoms, functional emotional development, and parental stress in children with autism disorder: A randomized clinical trial.","Today, early interventions to treat autistic children through parent training interventions is of outmost importance. Interventions are focused on developmental or behavioral approaches and are mostly individual or group ones. In the present study, both proposed approaches in the form of structured individual and group parent training sessions among Iranian families are investigated. This study was a randomized clinical trial which was performed in 2019-2020 in Tehran. Forty four 3-5 year-old ch","2021","07","21","Asian J Psychiatr","Asian journal of psychiatry","Autism; Early intervention; Parent-child relation; Parenting; Quality of life; Autism Spectrum Disorder; Autistic Disorder; COVID-19; Child; Humans; Iran; Pandemics; Parenting; Parents; Quality of Life; SARS-CoV-2","Akhani","Afsaneh","Clinical Psychology Department, School of Behavioral Sciences and Mental Health (Tehran Institute of Psychiatry), Iran University of Medical Sciences, Tehran, Iran. Electronic address: akhani.a@tak.iums.ac","akhani.a@tak.iums.ac.ir"
"700","34171493","10.1016/j.ajp.2021.102735","Parent training intervention for autism symptoms, functional emotional development, and parental stress in children with autism disorder: A randomized clinical trial.","Today, early interventions to treat autistic children through parent training interventions is of outmost importance. Interventions are focused on developmental or behavioral approaches and are mostly individual or group ones. In the present study, both proposed approaches in the form of structured individual and group parent training sessions among Iranian families are investigated. This study was a randomized clinical trial which was performed in 2019-2020 in Tehran. Forty four 3-5 year-old ch","2021","07","21","Asian J Psychiatr","Asian journal of psychiatry","Autism; Early intervention; Parent-child relation; Parenting; Quality of life; Autism Spectrum Disorder; Autistic Disorder; COVID-19; Child; Humans; Iran; Pandemics; Parenting; Parents; Quality of Life; SARS-CoV-2","Dehghani","Mahmood","Clinical Psychology Department, School of Behavioral Sciences and Mental Health (Tehran Institute of Psychiatry), Iran University of Medical Sciences, Tehran, Iran. Electronic address: dehghani.m@iums.ac","dehghani.m@iums.ac.ir"
"701","34171493","10.1016/j.ajp.2021.102735","Parent training intervention for autism symptoms, functional emotional development, and parental stress in children with autism disorder: A randomized clinical trial.","Today, early interventions to treat autistic children through parent training interventions is of outmost importance. Interventions are focused on developmental or behavioral approaches and are mostly individual or group ones. In the present study, both proposed approaches in the form of structured individual and group parent training sessions among Iranian families are investigated. This study was a randomized clinical trial which was performed in 2019-2020 in Tehran. Forty four 3-5 year-old ch","2021","07","21","Asian J Psychiatr","Asian journal of psychiatry","Autism; Early intervention; Parent-child relation; Parenting; Quality of life; Autism Spectrum Disorder; Autistic Disorder; COVID-19; Child; Humans; Iran; Pandemics; Parenting; Parents; Quality of Life; SARS-CoV-2","Gharraee","Banafsheh","Clinical Psychology Department, School of Behavioral Sciences and Mental Health (Tehran Institute of Psychiatry), Iran University of Medical Sciences, Tehran, Iran. Electronic address: gharraee.b@iums.ac","gharraee.b@iums.ac.ir"
"702","34171493","10.1016/j.ajp.2021.102735","Parent training intervention for autism symptoms, functional emotional development, and parental stress in children with autism disorder: A randomized clinical trial.","Today, early interventions to treat autistic children through parent training interventions is of outmost importance. Interventions are focused on developmental or behavioral approaches and are mostly individual or group ones. In the present study, both proposed approaches in the form of structured individual and group parent training sessions among Iranian families are investigated. This study was a randomized clinical trial which was performed in 2019-2020 in Tehran. Forty four 3-5 year-old ch","2021","07","21","Asian J Psychiatr","Asian journal of psychiatry","Autism; Early intervention; Parent-child relation; Parenting; Quality of life; Autism Spectrum Disorder; Autistic Disorder; COVID-19; Child; Humans; Iran; Pandemics; Parenting; Parents; Quality of Life; SARS-CoV-2","Hakim Shooshtari","Mitra","Department of Psychiatry, School of Sciences and Mental Health (Tehran Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: hakimshooshtari.m@iums.ac","hakimshooshtari.m@iums.ac.ir"
"703","34171485","10.1016/j.jbi.2021.103848","Face mask detection using deep learning: An approach to reduce risk of Coronavirus spread.","Effective strategies to restrain COVID-19 pandemic need high attention to mitigate negatively impacted communal health and global economy, with the brim-full horizon yet to unfold. In the absence of effective antiviral and limited medical resources, many measures are recommended by WHO to control the infection rate and avoid exhausting the limited medical resources. Wearing a mask is among the non-pharmaceutical intervention measures that can be used to cut the primary source of SARS-CoV2 drople","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Face mask detection; Object deletion; One-stage detector; Transfer learning; Two-stage detector","Sethi","Shilpa","Department of Computer Applications, J.C. Bose University of Science and Technology, Faridabad, India",NA
"704","34171485","10.1016/j.jbi.2021.103848","Face mask detection using deep learning: An approach to reduce risk of Coronavirus spread.","Effective strategies to restrain COVID-19 pandemic need high attention to mitigate negatively impacted communal health and global economy, with the brim-full horizon yet to unfold. In the absence of effective antiviral and limited medical resources, many measures are recommended by WHO to control the infection rate and avoid exhausting the limited medical resources. Wearing a mask is among the non-pharmaceutical intervention measures that can be used to cut the primary source of SARS-CoV2 drople","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Face mask detection; Object deletion; One-stage detector; Transfer learning; Two-stage detector","Kathuria","Mamta","Department of Computer Applications, J.C. Bose University of Science and Technology, Faridabad, India. Electronic address: mamtakathuria@jcboseust.ac","mamtakathuria@jcboseust.ac.in"
"705","34171485","10.1016/j.jbi.2021.103848","Face mask detection using deep learning: An approach to reduce risk of Coronavirus spread.","Effective strategies to restrain COVID-19 pandemic need high attention to mitigate negatively impacted communal health and global economy, with the brim-full horizon yet to unfold. In the absence of effective antiviral and limited medical resources, many measures are recommended by WHO to control the infection rate and avoid exhausting the limited medical resources. Wearing a mask is among the non-pharmaceutical intervention measures that can be used to cut the primary source of SARS-CoV2 drople","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Face mask detection; Object deletion; One-stage detector; Transfer learning; Two-stage detector","Kaushik","Trilok","R &amp",NA
"706","34171458","10.1016/j.cmi.2021.06.015","Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review.","Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac manifestations following the acute phase of the disease. To assess the range of cardiac sequelae after COVID-19 recovery. PubMed, Embase, Scopus (inception through 17 February 2021) and Google scholar (2019 through 17 February 2021). Prospective and retrospective studies, case reports and case series. Adult patients assessed for cardiac manifestations after COVID-19 recovery. Severe acute respiratory syndrome c","2021","07","11","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; Cardiac sequelae; Coronavirus; Heart injury; Long COVID-19; Post-acute COVID-19; SARS-CoV-2","Ramadan","Mohammad Said","Department of Precision Medicine, University of Campania 'L. Vanvitelli', Naples, Italy",NA
"707","34171458","10.1016/j.cmi.2021.06.015","Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review.","Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac manifestations following the acute phase of the disease. To assess the range of cardiac sequelae after COVID-19 recovery. PubMed, Embase, Scopus (inception through 17 February 2021) and Google scholar (2019 through 17 February 2021). Prospective and retrospective studies, case reports and case series. Adult patients assessed for cardiac manifestations after COVID-19 recovery. Severe acute respiratory syndrome c","2021","07","11","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; Cardiac sequelae; Coronavirus; Heart injury; Long COVID-19; Post-acute COVID-19; SARS-CoV-2","Bertolino","Lorenzo","Department of Precision Medicine, University of Campania 'L. Vanvitelli', Naples, Italy",NA
"708","34171458","10.1016/j.cmi.2021.06.015","Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review.","Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac manifestations following the acute phase of the disease. To assess the range of cardiac sequelae after COVID-19 recovery. PubMed, Embase, Scopus (inception through 17 February 2021) and Google scholar (2019 through 17 February 2021). Prospective and retrospective studies, case reports and case series. Adult patients assessed for cardiac manifestations after COVID-19 recovery. Severe acute respiratory syndrome c","2021","07","11","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; Cardiac sequelae; Coronavirus; Heart injury; Long COVID-19; Post-acute COVID-19; SARS-CoV-2","Zampino","Rosa","Department of Advanced Medical and Surgical Sciences, University of Campania 'L. Vanvitelli', Naples, Italy",NA
"709","34171458","10.1016/j.cmi.2021.06.015","Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review.","Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac manifestations following the acute phase of the disease. To assess the range of cardiac sequelae after COVID-19 recovery. PubMed, Embase, Scopus (inception through 17 February 2021) and Google scholar (2019 through 17 February 2021). Prospective and retrospective studies, case reports and case series. Adult patients assessed for cardiac manifestations after COVID-19 recovery. Severe acute respiratory syndrome c","2021","07","11","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","COVID-19; Cardiac sequelae; Coronavirus; Heart injury; Long COVID-19; Post-acute COVID-19; SARS-CoV-2","Durante-Mangoni","Emanuele","Department of Precision Medicine, University of Campania 'L. Vanvitelli', Naples, Italy","emanuele.durante@unicampania.it"
"710","34171435","10.1016/j.jhep.2021.06.014","Comment to the letter of Bril F et al. ""Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?""",NA,"2021","07","01","J Hepatol","Journal of hepatology","Autoimmune hepatitis; COVID-19 vaccine","Clayton-Chubb","Daniel","Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia. Electronic address: Chubb.Daniel@gmail","Chubb.Daniel@gmail.com"
"711","34171435","10.1016/j.jhep.2021.06.014","Comment to the letter of Bril F et al. ""Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?""",NA,"2021","07","01","J Hepatol","Journal of hepatology","Autoimmune hepatitis; COVID-19 vaccine","Schneider","Daniel","Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia",NA
"712","34171435","10.1016/j.jhep.2021.06.014","Comment to the letter of Bril F et al. ""Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?""",NA,"2021","07","01","J Hepatol","Journal of hepatology","Autoimmune hepatitis; COVID-19 vaccine","Freeman","Elliot","Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia",NA
"713","34171435","10.1016/j.jhep.2021.06.014","Comment to the letter of Bril F et al. ""Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?""",NA,"2021","07","01","J Hepatol","Journal of hepatology","Autoimmune hepatitis; COVID-19 vaccine","Kemp","William","Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia",NA
"714","34171435","10.1016/j.jhep.2021.06.014","Comment to the letter of Bril F et al. ""Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?""",NA,"2021","07","01","J Hepatol","Journal of hepatology","Autoimmune hepatitis; COVID-19 vaccine","Roberts","Stuart K","Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia",NA
"715","34171421","10.1016/j.gastrohep.2021.06.005",NA,"The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition associated with an inordinate response of the immune system to external agents. IBD treatments have been associated to an increased risk of bacterial and viral infections. This has raised the question o","2021","07","01","Gastroenterol Hepatol","Gastroenterologia y hepatologia","COVID-19 Vaccine; COVID-19 grave; COVID-19 incidence; Enfermedad Inflamatoria Intestina (EII); IBD-treatment; Incidencia por COVID-19; Inflammatory Bowel Disease (IBD); Severe COVID-19; Vacuna COVID-19; tratamiento de la EII","Suria","Carles","IBD Unit, Digestive Disease Department, University of Valencia, Clinic University Hospital of Valencia, 46010 Valencia, Spain. Electronic address: carles_71191@hotmail","71191@hotmail.com"
"716","34171421","10.1016/j.gastrohep.2021.06.005",NA,"The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition associated with an inordinate response of the immune system to external agents. IBD treatments have been associated to an increased risk of bacterial and viral infections. This has raised the question o","2021","07","01","Gastroenterol Hepatol","Gastroenterologia y hepatologia","COVID-19 Vaccine; COVID-19 grave; COVID-19 incidence; Enfermedad Inflamatoria Intestina (EII); IBD-treatment; Incidencia por COVID-19; Inflammatory Bowel Disease (IBD); Severe COVID-19; Vacuna COVID-19; tratamiento de la EII","Bosca-Watts","Marta M","IBD Unit, Digestive Disease Department, University of Valencia, Clinic University Hospital of Valencia, 46010 Valencia, Spain",NA
"717","34171421","10.1016/j.gastrohep.2021.06.005",NA,"The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition associated with an inordinate response of the immune system to external agents. IBD treatments have been associated to an increased risk of bacterial and viral infections. This has raised the question o","2021","07","01","Gastroenterol Hepatol","Gastroenterologia y hepatologia","COVID-19 Vaccine; COVID-19 grave; COVID-19 incidence; Enfermedad Inflamatoria Intestina (EII); IBD-treatment; Incidencia por COVID-19; Inflammatory Bowel Disease (IBD); Severe COVID-19; Vacuna COVID-19; tratamiento de la EII","Navarro","Pablo","IBD Unit, Digestive Disease Department, University of Valencia, Clinic University Hospital of Valencia, 46010 Valencia, Spain",NA
"718","34171421","10.1016/j.gastrohep.2021.06.005",NA,"The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition associated with an inordinate response of the immune system to external agents. IBD treatments have been associated to an increased risk of bacterial and viral infections. This has raised the question o","2021","07","01","Gastroenterol Hepatol","Gastroenterologia y hepatologia","COVID-19 Vaccine; COVID-19 grave; COVID-19 incidence; Enfermedad Inflamatoria Intestina (EII); IBD-treatment; Incidencia por COVID-19; Inflammatory Bowel Disease (IBD); Severe COVID-19; Vacuna COVID-19; tratamiento de la EII","Tosca","Joan","IBD Unit, Digestive Disease Department, University of Valencia, Clinic University Hospital of Valencia, 46010 Valencia, Spain",NA
"719","34171421","10.1016/j.gastrohep.2021.06.005",NA,"The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition associated with an inordinate response of the immune system to external agents. IBD treatments have been associated to an increased risk of bacterial and viral infections. This has raised the question o","2021","07","01","Gastroenterol Hepatol","Gastroenterologia y hepatologia","COVID-19 Vaccine; COVID-19 grave; COVID-19 incidence; Enfermedad Inflamatoria Intestina (EII); IBD-treatment; Incidencia por COVID-19; Inflammatory Bowel Disease (IBD); Severe COVID-19; Vacuna COVID-19; tratamiento de la EII","Anton","Rosario","IBD Unit, Digestive Disease Department, University of Valencia, Clinic University Hospital of Valencia, 46010 Valencia, Spain",NA
"720","34171421","10.1016/j.gastrohep.2021.06.005",NA,"The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition associated with an inordinate response of the immune system to external agents. IBD treatments have been associated to an increased risk of bacterial and viral infections. This has raised the question o","2021","07","01","Gastroenterol Hepatol","Gastroenterologia y hepatologia","COVID-19 Vaccine; COVID-19 grave; COVID-19 incidence; Enfermedad Inflamatoria Intestina (EII); IBD-treatment; Incidencia por COVID-19; Inflammatory Bowel Disease (IBD); Severe COVID-19; Vacuna COVID-19; tratamiento de la EII","Sanahuja","Ana","IBD Unit, Digestive Disease Department, University of Valencia, Clinic University Hospital of Valencia, 46010 Valencia, Spain",NA
"721","34171421","10.1016/j.gastrohep.2021.06.005",NA,"The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition associated with an inordinate response of the immune system to external agents. IBD treatments have been associated to an increased risk of bacterial and viral infections. This has raised the question o","2021","07","01","Gastroenterol Hepatol","Gastroenterologia y hepatologia","COVID-19 Vaccine; COVID-19 grave; COVID-19 incidence; Enfermedad Inflamatoria Intestina (EII); IBD-treatment; Incidencia por COVID-19; Inflammatory Bowel Disease (IBD); Severe COVID-19; Vacuna COVID-19; tratamiento de la EII","Revaliente","Marta","INCLIVA Biomedical Research, Institute, IBD Unit, Digestive Disease Department, University of Valencia, Clinic University Hospital of Valencia, 46010 Valencia, Spain",NA
"722","34171421","10.1016/j.gastrohep.2021.06.005",NA,"The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition associated with an inordinate response of the immune system to external agents. IBD treatments have been associated to an increased risk of bacterial and viral infections. This has raised the question o","2021","07","01","Gastroenterol Hepatol","Gastroenterologia y hepatologia","COVID-19 Vaccine; COVID-19 grave; COVID-19 incidence; Enfermedad Inflamatoria Intestina (EII); IBD-treatment; Incidencia por COVID-19; Inflammatory Bowel Disease (IBD); Severe COVID-19; Vacuna COVID-19; tratamiento de la EII","Miguel Minguez","M","IBD Unit, Digestive Disease Department, University of Valencia, Clinic University Hospital of Valencia, 46010 Valencia, Spain",NA
"723","34171411","10.1016/j.appet.2021.105451","Narratives from within 'lockdown': A qualitative exploration of the impact of COVID-19 confinement on individuals with anorexia nervosa.","The COVID-19 pandemic and associated 'lockdown' confinement restrictions have resulted in multiple challenges for those living with eating disorders. This qualitative study aimed to examine the lived, psychosocial experiences of individuals with anorexia nervosa from within COVID-19 'lockdown' confinement. Audio-recorded semi -structured interviews were conducted online during the first wave of the COVID-19 pandemic during confinement with a purposive sample of 12 participants who identified as ","2021","07","22","Appetite","Appetite","Anorexia nervosa; COVID-19; Eating disorders; Qualitative research","Hunter","Rachael","Psychology Department, Swansea University, Wales, UK. Electronic address: r.hunter@swansea.ac","r.hunter@swansea.ac.uk"
"724","34171411","10.1016/j.appet.2021.105451","Narratives from within 'lockdown': A qualitative exploration of the impact of COVID-19 confinement on individuals with anorexia nervosa.","The COVID-19 pandemic and associated 'lockdown' confinement restrictions have resulted in multiple challenges for those living with eating disorders. This qualitative study aimed to examine the lived, psychosocial experiences of individuals with anorexia nervosa from within COVID-19 'lockdown' confinement. Audio-recorded semi -structured interviews were conducted online during the first wave of the COVID-19 pandemic during confinement with a purposive sample of 12 participants who identified as ","2021","07","22","Appetite","Appetite","Anorexia nervosa; COVID-19; Eating disorders; Qualitative research","Gibson","Chloe","Psychology Department, Swansea University, Wales, UK",NA
"725","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Mazzucco","W","Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) Department, University of Palermo, Palermo, Italy","walter.mazzucco@unipa.it"
"726","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Chiara di Maio","V","Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy",NA
"727","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Bronte","F","Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) Department, University of Palermo, Palermo, Italy",NA
"728","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Fabeni","L","Laboratory of Virology, 'Lazzaro Spallanzani' National Institute for Infectious Diseases, IRCCS, Rome, Italy",NA
"729","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Pipitone","R M","Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) Department, University of Palermo, Palermo, Italy",NA
"730","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Grimaudo","S","Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) Department, University of Palermo, Palermo, Italy",NA
"731","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Ferraro","D","Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) Department, University of Palermo, Palermo, Italy",NA
"732","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Marotta","C","General Directorate of Health Prevention, Ministry of Health, Rome, Italy",NA
"733","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Aragri","M","Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy",NA
"734","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Macaluso","M","Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital, Cincinnati, OH, USA",NA
"735","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Vitale","F","Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) Department, University of Palermo, Palermo, Italy",NA
"736","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Di Raimondo","F","Division of Hematology, Azienda Ospedaliero-Universitaria Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy",NA
"737","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Ceccherini-Silberstein","F","Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy",NA
"738","34171407","10.1016/j.jhin.2021.06.007","Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.","Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the clinical risk management of an HCV outbreak among 128 thalassaemia outpatients followed at a thalassaemia centre of an Italian hospital. Epidemiological investigation and root-cause analysis were performed. All patients with acute hepatitis and known chronic infect","2021","07","23","J Hosp Infect","The Journal of hospital infection","Clinical risk management; Hepatitis C virus (HCV); Molecular epidemiology; Nosocomial outbreak; Phylogenetic analysis","Di Marco","V","Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) Department, University of Palermo, Palermo, Italy",NA
"739","34171382","10.1016/j.lfs.2021.119752","Zinc supplementation augments the suppressive effects of repurposed NF-<U+03BA>B inhibitors on ACE2 expression in human lung cell lines.","Angiotensin-converting enzyme 2 (ACE2) is a key negative regulator of the renin-angiotensin system and also a major receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we reveal a role for NF-<U+03BA>B in human lung cell expression of ACE2, and we further explore the potential utility of repurposing NF-<U+03BA>B inhibitors to downregulate ACE2. Expression of ACE2 was assessed by Western blotting and RT-qPCR in multiple human lung cell lines with or without NF-<U+03BA>B inhibito","2021","07","14","Life Sci","Life sciences","ACE2; Emetine; NF-kappa B; ROS; Triclabendazole; Zinc; Angiotensin-Converting Enzyme 2; Antiparasitic Agents; COVID-19; Cell Line; Down-Regulation; Drug Repositioning; Emetine; Humans; Lung; NF-kappa B; Pyrrolidines; Thiocarbamates; Triclabendazole; Zinc","Lee","Ming-Cheng","Department of Internal Medicine, Hospital and College of Medicine, National Taiwan University, Taipei 10051, Taiwan, ROC",NA
"740","34171382","10.1016/j.lfs.2021.119752","Zinc supplementation augments the suppressive effects of repurposed NF-<U+03BA>B inhibitors on ACE2 expression in human lung cell lines.","Angiotensin-converting enzyme 2 (ACE2) is a key negative regulator of the renin-angiotensin system and also a major receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we reveal a role for NF-<U+03BA>B in human lung cell expression of ACE2, and we further explore the potential utility of repurposing NF-<U+03BA>B inhibitors to downregulate ACE2. Expression of ACE2 was assessed by Western blotting and RT-qPCR in multiple human lung cell lines with or without NF-<U+03BA>B inhibito","2021","07","14","Life Sci","Life sciences","ACE2; Emetine; NF-kappa B; ROS; Triclabendazole; Zinc; Angiotensin-Converting Enzyme 2; Antiparasitic Agents; COVID-19; Cell Line; Down-Regulation; Drug Repositioning; Emetine; Humans; Lung; NF-kappa B; Pyrrolidines; Thiocarbamates; Triclabendazole; Zinc","Chen","Yin-Kai","Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 10002, Taiwan, ROC",NA
"741","34171382","10.1016/j.lfs.2021.119752","Zinc supplementation augments the suppressive effects of repurposed NF-<U+03BA>B inhibitors on ACE2 expression in human lung cell lines.","Angiotensin-converting enzyme 2 (ACE2) is a key negative regulator of the renin-angiotensin system and also a major receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we reveal a role for NF-<U+03BA>B in human lung cell expression of ACE2, and we further explore the potential utility of repurposing NF-<U+03BA>B inhibitors to downregulate ACE2. Expression of ACE2 was assessed by Western blotting and RT-qPCR in multiple human lung cell lines with or without NF-<U+03BA>B inhibito","2021","07","14","Life Sci","Life sciences","ACE2; Emetine; NF-kappa B; ROS; Triclabendazole; Zinc; Angiotensin-Converting Enzyme 2; Antiparasitic Agents; COVID-19; Cell Line; Down-Regulation; Drug Repositioning; Emetine; Humans; Lung; NF-kappa B; Pyrrolidines; Thiocarbamates; Triclabendazole; Zinc","Tsai-Wu","Jyy-Jih","Department of Medical Research, National Taiwan University Hospital, Taipei 10051, Taiwan, ROC",NA
"742","34171382","10.1016/j.lfs.2021.119752","Zinc supplementation augments the suppressive effects of repurposed NF-<U+03BA>B inhibitors on ACE2 expression in human lung cell lines.","Angiotensin-converting enzyme 2 (ACE2) is a key negative regulator of the renin-angiotensin system and also a major receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we reveal a role for NF-<U+03BA>B in human lung cell expression of ACE2, and we further explore the potential utility of repurposing NF-<U+03BA>B inhibitors to downregulate ACE2. Expression of ACE2 was assessed by Western blotting and RT-qPCR in multiple human lung cell lines with or without NF-<U+03BA>B inhibito","2021","07","14","Life Sci","Life sciences","ACE2; Emetine; NF-kappa B; ROS; Triclabendazole; Zinc; Angiotensin-Converting Enzyme 2; Antiparasitic Agents; COVID-19; Cell Line; Down-Regulation; Drug Repositioning; Emetine; Humans; Lung; NF-kappa B; Pyrrolidines; Thiocarbamates; Triclabendazole; Zinc","Hsu","Yih-Jen","Department of Integrated Diagnostics and Therapeutics, National Taiwan University Hospital, Taipei 10051, Taiwan, ROC",NA
"743","34171382","10.1016/j.lfs.2021.119752","Zinc supplementation augments the suppressive effects of repurposed NF-<U+03BA>B inhibitors on ACE2 expression in human lung cell lines.","Angiotensin-converting enzyme 2 (ACE2) is a key negative regulator of the renin-angiotensin system and also a major receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we reveal a role for NF-<U+03BA>B in human lung cell expression of ACE2, and we further explore the potential utility of repurposing NF-<U+03BA>B inhibitors to downregulate ACE2. Expression of ACE2 was assessed by Western blotting and RT-qPCR in multiple human lung cell lines with or without NF-<U+03BA>B inhibito","2021","07","14","Life Sci","Life sciences","ACE2; Emetine; NF-kappa B; ROS; Triclabendazole; Zinc; Angiotensin-Converting Enzyme 2; Antiparasitic Agents; COVID-19; Cell Line; Down-Regulation; Drug Repositioning; Emetine; Humans; Lung; NF-kappa B; Pyrrolidines; Thiocarbamates; Triclabendazole; Zinc","Lin","Bor-Ru","Department of Internal Medicine, Hospital and College of Medicine, National Taiwan University, Taipei 10051, Taiwan, ROC","brucelin@ntuh.gov.tw"
"744","34171370","10.1016/j.envres.2021.111582","New research on water, waste and energy management, with special focus on antibiotics and priority pollutants.","The Editors of the Virtual Special Issue (VSI) ""New Research on Water, Waste and Energy Management, with Special Focus on Antibiotics and Priority Pollutants"" (VSI WWEM-20) here present details corresponding to papers that have been accepted, as well as further comments on the matter. It should be noted that the VSI should be associated to a Conference that had been initially programmed to be held in Rome during the summer of 2020, Unfortunately, it was postponed due to the COVID-19 pandemic. Th","2021","07","20","Environ Res","Environmental research","Emerging pollutants; Pollution treatment; Priority pollutants; Waste management; Water pollution","Núñez-Delgado","Avelino","Dept. Soil Sci. and Agric. Chem., Univ. Santiago de Compostela, Engineering Polytech. School, Campus Univ. S/n, 27002, Lugo, Spain. Electronic address: avelino.nunez@usc","avelino.nunez@usc.es"
"745","34171370","10.1016/j.envres.2021.111582","New research on water, waste and energy management, with special focus on antibiotics and priority pollutants.","The Editors of the Virtual Special Issue (VSI) ""New Research on Water, Waste and Energy Management, with Special Focus on Antibiotics and Priority Pollutants"" (VSI WWEM-20) here present details corresponding to papers that have been accepted, as well as further comments on the matter. It should be noted that the VSI should be associated to a Conference that had been initially programmed to be held in Rome during the summer of 2020, Unfortunately, it was postponed due to the COVID-19 pandemic. Th","2021","07","20","Environ Res","Environmental research","Emerging pollutants; Pollution treatment; Priority pollutants; Waste management; Water pollution","Dominguez","Joaquín R","Department of Chemical Engineering and Physical Chemistry, University of Extremadura, Spain",NA
"746","34171370","10.1016/j.envres.2021.111582","New research on water, waste and energy management, with special focus on antibiotics and priority pollutants.","The Editors of the Virtual Special Issue (VSI) ""New Research on Water, Waste and Energy Management, with Special Focus on Antibiotics and Priority Pollutants"" (VSI WWEM-20) here present details corresponding to papers that have been accepted, as well as further comments on the matter. It should be noted that the VSI should be associated to a Conference that had been initially programmed to be held in Rome during the summer of 2020, Unfortunately, it was postponed due to the COVID-19 pandemic. Th","2021","07","20","Environ Res","Environmental research","Emerging pollutants; Pollution treatment; Priority pollutants; Waste management; Water pollution","Zhou","Yaoyu","College of Resources and Environment, Hunan Agricultural University, Changsha, 410128, Hunan Province, China",NA
"747","34171370","10.1016/j.envres.2021.111582","New research on water, waste and energy management, with special focus on antibiotics and priority pollutants.","The Editors of the Virtual Special Issue (VSI) ""New Research on Water, Waste and Energy Management, with Special Focus on Antibiotics and Priority Pollutants"" (VSI WWEM-20) here present details corresponding to papers that have been accepted, as well as further comments on the matter. It should be noted that the VSI should be associated to a Conference that had been initially programmed to be held in Rome during the summer of 2020, Unfortunately, it was postponed due to the COVID-19 pandemic. Th","2021","07","20","Environ Res","Environmental research","Emerging pollutants; Pollution treatment; Priority pollutants; Waste management; Water pollution","Race","Marco","Department of Civil and Mechanical Engineering, University of Cassino and Southern Lazio, Via di Biasio 43, 03043, Cassino, Italy",NA
"748","34171370","10.1016/j.envres.2021.111582","New research on water, waste and energy management, with special focus on antibiotics and priority pollutants.","The Editors of the Virtual Special Issue (VSI) ""New Research on Water, Waste and Energy Management, with Special Focus on Antibiotics and Priority Pollutants"" (VSI WWEM-20) here present details corresponding to papers that have been accepted, as well as further comments on the matter. It should be noted that the VSI should be associated to a Conference that had been initially programmed to be held in Rome during the summer of 2020, Unfortunately, it was postponed due to the COVID-19 pandemic. Th","2021","07","20","Environ Res","Environmental research","Emerging pollutants; Pollution treatment; Priority pollutants; Waste management; Water pollution","Domingo","José L","Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat Rovira I Virgili, Reus, Spain",NA
"749","34171346","10.1016/j.metabol.2021.154820","An updated meta-analysis on the relationship between obesity and COVID-19 mortality.",NA,"2021","07","23","Metabolism","Metabolism: clinical and experimental","Adjusted effect size; COVID-19; Meta-analysis; Mortality; Obesity","Wang","Yadong","Department of Toxicology, Henan Center for Disease Control and Prevention, Zhengzhou 450016, Henan Province, China",NA
"750","34171346","10.1016/j.metabol.2021.154820","An updated meta-analysis on the relationship between obesity and COVID-19 mortality.",NA,"2021","07","23","Metabolism","Metabolism: clinical and experimental","Adjusted effect size; COVID-19; Meta-analysis; Mortality; Obesity","Xu","Jie","Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, Henan Province, China",NA
"751","34171346","10.1016/j.metabol.2021.154820","An updated meta-analysis on the relationship between obesity and COVID-19 mortality.",NA,"2021","07","23","Metabolism","Metabolism: clinical and experimental","Adjusted effect size; COVID-19; Meta-analysis; Mortality; Obesity","Wang","Ying","Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, Henan Province, China",NA
"752","34171346","10.1016/j.metabol.2021.154820","An updated meta-analysis on the relationship between obesity and COVID-19 mortality.",NA,"2021","07","23","Metabolism","Metabolism: clinical and experimental","Adjusted effect size; COVID-19; Meta-analysis; Mortality; Obesity","Hou","Hongjie","Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, Henan Province, China",NA
"753","34171346","10.1016/j.metabol.2021.154820","An updated meta-analysis on the relationship between obesity and COVID-19 mortality.",NA,"2021","07","23","Metabolism","Metabolism: clinical and experimental","Adjusted effect size; COVID-19; Meta-analysis; Mortality; Obesity","Feng","Huifen","Department of Infectious Diseases, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China. Electronic address: huifen.feng@163","huifen.feng@163.com"
"754","34171346","10.1016/j.metabol.2021.154820","An updated meta-analysis on the relationship between obesity and COVID-19 mortality.",NA,"2021","07","23","Metabolism","Metabolism: clinical and experimental","Adjusted effect size; COVID-19; Meta-analysis; Mortality; Obesity","Yang","Haiyan","Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, Henan Province, China",NA
"755","34171345","10.1016/j.ypmed.2021.106694","Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors.","We aimed to estimate the coronavirus disease 2019 (COVID-19) vaccine acceptance rate and identify predictors associated with acceptance. To this end, we searched PubMed, Web of Science, Cochrane Library, and Embase databases until November 4, 2020. Meta-analyses were performed to estimate the rate with 95% confidence intervals (CI). Predictors were identified to be associated with vaccination intention based on the health belief model framework. Thirty-eight articles, with 81,173 individuals, we","2021","07","22","Prev Med","Preventive medicine","Acceptance; COVID-19; Predictors; Systematic review; Vaccine","Wang","Qiang","Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China",NA
"756","34171345","10.1016/j.ypmed.2021.106694","Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors.","We aimed to estimate the coronavirus disease 2019 (COVID-19) vaccine acceptance rate and identify predictors associated with acceptance. To this end, we searched PubMed, Web of Science, Cochrane Library, and Embase databases until November 4, 2020. Meta-analyses were performed to estimate the rate with 95% confidence intervals (CI). Predictors were identified to be associated with vaccination intention based on the health belief model framework. Thirty-eight articles, with 81,173 individuals, we","2021","07","22","Prev Med","Preventive medicine","Acceptance; COVID-19; Predictors; Systematic review; Vaccine","Yang","Liuqing","Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China",NA
"757","34171345","10.1016/j.ypmed.2021.106694","Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors.","We aimed to estimate the coronavirus disease 2019 (COVID-19) vaccine acceptance rate and identify predictors associated with acceptance. To this end, we searched PubMed, Web of Science, Cochrane Library, and Embase databases until November 4, 2020. Meta-analyses were performed to estimate the rate with 95% confidence intervals (CI). Predictors were identified to be associated with vaccination intention based on the health belief model framework. Thirty-eight articles, with 81,173 individuals, we","2021","07","22","Prev Med","Preventive medicine","Acceptance; COVID-19; Predictors; Systematic review; Vaccine","Jin","Hui","Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China","hld@163.com"
"758","34171345","10.1016/j.ypmed.2021.106694","Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors.","We aimed to estimate the coronavirus disease 2019 (COVID-19) vaccine acceptance rate and identify predictors associated with acceptance. To this end, we searched PubMed, Web of Science, Cochrane Library, and Embase databases until November 4, 2020. Meta-analyses were performed to estimate the rate with 95% confidence intervals (CI). Predictors were identified to be associated with vaccination intention based on the health belief model framework. Thirty-eight articles, with 81,173 individuals, we","2021","07","22","Prev Med","Preventive medicine","Acceptance; COVID-19; Predictors; Systematic review; Vaccine","Lin","Leesa","Department of Infectious Disease Epidemiology, London School of Hygiene &amp",NA
"759","34171343","10.1016/j.jviromet.2021.114217","Clinical usefulness of extraction-free PCR assay to detect SARS-CoV-2.","Due to the coronavirus disease 2019 pandemic, the demand for an easily accessible high-throughput screening test is increasing. We aimed to evaluate the usefulness of the extrac-tion-free polymerase chain reaction (PCR) as a screening test to detect severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Real-time reverse transcription PCR was performed in 300 samples (260 SARS-CoV-2 positives and 40 negatives), using both the conventional nucleic acid extraction method (standard method) a","2021","07","17","J Virol Methods","Journal of virological methods","COVID-19; Crude method; Direct PCR; Extraction-free PCR; No RNA extraction; SARS-CoV-2","Kim","Yu Kyung","Department of Clinical Pathology, School of Medicne, Kyungpook National University, Daegu, South Korea",NA
"760","34171343","10.1016/j.jviromet.2021.114217","Clinical usefulness of extraction-free PCR assay to detect SARS-CoV-2.","Due to the coronavirus disease 2019 pandemic, the demand for an easily accessible high-throughput screening test is increasing. We aimed to evaluate the usefulness of the extrac-tion-free polymerase chain reaction (PCR) as a screening test to detect severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Real-time reverse transcription PCR was performed in 300 samples (260 SARS-CoV-2 positives and 40 negatives), using both the conventional nucleic acid extraction method (standard method) a","2021","07","17","J Virol Methods","Journal of virological methods","COVID-19; Crude method; Direct PCR; Extraction-free PCR; No RNA extraction; SARS-CoV-2","Chang","Soon Hee","Department of Clinical Pathology, School of Medicne, Kyungpook National University, Daegu, South Korea. Electronic address: marta10@hanmail","marta10@hanmail.net"
"761","34171342","10.1016/j.jviromet.2021.114216","Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.","Currently, the rapid global spread of SARS-CoV-2 is related to G clade (including GH, GR, GRY and GV clades), which are associated with more than 98 % of sequenced viral isolates worldwide. The unprecedented velocity of spread of SARS-CoV-2 outbreak represents a critical need for prevention strategies. Vaccines are recently being available and antiviral drugs have shown limited efficacy in COVID-19 patients. Thus, it is needed to know how to reduce the infectivity of the virus by different physi","2021","07","23","J Virol Methods","Journal of virological methods","Alpha; COVID-19; Coronavirus; Gamma; UV dosage; UV-C; Virus inactivation; COVID-19; Hot Temperature; Humans; SARS-CoV-2; Ultraviolet Rays; Virus Inactivation","Ulloa","S","Molecular Genetics Sub Department, Institute of Public Health of Chile, Santiago, Chile",NA
"762","34171342","10.1016/j.jviromet.2021.114216","Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.","Currently, the rapid global spread of SARS-CoV-2 is related to G clade (including GH, GR, GRY and GV clades), which are associated with more than 98 % of sequenced viral isolates worldwide. The unprecedented velocity of spread of SARS-CoV-2 outbreak represents a critical need for prevention strategies. Vaccines are recently being available and antiviral drugs have shown limited efficacy in COVID-19 patients. Thus, it is needed to know how to reduce the infectivity of the virus by different physi","2021","07","23","J Virol Methods","Journal of virological methods","Alpha; COVID-19; Coronavirus; Gamma; UV dosage; UV-C; Virus inactivation; COVID-19; Hot Temperature; Humans; SARS-CoV-2; Ultraviolet Rays; Virus Inactivation","Bravo","C","Molecular Genetics Sub Department, Institute of Public Health of Chile, Santiago, Chile",NA
"763","34171342","10.1016/j.jviromet.2021.114216","Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.","Currently, the rapid global spread of SARS-CoV-2 is related to G clade (including GH, GR, GRY and GV clades), which are associated with more than 98 % of sequenced viral isolates worldwide. The unprecedented velocity of spread of SARS-CoV-2 outbreak represents a critical need for prevention strategies. Vaccines are recently being available and antiviral drugs have shown limited efficacy in COVID-19 patients. Thus, it is needed to know how to reduce the infectivity of the virus by different physi","2021","07","23","J Virol Methods","Journal of virological methods","Alpha; COVID-19; Coronavirus; Gamma; UV dosage; UV-C; Virus inactivation; COVID-19; Hot Temperature; Humans; SARS-CoV-2; Ultraviolet Rays; Virus Inactivation","Ramirez","E","Viral Diseases Sub Department, Institute of Public Health of Chile, Santiago, Chile",NA
"764","34171342","10.1016/j.jviromet.2021.114216","Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.","Currently, the rapid global spread of SARS-CoV-2 is related to G clade (including GH, GR, GRY and GV clades), which are associated with more than 98 % of sequenced viral isolates worldwide. The unprecedented velocity of spread of SARS-CoV-2 outbreak represents a critical need for prevention strategies. Vaccines are recently being available and antiviral drugs have shown limited efficacy in COVID-19 patients. Thus, it is needed to know how to reduce the infectivity of the virus by different physi","2021","07","23","J Virol Methods","Journal of virological methods","Alpha; COVID-19; Coronavirus; Gamma; UV dosage; UV-C; Virus inactivation; COVID-19; Hot Temperature; Humans; SARS-CoV-2; Ultraviolet Rays; Virus Inactivation","Fasce","R","Viral Diseases Sub Department, Institute of Public Health of Chile, Santiago, Chile",NA
"765","34171342","10.1016/j.jviromet.2021.114216","Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.","Currently, the rapid global spread of SARS-CoV-2 is related to G clade (including GH, GR, GRY and GV clades), which are associated with more than 98 % of sequenced viral isolates worldwide. The unprecedented velocity of spread of SARS-CoV-2 outbreak represents a critical need for prevention strategies. Vaccines are recently being available and antiviral drugs have shown limited efficacy in COVID-19 patients. Thus, it is needed to know how to reduce the infectivity of the virus by different physi","2021","07","23","J Virol Methods","Journal of virological methods","Alpha; COVID-19; Coronavirus; Gamma; UV dosage; UV-C; Virus inactivation; COVID-19; Hot Temperature; Humans; SARS-CoV-2; Ultraviolet Rays; Virus Inactivation","Fernandez","J","Molecular Genetics Sub Department, Institute of Public Health of Chile, Santiago, Chile. Electronic address: jfernand@ispch","jfernand@ispch.cl"
"766","34171328","10.1016/j.pharmthera.2021.107931","Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.","Infections of the Coronavirus SARS-CoV-2 continue to spread around the globe, causing Coronavirus Disease (COVID)-19. Infected people are at risk of developing acute interstitial pneumonia, which can result in lethal complications, particularly in patients with pre-existing co-morbidities. Novel prophylactic and therapeutic interventions are urgently needed to limit the infection-associated health risk for the population and to contain the pandemic. Animal models are indispensable to assessing t","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","Animal models; Antiviral immunity; COVID-19; SARS-CoV-2; Vaccine; Virus","Renn","Marcel","Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany",NA
"767","34171328","10.1016/j.pharmthera.2021.107931","Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.","Infections of the Coronavirus SARS-CoV-2 continue to spread around the globe, causing Coronavirus Disease (COVID)-19. Infected people are at risk of developing acute interstitial pneumonia, which can result in lethal complications, particularly in patients with pre-existing co-morbidities. Novel prophylactic and therapeutic interventions are urgently needed to limit the infection-associated health risk for the population and to contain the pandemic. Animal models are indispensable to assessing t","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","Animal models; Antiviral immunity; COVID-19; SARS-CoV-2; Vaccine; Virus","Bartok","Eva","Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany",NA
"768","34171328","10.1016/j.pharmthera.2021.107931","Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.","Infections of the Coronavirus SARS-CoV-2 continue to spread around the globe, causing Coronavirus Disease (COVID)-19. Infected people are at risk of developing acute interstitial pneumonia, which can result in lethal complications, particularly in patients with pre-existing co-morbidities. Novel prophylactic and therapeutic interventions are urgently needed to limit the infection-associated health risk for the population and to contain the pandemic. Animal models are indispensable to assessing t","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","Animal models; Antiviral immunity; COVID-19; SARS-CoV-2; Vaccine; Virus","Zillinger","Thomas","Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany",NA
"769","34171328","10.1016/j.pharmthera.2021.107931","Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.","Infections of the Coronavirus SARS-CoV-2 continue to spread around the globe, causing Coronavirus Disease (COVID)-19. Infected people are at risk of developing acute interstitial pneumonia, which can result in lethal complications, particularly in patients with pre-existing co-morbidities. Novel prophylactic and therapeutic interventions are urgently needed to limit the infection-associated health risk for the population and to contain the pandemic. Animal models are indispensable to assessing t","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","Animal models; Antiviral immunity; COVID-19; SARS-CoV-2; Vaccine; Virus","Hartmann","Gunther","Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany",NA
"770","34171328","10.1016/j.pharmthera.2021.107931","Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.","Infections of the Coronavirus SARS-CoV-2 continue to spread around the globe, causing Coronavirus Disease (COVID)-19. Infected people are at risk of developing acute interstitial pneumonia, which can result in lethal complications, particularly in patients with pre-existing co-morbidities. Novel prophylactic and therapeutic interventions are urgently needed to limit the infection-associated health risk for the population and to contain the pandemic. Animal models are indispensable to assessing t","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","Animal models; Antiviral immunity; COVID-19; SARS-CoV-2; Vaccine; Virus","Behrendt","Rayk","Institute for Immunology, Technische Universität Dresden, Medical Faculty Carl Gustav Carus, 01307 Dresden, Germany. Electronic address: rayk.behrendt@tu-dresden",NA
"771","34171326","10.1016/j.pharmthera.2021.107927","The role of CD71<sup>+</sup> erythroid cells in the regulation of the immune response.","Complex regulation of the immune response is necessary to support effective defense of an organism against hostile invaders and to maintain tolerance to harmless microorganisms and autoantigens. Recent studies revealed previously unappreciated roles of CD71<sup>+</sup> erythroid cells (CECs) in regulation of the immune response. CECs physiologically reside in the bone marrow where erythropoiesis takes place. Under stress conditions, CECs are enriched in some organs outside of the bone marrow as ","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","CD71(+) erythroid cells; Erythroid progenitor cells; Erythropoiesis; Immune response; Immunoregulation; Immunosuppression","Grzywa","Tomasz M","Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Street, 02-097 Warsaw, Poland","tomasz.grzywa@wum.edu.pl"
"772","34171326","10.1016/j.pharmthera.2021.107927","The role of CD71<sup>+</sup> erythroid cells in the regulation of the immune response.","Complex regulation of the immune response is necessary to support effective defense of an organism against hostile invaders and to maintain tolerance to harmless microorganisms and autoantigens. Recent studies revealed previously unappreciated roles of CD71<sup>+</sup> erythroid cells (CECs) in regulation of the immune response. CECs physiologically reside in the bone marrow where erythropoiesis takes place. Under stress conditions, CECs are enriched in some organs outside of the bone marrow as ","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","CD71(+) erythroid cells; Erythroid progenitor cells; Erythropoiesis; Immune response; Immunoregulation; Immunosuppression","Nowis","Dominika","Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Street, 02-097 Warsaw, Poland","dominika.nowis@wum.edu.pl"
"773","34171326","10.1016/j.pharmthera.2021.107927","The role of CD71<sup>+</sup> erythroid cells in the regulation of the immune response.","Complex regulation of the immune response is necessary to support effective defense of an organism against hostile invaders and to maintain tolerance to harmless microorganisms and autoantigens. Recent studies revealed previously unappreciated roles of CD71<sup>+</sup> erythroid cells (CECs) in regulation of the immune response. CECs physiologically reside in the bone marrow where erythropoiesis takes place. Under stress conditions, CECs are enriched in some organs outside of the bone marrow as ","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","CD71(+) erythroid cells; Erythroid progenitor cells; Erythropoiesis; Immune response; Immunoregulation; Immunosuppression","Golab","Jakub","Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Street, 02-097 Warsaw, Poland","jakub.golab@wum.edu.pl"
"774","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Weingarten-Gabbay","Shira","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA","shirawg@broadinstitute.org"
"775","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Klaeger","Susan","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: sklaeger@broadinstitute","sklaeger@broadinstitute.org"
"776","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Sarkizova","Siranush","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"777","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Pearlman","Leah R","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"778","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Chen","Da-Yuan","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"779","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Gallagher","Kathleen M E","Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA",NA
"780","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Bauer","Matthew R","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"781","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Taylor","Hannah B","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"782","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Dunn","W Augustine","Repertoire Immune Medicines, Cambridge, MA 02139, USA",NA
"783","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Tarr","Christina","Repertoire Immune Medicines, Cambridge, MA 02139, USA",NA
"784","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Sidney","John","Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA",NA
"785","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Rachimi","Suzanna","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"786","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Conway","Hasahn L","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"787","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Katsis","Katelin","Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA",NA
"788","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Wang","Yuntong","Repertoire Immune Medicines, Cambridge, MA 02139, USA",NA
"789","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Leistritz-Edwards","Del","Repertoire Immune Medicines, Cambridge, MA 02139, USA",NA
"790","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Durkin","Melissa R","Repertoire Immune Medicines, Cambridge, MA 02139, USA",NA
"791","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Tomkins-Tinch","Christopher H","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"792","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Finkel","Yaara","Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel",NA
"793","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Nachshon","Aharon","Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel",NA
"794","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Gentili","Matteo","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"795","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Rivera","Keith D","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"796","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Carulli","Isabel P","Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA",NA
"797","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Chea","Vipheaviny A","Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA",NA
"798","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Chandrashekar","Abishek","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA",NA
"799","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Bozkus","Cansu Cimen","Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA",NA
"800","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Carrington","Mary","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA",NA
"801","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Bhardwaj","Nina","Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA",NA
"802","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Barouch","Dan H","Harvard Medical School, Boston, MA 02115, USA",NA
"803","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Sette","Alessandro","Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA",NA
"804","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Maus","Marcela V","Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA",NA
"805","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Rice","Charles M","Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA",NA
"806","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Clauser","Karl R","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"807","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Keskin","Derin B","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"808","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Pregibon","Daniel C","Repertoire Immune Medicines, Cambridge, MA 02139, USA",NA
"809","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Hacohen","Nir","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"810","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Carr","Steven A","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"811","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Abelin","Jennifer G","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"812","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Saeed","Mohsan","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"813","34171305","10.1016/j.cell.2021.05.046","Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and","2021","07","23","Cell","Cell","HLA Class I; SARS-CoV-2; T Cell response; coronavirus; immunogenicity; out-of-frame ORF immunopeptidomics; viral infection","Sabeti","Pardis C","Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA",NA
"814","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Souilmi","Yassine","Australian Centre for Ancient DNA, School of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia",NA
"815","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Lauterbur","M Elise","University of Arizona Department of Ecology and Evolutionary Biology, Tucson, AZ, USA",NA
"816","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Tobler","Ray","Australian Centre for Ancient DNA, School of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia",NA
"817","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Huber","Christian D","Australian Centre for Ancient DNA, School of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia",NA
"818","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Johar","Angad S","Australian Centre for Ancient DNA, School of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia",NA
"819","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Moradi","Shayli Varasteh","CSIRO-QUT Synthetic Biology Alliance, Centre for Tropical Crops and Biocommodities, Queensland University of Technology, Brisbane, QLD 4001, Australia",NA
"820","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Johnston","Wayne A","CSIRO-QUT Synthetic Biology Alliance, Centre for Tropical Crops and Biocommodities, Queensland University of Technology, Brisbane, QLD 4001, Australia",NA
"821","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Krogan","Nevan J","QBI COVID-19 Research Group (QCRG), San Francisco, CA, USA",NA
"822","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Alexandrov","Kirill","CSIRO-QUT Synthetic Biology Alliance, Centre for Tropical Crops and Biocommodities, Queensland University of Technology, Brisbane, QLD 4001, Australia. Electronic address: kirill.alexandrov@qut.edu","kirill.alexandrov@qut.edu.au"
"823","34171302","10.1016/j.cub.2021.05.067","An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia.","The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors-pointing to which viruses have future pandemic potential. Here, we apply evolutionary a","2021","07","24","Curr Biol","Current biology : CB","ancient epidemics; coronaviruses; human genomes","Enard","David","University of Arizona Department of Ecology and Evolutionary Biology, Tucson, AZ, USA. Electronic address: denard@email.arizona","denard@email.arizona.edu"
"824","34171275","10.1016/S2352-3026(21)00146-0","Sustained prothrombotic changes in convalescent patients with COVID-19.",NA,"2021","07","01","Lancet Haematol","The Lancet. Haematology","COVID-19; Humans; Immunization, Passive; SARS-CoV-2; Treatment Outcome","von Meijenfeldt","Fien A","Department of Surgery, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, Netherlands",NA
"825","34171275","10.1016/S2352-3026(21)00146-0","Sustained prothrombotic changes in convalescent patients with COVID-19.",NA,"2021","07","01","Lancet Haematol","The Lancet. Haematology","COVID-19; Humans; Immunization, Passive; SARS-CoV-2; Treatment Outcome","Thålin","Charlotte","Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden",NA
"826","34171275","10.1016/S2352-3026(21)00146-0","Sustained prothrombotic changes in convalescent patients with COVID-19.",NA,"2021","07","01","Lancet Haematol","The Lancet. Haematology","COVID-19; Humans; Immunization, Passive; SARS-CoV-2; Treatment Outcome","Lisman","Ton","Department of Surgery, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, Netherlands. Electronic address: j.a.lisman@umcg","j.a.lisman@umcg.nl"
"827","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Motozono","Chihiro","Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan",NA
"828","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Toyoda","Mako","Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan",NA
"829","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Zahradnik","Jiri","Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel",NA
"830","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Saito","Akatsuki","Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki 8892192, Japan",NA
"831","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Nasser","Hesham","Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan",NA
"832","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Tan","Toong Seng","Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan",NA
"833","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Ngare","Isaac","Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan",NA
"834","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Kimura","Izumi","Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan",NA
"835","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Uriu","Keiya","Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan",NA
"836","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Kosugi","Yusuke","Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan",NA
"837","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Yue","Yuan","Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan",NA
"838","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Shimizu","Ryo","Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan",NA
"839","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Ito","Jumpei","Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan",NA
"840","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Torii","Shiho","Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 5650871, Japan",NA
"841","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Yonekawa","Akiko","Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 8128582, Japan",NA
"842","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Shimono","Nobuyuki","Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 8128582, Japan",NA
"843","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Nagasaki","Yoji","Division of Infectious Diseases, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Fukuoka 8108563, Japan",NA
"844","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Minami","Rumi","Internal Medicine, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka 8108563, Japan",NA
"845","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Toya","Takashi","Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo 1138677, Japan",NA
"846","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Sekiya","Noritaka","Department of Infection Prevention and Control, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo 1138677, Japan",NA
"847","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Fukuhara","Takasuke","Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Hokkaido 0608638, Japan",NA
"848","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Matsuura","Yoshiharu","Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 5650871, Japan",NA
"849","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Schreiber","Gideon","Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel",NA
"850","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Ikeda","Terumasa","Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan. Electronic address: ikedat@kumamoto-u.ac",NA
"851","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Nakagawa","So","Department of Molecular Life Science, Tokai University School of Medicine, Kanagawa 2591193, Japan",NA
"852","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Ueno","Takamasa","Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan. Electronic address: uenotaka@kumamoto-u.ac",NA
"853","34171266","10.1016/j.chom.2021.06.006","SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.","Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R","2021","07","20","Cell Host Microbe","Cell host &amp; microbe","B.1.1.298; B.1.427/429; COVID-19; L452R; SARS-CoV-2; Y453F; cellular immunity; naturally occurring variants; receptor-binding motif; spike protein","Sato","Kei","Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan",NA
"854","34171234","10.1016/S1473-3099(21)00338-8","SARS-CoV-2 variants and considerations of inferring causality on disease severity.",NA,"2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Cevik","Muge","Division of Infection and Global Health Research, School of Medicine, University of St Andrews, St Andrews KY16 9AX, UK. Electronic address: mc349@st-andrews.ac",NA
"855","34171234","10.1016/S1473-3099(21)00338-8","SARS-CoV-2 variants and considerations of inferring causality on disease severity.",NA,"2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Mishra","Sharmistha","Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, ON, Canada",NA
"856","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Patone","Martina","Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"857","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Thomas","Karen","Intensive Care National Audit &amp",NA
"858","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Hatch","Rob","Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK",NA
"859","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Tan","Pui San","Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"860","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Coupland","Carol","Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, UK",NA
"861","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Liao","Weiqi","Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK",NA
"862","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Mouncey","Paul","Intensive Care National Audit &amp",NA
"863","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Harrison","David","Intensive Care National Audit &amp",NA
"864","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Rowan","Kathryn","Intensive Care National Audit &amp",NA
"865","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Horby","Peter","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"866","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Watkinson","Peter","Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK",NA
"867","34171232","10.1016/S1473-3099(21)00318-2","Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.","A more transmissible variant of SARS-CoV-2, the variant of concern 202012/01 or lineage B.1.1.7, has emerged in the UK. We aimed to estimate the risk of critical care admission, mortality in patients who are critically ill, and overall mortality associated with lineage B.1.1.7 compared with non-B.1.1.7. We also compared clinical outcomes between these two groups. For this observational cohort study, we linked large primary care (QResearch), national critical care (Intensive Care National Audit &","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Hippisley-Cox","Julia","Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Electronic address: julia.hippisley-cox@phc.ox.ac","cox@phc.ox.ac.uk"
"868","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Bager","Peter","Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark","pbg@ssi.dk"
"869","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Wohlfahrt","Jan","Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark",NA
"870","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Fonager","Jannik","Department of Virus &amp",NA
"871","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Rasmussen","Morten","Department of Virus &amp",NA
"872","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Albertsen","Mads","Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark",NA
"873","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Michaelsen","Thomas Yssing","Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark",NA
"874","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Møller","Camilla Holten","Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark",NA
"875","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Ethelberg","Steen","Infectious Disease Epidemiology &amp",NA
"876","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Legarth","Rebecca","Infectious Disease Epidemiology &amp",NA
"877","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Button","Mia Sarah Fischer","Infectious Disease Epidemiology &amp",NA
"878","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Gubbels","Sophie","Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark",NA
"879","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Voldstedlund","Marianne","Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark",NA
"880","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Mølbak","Kåre","Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark",NA
"881","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Skov","Robert Leo","Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark",NA
"882","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Fomsgaard","Anders","Department of Virus &amp",NA
"883","34171231","10.1016/S1473-3099(21)00290-5","Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after December, 2020, and a concern that B.1.1.7 could cause more severe disease has been raised. Taking advantage of Denmark's high RT-PCR testing and whole genome sequencing capacities, we used national health register data to assess the risk of COVID-19 hospitalisation in individuals infected with B.1.1.7 compared with those with other SARS-CoV-2 lineages. We did an observational cohort study of all SARS-CoV-2-positive ca","2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Krause","Tyra Grove","Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark",NA
"884","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Zupancic","Jennifer M","Department of Chemical Engineering, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann Arbor, MI 48109, USA",NA
"885","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Desai","Alec A","Department of Chemical Engineering, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann Arbor, MI 48109, USA",NA
"886","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Schardt","John S","Department of Chemical Engineering, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann Arbor, MI 48109, USA",NA
"887","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Pornnoppadol","Ghasidit","Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA",NA
"888","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Makowski","Emily K","Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA",NA
"889","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Smith","Matthew D","Department of Chemical Engineering, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann Arbor, MI 48109, USA",NA
"890","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Kennedy","Andrew A","Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA",NA
"891","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Garcia de Mattos Barbosa","Mayara","Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA",NA
"892","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Cascalho","Marilia","Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA",NA
"893","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Lanigan","Thomas M","Division of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA",NA
"894","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Tai","Andrew W","Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA",NA
"895","34171229","10.1016/j.chembiol.2021.05.019","Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.","There is widespread interest in facile methods for generating potent neutralizing antibodies, nanobodies, and other affinity proteins against SARS-CoV-2 and related viruses to address current and future pandemics. While isolating antibodies from animals and humans are proven approaches, these methods are limited to the affinities, specificities, and functional activities of antibodies generated by the immune system. Here we report a surprisingly simple directed evolution method for generating na","2021","07","13","Cell Chem Biol","Cell chemical biology","ACE2; COVID-19; RBD; affinity; maturation; nanobody; neutralization; receptor-binding domain; spike; yeast","Tessier","Peter M","Department of Chemical Engineering, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Ann Arbor, MI 48109, USA","ptessier@umich.edu"
"896","34171221","10.1016/j.joms.2021.05.026","Changes in Emergency Patient Presentation to a Maxillofacial Surgery Department During the COVID-19 Pandemic.","To examine possible changes in the emergency patient volume and reasons for presentation to an oral and maxillofacial surgery department during the coronavirus disease 2019 (COVID-19) pandemic and the resulting contact prohibitions. We hypothesized that the pandemic would lead to fewer patients presenting with emergent conditions. A total of 939 patients, who presented to the Department for Oral and Maxillofacial Surgery of Hannover Medical School during the first 4 weeks of contact prohibitions","2021","07","01","J Oral Maxillofac Surg","Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons",NA,"Lentge","Fritjof","Department of Oral and Maxillofacial Surgery, Hannover Medical School, Hannover, Germany. Electronic address: lentge.fritjof@mh-hannover",NA
"897","34171221","10.1016/j.joms.2021.05.026","Changes in Emergency Patient Presentation to a Maxillofacial Surgery Department During the COVID-19 Pandemic.","To examine possible changes in the emergency patient volume and reasons for presentation to an oral and maxillofacial surgery department during the coronavirus disease 2019 (COVID-19) pandemic and the resulting contact prohibitions. We hypothesized that the pandemic would lead to fewer patients presenting with emergent conditions. A total of 939 patients, who presented to the Department for Oral and Maxillofacial Surgery of Hannover Medical School during the first 4 weeks of contact prohibitions","2021","07","01","J Oral Maxillofac Surg","Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons",NA,"Jehn","Philipp","Department of Oral and Maxillofacial Surgery, Hannover Medical School, Hannover, Germany",NA
"898","34171221","10.1016/j.joms.2021.05.026","Changes in Emergency Patient Presentation to a Maxillofacial Surgery Department During the COVID-19 Pandemic.","To examine possible changes in the emergency patient volume and reasons for presentation to an oral and maxillofacial surgery department during the coronavirus disease 2019 (COVID-19) pandemic and the resulting contact prohibitions. We hypothesized that the pandemic would lead to fewer patients presenting with emergent conditions. A total of 939 patients, who presented to the Department for Oral and Maxillofacial Surgery of Hannover Medical School during the first 4 weeks of contact prohibitions","2021","07","01","J Oral Maxillofac Surg","Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons",NA,"Zeller","Alexander Nicolai","Department of Oral and Maxillofacial Surgery, Hannover Medical School, Hannover, Germany",NA
"899","34171221","10.1016/j.joms.2021.05.026","Changes in Emergency Patient Presentation to a Maxillofacial Surgery Department During the COVID-19 Pandemic.","To examine possible changes in the emergency patient volume and reasons for presentation to an oral and maxillofacial surgery department during the coronavirus disease 2019 (COVID-19) pandemic and the resulting contact prohibitions. We hypothesized that the pandemic would lead to fewer patients presenting with emergent conditions. A total of 939 patients, who presented to the Department for Oral and Maxillofacial Surgery of Hannover Medical School during the first 4 weeks of contact prohibitions","2021","07","01","J Oral Maxillofac Surg","Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons",NA,"Spalthoff","Simon","Department of Oral and Maxillofacial Surgery, Hannover Medical School, Hannover, Germany",NA
"900","34171221","10.1016/j.joms.2021.05.026","Changes in Emergency Patient Presentation to a Maxillofacial Surgery Department During the COVID-19 Pandemic.","To examine possible changes in the emergency patient volume and reasons for presentation to an oral and maxillofacial surgery department during the coronavirus disease 2019 (COVID-19) pandemic and the resulting contact prohibitions. We hypothesized that the pandemic would lead to fewer patients presenting with emergent conditions. A total of 939 patients, who presented to the Department for Oral and Maxillofacial Surgery of Hannover Medical School during the first 4 weeks of contact prohibitions","2021","07","01","J Oral Maxillofac Surg","Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons",NA,"Rahlf","Björn","Department of Oral and Maxillofacial Surgery, Hannover Medical School, Hannover, Germany",NA
"901","34171221","10.1016/j.joms.2021.05.026","Changes in Emergency Patient Presentation to a Maxillofacial Surgery Department During the COVID-19 Pandemic.","To examine possible changes in the emergency patient volume and reasons for presentation to an oral and maxillofacial surgery department during the coronavirus disease 2019 (COVID-19) pandemic and the resulting contact prohibitions. We hypothesized that the pandemic would lead to fewer patients presenting with emergent conditions. A total of 939 patients, who presented to the Department for Oral and Maxillofacial Surgery of Hannover Medical School during the first 4 weeks of contact prohibitions","2021","07","01","J Oral Maxillofac Surg","Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons",NA,"Korn","Philippe","Department of Oral and Maxillofacial Surgery, Hannover Medical School, Hannover, Germany",NA
"902","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Chen","Xiaoping","Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"903","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Hu Mt","Wenjia","Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"904","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Yang","Miao","Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"905","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Ling","Jiaxin","Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, University of Uppsala, Uppsala, Sweden",NA
"906","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Zhang","Yongxi","Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"907","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Deng","Liping","Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"908","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Li","Jinlin","Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, University of Uppsala, Uppsala, Sweden",NA
"909","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Lundkvist","Åke","Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, University of Uppsala, Uppsala, Sweden",NA
"910","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Lindahl","Johanna F","Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, University of Uppsala, Uppsala, Sweden",NA
"911","34171164","10.1111/jch.14308","Risk factors for the delayed viral clearance in COVID-19 patients.","Comorbidities are important for the disease outcome of COVID-19, however, which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients are still unclear. Viral clearance is the most important laboratory test for defining the recovery of COVID-19 infections. To better understand which underlying diseases that are risk factors for delaying the viral clearance, we retrospectively analyzed 161 COVID-19 clinical cases in the Zhongnan Hospital of Wuhan University","2021","06","25","J Clin Hypertens (Greenwich)","Journal of clinical hypertension (Greenwich, Conn.)","COVID-19; SARS-CoV-2; hypertension; risk factors; viral clearance","Xiong","Yong","Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"912","34171157","10.1111/ijcp.14572","Does the COVID-19 pandemic cause late diagnosis and delay in treatment in developmental dysplasia of hip patients?","The aim of the current study was to search the effect of COVID-19 restriction on developmental dysplasia of hip (DDH) screening. We retrospectively reviewed the patients who brought to DDH screening in April-May and June-July 2020 and compared with the same period of 2019. We recorded age, gender, DDH type and risk factors of the patients. The number of patients taken for DDH screening was 430 and 400 in April-May 2019 and June-July 2019, respectively. In 2020, the number of patients taken for D","2021","07","05","Int J Clin Pract","International journal of clinical practice",NA,"Mert Dogan","Güleç","Department of Pediatric Radiology, Malatya Educational Research Hospital, Malatya, Turkey",NA
"913","34171157","10.1111/ijcp.14572","Does the COVID-19 pandemic cause late diagnosis and delay in treatment in developmental dysplasia of hip patients?","The aim of the current study was to search the effect of COVID-19 restriction on developmental dysplasia of hip (DDH) screening. We retrospectively reviewed the patients who brought to DDH screening in April-May and June-July 2020 and compared with the same period of 2019. We recorded age, gender, DDH type and risk factors of the patients. The number of patients taken for DDH screening was 430 and 400 in April-May 2019 and June-July 2019, respectively. In 2020, the number of patients taken for D","2021","07","05","Int J Clin Pract","International journal of clinical practice",NA,"Aslantürk","Okan","Department of Orthopedic and Trauma Surgery, Malatya Educational Research Hospital, Malatya, Turkey",NA
"914","34171156","10.1111/tpj.15390","Caffeoylquinic acids: chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity.","Caffeoylquinic acids (CQAs) are specialized plant metabolites we encounter in our daily life. Humans consume CQAs in mg-to-gram quantities through dietary consumption of plant products. CQAs are considered beneficial for human health, mainly due to their anti-inflammatory and antioxidant properties. Recently, new biosynthetic pathways via a peroxidase-type p-coumaric acid 3-hydroxylase enzyme were discovered. More recently, a new GDSL lipase-like enzyme able to transform monoCQAs into diCQA was ","2021","07","23","Plant J","The Plant journal : for cell and molecular biology","Nrf2 activation; caffeoylquinic acids; chlorogenic acid; cognitive decline; neuroprotective activity; specialized plant metabolites","Alcázar Magaña","Armando","Department of Chemistry, Oregon State University, Corvallis, OR, USA",NA
"915","34171156","10.1111/tpj.15390","Caffeoylquinic acids: chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity.","Caffeoylquinic acids (CQAs) are specialized plant metabolites we encounter in our daily life. Humans consume CQAs in mg-to-gram quantities through dietary consumption of plant products. CQAs are considered beneficial for human health, mainly due to their anti-inflammatory and antioxidant properties. Recently, new biosynthetic pathways via a peroxidase-type p-coumaric acid 3-hydroxylase enzyme were discovered. More recently, a new GDSL lipase-like enzyme able to transform monoCQAs into diCQA was ","2021","07","23","Plant J","The Plant journal : for cell and molecular biology","Nrf2 activation; caffeoylquinic acids; chlorogenic acid; cognitive decline; neuroprotective activity; specialized plant metabolites","Kamimura","Naofumi","Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, Japan",NA
"916","34171156","10.1111/tpj.15390","Caffeoylquinic acids: chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity.","Caffeoylquinic acids (CQAs) are specialized plant metabolites we encounter in our daily life. Humans consume CQAs in mg-to-gram quantities through dietary consumption of plant products. CQAs are considered beneficial for human health, mainly due to their anti-inflammatory and antioxidant properties. Recently, new biosynthetic pathways via a peroxidase-type p-coumaric acid 3-hydroxylase enzyme were discovered. More recently, a new GDSL lipase-like enzyme able to transform monoCQAs into diCQA was ","2021","07","23","Plant J","The Plant journal : for cell and molecular biology","Nrf2 activation; caffeoylquinic acids; chlorogenic acid; cognitive decline; neuroprotective activity; specialized plant metabolites","Soumyanath","Amala","BENFRA Botanical Dietary Supplements Research Center, Oregon Health and Science University, Portland, OR, USA",NA
"917","34171156","10.1111/tpj.15390","Caffeoylquinic acids: chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity.","Caffeoylquinic acids (CQAs) are specialized plant metabolites we encounter in our daily life. Humans consume CQAs in mg-to-gram quantities through dietary consumption of plant products. CQAs are considered beneficial for human health, mainly due to their anti-inflammatory and antioxidant properties. Recently, new biosynthetic pathways via a peroxidase-type p-coumaric acid 3-hydroxylase enzyme were discovered. More recently, a new GDSL lipase-like enzyme able to transform monoCQAs into diCQA was ","2021","07","23","Plant J","The Plant journal : for cell and molecular biology","Nrf2 activation; caffeoylquinic acids; chlorogenic acid; cognitive decline; neuroprotective activity; specialized plant metabolites","Stevens","Jan F","Linus Pauling Institute, Oregon State University, Corvallis, OR, USA",NA
"918","34171156","10.1111/tpj.15390","Caffeoylquinic acids: chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity.","Caffeoylquinic acids (CQAs) are specialized plant metabolites we encounter in our daily life. Humans consume CQAs in mg-to-gram quantities through dietary consumption of plant products. CQAs are considered beneficial for human health, mainly due to their anti-inflammatory and antioxidant properties. Recently, new biosynthetic pathways via a peroxidase-type p-coumaric acid 3-hydroxylase enzyme were discovered. More recently, a new GDSL lipase-like enzyme able to transform monoCQAs into diCQA was ","2021","07","23","Plant J","The Plant journal : for cell and molecular biology","Nrf2 activation; caffeoylquinic acids; chlorogenic acid; cognitive decline; neuroprotective activity; specialized plant metabolites","Maier","Claudia S","Department of Chemistry, Oregon State University, Corvallis, OR, USA",NA
"919","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Jagiasi","Bharat","Critical Care Department, Reliance Hospital, Navi Mumbai, Maharashtra, India",NA
"920","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Nasa","Prashant","Critical Care Medicine, NMC Specialty Hospital, Dubai, United Arab Emirates",NA
"921","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Chanchalani","Gunjan","Critical Care Medicine, Cumballa Hill Hospital, Mumbai, Maharashtra, India",NA
"922","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Ahmed","Ahsan","Anesthesiology and Critical Care, KPC Medical College and Hospital, Kolkata, West Bengal, India",NA
"923","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Ak","Ajith Kumar","Critical Care Medicine, Manipal Hospitals, Bengaluru, Karnataka, India",NA
"924","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Sodhi","Kanwalpreet","Department of Critical Care, Deep Hospital, Ludhiana, Punjab, India",NA
"925","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Mangal","Kishore","Critical Care, Eternal Hospital, Jaipur, Rajasthan, India",NA
"926","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Singh","Manoj K","Critical Care &amp",NA
"927","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Gupta","Nitesh","Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India",NA
"928","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Bidkar","Prasanna U","Department of Anaesthesiology and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India",NA
"929","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Tyagi","Ranvir S","Department of Anaesthesia and Critical Care Medicine, Synergy Plus Hospital, Agra, Uttar Pradesh, India",NA
"930","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Khanikar","Reshu G","Department of Critical Care Medicine, Health City Hospital, Guwahati, Assam, India",NA
"931","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Tripathy","Swagata","Anesthesia &amp",NA
"932","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Khanzode","Swapna","Medicine and Critical Care, Wockhardt Multispecialty Hospital, Nagpur, Maharashtra, India",NA
"933","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Subba Reddy","Kesavarapu","Department Of Critical Care Medicine, Apollo Health City, Hyderabad, Telangana, India",NA
"934","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Saigal","Saurabh","Anaesthesia and Intensive Care, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India",NA
"935","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Sivakumar","Vijay Anand","Velammal Medical college and Research Centre, Madurai, Tamil Nadu, India",NA
"936","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Javeri","Yash","Critical Care Medicine and Emergency Medicine, Regency Super Specialty Hospital, Lucknow, Uttar Pradesh, India",NA
"937","34171154","10.1111/ijcp.14574","Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.","During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adj","2021","07","18","Int J Clin Pract","International journal of clinical practice",NA,"Tekwani","Seema S","Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, GA, USA",NA
"938","34171139","10.1002/jmv.27156","Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study.","With the number of coronavirus disease 2019 (COVID-19) infected patients increasing all over the world, a large number of survivors have reported changes in their quality of life or experienced re-infection. So, we aimed to detect the percentage, type, and risk factors of persistent symptoms after improvement from acute COVID-19 infection and to detect the percentage of COVID-19 re-infection and degree of severity of the second infection. One hundred seventy-two (59 male, 113 female) patients wh","2021","07","02","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; persistent symptoms; re-infection; risk factors","Abdelrahman","Mona Mohammed","Tropical medicine and Gastroenterology Department, Faculty of Medicine, Sohag University, Sohag, Egypt",NA
"939","34171139","10.1002/jmv.27156","Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study.","With the number of coronavirus disease 2019 (COVID-19) infected patients increasing all over the world, a large number of survivors have reported changes in their quality of life or experienced re-infection. So, we aimed to detect the percentage, type, and risk factors of persistent symptoms after improvement from acute COVID-19 infection and to detect the percentage of COVID-19 re-infection and degree of severity of the second infection. One hundred seventy-two (59 male, 113 female) patients wh","2021","07","02","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; persistent symptoms; re-infection; risk factors","Abd-Elrahman","Noha Mohammed","Tropical medicine and Gastroenterology Department, Faculty of Medicine, Sohag University, Sohag, Egypt",NA
"940","34171139","10.1002/jmv.27156","Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study.","With the number of coronavirus disease 2019 (COVID-19) infected patients increasing all over the world, a large number of survivors have reported changes in their quality of life or experienced re-infection. So, we aimed to detect the percentage, type, and risk factors of persistent symptoms after improvement from acute COVID-19 infection and to detect the percentage of COVID-19 re-infection and degree of severity of the second infection. One hundred seventy-two (59 male, 113 female) patients wh","2021","07","02","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; persistent symptoms; re-infection; risk factors","Bakheet","Tasneem Mohammed","Public Health and Community Medicine Department, Faculty of Medicine, Sohag University, Sohag, Egypt",NA
"941","34171116","10.20882/adicciones.1686","Prioritizing COVID-19 vaccination for people with addictive disorders.",NA,"2021","06","25","Adicciones","Adicciones",NA,"Trujols","Joan","Unitat de Conductes Addictives, Servei de Psiquiatria, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid. jtrujols@santpau","jtrujols@santpau.cat"
"942","34171116","10.20882/adicciones.1686","Prioritizing COVID-19 vaccination for people with addictive disorders.",NA,"2021","06","25","Adicciones","Adicciones",NA,"Cadafalch","Josep","Unitat de Conductes Addictives, Servei de Psiquiatria, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid. jtrujols@santpau",NA
"943","34171116","10.20882/adicciones.1686","Prioritizing COVID-19 vaccination for people with addictive disorders.",NA,"2021","06","25","Adicciones","Adicciones",NA,"Alvarado","Pedro J","Unitat de Conductes Addictives, Servei de Psiquiatria, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid. jtrujols@santpau",NA
"944","34171116","10.20882/adicciones.1686","Prioritizing COVID-19 vaccination for people with addictive disorders.",NA,"2021","06","25","Adicciones","Adicciones",NA,"Duran-Sindreu","Santiago","Unitat de Conductes Addictives, Servei de Psiquiatria, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid. jtrujols@santpau",NA
"945","34171089","10.1093/gerona/glab184","APOE e4 genotypes increase risk of delirium during COVID-19 related hospitalizations: evidence from a large United Kingdom cohort.",NA,"2021","06","25","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences",NA,"Kuo","Chia-Ling","Connecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health, Farmington",NA
"946","34171089","10.1093/gerona/glab184","APOE e4 genotypes increase risk of delirium during COVID-19 related hospitalizations: evidence from a large United Kingdom cohort.",NA,"2021","06","25","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences",NA,"Pilling","Luke C","Epidemiology and Public Health Group, University of Exeter Medical School, UK",NA
"947","34171089","10.1093/gerona/glab184","APOE e4 genotypes increase risk of delirium during COVID-19 related hospitalizations: evidence from a large United Kingdom cohort.",NA,"2021","06","25","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences",NA,"Atkins","Janice L","Epidemiology and Public Health Group, University of Exeter Medical School, UK",NA
"948","34171089","10.1093/gerona/glab184","APOE e4 genotypes increase risk of delirium during COVID-19 related hospitalizations: evidence from a large United Kingdom cohort.",NA,"2021","06","25","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences",NA,"Fortinsky","Richard H","Center on Aging, University of Connecticut Health, Farmington",NA
"949","34171089","10.1093/gerona/glab184","APOE e4 genotypes increase risk of delirium during COVID-19 related hospitalizations: evidence from a large United Kingdom cohort.",NA,"2021","06","25","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences",NA,"Kuchel","George A","Center on Aging, University of Connecticut Health, Farmington",NA
"950","34171089","10.1093/gerona/glab184","APOE e4 genotypes increase risk of delirium during COVID-19 related hospitalizations: evidence from a large United Kingdom cohort.",NA,"2021","06","25","J Gerontol A Biol Sci Med Sci","The journals of gerontology. Series A, Biological sciences and medical sciences",NA,"Melzer","David","Epidemiology and Public Health Group, University of Exeter Medical School, UK",NA
"951","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Sava","Anca","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania","costea10@yahoo.com"
"952","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Costea","Claudia Florida","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania",NA
"953","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Turliuc","Serban","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania",NA
"954","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Eva","Lucian","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania",NA
"955","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Turliuc","Mihaela Dana","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania",NA
"956","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Dumitrescu","Gabriela Florenta","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania",NA
"957","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Dimitriu","Gabriela","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania",NA
"958","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Vornicu","Valeriana","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania",NA
"959","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Baltag","Liliana","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania",NA
"960","34171056","10.47162/RJME.61.4.09","Protection measures against SARS-CoV-2 infection for cytopathology and histopathology laboratories personnel: practical recommendations.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare workers are at high risk to be infected with this new coronavirus, particularly when they handle not only patients, but also their body fluids. In Romania, even though the protective measures to be used by medical staff in emergency departments, clinical departments, radiology departments, clinical laboratories and morgues services are well known, there is little information about the protection of medical s","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","COVID-19; Guidelines as Topic; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laboratory Personnel; Pandemics; Pathology; Romania; SARS-CoV-2","Dabija","Marius Gabriel","Department of Surgery II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania",NA
"961","34171050","10.47162/RJME.61.4.03","SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine.","Patients with serious mental illness are a high-risk category of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Patients with schizophrenia are not participatory and have increased mortality and morbidity, patients with dementia cannot be cared for while depression, anxiety, bipolar tubing are associated with low immune status. Social stress is amplified by social isolation, amplifying depression and the mechanisms of decreased immunity. Hygiene measures and prophylactic","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","Amantadine; Antiparkinson Agents; COVID-19; Comorbidity; Humans; Memantine; Mental Disorders; Pandemics; SARS-CoV-2","Marinescu","Ileana","Doctoral School, Department of Internal Medicine, Faculty of Dental Medicine, University of Medicine and Pharmacy of Craiova, Romania","psy@yahoo.com"
"962","34171050","10.47162/RJME.61.4.03","SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine.","Patients with serious mental illness are a high-risk category of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Patients with schizophrenia are not participatory and have increased mortality and morbidity, patients with dementia cannot be cared for while depression, anxiety, bipolar tubing are associated with low immune status. Social stress is amplified by social isolation, amplifying depression and the mechanisms of decreased immunity. Hygiene measures and prophylactic","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","Amantadine; Antiparkinson Agents; COVID-19; Comorbidity; Humans; Memantine; Mental Disorders; Pandemics; SARS-CoV-2","Marinescu","Dragos","Doctoral School, Department of Internal Medicine, Faculty of Dental Medicine, University of Medicine and Pharmacy of Craiova, Romania",NA
"963","34171050","10.47162/RJME.61.4.03","SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine.","Patients with serious mental illness are a high-risk category of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Patients with schizophrenia are not participatory and have increased mortality and morbidity, patients with dementia cannot be cared for while depression, anxiety, bipolar tubing are associated with low immune status. Social stress is amplified by social isolation, amplifying depression and the mechanisms of decreased immunity. Hygiene measures and prophylactic","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","Amantadine; Antiparkinson Agents; COVID-19; Comorbidity; Humans; Memantine; Mental Disorders; Pandemics; SARS-CoV-2","Mogoanta","Laurentiu","Doctoral School, Department of Internal Medicine, Faculty of Dental Medicine, University of Medicine and Pharmacy of Craiova, Romania",NA
"964","34171050","10.47162/RJME.61.4.03","SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine.","Patients with serious mental illness are a high-risk category of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Patients with schizophrenia are not participatory and have increased mortality and morbidity, patients with dementia cannot be cared for while depression, anxiety, bipolar tubing are associated with low immune status. Social stress is amplified by social isolation, amplifying depression and the mechanisms of decreased immunity. Hygiene measures and prophylactic","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","Amantadine; Antiparkinson Agents; COVID-19; Comorbidity; Humans; Memantine; Mental Disorders; Pandemics; SARS-CoV-2","Efrem","Ion Cristian","Doctoral School, Department of Internal Medicine, Faculty of Dental Medicine, University of Medicine and Pharmacy of Craiova, Romania",NA
"965","34171050","10.47162/RJME.61.4.03","SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine.","Patients with serious mental illness are a high-risk category of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Patients with schizophrenia are not participatory and have increased mortality and morbidity, patients with dementia cannot be cared for while depression, anxiety, bipolar tubing are associated with low immune status. Social stress is amplified by social isolation, amplifying depression and the mechanisms of decreased immunity. Hygiene measures and prophylactic","2021","07","07","Rom J Morphol Embryol","Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","Amantadine; Antiparkinson Agents; COVID-19; Comorbidity; Humans; Memantine; Mental Disorders; Pandemics; SARS-CoV-2","Stovicek","Puiu Olivian","Doctoral School, Department of Internal Medicine, Faculty of Dental Medicine, University of Medicine and Pharmacy of Craiova, Romania",NA
"966","34171047","10.1016/j.puhip.2020.100020","Peruvian efforts to contain COVID-19 fail to protect vulnerable population groups.","Peru is arguably providing a robust governmental response in the initial stages of the COVID-19 outbreak, with early lockdown measures and the implementation of relatively ambitious economic safety nets to protect families and enterprises. Despite this initial optimism, structural deficiencies in the public health system, high informality in the labor market, the new wave of migrants from Venezuela and the extremely diverse cultural characteristics of many areas exacerbate the number of potentia","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Migration; Peru; Public health; SARS-CoV-2; Vulnerable population","Vázquez-Rowe","Ian","Peruvian Life Cycle Assessment and Industrial Ecology Network (PELCAN), Department of Engineering, Pontificia Universidad Católica Del Perú, Avenida Universitaria 1801, San Miguel, 15088, Lima, Peru",NA
"967","34171047","10.1016/j.puhip.2020.100020","Peruvian efforts to contain COVID-19 fail to protect vulnerable population groups.","Peru is arguably providing a robust governmental response in the initial stages of the COVID-19 outbreak, with early lockdown measures and the implementation of relatively ambitious economic safety nets to protect families and enterprises. Despite this initial optimism, structural deficiencies in the public health system, high informality in the labor market, the new wave of migrants from Venezuela and the extremely diverse cultural characteristics of many areas exacerbate the number of potentia","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Migration; Peru; Public health; SARS-CoV-2; Vulnerable population","Gandolfi","Andrea","Asociación Grupo de Trabajo Redes (AGTR), Calle Las Dalias 251, Miraflores, 15074, Lima, Peru",NA
"968","34171046","10.1016/j.puhip.2020.100019","Whither are we bound? Rethinking the gendered frailty during COVID-19 pandemic.","The outbreak of the novel coronavirus disease 2019 (COVID-19) has demonstrated the urgency to reconsider social behavior and the health system quality to efficiently support and improve global health. Diverse global and country-specific mechanisms to fight COVID-19 have been displyed, but the gendered analysis of these efforts still remain too little too late. A critical consideration of the brunt of health and socioeconomic crises through gender lenses can improve understanding and direction of","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Coronavirus; Gender; Global public health; Pandemic; Sub-Saharan Africa","Gyasi","Razak M","African Population and Health Research Center (APHRC), Nairobi, Kenya",NA
"969","34171046","10.1016/j.puhip.2020.100019","Whither are we bound? Rethinking the gendered frailty during COVID-19 pandemic.","The outbreak of the novel coronavirus disease 2019 (COVID-19) has demonstrated the urgency to reconsider social behavior and the health system quality to efficiently support and improve global health. Diverse global and country-specific mechanisms to fight COVID-19 have been displyed, but the gendered analysis of these efforts still remain too little too late. A critical consideration of the brunt of health and socioeconomic crises through gender lenses can improve understanding and direction of","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Coronavirus; Gender; Global public health; Pandemic; Sub-Saharan Africa","Anderson","Eugenia A","Department of History and Political Studies, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana",NA
"970","34171045","10.1016/j.puhip.2020.100018","Risks of COVID19 outbreaks in Rohingya refugee camps in Bangladesh.","The COVID-19 pandemic was confirmed to have started spreading in Bangladesh since March 2020. Since then the new infections grew exponentially and now the rate is highest in Asia along with wider community-level transmission. In Bangladesh, the preventive measures have been found challenging to implement due to a lack of general awareness of COVID-19 and the absence of a social safety net. In this situation, there is a concern about the heightened risk of infection and its aftermath in Rohingya ","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Rohingya refugee in Bangladesh","Khan","Md Nuruzzaman","Department of Population Scences, Jatiya Kabi Kazi Nazrul Islam University, Bangladesh",NA
"971","34171045","10.1016/j.puhip.2020.100018","Risks of COVID19 outbreaks in Rohingya refugee camps in Bangladesh.","The COVID-19 pandemic was confirmed to have started spreading in Bangladesh since March 2020. Since then the new infections grew exponentially and now the rate is highest in Asia along with wider community-level transmission. In Bangladesh, the preventive measures have been found challenging to implement due to a lack of general awareness of COVID-19 and the absence of a social safety net. In this situation, there is a concern about the heightened risk of infection and its aftermath in Rohingya ","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Rohingya refugee in Bangladesh","Islam","M Mofizul","Department of Public Health, La Trobe University, Melbourne, Australia",NA
"972","34171045","10.1016/j.puhip.2020.100018","Risks of COVID19 outbreaks in Rohingya refugee camps in Bangladesh.","The COVID-19 pandemic was confirmed to have started spreading in Bangladesh since March 2020. Since then the new infections grew exponentially and now the rate is highest in Asia along with wider community-level transmission. In Bangladesh, the preventive measures have been found challenging to implement due to a lack of general awareness of COVID-19 and the absence of a social safety net. In this situation, there is a concern about the heightened risk of infection and its aftermath in Rohingya ","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Rohingya refugee in Bangladesh","Rahman","Md Mashiur","Independent Researcher, Bangladesh",NA
"973","34171044","10.1016/j.puhip.2020.100015","COVID-19 in Conflict: The devastating impact of withdrawing humanitarian support on universal health coverage in Yemen.","The authors warn that, in the context of Yemen, the closure of humanitarian lifesaving programmes and shifting support toward health security, i.e. to support COVID-19 response, at the expense of primary health care support, will undermine existing health system strengthening efforts, worsen the humanitarian crisis and will accentuate the impact of COVID-19. The authors urge the international community and the Government of Yemen to carefully consider a more comprehensive approach to support Yem","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Conflict; Fragility; Health system; Humanitarian aid; Outbreak; UHC; Yemen","Al-Awlaqi","Sameh","Modern Social Association, Aden, Yemen",NA
"974","34171044","10.1016/j.puhip.2020.100015","COVID-19 in Conflict: The devastating impact of withdrawing humanitarian support on universal health coverage in Yemen.","The authors warn that, in the context of Yemen, the closure of humanitarian lifesaving programmes and shifting support toward health security, i.e. to support COVID-19 response, at the expense of primary health care support, will undermine existing health system strengthening efforts, worsen the humanitarian crisis and will accentuate the impact of COVID-19. The authors urge the international community and the Government of Yemen to carefully consider a more comprehensive approach to support Yem","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Conflict; Fragility; Health system; Humanitarian aid; Outbreak; UHC; Yemen","Dureab","Fekri","Institute of Research for International Assistance, Akkon Hochschule, Berlin, Germany",NA
"975","34171044","10.1016/j.puhip.2020.100015","COVID-19 in Conflict: The devastating impact of withdrawing humanitarian support on universal health coverage in Yemen.","The authors warn that, in the context of Yemen, the closure of humanitarian lifesaving programmes and shifting support toward health security, i.e. to support COVID-19 response, at the expense of primary health care support, will undermine existing health system strengthening efforts, worsen the humanitarian crisis and will accentuate the impact of COVID-19. The authors urge the international community and the Government of Yemen to carefully consider a more comprehensive approach to support Yem","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Conflict; Fragility; Health system; Humanitarian aid; Outbreak; UHC; Yemen","Annuzaili","Dhekra","Specialist Paediatriacian, Senior Public Health Consultant, Ministry of Public Health and Population, Sana'a, Yemen",NA
"976","34171044","10.1016/j.puhip.2020.100015","COVID-19 in Conflict: The devastating impact of withdrawing humanitarian support on universal health coverage in Yemen.","The authors warn that, in the context of Yemen, the closure of humanitarian lifesaving programmes and shifting support toward health security, i.e. to support COVID-19 response, at the expense of primary health care support, will undermine existing health system strengthening efforts, worsen the humanitarian crisis and will accentuate the impact of COVID-19. The authors urge the international community and the Government of Yemen to carefully consider a more comprehensive approach to support Yem","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Conflict; Fragility; Health system; Humanitarian aid; Outbreak; UHC; Yemen","Al-Dheeb","N","Public Health Expert, Sana'a, Yemen",NA
"977","34171042","10.1016/j.puhip.2020.100013","On the importance of population-based serological surveys of SARS-CoV-2 without overlooking their inherent uncertainties.","The SARS-CoV-2 epidemic has caused an unprecedented public health situation and more than ever it is important to be well informed on methods to monitor and analyse the progression of the epidemic. This brief note aims to explain the scope in conducting large-scale serological surveys of SARS-CoV-2 to define the landscape of population immunity, without overlooking the inherent uncertainty steaming from sampling design and diagnostic validity. The note completes with a succinct appendix of simpl","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Antibodies; Coronavirus; Diagnostic validity; Random sampling; Seroepidemiology; Seroprevalence","Kritsotakis","Evangelos I","School of Medicine, University of Crete, 71003, Heraklion, Crete, Greece",NA
"978","34171041","10.1016/j.puhip.2020.100009","COVID-19: Challenges and its consequences for rural health care in India.","This commentary highlights the potential consequences of the COVID-19 pandemic for India's rural population. The rural health care system in India is not adequate or prepared to contain COVID-19 transmission, especially in many densely populated northern Indian States because of the shortage of doctors, hospital beds, and equipment. The COVID-19 pandemic creates a special challenge due to the paucity of testing services, weak surveillance system and above all poor medical care. The impacts of th","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; India; Pandemic; Public health; Rural health care; SARS-CoV-2","Kumar","Anant","Xavier Institute of Social Service, Ranchi, India",NA
"979","34171041","10.1016/j.puhip.2020.100009","COVID-19: Challenges and its consequences for rural health care in India.","This commentary highlights the potential consequences of the COVID-19 pandemic for India's rural population. The rural health care system in India is not adequate or prepared to contain COVID-19 transmission, especially in many densely populated northern Indian States because of the shortage of doctors, hospital beds, and equipment. The COVID-19 pandemic creates a special challenge due to the paucity of testing services, weak surveillance system and above all poor medical care. The impacts of th","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; India; Pandemic; Public health; Rural health care; SARS-CoV-2","Rajasekharan Nayar","K","Global Institute of Public Health, Thiruvananthapuram, Kerala, India",NA
"980","34171041","10.1016/j.puhip.2020.100009","COVID-19: Challenges and its consequences for rural health care in India.","This commentary highlights the potential consequences of the COVID-19 pandemic for India's rural population. The rural health care system in India is not adequate or prepared to contain COVID-19 transmission, especially in many densely populated northern Indian States because of the shortage of doctors, hospital beds, and equipment. The COVID-19 pandemic creates a special challenge due to the paucity of testing services, weak surveillance system and above all poor medical care. The impacts of th","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; India; Pandemic; Public health; Rural health care; SARS-CoV-2","Koya","Shaffi Fazaludeen","Boston University School of Public Health, Boston, MA, USA",NA
"981","34171039","10.1016/j.puhip.2020.100004","Can developing countries face novel coronavirus outbreak alone? The Iraqi situation.","Iraq is one of seven Arabic countries (Lebanon, Bahrain, Kuwait, Oman, Qatar and Saudi Arabia) that acquired novel coronavirus-19 disease (COVID-19) via people who have visited Iran recently. Iraqi outdated public healthcare settings are already overwhelmed with many acute injuries from ongoing unrest. Iraq faces six challenges in controlling COVID-19 [1]: A shortage in number of quarantine facilities [2], the availability of the testing which is limited to one governmental lab only in Baghdad [","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Challenges; Corona virus; Iraq","Mikhael","Ehab Mudher","University of Baghdad College of Pharmacy, Baghdad, Iraq",NA
"982","34171039","10.1016/j.puhip.2020.100004","Can developing countries face novel coronavirus outbreak alone? The Iraqi situation.","Iraq is one of seven Arabic countries (Lebanon, Bahrain, Kuwait, Oman, Qatar and Saudi Arabia) that acquired novel coronavirus-19 disease (COVID-19) via people who have visited Iran recently. Iraqi outdated public healthcare settings are already overwhelmed with many acute injuries from ongoing unrest. Iraq faces six challenges in controlling COVID-19 [1]: A shortage in number of quarantine facilities [2], the availability of the testing which is limited to one governmental lab only in Baghdad [","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Challenges; Corona virus; Iraq","Al-Jumaili","Ali Azeez","University of Baghdad College of Pharmacy, Baghdad, Iraq",NA
"983","34171037","10.1016/j.fsiml.2020.100022","Mental health services in Shanghai during the COVID-19 outbreak.",NA,"2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Mental health services","Xu","Yeqing","Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"984","34171037","10.1016/j.fsiml.2020.100022","Mental health services in Shanghai during the COVID-19 outbreak.",NA,"2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Mental health services","Shao","Yang","Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"985","34171037","10.1016/j.fsiml.2020.100022","Mental health services in Shanghai during the COVID-19 outbreak.",NA,"2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Mental health services","Huang","Jingjing","Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"986","34171036","10.1016/j.fsiml.2020.100018","What does social distancing mean for patients in forensic mental health settings?",NA,"2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; FRQ; Forensic; Mentally disordered offender; Restrictiveness; Social distancing","Tomlin","Jack","Department of Forensic Psychiatry, University of Rostock, Germany",NA
"987","34171035","10.1016/j.fsiml.2020.100013","Caring for persons in detention suffering with mental illness during the Covid-19 outbreak.",NA,"2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law",NA,"Liebrenz","Michael","Department of Forensic Psychiatry, Institute of Forensic Medicine, University of Bern, Bern, Switzerland",NA
"988","34171035","10.1016/j.fsiml.2020.100013","Caring for persons in detention suffering with mental illness during the Covid-19 outbreak.",NA,"2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law",NA,"Bhugra","Dinesh","Institute of Psychiatry, Psychology &amp",NA
"989","34171035","10.1016/j.fsiml.2020.100013","Caring for persons in detention suffering with mental illness during the Covid-19 outbreak.",NA,"2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law",NA,"Buadze","Anna","Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland",NA
"990","34171035","10.1016/j.fsiml.2020.100013","Caring for persons in detention suffering with mental illness during the Covid-19 outbreak.",NA,"2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law",NA,"Schleifer","Roman","Department of Forensic Psychiatry, Institute of Forensic Medicine, University of Bern, Bern, Switzerland",NA
"991","34171034","10.1016/j.jdin.2020.05.003","COVID-19 and wound care: A Canadian perspective.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Mufti","Asfandyar","Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada",NA
"992","34171034","10.1016/j.jdin.2020.05.003","COVID-19 and wound care: A Canadian perspective.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Sachdeva","Muskaan","Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada",NA
"993","34171034","10.1016/j.jdin.2020.05.003","COVID-19 and wound care: A Canadian perspective.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Maliyar","Khalad","Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada",NA
"994","34171034","10.1016/j.jdin.2020.05.003","COVID-19 and wound care: A Canadian perspective.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Sibbald","R Gary","Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada",NA
"995","34171033","10.1016/j.jdin.2020.06.001","Novel role of plastic wrap in COVID-19.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Chen","Yusha","Sichuan University West China Hospital, Department of Dermatovenereology, Chengdu, China",NA
"996","34171033","10.1016/j.jdin.2020.06.001","Novel role of plastic wrap in COVID-19.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Pradhan","Sushmita","Sichuan University West China Hospital, Department of Dermatovenereology, Chengdu, China",NA
"997","34171033","10.1016/j.jdin.2020.06.001","Novel role of plastic wrap in COVID-19.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Xue","Siliang","Sichuan University West China Hospital, Department of Dermatovenereology, Chengdu, China",NA
"998","34171032","10.1016/j.jdin.2020.05.004","Cutaneous drug eruptions associated with COVID-19 therapy.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Atzori","Laura","Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy",NA
"999","34171032","10.1016/j.jdin.2020.05.004","Cutaneous drug eruptions associated with COVID-19 therapy.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Perla","Stefania","Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy",NA
"1000","34171032","10.1016/j.jdin.2020.05.004","Cutaneous drug eruptions associated with COVID-19 therapy.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Atzori","Maria Giovanna","Dermatology Unit, Nuoro San Francesco Hospital, Nuoro, Italy",NA
"1001","34171032","10.1016/j.jdin.2020.05.004","Cutaneous drug eruptions associated with COVID-19 therapy.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Ferreli","Caterina","Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy",NA
"1002","34171032","10.1016/j.jdin.2020.05.004","Cutaneous drug eruptions associated with COVID-19 therapy.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Rongioletti","Franco","Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy",NA
"1004","34171021","10.1016/j.trip.2020.100141","Modal share changes due to COVID-19: The case of Budapest.","The COVID-19 pandemic has had a rapid and significant impact on mobility. One of the most important responses of countries worldwide to slow the spread of the pandemic is to restrict the movement of people, which has had a considerable effect on transport systems. However, the reduction of transport is not identical for all modes of transport: public transport has seen the greatest decline so far. Understanding urban modal share developments during a pandemic situation can help cities better pre","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Bike sharing; COVID-19; Cycling; Modal share; Public transport; Road transport","Bucsky","Péter","Doctoral School of Earth Sciences, University of Pécs, Pécs, Ifjúság útja 6, 7624, Hungary",NA
"1005","34171020","10.1016/j.trip.2020.100154","Impact of COVID-19 on transportation in Lagos, Nigeria.","The growing number of studies on the impact of COVID-19 is often discussed in the context of developed countries, highlighting a gap in the understanding of how the pandemic is impacting developing countries. This theoretical commentary focuses on the present and long-term impact of COVID-19 on transportation in Lagos State, Nigeria. The paper recognises the effect on transportation in emerging economies, where lockdowns and restrictions on movement may be ineffective, a state with high populati","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Lagos; Nigeria; Social distancing; Transportation","Mogaji","Emmanuel","University of Greenwich, London, UK",NA
"1006","34171019","10.1016/j.trip.2020.100150","How COVID-19 and the Dutch 'intelligent lockdown' change activities, work and travel behaviour: Evidence from longitudinal data in the Netherlands.","COVID-19 has massively affected the lives of people all over the world. This paper presents first insights in current and potential future effects of the virus and the Dutch government's 'intelligent lockdown' on people's activities and travel behaviour. Findings are based on a representative sample of about 2500 respondents from the Netherlands Mobility Panel (MPN). We show that approximately 80% of people reduced their activities outdoors, with a stronger decrease for older people. 44% of work","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Coronavirus; Longitudinal travel data; Netherlands Mobility Panel (MPN); Panel data; Travel behaviour","de Haas","Mathijs","KiM Netherlands Institute for Transport Policy Analysis, Bezuidenhoutseweg 20, 2594 AV The Hague, the Netherlands",NA
"1007","34171019","10.1016/j.trip.2020.100150","How COVID-19 and the Dutch 'intelligent lockdown' change activities, work and travel behaviour: Evidence from longitudinal data in the Netherlands.","COVID-19 has massively affected the lives of people all over the world. This paper presents first insights in current and potential future effects of the virus and the Dutch government's 'intelligent lockdown' on people's activities and travel behaviour. Findings are based on a representative sample of about 2500 respondents from the Netherlands Mobility Panel (MPN). We show that approximately 80% of people reduced their activities outdoors, with a stronger decrease for older people. 44% of work","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Coronavirus; Longitudinal travel data; Netherlands Mobility Panel (MPN); Panel data; Travel behaviour","Faber","Roel","KiM Netherlands Institute for Transport Policy Analysis, Bezuidenhoutseweg 20, 2594 AV The Hague, the Netherlands",NA
"1008","34171019","10.1016/j.trip.2020.100150","How COVID-19 and the Dutch 'intelligent lockdown' change activities, work and travel behaviour: Evidence from longitudinal data in the Netherlands.","COVID-19 has massively affected the lives of people all over the world. This paper presents first insights in current and potential future effects of the virus and the Dutch government's 'intelligent lockdown' on people's activities and travel behaviour. Findings are based on a representative sample of about 2500 respondents from the Netherlands Mobility Panel (MPN). We show that approximately 80% of people reduced their activities outdoors, with a stronger decrease for older people. 44% of work","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Coronavirus; Longitudinal travel data; Netherlands Mobility Panel (MPN); Panel data; Travel behaviour","Hamersma","Marije","KiM Netherlands Institute for Transport Policy Analysis, Bezuidenhoutseweg 20, 2594 AV The Hague, the Netherlands",NA
"1010","34171017","10.1016/j.trip.2020.100127","Influenza risk perception and travel-related health protection behavior in the US: Insights for the aftermath of the COVID-19 outbreak.","Influenza is a contagious virus affecting both one's health and economic productivity. This study evaluates uses a survey of 2168 individuals across the U.S. Ordered logit regressions are used to model risk perception and generalized ordered logit regressions are used to model risk mitigation travel-related decisions. Models are estimated for three influenza outbreak scenarios, specifically an individual's travel-related: 1) risk perceptions, 2) risk mitigation decisions when infected and the in","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Health protection behavior; Health risk perception; Seasonal influenza; Social distancing; Travel","Hotle","Susan","Virginia Polytechnic Institute and State University, School of Civil and Environmental Engineering, 750 Drillfield Drive, Blacksburg, VA 24061, United States of America",NA
"1011","34171017","10.1016/j.trip.2020.100127","Influenza risk perception and travel-related health protection behavior in the US: Insights for the aftermath of the COVID-19 outbreak.","Influenza is a contagious virus affecting both one's health and economic productivity. This study evaluates uses a survey of 2168 individuals across the U.S. Ordered logit regressions are used to model risk perception and generalized ordered logit regressions are used to model risk mitigation travel-related decisions. Models are estimated for three influenza outbreak scenarios, specifically an individual's travel-related: 1) risk perceptions, 2) risk mitigation decisions when infected and the in","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Health protection behavior; Health risk perception; Seasonal influenza; Social distancing; Travel","Murray-Tuite","Pamela","Clemson University, Glenn Department of Civil Engineering, 210 Lowry Hall, Clemson, SC 29634, United States of America",NA
"1012","34171017","10.1016/j.trip.2020.100127","Influenza risk perception and travel-related health protection behavior in the US: Insights for the aftermath of the COVID-19 outbreak.","Influenza is a contagious virus affecting both one's health and economic productivity. This study evaluates uses a survey of 2168 individuals across the U.S. Ordered logit regressions are used to model risk perception and generalized ordered logit regressions are used to model risk mitigation travel-related decisions. Models are estimated for three influenza outbreak scenarios, specifically an individual's travel-related: 1) risk perceptions, 2) risk mitigation decisions when infected and the in","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Health protection behavior; Health risk perception; Seasonal influenza; Social distancing; Travel","Singh","Kunal","Virginia Polytechnic Institute and State University, School of Civil and Environmental Engineering, 750 Drillfield Drive, Blacksburg, VA 24061, United States of America",NA
"1013","34171016","10.1016/j.trip.2020.100121","The effect of COVID-19 and subsequent social distancing on travel behavior.","The spread of the COVID-19 virus has resulted in unprecedented measures restricting travel and activity participation in many countries. Social distancing, i.e., reducing interactions between individuals in order to slow down the spread of the virus, has become the new norm. In this viewpoint I will discuss the potential implications of social distancing on daily travel patterns. Avoiding social contact might completely change the number and types of out-of-home activities people perform, and ho","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Health; Social distancing; Travel behavior; Well-being","De Vos","Jonas","Bartlett School of Planning, University College London, 14 Upper Woburn Place, London WC1H 0NN, United Kingdom",NA
"1014","34171015","10.1016/j.trip.2020.100111","Testing on the move: South Korea's rapid response to the COVID-19 pandemic.","The emergence of COVID-19 in South Korea, and the public and private sector response to it, serves as a valuable case study for countries facing similar outbreaks. This article focuses on how Korean health officials implemented drive-through and walk-through diagnostic testing, and extensive movement and contact tracing, to identify and inform exposed members of the public. Mobile applications from both government agencies and private developers played an important role in guiding people to test","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Contact tracing; Coronavirus; Drive-through testing; Mobile applications; Movement tracking","Lee","David","KAIST, Republic of Korea",NA
"1015","34171015","10.1016/j.trip.2020.100111","Testing on the move: South Korea's rapid response to the COVID-19 pandemic.","The emergence of COVID-19 in South Korea, and the public and private sector response to it, serves as a valuable case study for countries facing similar outbreaks. This article focuses on how Korean health officials implemented drive-through and walk-through diagnostic testing, and extensive movement and contact tracing, to identify and inform exposed members of the public. Mobile applications from both government agencies and private developers played an important role in guiding people to test","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Contact tracing; Coronavirus; Drive-through testing; Mobile applications; Movement tracking","Lee","Jaehong","KAIST, Republic of Korea",NA
"1016","34171014","10.1016/j.pdisas.2020.100109","COVID-19 Risk Assessment Tool: Dual application of risk communication and risk governance.","Risk awareness is the best way to prevent and slow-down the transmission of the COVID-19 pandemic. Risk awareness is achieved through communication of risk assessment. Effective risk communication is an important measure to control the infodemic. Most risk assessment tools focus on either tracking the affected patients or diagnosing a probable health condition through symptoms. RIKA India introduces an innovative Risk Assessment Tool which goes beyond the symptom detection and patient tracking. ","2021","06","28","Prog Disaster Sci","Progress in disaster science","Awareness generation; COVID-19 pandemic; Risk communication; Risk governance; Social behaviour","Chatterjee","Ranit","Resilience Innovation Knowledge Academy (RIKA), India",NA
"1017","34171014","10.1016/j.pdisas.2020.100109","COVID-19 Risk Assessment Tool: Dual application of risk communication and risk governance.","Risk awareness is the best way to prevent and slow-down the transmission of the COVID-19 pandemic. Risk awareness is achieved through communication of risk assessment. Effective risk communication is an important measure to control the infodemic. Most risk assessment tools focus on either tracking the affected patients or diagnosing a probable health condition through symptoms. RIKA India introduces an innovative Risk Assessment Tool which goes beyond the symptom detection and patient tracking. ","2021","06","28","Prog Disaster Sci","Progress in disaster science","Awareness generation; COVID-19 pandemic; Risk communication; Risk governance; Social behaviour","Bajwa","Sukhreet","Resilience Innovation Knowledge Academy (RIKA), India",NA
"1018","34171014","10.1016/j.pdisas.2020.100109","COVID-19 Risk Assessment Tool: Dual application of risk communication and risk governance.","Risk awareness is the best way to prevent and slow-down the transmission of the COVID-19 pandemic. Risk awareness is achieved through communication of risk assessment. Effective risk communication is an important measure to control the infodemic. Most risk assessment tools focus on either tracking the affected patients or diagnosing a probable health condition through symptoms. RIKA India introduces an innovative Risk Assessment Tool which goes beyond the symptom detection and patient tracking. ","2021","06","28","Prog Disaster Sci","Progress in disaster science","Awareness generation; COVID-19 pandemic; Risk communication; Risk governance; Social behaviour","Dwivedi","Disha","Resilience Innovation Knowledge Academy (RIKA), India",NA
"1019","34171014","10.1016/j.pdisas.2020.100109","COVID-19 Risk Assessment Tool: Dual application of risk communication and risk governance.","Risk awareness is the best way to prevent and slow-down the transmission of the COVID-19 pandemic. Risk awareness is achieved through communication of risk assessment. Effective risk communication is an important measure to control the infodemic. Most risk assessment tools focus on either tracking the affected patients or diagnosing a probable health condition through symptoms. RIKA India introduces an innovative Risk Assessment Tool which goes beyond the symptom detection and patient tracking. ","2021","06","28","Prog Disaster Sci","Progress in disaster science","Awareness generation; COVID-19 pandemic; Risk communication; Risk governance; Social behaviour","Kanji","Repaul","Gujarat Institute of Disaster Management, India",NA
"1020","34171014","10.1016/j.pdisas.2020.100109","COVID-19 Risk Assessment Tool: Dual application of risk communication and risk governance.","Risk awareness is the best way to prevent and slow-down the transmission of the COVID-19 pandemic. Risk awareness is achieved through communication of risk assessment. Effective risk communication is an important measure to control the infodemic. Most risk assessment tools focus on either tracking the affected patients or diagnosing a probable health condition through symptoms. RIKA India introduces an innovative Risk Assessment Tool which goes beyond the symptom detection and patient tracking. ","2021","06","28","Prog Disaster Sci","Progress in disaster science","Awareness generation; COVID-19 pandemic; Risk communication; Risk governance; Social behaviour","Ahammed","Moniruddin","Amazon Web Service, India",NA
"1021","34171014","10.1016/j.pdisas.2020.100109","COVID-19 Risk Assessment Tool: Dual application of risk communication and risk governance.","Risk awareness is the best way to prevent and slow-down the transmission of the COVID-19 pandemic. Risk awareness is achieved through communication of risk assessment. Effective risk communication is an important measure to control the infodemic. Most risk assessment tools focus on either tracking the affected patients or diagnosing a probable health condition through symptoms. RIKA India introduces an innovative Risk Assessment Tool which goes beyond the symptom detection and patient tracking. ","2021","06","28","Prog Disaster Sci","Progress in disaster science","Awareness generation; COVID-19 pandemic; Risk communication; Risk governance; Social behaviour","Shaw","Rajib","Resilience Innovation Knowledge Academy (RIKA), India",NA
"1022","34171013","10.1016/j.pdisas.2020.100102","Are we there yet? The transition from response to recovery for the COVID-19 pandemic.","There is no corner of the planet that has not been impacted by the rapid spread of the novel coronavirus, COVID-19. While the COVID-19 pandemic has already had far-reaching socioeconomic consequences commonly associated with natural hazards (such as disruption to society, economic damage, and loss of lives), the response of governments around the world has been unparalleled and unlike anything seen before. Governments are faced with a myriad of multi-dimensional effects of the pandemic, includin","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Disaster response; Recovery; Transition","Fakhruddin","Bapon Shm","Tonkin + Taylor, New Zealand",NA
"1023","34171013","10.1016/j.pdisas.2020.100102","Are we there yet? The transition from response to recovery for the COVID-19 pandemic.","There is no corner of the planet that has not been impacted by the rapid spread of the novel coronavirus, COVID-19. While the COVID-19 pandemic has already had far-reaching socioeconomic consequences commonly associated with natural hazards (such as disruption to society, economic damage, and loss of lives), the response of governments around the world has been unparalleled and unlike anything seen before. Governments are faced with a myriad of multi-dimensional effects of the pandemic, includin","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Disaster response; Recovery; Transition","Blanchard","Kevin","DRR Dynamics Ltd, United Kingdom",NA
"1024","34171013","10.1016/j.pdisas.2020.100102","Are we there yet? The transition from response to recovery for the COVID-19 pandemic.","There is no corner of the planet that has not been impacted by the rapid spread of the novel coronavirus, COVID-19. While the COVID-19 pandemic has already had far-reaching socioeconomic consequences commonly associated with natural hazards (such as disruption to society, economic damage, and loss of lives), the response of governments around the world has been unparalleled and unlike anything seen before. Governments are faced with a myriad of multi-dimensional effects of the pandemic, includin","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Disaster response; Recovery; Transition","Ragupathy","Durga","Tonkin + Taylor, New Zealand",NA
"1025","34170993","10.1002/fsh.10444","Coronavirus, Climate Change, and a Bit of Hope.",NA,"2021","06","28","Fisheries (Bethesda)","Fisheries",NA,"Bonar","Scott A",NA,NA
"1026","34170989","10.1016/j.ribaf.2020.101249","Stock markets' reaction to COVID-19: Cases or fatalities?","In this paper, we examine the stock markets' response to the COVID-19 pandemic. Using daily COVID-19 confirmed cases and deaths and stock market returns data from 64 countries over the period January 22, 2020 to April 17, 2020, we find that stock markets responded negatively to the growth in COVID-19 confirmed cases. That is, stock market returns declined as the number of confirmed cases increased. We further find that stock markets reacted more proactively to the growth in number of confirmed c","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Contagious disease; Coronavirus; Financial markets; Pandemic; SARS-CoV-2; Stock market","Ashraf","Badar Nadeem","School of Finance, Jiangxi University of Finance and Economics, Nanchang 330013, China",NA
"1027","34170988","10.1016/j.ribaf.2020.101248","Are cryptocurrencies a safe haven for equity markets? An international perspective from the COVID-19 pandemic.","The COVID-19 pandemic provided the first widespread bear market conditions since the inception of cryptocurrencies. We test the widely mooted safe haven properties of Bitcoin, Ethereum and Tether from the perspective of international equity index investors. Bitcoin and Ethereum are not a safe haven for the majority of international equity markets examined, with their inclusion adding to portfolio downside risk. Only investors in the Chinese CSI 300 index realized modest downside risk benefits (c","2021","06","28","Res Int Bus Finance","Research in international business and finance","Bitcoin; COVID-19; Cryptocurrency; Ethereum; Safe Haven; Tether","Conlon","Thomas","Smurfit Graduate School of Business, University College Dublin, Ireland",NA
"1028","34170988","10.1016/j.ribaf.2020.101248","Are cryptocurrencies a safe haven for equity markets? An international perspective from the COVID-19 pandemic.","The COVID-19 pandemic provided the first widespread bear market conditions since the inception of cryptocurrencies. We test the widely mooted safe haven properties of Bitcoin, Ethereum and Tether from the perspective of international equity index investors. Bitcoin and Ethereum are not a safe haven for the majority of international equity markets examined, with their inclusion adding to portfolio downside risk. Only investors in the Chinese CSI 300 index realized modest downside risk benefits (c","2021","06","28","Res Int Bus Finance","Research in international business and finance","Bitcoin; COVID-19; Cryptocurrency; Ethereum; Safe Haven; Tether","Corbet","Shaen","DCU Business School, Dublin City University, Dublin 9, Ireland",NA
"1029","34170988","10.1016/j.ribaf.2020.101248","Are cryptocurrencies a safe haven for equity markets? An international perspective from the COVID-19 pandemic.","The COVID-19 pandemic provided the first widespread bear market conditions since the inception of cryptocurrencies. We test the widely mooted safe haven properties of Bitcoin, Ethereum and Tether from the perspective of international equity index investors. Bitcoin and Ethereum are not a safe haven for the majority of international equity markets examined, with their inclusion adding to portfolio downside risk. Only investors in the Chinese CSI 300 index realized modest downside risk benefits (c","2021","06","28","Res Int Bus Finance","Research in international business and finance","Bitcoin; COVID-19; Cryptocurrency; Ethereum; Safe Haven; Tether","McGee","Richard J","Smurfit Graduate School of Business, University College Dublin, Ireland",NA
"1030","34170987","10.1016/j.nefro.2020.05.002","[Is the immune hyporesponsiveness of uremic patients a protective factor for severe COVID-19 pneumonia?]",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Florit","Enrique A","Instituto de Nefrología y Urología (ICNU), Hospital Clinic, Barcelona, España",NA
"1031","34170987","10.1016/j.nefro.2020.05.002","[Is the immune hyporesponsiveness of uremic patients a protective factor for severe COVID-19 pneumonia?]",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Diekmann","Fritz","Instituto de Nefrología y Urología (ICNU), Hospital Clinic, Barcelona, España",NA
"1032","34170986","10.1016/j.nefro.2020.05.003","[Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19].",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Sánchez Cadena","Abraham David","Servicio de Farmacia, Hospital General Universitario de Ciudad Real, Ciudad Real, España",NA
"1033","34170986","10.1016/j.nefro.2020.05.003","[Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19].",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Negreira Caamaño","Martín","Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, España",NA
"1034","34170986","10.1016/j.nefro.2020.05.003","[Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19].",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Pérez Serrano","Raúl","Servicio de Farmacia, Hospital General Universitario de Ciudad Real, Ciudad Real, España",NA
"1035","34170986","10.1016/j.nefro.2020.05.003","[Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19].",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Porras Leal","María Lourdes","Servicio de Medicina Interna, Hospital General Universitario de Ciudad Real, Ciudad Real, España",NA
"1036","34170973","10.1371/journal.pone.0253796","Impact of Covid-19 on attendances for a 1st episode of reduced fetal movements: A retrospective observational study.","Prior studies have demonstrated an increased stillbirth rate. It was suggested that the COVID-19 pandemic may have impacted on attendances for reduced fetal movements. Thus, we sought to ascertain the impact of the pandemic on attendances for reduced fetal movements (RFM) in our unit, ultrasound provision for reduced fetal movements, and the stillbirth rate. This was a single site retrospective cohort study involving all women complaining of a 1st episode of reduced fetal movements between 01/03","2021","07","05","PLoS One","PloS one","Adult; COVID-19; Female; Fetal Growth Retardation; Fetal Movement; Gestational Age; Humans; Pregnancy; Retrospective Studies; SARS-CoV-2; Stillbirth; Ultrasonography, Prenatal","Marques-Fernandez","Laia","Department of Obstetrics and Gynaecology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",NA
"1037","34170973","10.1371/journal.pone.0253796","Impact of Covid-19 on attendances for a 1st episode of reduced fetal movements: A retrospective observational study.","Prior studies have demonstrated an increased stillbirth rate. It was suggested that the COVID-19 pandemic may have impacted on attendances for reduced fetal movements. Thus, we sought to ascertain the impact of the pandemic on attendances for reduced fetal movements (RFM) in our unit, ultrasound provision for reduced fetal movements, and the stillbirth rate. This was a single site retrospective cohort study involving all women complaining of a 1st episode of reduced fetal movements between 01/03","2021","07","05","PLoS One","PloS one","Adult; COVID-19; Female; Fetal Growth Retardation; Fetal Movement; Gestational Age; Humans; Pregnancy; Retrospective Studies; SARS-CoV-2; Stillbirth; Ultrasonography, Prenatal","Sharma","Swati","Department of Obstetrics and Gynaecology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",NA
"1038","34170973","10.1371/journal.pone.0253796","Impact of Covid-19 on attendances for a 1st episode of reduced fetal movements: A retrospective observational study.","Prior studies have demonstrated an increased stillbirth rate. It was suggested that the COVID-19 pandemic may have impacted on attendances for reduced fetal movements. Thus, we sought to ascertain the impact of the pandemic on attendances for reduced fetal movements (RFM) in our unit, ultrasound provision for reduced fetal movements, and the stillbirth rate. This was a single site retrospective cohort study involving all women complaining of a 1st episode of reduced fetal movements between 01/03","2021","07","05","PLoS One","PloS one","Adult; COVID-19; Female; Fetal Growth Retardation; Fetal Movement; Gestational Age; Humans; Pregnancy; Retrospective Studies; SARS-CoV-2; Stillbirth; Ultrasonography, Prenatal","Mannu","Una","Department of Obstetrics and Gynaecology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",NA
"1039","34170973","10.1371/journal.pone.0253796","Impact of Covid-19 on attendances for a 1st episode of reduced fetal movements: A retrospective observational study.","Prior studies have demonstrated an increased stillbirth rate. It was suggested that the COVID-19 pandemic may have impacted on attendances for reduced fetal movements. Thus, we sought to ascertain the impact of the pandemic on attendances for reduced fetal movements (RFM) in our unit, ultrasound provision for reduced fetal movements, and the stillbirth rate. This was a single site retrospective cohort study involving all women complaining of a 1st episode of reduced fetal movements between 01/03","2021","07","05","PLoS One","PloS one","Adult; COVID-19; Female; Fetal Growth Retardation; Fetal Movement; Gestational Age; Humans; Pregnancy; Retrospective Studies; SARS-CoV-2; Stillbirth; Ultrasonography, Prenatal","Chong","Hsu Phern","Department of Obstetrics and Gynaecology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",NA
"1040","34170956","10.1371/journal.pone.0253654","Black Americans demonstrate comparatively low levels of depression and anxiety during the COVID-19 pandemic.","During public health crises like the COVID-19 pandemic, populations can experience worsening mental health. Prior reports have suggested that Black Americans experienced lower rates of anxiety and depression than White Americans before the pandemic; however, during the pandemic, outcomes may be different as Black Americans have been disproportionately affected in terms of mortality, hospitalization, COVID-19 infection, and job loss. We documented the differential mental health impact of COVID-19","2021","07","05","PLoS One","PloS one","Adolescent; Adult; African Americans; Aged; COVID-19; Depression; Female; Humans; Male; Mental Health; Middle Aged; Pandemics; SARS-CoV-2","Owens","Victoria","Joint Program in Survey Methodology (JPSM), University of Maryland &amp",NA
"1041","34170956","10.1371/journal.pone.0253654","Black Americans demonstrate comparatively low levels of depression and anxiety during the COVID-19 pandemic.","During public health crises like the COVID-19 pandemic, populations can experience worsening mental health. Prior reports have suggested that Black Americans experienced lower rates of anxiety and depression than White Americans before the pandemic; however, during the pandemic, outcomes may be different as Black Americans have been disproportionately affected in terms of mortality, hospitalization, COVID-19 infection, and job loss. We documented the differential mental health impact of COVID-19","2021","07","05","PLoS One","PloS one","Adolescent; Adult; African Americans; Aged; COVID-19; Depression; Female; Humans; Male; Mental Health; Middle Aged; Pandemics; SARS-CoV-2","Saw","Htay-Wah","Michigan Program in Survey Methodology (MPSM), Survey Research Center (SRC), Institute for Social Research (ISR), University of Michigan, Ann Arbor, Michigan, United States of America",NA
"1042","34170950","10.1371/journal.pone.0253767","Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure.","COVID-19's pulmonary manifestations are broad, ranging from pneumonia with no supplemental oxygen requirements to acute respiratory distress syndrome (ARDS) with acute respiratory failure (ARF). In response, new oxygenation strategies and therapeutics have been developed, but their large-scale effects on outcomes in severe COVID-19 patients remain unknown. Therefore, we aimed to examine the trends in mortality, mechanical ventilation, and cost over the first six months of the pandemic for adult ","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; Disease-Free Survival; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate","Yeates","Eric O","Department of Surgery, University of California Irvine, Orange, California, United States of America",NA
"1043","34170950","10.1371/journal.pone.0253767","Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure.","COVID-19's pulmonary manifestations are broad, ranging from pneumonia with no supplemental oxygen requirements to acute respiratory distress syndrome (ARDS) with acute respiratory failure (ARF). In response, new oxygenation strategies and therapeutics have been developed, but their large-scale effects on outcomes in severe COVID-19 patients remain unknown. Therefore, we aimed to examine the trends in mortality, mechanical ventilation, and cost over the first six months of the pandemic for adult ","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; Disease-Free Survival; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate","Nahmias","Jeffry","Department of Surgery, University of California Irvine, Orange, California, United States of America",NA
"1044","34170950","10.1371/journal.pone.0253767","Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure.","COVID-19's pulmonary manifestations are broad, ranging from pneumonia with no supplemental oxygen requirements to acute respiratory distress syndrome (ARDS) with acute respiratory failure (ARF). In response, new oxygenation strategies and therapeutics have been developed, but their large-scale effects on outcomes in severe COVID-19 patients remain unknown. Therefore, we aimed to examine the trends in mortality, mechanical ventilation, and cost over the first six months of the pandemic for adult ","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; Disease-Free Survival; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate","Chinn","Justine","Department of Surgery, University of California Irvine, Orange, California, United States of America",NA
"1045","34170950","10.1371/journal.pone.0253767","Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure.","COVID-19's pulmonary manifestations are broad, ranging from pneumonia with no supplemental oxygen requirements to acute respiratory distress syndrome (ARDS) with acute respiratory failure (ARF). In response, new oxygenation strategies and therapeutics have been developed, but their large-scale effects on outcomes in severe COVID-19 patients remain unknown. Therefore, we aimed to examine the trends in mortality, mechanical ventilation, and cost over the first six months of the pandemic for adult ","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; Disease-Free Survival; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate","Sullivan","Brittany","Department of Surgery, University of California Irvine, Orange, California, United States of America",NA
"1046","34170950","10.1371/journal.pone.0253767","Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure.","COVID-19's pulmonary manifestations are broad, ranging from pneumonia with no supplemental oxygen requirements to acute respiratory distress syndrome (ARDS) with acute respiratory failure (ARF). In response, new oxygenation strategies and therapeutics have been developed, but their large-scale effects on outcomes in severe COVID-19 patients remain unknown. Therefore, we aimed to examine the trends in mortality, mechanical ventilation, and cost over the first six months of the pandemic for adult ","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; Disease-Free Survival; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate","Stopenski","Stephen","Department of Surgery, University of California Irvine, Orange, California, United States of America",NA
"1047","34170950","10.1371/journal.pone.0253767","Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure.","COVID-19's pulmonary manifestations are broad, ranging from pneumonia with no supplemental oxygen requirements to acute respiratory distress syndrome (ARDS) with acute respiratory failure (ARF). In response, new oxygenation strategies and therapeutics have been developed, but their large-scale effects on outcomes in severe COVID-19 patients remain unknown. Therefore, we aimed to examine the trends in mortality, mechanical ventilation, and cost over the first six months of the pandemic for adult ","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; Disease-Free Survival; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate","Amin","Alpesh N","Department of Medicine, University of California Irvine, Orange, California, United States of America",NA
"1048","34170950","10.1371/journal.pone.0253767","Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure.","COVID-19's pulmonary manifestations are broad, ranging from pneumonia with no supplemental oxygen requirements to acute respiratory distress syndrome (ARDS) with acute respiratory failure (ARF). In response, new oxygenation strategies and therapeutics have been developed, but their large-scale effects on outcomes in severe COVID-19 patients remain unknown. Therefore, we aimed to examine the trends in mortality, mechanical ventilation, and cost over the first six months of the pandemic for adult ","2021","07","05","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; Disease-Free Survival; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate","Nguyen","Ninh T","Department of Surgery, University of California Irvine, Orange, California, United States of America",NA
"1049","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Frank","Mayu O","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1050","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Blachere","Nathalie E","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1051","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Parveen","Salina","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1052","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Hacisuleyman","Ezgi","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1053","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Fak","John","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1054","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Luna","Joseph M","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1055","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Michailidis","Eleftherios","Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, United States of America",NA
"1056","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Wright","Samara","Child and Family Center, The Rockefeller University, New York, NY, United States of America",NA
"1057","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Stark","Pamela","Child and Family Center, The Rockefeller University, New York, NY, United States of America",NA
"1058","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Campbell","Ann","Occupational Health Services, The Rockefeller University, New York, NY, United States of America",NA
"1059","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Foo","Ashley","Occupational Health Services, The Rockefeller University, New York, NY, United States of America",NA
"1060","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Sakmar","Thomas P","Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, United States of America",NA
"1061","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Huffman","Virginia","Human Resources, The Rockefeller University, New York, NY, United States of America",NA
"1062","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Bergh","Marissa","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1063","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Goldfarb","Audrey","Laboratory of Cell Biology and Genetics, The Rockefeller University, New York, NY, United States of America",NA
"1064","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Mansisidor","Andres","Laboratory of Genome Architecture and Dynamics, The Rockefeller University, New York, NY, United States of America",NA
"1065","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Patriotis","Agata L","Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY, United States of America",NA
"1066","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Palmquist","Karl H","Laboratory of Morphogenesis, The Rockefeller University, New York, NY, United States of America",NA
"1067","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Poulton","Nicolas","Laboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, United States of America",NA
"1068","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Leicher","Rachel","Laboratory of Nanoscale Biophysics and Biochemistry, The Rockefeller University, New York, NY, United States of America",NA
"1069","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Vargas","César D M","Laboratory of Neurogenetics of Language, The Rockefeller University, New York, NY, United States of America",NA
"1070","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Duba","Irene","Laboratory of Genome Architecture and Dynamics, The Rockefeller University, New York, NY, United States of America",NA
"1071","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Hurley","Arlene","Rockefeller University Hospital, The Rockefeller University, New York, NY, United States of America",NA
"1072","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Colagreco","Joseph","Leonard Wagner Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY, United States of America",NA
"1073","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Pagane","Nicole","Laboratory of Genome Architecture and Dynamics, The Rockefeller University, New York, NY, United States of America",NA
"1074","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Orange","Dana E","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1075","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Mora","Kevin","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1076","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Rakeman","Jennifer L","Public Health Laboratory, New York City Department of Health and Health and Mental Hygiene, New York, NY, United States of America",NA
"1077","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Fowler","Randal C","Public Health Laboratory, New York City Department of Health and Health and Mental Hygiene, New York, NY, United States of America",NA
"1078","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Fernandes","Helen","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1079","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Lamendola-Essel","Michelle F","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1080","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Didkovsky","Nicholas","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1081","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Silvera","Leopolda","Elmhurst Hospital Center, New York City Health and Hospitals, Elmhurst, NY, United States of America",NA
"1082","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Masci","Joseph","Elmhurst Hospital Center, New York City Health and Hospitals, Elmhurst, NY, United States of America",NA
"1083","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Allen","Machelle","Elmhurst Hospital Center, New York City Health and Hospitals, Elmhurst, NY, United States of America",NA
"1084","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Rice","Charles M","Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, United States of America",NA
"1085","34170927","10.1371/journal.pone.0252949","DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2.","To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 µl saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/µl in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature u","2021","07","05","PLoS One","PloS one","COVID-19; COVID-19 Nucleic Acid Testing; Child; Female; Humans; Male; SARS-CoV-2; Saliva; Schools; Specimen Handling","Darnell","Robert B","Laboratory of Molecular Neuro-oncology, The Rockefeller University, New York, NY, United States of America",NA
"1086","34170910","10.1371/journal.pone.0242471","Risk perceptions and preventive practices of COVID-19 among healthcare professionals in public hospitals in Addis Ababa, Ethiopia.","Healthcare professionals are at higher risk of contracting the new coronavirus disease 2019 (COVID-19). Although appropriate preventive measures are the most important interventions to prevent coronavirus infection among healthcare workers, they are also highly concerned about the consequences of the pandemic. The aim of this cross-sectional study was to assess preventive practices, perceived risk and worry about COVID-19 crisis among healthcare professionals at six public hospitals in Addis Aba","2021","07","05","PLoS One","PloS one","Adult; COVID-19; Cross-Sectional Studies; Ethiopia; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Hospitals, Public; Humans; Male; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Deressa","Wakgari","Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia",NA
"1087","34170910","10.1371/journal.pone.0242471","Risk perceptions and preventive practices of COVID-19 among healthcare professionals in public hospitals in Addis Ababa, Ethiopia.","Healthcare professionals are at higher risk of contracting the new coronavirus disease 2019 (COVID-19). Although appropriate preventive measures are the most important interventions to prevent coronavirus infection among healthcare workers, they are also highly concerned about the consequences of the pandemic. The aim of this cross-sectional study was to assess preventive practices, perceived risk and worry about COVID-19 crisis among healthcare professionals at six public hospitals in Addis Aba","2021","07","05","PLoS One","PloS one","Adult; COVID-19; Cross-Sectional Studies; Ethiopia; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Hospitals, Public; Humans; Male; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Worku","Alemayehu","Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia",NA
"1088","34170910","10.1371/journal.pone.0242471","Risk perceptions and preventive practices of COVID-19 among healthcare professionals in public hospitals in Addis Ababa, Ethiopia.","Healthcare professionals are at higher risk of contracting the new coronavirus disease 2019 (COVID-19). Although appropriate preventive measures are the most important interventions to prevent coronavirus infection among healthcare workers, they are also highly concerned about the consequences of the pandemic. The aim of this cross-sectional study was to assess preventive practices, perceived risk and worry about COVID-19 crisis among healthcare professionals at six public hospitals in Addis Aba","2021","07","05","PLoS One","PloS one","Adult; COVID-19; Cross-Sectional Studies; Ethiopia; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Hospitals, Public; Humans; Male; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Abebe","Workeabeba","Department of Pediatrics and Child Health, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia",NA
"1089","34170910","10.1371/journal.pone.0242471","Risk perceptions and preventive practices of COVID-19 among healthcare professionals in public hospitals in Addis Ababa, Ethiopia.","Healthcare professionals are at higher risk of contracting the new coronavirus disease 2019 (COVID-19). Although appropriate preventive measures are the most important interventions to prevent coronavirus infection among healthcare workers, they are also highly concerned about the consequences of the pandemic. The aim of this cross-sectional study was to assess preventive practices, perceived risk and worry about COVID-19 crisis among healthcare professionals at six public hospitals in Addis Aba","2021","07","05","PLoS One","PloS one","Adult; COVID-19; Cross-Sectional Studies; Ethiopia; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Hospitals, Public; Humans; Male; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Gizaw","Muluken","Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia",NA
"1090","34170910","10.1371/journal.pone.0242471","Risk perceptions and preventive practices of COVID-19 among healthcare professionals in public hospitals in Addis Ababa, Ethiopia.","Healthcare professionals are at higher risk of contracting the new coronavirus disease 2019 (COVID-19). Although appropriate preventive measures are the most important interventions to prevent coronavirus infection among healthcare workers, they are also highly concerned about the consequences of the pandemic. The aim of this cross-sectional study was to assess preventive practices, perceived risk and worry about COVID-19 crisis among healthcare professionals at six public hospitals in Addis Aba","2021","07","05","PLoS One","PloS one","Adult; COVID-19; Cross-Sectional Studies; Ethiopia; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Hospitals, Public; Humans; Male; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Amogne","Wondwossen","Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia",NA
"1091","34170891","","Exploring Cancer Registrars' Perceptions of the Quality and Use of Cancer Registry Data for Care Coordination and Other Purposes.","Hospital cancer registry data are used for a variety of aspects of patient care, yet one of the lesser used purposes of cancer registry data is to improve care coordination. The purposes of this study were to assess hospital cancer registrars' perceptions of (1) the use of and quality of hospital cancer registry data for care coordination and other purposes; (2) the availability of all needed data for complete hospital cancer registry data collection; and (3) the data collection of COVID-19 effe","2021","06","29","J Registry Manag","Journal of registry management","COVID-19 pandemic; cancer registry data; care coordination; data quality; data use; hospital cancer registry; COVID-19; Data Collection; Humans; Neoplasms; Perception; Registries; SARS-CoV-2","Peterson","Jennifer",NA,NA
"1092","34170891","","Exploring Cancer Registrars' Perceptions of the Quality and Use of Cancer Registry Data for Care Coordination and Other Purposes.","Hospital cancer registry data are used for a variety of aspects of patient care, yet one of the lesser used purposes of cancer registry data is to improve care coordination. The purposes of this study were to assess hospital cancer registrars' perceptions of (1) the use of and quality of hospital cancer registry data for care coordination and other purposes; (2) the availability of all needed data for complete hospital cancer registry data collection; and (3) the data collection of COVID-19 effe","2021","06","29","J Registry Manag","Journal of registry management","COVID-19 pandemic; cancer registry data; care coordination; data quality; data use; hospital cancer registry; COVID-19; Data Collection; Humans; Neoplasms; Perception; Registries; SARS-CoV-2","Houser","Shannon H",NA,NA
"1093","34170891","","Exploring Cancer Registrars' Perceptions of the Quality and Use of Cancer Registry Data for Care Coordination and Other Purposes.","Hospital cancer registry data are used for a variety of aspects of patient care, yet one of the lesser used purposes of cancer registry data is to improve care coordination. The purposes of this study were to assess hospital cancer registrars' perceptions of (1) the use of and quality of hospital cancer registry data for care coordination and other purposes; (2) the availability of all needed data for complete hospital cancer registry data collection; and (3) the data collection of COVID-19 effe","2021","06","29","J Registry Manag","Journal of registry management","COVID-19 pandemic; cancer registry data; care coordination; data quality; data use; hospital cancer registry; COVID-19; Data Collection; Humans; Neoplasms; Perception; Registries; SARS-CoV-2","Flite","Cathy A",NA,NA
"1094","34170891","","Exploring Cancer Registrars' Perceptions of the Quality and Use of Cancer Registry Data for Care Coordination and Other Purposes.","Hospital cancer registry data are used for a variety of aspects of patient care, yet one of the lesser used purposes of cancer registry data is to improve care coordination. The purposes of this study were to assess hospital cancer registrars' perceptions of (1) the use of and quality of hospital cancer registry data for care coordination and other purposes; (2) the availability of all needed data for complete hospital cancer registry data collection; and (3) the data collection of COVID-19 effe","2021","06","29","J Registry Manag","Journal of registry management","COVID-19 pandemic; cancer registry data; care coordination; data quality; data use; hospital cancer registry; COVID-19; Data Collection; Humans; Neoplasms; Perception; Registries; SARS-CoV-2","Kinnerson","Lakesha",NA,NA
"1095","34170891","","Exploring Cancer Registrars' Perceptions of the Quality and Use of Cancer Registry Data for Care Coordination and Other Purposes.","Hospital cancer registry data are used for a variety of aspects of patient care, yet one of the lesser used purposes of cancer registry data is to improve care coordination. The purposes of this study were to assess hospital cancer registrars' perceptions of (1) the use of and quality of hospital cancer registry data for care coordination and other purposes; (2) the availability of all needed data for complete hospital cancer registry data collection; and (3) the data collection of COVID-19 effe","2021","06","29","J Registry Manag","Journal of registry management","COVID-19 pandemic; cancer registry data; care coordination; data quality; data use; hospital cancer registry; COVID-19; Data Collection; Humans; Neoplasms; Perception; Registries; SARS-CoV-2","Birchfield","Hannah",NA,NA
"1096","34170891","","Exploring Cancer Registrars' Perceptions of the Quality and Use of Cancer Registry Data for Care Coordination and Other Purposes.","Hospital cancer registry data are used for a variety of aspects of patient care, yet one of the lesser used purposes of cancer registry data is to improve care coordination. The purposes of this study were to assess hospital cancer registrars' perceptions of (1) the use of and quality of hospital cancer registry data for care coordination and other purposes; (2) the availability of all needed data for complete hospital cancer registry data collection; and (3) the data collection of COVID-19 effe","2021","06","29","J Registry Manag","Journal of registry management","COVID-19 pandemic; cancer registry data; care coordination; data quality; data use; hospital cancer registry; COVID-19; Data Collection; Humans; Neoplasms; Perception; Registries; SARS-CoV-2","Post","April",NA,NA
"1097","34170872","10.1097/01.NUMA.0000754120.29685.44","Perceptions of clinical leaders' abilities to lead COVID-19 clinics.",NA,"2021","07","01","Nurs Manage","Nursing management","Attitude of Health Personnel; COVID-19; Humans; Leadership; Nurse Administrators; Practice Patterns, Nurses'","Bernhardt","Jean M","In Boston, Mass., Jean M. Bernhardt is a nurse administrator and family NP at Massachusetts General Hospital and Elizabeth B. Benoit is an independent data analyst",NA
"1098","34170872","10.1097/01.NUMA.0000754120.29685.44","Perceptions of clinical leaders' abilities to lead COVID-19 clinics.",NA,"2021","07","01","Nurs Manage","Nursing management","Attitude of Health Personnel; COVID-19; Humans; Leadership; Nurse Administrators; Practice Patterns, Nurses'","Benoit","Elizabeth B","In Boston, Mass., Jean M. Bernhardt is a nurse administrator and family NP at Massachusetts General Hospital and Elizabeth B. Benoit is an independent data analyst",NA
"1099","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Atsawawaranunt","Kamolthip","Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand",NA
"1100","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Kochakarn","Theerarat","COVID-19 Network Investigations Alliance (CONI), Bangkok, Thailand",NA
"1101","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Kongklieng","Amornmas","Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand",NA
"1102","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Panwijitkul","Pakkaporn","Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand",NA
"1103","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Tragoolpua","Rujira","Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand",NA
"1104","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Jaradilokkul","Kanyarat","Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand",NA
"1105","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Kaewmalang","Prayuth","Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand",NA
"1106","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Loesbanluechai","Duangkamon","COVID-19 Network Investigations Alliance (CONI), Bangkok, Thailand",NA
"1107","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Kotanan","Namfon","COVID-19 Network Investigations Alliance (CONI), Bangkok, Thailand",NA
"1108","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Joonlasak","Khajohn","COVID-19 Network Investigations Alliance (CONI), Bangkok, Thailand",NA
"1109","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Batty","Elizabeth M","COVID-19 Network Investigations Alliance (CONI), Bangkok, Thailand",NA
"1110","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Mungaomklang","Anek","The Office of Disease Prevention and Control 4 Saraburi, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand",NA
"1111","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Pawun","Vichan","Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand",NA
"1112","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Chantratita","Wasun","COVID-19 Network Investigations Alliance (CONI), Bangkok, Thailand",NA
"1113","34170846","10.4269/ajtmh.21-0344","COVID-19 Transmission among Healthcare Workers at a Quarantine Facility in Thailand: Genomic and Outbreak Investigations.","During the COVID-19 pandemic, Thailand implemented a quarantine program at approved quarantine facilities for every international traveler. Here, we report an epidemiological and genomic investigation of a COVID-19 cluster consisting of seven healthcare workers (HCWs) at a quarantine facility and its partnered hospital in Thailand. Outbreak investigations were implemented to obtain contact tracing data and to establish chains of transmission. Genomic sequencing of SARS-CoV-2 with samples within ","2021","06","25","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Chookajorn","Thanat","COVID-19 Network Investigations Alliance (CONI), Bangkok, Thailand",NA
"1114","34170838","10.2196/29952","Measuring the Impact of COVID-19 on a Sample of Mental Health Patients: Results from the Siyan Epidemic-Pandemic Impacts Inventory.","Recent research has shown that the impacts of the COVID-19 pandemic and social isolation on people's mental health are quite extensive, but there are limited studies on the effects of the pandemic on patients with mental health disorders. The objective of the present study was to assess the negative impacts of the COVID-19 pandemic on individuals who have previously sought treatment for a mental health disorder. The current study uses the newly developed Epidemic-Pandemic Impacts Inventory (EPII","2021","06","25","JMIR Form Res","JMIR formative research",NA,"Shah","Anish","Siyan Clinical Corporation, 480 Tesconi Cir b, Santa Rosa, US",NA
"1115","34170838","10.2196/29952","Measuring the Impact of COVID-19 on a Sample of Mental Health Patients: Results from the Siyan Epidemic-Pandemic Impacts Inventory.","Recent research has shown that the impacts of the COVID-19 pandemic and social isolation on people's mental health are quite extensive, but there are limited studies on the effects of the pandemic on patients with mental health disorders. The objective of the present study was to assess the negative impacts of the COVID-19 pandemic on individuals who have previously sought treatment for a mental health disorder. The current study uses the newly developed Epidemic-Pandemic Impacts Inventory (EPII","2021","06","25","JMIR Form Res","JMIR formative research",NA,"Darling","Michele","LPC Consulting Associates, Sacramento, US",NA
"1116","34170838","10.2196/29952","Measuring the Impact of COVID-19 on a Sample of Mental Health Patients: Results from the Siyan Epidemic-Pandemic Impacts Inventory.","Recent research has shown that the impacts of the COVID-19 pandemic and social isolation on people's mental health are quite extensive, but there are limited studies on the effects of the pandemic on patients with mental health disorders. The objective of the present study was to assess the negative impacts of the COVID-19 pandemic on individuals who have previously sought treatment for a mental health disorder. The current study uses the newly developed Epidemic-Pandemic Impacts Inventory (EPII","2021","06","25","JMIR Form Res","JMIR formative research",NA,"Arstein-Kerslake","Olivia","LPC Consulting Associates, Sacramento, US",NA
"1117","34170838","10.2196/29952","Measuring the Impact of COVID-19 on a Sample of Mental Health Patients: Results from the Siyan Epidemic-Pandemic Impacts Inventory.","Recent research has shown that the impacts of the COVID-19 pandemic and social isolation on people's mental health are quite extensive, but there are limited studies on the effects of the pandemic on patients with mental health disorders. The objective of the present study was to assess the negative impacts of the COVID-19 pandemic on individuals who have previously sought treatment for a mental health disorder. The current study uses the newly developed Epidemic-Pandemic Impacts Inventory (EPII","2021","06","25","JMIR Form Res","JMIR formative research",NA,"Morgan","Tiffany","Siyan Clinical Corporation, 480 Tesconi Cir b, Santa Rosa, US",NA
"1118","34170838","10.2196/29952","Measuring the Impact of COVID-19 on a Sample of Mental Health Patients: Results from the Siyan Epidemic-Pandemic Impacts Inventory.","Recent research has shown that the impacts of the COVID-19 pandemic and social isolation on people's mental health are quite extensive, but there are limited studies on the effects of the pandemic on patients with mental health disorders. The objective of the present study was to assess the negative impacts of the COVID-19 pandemic on individuals who have previously sought treatment for a mental health disorder. The current study uses the newly developed Epidemic-Pandemic Impacts Inventory (EPII","2021","06","25","JMIR Form Res","JMIR formative research",NA,"Vance Tovrea","Aubreen","Siyan Clinical Corporation, 480 Tesconi Cir b, Santa Rosa, US",NA
"1119","34170838","10.2196/29952","Measuring the Impact of COVID-19 on a Sample of Mental Health Patients: Results from the Siyan Epidemic-Pandemic Impacts Inventory.","Recent research has shown that the impacts of the COVID-19 pandemic and social isolation on people's mental health are quite extensive, but there are limited studies on the effects of the pandemic on patients with mental health disorders. The objective of the present study was to assess the negative impacts of the COVID-19 pandemic on individuals who have previously sought treatment for a mental health disorder. The current study uses the newly developed Epidemic-Pandemic Impacts Inventory (EPII","2021","06","25","JMIR Form Res","JMIR formative research",NA,"Young","James","Siyan Clinical Corporation, 480 Tesconi Cir b, Santa Rosa, US",NA
"1120","34170838","10.2196/29952","Measuring the Impact of COVID-19 on a Sample of Mental Health Patients: Results from the Siyan Epidemic-Pandemic Impacts Inventory.","Recent research has shown that the impacts of the COVID-19 pandemic and social isolation on people's mental health are quite extensive, but there are limited studies on the effects of the pandemic on patients with mental health disorders. The objective of the present study was to assess the negative impacts of the COVID-19 pandemic on individuals who have previously sought treatment for a mental health disorder. The current study uses the newly developed Epidemic-Pandemic Impacts Inventory (EPII","2021","06","25","JMIR Form Res","JMIR formative research",NA,"Laines","Helen","Siyan Clinical Corporation, 480 Tesconi Cir b, Santa Rosa, US",NA
"1121","34170801","10.1080/01612840.2021.1931586","""It Was Never Enough"": The Meaning of Nurses' Experiences Caring for Patients during the COVID-19 Pandemic.","This study's aim was to understand nurses' caring experiences during the recent pandemic in the United States. Using an interpretive phenomenological approach, 15 participants provided the meaning of the care they provided. Five major themes were interpreted: If not us, then who?; Accepting uncertainty; It was never enough; Finding self and our voices in a new role; and Believing it was worth it. The study results have implications for psychiatric-mental health nurse clinici","2021","06","25","Issues Ment Health Nurs","Issues in mental health nursing",NA,"White","Jane H","Office of the Chief Nurse Executive, Institute for Nursing, Northwell Health, New Hyde Park, New York, USA",NA
"1122","34170793","10.1080/21645515.2021.1929695","Likelihood of COVID-19 vaccination by subgroups across the US: post-election trends and disparities.","The coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted older individuals, those with lower educational attainment, and Black and Hispanic populations, yet vaccine hesitancy remains prevalent. Because widespread uptake of COVID-19 vaccines is critical to end the pandemic, addressing vaccine hesitancy is an important public health priority. Between April 1, 2020 and March 16, 2021, we have repeatedly surveyed a nationally representative online panel of adults and have tra","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Black; COVID-19; Hispanic; disparities; older adults; racial/ethnic minorities; vaccination; vaccine hesitancy","Szilagyi","Peter G","Department of Pediatrics, UCLA Mattel Children's Hospital, University of California at Los Angeles, Los Angeles, CA, USA",NA
"1123","34170793","10.1080/21645515.2021.1929695","Likelihood of COVID-19 vaccination by subgroups across the US: post-election trends and disparities.","The coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted older individuals, those with lower educational attainment, and Black and Hispanic populations, yet vaccine hesitancy remains prevalent. Because widespread uptake of COVID-19 vaccines is critical to end the pandemic, addressing vaccine hesitancy is an important public health priority. Between April 1, 2020 and March 16, 2021, we have repeatedly surveyed a nationally representative online panel of adults and have tra","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Black; COVID-19; Hispanic; disparities; older adults; racial/ethnic minorities; vaccination; vaccine hesitancy","Thomas","Kyla","Dornsife College of Letters Arts and Sciences, Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA",NA
"1124","34170793","10.1080/21645515.2021.1929695","Likelihood of COVID-19 vaccination by subgroups across the US: post-election trends and disparities.","The coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted older individuals, those with lower educational attainment, and Black and Hispanic populations, yet vaccine hesitancy remains prevalent. Because widespread uptake of COVID-19 vaccines is critical to end the pandemic, addressing vaccine hesitancy is an important public health priority. Between April 1, 2020 and March 16, 2021, we have repeatedly surveyed a nationally representative online panel of adults and have tra","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Black; COVID-19; Hispanic; disparities; older adults; racial/ethnic minorities; vaccination; vaccine hesitancy","Shah","Megha D","Los Angeles County Department of Public Health, Office of Health Assessment and Epidemiology, Los Angeles, CA, USA",NA
"1125","34170793","10.1080/21645515.2021.1929695","Likelihood of COVID-19 vaccination by subgroups across the US: post-election trends and disparities.","The coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted older individuals, those with lower educational attainment, and Black and Hispanic populations, yet vaccine hesitancy remains prevalent. Because widespread uptake of COVID-19 vaccines is critical to end the pandemic, addressing vaccine hesitancy is an important public health priority. Between April 1, 2020 and March 16, 2021, we have repeatedly surveyed a nationally representative online panel of adults and have tra","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Black; COVID-19; Hispanic; disparities; older adults; racial/ethnic minorities; vaccination; vaccine hesitancy","Vizueta","Nathalie","Department of Pediatrics, UCLA Mattel Children's Hospital, University of California at Los Angeles, Los Angeles, CA, USA",NA
"1126","34170793","10.1080/21645515.2021.1929695","Likelihood of COVID-19 vaccination by subgroups across the US: post-election trends and disparities.","The coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted older individuals, those with lower educational attainment, and Black and Hispanic populations, yet vaccine hesitancy remains prevalent. Because widespread uptake of COVID-19 vaccines is critical to end the pandemic, addressing vaccine hesitancy is an important public health priority. Between April 1, 2020 and March 16, 2021, we have repeatedly surveyed a nationally representative online panel of adults and have tra","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Black; COVID-19; Hispanic; disparities; older adults; racial/ethnic minorities; vaccination; vaccine hesitancy","Cui","Yan","Los Angeles County Department of Public Health, Office of Health Assessment and Epidemiology, Los Angeles, CA, USA",NA
"1127","34170793","10.1080/21645515.2021.1929695","Likelihood of COVID-19 vaccination by subgroups across the US: post-election trends and disparities.","The coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted older individuals, those with lower educational attainment, and Black and Hispanic populations, yet vaccine hesitancy remains prevalent. Because widespread uptake of COVID-19 vaccines is critical to end the pandemic, addressing vaccine hesitancy is an important public health priority. Between April 1, 2020 and March 16, 2021, we have repeatedly surveyed a nationally representative online panel of adults and have tra","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Black; COVID-19; Hispanic; disparities; older adults; racial/ethnic minorities; vaccination; vaccine hesitancy","Vangala","Sitaram","Department of Medicine Statistics Core, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA",NA
"1128","34170793","10.1080/21645515.2021.1929695","Likelihood of COVID-19 vaccination by subgroups across the US: post-election trends and disparities.","The coronavirus disease 2019 (COVID-19) pandemic has disproportionately impacted older individuals, those with lower educational attainment, and Black and Hispanic populations, yet vaccine hesitancy remains prevalent. Because widespread uptake of COVID-19 vaccines is critical to end the pandemic, addressing vaccine hesitancy is an important public health priority. Between April 1, 2020 and March 16, 2021, we have repeatedly surveyed a nationally representative online panel of adults and have tra","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Black; COVID-19; Hispanic; disparities; older adults; racial/ethnic minorities; vaccination; vaccine hesitancy","Kapteyn","Arie","Dornsife College of Letters Arts and Sciences, Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA",NA
"1129","34170792","10.1080/21645515.2021.1933687","Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study.","Objective: The Theory of Planned Behavior (TPB) is one of the most robust models in explaining health-related behavior. In this study, we tested the extended TPB to predict university students' intentions to uptake COVID-19 vaccination.Methods: An online cross-sectional survey was developed to investigate students' intention to uptake the COVID-19 vaccine based on the components of the TPB (i.e., attitude, subjective norms, and perceived behavioral control) and extended components ","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; risk perception; theory of planned behavior; university students; vaccination uptake","Fan","Chia-Wei","Department of Occupational Therapy, AdventHealth University, Orlando, FL, USA",NA
"1130","34170792","10.1080/21645515.2021.1933687","Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study.","Objective: The Theory of Planned Behavior (TPB) is one of the most robust models in explaining health-related behavior. In this study, we tested the extended TPB to predict university students' intentions to uptake COVID-19 vaccination.Methods: An online cross-sectional survey was developed to investigate students' intention to uptake the COVID-19 vaccine based on the components of the TPB (i.e., attitude, subjective norms, and perceived behavioral control) and extended components ","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; risk perception; theory of planned behavior; university students; vaccination uptake","Chen","I-Hua","School of Education Science, Minnan Normal University, Zhangzhou, China",NA
"1131","34170792","10.1080/21645515.2021.1933687","Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study.","Objective: The Theory of Planned Behavior (TPB) is one of the most robust models in explaining health-related behavior. In this study, we tested the extended TPB to predict university students' intentions to uptake COVID-19 vaccination.Methods: An online cross-sectional survey was developed to investigate students' intention to uptake the COVID-19 vaccine based on the components of the TPB (i.e., attitude, subjective norms, and perceived behavioral control) and extended components ","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; risk perception; theory of planned behavior; university students; vaccination uptake","Ko","Nai-Ying","Department of Nursing, College of Medicine, National Cheng Kung University, Tainan, Taiwan",NA
"1132","34170792","10.1080/21645515.2021.1933687","Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study.","Objective: The Theory of Planned Behavior (TPB) is one of the most robust models in explaining health-related behavior. In this study, we tested the extended TPB to predict university students' intentions to uptake COVID-19 vaccination.Methods: An online cross-sectional survey was developed to investigate students' intention to uptake the COVID-19 vaccine based on the components of the TPB (i.e., attitude, subjective norms, and perceived behavioral control) and extended components ","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; risk perception; theory of planned behavior; university students; vaccination uptake","Yen","Cheng-Fang","Department of Psychiatry, Kaohsiung Medical University Hospital &amp",NA
"1133","34170792","10.1080/21645515.2021.1933687","Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study.","Objective: The Theory of Planned Behavior (TPB) is one of the most robust models in explaining health-related behavior. In this study, we tested the extended TPB to predict university students' intentions to uptake COVID-19 vaccination.Methods: An online cross-sectional survey was developed to investigate students' intention to uptake the COVID-19 vaccine based on the components of the TPB (i.e., attitude, subjective norms, and perceived behavioral control) and extended components ","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; risk perception; theory of planned behavior; university students; vaccination uptake","Lin","Chung-Ying","Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan",NA
"1134","34170792","10.1080/21645515.2021.1933687","Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study.","Objective: The Theory of Planned Behavior (TPB) is one of the most robust models in explaining health-related behavior. In this study, we tested the extended TPB to predict university students' intentions to uptake COVID-19 vaccination.Methods: An online cross-sectional survey was developed to investigate students' intention to uptake the COVID-19 vaccine based on the components of the TPB (i.e., attitude, subjective norms, and perceived behavioral control) and extended components ","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; risk perception; theory of planned behavior; university students; vaccination uptake","Griffiths","Mark D","International Gaming Research Unit, Psychology Department, Nottingham Trent University, Nottingham, UK",NA
"1135","34170792","10.1080/21645515.2021.1933687","Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study.","Objective: The Theory of Planned Behavior (TPB) is one of the most robust models in explaining health-related behavior. In this study, we tested the extended TPB to predict university students' intentions to uptake COVID-19 vaccination.Methods: An online cross-sectional survey was developed to investigate students' intention to uptake the COVID-19 vaccine based on the components of the TPB (i.e., attitude, subjective norms, and perceived behavioral control) and extended components ","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; risk perception; theory of planned behavior; university students; vaccination uptake","Pakpour","Amir H","Department of Nursing, School of Health and Welfare, Jönköping University, Jönköping, Sweden",NA
"1136","34170791","10.1080/21645515.2021.1925502","Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.","Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects approximately 20% of children and 10% of adults. The implication of vaccines as a trigger for the de novo onset of AD in children or as a cause of exacerbation in individuals with a history of AD has long been debated. We present a brief review of the literature on AD and traditional vaccinations, proposing in addition the main recommendations for the management of patients with AD undergoing the vaccine against the SARS-","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Atopic dermatitis; covid-19; dermatologist; dermatology; recommendations; vaccination; vaccine","Simonetti","Oriana","Dermatological Clinic Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy",NA
"1137","34170791","10.1080/21645515.2021.1925502","Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.","Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects approximately 20% of children and 10% of adults. The implication of vaccines as a trigger for the de novo onset of AD in children or as a cause of exacerbation in individuals with a history of AD has long been debated. We present a brief review of the literature on AD and traditional vaccinations, proposing in addition the main recommendations for the management of patients with AD undergoing the vaccine against the SARS-","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Atopic dermatitis; covid-19; dermatologist; dermatology; recommendations; vaccination; vaccine","Radi","Giulia","Dermatological Clinic Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy",NA
"1138","34170791","10.1080/21645515.2021.1925502","Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.","Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects approximately 20% of children and 10% of adults. The implication of vaccines as a trigger for the de novo onset of AD in children or as a cause of exacerbation in individuals with a history of AD has long been debated. We present a brief review of the literature on AD and traditional vaccinations, proposing in addition the main recommendations for the management of patients with AD undergoing the vaccine against the SARS-","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Atopic dermatitis; covid-19; dermatologist; dermatology; recommendations; vaccination; vaccine","Molinelli","Elisa","Dermatological Clinic Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy",NA
"1139","34170791","10.1080/21645515.2021.1925502","Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.","Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects approximately 20% of children and 10% of adults. The implication of vaccines as a trigger for the de novo onset of AD in children or as a cause of exacerbation in individuals with a history of AD has long been debated. We present a brief review of the literature on AD and traditional vaccinations, proposing in addition the main recommendations for the management of patients with AD undergoing the vaccine against the SARS-","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Atopic dermatitis; covid-19; dermatologist; dermatology; recommendations; vaccination; vaccine","Rizzetto","Giulio","Dermatological Clinic Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy",NA
"1140","34170791","10.1080/21645515.2021.1925502","Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.","Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects approximately 20% of children and 10% of adults. The implication of vaccines as a trigger for the de novo onset of AD in children or as a cause of exacerbation in individuals with a history of AD has long been debated. We present a brief review of the literature on AD and traditional vaccinations, proposing in addition the main recommendations for the management of patients with AD undergoing the vaccine against the SARS-","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Atopic dermatitis; covid-19; dermatologist; dermatology; recommendations; vaccination; vaccine","Diotallevi","Federico","Dermatological Clinic Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy",NA
"1141","34170791","10.1080/21645515.2021.1925502","Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.","Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects approximately 20% of children and 10% of adults. The implication of vaccines as a trigger for the de novo onset of AD in children or as a cause of exacerbation in individuals with a history of AD has long been debated. We present a brief review of the literature on AD and traditional vaccinations, proposing in addition the main recommendations for the management of patients with AD undergoing the vaccine against the SARS-","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Atopic dermatitis; covid-19; dermatologist; dermatology; recommendations; vaccination; vaccine","Offidani","Annamaria","Dermatological Clinic Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy",NA
"1142","34170790","10.1080/21645515.2021.1936862","Vaccine certificate during domestic traveling: a potential initiative to prevent COVID-19 waves in India.","India, the second-most populous country in the world, is struggling with the second wave of the COVID-19 triggered by SARS-CoV-2. This letter aims to highlight the necessity of the vaccine certificate during nationwide traveling to prevent further waves of the COVID-19 in the different states of India. Such policies have already been in existence for international travel termed as vaccine passports. The compulsory vaccine certificates need to be in existence to prevent the rapid spread of the CO","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Co-WIN; India; SARS-CoV-2; traveling; vaccine certificate","Choudhary","Om Prakash","Department of Veterinary Anatomy and Histology, College of Veterinary Sciences and Animal Husbandry, Central Agricultural University (I), Aizawl, India",NA
"1143","34170790","10.1080/21645515.2021.1936862","Vaccine certificate during domestic traveling: a potential initiative to prevent COVID-19 waves in India.","India, the second-most populous country in the world, is struggling with the second wave of the COVID-19 triggered by SARS-CoV-2. This letter aims to highlight the necessity of the vaccine certificate during nationwide traveling to prevent further waves of the COVID-19 in the different states of India. Such policies have already been in existence for international travel termed as vaccine passports. The compulsory vaccine certificates need to be in existence to prevent the rapid spread of the CO","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Co-WIN; India; SARS-CoV-2; traveling; vaccine certificate","Priyanka","Independent Researcher, 07, Type IV Quarter, College of Veterinary Sciences and Animal Husbandry, Central Agricultural University (I), Aizawl, India","Department of Veterinary Anatomy and Histology, College of Veterinary Sciences and Animal Husbandry, Central Agricultural University (I), Aizawl, India","34170790"
"1144","34170790","10.1080/21645515.2021.1936862","Vaccine certificate during domestic traveling: a potential initiative to prevent COVID-19 waves in India.","India, the second-most populous country in the world, is struggling with the second wave of the COVID-19 triggered by SARS-CoV-2. This letter aims to highlight the necessity of the vaccine certificate during nationwide traveling to prevent further waves of the COVID-19 in the different states of India. Such policies have already been in existence for international travel termed as vaccine passports. The compulsory vaccine certificates need to be in existence to prevent the rapid spread of the CO","2021","06","25","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Co-WIN; India; SARS-CoV-2; traveling; vaccine certificate","Singh","Indraj","Community Health Centre, Saharanpur, India",NA
"1145","34170789","10.1164/rccm.202008-3044IM","Lung Recruiting Effect of Prone Positioning in Spontaneously Breathing COVID-19 Patients Assessed by Electrical Impedance Tomography.",NA,"2021","06","25","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19; SARS-CoV-2; electrical impedance tomography; lung recruitment; prone positioning","Brunin","Yannick","Centre Hospitalier Universitaire de Besançon, 55049, Department of Anesthesiology and Intensive Care Medicine, Besancon, France",NA
"1146","34170789","10.1164/rccm.202008-3044IM","Lung Recruiting Effect of Prone Positioning in Spontaneously Breathing COVID-19 Patients Assessed by Electrical Impedance Tomography.",NA,"2021","06","25","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19; SARS-CoV-2; electrical impedance tomography; lung recruitment; prone positioning","Despres","Cyrielle","Centre Hospitalier Universitaire de Besançon, 55049, Departement of Anesthesiology and Intensive Care Medicine, Besancon, France",NA
"1147","34170789","10.1164/rccm.202008-3044IM","Lung Recruiting Effect of Prone Positioning in Spontaneously Breathing COVID-19 Patients Assessed by Electrical Impedance Tomography.",NA,"2021","06","25","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19; SARS-CoV-2; electrical impedance tomography; lung recruitment; prone positioning","Pili-Floury","Sebastien","Centre Hospitalier Universitaire de Besançon, 55049, Departement of Anesthesiology and Intensive Care Medicine, Besancon, France",NA
"1148","34170789","10.1164/rccm.202008-3044IM","Lung Recruiting Effect of Prone Positioning in Spontaneously Breathing COVID-19 Patients Assessed by Electrical Impedance Tomography.",NA,"2021","06","25","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19; SARS-CoV-2; electrical impedance tomography; lung recruitment; prone positioning","Besch","Guillaume","Centre Hospitalier Universitaire de Besançon, 55049, Departement of Anesthesiology and Intensive Care Medicine, Besancon, France",NA
"1149","34170788","10.1080/21645515.2021.1943988","COVID-19 vaccine development from the perspective of cancer patients.","Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patients at various stages, so the safety and effectiveness on cancer patients is unknown. This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID-19 vaccines","2021","07","20","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; COVID-19 vaccine; Cancer patients; SARS-CoV-2; clinical trials; immunosuppression","He","Yang","Department of Gynecological Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1150","34170788","10.1080/21645515.2021.1943988","COVID-19 vaccine development from the perspective of cancer patients.","Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patients at various stages, so the safety and effectiveness on cancer patients is unknown. This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID-19 vaccines","2021","07","20","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; COVID-19 vaccine; Cancer patients; SARS-CoV-2; clinical trials; immunosuppression","Ding","Yi","Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1151","34170788","10.1080/21645515.2021.1943988","COVID-19 vaccine development from the perspective of cancer patients.","Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patients at various stages, so the safety and effectiveness on cancer patients is unknown. This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID-19 vaccines","2021","07","20","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; COVID-19 vaccine; Cancer patients; SARS-CoV-2; clinical trials; immunosuppression","Cao","Bo","Department of Gynecological Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1152","34170788","10.1080/21645515.2021.1943988","COVID-19 vaccine development from the perspective of cancer patients.","Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patients at various stages, so the safety and effectiveness on cancer patients is unknown. This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID-19 vaccines","2021","07","20","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; COVID-19 vaccine; Cancer patients; SARS-CoV-2; clinical trials; immunosuppression","Huang","Yi","Department of Gynecological Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1153","34170788","10.1080/21645515.2021.1943988","COVID-19 vaccine development from the perspective of cancer patients.","Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patients at various stages, so the safety and effectiveness on cancer patients is unknown. This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID-19 vaccines","2021","07","20","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; COVID-19 vaccine; Cancer patients; SARS-CoV-2; clinical trials; immunosuppression","Wang","Xiao","Department of Radiation Oncology, Rutgers-Cancer Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA",NA
"1154","34170785","10.1080/07317115.2021.1937424","Strategies and actions to enable meaningful family connections in nursing homes during the COVID-19: A Scoping Review.","Objectives: To better understand the impact of visitor restrictions on nursing home residents and their families as well as strategies and actions that were conducted in nursing homes during the COVID-19 pandemic.Methods: A scoping review was carried out in October 2020. Several electronic databases were used: Cochrane Plus, Scopus, Web of Sciences and PubMed. 725 results were identified. We included 10 articles.Results: Thematic analysis obtained the following categories: t","2021","06","25","Clin Gerontol","Clinical gerontologist","Aging; Caregivers; Family; Health Care Providers; Long-term Care Facility; Older Adults; Social Isolation; Social Participation; Well-being; caregivers; caregiving; elderly; gerontology; health; international aging; interventions; long-term care; nursing","Veiga-Seijo","Raquel","Department of Health Sciences, Faculty of Nursery and Podiatry, Ferrol Campus, Universidade da Coruña (University of A Coruña),Ferrol,A Coruña, Spain",NA
"1155","34170785","10.1080/07317115.2021.1937424","Strategies and actions to enable meaningful family connections in nursing homes during the COVID-19: A Scoping Review.","Objectives: To better understand the impact of visitor restrictions on nursing home residents and their families as well as strategies and actions that were conducted in nursing homes during the COVID-19 pandemic.Methods: A scoping review was carried out in October 2020. Several electronic databases were used: Cochrane Plus, Scopus, Web of Sciences and PubMed. 725 results were identified. We included 10 articles.Results: Thematic analysis obtained the following categories: t","2021","06","25","Clin Gerontol","Clinical gerontologist","Aging; Caregivers; Family; Health Care Providers; Long-term Care Facility; Older Adults; Social Isolation; Social Participation; Well-being; caregivers; caregiving; elderly; gerontology; health; international aging; interventions; long-term care; nursing","Miranda-Duro","María Del Carmen","CITIC(Centre for Information and Communications Technology Research),TALIONIS Group,Elviña Campus, Universidade da Coruña (University of A Coruña), A Coruña, Spain",NA
"1156","34170785","10.1080/07317115.2021.1937424","Strategies and actions to enable meaningful family connections in nursing homes during the COVID-19: A Scoping Review.","Objectives: To better understand the impact of visitor restrictions on nursing home residents and their families as well as strategies and actions that were conducted in nursing homes during the COVID-19 pandemic.Methods: A scoping review was carried out in October 2020. Several electronic databases were used: Cochrane Plus, Scopus, Web of Sciences and PubMed. 725 results were identified. We included 10 articles.Results: Thematic analysis obtained the following categories: t","2021","06","25","Clin Gerontol","Clinical gerontologist","Aging; Caregivers; Family; Health Care Providers; Long-term Care Facility; Older Adults; Social Isolation; Social Participation; Well-being; caregivers; caregiving; elderly; gerontology; health; international aging; interventions; long-term care; nursing","Veiga-Seijo","Silvia","Department of Health Sciences, Faculty of Health Sciences, Oza Campus, Universidade da Coruña (University of A Coruña), A Coruña, Spain",NA
"1157","34170781","10.1513/AnnalsATS.202103-364OC","Incidence, Characteristics, and Outcomes of Ventilator-Associated Events during the COVID-19 Pandemic.","Ventilator-associated event (VAE) surveillance provides an objective means to measure and compare complications that develop during mechanical ventilation by identifying patients with sustained increases in ventilator settings after a period of stable or decreasing ventilator settings. The impact of the Covid-19 pandemic on VAE rates and characteristics is unknown. To compare the incidence, causes, and outcomes of VAE during the Covid-19 pandemic year vs pre-pandemic years and amongst ventilated","2021","06","25","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Weinberger","Jeremy","Brigham and Women's Hospital, 1861, Pulmonary and Critical Care , Boston, Massachusetts, United States","jweinberger@bwh.harvard.edu"
"1158","34170781","10.1513/AnnalsATS.202103-364OC","Incidence, Characteristics, and Outcomes of Ventilator-Associated Events during the COVID-19 Pandemic.","Ventilator-associated event (VAE) surveillance provides an objective means to measure and compare complications that develop during mechanical ventilation by identifying patients with sustained increases in ventilator settings after a period of stable or decreasing ventilator settings. The impact of the Covid-19 pandemic on VAE rates and characteristics is unknown. To compare the incidence, causes, and outcomes of VAE during the Covid-19 pandemic year vs pre-pandemic years and amongst ventilated","2021","06","25","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Rhee","Chanu","Harvard Medical School, 1811, Department of Population Medicine, Boston, Massachusetts, United States",NA
"1159","34170781","10.1513/AnnalsATS.202103-364OC","Incidence, Characteristics, and Outcomes of Ventilator-Associated Events during the COVID-19 Pandemic.","Ventilator-associated event (VAE) surveillance provides an objective means to measure and compare complications that develop during mechanical ventilation by identifying patients with sustained increases in ventilator settings after a period of stable or decreasing ventilator settings. The impact of the Covid-19 pandemic on VAE rates and characteristics is unknown. To compare the incidence, causes, and outcomes of VAE during the Covid-19 pandemic year vs pre-pandemic years and amongst ventilated","2021","06","25","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Klompas","Michael","Harvard Medical School, 1811, Department of Population Medicine, Boston, Massachusetts, United States",NA
"1160","34170732","10.12968/bjon.2021.30.12.742","Emergency management of neck stoma patients during the coronavirus pandemic: a national nurse survey.","Neck stoma patient care involves significant clinical complexity. Inadequate staff training, equipment provision and infrastructure have all been highlighted as causes for avoidable patient harm. To establish the perception of knowledge and confidence levels relating to the emergency management of neck stomas among UK nurses during the COVID-19 pandemic. A nationwide prospective electronic survey of both primary and secondary care nurses via the Royal College of Nursing and social media. 402 res","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; Education; Laryngectomy; Management; Nursing; Tracheostomy; COVID-19; Emergency Nursing; Health Care Surveys; Humans; Pandemics; Prospective Studies; Tracheostomy; United Kingdom","Senior","Andrew","ENT Registrar, Birmingham Women's and Children's NHS Foundation Trust",NA
"1161","34170732","10.12968/bjon.2021.30.12.742","Emergency management of neck stoma patients during the coronavirus pandemic: a national nurse survey.","Neck stoma patient care involves significant clinical complexity. Inadequate staff training, equipment provision and infrastructure have all been highlighted as causes for avoidable patient harm. To establish the perception of knowledge and confidence levels relating to the emergency management of neck stomas among UK nurses during the COVID-19 pandemic. A nationwide prospective electronic survey of both primary and secondary care nurses via the Royal College of Nursing and social media. 402 res","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; Education; Laryngectomy; Management; Nursing; Tracheostomy; COVID-19; Emergency Nursing; Health Care Surveys; Humans; Pandemics; Prospective Studies; Tracheostomy; United Kingdom","Chan","Jacquline","ENT Registrar, Princess Royal hospital, Telford",NA
"1162","34170732","10.12968/bjon.2021.30.12.742","Emergency management of neck stoma patients during the coronavirus pandemic: a national nurse survey.","Neck stoma patient care involves significant clinical complexity. Inadequate staff training, equipment provision and infrastructure have all been highlighted as causes for avoidable patient harm. To establish the perception of knowledge and confidence levels relating to the emergency management of neck stomas among UK nurses during the COVID-19 pandemic. A nationwide prospective electronic survey of both primary and secondary care nurses via the Royal College of Nursing and social media. 402 res","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; Education; Laryngectomy; Management; Nursing; Tracheostomy; COVID-19; Emergency Nursing; Health Care Surveys; Humans; Pandemics; Prospective Studies; Tracheostomy; United Kingdom","Brookes","Kim","Head and Neck Clinical Nurse Specialist, Royal Wolverhampton New Cross Hospital, Wolverhampton",NA
"1163","34170732","10.12968/bjon.2021.30.12.742","Emergency management of neck stoma patients during the coronavirus pandemic: a national nurse survey.","Neck stoma patient care involves significant clinical complexity. Inadequate staff training, equipment provision and infrastructure have all been highlighted as causes for avoidable patient harm. To establish the perception of knowledge and confidence levels relating to the emergency management of neck stomas among UK nurses during the COVID-19 pandemic. A nationwide prospective electronic survey of both primary and secondary care nurses via the Royal College of Nursing and social media. 402 res","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; Education; Laryngectomy; Management; Nursing; Tracheostomy; COVID-19; Emergency Nursing; Health Care Surveys; Humans; Pandemics; Prospective Studies; Tracheostomy; United Kingdom","Jolly","Karan","ENT Registrar, Princess Royal Hospital, Telford",NA
"1164","34170732","10.12968/bjon.2021.30.12.742","Emergency management of neck stoma patients during the coronavirus pandemic: a national nurse survey.","Neck stoma patient care involves significant clinical complexity. Inadequate staff training, equipment provision and infrastructure have all been highlighted as causes for avoidable patient harm. To establish the perception of knowledge and confidence levels relating to the emergency management of neck stomas among UK nurses during the COVID-19 pandemic. A nationwide prospective electronic survey of both primary and secondary care nurses via the Royal College of Nursing and social media. 402 res","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; Education; Laryngectomy; Management; Nursing; Tracheostomy; COVID-19; Emergency Nursing; Health Care Surveys; Humans; Pandemics; Prospective Studies; Tracheostomy; United Kingdom","Darr","Adnan","ENT Registrar, Princess Royal Hospital, Telford",NA
"1165","34170732","10.12968/bjon.2021.30.12.742","Emergency management of neck stoma patients during the coronavirus pandemic: a national nurse survey.","Neck stoma patient care involves significant clinical complexity. Inadequate staff training, equipment provision and infrastructure have all been highlighted as causes for avoidable patient harm. To establish the perception of knowledge and confidence levels relating to the emergency management of neck stomas among UK nurses during the COVID-19 pandemic. A nationwide prospective electronic survey of both primary and secondary care nurses via the Royal College of Nursing and social media. 402 res","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; Education; Laryngectomy; Management; Nursing; Tracheostomy; COVID-19; Emergency Nursing; Health Care Surveys; Humans; Pandemics; Prospective Studies; Tracheostomy; United Kingdom","Ameen","Rohan","ENT Senior House Officer, Princess Royal Hospital, Telford",NA
"1166","34170731","10.12968/bjon.2021.30.12.763","Can we reduce the risk of burnout?","Sam Foster, Chief Nurse, Oxford University Hospitals, considers the concerns raised regarding staff shortages, excessive workloads and burnout, exacerbated by the COVID-19 pandemic.","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Burnout, Professional; COVID-19; England; Hospitals, University; Humans; Nursing Staff, Hospital; Pandemics; Risk Assessment","Foster","Sam","Chief Nurse, Oxford University Hospitals",NA
"1167","34170724","10.12968/bjon.2021.30.12.734","Redeployment during the first wave of the COVID-19 pandemic: implications for a clinical research workforce.","Health professionals are considered a group vulnerable to developing mental health symptoms during a pandemic, with redeployment being a risk factor. However, previous literature suggests workplace communication can be a protective element. An audit aimed to evaluate NHS research staff's experiences of redeployment in order to provide suggestions for future improvements in the process. A questionnaire was disseminated to all staff in the clinical research directorate of an NHS trust. Responses w","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; Communication; Negative psychological outcomes; Pandemic; Redeployment; COVID-19; Clinical Nursing Research; Health Workforce; Humans; Pandemics; United Kingdom","Walker","Kathryn Louise","Newcastle Clinical Ageing Research Unit, Campus for Ageing and Vitality, Newcastle upon Tyne",NA
"1168","34170724","10.12968/bjon.2021.30.12.734","Redeployment during the first wave of the COVID-19 pandemic: implications for a clinical research workforce.","Health professionals are considered a group vulnerable to developing mental health symptoms during a pandemic, with redeployment being a risk factor. However, previous literature suggests workplace communication can be a protective element. An audit aimed to evaluate NHS research staff's experiences of redeployment in order to provide suggestions for future improvements in the process. A questionnaire was disseminated to all staff in the clinical research directorate of an NHS trust. Responses w","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","COVID-19; Communication; Negative psychological outcomes; Pandemic; Redeployment; COVID-19; Clinical Nursing Research; Health Workforce; Humans; Pandemics; United Kingdom","Gerakios","Florence","Newcastle Clinical Ageing Research Unit, Campus for Ageing and Vitality, Newcastle upon Tyne",NA
"1169","34170721","10.12968/bjon.2021.30.12.730","COVID-19 and adult congenital heart disease services: impact on support and advice from nurse specialists.","Although the focus on service provision in response to the COVID-19 pandemic has mainly been on acute and particularly intensive care, it is important to consider other services that are still needed. This is especially the case for vulnerable patients with long-term conditions, such as those under the care of an adult congenital heart disease (ACHD) service. The authors conducted a survey of ACHD nurse specialists in centres across the UK to acertain what they were planning in terms of the rede","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Clinical nurse specialist; Congenital heart disease; Long-term conditions; Nurse-led advice lines; Adult; COVID-19; Health Services Accessibility; Heart Defects, Congenital; Humans; Nurse Specialists; Pandemics; United Kingdom","Anthony","James","Clinical Nurse Specialist in Adult Congenital Heart Disease, Adult Congenital Heart Disease Unit, University Hospitals Birmingham NHS Foundation Trust",NA
"1170","34170721","10.12968/bjon.2021.30.12.730","COVID-19 and adult congenital heart disease services: impact on support and advice from nurse specialists.","Although the focus on service provision in response to the COVID-19 pandemic has mainly been on acute and particularly intensive care, it is important to consider other services that are still needed. This is especially the case for vulnerable patients with long-term conditions, such as those under the care of an adult congenital heart disease (ACHD) service. The authors conducted a survey of ACHD nurse specialists in centres across the UK to acertain what they were planning in terms of the rede","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Clinical nurse specialist; Congenital heart disease; Long-term conditions; Nurse-led advice lines; Adult; COVID-19; Health Services Accessibility; Heart Defects, Congenital; Humans; Nurse Specialists; Pandemics; United Kingdom","Prabhakar","Chethan Ram Kasargod","International Fellow, Adult Congenital Heart Disease Unit, University Hospitals Birmingham NHS Foundation Trust",NA
"1171","34170721","10.12968/bjon.2021.30.12.730","COVID-19 and adult congenital heart disease services: impact on support and advice from nurse specialists.","Although the focus on service provision in response to the COVID-19 pandemic has mainly been on acute and particularly intensive care, it is important to consider other services that are still needed. This is especially the case for vulnerable patients with long-term conditions, such as those under the care of an adult congenital heart disease (ACHD) service. The authors conducted a survey of ACHD nurse specialists in centres across the UK to acertain what they were planning in terms of the rede","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Clinical nurse specialist; Congenital heart disease; Long-term conditions; Nurse-led advice lines; Adult; COVID-19; Health Services Accessibility; Heart Defects, Congenital; Humans; Nurse Specialists; Pandemics; United Kingdom","Clift","Paul","Consultant Cardiologist, Adult Congenital Heart Disease Unit, University Hospitals Birmingham NHS Foundation Trust",NA
"1172","34170721","10.12968/bjon.2021.30.12.730","COVID-19 and adult congenital heart disease services: impact on support and advice from nurse specialists.","Although the focus on service provision in response to the COVID-19 pandemic has mainly been on acute and particularly intensive care, it is important to consider other services that are still needed. This is especially the case for vulnerable patients with long-term conditions, such as those under the care of an adult congenital heart disease (ACHD) service. The authors conducted a survey of ACHD nurse specialists in centres across the UK to acertain what they were planning in terms of the rede","2021","07","01","Br J Nurs","British journal of nursing (Mark Allen Publishing)","Clinical nurse specialist; Congenital heart disease; Long-term conditions; Nurse-led advice lines; Adult; COVID-19; Health Services Accessibility; Heart Defects, Congenital; Humans; Nurse Specialists; Pandemics; United Kingdom","Hudsmith","Lucy","Consultant Cardiologist, Adult Congenital Heart Disease Unit, University Hospitals Birmingham NHS Foundation Trust",NA
"1173","34170680","10.1021/acs.analchem.1c01078","Plasmonic Biosensor Augmented by a Genetic Algorithm for Ultra-Rapid, Label-Free, and Multi-Functional Detection of COVID-19.","The novel coronavirus (COVID-19) is spreading globally due to its super contagiousness, and the pandemic caused by it has caused serious damage to the health and social economy of all countries in the world. However, conventional diagnostic methods are not conducive to large-scale screening and early identification of infected persons due to their long detection time. Therefore, there is an urgent need to develop a new COVID-19 test method that can deliver results in real time and on-site. In th","2021","07","19","Anal Chem","Analytical chemistry","Algorithms; Biosensing Techniques; COVID-19; Humans; Pandemics; SARS-CoV-2","Li","Dongxiao","Key Laboratory of Optoelectronic Technology &amp",NA
"1174","34170680","10.1021/acs.analchem.1c01078","Plasmonic Biosensor Augmented by a Genetic Algorithm for Ultra-Rapid, Label-Free, and Multi-Functional Detection of COVID-19.","The novel coronavirus (COVID-19) is spreading globally due to its super contagiousness, and the pandemic caused by it has caused serious damage to the health and social economy of all countries in the world. However, conventional diagnostic methods are not conducive to large-scale screening and early identification of infected persons due to their long detection time. Therefore, there is an urgent need to develop a new COVID-19 test method that can deliver results in real time and on-site. In th","2021","07","19","Anal Chem","Analytical chemistry","Algorithms; Biosensing Techniques; COVID-19; Humans; Pandemics; SARS-CoV-2","Zhou","Hong","Key Laboratory of Optoelectronic Technology &amp",NA
"1175","34170680","10.1021/acs.analchem.1c01078","Plasmonic Biosensor Augmented by a Genetic Algorithm for Ultra-Rapid, Label-Free, and Multi-Functional Detection of COVID-19.","The novel coronavirus (COVID-19) is spreading globally due to its super contagiousness, and the pandemic caused by it has caused serious damage to the health and social economy of all countries in the world. However, conventional diagnostic methods are not conducive to large-scale screening and early identification of infected persons due to their long detection time. Therefore, there is an urgent need to develop a new COVID-19 test method that can deliver results in real time and on-site. In th","2021","07","19","Anal Chem","Analytical chemistry","Algorithms; Biosensing Techniques; COVID-19; Humans; Pandemics; SARS-CoV-2","Hui","Xindan","Key Laboratory of Optoelectronic Technology &amp",NA
"1176","34170680","10.1021/acs.analchem.1c01078","Plasmonic Biosensor Augmented by a Genetic Algorithm for Ultra-Rapid, Label-Free, and Multi-Functional Detection of COVID-19.","The novel coronavirus (COVID-19) is spreading globally due to its super contagiousness, and the pandemic caused by it has caused serious damage to the health and social economy of all countries in the world. However, conventional diagnostic methods are not conducive to large-scale screening and early identification of infected persons due to their long detection time. Therefore, there is an urgent need to develop a new COVID-19 test method that can deliver results in real time and on-site. In th","2021","07","19","Anal Chem","Analytical chemistry","Algorithms; Biosensing Techniques; COVID-19; Humans; Pandemics; SARS-CoV-2","He","Xianming","Key Laboratory of Optoelectronic Technology &amp",NA
"1177","34170680","10.1021/acs.analchem.1c01078","Plasmonic Biosensor Augmented by a Genetic Algorithm for Ultra-Rapid, Label-Free, and Multi-Functional Detection of COVID-19.","The novel coronavirus (COVID-19) is spreading globally due to its super contagiousness, and the pandemic caused by it has caused serious damage to the health and social economy of all countries in the world. However, conventional diagnostic methods are not conducive to large-scale screening and early identification of infected persons due to their long detection time. Therefore, there is an urgent need to develop a new COVID-19 test method that can deliver results in real time and on-site. In th","2021","07","19","Anal Chem","Analytical chemistry","Algorithms; Biosensing Techniques; COVID-19; Humans; Pandemics; SARS-CoV-2","Mu","Xiaojing","Key Laboratory of Optoelectronic Technology &amp",NA
"1178","34170654","","Assessment of Clinical Profile &amp; Risk Factors Associated with Adverse Outcome in COVID-19 Patients at a Tertiary Care Hospital in Central India - A Retrospective Record Based Study.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; India; Retrospective Studies; Risk Factors; SARS-CoV-2; Tertiary Care Centers","Jain","Shailendra Kumar","Assistant Professor, Dept. of Gastroenterology",NA
"1179","34170654","","Assessment of Clinical Profile &amp; Risk Factors Associated with Adverse Outcome in COVID-19 Patients at a Tertiary Care Hospital in Central India - A Retrospective Record Based Study.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; India; Retrospective Studies; Risk Factors; SARS-CoV-2; Tertiary Care Centers","Dudani","Anshul","Senior Resident, Dept. of Medicine",NA
"1180","34170654","","Assessment of Clinical Profile &amp; Risk Factors Associated with Adverse Outcome in COVID-19 Patients at a Tertiary Care Hospital in Central India - A Retrospective Record Based Study.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; India; Retrospective Studies; Risk Factors; SARS-CoV-2; Tertiary Care Centers","Jaiswal","Naveen","Resident Medical Officer, Associate Professor",NA
"1181","34170654","","Assessment of Clinical Profile &amp; Risk Factors Associated with Adverse Outcome in COVID-19 Patients at a Tertiary Care Hospital in Central India - A Retrospective Record Based Study.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; India; Retrospective Studies; Risk Factors; SARS-CoV-2; Tertiary Care Centers","Deopujari","Kuldeep","Associate Professor",NA
"1182","34170654","","Assessment of Clinical Profile &amp; Risk Factors Associated with Adverse Outcome in COVID-19 Patients at a Tertiary Care Hospital in Central India - A Retrospective Record Based Study.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; India; Retrospective Studies; Risk Factors; SARS-CoV-2; Tertiary Care Centers","Simmi Dube","Simmi","Professor &amp",NA
"1183","34170653","10.0104/japi.2021.03","Psychiatric Sequelae and COVID Experiences of Post COVID -19 Recovered Resident Doctors and Interns of a Tertiary General Hospital in Mumbai.","The wide and profound psychological impact of the COVID pandemic on people has been demonstrated by several studies. A survey from the Indian Medical Association (IMA) showed that at least 500 doctors have been infected across Maharashtra, with Mumbai doctors making it to the top of the list. The most infected are the resident doctors working in government hospitals. A few doctors also have lost their lives while working in this pandemic. The delicate balance between duty, altruism and fear for ","2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","Anxiety; COVID-19; Cross-Sectional Studies; Depression; Hospitals, General; Humans; India; Pandemics; SARS-CoV-2","Sawant","Neena","Professor &amp",NA
"1184","34170653","10.0104/japi.2021.03","Psychiatric Sequelae and COVID Experiences of Post COVID -19 Recovered Resident Doctors and Interns of a Tertiary General Hospital in Mumbai.","The wide and profound psychological impact of the COVID pandemic on people has been demonstrated by several studies. A survey from the Indian Medical Association (IMA) showed that at least 500 doctors have been infected across Maharashtra, with Mumbai doctors making it to the top of the list. The most infected are the resident doctors working in government hospitals. A few doctors also have lost their lives while working in this pandemic. The delicate balance between duty, altruism and fear for ","2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","Anxiety; COVID-19; Cross-Sectional Studies; Depression; Hospitals, General; Humans; India; Pandemics; SARS-CoV-2","Ingawale","Sushrut","PGY-3 Resident, Department of Medicine",NA
"1185","34170653","10.0104/japi.2021.03","Psychiatric Sequelae and COVID Experiences of Post COVID -19 Recovered Resident Doctors and Interns of a Tertiary General Hospital in Mumbai.","The wide and profound psychological impact of the COVID pandemic on people has been demonstrated by several studies. A survey from the Indian Medical Association (IMA) showed that at least 500 doctors have been infected across Maharashtra, with Mumbai doctors making it to the top of the list. The most infected are the resident doctors working in government hospitals. A few doctors also have lost their lives while working in this pandemic. The delicate balance between duty, altruism and fear for ","2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","Anxiety; COVID-19; Cross-Sectional Studies; Depression; Hospitals, General; Humans; India; Pandemics; SARS-CoV-2","Lokhande","Urja","Pre-Final year MBBS Student",NA
"1186","34170653","10.0104/japi.2021.03","Psychiatric Sequelae and COVID Experiences of Post COVID -19 Recovered Resident Doctors and Interns of a Tertiary General Hospital in Mumbai.","The wide and profound psychological impact of the COVID pandemic on people has been demonstrated by several studies. A survey from the Indian Medical Association (IMA) showed that at least 500 doctors have been infected across Maharashtra, with Mumbai doctors making it to the top of the list. The most infected are the resident doctors working in government hospitals. A few doctors also have lost their lives while working in this pandemic. The delicate balance between duty, altruism and fear for ","2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","Anxiety; COVID-19; Cross-Sectional Studies; Depression; Hospitals, General; Humans; India; Pandemics; SARS-CoV-2","Patil","Sanket","Pre-Final year MBBS Student",NA
"1187","34170653","10.0104/japi.2021.03","Psychiatric Sequelae and COVID Experiences of Post COVID -19 Recovered Resident Doctors and Interns of a Tertiary General Hospital in Mumbai.","The wide and profound psychological impact of the COVID pandemic on people has been demonstrated by several studies. A survey from the Indian Medical Association (IMA) showed that at least 500 doctors have been infected across Maharashtra, with Mumbai doctors making it to the top of the list. The most infected are the resident doctors working in government hospitals. A few doctors also have lost their lives while working in this pandemic. The delicate balance between duty, altruism and fear for ","2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","Anxiety; COVID-19; Cross-Sectional Studies; Depression; Hospitals, General; Humans; India; Pandemics; SARS-CoV-2","Ayub","Eera Fatima Mohammed","Final Year MBBS Student, Seth GSMC &amp",NA
"1188","34170653","10.0104/japi.2021.03","Psychiatric Sequelae and COVID Experiences of Post COVID -19 Recovered Resident Doctors and Interns of a Tertiary General Hospital in Mumbai.","The wide and profound psychological impact of the COVID pandemic on people has been demonstrated by several studies. A survey from the Indian Medical Association (IMA) showed that at least 500 doctors have been infected across Maharashtra, with Mumbai doctors making it to the top of the list. The most infected are the resident doctors working in government hospitals. A few doctors also have lost their lives while working in this pandemic. The delicate balance between duty, altruism and fear for ","2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","Anxiety; COVID-19; Cross-Sectional Studies; Depression; Hospitals, General; Humans; India; Pandemics; SARS-CoV-2","Rathi","Vedant","Final Year MBBS Student, Seth GSMC &amp",NA
"1189","34170652","","Impact of COVID-19 on Fatigue and Exercise Capacity in Patients Treated at a Dedicated COVID Hospital.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Exercise Tolerance; Fatigue; Hospitals; Humans; SARS-CoV-2","Verma","Chhaya V","Professor &amp",NA
"1190","34170652","","Impact of COVID-19 on Fatigue and Exercise Capacity in Patients Treated at a Dedicated COVID Hospital.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Exercise Tolerance; Fatigue; Hospitals; Humans; SARS-CoV-2","Mhatre","Sayali D","Final Year Postgraduate Student Corresponding Author",NA
"1191","34170652","","Impact of COVID-19 on Fatigue and Exercise Capacity in Patients Treated at a Dedicated COVID Hospital.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Exercise Tolerance; Fatigue; Hospitals; Humans; SARS-CoV-2","Mangaonkar","Anagha N","Physiotherapy School and Centre",NA
"1192","34170652","","Impact of COVID-19 on Fatigue and Exercise Capacity in Patients Treated at a Dedicated COVID Hospital.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Exercise Tolerance; Fatigue; Hospitals; Humans; SARS-CoV-2","Kaneria","Mala V","Additional Professor and Unit Head Department of Medicine",NA
"1193","34170652","","Impact of COVID-19 on Fatigue and Exercise Capacity in Patients Treated at a Dedicated COVID Hospital.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Exercise Tolerance; Fatigue; Hospitals; Humans; SARS-CoV-2","Bharmal","Ramesh N","Dean, TNMC and BYLNCH, Mumbai, Maharashtra",NA
"1194","34170650","","COVID 19 and Role of Physiotherapy.",NA,"2021","06","30","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; Medicine; Physical Therapy Modalities; SARS-CoV-2","Jiandani","Mariya P","Associate Professor, Physiotherapy Department, Seth GSMC &amp",NA
"1195","34170629","10.1111/tbed.14203","The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.",NA,"2021","07","02","Transbound Emerg Dis","Transboundary and emerging diseases","Bangladesh; Dhaka; SARS-CoV-2; variant","Rahman","Mustafizur","Virology Laboratory, icddr,b: International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh",NA
"1196","34170629","10.1111/tbed.14203","The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.",NA,"2021","07","02","Transbound Emerg Dis","Transboundary and emerging diseases","Bangladesh; Dhaka; SARS-CoV-2; variant","Shirin","Tahmina","Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh",NA
"1197","34170629","10.1111/tbed.14203","The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.",NA,"2021","07","02","Transbound Emerg Dis","Transboundary and emerging diseases","Bangladesh; Dhaka; SARS-CoV-2; variant","Rahman","Sezanur","Virology Laboratory, icddr,b: International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh",NA
"1198","34170629","10.1111/tbed.14203","The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.",NA,"2021","07","02","Transbound Emerg Dis","Transboundary and emerging diseases","Bangladesh; Dhaka; SARS-CoV-2; variant","Rahman","M Mahfuzur","Virology Laboratory, icddr,b: International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh",NA
"1199","34170629","10.1111/tbed.14203","The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.",NA,"2021","07","02","Transbound Emerg Dis","Transboundary and emerging diseases","Bangladesh; Dhaka; SARS-CoV-2; variant","Hossain","Mohammad Enayet","Virology Laboratory, icddr,b: International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh",NA
"1200","34170629","10.1111/tbed.14203","The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.",NA,"2021","07","02","Transbound Emerg Dis","Transboundary and emerging diseases","Bangladesh; Dhaka; SARS-CoV-2; variant","Khan","Manjur Hossain","Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh",NA
"1201","34170629","10.1111/tbed.14203","The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.",NA,"2021","07","02","Transbound Emerg Dis","Transboundary and emerging diseases","Bangladesh; Dhaka; SARS-CoV-2; variant","Rahman","Mohammed Ziaur","Virology Laboratory, icddr,b: International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh",NA
"1202","34170629","10.1111/tbed.14203","The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.",NA,"2021","07","02","Transbound Emerg Dis","Transboundary and emerging diseases","Bangladesh; Dhaka; SARS-CoV-2; variant","Arifeen","Shams El","Virology Laboratory, icddr,b: International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh",NA
"1203","34170629","10.1111/tbed.14203","The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh.",NA,"2021","07","02","Transbound Emerg Dis","Transboundary and emerging diseases","Bangladesh; Dhaka; SARS-CoV-2; variant","Ahmed","Tahmeed","Virology Laboratory, icddr,b: International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh",NA
"1204","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Stranieri","Angelica","Department of Veterinary Medicine, University of Milan, Italy",NA
"1205","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Lauzi","Stefania","Department of Veterinary Medicine, University of Milan, Italy",NA
"1206","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Giordano","Alessia","Department of Veterinary Medicine, University of Milan, Italy",NA
"1207","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Galimberti","Luigi","Agenzia di Tutela della Salute - ATS città metropolitana di Milano Distretto Veterinario Alto Lodigiano, Sant'Angelo Lodigiano, Lodi, Italy",NA
"1208","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Ratti","Gabriele","Department of Veterinary Medicine, University of Milan, Italy",NA
"1209","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Decaro","Nicola","Department of Veterinary Medicine, University of Bari ""Aldo Moro"", Valenzano, Bari, Italy",NA
"1210","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Brioschi","Federica","Department of Veterinary Medicine, University of Milan, Italy",NA
"1211","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Lelli","Davide","Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Brescia, Italy",NA
"1212","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Gabba","Silvia","PTP Science Park, Lodi, Italy",NA
"1213","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Amarachi","Ndiana Linda","Department of Veterinary Medicine, University of Bari ""Aldo Moro"", Valenzano, Bari, Italy",NA
"1214","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Lorusso","Eleonora","Department of Veterinary Medicine, University of Bari ""Aldo Moro"", Valenzano, Bari, Italy",NA
"1215","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Moreno","Ana","Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Brescia, Italy",NA
"1216","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Trogu","Tiziana","Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Brescia, Italy",NA
"1217","34170624","10.1111/tbed.14200","Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats.","SARS-CoV-2 positive or seropositive owned cats have been reported worldwide. The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2. The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodie","2021","06","30","Transbound Emerg Dis","Transboundary and emerging diseases","COVID-19; SARS-CoV-2; one health; stray cats","Paltrinieri","Saverio","Department of Veterinary Medicine, University of Milan, Italy",NA
"1218","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Huang","Jiana","The Six Affiliated Hospital, Sun Yat-sen University, Guangzhou, China",NA
"1219","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Gao","Jiebing","The Cardiovascular Center, Department of Cardiology and Radiology, Interventional Medical Center, Guangdong Provincial Key Laboratory of Biomedical Imaging, Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China",NA
"1220","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Zhu","Wenliang","Department of Physiology, The School of Medicine of Jinan University, Guangzhou, China",NA
"1221","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Feng","Ruiling","Department of Oncology, The First Affiliated Hospital of Shantou University, Shantou, China",NA
"1222","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Liu","Qianru","Department of Physiology, The School of Medicine of Jinan University, Guangzhou, China",NA
"1223","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Chen","Xiumin","Department of Physiology, The School of Medicine of Jinan University, Guangzhou, China",NA
"1224","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Huang","Jingmin","Department of Physiology, The School of Medicine of Jinan University, Guangzhou, China",NA
"1225","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Yang","Zhe","The Cardiovascular Center, Department of Cardiology and Radiology, Interventional Medical Center, Guangdong Provincial Key Laboratory of Biomedical Imaging, Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China",NA
"1226","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Lin","Xiufang","The Cardiovascular Center, Department of Cardiology and Radiology, Interventional Medical Center, Guangdong Provincial Key Laboratory of Biomedical Imaging, Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China",NA
"1227","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Zhang","Zuoquan","The Cardiovascular Center, Department of Cardiology and Radiology, Interventional Medical Center, Guangdong Provincial Key Laboratory of Biomedical Imaging, Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China",NA
"1228","34170611","10.1111/ijcp.14571","Indicators and prediction models for the severity of Covid-19.","Coronavirus disease 2019 (Covid-19) is outbreaking globally. We aimed to analyse the clinical characteristics, cardiac injury, electrocardiogram and computed tomography (CT) features of patients confirmed Covid-19 and explored the prediction models for the severity of Covid-19. A retrospective and single-centre study enrolled 98 laboratory-confirmed Covid-19 patients. Clinical data, electrocardiogram and CT features were collected and analysed using Statistical Package for the Social Sciences so","2021","07","06","Int J Clin Pract","International journal of clinical practice",NA,"Lin","Yubi","The Cardiovascular Center, Department of Cardiology and Radiology, Interventional Medical Center, Guangdong Provincial Key Laboratory of Biomedical Imaging, Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China",NA
"1229","34170578","10.1111/jocs.15774","From COVID-19 or because COVID-19?","Infections and pandemics will condition us in an increasingly predominant way regarding diagnostic, medical, and surgical activities in all specialist areas. Particularly cardiovascular disease represents an important field also during other health crisis like COV19 pandemia. A common strategy in the future, to cohabit with pandemic events and to be able to continue an elective and not only emergency cardiac surgery program represents an imperative.","2021","06","25","J Card Surg","Journal of cardiac surgery","COVID-19; cardiac surgery","Actis Dato","Guglielmo M","Department of Cardiac Surgery, Ospedale Mauriziano ""Umberto I"", Turin, Italy",NA
"1230","34170561","10.1002/jmv.27160","Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.","Coronavirus disease 2019 (COVID-19) is an infectious disease, and the reason behind the currently ongoing pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme (ACE2) has been recognized as the specific receptor of the SARS-CoV-2 virus. Although the possible effect of ACE2 gene polymorphism remains unknown, human ACE2 receptor expression influences SARS-CoV-2 susceptibility and COVID-19 disease outcome. In this study, we aimed to investig","2021","07","10","J Med Virol","Journal of medical virology","ACE; ACE2; COVID-19; rs2106809; rs2285666","Karakas Çelik","Sevim","Department of Medical Genetics, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"1231","34170561","10.1002/jmv.27160","Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.","Coronavirus disease 2019 (COVID-19) is an infectious disease, and the reason behind the currently ongoing pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme (ACE2) has been recognized as the specific receptor of the SARS-CoV-2 virus. Although the possible effect of ACE2 gene polymorphism remains unknown, human ACE2 receptor expression influences SARS-CoV-2 susceptibility and COVID-19 disease outcome. In this study, we aimed to investig","2021","07","10","J Med Virol","Journal of medical virology","ACE; ACE2; COVID-19; rs2106809; rs2285666","Çakmak Genç","Günes","Department of Medical Genetics, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"1232","34170561","10.1002/jmv.27160","Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.","Coronavirus disease 2019 (COVID-19) is an infectious disease, and the reason behind the currently ongoing pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme (ACE2) has been recognized as the specific receptor of the SARS-CoV-2 virus. Although the possible effect of ACE2 gene polymorphism remains unknown, human ACE2 receptor expression influences SARS-CoV-2 susceptibility and COVID-19 disease outcome. In this study, we aimed to investig","2021","07","10","J Med Virol","Journal of medical virology","ACE; ACE2; COVID-19; rs2106809; rs2285666","Piskin","Nihal","Department of Infectious Diseases and Clinical Microbiology, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"1233","34170561","10.1002/jmv.27160","Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.","Coronavirus disease 2019 (COVID-19) is an infectious disease, and the reason behind the currently ongoing pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme (ACE2) has been recognized as the specific receptor of the SARS-CoV-2 virus. Although the possible effect of ACE2 gene polymorphism remains unknown, human ACE2 receptor expression influences SARS-CoV-2 susceptibility and COVID-19 disease outcome. In this study, we aimed to investig","2021","07","10","J Med Virol","Journal of medical virology","ACE; ACE2; COVID-19; rs2106809; rs2285666","Açikgöz","Bilgehan","Department of Public Health, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"1234","34170561","10.1002/jmv.27160","Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.","Coronavirus disease 2019 (COVID-19) is an infectious disease, and the reason behind the currently ongoing pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme (ACE2) has been recognized as the specific receptor of the SARS-CoV-2 virus. Although the possible effect of ACE2 gene polymorphism remains unknown, human ACE2 receptor expression influences SARS-CoV-2 susceptibility and COVID-19 disease outcome. In this study, we aimed to investig","2021","07","10","J Med Virol","Journal of medical virology","ACE; ACE2; COVID-19; rs2106809; rs2285666","Altinsoy","Bülent","Department of Pulmonary Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"1235","34170561","10.1002/jmv.27160","Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.","Coronavirus disease 2019 (COVID-19) is an infectious disease, and the reason behind the currently ongoing pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme (ACE2) has been recognized as the specific receptor of the SARS-CoV-2 virus. Although the possible effect of ACE2 gene polymorphism remains unknown, human ACE2 receptor expression influences SARS-CoV-2 susceptibility and COVID-19 disease outcome. In this study, we aimed to investig","2021","07","10","J Med Virol","Journal of medical virology","ACE; ACE2; COVID-19; rs2106809; rs2285666","Kurucu Issiz","Basak","Department of Medical Genetics, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"1236","34170561","10.1002/jmv.27160","Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.","Coronavirus disease 2019 (COVID-19) is an infectious disease, and the reason behind the currently ongoing pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme (ACE2) has been recognized as the specific receptor of the SARS-CoV-2 virus. Although the possible effect of ACE2 gene polymorphism remains unknown, human ACE2 receptor expression influences SARS-CoV-2 susceptibility and COVID-19 disease outcome. In this study, we aimed to investig","2021","07","10","J Med Virol","Journal of medical virology","ACE; ACE2; COVID-19; rs2106809; rs2285666","Dursun","Ahmet","Department of Medical Genetics, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"1237","34170556","10.1002/jmv.27158","Paracetamol in the home treatment of early COVID-19 symptoms: A possible foe rather than a friend for elderly patients?",NA,"2021","07","01","J Med Virol","Journal of medical virology",NA,"Pandolfi","Sergio","SIOOT, High School in Oxygen Ozone Therapy, University of Pavia, Pavia, Italy",NA
"1238","34170556","10.1002/jmv.27158","Paracetamol in the home treatment of early COVID-19 symptoms: A possible foe rather than a friend for elderly patients?",NA,"2021","07","01","J Med Virol","Journal of medical virology",NA,"Simonetti","Vincenzo","SIOOT, High School in Oxygen Ozone Therapy, University of Pavia, Pavia, Italy",NA
"1239","34170556","10.1002/jmv.27158","Paracetamol in the home treatment of early COVID-19 symptoms: A possible foe rather than a friend for elderly patients?",NA,"2021","07","01","J Med Virol","Journal of medical virology",NA,"Ricevuti","Giovanni","Department of Drug Science, University of Pavia, Pavia, Italy",NA
"1240","34170556","10.1002/jmv.27158","Paracetamol in the home treatment of early COVID-19 symptoms: A possible foe rather than a friend for elderly patients?",NA,"2021","07","01","J Med Virol","Journal of medical virology",NA,"Chirumbolo","Salvatore","Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy",NA
"1241","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Matsuzaki","Nanako","Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan",NA
"1242","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Orihara","Yuta","Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan",NA
"1243","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Kodana","Masahiro","Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan",NA
"1244","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Kitagawa","Yutaro","Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan",NA
"1245","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Matsuoka","Masaru","Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan",NA
"1246","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Kawamura","Rieko","Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan",NA
"1247","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Takeuchi","Shinichi","Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan",NA
"1248","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Imai","Kazuo","Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan",NA
"1249","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Tarumoto","Norihito","Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan",NA
"1250","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Maesaki","Shigefumi","Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan",NA
"1251","34170555","10.1002/jmv.27153","Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS<sup>®</sup> SARS-CoV-2 Antigen Test.","A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS<sup>®</sup> SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE<sup>®</sup> SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79","2021","06","25","J Med Virol","Journal of medical virology","CLEIA; COVID-19; Nasopharyngeal swab; RT-qPCR; SARS-CoV-2","Maeda","Takuya","Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan",NA
"1252","34170553","10.1111/jocs.15772","Training in cardiothoracic surgery: Another victim of COVID-19 pandemic.",NA,"2021","06","25","J Card Surg","Journal of cardiac surgery","COVID-19; SARS-CoV-2; surgical education; training","Yusuf","Naeem","Department of Surgery, University Teaching Hospitals, Lusaka, Zambia",NA
"1253","34170553","10.1111/jocs.15772","Training in cardiothoracic surgery: Another victim of COVID-19 pandemic.",NA,"2021","06","25","J Card Surg","Journal of cardiac surgery","COVID-19; SARS-CoV-2; surgical education; training","Hussain","Nafisa","School of Medicine, University of Liverpool, Liverpool, UK",NA
"1254","34170553","10.1111/jocs.15772","Training in cardiothoracic surgery: Another victim of COVID-19 pandemic.",NA,"2021","06","25","J Card Surg","Journal of cardiac surgery","COVID-19; SARS-CoV-2; surgical education; training","Sherif","Mohamed","Department of Cardiothoracic Surgery, Northern General Hospital, Sheffield, UK",NA
"1255","34170553","10.1111/jocs.15772","Training in cardiothoracic surgery: Another victim of COVID-19 pandemic.",NA,"2021","06","25","J Card Surg","Journal of cardiac surgery","COVID-19; SARS-CoV-2; surgical education; training","Harky","Amer","Department of Cardiothoracic Surgery, Liverpool Heart and Chest, Liverpool, UK",NA
"1256","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Khan","Farman","Department of Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1257","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Sharma","Praveen","Department of Neurology, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1258","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Pandey","Saurabh","Department of Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1259","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Sharma","Deepak","Department of Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1260","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","V","Vijayavarman","Department of Neurology, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1261","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Kumar","Neeraj","Department of Neurology, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1262","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Shukla","Suruchi","Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1263","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Dandu","Himanshu","Department of Infectious Diseases, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1264","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Jain","Amita","Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1265","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Garg","Ravindra K","Department of Neurology, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1266","34170552","10.1002/jmv.27159","COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?","Coronavirus disease 2019 (COVID-19) has been shown to be associated with a lot of neurological complications, of whom Guillain-Barre syndrome (GBS) is an important post-infectious consequentiality. More than 220 patients with GBS have been reported thus far. We intend to share our experience with five patients of GBS where one of them had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the cerebrospinal fluid (CSF). This is the first-ever report demonstrating the presence of SARS","2021","07","06","J Med Virol","Journal of medical virology","COVID-19; Guillain-Barre syndrome; cerebrospinal fluid; reverse-transcriptase polymerase chain reaction","Malhotra","Hardeep S","Department of Neurology, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"1267","34170549","10.1111/jnc.15459","Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and synthesis.","Neurological symptoms are frequently reported in patients suffering from COVID-19. Common CNS-related symptoms include anosmia, caused by viral interaction with either neurons or supporting cells in nasal olfactory tissues. Diffuse encephalopathy is the most common sign of CNS dysfunction, which likely results from the CNS consequences of the systemic inflammatory syndrome associated with severe COVID-19. Additionally, microvascular injuries and thromboembolic events likely contribute to the neu","2021","06","25","J Neurochem","Journal of neurochemistry","COVID-19; SARS-CoV-2; biomarker; central nervous system; cerebrospinal fluid","Edén","Arvid","Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden",NA
"1268","34170549","10.1111/jnc.15459","Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and synthesis.","Neurological symptoms are frequently reported in patients suffering from COVID-19. Common CNS-related symptoms include anosmia, caused by viral interaction with either neurons or supporting cells in nasal olfactory tissues. Diffuse encephalopathy is the most common sign of CNS dysfunction, which likely results from the CNS consequences of the systemic inflammatory syndrome associated with severe COVID-19. Additionally, microvascular injuries and thromboembolic events likely contribute to the neu","2021","06","25","J Neurochem","Journal of neurochemistry","COVID-19; SARS-CoV-2; biomarker; central nervous system; cerebrospinal fluid","Simrén","Joel","Department of Psychiatry and Neurochemistry, Institute of Neuroscience &amp",NA
"1269","34170549","10.1111/jnc.15459","Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and synthesis.","Neurological symptoms are frequently reported in patients suffering from COVID-19. Common CNS-related symptoms include anosmia, caused by viral interaction with either neurons or supporting cells in nasal olfactory tissues. Diffuse encephalopathy is the most common sign of CNS dysfunction, which likely results from the CNS consequences of the systemic inflammatory syndrome associated with severe COVID-19. Additionally, microvascular injuries and thromboembolic events likely contribute to the neu","2021","06","25","J Neurochem","Journal of neurochemistry","COVID-19; SARS-CoV-2; biomarker; central nervous system; cerebrospinal fluid","Price","Richard W","Department of Neurology, University of California San Francisco, San Francisco, USA",NA
"1270","34170549","10.1111/jnc.15459","Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and synthesis.","Neurological symptoms are frequently reported in patients suffering from COVID-19. Common CNS-related symptoms include anosmia, caused by viral interaction with either neurons or supporting cells in nasal olfactory tissues. Diffuse encephalopathy is the most common sign of CNS dysfunction, which likely results from the CNS consequences of the systemic inflammatory syndrome associated with severe COVID-19. Additionally, microvascular injuries and thromboembolic events likely contribute to the neu","2021","06","25","J Neurochem","Journal of neurochemistry","COVID-19; SARS-CoV-2; biomarker; central nervous system; cerebrospinal fluid","Zetterberg","Henrik","Department of Psychiatry and Neurochemistry, Institute of Neuroscience &amp",NA
"1271","34170549","10.1111/jnc.15459","Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and synthesis.","Neurological symptoms are frequently reported in patients suffering from COVID-19. Common CNS-related symptoms include anosmia, caused by viral interaction with either neurons or supporting cells in nasal olfactory tissues. Diffuse encephalopathy is the most common sign of CNS dysfunction, which likely results from the CNS consequences of the systemic inflammatory syndrome associated with severe COVID-19. Additionally, microvascular injuries and thromboembolic events likely contribute to the neu","2021","06","25","J Neurochem","Journal of neurochemistry","COVID-19; SARS-CoV-2; biomarker; central nervous system; cerebrospinal fluid","Gisslén","Magnus","Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden",NA
"1272","34170535","10.1111/apt.16459","Editorial: IBD medications during the COVID-19 pandemic-are they safe to use?",NA,"2021","06","30","Aliment Pharmacol Ther","Alimentary pharmacology &amp; therapeutics","COVID-19; Humans; Inflammatory Bowel Diseases; Pandemics; SARS-CoV-2","Fan","Dali","Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand",NA
"1273","34170535","10.1111/apt.16459","Editorial: IBD medications during the COVID-19 pandemic-are they safe to use?",NA,"2021","06","30","Aliment Pharmacol Ther","Alimentary pharmacology &amp; therapeutics","COVID-19; Humans; Inflammatory Bowel Diseases; Pandemics; SARS-CoV-2","Gearry","Richard B","Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand",NA
"1274","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"Tang","Cynthia Y","School of Medicine, University of Missouri, Columbia, Missouri, USA",NA
"1275","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"Wang","Yang","School of Medicine, University of Missouri, Columbia, Missouri, USA",NA
"1276","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"McElroy","Jane A","School of Medicine, University of Missouri, Columbia, Missouri, USA",NA
"1277","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"Li","Tao","Walter Reed Army Institute of Research, Silver Spring, Maryland, USA",NA
"1278","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"Hammer","Richard","School of Medicine, University of Missouri, Columbia, Missouri, USA",NA
"1279","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"Ritter","Detlef","School of Medicine, University of Missouri, Columbia, Missouri, USA",NA
"1280","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"Lidl","Grace M","Walter Reed Army Institute of Research, Silver Spring, Maryland, USA",NA
"1281","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"Webby","Richard","Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA",NA
"1282","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"Hang","Jun","Walter Reed Army Institute of Research, Silver Spring, Maryland, USA",NA
"1283","34170528","10.1002/jmv.27154","Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.",NA,"2021","07","05","J Med Virol","Journal of medical virology",NA,"Wan","Xiu-Feng","School of Medicine, University of Missouri, Columbia, Missouri, USA",NA
"1284","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Perchetti","Garrett A","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1285","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Zhu","Haiying","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1286","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Mills","Margaret G","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1287","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Shrestha","Lasata","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1288","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Wagner","Cassia","Department of Genome Sciences, University of Washington, Seattle, Washington, USA",NA
"1289","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Bakhash","Shah Mohamed","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1290","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Lin","Michelle J","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1291","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Xie","Hong","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1292","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Huang","Meei-Li","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1293","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Mathias","Patrick","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1294","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Bedford","Trevor","Department of Genome Sciences, University of Washington, Seattle, Washington, USA",NA
"1295","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Jerome","Keith R","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1296","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Greninger","Alexander L","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1297","34170525","10.1002/jmv.27155","Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.","Real-time epidemiological tracking of variants of concern (VOCs) can help limit the spread of more contagious forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as those containing the N501Y mutation. Typically, genetic sequencing is required to be able to track VOCs in real-time. However, sequencing can take time and may not be accessible in all laboratories. Genotyping by RT-ddPCR offers an alternative to rapidly detect VOCs through discrimination of specific alleles s","2021","07","03","J Med Virol","Journal of medical virology","B.1.1.7; COVID-19; N501Y; SARS-CoV-2; SGTF; ddPCR","Roychoudhury","Pavitra","Department of Laboratory Medicine and Pathology, Virology Division, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1298","34170519","10.1002/jmv.27152","Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients.","Anti-SARS-CoV-2 IgG and IgM antibodies have been widely used to assist clinical diagnosis. Our previous study reported a discrepancy in SARS-CoV-2 antibody response between male and female COVID-19 patients. However, the duration and discrepancy between ages as well as sexes of SARS-CoV-2 antibody in convalescent COVID-19 patients have not been clarified. In this study, a total of 538 health-examination individuals who were confirmed SARS-CoV-2 infection one year ago were enrolled. Blood samples","2021","06","25","J Med Virol","Journal of medical virology","COVID-19 convalescent patients; SARS-CoV-2 antibody duration; age difference of SARS-CoV-2 antibody response","Zeng","Fanfan","Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1299","34170519","10.1002/jmv.27152","Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients.","Anti-SARS-CoV-2 IgG and IgM antibodies have been widely used to assist clinical diagnosis. Our previous study reported a discrepancy in SARS-CoV-2 antibody response between male and female COVID-19 patients. However, the duration and discrepancy between ages as well as sexes of SARS-CoV-2 antibody in convalescent COVID-19 patients have not been clarified. In this study, a total of 538 health-examination individuals who were confirmed SARS-CoV-2 infection one year ago were enrolled. Blood samples","2021","06","25","J Med Virol","Journal of medical virology","COVID-19 convalescent patients; SARS-CoV-2 antibody duration; age difference of SARS-CoV-2 antibody response","Wu","Mengjun","Department of Otorhinolaryngology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1300","34170519","10.1002/jmv.27152","Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients.","Anti-SARS-CoV-2 IgG and IgM antibodies have been widely used to assist clinical diagnosis. Our previous study reported a discrepancy in SARS-CoV-2 antibody response between male and female COVID-19 patients. However, the duration and discrepancy between ages as well as sexes of SARS-CoV-2 antibody in convalescent COVID-19 patients have not been clarified. In this study, a total of 538 health-examination individuals who were confirmed SARS-CoV-2 infection one year ago were enrolled. Blood samples","2021","06","25","J Med Virol","Journal of medical virology","COVID-19 convalescent patients; SARS-CoV-2 antibody duration; age difference of SARS-CoV-2 antibody response","Wang","Jinbiao","Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1301","34170519","10.1002/jmv.27152","Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients.","Anti-SARS-CoV-2 IgG and IgM antibodies have been widely used to assist clinical diagnosis. Our previous study reported a discrepancy in SARS-CoV-2 antibody response between male and female COVID-19 patients. However, the duration and discrepancy between ages as well as sexes of SARS-CoV-2 antibody in convalescent COVID-19 patients have not been clarified. In this study, a total of 538 health-examination individuals who were confirmed SARS-CoV-2 infection one year ago were enrolled. Blood samples","2021","06","25","J Med Virol","Journal of medical virology","COVID-19 convalescent patients; SARS-CoV-2 antibody duration; age difference of SARS-CoV-2 antibody response","Li","Jianyu","Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1302","34170519","10.1002/jmv.27152","Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients.","Anti-SARS-CoV-2 IgG and IgM antibodies have been widely used to assist clinical diagnosis. Our previous study reported a discrepancy in SARS-CoV-2 antibody response between male and female COVID-19 patients. However, the duration and discrepancy between ages as well as sexes of SARS-CoV-2 antibody in convalescent COVID-19 patients have not been clarified. In this study, a total of 538 health-examination individuals who were confirmed SARS-CoV-2 infection one year ago were enrolled. Blood samples","2021","06","25","J Med Virol","Journal of medical virology","COVID-19 convalescent patients; SARS-CoV-2 antibody duration; age difference of SARS-CoV-2 antibody response","Hu","Guoyun","Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1303","34170519","10.1002/jmv.27152","Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients.","Anti-SARS-CoV-2 IgG and IgM antibodies have been widely used to assist clinical diagnosis. Our previous study reported a discrepancy in SARS-CoV-2 antibody response between male and female COVID-19 patients. However, the duration and discrepancy between ages as well as sexes of SARS-CoV-2 antibody in convalescent COVID-19 patients have not been clarified. In this study, a total of 538 health-examination individuals who were confirmed SARS-CoV-2 infection one year ago were enrolled. Blood samples","2021","06","25","J Med Virol","Journal of medical virology","COVID-19 convalescent patients; SARS-CoV-2 antibody duration; age difference of SARS-CoV-2 antibody response","Wang","Lin","Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1304","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Ottolina","Davide","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy. ottolina.davide@asst-fbf-sacco",NA
"1305","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Zazzeron","Luca","Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA",NA
"1306","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Trevisi","Letizia","Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA",NA
"1307","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Agarossi","Andrea","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy",NA
"1308","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Colombo","Riccardo","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy",NA
"1309","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Fossali","Tommaso","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy",NA
"1310","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Passeri","Mattia","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy",NA
"1311","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Borghi","Beatrice","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy",NA
"1312","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Ballone","Elisabetta","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy",NA
"1313","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Rech","Roberto","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy",NA
"1314","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Castelli","Antonio","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy",NA
"1315","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Catena","Emanuele","Department of Anesthesia and Critical Care, ""Luigi Sacco"" Hospital, ASST Fatebenefratelli-Sacco, Via G.B. Grassi, 74, 20157, Milan, Italy",NA
"1316","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Nebuloni","Manuela","'L. Sacco' Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy",NA
"1317","34170508","10.1007/s40620-021-01100-3","Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP).","Acute kidney injury (AKI) in Covid-19 patients admitted to the intensive care unit (ICU) is common, and its severity may be associated with unfavorable outcomes. Severe Covid-19 fulfills the diagnostic criteria for acute respiratory distress syndrome (ARDS); however, it is unclear whether there is any relationship between ventilatory management and AKI development in Covid-19 ICU patients. To describe the clinical course and outcomes of Covid-19 ICU patients, focusing on ventilatory management a","2021","07","01","J Nephrol","Journal of nephrology","AKI; ARDS; Covid-19; Intensive care; PEEP","Gallieni","Maurizio","'L. Sacco' Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy",NA
"1318","34170504","10.1007/s12519-021-00439-8","Maternal mental health and well-being during the COVID-19 pandemic in Beijing, China.","The aim of this study is to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on breastfeeding women and to identify predictors of maternal mental health and coping. Mothers aged = 18 years with a breast-fed infant = 18 months of age during the COVID-19 pandemic in Beijing, China, completed a questionnaire. Descriptive analysis of lockdown consequences was performed and predictors of these outcomes were examined using stepwise linear regression. Of 2233 participants, 29.9%,","2021","07","22","World J Pediatr","World journal of pediatrics : WJP","Coping; Coronavirus disease 2019; Maternal health; Mental health; Postpartum; Adaptation, Psychological; Adolescent; Adult; Beijing; Breast Feeding; COVID-19; Female; Humans; Infant; Infant, Newborn; Maternal Health; Mental Health; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Wei","Zhuang","Department of Child Healthcare, Beijing Children's HospitalCapital Medical UniversityNational Center for Children's Health, Beijing, China",NA
"1319","34170504","10.1007/s12519-021-00439-8","Maternal mental health and well-being during the COVID-19 pandemic in Beijing, China.","The aim of this study is to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on breastfeeding women and to identify predictors of maternal mental health and coping. Mothers aged = 18 years with a breast-fed infant = 18 months of age during the COVID-19 pandemic in Beijing, China, completed a questionnaire. Descriptive analysis of lockdown consequences was performed and predictors of these outcomes were examined using stepwise linear regression. Of 2233 participants, 29.9%,","2021","07","22","World J Pediatr","World journal of pediatrics : WJP","Coping; Coronavirus disease 2019; Maternal health; Mental health; Postpartum; Adaptation, Psychological; Adolescent; Adult; Beijing; Breast Feeding; COVID-19; Female; Humans; Infant; Infant, Newborn; Maternal Health; Mental Health; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Gao","Ming-Yue","Population, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK",NA
"1320","34170504","10.1007/s12519-021-00439-8","Maternal mental health and well-being during the COVID-19 pandemic in Beijing, China.","The aim of this study is to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on breastfeeding women and to identify predictors of maternal mental health and coping. Mothers aged = 18 years with a breast-fed infant = 18 months of age during the COVID-19 pandemic in Beijing, China, completed a questionnaire. Descriptive analysis of lockdown consequences was performed and predictors of these outcomes were examined using stepwise linear regression. Of 2233 participants, 29.9%,","2021","07","22","World J Pediatr","World journal of pediatrics : WJP","Coping; Coronavirus disease 2019; Maternal health; Mental health; Postpartum; Adaptation, Psychological; Adolescent; Adult; Beijing; Breast Feeding; COVID-19; Female; Humans; Infant; Infant, Newborn; Maternal Health; Mental Health; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Fewtrell","Mary","Population, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK",NA
"1321","34170504","10.1007/s12519-021-00439-8","Maternal mental health and well-being during the COVID-19 pandemic in Beijing, China.","The aim of this study is to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on breastfeeding women and to identify predictors of maternal mental health and coping. Mothers aged = 18 years with a breast-fed infant = 18 months of age during the COVID-19 pandemic in Beijing, China, completed a questionnaire. Descriptive analysis of lockdown consequences was performed and predictors of these outcomes were examined using stepwise linear regression. Of 2233 participants, 29.9%,","2021","07","22","World J Pediatr","World journal of pediatrics : WJP","Coping; Coronavirus disease 2019; Maternal health; Mental health; Postpartum; Adaptation, Psychological; Adolescent; Adult; Beijing; Breast Feeding; COVID-19; Female; Humans; Infant; Infant, Newborn; Maternal Health; Mental Health; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Wells","Jonathan","Population, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK",NA
"1322","34170504","10.1007/s12519-021-00439-8","Maternal mental health and well-being during the COVID-19 pandemic in Beijing, China.","The aim of this study is to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on breastfeeding women and to identify predictors of maternal mental health and coping. Mothers aged = 18 years with a breast-fed infant = 18 months of age during the COVID-19 pandemic in Beijing, China, completed a questionnaire. Descriptive analysis of lockdown consequences was performed and predictors of these outcomes were examined using stepwise linear regression. Of 2233 participants, 29.9%,","2021","07","22","World J Pediatr","World journal of pediatrics : WJP","Coping; Coronavirus disease 2019; Maternal health; Mental health; Postpartum; Adaptation, Psychological; Adolescent; Adult; Beijing; Breast Feeding; COVID-19; Female; Humans; Infant; Infant, Newborn; Maternal Health; Mental Health; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Yu","Jin-Yue","Population, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK. jin.yu.16@ucl.ac","jin.yu.16@ucl.ac.uk"
"1323","34170503","10.1007/s12519-021-00434-z","Clinical characteristics of COVID-19 in family clusters: a systematic review.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread around the world and reports of children during early epidemic period showed features of family clusters. The aim of this study is to assess clinical profiles of COVID-19 in family clusters with children. We performed a systematic literature review of English database (PubMed, Web of Science) and Chinese database ("" www.cnki.net "", "" www.cqvip.com "" and "" www.Wanfangdata.com.cn ""","2021","07","01","World J Pediatr","World journal of pediatrics : WJP","Children; Coronavirus disease 2019; Family clusters; Severe acute respiratory syndrome coronavirus 2","Song","Wen-Liang","Department of Pediatrics, Shengjing Hospital of China Medical University, No.36, SanHao Street, Shenyang, 110004, China",NA
"1324","34170503","10.1007/s12519-021-00434-z","Clinical characteristics of COVID-19 in family clusters: a systematic review.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread around the world and reports of children during early epidemic period showed features of family clusters. The aim of this study is to assess clinical profiles of COVID-19 in family clusters with children. We performed a systematic literature review of English database (PubMed, Web of Science) and Chinese database ("" www.cnki.net "", "" www.cqvip.com "" and "" www.Wanfangdata.com.cn ""","2021","07","01","World J Pediatr","World journal of pediatrics : WJP","Children; Coronavirus disease 2019; Family clusters; Severe acute respiratory syndrome coronavirus 2","Zou","Ning","Department of Pediatrics, Shengjing Hospital of China Medical University, No.36, SanHao Street, Shenyang, 110004, China",NA
"1325","34170503","10.1007/s12519-021-00434-z","Clinical characteristics of COVID-19 in family clusters: a systematic review.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread around the world and reports of children during early epidemic period showed features of family clusters. The aim of this study is to assess clinical profiles of COVID-19 in family clusters with children. We performed a systematic literature review of English database (PubMed, Web of Science) and Chinese database ("" www.cnki.net "", "" www.cqvip.com "" and "" www.Wanfangdata.com.cn ""","2021","07","01","World J Pediatr","World journal of pediatrics : WJP","Children; Coronavirus disease 2019; Family clusters; Severe acute respiratory syndrome coronavirus 2","Guan","Wen-He","Department of Pediatrics, Shengjing Hospital of China Medical University, No.36, SanHao Street, Shenyang, 110004, China",NA
"1326","34170503","10.1007/s12519-021-00434-z","Clinical characteristics of COVID-19 in family clusters: a systematic review.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread around the world and reports of children during early epidemic period showed features of family clusters. The aim of this study is to assess clinical profiles of COVID-19 in family clusters with children. We performed a systematic literature review of English database (PubMed, Web of Science) and Chinese database ("" www.cnki.net "", "" www.cqvip.com "" and "" www.Wanfangdata.com.cn ""","2021","07","01","World J Pediatr","World journal of pediatrics : WJP","Children; Coronavirus disease 2019; Family clusters; Severe acute respiratory syndrome coronavirus 2","Pan","Jia-Li","Department of Pediatrics, Shengjing Hospital of China Medical University, No.36, SanHao Street, Shenyang, 110004, China",NA
"1327","34170503","10.1007/s12519-021-00434-z","Clinical characteristics of COVID-19 in family clusters: a systematic review.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread around the world and reports of children during early epidemic period showed features of family clusters. The aim of this study is to assess clinical profiles of COVID-19 in family clusters with children. We performed a systematic literature review of English database (PubMed, Web of Science) and Chinese database ("" www.cnki.net "", "" www.cqvip.com "" and "" www.Wanfangdata.com.cn ""","2021","07","01","World J Pediatr","World journal of pediatrics : WJP","Children; Coronavirus disease 2019; Family clusters; Severe acute respiratory syndrome coronavirus 2","Xu","Wei","Department of Pediatrics, Shengjing Hospital of China Medical University, No.36, SanHao Street, Shenyang, 110004, China. tomxu.123@163","tomxu.123@163.com"
"1329","34170453","10.1007/s11606-021-06968-2","Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19.",NA,"2021","07","01","J Gen Intern Med","Journal of general internal medicine",NA,"Hernandez","Inmaculada","Division of Clinical Pharmacy, University of California, San Diego, La Jolla, CA, USA. inhernandez@health.ucsd","inhernandez@health.ucsd.edu"
"1330","34170453","10.1007/s11606-021-06968-2","Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19.",NA,"2021","07","01","J Gen Intern Med","Journal of general internal medicine",NA,"Gul","Zeynep","Department of Urology, UPMC, Pittsburgh, PA, USA",NA
"1331","34170453","10.1007/s11606-021-06968-2","Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19.",NA,"2021","07","01","J Gen Intern Med","Journal of general internal medicine",NA,"Gellad","Walid F","Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA",NA
"1332","34170453","10.1007/s11606-021-06968-2","Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19.",NA,"2021","07","01","J Gen Intern Med","Journal of general internal medicine",NA,"Davies","Benjamin J","Department of Urology, UPMC, Pittsburgh, PA, USA",NA
"1333","34170445","10.1007/s10067-021-05835-z","Isolated ""puffy hands"" following COVID-19: clue to a long-term capillary leakage syndrome?",NA,"2021","07","01","Clin Rheumatol","Clinical rheumatology",NA,"Ciaffi","Jacopo","Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, SSD Medicina e Reumatologia, 40136, Bologna, Italy. jacopo.ciaffi91@gmail","jacopo.ciaffi91@gmail.com"
"1334","34170445","10.1007/s10067-021-05835-z","Isolated ""puffy hands"" following COVID-19: clue to a long-term capillary leakage syndrome?",NA,"2021","07","01","Clin Rheumatol","Clinical rheumatology",NA,"Meliconi","Riccardo","Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, SSD Medicina e Reumatologia, 40136, Bologna, Italy",NA
"1335","34170445","10.1007/s10067-021-05835-z","Isolated ""puffy hands"" following COVID-19: clue to a long-term capillary leakage syndrome?",NA,"2021","07","01","Clin Rheumatol","Clinical rheumatology",NA,"Ruscitti","Piero","Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy",NA
"1336","34170445","10.1007/s10067-021-05835-z","Isolated ""puffy hands"" following COVID-19: clue to a long-term capillary leakage syndrome?",NA,"2021","07","01","Clin Rheumatol","Clinical rheumatology",NA,"Iagnocco","Annamaria","Academic Rheumatology Centre MFRU, Dipartimento Scienze Cliniche E Biologiche, Università Degli Studi Di Torino, Torino, Italy",NA
"1337","34170445","10.1007/s10067-021-05835-z","Isolated ""puffy hands"" following COVID-19: clue to a long-term capillary leakage syndrome?",NA,"2021","07","01","Clin Rheumatol","Clinical rheumatology",NA,"Ferri","Clodoveo","Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Italy",NA
"1338","34170445","10.1007/s10067-021-05835-z","Isolated ""puffy hands"" following COVID-19: clue to a long-term capillary leakage syndrome?",NA,"2021","07","01","Clin Rheumatol","Clinical rheumatology",NA,"Giacomelli","Roberto","Unit of Allergology, Immunology, Rheumatology, Department of Medicine, Università Campus Bio-Medico Di Roma, Rome, Italy",NA
"1339","34170445","10.1007/s10067-021-05835-z","Isolated ""puffy hands"" following COVID-19: clue to a long-term capillary leakage syndrome?",NA,"2021","07","01","Clin Rheumatol","Clinical rheumatology",NA,"Ursini","Francesco","Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, SSD Medicina e Reumatologia, 40136, Bologna, Italy",NA
"1340","34170430","10.1245/s10434-021-10319-0","Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.","During the height of the coronavirus disease 2019 (COVID-19) pandemic, elective surgeries, including oncologic surgeries, were delayed. Little prospective data existed to guide practice, and professional surgical societies issued recommendations grounded mainly in common sense and expert consensus, such as medical therapy for early-stage breast and prostate cancer patients. To understand the patient experience of delay in cancer surgery during the pandemic, we interviewed breast and prostate can","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Sokas","Claire","Department of Surgery, Center for Surgery and Public Health, Brigham and Woman's Hospital, Boston, MA, USA. csokas@bwh.harvard","csokas@bwh.harvard.edu"
"1341","34170430","10.1245/s10434-021-10319-0","Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.","During the height of the coronavirus disease 2019 (COVID-19) pandemic, elective surgeries, including oncologic surgeries, were delayed. Little prospective data existed to guide practice, and professional surgical societies issued recommendations grounded mainly in common sense and expert consensus, such as medical therapy for early-stage breast and prostate cancer patients. To understand the patient experience of delay in cancer surgery during the pandemic, we interviewed breast and prostate can","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Kelly","Masami","Department of Surgery, Center for Surgery and Public Health, Brigham and Woman's Hospital, Boston, MA, USA",NA
"1342","34170430","10.1245/s10434-021-10319-0","Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.","During the height of the coronavirus disease 2019 (COVID-19) pandemic, elective surgeries, including oncologic surgeries, were delayed. Little prospective data existed to guide practice, and professional surgical societies issued recommendations grounded mainly in common sense and expert consensus, such as medical therapy for early-stage breast and prostate cancer patients. To understand the patient experience of delay in cancer surgery during the pandemic, we interviewed breast and prostate can","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Sheu","Christina","Department of Surgery, Center for Surgery and Public Health, Brigham and Woman's Hospital, Boston, MA, USA",NA
"1343","34170430","10.1245/s10434-021-10319-0","Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.","During the height of the coronavirus disease 2019 (COVID-19) pandemic, elective surgeries, including oncologic surgeries, were delayed. Little prospective data existed to guide practice, and professional surgical societies issued recommendations grounded mainly in common sense and expert consensus, such as medical therapy for early-stage breast and prostate cancer patients. To understand the patient experience of delay in cancer surgery during the pandemic, we interviewed breast and prostate can","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Song","Julia","Harvard Medical School, Boston, MA, USA",NA
"1344","34170430","10.1245/s10434-021-10319-0","Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.","During the height of the coronavirus disease 2019 (COVID-19) pandemic, elective surgeries, including oncologic surgeries, were delayed. Little prospective data existed to guide practice, and professional surgical societies issued recommendations grounded mainly in common sense and expert consensus, such as medical therapy for early-stage breast and prostate cancer patients. To understand the patient experience of delay in cancer surgery during the pandemic, we interviewed breast and prostate can","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Welch","H Gilbert","Department of Surgery, Center for Surgery and Public Health, Brigham and Woman's Hospital, Boston, MA, USA",NA
"1345","34170430","10.1245/s10434-021-10319-0","Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.","During the height of the coronavirus disease 2019 (COVID-19) pandemic, elective surgeries, including oncologic surgeries, were delayed. Little prospective data existed to guide practice, and professional surgical societies issued recommendations grounded mainly in common sense and expert consensus, such as medical therapy for early-stage breast and prostate cancer patients. To understand the patient experience of delay in cancer surgery during the pandemic, we interviewed breast and prostate can","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Bergmark","Regan","Department of Surgery, Center for Surgery and Public Health, Brigham and Woman's Hospital, Boston, MA, USA",NA
"1346","34170430","10.1245/s10434-021-10319-0","Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.","During the height of the coronavirus disease 2019 (COVID-19) pandemic, elective surgeries, including oncologic surgeries, were delayed. Little prospective data existed to guide practice, and professional surgical societies issued recommendations grounded mainly in common sense and expert consensus, such as medical therapy for early-stage breast and prostate cancer patients. To understand the patient experience of delay in cancer surgery during the pandemic, we interviewed breast and prostate can","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Minami","Christina","Department of Surgery, Center for Surgery and Public Health, Brigham and Woman's Hospital, Boston, MA, USA",NA
"1347","34170430","10.1245/s10434-021-10319-0","Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.","During the height of the coronavirus disease 2019 (COVID-19) pandemic, elective surgeries, including oncologic surgeries, were delayed. Little prospective data existed to guide practice, and professional surgical societies issued recommendations grounded mainly in common sense and expert consensus, such as medical therapy for early-stage breast and prostate cancer patients. To understand the patient experience of delay in cancer surgery during the pandemic, we interviewed breast and prostate can","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Trinh","Quoc-Dien","Department of Surgery, Center for Surgery and Public Health, Brigham and Woman's Hospital, Boston, MA, USA",NA
"1348","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Angurana","Authors Suresh Kumar","Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatrics Centre",NA
"1349","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Awasthi","Puspraj","Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatrics Centre",NA
"1350","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Thakur","Ajay","Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatrics Centre",NA
"1351","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Randhawa","Manjinder Singh","Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatrics Centre",NA
"1352","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Nallasamy","Karthi","Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatrics Centre",NA
"1353","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Kumar","Manoj Rohit","Department of Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India",NA
"1354","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Naganur","Sanjeev","Department of Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India",NA
"1355","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Kumar","Mahendra","Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India",NA
"1356","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Goyal","Kapil","Department of Virology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India",NA
"1357","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Ghosh","Arnab","Department of Virology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India",NA
"1358","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Bansal","Arun","Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatrics Centre",NA
"1359","34170328","10.1093/tropej/fmab055","Intensive care needs and short-term outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.","To describe the intensive care needs and outcome of Multisystem Inflammatory Syndrome in Children (MIS-C). This retrospective study was conducted in the Pediatric Emergency and Intensive Care Units and COVID-19 hospital of a tertiary care teaching and referral hospital in North India over a period of 5 months (September 2020-January 2021). Clinical details, laboratory investigations, intensive care needs, treatment, and short-term outcome were recorded. Forty children with median (IQR) age of 7 ","2021","06","25","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; Critically ill children; Hyperinflammation; Intravenous Immunoglobulin; MIS-C; Mechanical Ventilation; Myocarditis; PICU; PIMS-TS; SARS-CoV-2; Steroids","Jayashree","Muralidharan","Division of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatrics Centre",NA
"1360","34170323","10.1093/tbm/ibab080","Motivating people to stay at home: using the Health Belief Model to improve the effectiveness of public health messaging during the COVID-19 pandemic.",NA,"2021","06","25","Transl Behav Med","Translational behavioral medicine","Health Belief Model; Persuasion; Public health messaging; Stay at home","Maunder","Larah","Department of Psychology, Queen's University, Kingston, Ontario, Canada",NA
"1361","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Suhandynata","Raymond T","Department of Pathology UC San Diego Health, San Diego CA",NA
"1362","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Bevins","Nicholas J","Department of Pathology UC San Diego Health, San Diego CA",NA
"1363","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Tran","Jenny T","Department of Immunology and Microbiology, The Scripps Research Institution, San Diego, CA",NA
"1364","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Huang","Deli","Department of Immunology and Microbiology, The Scripps Research Institution, San Diego, CA",NA
"1365","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Hoffman","Melissa A","Department of Pathology UC San Diego Health, San Diego CA",NA
"1366","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Lund","Kyle","Department of Pathology UC San Diego Health, San Diego CA",NA
"1367","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Kelner","Michael J","Department of Pathology UC San Diego Health, San Diego CA",NA
"1368","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","McLawhon","Ronald W","Department of Pathology UC San Diego Health, San Diego CA",NA
"1369","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Gonias","Steven L","Department of Pathology UC San Diego Health, San Diego CA",NA
"1370","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Nemazee","David","Department of Immunology and Microbiology, The Scripps Research Institution, San Diego, CA",NA
"1371","34170314","10.1093/jalm/jfab080","SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated. The ability of four commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 SARS-CoV-2 PCR-positive patients, 89 SARS-CoV-2-vaccinated healthcare workers (Pfi","2021","06","29","J Appl Lab Med","The journal of applied laboratory medicine","COVID-19; Commercial Assays; Neutralizing Antibodies; SARS-CoV-2; Serology; Vaccines","Fitzgerald","Robert L","Department of Pathology UC San Diego Health, San Diego CA",NA
"1372","34170307","10.1001/jamanetworkopen.2021.14526","Utility of Mass SARS-CoV-2 Testing of Asymptomatic Patients Before Ambulatory and Inpatient Preplanned Procedures Requiring Moderate Sedation or General Anesthesia.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adult; Aged; Anesthesia, General; Asymptomatic Diseases; COVID-19 Testing; Conscious Sedation; Female; Humans; Male; Mass Screening; Methods; Middle Aged; Quality Improvement","Roberts","Scott C","Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut",NA
"1373","34170307","10.1001/jamanetworkopen.2021.14526","Utility of Mass SARS-CoV-2 Testing of Asymptomatic Patients Before Ambulatory and Inpatient Preplanned Procedures Requiring Moderate Sedation or General Anesthesia.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adult; Aged; Anesthesia, General; Asymptomatic Diseases; COVID-19 Testing; Conscious Sedation; Female; Humans; Male; Mass Screening; Methods; Middle Aged; Quality Improvement","Peaper","David R","Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut",NA
"1374","34170307","10.1001/jamanetworkopen.2021.14526","Utility of Mass SARS-CoV-2 Testing of Asymptomatic Patients Before Ambulatory and Inpatient Preplanned Procedures Requiring Moderate Sedation or General Anesthesia.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adult; Aged; Anesthesia, General; Asymptomatic Diseases; COVID-19 Testing; Conscious Sedation; Female; Humans; Male; Mass Screening; Methods; Middle Aged; Quality Improvement","Sussman","L Scott","Clinical Redesign, Yale New Haven Health, New Haven, Connecticut",NA
"1375","34170307","10.1001/jamanetworkopen.2021.14526","Utility of Mass SARS-CoV-2 Testing of Asymptomatic Patients Before Ambulatory and Inpatient Preplanned Procedures Requiring Moderate Sedation or General Anesthesia.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adult; Aged; Anesthesia, General; Asymptomatic Diseases; COVID-19 Testing; Conscious Sedation; Female; Humans; Male; Mass Screening; Methods; Middle Aged; Quality Improvement","Martinello","Richard A","Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut",NA
"1376","34170307","10.1001/jamanetworkopen.2021.14526","Utility of Mass SARS-CoV-2 Testing of Asymptomatic Patients Before Ambulatory and Inpatient Preplanned Procedures Requiring Moderate Sedation or General Anesthesia.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adult; Aged; Anesthesia, General; Asymptomatic Diseases; COVID-19 Testing; Conscious Sedation; Female; Humans; Male; Mass Screening; Methods; Middle Aged; Quality Improvement","Pettker","Christian M","Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut",NA
"1377","34170306","10.1001/jamanetworkopen.2021.14531","Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19 Vaccines; Canada; Drug Approval; Europe; Humans; Immunization Programs; Quality Improvement; United States; United States Food and Drug Administration","Lythgoe","Mark P","Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom",NA
"1378","34170306","10.1001/jamanetworkopen.2021.14531","Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19 Vaccines; Canada; Drug Approval; Europe; Humans; Immunization Programs; Quality Improvement; United States; United States Food and Drug Administration","Middleton","Paul","Department of Metabolism, Digestion and Reproduction, Imperial College London, St Mary's Hospital, United Kingdom",NA
"1379","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Hamer","Davidson H","Department of Global Health, Boston University School of Public Health, Boston, Massachusetts",NA
"1380","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","White","Laura F","Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts",NA
"1381","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Jenkins","Helen E","Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts",NA
"1382","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Gill","Christopher J","Department of Global Health, Boston University School of Public Health, Boston, Massachusetts",NA
"1383","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Landsberg","Hannah E","Student Health Services, Healthway, Boston University, Boston, Massachusetts",NA
"1384","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Klapperich","Catherine","Precision Diagnostics Center, Boston University, Boston, Massachusetts",NA
"1385","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Bulekova","Katia","Information Services and Technology, Boston University, Boston, Massachusetts",NA
"1386","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Platt","Judy","Student Health Services, Healthway, Boston University, Boston, Massachusetts",NA
"1387","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Decarie","Linette","Boston University Analytical Services &amp",NA
"1388","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Gilmore","Wayne","Information Services and Technology, Boston University, Boston, Massachusetts",NA
"1389","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Pilkington","Megan","Boston University Analytical Services &amp",NA
"1390","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","MacDowell","Trevor L","Information Services and Technology, Boston University, Boston, Massachusetts",NA
"1391","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Faria","Mark A","Information Services and Technology, Boston University, Boston, Massachusetts",NA
"1392","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Densmore","Douglas","Electrical and Computer Engineering, Boston University, Boston, Massachusetts",NA
"1393","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Landaverde","Lena","Student Health Services, Healthway, Boston University, Boston, Massachusetts",NA
"1394","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Li","Wenrui","Department of Mathematics and Statistics, Boston University, Boston, Massachusetts",NA
"1395","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Rose","Tom","Human Resources, Boston University, Boston, Massachusetts",NA
"1396","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Burgay","Stephen P","Office of External Affairs, Boston University, Boston, Massachusetts",NA
"1397","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Miller","Candice","BU Clinical Testing Laboratory, Research Department, Boston University, Boston, Massachusetts",NA
"1398","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Doucette-Stamm","Lynn","BU Clinical Testing Laboratory, Research Department, Boston University, Boston, Massachusetts",NA
"1399","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Lockard","Kelly","Continuous Improvement &amp",NA
"1400","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Elmore","Kenneth","Office of the Provost, Boston University, Boston, Massachusetts",NA
"1401","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Schroeder","Tracy","Information Services and Technology, Boston University, Boston, Massachusetts",NA
"1402","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Zaia","Ann M","Occupational Health Center, Boston University, Boston Massachusetts",NA
"1403","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Kolaczyk","Eric D","Department of Mathematics and Statistics, Boston University, Boston, Massachusetts",NA
"1404","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Waters","Gloria","Office of the Provost, Boston University, Boston, Massachusetts",NA
"1405","34170303","10.1001/jamanetworkopen.2021.16425","Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.","The COVID-19 pandemic has severely disrupted US educational institutions. Given potential adverse financial and psychosocial effects of campus closures, many institutions developed strategies to reopen campuses in the fall 2020 semester despite the ongoing threat of COVID-19. However, many institutions opted to have limited campus reopening to minimize potential risk of spread of SARS-CoV-2. To analyze how Boston University (BU) fully reopened its campus in the fall of 2020 and controlled COVID-","2021","07","05","JAMA Netw Open","JAMA network open","Boston; COVID-19; Contact Tracing; Hand Hygiene; Humans; Infection Control; Quarantine; Universities; Urban Population","Brown","Robert A","College of Engineering, Boston University, Boston, Massachusetts",NA
"1406","34170299","10.5858/arpa.2021-0221-LE","The Coronavirus Disease 2019 (COVID-19) Pandemic's Impact on Social Interaction in Pathology.",NA,"2021","06","25","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Montironi","Rodolfo","Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy",NA
"1407","34170299","10.5858/arpa.2021-0221-LE","The Coronavirus Disease 2019 (COVID-19) Pandemic's Impact on Social Interaction in Pathology.",NA,"2021","06","25","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Cimadamore","Alessia","Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy",NA
"1408","34170299","10.5858/arpa.2021-0221-LE","The Coronavirus Disease 2019 (COVID-19) Pandemic's Impact on Social Interaction in Pathology.",NA,"2021","06","25","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Cheng","Liang","Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis",NA
"1409","34170299","10.5858/arpa.2021-0221-LE","The Coronavirus Disease 2019 (COVID-19) Pandemic's Impact on Social Interaction in Pathology.",NA,"2021","06","25","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Lopez-Beltran","Antonio","Department of Morphological Sciences, Cordoba University Medical School, Cordoba, Spain",NA
"1410","34170299","10.5858/arpa.2021-0221-LE","The Coronavirus Disease 2019 (COVID-19) Pandemic's Impact on Social Interaction in Pathology.",NA,"2021","06","25","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Scarpelli","Marina","Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy",NA
"1411","34170290","10.1242/dev.188367","Science shines in a new virtual SY-Stem.","The third 'Symposium for the Next Generation of Stem Cell Research' (SY-Stem) was held virtually on 3-5 March 2021, having been cancelled in 2020 due to the COVID-19 pandemic. As in previous years, the meeting highlighted the work of early career researchers, ranging from postgraduate students to young group leaders working in developmental and stem cell biology. Here, we summarize the excellent work presented at the Symposium, which covered topics ranging from pluripotency, species-specific asp","2021","06","30","Development","Development (Cambridge, England)","Differentiation; Organoid; Pluripotent; Single cell; Stem cell; Animals; COVID-19; Cell Differentiation; Congresses as Topic; History, 21st Century; Humans; Internet; Inventions; Online Systems; Pandemics; Single-Cell Analysis; Stem Cell Research; Stem Cells; Tissue Culture Techniques","Buecker","Christa","Max Perutz Labs Vienna, University of Vienna, Vienna BioCenter, Dr Bohr Gasse 9, 1030 Vienna, Austria",NA
"1412","34170290","10.1242/dev.188367","Science shines in a new virtual SY-Stem.","The third 'Symposium for the Next Generation of Stem Cell Research' (SY-Stem) was held virtually on 3-5 March 2021, having been cancelled in 2020 due to the COVID-19 pandemic. As in previous years, the meeting highlighted the work of early career researchers, ranging from postgraduate students to young group leaders working in developmental and stem cell biology. Here, we summarize the excellent work presented at the Symposium, which covered topics ranging from pluripotency, species-specific asp","2021","06","30","Development","Development (Cambridge, England)","Differentiation; Organoid; Pluripotent; Single cell; Stem cell; Animals; COVID-19; Cell Differentiation; Congresses as Topic; History, 21st Century; Humans; Internet; Inventions; Online Systems; Pandemics; Single-Cell Analysis; Stem Cell Research; Stem Cells; Tissue Culture Techniques","Merkle","Florian T","Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, Wellcome Trust - Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK",NA
"1413","34170283","10.1093/ajhp/zxab257","A pharmacist-managed virtual consult service to improve tuberculosis screening.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. To describe a pharmacist-managed ","2021","06","25","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Sasnovskaya","Veranika","University of Illinois at Chicago Hospital and Health Sciences System, Chicago, IL, and Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA",NA
"1414","34170283","10.1093/ajhp/zxab257","A pharmacist-managed virtual consult service to improve tuberculosis screening.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. To describe a pharmacist-managed ","2021","06","25","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Kumor","Lisa M","University of Illinois at Chicago Hospital and Health Sciences System, Chicago, IL, and Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA",NA
"1415","34170283","10.1093/ajhp/zxab257","A pharmacist-managed virtual consult service to improve tuberculosis screening.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. To describe a pharmacist-managed ","2021","06","25","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Stubbings","JoAnn","Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA",NA
"1416","34170283","10.1093/ajhp/zxab257","A pharmacist-managed virtual consult service to improve tuberculosis screening.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. To describe a pharmacist-managed ","2021","06","25","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Chevalier","Aimee","Clinical Pharmacist, Arthritis and Kidney Center, University of Illinois Hospital and Health Sciences System, Chicago, IL, and Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA",NA
"1417","34170193","10.1080/14015439.2021.1939413","Stress and autonomic dysfunction symptoms related to voice in Brazilian university professors during the covid-19 pandemic.","To analyze the association of autonomic dysfunction symptoms with stress in Brazilian university professors of the Speech Language-Pathology course during the Covid-19 pandemic. Fifty-five Brazilian university professors participated in the study, with a mean age of 42 years and 10 months old (±8.75), 49 female and six male subjects. The evaluated outcomes were the symptoms of stress and self-assessment of autonomic dysfunction symptoms. The results were inferentially analyzed using binary logis","2021","07","15","Logoped Phoniatr Vocol","Logopedics, phoniatrics, vocology","Coronavirus; pandemics; signs and symptoms; stress; voice","Veis Ribeiro","Vanessa","Department of Speech Language-Pathology, Universidade Federal de Sergipe, Lagarto, Sergipe, Brazil",NA
"1418","34170193","10.1080/14015439.2021.1939413","Stress and autonomic dysfunction symptoms related to voice in Brazilian university professors during the covid-19 pandemic.","To analyze the association of autonomic dysfunction symptoms with stress in Brazilian university professors of the Speech Language-Pathology course during the Covid-19 pandemic. Fifty-five Brazilian university professors participated in the study, with a mean age of 42 years and 10 months old (±8.75), 49 female and six male subjects. The evaluated outcomes were the symptoms of stress and self-assessment of autonomic dysfunction symptoms. The results were inferentially analyzed using binary logis","2021","07","15","Logoped Phoniatr Vocol","Logopedics, phoniatrics, vocology","Coronavirus; pandemics; signs and symptoms; stress; voice","Silva","Kelly da","Department of Speech Language-Pathology, Universidade Federal de Sergipe, Lagarto, Sergipe, Brazil",NA
"1419","34170193","10.1080/14015439.2021.1939413","Stress and autonomic dysfunction symptoms related to voice in Brazilian university professors during the covid-19 pandemic.","To analyze the association of autonomic dysfunction symptoms with stress in Brazilian university professors of the Speech Language-Pathology course during the Covid-19 pandemic. Fifty-five Brazilian university professors participated in the study, with a mean age of 42 years and 10 months old (±8.75), 49 female and six male subjects. The evaluated outcomes were the symptoms of stress and self-assessment of autonomic dysfunction symptoms. The results were inferentially analyzed using binary logis","2021","07","15","Logoped Phoniatr Vocol","Logopedics, phoniatrics, vocology","Coronavirus; pandemics; signs and symptoms; stress; voice","Guedes-Granzotti","Raphaela Barroso","Department of Speech Language-Pathology, Universidade Federal de Sergipe, Lagarto, Sergipe, Brazil",NA
"1420","34170193","10.1080/14015439.2021.1939413","Stress and autonomic dysfunction symptoms related to voice in Brazilian university professors during the covid-19 pandemic.","To analyze the association of autonomic dysfunction symptoms with stress in Brazilian university professors of the Speech Language-Pathology course during the Covid-19 pandemic. Fifty-five Brazilian university professors participated in the study, with a mean age of 42 years and 10 months old (±8.75), 49 female and six male subjects. The evaluated outcomes were the symptoms of stress and self-assessment of autonomic dysfunction symptoms. The results were inferentially analyzed using binary logis","2021","07","15","Logoped Phoniatr Vocol","Logopedics, phoniatrics, vocology","Coronavirus; pandemics; signs and symptoms; stress; voice","César","Carla Patrícia Hernandez Alves Ribeiro","Department of Speech Language-Pathology, Universidade Federal de Sergipe, Lagarto, Sergipe, Brazil",NA
"1421","34170193","10.1080/14015439.2021.1939413","Stress and autonomic dysfunction symptoms related to voice in Brazilian university professors during the covid-19 pandemic.","To analyze the association of autonomic dysfunction symptoms with stress in Brazilian university professors of the Speech Language-Pathology course during the Covid-19 pandemic. Fifty-five Brazilian university professors participated in the study, with a mean age of 42 years and 10 months old (±8.75), 49 female and six male subjects. The evaluated outcomes were the symptoms of stress and self-assessment of autonomic dysfunction symptoms. The results were inferentially analyzed using binary logis","2021","07","15","Logoped Phoniatr Vocol","Logopedics, phoniatrics, vocology","Coronavirus; pandemics; signs and symptoms; stress; voice","Pinatti Moreira","Patrícia","Department of Speech Language-Pathology, Universidade Federal de Sergipe, Lagarto, Sergipe, Brazil",NA
"1422","34170193","10.1080/14015439.2021.1939413","Stress and autonomic dysfunction symptoms related to voice in Brazilian university professors during the covid-19 pandemic.","To analyze the association of autonomic dysfunction symptoms with stress in Brazilian university professors of the Speech Language-Pathology course during the Covid-19 pandemic. Fifty-five Brazilian university professors participated in the study, with a mean age of 42 years and 10 months old (±8.75), 49 female and six male subjects. The evaluated outcomes were the symptoms of stress and self-assessment of autonomic dysfunction symptoms. The results were inferentially analyzed using binary logis","2021","07","15","Logoped Phoniatr Vocol","Logopedics, phoniatrics, vocology","Coronavirus; pandemics; signs and symptoms; stress; voice","Santos","Nathalia Monteiro","Postgraduate Program in Speech Language-Pathology, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil",NA
"1423","34170193","10.1080/14015439.2021.1939413","Stress and autonomic dysfunction symptoms related to voice in Brazilian university professors during the covid-19 pandemic.","To analyze the association of autonomic dysfunction symptoms with stress in Brazilian university professors of the Speech Language-Pathology course during the Covid-19 pandemic. Fifty-five Brazilian university professors participated in the study, with a mean age of 42 years and 10 months old (±8.75), 49 female and six male subjects. The evaluated outcomes were the symptoms of stress and self-assessment of autonomic dysfunction symptoms. The results were inferentially analyzed using binary logis","2021","07","15","Logoped Phoniatr Vocol","Logopedics, phoniatrics, vocology","Coronavirus; pandemics; signs and symptoms; stress; voice","Dornelas","Rodrigo","Department of Speech Language-Pathology, Universidade Federal de Sergipe, Lagarto, Sergipe, Brazil",NA
"1424","34170122","10.1021/acsnano.1c03249","Photocatalytic Rejuvenation Enabled Self-Sanitizing, Reusable, and Biodegradable Masks against COVID-19.","Personal protective equipment (PPE) has been highly recommended by the U.S. Centers for Disease Control and Prevention for self-protection during the disastrous SARS-CoV-2 (COVID-19) pandemic. Nevertheless, massive utilization of PPE encounters significant challenges in recycling and sterilizing the used masks. To tackle the associated plastic pollution of used masks, in this work, we designed a reusable, biodegradable, and antibacterial mask. The mask was fabricated by the electrospinning of po","2021","07","09","ACS Nano","ACS nano","COVID-19; N-TiO2; environmental friendliness; mask rejuvenation; mask reuse; photocatalysis","Li","Qiang","Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts 02115, United States",NA
"1425","34170122","10.1021/acsnano.1c03249","Photocatalytic Rejuvenation Enabled Self-Sanitizing, Reusable, and Biodegradable Masks against COVID-19.","Personal protective equipment (PPE) has been highly recommended by the U.S. Centers for Disease Control and Prevention for self-protection during the disastrous SARS-CoV-2 (COVID-19) pandemic. Nevertheless, massive utilization of PPE encounters significant challenges in recycling and sterilizing the used masks. To tackle the associated plastic pollution of used masks, in this work, we designed a reusable, biodegradable, and antibacterial mask. The mask was fabricated by the electrospinning of po","2021","07","09","ACS Nano","ACS nano","COVID-19; N-TiO2; environmental friendliness; mask rejuvenation; mask reuse; photocatalysis","Yin","Yongchao","Department of Biology, Northeastern University, Boston, Massachusetts 02115, United States",NA
"1426","34170122","10.1021/acsnano.1c03249","Photocatalytic Rejuvenation Enabled Self-Sanitizing, Reusable, and Biodegradable Masks against COVID-19.","Personal protective equipment (PPE) has been highly recommended by the U.S. Centers for Disease Control and Prevention for self-protection during the disastrous SARS-CoV-2 (COVID-19) pandemic. Nevertheless, massive utilization of PPE encounters significant challenges in recycling and sterilizing the used masks. To tackle the associated plastic pollution of used masks, in this work, we designed a reusable, biodegradable, and antibacterial mask. The mask was fabricated by the electrospinning of po","2021","07","09","ACS Nano","ACS nano","COVID-19; N-TiO2; environmental friendliness; mask rejuvenation; mask reuse; photocatalysis","Cao","Daxian","Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts 02115, United States",NA
"1427","34170122","10.1021/acsnano.1c03249","Photocatalytic Rejuvenation Enabled Self-Sanitizing, Reusable, and Biodegradable Masks against COVID-19.","Personal protective equipment (PPE) has been highly recommended by the U.S. Centers for Disease Control and Prevention for self-protection during the disastrous SARS-CoV-2 (COVID-19) pandemic. Nevertheless, massive utilization of PPE encounters significant challenges in recycling and sterilizing the used masks. To tackle the associated plastic pollution of used masks, in this work, we designed a reusable, biodegradable, and antibacterial mask. The mask was fabricated by the electrospinning of po","2021","07","09","ACS Nano","ACS nano","COVID-19; N-TiO2; environmental friendliness; mask rejuvenation; mask reuse; photocatalysis","Wang","Ying","Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts 02115, United States",NA
"1428","34170122","10.1021/acsnano.1c03249","Photocatalytic Rejuvenation Enabled Self-Sanitizing, Reusable, and Biodegradable Masks against COVID-19.","Personal protective equipment (PPE) has been highly recommended by the U.S. Centers for Disease Control and Prevention for self-protection during the disastrous SARS-CoV-2 (COVID-19) pandemic. Nevertheless, massive utilization of PPE encounters significant challenges in recycling and sterilizing the used masks. To tackle the associated plastic pollution of used masks, in this work, we designed a reusable, biodegradable, and antibacterial mask. The mask was fabricated by the electrospinning of po","2021","07","09","ACS Nano","ACS nano","COVID-19; N-TiO2; environmental friendliness; mask rejuvenation; mask reuse; photocatalysis","Luan","Pengcheng","Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts 02115, United States",NA
"1429","34170122","10.1021/acsnano.1c03249","Photocatalytic Rejuvenation Enabled Self-Sanitizing, Reusable, and Biodegradable Masks against COVID-19.","Personal protective equipment (PPE) has been highly recommended by the U.S. Centers for Disease Control and Prevention for self-protection during the disastrous SARS-CoV-2 (COVID-19) pandemic. Nevertheless, massive utilization of PPE encounters significant challenges in recycling and sterilizing the used masks. To tackle the associated plastic pollution of used masks, in this work, we designed a reusable, biodegradable, and antibacterial mask. The mask was fabricated by the electrospinning of po","2021","07","09","ACS Nano","ACS nano","COVID-19; N-TiO2; environmental friendliness; mask rejuvenation; mask reuse; photocatalysis","Sun","Xiao","Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts 02115, United States",NA
"1430","34170122","10.1021/acsnano.1c03249","Photocatalytic Rejuvenation Enabled Self-Sanitizing, Reusable, and Biodegradable Masks against COVID-19.","Personal protective equipment (PPE) has been highly recommended by the U.S. Centers for Disease Control and Prevention for self-protection during the disastrous SARS-CoV-2 (COVID-19) pandemic. Nevertheless, massive utilization of PPE encounters significant challenges in recycling and sterilizing the used masks. To tackle the associated plastic pollution of used masks, in this work, we designed a reusable, biodegradable, and antibacterial mask. The mask was fabricated by the electrospinning of po","2021","07","09","ACS Nano","ACS nano","COVID-19; N-TiO2; environmental friendliness; mask rejuvenation; mask reuse; photocatalysis","Liang","Wentao","Kostas Advanced Nanocharacterization Facility (KANCF), Northeastern University, Burlington, Massachusetts 01803, United States",NA
"1431","34170122","10.1021/acsnano.1c03249","Photocatalytic Rejuvenation Enabled Self-Sanitizing, Reusable, and Biodegradable Masks against COVID-19.","Personal protective equipment (PPE) has been highly recommended by the U.S. Centers for Disease Control and Prevention for self-protection during the disastrous SARS-CoV-2 (COVID-19) pandemic. Nevertheless, massive utilization of PPE encounters significant challenges in recycling and sterilizing the used masks. To tackle the associated plastic pollution of used masks, in this work, we designed a reusable, biodegradable, and antibacterial mask. The mask was fabricated by the electrospinning of po","2021","07","09","ACS Nano","ACS nano","COVID-19; N-TiO2; environmental friendliness; mask rejuvenation; mask reuse; photocatalysis","Zhu","Hongli","Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts 02115, United States",NA
"1432","34170089","10.4142/jvs.2021.22.e48","Assessing the risk of recurrence of porcine epidemic diarrhea virus in affected farms on Jeju Island, South Korea.","Porcine epidemic diarrhea virus (PEDV) is a swine enteropathogenic coronavirus that has devastated the swine industry in South Korea over the last 30 years. The lack of an effective method to control the endemics has led to a surge in PEDV recurrences in affected farms throughout the country. In the first step toward establishing systematic monitoring of and active control measures over the swine populations, we constructed an assessment model that evaluates the status of (1) biosecurity, (2) he","2021","06","25","J Vet Sci","Journal of veterinary science","Biosecurity; PEDV; endemic; sow immunity; virus circulation","Jang","Guehwan","Animal Virology Laboratory, School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Korea",NA
"1433","34170089","10.4142/jvs.2021.22.e48","Assessing the risk of recurrence of porcine epidemic diarrhea virus in affected farms on Jeju Island, South Korea.","Porcine epidemic diarrhea virus (PEDV) is a swine enteropathogenic coronavirus that has devastated the swine industry in South Korea over the last 30 years. The lack of an effective method to control the endemics has led to a surge in PEDV recurrences in affected farms throughout the country. In the first step toward establishing systematic monitoring of and active control measures over the swine populations, we constructed an assessment model that evaluates the status of (1) biosecurity, (2) he","2021","06","25","J Vet Sci","Journal of veterinary science","Biosecurity; PEDV; endemic; sow immunity; virus circulation","Lee","Sunhee","Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea",NA
"1434","34170089","10.4142/jvs.2021.22.e48","Assessing the risk of recurrence of porcine epidemic diarrhea virus in affected farms on Jeju Island, South Korea.","Porcine epidemic diarrhea virus (PEDV) is a swine enteropathogenic coronavirus that has devastated the swine industry in South Korea over the last 30 years. The lack of an effective method to control the endemics has led to a surge in PEDV recurrences in affected farms throughout the country. In the first step toward establishing systematic monitoring of and active control measures over the swine populations, we constructed an assessment model that evaluates the status of (1) biosecurity, (2) he","2021","06","25","J Vet Sci","Journal of veterinary science","Biosecurity; PEDV; endemic; sow immunity; virus circulation","Lee","Changhee","Animal Virology Laboratory, School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Korea. changhee@knu.ac","changhee@knu.ac.kr"
"1435","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Richter","Dimitrios","Euroclinic Hospital, Athens, Greece",NA
"1436","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Guasti","Luigina","University of Insubria, ASST dei Sette Laghi, Varese, Italy",NA
"1437","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Koehler","Friedrich","Medical Department, Division of Cardiology and Angiology, Centre for Cardiovascular Telemedicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany",NA
"1438","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Squizzato","Alessandro","University of Insubria, ASST Lariana, Como, Italy",NA
"1439","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Nistri","Stefano","CMSR Veneto Medica-Cardiology Service, Altavilla Vicentina, Italy",NA
"1440","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Christodorescu","Ruxandra","Victor Babes University of Medicine and Pharmacy, Timi<U+0219>oara, Romania",NA
"1441","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Dievart","Francois","ELSAN Clinique Villette, Dunkirk, France",NA
"1442","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Gaudio","Giovanni","University of Insubria, ASST dei Sette Laghi, Varese, Italy",NA
"1443","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Asteggiano","Riccardo","University of Insubria, ASST dei Sette Laghi, Varese, Italy",NA
"1444","34170086","10.1002/ehf2.13466","Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.","Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infectio","2021","07","02","ESC Heart Fail","ESC heart failure","COVID-19; Digital health; General cardiology; Late phase; Myocardial injury; Pandemic; Pneumonia; Post-COVID; SARS-CoV-2; Telemedicine; Wearables; Long COVID-19 illness","Ferrini","Marc","CH Saint Joseph et Saint Luc, Lyon, France",NA
"1445","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","de Melo","Guilherme Dias","Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France",NA
"1446","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Lazarini","Françoise","Perception and Memory Unit, Institut Pasteur, CNRS UMR 3571, Paris, France",NA
"1447","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Larrous","Florence","Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France",NA
"1448","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Feige","Lena","Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France",NA
"1449","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Kornobis","Etienne","Biomics Technological Platform, Center for Technological Resources and Research (C2RT), Institut Pasteur, Paris, France",NA
"1450","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Levallois","Sylvain","Biology of Infection Unit, Institut Pasteur, Inserm U1117, Paris, France",NA
"1451","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Marchio","Agnès","Nuclear Organization and Oncogenesis Unit, Institut Pasteur, Paris, France",NA
"1452","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Kergoat","Lauriane","Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France",NA
"1453","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Hardy","David","Experimental Neuropathology Unit, Institut Pasteur, Paris, France",NA
"1454","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Cokelaer","Thomas","Biomics Technological Platform, Center for Technological Resources and Research (C2RT), Institut Pasteur, Paris, France",NA
"1455","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Pineau","Pascal","Nuclear Organization and Oncogenesis Unit, Institut Pasteur, Paris, France",NA
"1456","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Lecuit","Marc","Biology of Infection Unit, Institut Pasteur, Inserm U1117, Paris, France",NA
"1457","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Lledo","Pierre-Marie","Perception and Memory Unit, Institut Pasteur, CNRS UMR 3571, Paris, France",NA
"1458","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Changeux","Jean-Pierre","Neuroscience Department, Institut Pasteur, Collège de France, Paris, France",NA
"1459","34170074","10.15252/emmm.202114122","Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.","The devastating pandemic due to SARS-CoV-2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID-19, including the contribution of inflammation to disease. It also warrants for the search of immunomodulatory drugs that could improve disease outcome. Here, we show that standard doses of ivermectin (IVM), an anti-parasitic drug with potential immunomodulatory activities throug","2021","07","12","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; coronavirus; inflammation; ivermectin; viral infections","Bourhy","Hervé","Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France",NA
"1460","34170008","10.1111/bjh.17631","Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.",NA,"2021","06","25","Br J Haematol","British journal of haematology","SARS-CoV-2; anti-PF4 antibodies; immune thrombocytopenic purpura; primary immune thrombocytopenia; vaccine","De Stefano","Valerio","Diagnostic Imaging, Oncological Radiotherapy, and Hematology department, Fondazione Universitaria Policlinico A. Gemelli-IRCCS-Catholic University of Sacred Heart of Rome, Roma, Italy",NA
"1461","34170008","10.1111/bjh.17631","Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.",NA,"2021","06","25","Br J Haematol","British journal of haematology","SARS-CoV-2; anti-PF4 antibodies; immune thrombocytopenic purpura; primary immune thrombocytopenia; vaccine","Candelli","Marcello","Emergency Medicine Department, Fondazione Universitaria Policlinico A. Gemelli-IRCCS-Catholic University of Sacred Heart of Rome, Roma, Italy",NA
"1462","34170008","10.1111/bjh.17631","Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.",NA,"2021","06","25","Br J Haematol","British journal of haematology","SARS-CoV-2; anti-PF4 antibodies; immune thrombocytopenic purpura; primary immune thrombocytopenia; vaccine","Rossi","Elena","Diagnostic Imaging, Oncological Radiotherapy, and Hematology department, Fondazione Universitaria Policlinico A. Gemelli-IRCCS-Catholic University of Sacred Heart of Rome, Roma, Italy",NA
"1463","34170008","10.1111/bjh.17631","Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.",NA,"2021","06","25","Br J Haematol","British journal of haematology","SARS-CoV-2; anti-PF4 antibodies; immune thrombocytopenic purpura; primary immune thrombocytopenia; vaccine","Franceschi","Francesco","Emergency Medicine Department, Fondazione Universitaria Policlinico A. Gemelli-IRCCS-Catholic University of Sacred Heart of Rome, Roma, Italy",NA
"1464","34170003","10.33588/rn.7301.2021042","[Weakness as a complication of COVID-19 in critically ill patients: clinical features and prognostic factors in a case series].","Weakness is a frequent complication in those critically ill due to COVID-19. This study describes its characteristics and the factors that can condition and predict it. We conducted a prospective, descriptive, observational study of patients admitted to the intensive care unit (ICU) due to COVID-19 between April and May 2020 with muscle weakness. A motor balance equal to or lower than 3/5 according to the modified Medical Research Council muscle strength scale was considered to be severe clinica","2021","07","15","Rev Neurol","Revista de neurologia","Adult; Aged; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Muscle Weakness; Prognosis; Prospective Studies","Ballvé","A","Hospital Universitari Vall d'Hebron, 08035 Barcelona, España",NA
"1465","34170003","10.33588/rn.7301.2021042","[Weakness as a complication of COVID-19 in critically ill patients: clinical features and prognostic factors in a case series].","Weakness is a frequent complication in those critically ill due to COVID-19. This study describes its characteristics and the factors that can condition and predict it. We conducted a prospective, descriptive, observational study of patients admitted to the intensive care unit (ICU) due to COVID-19 between April and May 2020 with muscle weakness. A motor balance equal to or lower than 3/5 according to the modified Medical Research Council muscle strength scale was considered to be severe clinica","2021","07","15","Rev Neurol","Revista de neurologia","Adult; Aged; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Muscle Weakness; Prognosis; Prospective Studies","Llauradó","A","Hospital Universitari Vall d'Hebron, 08035 Barcelona, España",NA
"1466","34170003","10.33588/rn.7301.2021042","[Weakness as a complication of COVID-19 in critically ill patients: clinical features and prognostic factors in a case series].","Weakness is a frequent complication in those critically ill due to COVID-19. This study describes its characteristics and the factors that can condition and predict it. We conducted a prospective, descriptive, observational study of patients admitted to the intensive care unit (ICU) due to COVID-19 between April and May 2020 with muscle weakness. A motor balance equal to or lower than 3/5 according to the modified Medical Research Council muscle strength scale was considered to be severe clinica","2021","07","15","Rev Neurol","Revista de neurologia","Adult; Aged; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Muscle Weakness; Prognosis; Prospective Studies","Palasí","A","Hospital Universitari Vall d'Hebron, 08035 Barcelona, España",NA
"1467","34170003","10.33588/rn.7301.2021042","[Weakness as a complication of COVID-19 in critically ill patients: clinical features and prognostic factors in a case series].","Weakness is a frequent complication in those critically ill due to COVID-19. This study describes its characteristics and the factors that can condition and predict it. We conducted a prospective, descriptive, observational study of patients admitted to the intensive care unit (ICU) due to COVID-19 between April and May 2020 with muscle weakness. A motor balance equal to or lower than 3/5 according to the modified Medical Research Council muscle strength scale was considered to be severe clinica","2021","07","15","Rev Neurol","Revista de neurologia","Adult; Aged; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Muscle Weakness; Prognosis; Prospective Studies","Quintana","M","Hospital Universitari Vall d'Hebron, 08035 Barcelona, España",NA
"1468","34170003","10.33588/rn.7301.2021042","[Weakness as a complication of COVID-19 in critically ill patients: clinical features and prognostic factors in a case series].","Weakness is a frequent complication in those critically ill due to COVID-19. This study describes its characteristics and the factors that can condition and predict it. We conducted a prospective, descriptive, observational study of patients admitted to the intensive care unit (ICU) due to COVID-19 between April and May 2020 with muscle weakness. A motor balance equal to or lower than 3/5 according to the modified Medical Research Council muscle strength scale was considered to be severe clinica","2021","07","15","Rev Neurol","Revista de neurologia","Adult; Aged; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Muscle Weakness; Prognosis; Prospective Studies","Martínez-Sáez","E","Hospital Universitari Vall d'Hebron, 08035 Barcelona, España",NA
"1469","34170003","10.33588/rn.7301.2021042","[Weakness as a complication of COVID-19 in critically ill patients: clinical features and prognostic factors in a case series].","Weakness is a frequent complication in those critically ill due to COVID-19. This study describes its characteristics and the factors that can condition and predict it. We conducted a prospective, descriptive, observational study of patients admitted to the intensive care unit (ICU) due to COVID-19 between April and May 2020 with muscle weakness. A motor balance equal to or lower than 3/5 according to the modified Medical Research Council muscle strength scale was considered to be severe clinica","2021","07","15","Rev Neurol","Revista de neurologia","Adult; Aged; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Muscle Weakness; Prognosis; Prospective Studies","Laínez","E","Hospital Universitari Vall d'Hebron, 08035 Barcelona, España",NA
"1470","34170003","10.33588/rn.7301.2021042","[Weakness as a complication of COVID-19 in critically ill patients: clinical features and prognostic factors in a case series].","Weakness is a frequent complication in those critically ill due to COVID-19. This study describes its characteristics and the factors that can condition and predict it. We conducted a prospective, descriptive, observational study of patients admitted to the intensive care unit (ICU) due to COVID-19 between April and May 2020 with muscle weakness. A motor balance equal to or lower than 3/5 according to the modified Medical Research Council muscle strength scale was considered to be severe clinica","2021","07","15","Rev Neurol","Revista de neurologia","Adult; Aged; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Muscle Weakness; Prognosis; Prospective Studies","Raguer","N","Hospital Universitari Vall d'Hebron, 08035 Barcelona, España",NA
"1471","34170003","10.33588/rn.7301.2021042","[Weakness as a complication of COVID-19 in critically ill patients: clinical features and prognostic factors in a case series].","Weakness is a frequent complication in those critically ill due to COVID-19. This study describes its characteristics and the factors that can condition and predict it. We conducted a prospective, descriptive, observational study of patients admitted to the intensive care unit (ICU) due to COVID-19 between April and May 2020 with muscle weakness. A motor balance equal to or lower than 3/5 according to the modified Medical Research Council muscle strength scale was considered to be severe clinica","2021","07","15","Rev Neurol","Revista de neurologia","Adult; Aged; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Muscle Weakness; Prognosis; Prospective Studies","Juntas-Morales","R","Hospital Universitari Vall d'Hebron, 08035 Barcelona, España",NA
"1472","34169960","10.1093/fampra/cmab042","'I was scared I will end up in another abortion': a mixed-methods study assessing the impact of COVID-19 pandemic and lockdown on the antenatal care of pregnant women in Puducherry, South India.","As a mitigation measure for COVID-19 pandemic, lockdown was implemented in India for a period of 2 months (24 March-31 May 2020). Disruption in antenatal care (ANC) provisions during lockdown is expected due to diversion of public health facilities on pandemic. To assess the proportion of pregnant women who had not completed the ideal number of antenatal visits, availability of iron-folic acid (IFA) supplements and challenges in availing health services during the period of lockdown. A concurren","2021","06","25","Fam Pract","Family practice","Antenatal care; COVID; lockdown; maternal health; problems during pregnancy; teleconsultation","Ulaganeethi","Revathi","Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India",NA
"1473","34169960","10.1093/fampra/cmab042","'I was scared I will end up in another abortion': a mixed-methods study assessing the impact of COVID-19 pandemic and lockdown on the antenatal care of pregnant women in Puducherry, South India.","As a mitigation measure for COVID-19 pandemic, lockdown was implemented in India for a period of 2 months (24 March-31 May 2020). Disruption in antenatal care (ANC) provisions during lockdown is expected due to diversion of public health facilities on pandemic. To assess the proportion of pregnant women who had not completed the ideal number of antenatal visits, availability of iron-folic acid (IFA) supplements and challenges in availing health services during the period of lockdown. A concurren","2021","06","25","Fam Pract","Family practice","Antenatal care; COVID; lockdown; maternal health; problems during pregnancy; teleconsultation","Dorairajan","Gowri","Department of Obstetrics and Gynaecology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India",NA
"1474","34169960","10.1093/fampra/cmab042","'I was scared I will end up in another abortion': a mixed-methods study assessing the impact of COVID-19 pandemic and lockdown on the antenatal care of pregnant women in Puducherry, South India.","As a mitigation measure for COVID-19 pandemic, lockdown was implemented in India for a period of 2 months (24 March-31 May 2020). Disruption in antenatal care (ANC) provisions during lockdown is expected due to diversion of public health facilities on pandemic. To assess the proportion of pregnant women who had not completed the ideal number of antenatal visits, availability of iron-folic acid (IFA) supplements and challenges in availing health services during the period of lockdown. A concurren","2021","06","25","Fam Pract","Family practice","Antenatal care; COVID; lockdown; maternal health; problems during pregnancy; teleconsultation","Ramaswamy","Gomathi","Department of Preventive and Social Medicine, All India Institute of medical Sciences, Bibinagar, Hyderabad, India",NA
"1475","34169960","10.1093/fampra/cmab042","'I was scared I will end up in another abortion': a mixed-methods study assessing the impact of COVID-19 pandemic and lockdown on the antenatal care of pregnant women in Puducherry, South India.","As a mitigation measure for COVID-19 pandemic, lockdown was implemented in India for a period of 2 months (24 March-31 May 2020). Disruption in antenatal care (ANC) provisions during lockdown is expected due to diversion of public health facilities on pandemic. To assess the proportion of pregnant women who had not completed the ideal number of antenatal visits, availability of iron-folic acid (IFA) supplements and challenges in availing health services during the period of lockdown. A concurren","2021","06","25","Fam Pract","Family practice","Antenatal care; COVID; lockdown; maternal health; problems during pregnancy; teleconsultation","Thekkur","Pruthu","Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, Paris, France",NA
"1476","34169960","10.1093/fampra/cmab042","'I was scared I will end up in another abortion': a mixed-methods study assessing the impact of COVID-19 pandemic and lockdown on the antenatal care of pregnant women in Puducherry, South India.","As a mitigation measure for COVID-19 pandemic, lockdown was implemented in India for a period of 2 months (24 March-31 May 2020). Disruption in antenatal care (ANC) provisions during lockdown is expected due to diversion of public health facilities on pandemic. To assess the proportion of pregnant women who had not completed the ideal number of antenatal visits, availability of iron-folic acid (IFA) supplements and challenges in availing health services during the period of lockdown. A concurren","2021","06","25","Fam Pract","Family practice","Antenatal care; COVID; lockdown; maternal health; problems during pregnancy; teleconsultation","Olickal","Jeby Jose","Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India",NA
"1477","34169960","10.1093/fampra/cmab042","'I was scared I will end up in another abortion': a mixed-methods study assessing the impact of COVID-19 pandemic and lockdown on the antenatal care of pregnant women in Puducherry, South India.","As a mitigation measure for COVID-19 pandemic, lockdown was implemented in India for a period of 2 months (24 March-31 May 2020). Disruption in antenatal care (ANC) provisions during lockdown is expected due to diversion of public health facilities on pandemic. To assess the proportion of pregnant women who had not completed the ideal number of antenatal visits, availability of iron-folic acid (IFA) supplements and challenges in availing health services during the period of lockdown. A concurren","2021","06","25","Fam Pract","Family practice","Antenatal care; COVID; lockdown; maternal health; problems during pregnancy; teleconsultation","Rajkumari","Nonika","Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India",NA
"1478","34169960","10.1093/fampra/cmab042","'I was scared I will end up in another abortion': a mixed-methods study assessing the impact of COVID-19 pandemic and lockdown on the antenatal care of pregnant women in Puducherry, South India.","As a mitigation measure for COVID-19 pandemic, lockdown was implemented in India for a period of 2 months (24 March-31 May 2020). Disruption in antenatal care (ANC) provisions during lockdown is expected due to diversion of public health facilities on pandemic. To assess the proportion of pregnant women who had not completed the ideal number of antenatal visits, availability of iron-folic acid (IFA) supplements and challenges in availing health services during the period of lockdown. A concurren","2021","06","25","Fam Pract","Family practice","Antenatal care; COVID; lockdown; maternal health; problems during pregnancy; teleconsultation","Kumar Saya","Ganesh","Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India",NA
"1479","34169944","10.1039/d1cc02546e","CRISPR/Cas12a-mediated gold nanoparticle aggregation for colorimetric detection of SARS-CoV-2.","The trans-cleavage activity of the target-activated CRISPR/Cas12a liberated an RNA crosslinker from a molecular transducer, which facilitated the assembly of gold nanoparticles. Integration of the molecular transducer with isothermal amplification and CRISPR/Cas12a resulted in visual detection of the N gene and E gene of SARS-CoV-2 in 45 min.","2021","07","15","Chem Commun (Camb)","Chemical communications (Cambridge, England)","COVID-19; CRISPR-Cas Systems; Colorimetry; Cross-Linking Reagents; Genes, Viral; Gold; Metal Nanoparticles; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA; SARS-CoV-2","Cao","Yiren","Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. hongquan@ualberta.ca xc.le@ualberta","hongquan@ualberta.ca"
"1480","34169944","10.1039/d1cc02546e","CRISPR/Cas12a-mediated gold nanoparticle aggregation for colorimetric detection of SARS-CoV-2.","The trans-cleavage activity of the target-activated CRISPR/Cas12a liberated an RNA crosslinker from a molecular transducer, which facilitated the assembly of gold nanoparticles. Integration of the molecular transducer with isothermal amplification and CRISPR/Cas12a resulted in visual detection of the N gene and E gene of SARS-CoV-2 in 45 min.","2021","07","15","Chem Commun (Camb)","Chemical communications (Cambridge, England)","COVID-19; CRISPR-Cas Systems; Colorimetry; Cross-Linking Reagents; Genes, Viral; Gold; Metal Nanoparticles; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA; SARS-CoV-2","Wu","Jinjun","Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. hongquan@ualberta.ca xc.le@ualberta","hongquan@ualberta.ca"
"1481","34169944","10.1039/d1cc02546e","CRISPR/Cas12a-mediated gold nanoparticle aggregation for colorimetric detection of SARS-CoV-2.","The trans-cleavage activity of the target-activated CRISPR/Cas12a liberated an RNA crosslinker from a molecular transducer, which facilitated the assembly of gold nanoparticles. Integration of the molecular transducer with isothermal amplification and CRISPR/Cas12a resulted in visual detection of the N gene and E gene of SARS-CoV-2 in 45 min.","2021","07","15","Chem Commun (Camb)","Chemical communications (Cambridge, England)","COVID-19; CRISPR-Cas Systems; Colorimetry; Cross-Linking Reagents; Genes, Viral; Gold; Metal Nanoparticles; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA; SARS-CoV-2","Pang","Bo","Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. hongquan@ualberta.ca xc.le@ualberta","hongquan@ualberta.ca"
"1482","34169944","10.1039/d1cc02546e","CRISPR/Cas12a-mediated gold nanoparticle aggregation for colorimetric detection of SARS-CoV-2.","The trans-cleavage activity of the target-activated CRISPR/Cas12a liberated an RNA crosslinker from a molecular transducer, which facilitated the assembly of gold nanoparticles. Integration of the molecular transducer with isothermal amplification and CRISPR/Cas12a resulted in visual detection of the N gene and E gene of SARS-CoV-2 in 45 min.","2021","07","15","Chem Commun (Camb)","Chemical communications (Cambridge, England)","COVID-19; CRISPR-Cas Systems; Colorimetry; Cross-Linking Reagents; Genes, Viral; Gold; Metal Nanoparticles; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA; SARS-CoV-2","Zhang","Hongquan","Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. hongquan@ualberta.ca xc.le@ualberta","hongquan@ualberta.ca"
"1483","34169944","10.1039/d1cc02546e","CRISPR/Cas12a-mediated gold nanoparticle aggregation for colorimetric detection of SARS-CoV-2.","The trans-cleavage activity of the target-activated CRISPR/Cas12a liberated an RNA crosslinker from a molecular transducer, which facilitated the assembly of gold nanoparticles. Integration of the molecular transducer with isothermal amplification and CRISPR/Cas12a resulted in visual detection of the N gene and E gene of SARS-CoV-2 in 45 min.","2021","07","15","Chem Commun (Camb)","Chemical communications (Cambridge, England)","COVID-19; CRISPR-Cas Systems; Colorimetry; Cross-Linking Reagents; Genes, Viral; Gold; Metal Nanoparticles; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA; SARS-CoV-2","Le","X Chris","Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. hongquan@ualberta.ca xc.le@ualberta","hongquan@ualberta.ca"
"1484","34169915","10.4103/ijp.ijp_173_21","Attitude toward COVID-19 vaccination: A cross-sectional study on healthcare professionals.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Attitude of Health Personnel; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Surveys and Questionnaires","Velumani","Suresh","Department of Mental Health, Sumandeep Nursing College, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India",NA
"1485","34169915","10.4103/ijp.ijp_173_21","Attitude toward COVID-19 vaccination: A cross-sectional study on healthcare professionals.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Attitude of Health Personnel; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Surveys and Questionnaires","Arpita","Patel","Department of Mental Health, Sumandeep Nursing College, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India",NA
"1486","34169915","10.4103/ijp.ijp_173_21","Attitude toward COVID-19 vaccination: A cross-sectional study on healthcare professionals.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Attitude of Health Personnel; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Surveys and Questionnaires","Balaraman","Ramachandran","Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India",NA
"1487","34169913","10.4103/ijp.IJP_33_21","Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Administration, Intravenous; Adult; Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Female; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult","Vityala","Yethindra","Department of Pathology, International Higher School of Medicine, International University of Kyrgyzstan, Kyrgyzstan, China",NA
"1488","34169913","10.4103/ijp.IJP_33_21","Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Administration, Intravenous; Adult; Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Female; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult","Tagaev","Tugolbai","Department of Public Health and Healthcare, I.K. Akhunbaev Kyrgyz State Medical Academy, Kyrgyzstan, China",NA
"1489","34169913","10.4103/ijp.IJP_33_21","Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Administration, Intravenous; Adult; Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Female; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult","Mamatov","Sagynali","Department of Hospital Internal Medicine, Occupational Pathology with a Course of Hematology, I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan, China",NA
"1490","34169913","10.4103/ijp.IJP_33_21","Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Administration, Intravenous; Adult; Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Female; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult","Aidarov","Ziiabidin","Department of Public Health and Healthcare, I.K. Akhunbaev Kyrgyz State Medical Academy, Kyrgyzstan, China",NA
"1491","34169913","10.4103/ijp.IJP_33_21","Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Administration, Intravenous; Adult; Antibodies, Monoclonal, Humanized; Biomarkers; COVID-19; Female; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult","Harinath","Panchadcharam","Department of Anatomy and Neuroscience, Jinzhou Medical University, Jinzhou, Liaoning, China",NA
"1492","34169911","10.4103/ijp.ijp_382_21","Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.","Present systematic review aimed to analyze the effect of inhaled nitric oxide (iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC), antiviral medications, and other medicines. Medline (PubMed), Scopus, Embase, Ovid, Web of Science, Science Direct, Wiley Online Library, BioRxiv and MedRxiv, and Cochrane (up to April 20, 2021) were the search databases. Two reviewers (SK and CK) independently selected the electronic published literature that studied the effect of n","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; Coronavirus; inhaled nitric oxide; nitric oxide; oxygenation; ventilation; Administration, Inhalation; Bronchodilator Agents; COVID-19; Critical Illness; Humans; Nitric Oxide; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Treatment Outcome","Prakash","Ajay","Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India",NA
"1493","34169911","10.4103/ijp.ijp_382_21","Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.","Present systematic review aimed to analyze the effect of inhaled nitric oxide (iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC), antiviral medications, and other medicines. Medline (PubMed), Scopus, Embase, Ovid, Web of Science, Science Direct, Wiley Online Library, BioRxiv and MedRxiv, and Cochrane (up to April 20, 2021) were the search databases. Two reviewers (SK and CK) independently selected the electronic published literature that studied the effect of n","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; Coronavirus; inhaled nitric oxide; nitric oxide; oxygenation; ventilation; Administration, Inhalation; Bronchodilator Agents; COVID-19; Critical Illness; Humans; Nitric Oxide; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Treatment Outcome","Kaur","Sukhmeet","Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India",NA
"1494","34169911","10.4103/ijp.ijp_382_21","Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.","Present systematic review aimed to analyze the effect of inhaled nitric oxide (iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC), antiviral medications, and other medicines. Medline (PubMed), Scopus, Embase, Ovid, Web of Science, Science Direct, Wiley Online Library, BioRxiv and MedRxiv, and Cochrane (up to April 20, 2021) were the search databases. Two reviewers (SK and CK) independently selected the electronic published literature that studied the effect of n","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; Coronavirus; inhaled nitric oxide; nitric oxide; oxygenation; ventilation; Administration, Inhalation; Bronchodilator Agents; COVID-19; Critical Illness; Humans; Nitric Oxide; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Treatment Outcome","Kaur","Charanjeet","Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India",NA
"1495","34169911","10.4103/ijp.ijp_382_21","Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.","Present systematic review aimed to analyze the effect of inhaled nitric oxide (iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC), antiviral medications, and other medicines. Medline (PubMed), Scopus, Embase, Ovid, Web of Science, Science Direct, Wiley Online Library, BioRxiv and MedRxiv, and Cochrane (up to April 20, 2021) were the search databases. Two reviewers (SK and CK) independently selected the electronic published literature that studied the effect of n","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; Coronavirus; inhaled nitric oxide; nitric oxide; oxygenation; ventilation; Administration, Inhalation; Bronchodilator Agents; COVID-19; Critical Illness; Humans; Nitric Oxide; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Treatment Outcome","Prabha","Praisy K","Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India",NA
"1496","34169911","10.4103/ijp.ijp_382_21","Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.","Present systematic review aimed to analyze the effect of inhaled nitric oxide (iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC), antiviral medications, and other medicines. Medline (PubMed), Scopus, Embase, Ovid, Web of Science, Science Direct, Wiley Online Library, BioRxiv and MedRxiv, and Cochrane (up to April 20, 2021) were the search databases. Two reviewers (SK and CK) independently selected the electronic published literature that studied the effect of n","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; Coronavirus; inhaled nitric oxide; nitric oxide; oxygenation; ventilation; Administration, Inhalation; Bronchodilator Agents; COVID-19; Critical Illness; Humans; Nitric Oxide; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Treatment Outcome","Bhatacharya","Anusuya","Department of Ophthalmology, GMCH, Chandigarh, India",NA
"1497","34169911","10.4103/ijp.ijp_382_21","Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.","Present systematic review aimed to analyze the effect of inhaled nitric oxide (iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC), antiviral medications, and other medicines. Medline (PubMed), Scopus, Embase, Ovid, Web of Science, Science Direct, Wiley Online Library, BioRxiv and MedRxiv, and Cochrane (up to April 20, 2021) were the search databases. Two reviewers (SK and CK) independently selected the electronic published literature that studied the effect of n","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; Coronavirus; inhaled nitric oxide; nitric oxide; oxygenation; ventilation; Administration, Inhalation; Bronchodilator Agents; COVID-19; Critical Illness; Humans; Nitric Oxide; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Treatment Outcome","Sarma","Phulen","Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India",NA
"1498","34169911","10.4103/ijp.ijp_382_21","Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.","Present systematic review aimed to analyze the effect of inhaled nitric oxide (iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC), antiviral medications, and other medicines. Medline (PubMed), Scopus, Embase, Ovid, Web of Science, Science Direct, Wiley Online Library, BioRxiv and MedRxiv, and Cochrane (up to April 20, 2021) were the search databases. Two reviewers (SK and CK) independently selected the electronic published literature that studied the effect of n","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; Coronavirus; inhaled nitric oxide; nitric oxide; oxygenation; ventilation; Administration, Inhalation; Bronchodilator Agents; COVID-19; Critical Illness; Humans; Nitric Oxide; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Treatment Outcome","Medhi","Bikash","Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India",NA
"1499","34169908","10.4103/ijp.IJP_615_20","Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors.","Although many potent drugs have been used for cytokine storm, mortality is high for patients with coronavirus disease-2019 (COVID-19), which is followed up in the intensive care unit. Interferons (IFNs) are the major cytokines of the antiviral defense system released from many cell types. However, IFN-<U+03B3> plays a key role in both primary and secondary cytokine storms. If the cytokine storm is not treated urgently, it will be fatal; therefore, it should be treated immediately. Anakinra, an interleu","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; SARS-CoV-2; cytokine storm; emapalumab; interferon; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antirheumatic Agents; COVID-19; Cytokine Release Syndrome; Disease Progression; Drug Resistance, Viral; Humans; Interferon-gamma; Interleukin 1 Receptor Antagonist Protein; Interleukins; Janus Kinase Inhibitors; Recurrence","Cure","Erkan","Department of Internal Medicine, Ota and Jinemed Hospital, Istanbul, Turkey",NA
"1500","34169908","10.4103/ijp.IJP_615_20","Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors.","Although many potent drugs have been used for cytokine storm, mortality is high for patients with coronavirus disease-2019 (COVID-19), which is followed up in the intensive care unit. Interferons (IFNs) are the major cytokines of the antiviral defense system released from many cell types. However, IFN-<U+03B3> plays a key role in both primary and secondary cytokine storms. If the cytokine storm is not treated urgently, it will be fatal; therefore, it should be treated immediately. Anakinra, an interleu","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; SARS-CoV-2; cytokine storm; emapalumab; interferon; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antirheumatic Agents; COVID-19; Cytokine Release Syndrome; Disease Progression; Drug Resistance, Viral; Humans; Interferon-gamma; Interleukin 1 Receptor Antagonist Protein; Interleukins; Janus Kinase Inhibitors; Recurrence","Kucuk","Adem","Department of Rheumatology, Meram Tip Faculty, Necmettin Erbakan University, Konya, Turkey",NA
"1501","34169908","10.4103/ijp.IJP_615_20","Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors.","Although many potent drugs have been used for cytokine storm, mortality is high for patients with coronavirus disease-2019 (COVID-19), which is followed up in the intensive care unit. Interferons (IFNs) are the major cytokines of the antiviral defense system released from many cell types. However, IFN-<U+03B3> plays a key role in both primary and secondary cytokine storms. If the cytokine storm is not treated urgently, it will be fatal; therefore, it should be treated immediately. Anakinra, an interleu","2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","COVID-19; SARS-CoV-2; cytokine storm; emapalumab; interferon; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antirheumatic Agents; COVID-19; Cytokine Release Syndrome; Disease Progression; Drug Resistance, Viral; Humans; Interferon-gamma; Interleukin 1 Receptor Antagonist Protein; Interleukins; Janus Kinase Inhibitors; Recurrence","Cure","Medine Cumhur","Department of Biochemistry, Private Kucukcekmece Hospital, Istanbul, Turkey",NA
"1502","34169902","10.4103/ijp.ijp_430_21","Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Anti-Bacterial Agents; Antimicrobial Stewardship; COVID-19; Disease Outbreaks; Drug Resistance, Bacterial; Global Health; Humans","Mahalmani","Vidya","Department of Pharmacology, Jawaharlal Nehru Medical College, KAHER, Belgaum, Karnataka, India",NA
"1503","34169902","10.4103/ijp.ijp_430_21","Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Anti-Bacterial Agents; Antimicrobial Stewardship; COVID-19; Disease Outbreaks; Drug Resistance, Bacterial; Global Health; Humans","Kumaravel","J","Department of Pharmacology, PGIMER, Chandigarh, India",NA
"1504","34169902","10.4103/ijp.ijp_430_21","Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Anti-Bacterial Agents; Antimicrobial Stewardship; COVID-19; Disease Outbreaks; Drug Resistance, Bacterial; Global Health; Humans","Jain","Manav","Department of Pharmacology, PGIMER, Chandigarh, India",NA
"1505","34169902","10.4103/ijp.ijp_430_21","Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Anti-Bacterial Agents; Antimicrobial Stewardship; COVID-19; Disease Outbreaks; Drug Resistance, Bacterial; Global Health; Humans","Prakash","Ajay","Department of Pharmacology, PGIMER, Chandigarh, India",NA
"1506","34169902","10.4103/ijp.ijp_430_21","Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak.",NA,"2021","07","07","Indian J Pharmacol","Indian journal of pharmacology","Anti-Bacterial Agents; Antimicrobial Stewardship; COVID-19; Disease Outbreaks; Drug Resistance, Bacterial; Global Health; Humans","Medhi","Bikash","Department of Pharmacology, PGIMER, Chandigarh, India",NA
"1507","34169883","10.4103/0028-3886.319215","A Letter on the Need for Uniform Residency Training Programs and the Challenges During COVID-19 Pandemic for India.",NA,"2021","06","30","Neurol India","Neurology India","COVID-19; Humans; India; Internship and Residency; Pandemics; SARS-CoV-2","Banerji","A K","Department of Neurosurgery, AIIMS, New Delhi, India",NA
"1508","34169840","10.4103/0028-3886.319259","How can India be Prepared for the Third Wave?",NA,"2021","06","30","Neurol India","Neurology India","COVID-19; Humans; India","Ravi","V","Nodal Officer for Genomic Confirmation of SARS-CoV-2, Government of Karnataka, Retired Professor and Head, Department of Neurovirology, NIMHANS, Bengaluru, Karnataka, India",NA
"1509","34169831","","Academic stress in Danish medical and health science students during the COVID-19 lock-down.","COVID-19 has disrupted normal life and resulted in an online transformation of teaching. Little is known about how these changes affected academic stress in students. This study examined the role of changes of teaching methods on academic stress among university students during the first lockdown in Denmark. The cross-sectional survey was part of the international ""COVID-19 International Student Well-being Study"" and included responses on socio-economic characteristics, infection worries, academ","2021","07","23","Dan Med J","Danish medical journal","Adult; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Denmark; Female; Humans; Male; SARS-CoV-2; Stress, Psychological; Students; Students, Medical","Guldager","Julie Dalgaard","jguldager@health.sdu","jguldager@health.sdu.dk"
"1510","34169831","","Academic stress in Danish medical and health science students during the COVID-19 lock-down.","COVID-19 has disrupted normal life and resulted in an online transformation of teaching. Little is known about how these changes affected academic stress in students. This study examined the role of changes of teaching methods on academic stress among university students during the first lockdown in Denmark. The cross-sectional survey was part of the international ""COVID-19 International Student Well-being Study"" and included responses on socio-economic characteristics, infection worries, academ","2021","07","23","Dan Med J","Danish medical journal","Adult; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Denmark; Female; Humans; Male; SARS-CoV-2; Stress, Psychological; Students; Students, Medical","Jervelund","Signe","jguldager@health.sdu",NA
"1511","34169831","","Academic stress in Danish medical and health science students during the COVID-19 lock-down.","COVID-19 has disrupted normal life and resulted in an online transformation of teaching. Little is known about how these changes affected academic stress in students. This study examined the role of changes of teaching methods on academic stress among university students during the first lockdown in Denmark. The cross-sectional survey was part of the international ""COVID-19 International Student Well-being Study"" and included responses on socio-economic characteristics, infection worries, academ","2021","07","23","Dan Med J","Danish medical journal","Adult; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Denmark; Female; Humans; Male; SARS-CoV-2; Stress, Psychological; Students; Students, Medical","Berg-Beckhoff","Gabriele","jguldager@health.sdu",NA
"1512","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Jakobsen","Kathrine Kronberg","Christian.von.Buchwald@regionh",NA
"1513","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Jensen","Jakob Schmidt","Christian.von.Buchwald@regionh",NA
"1514","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Todsen","Tobias","Christian.von.Buchwald@regionh",NA
"1515","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Tolsaard","Martin Grønnebæk","Christian.von.Buchwald@regionh",NA
"1516","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Kirkby","Nikolai","Christian.von.Buchwald@regionh",NA
"1517","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Lippert","Freddy","Christian.von.Buchwald@regionh",NA
"1518","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Vangsted","Anne-Marie","Christian.von.Buchwald@regionh",NA
"1519","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Martel","Cyril Jean-Marie","Christian.von.Buchwald@regionh",NA
"1520","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Klokker","Mads","Christian.von.Buchwald@regionh",NA
"1521","34169830","","Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.","Fast and accurate detection of SARS-CoV-2 is essential in limiting the COVID-19 pandemic. Rapid antigen (AG) tests provide results within minutes; however, their accuracy has been questioned. The study aims to determine the accuracy and cost of the STANDARD Q COVID-19 AG test compared with RT-PCR. Individuals 18 years or older with an appointment for a RT-PCR test on 26-31 December 2020 at a public test centre in Copenhagen, Denmark were invited to participate. An oropharyngeal swab was collecte","2021","07","23","Dan Med J","Danish medical journal","Antigens, Viral; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Testing; Denmark; Female; Humans; Middle Aged; Pandemics; RNA, Viral; RNA-Directed DNA Polymerase; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","von Buchwald","Christian","Christian.von.Buchwald@regionh","Christian.von.Buchwald@regionh.dk"
"1522","34169822","","[Virtual consultations in paediatrics].","During the COVID-19 pandemic, telemedicine and virtual consultations have been rapidly implemented in paediatrics all over the world. Previous and current studies have shown satisfaction with telemedicine, especially from a parental perspective. The largest barrier for implementation is technology. Some studies have found telemedicine equal to in-person visits. Only few studies have measured clinical outcomes, and the perspective of the child and adolescents as well as healthcare personal is rar","2021","07","01","Ugeskr Laeger","Ugeskrift for laeger","Adolescent; COVID-19; Child; Humans; Pandemics; Patient Satisfaction; Pediatrics; Referral and Consultation; SARS-CoV-2; Telemedicine","Nielsen","Ole Haubjerg","ole.haubjerg.nielsen@regionh","ole.haubjerg.nielsen@regionh.dk"
"1523","34169822","","[Virtual consultations in paediatrics].","During the COVID-19 pandemic, telemedicine and virtual consultations have been rapidly implemented in paediatrics all over the world. Previous and current studies have shown satisfaction with telemedicine, especially from a parental perspective. The largest barrier for implementation is technology. Some studies have found telemedicine equal to in-person visits. Only few studies have measured clinical outcomes, and the perspective of the child and adolescents as well as healthcare personal is rar","2021","07","01","Ugeskr Laeger","Ugeskrift for laeger","Adolescent; COVID-19; Child; Humans; Pandemics; Patient Satisfaction; Pediatrics; Referral and Consultation; SARS-CoV-2; Telemedicine","Teilmann","Grete Katrine","ole.haubjerg.nielsen@regionh",NA
"1524","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Mateo-Urdiales","Alberto","Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy",NA
"1525","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Spila Alegiani","Stefania","National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy",NA
"1526","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Fabiani","Massimo","Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy",NA
"1527","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Pezzotti","Patrizio","Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy",NA
"1528","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Filia","Antonietta","Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy",NA
"1529","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Massari","Marco","National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy",NA
"1530","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Riccardo","Flavia","Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy",NA
"1531","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Tallon","Marco","Department of Informatics, Istituto Superiore di Sanità, Rome, Italy",NA
"1532","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Proietti","Valeria","DG-SISS, Ministero della Salute, Rome, Italy",NA
"1533","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Del Manso","Martina","Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy",NA
"1534","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Puopolo","Maria","Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy",NA
"1535","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Spuri","Matteo","Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy",NA
"1536","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Morciano","Cristina","Research Coordination and Support Service, Istituto Superiore di Sanità, Rome, Italy",NA
"1537","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","D'Ancona","Fortunato Paolo","Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy",NA
"1538","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Da Cas","Roberto","National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy",NA
"1539","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Battilomo","Serena","DG-SISS, Ministero della Salute, Rome, Italy",NA
"1540","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Bella","Antonino","Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy",NA
"1541","34169819","10.2807/1560-7917.ES.2021.26.25.2100507","Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.","To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0-14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (incidence rate ratios (IRR): 0.22; 95% CI: 0.21-0.24) 43-49 days post-first dose. Similarly, hospitalisation and death risks decreased, with 89% (IRR: 0.11; 95% CI: 0.09-0.15) and 93% (IRR: 0.07; 95% ","2021","06","30","Euro Surveill","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","COVID-19; Italy; pandemic; vaccination; COVID-19; COVID-19 Vaccines; Hospitalization; Hospitals; Humans; Italy; SARS-CoV-2; Vaccines","Menniti-Ippolito","Francesca","National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy",NA
"1542","34169816","10.1017/ice.2021.302","Promoting coronavirus disease 2019 (COVID-19) vaccination: Do we need to reframe how we present risk?",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Doll","Michelle","Virginia Commonwealth University Health System, Richmond, Virginia",NA
"1543","34169816","10.1017/ice.2021.302","Promoting coronavirus disease 2019 (COVID-19) vaccination: Do we need to reframe how we present risk?",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Guidry","Jeanine P D","Virginia Commonwealth University, RichmondVirginia",NA
"1544","34169816","10.1017/ice.2021.302","Promoting coronavirus disease 2019 (COVID-19) vaccination: Do we need to reframe how we present risk?",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Pryor","Rachel","Virginia Commonwealth University Health System, Richmond, Virginia",NA
"1545","34169816","10.1017/ice.2021.302","Promoting coronavirus disease 2019 (COVID-19) vaccination: Do we need to reframe how we present risk?",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Kellermann","Arthur L","Virginia Commonwealth University Health System, Richmond, Virginia",NA
"1546","34169816","10.1017/ice.2021.302","Promoting coronavirus disease 2019 (COVID-19) vaccination: Do we need to reframe how we present risk?",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Stevens","Michael P","Virginia Commonwealth University Health System, Richmond, Virginia",NA
"1547","34169815","10.1017/ice.2021.303","Striking absence of ""usual suspects"" during the winter of the coronavirus disease 2019 (COVID-19) pandemic 2020-2021.",NA,"2021","07","10","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Sarvepalli","Siri S","Wayne State University School of Medicine, Detroit, Michigan",NA
"1548","34169815","10.1017/ice.2021.303","Striking absence of ""usual suspects"" during the winter of the coronavirus disease 2019 (COVID-19) pandemic 2020-2021.",NA,"2021","07","10","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Cruz","Angela Beatriz V","Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan",NA
"1549","34169815","10.1017/ice.2021.303","Striking absence of ""usual suspects"" during the winter of the coronavirus disease 2019 (COVID-19) pandemic 2020-2021.",NA,"2021","07","10","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Chopra","Teena","Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan",NA
"1550","34169815","10.1017/ice.2021.303","Striking absence of ""usual suspects"" during the winter of the coronavirus disease 2019 (COVID-19) pandemic 2020-2021.",NA,"2021","07","10","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Salimnia","Hossein","Wayne State University, Detroit Medical Center, Detroit, Michigan",NA
"1551","34169815","10.1017/ice.2021.303","Striking absence of ""usual suspects"" during the winter of the coronavirus disease 2019 (COVID-19) pandemic 2020-2021.",NA,"2021","07","10","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Chandrasekar","Pranatharthi","Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan",NA
"1552","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Alsuhaibani","Mohammed A","University of Iowa Hospitals &amp",NA
"1553","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Kobayashi","Takaaki","University of Iowa Hospitals &amp",NA
"1554","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Trannel","Alexandra","University of Iowa Hospitals &amp",NA
"1555","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Holley","Stephanie","University of Iowa Hospitals &amp",NA
"1556","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Abosi","Oluchi J","University of Iowa Hospitals &amp",NA
"1557","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Jenn","Kyle E","University of Iowa Hospitals &amp",NA
"1558","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Meacham","Holly","University of Iowa Hospitals &amp",NA
"1559","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Sheeler","Lorinda","University of Iowa Hospitals &amp",NA
"1560","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Etienne","William","University of Iowa Hospitals &amp",NA
"1561","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Dains","Angelique","University of Iowa Hospitals &amp",NA
"1562","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Kukla","Mary E","University of Iowa Hospitals &amp",NA
"1563","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Ward","Emily","University of Iowa Hospitals &amp",NA
"1564","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Ford","Bradley","University of Iowa Hospitals &amp",NA
"1565","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Edmond","Michael B","Department of Medicine, West Virginia University School of Medicine, Morgantown, West Virginia, United States",NA
"1566","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Wellington","Melanie","University of Iowa Hospitals &amp",NA
"1567","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Diekema","Daniel J","University of Iowa Hospitals &amp",NA
"1568","34169812","10.1017/ice.2021.294","Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.","Patients admitted to the hospital may unknowingly carry severe acute respiratory coronavirus virus 2 (SARS-CoV-2), and hospitals have implemented SARS-CoV-2 admission screening. However, because SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) assays may remain positive for months after infection, positive results may represent active or past infection. We determined the prevalence and infectiousness of patients who were admitted for reasons unrelated to COVID-19 but tested po","2021","07","20","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Salinas","Jorge L","University of Iowa Hospitals &amp",NA
"1569","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Lou","Jun-Yang","Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA",NA
"1570","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Kennedy","Kevin F","Independent statistical Consultant, Kansas City, MO, USA",NA
"1571","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Menard","Matthew T","Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA",NA
"1572","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Abbott","J Dawn","Division of Cardiology, Alpert Medical School of Brown University, Providence, RI, USA",NA
"1573","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Secemsky","Eric A","Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA",NA
"1574","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Goodney","Philip P","Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA",NA
"1575","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Saad","Marwan","Division of Cardiology, Alpert Medical School of Brown University, Providence, RI, USA",NA
"1576","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Soukas","Peter A","Division of Cardiology, Alpert Medical School of Brown University, Providence, RI, USA",NA
"1577","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Hyder","Omar N","Division of Cardiology, Alpert Medical School of Brown University, Providence, RI, USA",NA
"1578","34169796","10.1177/1358863X211021918","North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.","The coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized. Volume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative<sup>®</sup>. Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression. The final ","2021","06","25","Vasc Med","Vascular medicine (London, England)","COVID-19; endovascular therapy; peripheral artery disease (PAD); registries; vascular surgery","Aronow","Herbert D","Division of Cardiology, Alpert Medical School of Brown University, Providence, RI, USA",NA
"1579","34169783","10.1080/03009742.2021.1917145","Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review.","Objective: Systemic capillary leak syndrome (SCLS) is a severe condition characterized by the coexistence of hypovolaemic shock, haemococentration, and hypoalbuminaemia, without albuminuria, that may progress to multiorgan failure and an unfavourable outcome. Its development is often triggered by viral infections, such as influenza A virus, but it is unclear whether it is also triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We aimed to investigated the associati","2021","06","25","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Beber","A","Respiratory Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy",NA
"1580","34169783","10.1080/03009742.2021.1917145","Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review.","Objective: Systemic capillary leak syndrome (SCLS) is a severe condition characterized by the coexistence of hypovolaemic shock, haemococentration, and hypoalbuminaemia, without albuminuria, that may progress to multiorgan failure and an unfavourable outcome. Its development is often triggered by viral infections, such as influenza A virus, but it is unclear whether it is also triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We aimed to investigated the associati","2021","06","25","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Dellai","F","Respiratory Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy",NA
"1581","34169783","10.1080/03009742.2021.1917145","Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review.","Objective: Systemic capillary leak syndrome (SCLS) is a severe condition characterized by the coexistence of hypovolaemic shock, haemococentration, and hypoalbuminaemia, without albuminuria, that may progress to multiorgan failure and an unfavourable outcome. Its development is often triggered by viral infections, such as influenza A virus, but it is unclear whether it is also triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We aimed to investigated the associati","2021","06","25","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Abdel Jaber","M","Department of Medicine, Rheumatology Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy",NA
"1582","34169783","10.1080/03009742.2021.1917145","Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review.","Objective: Systemic capillary leak syndrome (SCLS) is a severe condition characterized by the coexistence of hypovolaemic shock, haemococentration, and hypoalbuminaemia, without albuminuria, that may progress to multiorgan failure and an unfavourable outcome. Its development is often triggered by viral infections, such as influenza A virus, but it is unclear whether it is also triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We aimed to investigated the associati","2021","06","25","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Peterlana","D","Department of Medicine, Internal Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy",NA
"1583","34169783","10.1080/03009742.2021.1917145","Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review.","Objective: Systemic capillary leak syndrome (SCLS) is a severe condition characterized by the coexistence of hypovolaemic shock, haemococentration, and hypoalbuminaemia, without albuminuria, that may progress to multiorgan failure and an unfavourable outcome. Its development is often triggered by viral infections, such as influenza A virus, but it is unclear whether it is also triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We aimed to investigated the associati","2021","06","25","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Brunori","G","Respiratory Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy",NA
"1584","34169783","10.1080/03009742.2021.1917145","Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review.","Objective: Systemic capillary leak syndrome (SCLS) is a severe condition characterized by the coexistence of hypovolaemic shock, haemococentration, and hypoalbuminaemia, without albuminuria, that may progress to multiorgan failure and an unfavourable outcome. Its development is often triggered by viral infections, such as influenza A virus, but it is unclear whether it is also triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We aimed to investigated the associati","2021","06","25","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Maino","A","Department of Medicine, Internal Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy",NA
"1585","34169772","10.1177/10760296211013104","Clinical Features of COVID-19 Patients With Venous Thromboembolism.","This study aimed to assess the clinical features of coronavirus disease 2019 (COVID-19) patients with VTE, to help develop preventive measures for venous thromboembolism (VTE in COVID-19) cases. COVID-19 patients admitted to Henan Provincial People's Hospital were retrospectively analyzed, including 23, 4 and 8 cases with mild to moderate, severe and critical symptoms, respectively. VTE incidence, age at onset, relevant laboratory parameters and prognosis were analyzed. Overall, VTE incidence in","2021","07","01","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; incidence; pneumonia; venous thromboembolism; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; China; Female; Fibrin Fibrinogen Degradation Products; Humans; Incidence; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Venous Thromboembolism; Young Adult","Liang","Kai","Department of Vascular Surgery, 89632Henan Provincial People's Hospital, the Affiliated People's Hospital of Zhengzhou University, the Affiliated People's Hospital of Henan University, Zhengzhou, Henan, China",NA
"1586","34169772","10.1177/10760296211013104","Clinical Features of COVID-19 Patients With Venous Thromboembolism.","This study aimed to assess the clinical features of coronavirus disease 2019 (COVID-19) patients with VTE, to help develop preventive measures for venous thromboembolism (VTE in COVID-19) cases. COVID-19 patients admitted to Henan Provincial People's Hospital were retrospectively analyzed, including 23, 4 and 8 cases with mild to moderate, severe and critical symptoms, respectively. VTE incidence, age at onset, relevant laboratory parameters and prognosis were analyzed. Overall, VTE incidence in","2021","07","01","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; incidence; pneumonia; venous thromboembolism; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; China; Female; Fibrin Fibrinogen Degradation Products; Humans; Incidence; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Venous Thromboembolism; Young Adult","Fu","Ying","Department of Hematology, 89632Henan Provincial People's Hospital, the Affiliated People's Hospital of Zhengzhou University, the Affiliated People's Hospital of Henan University, Zhengzhou, Henan, China",NA
"1587","34169772","10.1177/10760296211013104","Clinical Features of COVID-19 Patients With Venous Thromboembolism.","This study aimed to assess the clinical features of coronavirus disease 2019 (COVID-19) patients with VTE, to help develop preventive measures for venous thromboembolism (VTE in COVID-19) cases. COVID-19 patients admitted to Henan Provincial People's Hospital were retrospectively analyzed, including 23, 4 and 8 cases with mild to moderate, severe and critical symptoms, respectively. VTE incidence, age at onset, relevant laboratory parameters and prognosis were analyzed. Overall, VTE incidence in","2021","07","01","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; incidence; pneumonia; venous thromboembolism; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; China; Female; Fibrin Fibrinogen Degradation Products; Humans; Incidence; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Venous Thromboembolism; Young Adult","Kang","Yi","Department of Infectious Disease, 89632Henan Provincial People's Hospital, the Affiliated People's Hospital of Zhengzhou University, the Affiliated People's Hospital of Henan University, Zhengzhou, Henan, China",NA
"1588","34169772","10.1177/10760296211013104","Clinical Features of COVID-19 Patients With Venous Thromboembolism.","This study aimed to assess the clinical features of coronavirus disease 2019 (COVID-19) patients with VTE, to help develop preventive measures for venous thromboembolism (VTE in COVID-19) cases. COVID-19 patients admitted to Henan Provincial People's Hospital were retrospectively analyzed, including 23, 4 and 8 cases with mild to moderate, severe and critical symptoms, respectively. VTE incidence, age at onset, relevant laboratory parameters and prognosis were analyzed. Overall, VTE incidence in","2021","07","01","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; incidence; pneumonia; venous thromboembolism; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; China; Female; Fibrin Fibrinogen Degradation Products; Humans; Incidence; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Venous Thromboembolism; Young Adult","Shao","Huanzhang","ICU, 89632Henan Provincial People's Hospital, the Affiliated People's Hospital of Zhengzhou University, the Affiliated People's Hospital of Henan University, Zhengzhou, Henan, China",NA
"1589","34169772","10.1177/10760296211013104","Clinical Features of COVID-19 Patients With Venous Thromboembolism.","This study aimed to assess the clinical features of coronavirus disease 2019 (COVID-19) patients with VTE, to help develop preventive measures for venous thromboembolism (VTE in COVID-19) cases. COVID-19 patients admitted to Henan Provincial People's Hospital were retrospectively analyzed, including 23, 4 and 8 cases with mild to moderate, severe and critical symptoms, respectively. VTE incidence, age at onset, relevant laboratory parameters and prognosis were analyzed. Overall, VTE incidence in","2021","07","01","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; incidence; pneumonia; venous thromboembolism; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; China; Female; Fibrin Fibrinogen Degradation Products; Humans; Incidence; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Venous Thromboembolism; Young Adult","Yang","Jianxu","ICU, 89632Henan Provincial People's Hospital, the Affiliated People's Hospital of Zhengzhou University, the Affiliated People's Hospital of Henan University, Zhengzhou, Henan, China",NA
"1590","34169772","10.1177/10760296211013104","Clinical Features of COVID-19 Patients With Venous Thromboembolism.","This study aimed to assess the clinical features of coronavirus disease 2019 (COVID-19) patients with VTE, to help develop preventive measures for venous thromboembolism (VTE in COVID-19) cases. COVID-19 patients admitted to Henan Provincial People's Hospital were retrospectively analyzed, including 23, 4 and 8 cases with mild to moderate, severe and critical symptoms, respectively. VTE incidence, age at onset, relevant laboratory parameters and prognosis were analyzed. Overall, VTE incidence in","2021","07","01","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; incidence; pneumonia; venous thromboembolism; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; China; Female; Fibrin Fibrinogen Degradation Products; Humans; Incidence; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Venous Thromboembolism; Young Adult","Cui","Mingzhe","Department of Vascular Surgery, 89632Henan Provincial People's Hospital, the Affiliated People's Hospital of Zhengzhou University, the Affiliated People's Hospital of Henan University, Zhengzhou, Henan, China",NA
"1591","34169772","10.1177/10760296211013104","Clinical Features of COVID-19 Patients With Venous Thromboembolism.","This study aimed to assess the clinical features of coronavirus disease 2019 (COVID-19) patients with VTE, to help develop preventive measures for venous thromboembolism (VTE in COVID-19) cases. COVID-19 patients admitted to Henan Provincial People's Hospital were retrospectively analyzed, including 23, 4 and 8 cases with mild to moderate, severe and critical symptoms, respectively. VTE incidence, age at onset, relevant laboratory parameters and prognosis were analyzed. Overall, VTE incidence in","2021","07","01","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; incidence; pneumonia; venous thromboembolism; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; China; Female; Fibrin Fibrinogen Degradation Products; Humans; Incidence; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Venous Thromboembolism; Young Adult","Zhai","Shuiting","Department of Vascular Surgery, 89632Henan Provincial People's Hospital, the Affiliated People's Hospital of Zhengzhou University, the Affiliated People's Hospital of Henan University, Zhengzhou, Henan, China",NA
"1592","34169750","10.1177/13623613211014995","'Anything but the phone!': Communication mode preferences in the autism community.","What is already known about the topic?There has been a lot of research into things like how autistic people's communication styles are different to those of non-autistic people, especially among children. This has tended to focus on parent reports and experiments, rather than asking autistic people about their own experiences and preferences regarding communication.What does this article add?This article is the first to ask autistic adults how they prefer to communicate in differen","2021","06","25","Autism","Autism : the international journal of research and practice","adults; autism spectrum disorders; communication and language; technology","Howard","Philippa L","University of Bristol, UK",NA
"1593","34169750","10.1177/13623613211014995","'Anything but the phone!': Communication mode preferences in the autism community.","What is already known about the topic?There has been a lot of research into things like how autistic people's communication styles are different to those of non-autistic people, especially among children. This has tended to focus on parent reports and experiments, rather than asking autistic people about their own experiences and preferences regarding communication.What does this article add?This article is the first to ask autistic adults how they prefer to communicate in differen","2021","06","25","Autism","Autism : the international journal of research and practice","adults; autism spectrum disorders; communication and language; technology","Sedgewick","Felicity","University of Bristol, UK",NA
"1594","34169729","10.4155/fmc-2021-0025","Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.","Background: The new coronavirus pandemic has had a significant impact worldwide, and therapeutic treatment for this viral infection is being strongly pursued. Efforts have been undertaken by medicinal chemists to discover molecules or known drugs that may be effective in COVID-19 treatment - in particular, targeting the main protease (Mpro) of the virus. Materials &amp; methods: We have employed an innovative strategy - application of ligand- and structure-based virtual screening -","2021","07","23","Future Med Chem","Future medicinal chemistry","COVID-19; SARS-CoV-2; drug repositioning; ligand-based drug discovery; main-protease (Mpro); structure-based drug discovery","Federico","Leonardo Bruno","Computational Laboratory of Pharmaceutical Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café, s/n, Ribeirão Preto, SP, 14040-903, Brazil",NA
"1595","34169729","10.4155/fmc-2021-0025","Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.","Background: The new coronavirus pandemic has had a significant impact worldwide, and therapeutic treatment for this viral infection is being strongly pursued. Efforts have been undertaken by medicinal chemists to discover molecules or known drugs that may be effective in COVID-19 treatment - in particular, targeting the main protease (Mpro) of the virus. Materials &amp; methods: We have employed an innovative strategy - application of ligand- and structure-based virtual screening -","2021","07","23","Future Med Chem","Future medicinal chemistry","COVID-19; SARS-CoV-2; drug repositioning; ligand-based drug discovery; main-protease (Mpro); structure-based drug discovery","Silva","Guilherme Martins","Departamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, 14040-901, Brazil",NA
"1596","34169729","10.4155/fmc-2021-0025","Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.","Background: The new coronavirus pandemic has had a significant impact worldwide, and therapeutic treatment for this viral infection is being strongly pursued. Efforts have been undertaken by medicinal chemists to discover molecules or known drugs that may be effective in COVID-19 treatment - in particular, targeting the main protease (Mpro) of the virus. Materials &amp; methods: We have employed an innovative strategy - application of ligand- and structure-based virtual screening -","2021","07","23","Future Med Chem","Future medicinal chemistry","COVID-19; SARS-CoV-2; drug repositioning; ligand-based drug discovery; main-protease (Mpro); structure-based drug discovery","da Silva Hage-Melim","Lorane Izabel","Laboratory of Pharmaceutical &amp",NA
"1597","34169729","10.4155/fmc-2021-0025","Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.","Background: The new coronavirus pandemic has had a significant impact worldwide, and therapeutic treatment for this viral infection is being strongly pursued. Efforts have been undertaken by medicinal chemists to discover molecules or known drugs that may be effective in COVID-19 treatment - in particular, targeting the main protease (Mpro) of the virus. Materials &amp; methods: We have employed an innovative strategy - application of ligand- and structure-based virtual screening -","2021","07","23","Future Med Chem","Future medicinal chemistry","COVID-19; SARS-CoV-2; drug repositioning; ligand-based drug discovery; main-protease (Mpro); structure-based drug discovery","Gomes","Suzane Quintana","Departamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, 14040-901, Brazil",NA
"1598","34169729","10.4155/fmc-2021-0025","Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.","Background: The new coronavirus pandemic has had a significant impact worldwide, and therapeutic treatment for this viral infection is being strongly pursued. Efforts have been undertaken by medicinal chemists to discover molecules or known drugs that may be effective in COVID-19 treatment - in particular, targeting the main protease (Mpro) of the virus. Materials &amp; methods: We have employed an innovative strategy - application of ligand- and structure-based virtual screening -","2021","07","23","Future Med Chem","Future medicinal chemistry","COVID-19; SARS-CoV-2; drug repositioning; ligand-based drug discovery; main-protease (Mpro); structure-based drug discovery","Barcelos","Mariana Pegrucci","Computational Laboratory of Pharmaceutical Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café, s/n, Ribeirão Preto, SP, 14040-903, Brazil",NA
"1599","34169729","10.4155/fmc-2021-0025","Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.","Background: The new coronavirus pandemic has had a significant impact worldwide, and therapeutic treatment for this viral infection is being strongly pursued. Efforts have been undertaken by medicinal chemists to discover molecules or known drugs that may be effective in COVID-19 treatment - in particular, targeting the main protease (Mpro) of the virus. Materials &amp; methods: We have employed an innovative strategy - application of ligand- and structure-based virtual screening -","2021","07","23","Future Med Chem","Future medicinal chemistry","COVID-19; SARS-CoV-2; drug repositioning; ligand-based drug discovery; main-protease (Mpro); structure-based drug discovery","Galindo Francischini","Isaque Antônio","Computational Laboratory of Pharmaceutical Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café, s/n, Ribeirão Preto, SP, 14040-903, Brazil",NA
"1600","34169729","10.4155/fmc-2021-0025","Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.","Background: The new coronavirus pandemic has had a significant impact worldwide, and therapeutic treatment for this viral infection is being strongly pursued. Efforts have been undertaken by medicinal chemists to discover molecules or known drugs that may be effective in COVID-19 treatment - in particular, targeting the main protease (Mpro) of the virus. Materials &amp; methods: We have employed an innovative strategy - application of ligand- and structure-based virtual screening -","2021","07","23","Future Med Chem","Future medicinal chemistry","COVID-19; SARS-CoV-2; drug repositioning; ligand-based drug discovery; main-protease (Mpro); structure-based drug discovery","Tomich de Paula da Silva","Carlos Henrique","Computational Laboratory of Pharmaceutical Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café, s/n, Ribeirão Preto, SP, 14040-903, Brazil",NA
"1601","34169728","10.4155/fmc-2020-0264","Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors.","The COVID-19 outbreak has thrown the world into an unprecedented crisis. It has posed a challenge to scientists around the globe who are working tirelessly to combat this pandemic. We herein report a set of molecules that may serve as possible inhibitors of the SARS-CoV-2 main protease. To identify these molecules, we followed a combinatorial structure-based strategy, which includes high-throughput virtual screening, molecular docking and WaterMap calculations. The study was carried out using Pr","2021","06","30","Future Med Chem","Future medicinal chemistry","SARS-CoV-2; drug discovery; main protease; structure based drug design; water thermodynamics","Sobhia","M Elizabeth","Department of Pharmacoinformatics, National Institute of Pharmaceutical Education &amp",NA
"1602","34169728","10.4155/fmc-2020-0264","Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors.","The COVID-19 outbreak has thrown the world into an unprecedented crisis. It has posed a challenge to scientists around the globe who are working tirelessly to combat this pandemic. We herein report a set of molecules that may serve as possible inhibitors of the SARS-CoV-2 main protease. To identify these molecules, we followed a combinatorial structure-based strategy, which includes high-throughput virtual screening, molecular docking and WaterMap calculations. The study was carried out using Pr","2021","06","30","Future Med Chem","Future medicinal chemistry","SARS-CoV-2; drug discovery; main protease; structure based drug design; water thermodynamics","Kumar","G Siva","Department of Pharmacoinformatics, National Institute of Pharmaceutical Education &amp",NA
"1603","34169728","10.4155/fmc-2020-0264","Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors.","The COVID-19 outbreak has thrown the world into an unprecedented crisis. It has posed a challenge to scientists around the globe who are working tirelessly to combat this pandemic. We herein report a set of molecules that may serve as possible inhibitors of the SARS-CoV-2 main protease. To identify these molecules, we followed a combinatorial structure-based strategy, which includes high-throughput virtual screening, molecular docking and WaterMap calculations. The study was carried out using Pr","2021","06","30","Future Med Chem","Future medicinal chemistry","SARS-CoV-2; drug discovery; main protease; structure based drug design; water thermodynamics","Sivangula","Srikanth","Department of Pharmacoinformatics, National Institute of Pharmaceutical Education &amp",NA
"1604","34169728","10.4155/fmc-2020-0264","Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors.","The COVID-19 outbreak has thrown the world into an unprecedented crisis. It has posed a challenge to scientists around the globe who are working tirelessly to combat this pandemic. We herein report a set of molecules that may serve as possible inhibitors of the SARS-CoV-2 main protease. To identify these molecules, we followed a combinatorial structure-based strategy, which includes high-throughput virtual screening, molecular docking and WaterMap calculations. The study was carried out using Pr","2021","06","30","Future Med Chem","Future medicinal chemistry","SARS-CoV-2; drug discovery; main protease; structure based drug design; water thermodynamics","Ghosh","Ketan","Department of Pharmacoinformatics, National Institute of Pharmaceutical Education &amp",NA
"1605","34169728","10.4155/fmc-2020-0264","Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors.","The COVID-19 outbreak has thrown the world into an unprecedented crisis. It has posed a challenge to scientists around the globe who are working tirelessly to combat this pandemic. We herein report a set of molecules that may serve as possible inhibitors of the SARS-CoV-2 main protease. To identify these molecules, we followed a combinatorial structure-based strategy, which includes high-throughput virtual screening, molecular docking and WaterMap calculations. The study was carried out using Pr","2021","06","30","Future Med Chem","Future medicinal chemistry","SARS-CoV-2; drug discovery; main protease; structure based drug design; water thermodynamics","Singh","Harmanpreet","Department of Pharmacoinformatics, National Institute of Pharmaceutical Education &amp",NA
"1606","34169728","10.4155/fmc-2020-0264","Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors.","The COVID-19 outbreak has thrown the world into an unprecedented crisis. It has posed a challenge to scientists around the globe who are working tirelessly to combat this pandemic. We herein report a set of molecules that may serve as possible inhibitors of the SARS-CoV-2 main protease. To identify these molecules, we followed a combinatorial structure-based strategy, which includes high-throughput virtual screening, molecular docking and WaterMap calculations. The study was carried out using Pr","2021","06","30","Future Med Chem","Future medicinal chemistry","SARS-CoV-2; drug discovery; main protease; structure based drug design; water thermodynamics","Haokip","Thongtinlal","Department of Pharmacoinformatics, National Institute of Pharmaceutical Education &amp",NA
"1607","34169728","10.4155/fmc-2020-0264","Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors.","The COVID-19 outbreak has thrown the world into an unprecedented crisis. It has posed a challenge to scientists around the globe who are working tirelessly to combat this pandemic. We herein report a set of molecules that may serve as possible inhibitors of the SARS-CoV-2 main protease. To identify these molecules, we followed a combinatorial structure-based strategy, which includes high-throughput virtual screening, molecular docking and WaterMap calculations. The study was carried out using Pr","2021","06","30","Future Med Chem","Future medicinal chemistry","SARS-CoV-2; drug discovery; main protease; structure based drug design; water thermodynamics","Gibson","Joseph","Postgraduate Institute of Medical Education &amp",NA
"1608","34169702","","Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.","Almost 13 months have passed since the World Health Organization (WHO) declared the coronavirus disease 19 (COVID-19) pandemic, caused by the SARS-CoV-2, on March 11th, 2020. During this period, we have realized that the most effective weapon we have to prevent SARS-CoV-2 infection, or to make it less aggressive, is vaccines. Currently, according to the WHO document ""Draft landscape of COVID-19 candidate vaccines,"" there are 275 vaccines in development against the virus, although at the moment t","2021","07","05","Acta Dermatovenerol Alp Pannonica Adriat","Acta dermatovenerologica Alpina, Pannonica, et Adriatica","COVID-19; COVID-19 Vaccines; Clinical Competence; Dermatitis, Atopic; Dermatologists; Europe; Humans; Practice Patterns, Physicians'","Diotallevi","Federico","Dermatology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy",NA
"1609","34169702","","Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.","Almost 13 months have passed since the World Health Organization (WHO) declared the coronavirus disease 19 (COVID-19) pandemic, caused by the SARS-CoV-2, on March 11th, 2020. During this period, we have realized that the most effective weapon we have to prevent SARS-CoV-2 infection, or to make it less aggressive, is vaccines. Currently, according to the WHO document ""Draft landscape of COVID-19 candidate vaccines,"" there are 275 vaccines in development against the virus, although at the moment t","2021","07","05","Acta Dermatovenerol Alp Pannonica Adriat","Acta dermatovenerologica Alpina, Pannonica, et Adriatica","COVID-19; COVID-19 Vaccines; Clinical Competence; Dermatitis, Atopic; Dermatologists; Europe; Humans; Practice Patterns, Physicians'","Simonetti","Oriana","Dermatology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy",NA
"1610","34169702","","Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.","Almost 13 months have passed since the World Health Organization (WHO) declared the coronavirus disease 19 (COVID-19) pandemic, caused by the SARS-CoV-2, on March 11th, 2020. During this period, we have realized that the most effective weapon we have to prevent SARS-CoV-2 infection, or to make it less aggressive, is vaccines. Currently, according to the WHO document ""Draft landscape of COVID-19 candidate vaccines,"" there are 275 vaccines in development against the virus, although at the moment t","2021","07","05","Acta Dermatovenerol Alp Pannonica Adriat","Acta dermatovenerologica Alpina, Pannonica, et Adriatica","COVID-19; COVID-19 Vaccines; Clinical Competence; Dermatitis, Atopic; Dermatologists; Europe; Humans; Practice Patterns, Physicians'","Radi","Giulia","Dermatology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy",NA
"1611","34169702","","Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.","Almost 13 months have passed since the World Health Organization (WHO) declared the coronavirus disease 19 (COVID-19) pandemic, caused by the SARS-CoV-2, on March 11th, 2020. During this period, we have realized that the most effective weapon we have to prevent SARS-CoV-2 infection, or to make it less aggressive, is vaccines. Currently, according to the WHO document ""Draft landscape of COVID-19 candidate vaccines,"" there are 275 vaccines in development against the virus, although at the moment t","2021","07","05","Acta Dermatovenerol Alp Pannonica Adriat","Acta dermatovenerologica Alpina, Pannonica, et Adriatica","COVID-19; COVID-19 Vaccines; Clinical Competence; Dermatitis, Atopic; Dermatologists; Europe; Humans; Practice Patterns, Physicians'","Molinelli","Elisa","Dermatology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy",NA
"1612","34169702","","Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.","Almost 13 months have passed since the World Health Organization (WHO) declared the coronavirus disease 19 (COVID-19) pandemic, caused by the SARS-CoV-2, on March 11th, 2020. During this period, we have realized that the most effective weapon we have to prevent SARS-CoV-2 infection, or to make it less aggressive, is vaccines. Currently, according to the WHO document ""Draft landscape of COVID-19 candidate vaccines,"" there are 275 vaccines in development against the virus, although at the moment t","2021","07","05","Acta Dermatovenerol Alp Pannonica Adriat","Acta dermatovenerologica Alpina, Pannonica, et Adriatica","COVID-19; COVID-19 Vaccines; Clinical Competence; Dermatitis, Atopic; Dermatologists; Europe; Humans; Practice Patterns, Physicians'","Rizzetto","Giulio","Dermatology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy",NA
"1613","34169702","","Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.","Almost 13 months have passed since the World Health Organization (WHO) declared the coronavirus disease 19 (COVID-19) pandemic, caused by the SARS-CoV-2, on March 11th, 2020. During this period, we have realized that the most effective weapon we have to prevent SARS-CoV-2 infection, or to make it less aggressive, is vaccines. Currently, according to the WHO document ""Draft landscape of COVID-19 candidate vaccines,"" there are 275 vaccines in development against the virus, although at the moment t","2021","07","05","Acta Dermatovenerol Alp Pannonica Adriat","Acta dermatovenerologica Alpina, Pannonica, et Adriatica","COVID-19; COVID-19 Vaccines; Clinical Competence; Dermatitis, Atopic; Dermatologists; Europe; Humans; Practice Patterns, Physicians'","Cirioni","Oscar","Infectious Diseases Clinic, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy",NA
"1614","34169702","","Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.","Almost 13 months have passed since the World Health Organization (WHO) declared the coronavirus disease 19 (COVID-19) pandemic, caused by the SARS-CoV-2, on March 11th, 2020. During this period, we have realized that the most effective weapon we have to prevent SARS-CoV-2 infection, or to make it less aggressive, is vaccines. Currently, according to the WHO document ""Draft landscape of COVID-19 candidate vaccines,"" there are 275 vaccines in development against the virus, although at the moment t","2021","07","05","Acta Dermatovenerol Alp Pannonica Adriat","Acta dermatovenerologica Alpina, Pannonica, et Adriatica","COVID-19; COVID-19 Vaccines; Clinical Competence; Dermatitis, Atopic; Dermatologists; Europe; Humans; Practice Patterns, Physicians'","D'Errico","Marcello Mario","Department of Biomedical Sciences and Public Health, Section of Hygiene, Preventive Medicine and Public Health, Polytechnic University of Marche, Ancona, Italy",NA
"1615","34169702","","Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.","Almost 13 months have passed since the World Health Organization (WHO) declared the coronavirus disease 19 (COVID-19) pandemic, caused by the SARS-CoV-2, on March 11th, 2020. During this period, we have realized that the most effective weapon we have to prevent SARS-CoV-2 infection, or to make it less aggressive, is vaccines. Currently, according to the WHO document ""Draft landscape of COVID-19 candidate vaccines,"" there are 275 vaccines in development against the virus, although at the moment t","2021","07","05","Acta Dermatovenerol Alp Pannonica Adriat","Acta dermatovenerologica Alpina, Pannonica, et Adriatica","COVID-19; COVID-19 Vaccines; Clinical Competence; Dermatitis, Atopic; Dermatologists; Europe; Humans; Practice Patterns, Physicians'","Offidani","Annamaria","Dermatology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy",NA
"1616","34169691","","[An overview on acute kidney injury in COVID-19].","SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is ","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","AKI; COVID-19; CRRT; Ospedale Domenico Cotugno; extracorporeal purification therapies; Acute Kidney Injury; Adult; COVID-19; Conservative Treatment; Critical Illness; Cytokine Release Syndrome; Hospital Mortality; Humans; Intensive Care Units; Middle Aged; Pandemics; Renal Dialysis; Renal Replacement Therapy; Risk Factors","Altobelli","Claudia","A.O.R.N. Ospedali dei Colli - Monaldi, Cotugno, CTO - P.O. Domenico Cotugno, U.O.C. Nefrologia e Dialisi, Napoli, Italy",NA
"1617","34169691","","[An overview on acute kidney injury in COVID-19].","SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is ","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","AKI; COVID-19; CRRT; Ospedale Domenico Cotugno; extracorporeal purification therapies; Acute Kidney Injury; Adult; COVID-19; Conservative Treatment; Critical Illness; Cytokine Release Syndrome; Hospital Mortality; Humans; Intensive Care Units; Middle Aged; Pandemics; Renal Dialysis; Renal Replacement Therapy; Risk Factors","de Pascale","Emanuela","A.O.R.N. Ospedali dei Colli - Monaldi, Cotugno, CTO - P.O. Domenico Cotugno, U.O.C. Nefrologia e Dialisi, Napoli, Italy",NA
"1618","34169691","","[An overview on acute kidney injury in COVID-19].","SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is ","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","AKI; COVID-19; CRRT; Ospedale Domenico Cotugno; extracorporeal purification therapies; Acute Kidney Injury; Adult; COVID-19; Conservative Treatment; Critical Illness; Cytokine Release Syndrome; Hospital Mortality; Humans; Intensive Care Units; Middle Aged; Pandemics; Renal Dialysis; Renal Replacement Therapy; Risk Factors","Di Natale","Gabriella","A.O.R.N. Ospedali dei Colli - Monaldi, Cotugno, CTO - P.O. Domenico Cotugno, U.O.C. Nefrologia e Dialisi, Napoli, Italy",NA
"1619","34169691","","[An overview on acute kidney injury in COVID-19].","SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is ","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","AKI; COVID-19; CRRT; Ospedale Domenico Cotugno; extracorporeal purification therapies; Acute Kidney Injury; Adult; COVID-19; Conservative Treatment; Critical Illness; Cytokine Release Syndrome; Hospital Mortality; Humans; Intensive Care Units; Middle Aged; Pandemics; Renal Dialysis; Renal Replacement Therapy; Risk Factors","Marinelli","Gaia","A.O.R.N. Ospedali dei Colli - Monaldi, Cotugno, CTO - P.O. Domenico Cotugno, U.O.C. Nefrologia e Dialisi, Napoli, Italy",NA
"1620","34169691","","[An overview on acute kidney injury in COVID-19].","SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is ","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","AKI; COVID-19; CRRT; Ospedale Domenico Cotugno; extracorporeal purification therapies; Acute Kidney Injury; Adult; COVID-19; Conservative Treatment; Critical Illness; Cytokine Release Syndrome; Hospital Mortality; Humans; Intensive Care Units; Middle Aged; Pandemics; Renal Dialysis; Renal Replacement Therapy; Risk Factors","Minco","Maristella","A.O.R.N. Ospedali dei Colli - Monaldi, Cotugno, CTO - P.O. Domenico Cotugno, U.O.C. Nefrologia e Dialisi, Napoli, Italy",NA
"1621","34169691","","[An overview on acute kidney injury in COVID-19].","SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is ","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","AKI; COVID-19; CRRT; Ospedale Domenico Cotugno; extracorporeal purification therapies; Acute Kidney Injury; Adult; COVID-19; Conservative Treatment; Critical Illness; Cytokine Release Syndrome; Hospital Mortality; Humans; Intensive Care Units; Middle Aged; Pandemics; Renal Dialysis; Renal Replacement Therapy; Risk Factors","Mirenghi","Francesco","A.O.R.N. Ospedali dei Colli - Monaldi, Cotugno, CTO - P.O. Domenico Cotugno, U.O.C. Nefrologia e Dialisi, Napoli, Italy",NA
"1622","34169691","","[An overview on acute kidney injury in COVID-19].","SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is ","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","AKI; COVID-19; CRRT; Ospedale Domenico Cotugno; extracorporeal purification therapies; Acute Kidney Injury; Adult; COVID-19; Conservative Treatment; Critical Illness; Cytokine Release Syndrome; Hospital Mortality; Humans; Intensive Care Units; Middle Aged; Pandemics; Renal Dialysis; Renal Replacement Therapy; Risk Factors","Russo","Roberta","A.O.R.N. Ospedali dei Colli - Monaldi, Cotugno, CTO - P.O. Domenico Cotugno, U.O.C. Nefrologia e Dialisi, Napoli, Italy",NA
"1623","34169691","","[An overview on acute kidney injury in COVID-19].","SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is ","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","AKI; COVID-19; CRRT; Ospedale Domenico Cotugno; extracorporeal purification therapies; Acute Kidney Injury; Adult; COVID-19; Conservative Treatment; Critical Illness; Cytokine Release Syndrome; Hospital Mortality; Humans; Intensive Care Units; Middle Aged; Pandemics; Renal Dialysis; Renal Replacement Therapy; Risk Factors","Pluvio","Corrado","A.O.R.N. Ospedali dei Colli - Monaldi, Cotugno, CTO - P.O. Domenico Cotugno, U.O.C. Nefrologia e Dialisi, Napoli, Italy",NA
"1624","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Neradova","Aegida","Department of Nephrology &amp",NA
"1625","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Vajgel","Gisele","Department of Renal Medicine, Royal Free Campus, UCL, Rowland Hill Street, London, UK",NA
"1626","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Hendra","Heidy","Department of Nephrology &amp",NA
"1627","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Antonelou","Marilina","Department of Nephrology &amp",NA
"1628","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Kostakis","Ioannis D","Department of HPB Surgery and Liver Transplantation, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK",NA
"1629","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Wright","David","Department of Nephrology &amp",NA
"1630","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Masson","Philip","Department of Nephrology &amp",NA
"1631","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Milne","Sarah E","Department of Nephrology &amp",NA
"1632","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Jones","Gareth","Department of Nephrology &amp",NA
"1633","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Salama","Alan","Department of Nephrology &amp",NA
"1634","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Davenport","Andrew","Department of Nephrology &amp",NA
"1635","34169690","","Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.","Background: Frailty is a known predictor of mortality and poor outcomes during hospital admission. In this large renal retrospective cohort study, we investigated whether frailer COVID-19 positive renal patients had worse outcomes. Design: All SARS-Cov-2 positive renal patients aged =18 years who presented to the emergency department at the Royal Free Hospital or at the satellite dialysis centres from 10th of March until the 10th of May 2020, with recent data on frailty, were inclu","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","SARS-Cov-2; frailty; renal patients; Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Emergency Service, Hospital; Female; Frailty; Hospitalization; Humans; Kidney Diseases; Kidney Transplantation; London; Male; Middle Aged; Pandemics; Regression Analysis; Renal Dialysis; Retrospective Studies; Risk Factors; Transplant Recipients; Young Adult","Burns","Áine","Department of Nephrology &amp",NA
"1636","34169689","","[Nephrology: where we stand and where we should go].","In the last year, the Italian National Health Service as a whole and the Nephrology community have been severely challenged by the pandemic. It has been a dramatic stress test for the entire healthcare system, not only in Italy but worldwide. The general organization of our Nephrology units and our models of care were put under extreme pressure, and we had to quickly adopt unprecedented clinical practice recommendations and organizational models to overcome the impasse caused by the pandemic. Th","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","COVID-19 pandemic; National Health Service; Nephrology Census; new organizational requirements; COVID-19; Censuses; Humans; Italy; Models, Organizational; Nephrology; Pandemics; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Physicians; Renal Dialysis","Quintaliani","Giuseppe","Segretario Fondazione Italiana del Rene, Roma, Italy",NA
"1637","34169689","","[Nephrology: where we stand and where we should go].","In the last year, the Italian National Health Service as a whole and the Nephrology community have been severely challenged by the pandemic. It has been a dramatic stress test for the entire healthcare system, not only in Italy but worldwide. The general organization of our Nephrology units and our models of care were put under extreme pressure, and we had to quickly adopt unprecedented clinical practice recommendations and organizational models to overcome the impasse caused by the pandemic. Th","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","COVID-19 pandemic; National Health Service; Nephrology Census; new organizational requirements; COVID-19; Censuses; Humans; Italy; Models, Organizational; Nephrology; Pandemics; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Physicians; Renal Dialysis","Nordio","Maurizio","Unità di Nefrologia, Ospedale di Treviso, Treviso, Italy",NA
"1638","34169689","","[Nephrology: where we stand and where we should go].","In the last year, the Italian National Health Service as a whole and the Nephrology community have been severely challenged by the pandemic. It has been a dramatic stress test for the entire healthcare system, not only in Italy but worldwide. The general organization of our Nephrology units and our models of care were put under extreme pressure, and we had to quickly adopt unprecedented clinical practice recommendations and organizational models to overcome the impasse caused by the pandemic. Th","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","COVID-19 pandemic; National Health Service; Nephrology Census; new organizational requirements; COVID-19; Censuses; Humans; Italy; Models, Organizational; Nephrology; Pandemics; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Physicians; Renal Dialysis","Reboldi","Gianpaolo","Commissione Epidemiologia SIN",NA
"1639","34169689","","[Nephrology: where we stand and where we should go].","In the last year, the Italian National Health Service as a whole and the Nephrology community have been severely challenged by the pandemic. It has been a dramatic stress test for the entire healthcare system, not only in Italy but worldwide. The general organization of our Nephrology units and our models of care were put under extreme pressure, and we had to quickly adopt unprecedented clinical practice recommendations and organizational models to overcome the impasse caused by the pandemic. Th","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","COVID-19 pandemic; National Health Service; Nephrology Census; new organizational requirements; COVID-19; Censuses; Humans; Italy; Models, Organizational; Nephrology; Pandemics; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Physicians; Renal Dialysis","Aucella","Filippo","IRCCS ""Casa Sollievo Della Sofferenza"", Istituto scientifico per la ricerca e cura, San Giovanni Rotondo (FG), Italy",NA
"1640","34169689","","[Nephrology: where we stand and where we should go].","In the last year, the Italian National Health Service as a whole and the Nephrology community have been severely challenged by the pandemic. It has been a dramatic stress test for the entire healthcare system, not only in Italy but worldwide. The general organization of our Nephrology units and our models of care were put under extreme pressure, and we had to quickly adopt unprecedented clinical practice recommendations and organizational models to overcome the impasse caused by the pandemic. Th","2021","07","02","G Ital Nefrol","Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia","COVID-19 pandemic; National Health Service; Nephrology Census; new organizational requirements; COVID-19; Censuses; Humans; Italy; Models, Organizational; Nephrology; Pandemics; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Physicians; Renal Dialysis","Brunori","Giuliano","SC di Nefrologia e Dialisi, Ospedale di Trento, Trento, Italy",NA
"1641","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Agarwal","Ashok","American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA. agarwaa@ccf","agarwaa@ccf.org"
"1642","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Finelli","Renata","American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA",NA
"1643","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Durairajanayagam","Damayanthi","Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Selangor, Malaysia",NA
"1644","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Leisegang","Kristian","Department of Physiology, School of Natural Medicine, Faculty of Community and Health Sciences, University of the Western Cape, Bellville, South Africa",NA
"1645","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Sharma","Rakesh","American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA",NA
"1646","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Gupta","Sajal","American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA",NA
"1647","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Singh","Neha","NOVA IVF, Gorakhpur, India",NA
"1648","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Belo","Andrea","Huntington Centro de Medicina Reproditiva S/A, Sao Paulo, São Paulo, Brazil",NA
"1649","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Darbandi","Mahsa","Fetal Health Research Center, Hope Generation Foundation, Tehran, Iran",NA
"1650","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Madani","Sarah","Department of Biology and Physiology of Organisms, Faculty of Biological Sciences, University of Science and Technnology, Houari Boumedien, Algiers, Algeria",NA
"1651","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Covarrubias","Simryn","University of San Francisco, San Francisco, CA, USA",NA
"1652","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Darbandi","Sara","Fetal Health Research Center, Hope Generation Foundation, Tehran, Iran",NA
"1653","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Sadeghi","Raha","University of San Francisco, San Francisco, CA, USA",NA
"1654","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Pompeu","Camila","Instituto Ideia Fèrtil, Santo Andrè, Brazil",NA
"1655","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Boitrelle","Florence","Reproductive Biology, Fertility Preservation, Andrology, CECOS, Poissy Hospital, Poissy, France",NA
"1656","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Kandil","Hussein","Fakih IVF Fertility Center, Abu Dhabi, UAE",NA
"1657","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Saleh","Ramadan","Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University, Sohag, Egypt",NA
"1658","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Arafa","Mohamed","American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA",NA
"1659","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Vogiatzi","Paraskevi","Andromed Health &amp",NA
"1660","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Rosas","Israel Maldonado","Citmer Reproductive Medicine, IVF LAB, Mexico City, Mexico",NA
"1661","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Anagnostopoulou","Christina","IVF Clinic ""Akeso-Embryo ART"", Athens, Greece",NA
"1662","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Chockalingam","Annapoorani","Gene2Genome, Jacksonville, FL, USA",NA
"1663","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Wirka","Kelly Athayde","Fertility &amp",NA
"1664","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Sallam","Hassan N","Department of Obstetrics and Gynaecology, Alexandria University Faculty of Medicine, Alexandria, Egypt",NA
"1665","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Shah","Rupin","Department of Urology, Lilavati Hospital and Research Centre, Mumbai, India",NA
"1666","34169688","10.5534/wjmh.210075","A Web-Based Global Educational Model for Training in Semen Analysis during the COVID-19 Pandemic.","In response to the COVID-19 pandemic, the American Center for Reproductive Medicine (ACRM) transitioned its annual training in assisted reproductive technology (ART) from a hands-on, laboratory-based training course to a fully online training endorsed by the American College of Embryology. Here we describe our experience and assess the quality of an online training format based on participant outcomes for the first three modules of a planned series of online ART training. These modules included ","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; Education, distance; Semen analysis; Surveys and questionnaires","Henkel","Ralf","American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA",NA
"1667","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Chung","Eric","AndroUrology Centre, University of Queensland, Brisbane, QLD, Australia","ericchg@hotmail.com"
"1668","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Jiann","Bang Ping","Department of Urology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan",NA
"1669","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Nagao","Koichi","Department of Urology, Toho University, Tokyo, Japan",NA
"1670","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Hakim","Lukman","Department of Urology, Airlangga University, Dr Soetomo Hospital, Surabaya, Indonesia",NA
"1671","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Huang","William","Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"1672","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Lee","Joe","Department of Urology, National University Hospital, Singapore",NA
"1673","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Lin","Haocheng","Department of Urology and Andrology, Peking University Third Hospital, Beijing, China",NA
"1674","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Mai","Dung Ba Tien","Department of Urology, Binh Dan Hospital, Ho Chi Minh City, Vietnam",NA
"1675","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Nguyen","Quang","Centre of Andrology, Department of Urology, Viet Duc University Hospital, Hanoi, Vietnam",NA
"1676","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Park","Hyun Jun","Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea",NA
"1677","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Sato","Yoshikazu","Department of Urology, Sanjukai Hospital, Sapporo, Japan",NA
"1678","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Tantiwongse","Kavirach","Department of Urology, Chulalongkorn University Hospital, Bangkok, Thailand",NA
"1679","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Yuan","Yiming","Andrology Centre, Peking University First Hospital, Peking University, Beijing, China",NA
"1680","34169677","10.5534/wjmh.210033","COVID Pandemic Impact on Healthcare Provision and Patient Psychosocial Distress: A Multi-National Cross-Sectional Survey among Asia-Pacific Countries.","COVID pandemic significantly affected the delivery and maintenance of healthcare system, resulting in greater utilization of digital health interventions. This multi-national cross-sectional survey was administered to clinicians working in major Asia-Pacific cities during the mandatory social lockdown period in June 2020. Clinical demographics and professional data, delivery of Andrology-related healthcare services, and patient distress based on validated questionnaires such as Depression and An","2021","06","25","World J Mens Health","The world journal of men's health","Andrology; COVID-19; Digital technology; Psychological distress; Telemedicine","Park","Kwangsung","Department of Urology, Chonnam National University Medical School, Gwangju, Korea",NA
"1681","34169670","10.1111/irv.12880","Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019-2020 season.","The association of influenza vaccine and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was assessed by test-negative design using data collected for a study of outpatient COVID-19-like illness with onset dates from June to September 2020. Multivariable logistic regression models examined the association between receipt of 2019-2020 influenza vaccine and PCR-confirmed SARS-CoV-2 with adjustment for potential confounders. Receipt of influenza vaccine during the 2019-2020 i","2021","06","25","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; PCR; SARS-CoV-2; influenza vaccine; outpatient","King","Jennifer P","Center for Clinical Epidemiology &amp",NA
"1682","34169670","10.1111/irv.12880","Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019-2020 season.","The association of influenza vaccine and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was assessed by test-negative design using data collected for a study of outpatient COVID-19-like illness with onset dates from June to September 2020. Multivariable logistic regression models examined the association between receipt of 2019-2020 influenza vaccine and PCR-confirmed SARS-CoV-2 with adjustment for potential confounders. Receipt of influenza vaccine during the 2019-2020 i","2021","06","25","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; PCR; SARS-CoV-2; influenza vaccine; outpatient","McLean","Huong Q","Center for Clinical Epidemiology &amp",NA
"1683","34169670","10.1111/irv.12880","Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019-2020 season.","The association of influenza vaccine and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was assessed by test-negative design using data collected for a study of outpatient COVID-19-like illness with onset dates from June to September 2020. Multivariable logistic regression models examined the association between receipt of 2019-2020 influenza vaccine and PCR-confirmed SARS-CoV-2 with adjustment for potential confounders. Receipt of influenza vaccine during the 2019-2020 i","2021","06","25","Influenza Other Respir Viruses","Influenza and other respiratory viruses","COVID-19; PCR; SARS-CoV-2; influenza vaccine; outpatient","Belongia","Edward A","Center for Clinical Epidemiology &amp",NA
"1684","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Jo","Soojung","Arizona State University, Phoenix, Arizona, USA",NA
"1685","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Kurt","Sule","Karadeniz Technical University, Ortahisar, Turkey",NA
"1686","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Bennett","Jo Anne","National Institute of Public Health, Ministry of Health, Conakry, Guinea",NA
"1687","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Mayer","Kala","University of Portland, Portland, Oregon, USA",NA
"1688","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Pituch","Keenan A","Arizona State University, Phoenix, Arizona, USA",NA
"1689","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Simpson","Vicki","Purdue University, West Lafayette, Indiana, USA",NA
"1690","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Skibiski","Jeanie","Missouri State University, Springfield, Missouri, USA",NA
"1691","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Takagi","Etsuko","Teikyo University of Science, Tokyo, Japan",NA
"1692","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Karaaslan","Mehtap Metin","Recep Tayyip Erdogan University School of Health, Rize, Turkey",NA
"1693","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Ozluk","Bilgen","Necmettin Erbakan University, Konya, Turkey",NA
"1694","34169629","10.1111/nhs.12863","Nurses' resilience in the face of coronavirus (COVID-19): An international view.","The purpose of this cross-sectional study was to examine factors associated with nurses' resilience during the COVID-19 pandemic. Data were collected in the latter half of 2020 from 904 nurses across Japan, Republic of Korea, Republic of Turkey, and the United States. The questionnaire included the Connor-Davidson Resilience Scale 10, plus demographics and 20 questions about practice environment, workplace safety concerning infection control, COVID-related experience, and organizational support.","2021","07","21","Nurs Health Sci","Nursing &amp; health sciences","CD-RISC; COVID-19; healthcare workers; nurses; pandemics; resilience; stress","Reifsnider","Elizabeth","Arizona State University, Phoenix, Arizona, USA",NA
"1695","34169627","10.1111/hdi.12959","Travel arrangements in hemodialysis patients during the COVID-19 pandemic including London-style ""black cabs"" for transfer to a designated isolation unit.",NA,"2021","06","25","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis",NA,"Fox","Victoria","Salford Royal NHS Foundation Trust, Salford, UK",NA
"1696","34169627","10.1111/hdi.12959","Travel arrangements in hemodialysis patients during the COVID-19 pandemic including London-style ""black cabs"" for transfer to a designated isolation unit.",NA,"2021","06","25","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis",NA,"Poulikakos","Dimitrios","Salford Royal NHS Foundation Trust, Salford, UK",NA
"1697","34169609","10.1002/cpp.2639","The COVID-19 anxiety syndrome and selective attentional bias towards COVID-19-related stimuli in UK residents during the 2020-2021 pandemic.","The psychological and social effects of the COVID-19 pandemic are pervasive, and there is potential for a long-lasting impact on mental health. In the current study, we sought to provide, in a representative sample of UK residents during the third COVID-19 lockdown in February 2021, further evidence for the validation of the COVID-19 anxiety syndrome construct. We did this by evaluating the COVID-19 anxiety syndrome against measures of personality, health anxiety and COVID-19 anxiety in predicti","2021","07","02","Clin Psychol Psychother","Clinical psychology &amp; psychotherapy","COVID-19 anxiety; COVID-19 anxiety syndrome; attentional bias; health anxiety; personality traits; psychological distress","Albery","Ian P","Centre for Addictive Behaviours Research, School of Applied Sciences, London South Bank University, London, UK",NA
"1698","34169609","10.1002/cpp.2639","The COVID-19 anxiety syndrome and selective attentional bias towards COVID-19-related stimuli in UK residents during the 2020-2021 pandemic.","The psychological and social effects of the COVID-19 pandemic are pervasive, and there is potential for a long-lasting impact on mental health. In the current study, we sought to provide, in a representative sample of UK residents during the third COVID-19 lockdown in February 2021, further evidence for the validation of the COVID-19 anxiety syndrome construct. We did this by evaluating the COVID-19 anxiety syndrome against measures of personality, health anxiety and COVID-19 anxiety in predicti","2021","07","02","Clin Psychol Psychother","Clinical psychology &amp; psychotherapy","COVID-19 anxiety; COVID-19 anxiety syndrome; attentional bias; health anxiety; personality traits; psychological distress","Spada","Marcantonio M","Centre for Addictive Behaviours Research, School of Applied Sciences, London South Bank University, London, UK",NA
"1699","34169609","10.1002/cpp.2639","The COVID-19 anxiety syndrome and selective attentional bias towards COVID-19-related stimuli in UK residents during the 2020-2021 pandemic.","The psychological and social effects of the COVID-19 pandemic are pervasive, and there is potential for a long-lasting impact on mental health. In the current study, we sought to provide, in a representative sample of UK residents during the third COVID-19 lockdown in February 2021, further evidence for the validation of the COVID-19 anxiety syndrome construct. We did this by evaluating the COVID-19 anxiety syndrome against measures of personality, health anxiety and COVID-19 anxiety in predicti","2021","07","02","Clin Psychol Psychother","Clinical psychology &amp; psychotherapy","COVID-19 anxiety; COVID-19 anxiety syndrome; attentional bias; health anxiety; personality traits; psychological distress","Nikcevic","Ana V","Department of Psychology, Kingston University, London, UK",NA
"1700","34169588","10.1111/jdv.17480","Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Solimani","F","Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany",NA
"1701","34169588","10.1111/jdv.17480","Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Mansour","Y","Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany",NA
"1702","34169588","10.1111/jdv.17480","Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Didona","D","Department of Dermatology and Allergology, Philipps University, Marburg, Germany",NA
"1703","34169588","10.1111/jdv.17480","Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Dilling","A","Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany",NA
"1704","34169588","10.1111/jdv.17480","Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Ghoreschi","K","Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany",NA
"1705","34169588","10.1111/jdv.17480","Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.",NA,"2021","07","12","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Meier","K","Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany",NA
"1706","34169578","10.1111/jdv.17472","The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?",NA,"2021","07","13","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Damiani","G","Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy",NA
"1707","34169578","10.1111/jdv.17472","The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?",NA,"2021","07","13","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Pacifico","A","Clinical Dermatology Department, IRCCS S. Gallicano Dermatological Institute, Rome, Italy",NA
"1708","34169578","10.1111/jdv.17472","The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?",NA,"2021","07","13","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Pelloni","F","Private Dermatology Practice, Lugano, Switzerland",NA
"1709","34169578","10.1111/jdv.17472","The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?",NA,"2021","07","13","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV",NA,"Iorizzo","M","Private Dermatology Practice, Lugano, Switzerland",NA
"1710","34169574","10.1111/sdi.12997","Aftermath of fortnightly universal testing for severe acute respiratory corona virus-2 infection in maintenance hemodialysis patients.","Asymptomatic maintenance hemodialysis patients with acute respiratory corona virus-2 (SARS-COV-2) are missed with pre-dialysis screening without testing. The possible ideal strategy of testing each patient before each shift with reverse transcription polymerase chain reaction (RT-PCR) is not feasible. We aimed to study the effectiveness of fortnightly screening with RT-PCR for SARS-CoV-2 in curbing transmission. Between July 1, 2020 and September 30, 2020, all 273 patients receiving hemodialysis","2021","06","25","Semin Dial","Seminars in dialysis",NA,"Patel","Manas R","Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India",NA
"1711","34169574","10.1111/sdi.12997","Aftermath of fortnightly universal testing for severe acute respiratory corona virus-2 infection in maintenance hemodialysis patients.","Asymptomatic maintenance hemodialysis patients with acute respiratory corona virus-2 (SARS-COV-2) are missed with pre-dialysis screening without testing. The possible ideal strategy of testing each patient before each shift with reverse transcription polymerase chain reaction (RT-PCR) is not feasible. We aimed to study the effectiveness of fortnightly screening with RT-PCR for SARS-CoV-2 in curbing transmission. Between July 1, 2020 and September 30, 2020, all 273 patients receiving hemodialysis","2021","06","25","Semin Dial","Seminars in dialysis",NA,"Kushwaha","Ravi S","Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India",NA
"1712","34169574","10.1111/sdi.12997","Aftermath of fortnightly universal testing for severe acute respiratory corona virus-2 infection in maintenance hemodialysis patients.","Asymptomatic maintenance hemodialysis patients with acute respiratory corona virus-2 (SARS-COV-2) are missed with pre-dialysis screening without testing. The possible ideal strategy of testing each patient before each shift with reverse transcription polymerase chain reaction (RT-PCR) is not feasible. We aimed to study the effectiveness of fortnightly screening with RT-PCR for SARS-CoV-2 in curbing transmission. Between July 1, 2020 and September 30, 2020, all 273 patients receiving hemodialysis","2021","06","25","Semin Dial","Seminars in dialysis",NA,"Behera","Manas","Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India",NA
"1713","34169574","10.1111/sdi.12997","Aftermath of fortnightly universal testing for severe acute respiratory corona virus-2 infection in maintenance hemodialysis patients.","Asymptomatic maintenance hemodialysis patients with acute respiratory corona virus-2 (SARS-COV-2) are missed with pre-dialysis screening without testing. The possible ideal strategy of testing each patient before each shift with reverse transcription polymerase chain reaction (RT-PCR) is not feasible. We aimed to study the effectiveness of fortnightly screening with RT-PCR for SARS-CoV-2 in curbing transmission. Between July 1, 2020 and September 30, 2020, all 273 patients receiving hemodialysis","2021","06","25","Semin Dial","Seminars in dialysis",NA,"Bhadauria","Dharmendra S","Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India",NA
"1714","34169574","10.1111/sdi.12997","Aftermath of fortnightly universal testing for severe acute respiratory corona virus-2 infection in maintenance hemodialysis patients.","Asymptomatic maintenance hemodialysis patients with acute respiratory corona virus-2 (SARS-COV-2) are missed with pre-dialysis screening without testing. The possible ideal strategy of testing each patient before each shift with reverse transcription polymerase chain reaction (RT-PCR) is not feasible. We aimed to study the effectiveness of fortnightly screening with RT-PCR for SARS-CoV-2 in curbing transmission. Between July 1, 2020 and September 30, 2020, all 273 patients receiving hemodialysis","2021","06","25","Semin Dial","Seminars in dialysis",NA,"Yachha","Monika","Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India",NA
"1715","34169574","10.1111/sdi.12997","Aftermath of fortnightly universal testing for severe acute respiratory corona virus-2 infection in maintenance hemodialysis patients.","Asymptomatic maintenance hemodialysis patients with acute respiratory corona virus-2 (SARS-COV-2) are missed with pre-dialysis screening without testing. The possible ideal strategy of testing each patient before each shift with reverse transcription polymerase chain reaction (RT-PCR) is not feasible. We aimed to study the effectiveness of fortnightly screening with RT-PCR for SARS-CoV-2 in curbing transmission. Between July 1, 2020 and September 30, 2020, all 273 patients receiving hemodialysis","2021","06","25","Semin Dial","Seminars in dialysis",NA,"Kaul","Anupma","Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India",NA
"1716","34169574","10.1111/sdi.12997","Aftermath of fortnightly universal testing for severe acute respiratory corona virus-2 infection in maintenance hemodialysis patients.","Asymptomatic maintenance hemodialysis patients with acute respiratory corona virus-2 (SARS-COV-2) are missed with pre-dialysis screening without testing. The possible ideal strategy of testing each patient before each shift with reverse transcription polymerase chain reaction (RT-PCR) is not feasible. We aimed to study the effectiveness of fortnightly screening with RT-PCR for SARS-CoV-2 in curbing transmission. Between July 1, 2020 and September 30, 2020, all 273 patients receiving hemodialysis","2021","06","25","Semin Dial","Seminars in dialysis",NA,"Prasad","Narayan","Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India",NA
"1717","34169568","10.1002/prot.26164","Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.","The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still has serious negative effects on health, social life, and economics. Recently, vaccines from various companies have been urgently approved to control SARS-CoV-2 infections. However, any specific antiviral drug has not been confirmed so far for regular treatment. An important target is the main protease (M<sup>pro</sup> ), which plays a major role in replication of the virus. ","2021","07","05","Proteins","Proteins","SARS-CoV-2; allostery; drug repurposing; main protease","Yuce","Merve","Department of Chemical Engineering, Istanbul Technical University, Istanbul, Turkey",NA
"1718","34169568","10.1002/prot.26164","Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.","The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still has serious negative effects on health, social life, and economics. Recently, vaccines from various companies have been urgently approved to control SARS-CoV-2 infections. However, any specific antiviral drug has not been confirmed so far for regular treatment. An important target is the main protease (M<sup>pro</sup> ), which plays a major role in replication of the virus. ","2021","07","05","Proteins","Proteins","SARS-CoV-2; allostery; drug repurposing; main protease","Cicek","Erdem","Computational Science and Engineering Division, Informatics Institute, Istanbul Technical University, Istanbul, Turkey",NA
"1719","34169568","10.1002/prot.26164","Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.","The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still has serious negative effects on health, social life, and economics. Recently, vaccines from various companies have been urgently approved to control SARS-CoV-2 infections. However, any specific antiviral drug has not been confirmed so far for regular treatment. An important target is the main protease (M<sup>pro</sup> ), which plays a major role in replication of the virus. ","2021","07","05","Proteins","Proteins","SARS-CoV-2; allostery; drug repurposing; main protease","Inan","Tugce","Department of Chemical Engineering, Istanbul Technical University, Istanbul, Turkey",NA
"1720","34169568","10.1002/prot.26164","Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.","The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still has serious negative effects on health, social life, and economics. Recently, vaccines from various companies have been urgently approved to control SARS-CoV-2 infections. However, any specific antiviral drug has not been confirmed so far for regular treatment. An important target is the main protease (M<sup>pro</sup> ), which plays a major role in replication of the virus. ","2021","07","05","Proteins","Proteins","SARS-CoV-2; allostery; drug repurposing; main protease","Dag","Aslihan Basak","Department of Molecular Biology and Genetics, Istanbul Technical University, Istanbul, Turkey",NA
"1721","34169568","10.1002/prot.26164","Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.","The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still has serious negative effects on health, social life, and economics. Recently, vaccines from various companies have been urgently approved to control SARS-CoV-2 infections. However, any specific antiviral drug has not been confirmed so far for regular treatment. An important target is the main protease (M<sup>pro</sup> ), which plays a major role in replication of the virus. ","2021","07","05","Proteins","Proteins","SARS-CoV-2; allostery; drug repurposing; main protease","Kurkcuoglu","Ozge","Department of Chemical Engineering, Istanbul Technical University, Istanbul, Turkey",NA
"1722","34169568","10.1002/prot.26164","Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.","The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still has serious negative effects on health, social life, and economics. Recently, vaccines from various companies have been urgently approved to control SARS-CoV-2 infections. However, any specific antiviral drug has not been confirmed so far for regular treatment. An important target is the main protease (M<sup>pro</sup> ), which plays a major role in replication of the virus. ","2021","07","05","Proteins","Proteins","SARS-CoV-2; allostery; drug repurposing; main protease","Sungur","Fethiye Aylin","Computational Science and Engineering Division, Informatics Institute, Istanbul Technical University, Istanbul, Turkey",NA
"1723","34169519","10.1002/jdd.12701","Should attendance for preclinical simulation and clinical education be mandatory?","Mandatory attendance, particularly in didactic settings, is a highly debated topic in higher education, including dental education. Within dental education, a large portion of education occurs in preclinical laboratories and clinical environments. There is little to no research on attendance in these settings in dental schools. This point/counterpoint paper examines the pros and cons of mandatory attendance in these highly specialized educational settings. With the backdrop of the COVID-19 pande","2021","06","25","J Dent Educ","Journal of dental education","attendance; clinical education; humanism; mandatory; professional socialization; simulation","Saeed","Sophia G","Department of General Practice and Dental Public Health, UTHealth School of Dentistry at Houston, Houston, Texas, USA",NA
"1724","34169519","10.1002/jdd.12701","Should attendance for preclinical simulation and clinical education be mandatory?","Mandatory attendance, particularly in didactic settings, is a highly debated topic in higher education, including dental education. Within dental education, a large portion of education occurs in preclinical laboratories and clinical environments. There is little to no research on attendance in these settings in dental schools. This point/counterpoint paper examines the pros and cons of mandatory attendance in these highly specialized educational settings. With the backdrop of the COVID-19 pande","2021","06","25","J Dent Educ","Journal of dental education","attendance; clinical education; humanism; mandatory; professional socialization; simulation","Bain","Jennifer L","Department of Periodontics and Preventive Sciences, School of Dentistry, The University of Mississippi Medical Center, Jackson, Mississippi, USA",NA
"1725","34169519","10.1002/jdd.12701","Should attendance for preclinical simulation and clinical education be mandatory?","Mandatory attendance, particularly in didactic settings, is a highly debated topic in higher education, including dental education. Within dental education, a large portion of education occurs in preclinical laboratories and clinical environments. There is little to no research on attendance in these settings in dental schools. This point/counterpoint paper examines the pros and cons of mandatory attendance in these highly specialized educational settings. With the backdrop of the COVID-19 pande","2021","06","25","J Dent Educ","Journal of dental education","attendance; clinical education; humanism; mandatory; professional socialization; simulation","Khoo","Edmund","Department of Orthodontics, College of Dentistry, New York University, New York City, New York, USA",NA
"1726","34169519","10.1002/jdd.12701","Should attendance for preclinical simulation and clinical education be mandatory?","Mandatory attendance, particularly in didactic settings, is a highly debated topic in higher education, including dental education. Within dental education, a large portion of education occurs in preclinical laboratories and clinical environments. There is little to no research on attendance in these settings in dental schools. This point/counterpoint paper examines the pros and cons of mandatory attendance in these highly specialized educational settings. With the backdrop of the COVID-19 pande","2021","06","25","J Dent Educ","Journal of dental education","attendance; clinical education; humanism; mandatory; professional socialization; simulation","Siqueira","Walter L","College of Dentistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1727","34169519","10.1002/jdd.12701","Should attendance for preclinical simulation and clinical education be mandatory?","Mandatory attendance, particularly in didactic settings, is a highly debated topic in higher education, including dental education. Within dental education, a large portion of education occurs in preclinical laboratories and clinical environments. There is little to no research on attendance in these settings in dental schools. This point/counterpoint paper examines the pros and cons of mandatory attendance in these highly specialized educational settings. With the backdrop of the COVID-19 pande","2021","06","25","J Dent Educ","Journal of dental education","attendance; clinical education; humanism; mandatory; professional socialization; simulation","van der Hoeven","Ransome","Department of Diagnostic and Biomedical Sciences, UTHealth School of Dentistry at Houston, Houston, Texas, USA",NA
"1728","34169518","10.1002/ijop.12789","Thinking of future as an older individual increases perceived risks for age-related diseases but not for COVID-19.","Actively thinking of one's future as an older individual could increase perceived risk and risk aversion. This could be particularly relevant for COVID-19, if we consider the common representation of the risk of being infected by COVID-19 as associated with being older. Increased perceived risk could bear consequences on the adoption of preventive behaviours. Thus, we investigated whether increasing the salience of individuals' future as an older adult would impact on their perceived risk for CO","2021","06","25","Int J Psychol","International journal of psychology : Journal international de psychologie","Age priming; Age-related diseases; COVID-19; Future-oriented thinking; Risk perception","Monzani","Dario","Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy",NA
"1729","34169518","10.1002/ijop.12789","Thinking of future as an older individual increases perceived risks for age-related diseases but not for COVID-19.","Actively thinking of one's future as an older individual could increase perceived risk and risk aversion. This could be particularly relevant for COVID-19, if we consider the common representation of the risk of being infected by COVID-19 as associated with being older. Increased perceived risk could bear consequences on the adoption of preventive behaviours. Thus, we investigated whether increasing the salience of individuals' future as an older adult would impact on their perceived risk for CO","2021","06","25","Int J Psychol","International journal of psychology : Journal international de psychologie","Age priming; Age-related diseases; COVID-19; Future-oriented thinking; Risk perception","Marinucci","Marco","Department of Psychology, University of Milano - Bicocca, Milan, Italy",NA
"1730","34169518","10.1002/ijop.12789","Thinking of future as an older individual increases perceived risks for age-related diseases but not for COVID-19.","Actively thinking of one's future as an older individual could increase perceived risk and risk aversion. This could be particularly relevant for COVID-19, if we consider the common representation of the risk of being infected by COVID-19 as associated with being older. Increased perceived risk could bear consequences on the adoption of preventive behaviours. Thus, we investigated whether increasing the salience of individuals' future as an older adult would impact on their perceived risk for CO","2021","06","25","Int J Psychol","International journal of psychology : Journal international de psychologie","Age priming; Age-related diseases; COVID-19; Future-oriented thinking; Risk perception","Pancani","Luca","Department of Psychology, University of Milano - Bicocca, Milan, Italy",NA
"1731","34169518","10.1002/ijop.12789","Thinking of future as an older individual increases perceived risks for age-related diseases but not for COVID-19.","Actively thinking of one's future as an older individual could increase perceived risk and risk aversion. This could be particularly relevant for COVID-19, if we consider the common representation of the risk of being infected by COVID-19 as associated with being older. Increased perceived risk could bear consequences on the adoption of preventive behaviours. Thus, we investigated whether increasing the salience of individuals' future as an older adult would impact on their perceived risk for CO","2021","06","25","Int J Psychol","International journal of psychology : Journal international de psychologie","Age priming; Age-related diseases; COVID-19; Future-oriented thinking; Risk perception","Rusconi","Patrice","School of Psychology, University of Surrey, Guildford, UK",NA
"1732","34169518","10.1002/ijop.12789","Thinking of future as an older individual increases perceived risks for age-related diseases but not for COVID-19.","Actively thinking of one's future as an older individual could increase perceived risk and risk aversion. This could be particularly relevant for COVID-19, if we consider the common representation of the risk of being infected by COVID-19 as associated with being older. Increased perceived risk could bear consequences on the adoption of preventive behaviours. Thus, we investigated whether increasing the salience of individuals' future as an older adult would impact on their perceived risk for CO","2021","06","25","Int J Psychol","International journal of psychology : Journal international de psychologie","Age priming; Age-related diseases; COVID-19; Future-oriented thinking; Risk perception","Mazzoni","Davide","Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy",NA
"1733","34169518","10.1002/ijop.12789","Thinking of future as an older individual increases perceived risks for age-related diseases but not for COVID-19.","Actively thinking of one's future as an older individual could increase perceived risk and risk aversion. This could be particularly relevant for COVID-19, if we consider the common representation of the risk of being infected by COVID-19 as associated with being older. Increased perceived risk could bear consequences on the adoption of preventive behaviours. Thus, we investigated whether increasing the salience of individuals' future as an older adult would impact on their perceived risk for CO","2021","06","25","Int J Psychol","International journal of psychology : Journal international de psychologie","Age priming; Age-related diseases; COVID-19; Future-oriented thinking; Risk perception","Pravettoni","Gabriella","Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy",NA
"1734","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Gerotziafas","Grigoris T","Sorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France",NA
"1735","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Catalano","Mariella","Research Center on Vascular Disease &amp",NA
"1736","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Theodorou","Yiannis","Centre d'Immunologie et des Maladies Infectieuses UPMC UMRS CR7, Inserm U1135, CNRS ERL 8255, Paris, France",NA
"1737","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Dreden","Patrick Van","Sorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France",NA
"1738","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Marechal","Vincent","Sorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France",NA
"1739","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Spyropoulos","Alex C","Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States",NA
"1740","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Carter","Charles","Department of Clinical Research, College of Pharmacy &amp",NA
"1741","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Jabeen","Nusrat","Department of Microbiology, University of Karachi, Karachi, Pakistan",NA
"1742","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Harenberg","Job","Department for Physical Chemistry, Heidelberg University, Heidelberg, Germany",NA
"1743","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Elalamy","Ismail","Sorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France",NA
"1744","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Falanga","Anna","Immunohematology and Transfusion Medicine Department, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy",NA
"1745","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Fareed","Jawed","Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, United States",NA
"1746","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Agathaggelou","Petros","Cyprus Department of Interventional Cardiology, American Heart Institute of Cyprus, Nicosia, Cyprus",NA
"1747","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Antic","Darko","Clinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia",NA
"1748","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Antignani","Pier Luigi","Vascular Center, Nuova Villa Claudia, Rome, Italy",NA
"1749","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Bosch","Manuel Monreal","Department of Internal Medicine, Hospital Universitario Germans Trias i Pujol de Badalona, Universidad Católica de Murcia, Murcia, Spain",NA
"1750","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Brenner","Benjamin","Thrombosis and Hemostasis Unit, Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel",NA
"1751","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Chekhonin","Vladimir","Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia",NA
"1752","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Colgan","Mary-Paula","Department of Vascular Surgery, St. James's Hospital/Trinity College Dublin, Dublin, Ireland",NA
"1753","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Dimopoulos","Meletios-Athanasios","Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece",NA
"1754","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Douketis","Jim","Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada",NA
"1755","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Elnazar","Essam Abo","Department of Surgery, Ministry of Health, Saudi Arabia",NA
"1756","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Farkas","Katalin","Department of Angiology, St. Imre University Teaching Hospital, Budapest, Hungary",NA
"1757","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Fazeli","Bahare","Immunology Department, Avicenna (Bu-Ali) Research Institute, Mashhad University of Medical Sciences, Iran",NA
"1758","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Fowkes","Gerry","Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom",NA
"1759","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Gu","Yongquan","Department of Vascular Surgery, Xuan Wu Hospital, Capital Medical University and Institute of Vascular Surgery, Capital Medical University, Beijing, China",NA
"1760","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Gligorov","Joseph","Sorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France",NA
"1761","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Ligocki","Mark A","Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, United States",NA
"1762","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Indran","Tishya","Australia Department of Haematology, Monash Health, Clayton, Victoria, Australia",NA
"1763","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Kannan","Meganathan","Division of Blood and Vascular Biology, Department of Life Sciences, School of Life Sciences, Central University of Tamil Nadu, Thiruvarur, India",NA
"1764","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Kantarcioglu","Bulent","Department of Hematology, Okmeydani Training and Research Hospital, Istanbul, Turkey",NA
"1765","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Kasse","Abdoul Aziz","Institut du Cancer UCAD, Centre International de Cancérologie de Dakar, Dakar, Senegal",NA
"1766","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Konstantinidis","Kostantinos","th Surgical Department, Group of Vascular Surgery, Hippokrateio General University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1767","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Leivano","Fabio","Department of Pharmacology and Neuroscience, Cardiovascular Research Institute, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, United States",NA
"1768","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Lewis","Joseph","Department of Surgery, Stony Brook Southampton Hospital, Southampton, New York, United States",NA
"1769","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Makatsariya","Alexander","Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia",NA
"1770","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Mbaye","P Massamba","Université Virtuelle du Sénégal, Dakar, Senegal",NA
"1771","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Mahé","Isabelle","Innovative Therapies in Haemostasis, Hôpital Louis Mourier, APHP, Colombes, Université de Paris, INSERM, F-75006 Paris, France",NA
"1772","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Panovska-Stavridis","Irina","University Clinic of Hematology, Skopje, Republic of North Macedonia",NA
"1773","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Olinic","Dan-Mircea","Medical Clinic No. 1, University of Medicine and Pharmacy, Cluj-Napoca, Romania",NA
"1774","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Papageorgiou","Chryssa","Service Anesthésie, Réanimation et Médecine Périopératoire, Hôpital Tenon, Hôpitaux Universitaires de l'Est Parisien, Assistance Publique Hôpitaux de Paris, Faculté de médecine, Sorbonne Université, Paris, France",NA
"1775","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Pecsvarady","Zsolt","Department of Vascular Medicine, Flor Ferenc Teaching Hospital, Kistarcsa, Hungary",NA
"1776","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Pillon","Sergio","UOSD Angiology, San Camillo-Forlanini Hospital, National Health Institute ISS, AO San Camillo Forlanini, Rome, Italy",NA
"1777","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Ramacciotti","Eduardo","Hemostasis &amp",NA
"1778","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Abdel-Razeq","Hikmat","Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan",NA
"1779","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Sabbah","Michele","Sorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France",NA
"1780","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Sassi","Mouna","Laboratoire de Biologie, Centre de Maternité et de Néonatologie, Hôpital Fattouma Bourguiba, Monastir, Tunisia",NA
"1781","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Schernthaner","Gerit","Division of Angiology, Department of Internal Medicine 2, Medical University of Vienna, Vienna, Austria",NA
"1782","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Siddiqui","Fakiha","Cardiovascular Research Institute, Health Sciences Divisions, Loyola University Chicago, Maywood, Illinois, United States",NA
"1783","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Shiomura","Jin","Nobelpharma Co. Ltd., Chuo-ku, Tokyo, Japan",NA
"1784","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Slama-Schwok","Anny","Sorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France",NA
"1785","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Wautrecht","Jean Claude","Service de Pathologie Vasculaire, Hôpital ERASME, Université Libre de Bruxelles, Brussels, Belgium",NA
"1786","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Tafur","Alfonso","Vascular Medicine, Northshore Cardiovascular Institute, Skokie, Illinois, United States",NA
"1787","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Taher","Ali","Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon",NA
"1788","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Klein-Wegel","Peter","Klinik für Angiologie, Zentrum für Innere Medizin II, Ernst von Bergmann Klinikum, Potsdam, Germany",NA
"1789","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Zhai","Zenguo","Center of Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Peking University Health Science Center, Capital Medical University, Beijing, China",NA
"1790","34169495","10.1055/a-1535-8807","The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper."," One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.  Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program","2021","07","21","Thromb Haemost","Thrombosis and haemostasis",NA,"Zoubida","Tazi Mezalek","Clinical Hematology - Internal Medicine, Ibn Sina hospital, Mohammed V University, -Rabat, Morocco",NA
"1791","34169493","10.1055/a-1535-9002","PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison."," Coronavirus disease 2019 vaccine ChAdOx1 nCov-19 may rarely lead to vaccine-induced thrombotic thrombocytopenia (VITT). Antibody-mediated, platelet factor 4 (PF4)-dependent platelet activation appears to resemble a key mechanism in VITT, partially comparable to heparin-induced thrombocytopenia. The use of PF4/heparin immunoassays has been proposed as part of a diagnostic approach, but their sensitivity has not been established.  Sera from 12 well-defined VITT patients were first studied by two ","2021","07","20","Thromb Haemost","Thrombosis and haemostasis",NA,"Sachs","Ulrich J","Department of Thrombosis and Haemostasis, Giessen University Hospital, Giessen, Germany",NA
"1792","34169493","10.1055/a-1535-9002","PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison."," Coronavirus disease 2019 vaccine ChAdOx1 nCov-19 may rarely lead to vaccine-induced thrombotic thrombocytopenia (VITT). Antibody-mediated, platelet factor 4 (PF4)-dependent platelet activation appears to resemble a key mechanism in VITT, partially comparable to heparin-induced thrombocytopenia. The use of PF4/heparin immunoassays has been proposed as part of a diagnostic approach, but their sensitivity has not been established.  Sera from 12 well-defined VITT patients were first studied by two ","2021","07","20","Thromb Haemost","Thrombosis and haemostasis",NA,"Cooper","Nina","Department of Thrombosis and Haemostasis, Giessen University Hospital, Giessen, Germany",NA
"1793","34169493","10.1055/a-1535-9002","PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison."," Coronavirus disease 2019 vaccine ChAdOx1 nCov-19 may rarely lead to vaccine-induced thrombotic thrombocytopenia (VITT). Antibody-mediated, platelet factor 4 (PF4)-dependent platelet activation appears to resemble a key mechanism in VITT, partially comparable to heparin-induced thrombocytopenia. The use of PF4/heparin immunoassays has been proposed as part of a diagnostic approach, but their sensitivity has not been established.  Sera from 12 well-defined VITT patients were first studied by two ","2021","07","20","Thromb Haemost","Thrombosis and haemostasis",NA,"Czwalinna","Andreas","Amedes WagnerStibbe Medical Laboratory, Hannover, Germany",NA
"1794","34169493","10.1055/a-1535-9002","PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison."," Coronavirus disease 2019 vaccine ChAdOx1 nCov-19 may rarely lead to vaccine-induced thrombotic thrombocytopenia (VITT). Antibody-mediated, platelet factor 4 (PF4)-dependent platelet activation appears to resemble a key mechanism in VITT, partially comparable to heparin-induced thrombocytopenia. The use of PF4/heparin immunoassays has been proposed as part of a diagnostic approach, but their sensitivity has not been established.  Sera from 12 well-defined VITT patients were first studied by two ","2021","07","20","Thromb Haemost","Thrombosis and haemostasis",NA,"Müller","Jens","Institute for Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany",NA
"1795","34169493","10.1055/a-1535-9002","PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison."," Coronavirus disease 2019 vaccine ChAdOx1 nCov-19 may rarely lead to vaccine-induced thrombotic thrombocytopenia (VITT). Antibody-mediated, platelet factor 4 (PF4)-dependent platelet activation appears to resemble a key mechanism in VITT, partially comparable to heparin-induced thrombocytopenia. The use of PF4/heparin immunoassays has been proposed as part of a diagnostic approach, but their sensitivity has not been established.  Sera from 12 well-defined VITT patients were first studied by two ","2021","07","20","Thromb Haemost","Thrombosis and haemostasis",NA,"Pötzsch","Bernd","Institute for Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany",NA
"1796","34169493","10.1055/a-1535-9002","PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison."," Coronavirus disease 2019 vaccine ChAdOx1 nCov-19 may rarely lead to vaccine-induced thrombotic thrombocytopenia (VITT). Antibody-mediated, platelet factor 4 (PF4)-dependent platelet activation appears to resemble a key mechanism in VITT, partially comparable to heparin-induced thrombocytopenia. The use of PF4/heparin immunoassays has been proposed as part of a diagnostic approach, but their sensitivity has not been established.  Sera from 12 well-defined VITT patients were first studied by two ","2021","07","20","Thromb Haemost","Thrombosis and haemostasis",NA,"Tiede","Andreas","Department of Haematology, Haemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany",NA
"1797","34169493","10.1055/a-1535-9002","PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison."," Coronavirus disease 2019 vaccine ChAdOx1 nCov-19 may rarely lead to vaccine-induced thrombotic thrombocytopenia (VITT). Antibody-mediated, platelet factor 4 (PF4)-dependent platelet activation appears to resemble a key mechanism in VITT, partially comparable to heparin-induced thrombocytopenia. The use of PF4/heparin immunoassays has been proposed as part of a diagnostic approach, but their sensitivity has not been established.  Sera from 12 well-defined VITT patients were first studied by two ","2021","07","20","Thromb Haemost","Thrombosis and haemostasis",NA,"Althaus","Karina","Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany",NA
"1798","34169488","10.1007/s40615-021-01075-8","Pacific Islanders in the Era of COVID-19: an Overlooked Community in Need.","Pacific Islanders (PIs), an indigenous, diverse population in the USA, have endured generational burdens of Western colonization and institutional racism that placed this population at socioeconomic and health disadvantages, such as in poverty, chronic disease, and now COVID-19. However, little is known about the impact of COVID-19 on this historically disadvantaged population. This study assessed the extent US PIs have been adversely affected by COVID-19 across the 50 states. Using state-level ","2021","07","01","J Racial Ethn Health Disparities","Journal of racial and ethnic health disparities","COVID-19; Epidemics; Health equity; Pacific Islander; Racial disparities","Cha","Leah","University of Wisconsin School of Medicine and Public Health, Madison, WI, USA",NA
"1799","34169488","10.1007/s40615-021-01075-8","Pacific Islanders in the Era of COVID-19: an Overlooked Community in Need.","Pacific Islanders (PIs), an indigenous, diverse population in the USA, have endured generational burdens of Western colonization and institutional racism that placed this population at socioeconomic and health disadvantages, such as in poverty, chronic disease, and now COVID-19. However, little is known about the impact of COVID-19 on this historically disadvantaged population. This study assessed the extent US PIs have been adversely affected by COVID-19 across the 50 states. Using state-level ","2021","07","01","J Racial Ethn Health Disparities","Journal of racial and ethnic health disparities","COVID-19; Epidemics; Health equity; Pacific Islander; Racial disparities","Le","Thomas","Johns Hopkins University School of Medicine, Baltimore, MD, USA",NA
"1800","34169488","10.1007/s40615-021-01075-8","Pacific Islanders in the Era of COVID-19: an Overlooked Community in Need.","Pacific Islanders (PIs), an indigenous, diverse population in the USA, have endured generational burdens of Western colonization and institutional racism that placed this population at socioeconomic and health disadvantages, such as in poverty, chronic disease, and now COVID-19. However, little is known about the impact of COVID-19 on this historically disadvantaged population. This study assessed the extent US PIs have been adversely affected by COVID-19 across the 50 states. Using state-level ","2021","07","01","J Racial Ethn Health Disparities","Journal of racial and ethnic health disparities","COVID-19; Epidemics; Health equity; Pacific Islander; Racial disparities","Ve'e","Taunuu","Regional Pacific Islander Taskforce, Hayward, CA, USA",NA
"1801","34169488","10.1007/s40615-021-01075-8","Pacific Islanders in the Era of COVID-19: an Overlooked Community in Need.","Pacific Islanders (PIs), an indigenous, diverse population in the USA, have endured generational burdens of Western colonization and institutional racism that placed this population at socioeconomic and health disadvantages, such as in poverty, chronic disease, and now COVID-19. However, little is known about the impact of COVID-19 on this historically disadvantaged population. This study assessed the extent US PIs have been adversely affected by COVID-19 across the 50 states. Using state-level ","2021","07","01","J Racial Ethn Health Disparities","Journal of racial and ethnic health disparities","COVID-19; Epidemics; Health equity; Pacific Islander; Racial disparities","Ah Soon","Natalie T","RAMS, Inc. (Richmond Area Multi-Services), San Francisco, CA, USA",NA
"1802","34169488","10.1007/s40615-021-01075-8","Pacific Islanders in the Era of COVID-19: an Overlooked Community in Need.","Pacific Islanders (PIs), an indigenous, diverse population in the USA, have endured generational burdens of Western colonization and institutional racism that placed this population at socioeconomic and health disadvantages, such as in poverty, chronic disease, and now COVID-19. However, little is known about the impact of COVID-19 on this historically disadvantaged population. This study assessed the extent US PIs have been adversely affected by COVID-19 across the 50 states. Using state-level ","2021","07","01","J Racial Ethn Health Disparities","Journal of racial and ethnic health disparities","COVID-19; Epidemics; Health equity; Pacific Islander; Racial disparities","Tseng","Winston","Berkeley Public Health, University of California, Berkeley Berkeley Public Health, 2199 Addison St, Room 435, CA, Berkeley, USA. winston@berkeley","winston@berkeley.edu"
"1803","34169485","10.1007/s40258-021-00667-z","Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.","Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immed","2021","07","01","Appl Health Econ Health Policy","Applied health economics and health policy",NA,"Buhat","Christian Alvin H","Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines. chbuhat@up.edu","chbuhat@up.edu.ph"
"1804","34169485","10.1007/s40258-021-00667-z","Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.","Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immed","2021","07","01","Appl Health Econ Health Policy","Applied health economics and health policy",NA,"Lutero","Destiny S M","Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines",NA
"1805","34169485","10.1007/s40258-021-00667-z","Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.","Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immed","2021","07","01","Appl Health Econ Health Policy","Applied health economics and health policy",NA,"Olave","Yancee H","Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines",NA
"1806","34169485","10.1007/s40258-021-00667-z","Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.","Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immed","2021","07","01","Appl Health Econ Health Policy","Applied health economics and health policy",NA,"Quindala","Kemuel M","Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines",NA
"1807","34169485","10.1007/s40258-021-00667-z","Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.","Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immed","2021","07","01","Appl Health Econ Health Policy","Applied health economics and health policy",NA,"Recreo","Mary Grace P","Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines",NA
"1808","34169485","10.1007/s40258-021-00667-z","Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.","Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immed","2021","07","01","Appl Health Econ Health Policy","Applied health economics and health policy",NA,"Talabis","Dylan Antonio S J","Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines",NA
"1809","34169485","10.1007/s40258-021-00667-z","Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.","Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immed","2021","07","01","Appl Health Econ Health Policy","Applied health economics and health policy",NA,"Torres","Monica C","Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines",NA
"1810","34169485","10.1007/s40258-021-00667-z","Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.","Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immed","2021","07","01","Appl Health Econ Health Policy","Applied health economics and health policy",NA,"Tubay","Jerrold M","Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines",NA
"1811","34169485","10.1007/s40258-021-00667-z","Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.","Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immed","2021","07","01","Appl Health Econ Health Policy","Applied health economics and health policy",NA,"Rabajante","Jomar F","Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines",NA
"1812","34169470","10.1007/s11130-021-00907-6","The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa.","Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the coronavirus disease-19 (COVID-19), in December 2019, the infection has spread around the globe. Some of the risk factors include social distancing, mask wearing, hand washing with soap, obesity, diabetes, hypertension, asthma, cardiovascular disease, and dysbiosis. Evidence has shown the incidence of total infection and death rates to be lower in sub-Saharan Africa when compared with North Afri","2021","07","01","Plant Foods Hum Nutr","Plant foods for human nutrition (Dordrecht, Netherlands)","COVID-19; Diet; Infection; SARS-CoV-2; Sub-Saharan Africa; Young age","Losso","Jack N","School of Nutrition and Food Sciences, Louisiana State University, Baton Rouge, LA, USA. jlosso@lsu","jlosso@lsu.edu"
"1813","34169470","10.1007/s11130-021-00907-6","The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa.","Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the coronavirus disease-19 (COVID-19), in December 2019, the infection has spread around the globe. Some of the risk factors include social distancing, mask wearing, hand washing with soap, obesity, diabetes, hypertension, asthma, cardiovascular disease, and dysbiosis. Evidence has shown the incidence of total infection and death rates to be lower in sub-Saharan Africa when compared with North Afri","2021","07","01","Plant Foods Hum Nutr","Plant foods for human nutrition (Dordrecht, Netherlands)","COVID-19; Diet; Infection; SARS-CoV-2; Sub-Saharan Africa; Young age","Losso","MerryJean N","Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"1814","34169470","10.1007/s11130-021-00907-6","The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa.","Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the coronavirus disease-19 (COVID-19), in December 2019, the infection has spread around the globe. Some of the risk factors include social distancing, mask wearing, hand washing with soap, obesity, diabetes, hypertension, asthma, cardiovascular disease, and dysbiosis. Evidence has shown the incidence of total infection and death rates to be lower in sub-Saharan Africa when compared with North Afri","2021","07","01","Plant Foods Hum Nutr","Plant foods for human nutrition (Dordrecht, Netherlands)","COVID-19; Diet; Infection; SARS-CoV-2; Sub-Saharan Africa; Young age","Toc","Marco","Department of Food Science and Nutrition, University of Illinois, Urbana Champaign, Champaign, IL, USA",NA
"1815","34169470","10.1007/s11130-021-00907-6","The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa.","Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the coronavirus disease-19 (COVID-19), in December 2019, the infection has spread around the globe. Some of the risk factors include social distancing, mask wearing, hand washing with soap, obesity, diabetes, hypertension, asthma, cardiovascular disease, and dysbiosis. Evidence has shown the incidence of total infection and death rates to be lower in sub-Saharan Africa when compared with North Afri","2021","07","01","Plant Foods Hum Nutr","Plant foods for human nutrition (Dordrecht, Netherlands)","COVID-19; Diet; Infection; SARS-CoV-2; Sub-Saharan Africa; Young age","Inungu","Joseph N","School of Health Sciences, Central Michigan University, Mt Pleasant, MI, USA",NA
"1816","34169470","10.1007/s11130-021-00907-6","The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa.","Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the coronavirus disease-19 (COVID-19), in December 2019, the infection has spread around the globe. Some of the risk factors include social distancing, mask wearing, hand washing with soap, obesity, diabetes, hypertension, asthma, cardiovascular disease, and dysbiosis. Evidence has shown the incidence of total infection and death rates to be lower in sub-Saharan Africa when compared with North Afri","2021","07","01","Plant Foods Hum Nutr","Plant foods for human nutrition (Dordrecht, Netherlands)","COVID-19; Diet; Infection; SARS-CoV-2; Sub-Saharan Africa; Young age","Finley","John W","School of Nutrition and Food Sciences, Louisiana State University, Baton Rouge, LA, USA",NA
"1817","34169468","10.1007/s40123-021-00360-3","Digital Tools for the Self-Assessment of Visual Acuity: A Systematic Review.","Numerous digital tools to self-assess visual acuity have been introduced. The recent COVID-19 pandemic underlined the need for high-quality remote care. This review gives a current overview of digital tools for remotely assessing visual function and reports on their accuracy. We searched the databases of Embase and Pubmed, and systematically reviewed the literature, conforming to PRISMA guidelines. Two preliminary papers were added from medRxiv.org. The main outcome was the agreement of the digi","2021","07","01","Ophthalmol Ther","Ophthalmology and therapy","Digital health; Mobile health; Remote care; Self-assessment; Telehealth; Telemedicine; VA; Visual acuity; e-Health; m-Health","Claessens","Janneau L J","Department of Ophthalmology, University Medical Center Utrecht, Heidelberglaan 100, 3508 GX, Utrecht, The Netherlands. j.l.j.claessens@umcutrecht","j.l.j.claessens@umcutrecht.nl"
"1818","34169468","10.1007/s40123-021-00360-3","Digital Tools for the Self-Assessment of Visual Acuity: A Systematic Review.","Numerous digital tools to self-assess visual acuity have been introduced. The recent COVID-19 pandemic underlined the need for high-quality remote care. This review gives a current overview of digital tools for remotely assessing visual function and reports on their accuracy. We searched the databases of Embase and Pubmed, and systematically reviewed the literature, conforming to PRISMA guidelines. Two preliminary papers were added from medRxiv.org. The main outcome was the agreement of the digi","2021","07","01","Ophthalmol Ther","Ophthalmology and therapy","Digital health; Mobile health; Remote care; Self-assessment; Telehealth; Telemedicine; VA; Visual acuity; e-Health; m-Health","Geuvers","Judith R","Faculty of Medicine, Utrecht University, Utrecht, The Netherlands",NA
"1819","34169468","10.1007/s40123-021-00360-3","Digital Tools for the Self-Assessment of Visual Acuity: A Systematic Review.","Numerous digital tools to self-assess visual acuity have been introduced. The recent COVID-19 pandemic underlined the need for high-quality remote care. This review gives a current overview of digital tools for remotely assessing visual function and reports on their accuracy. We searched the databases of Embase and Pubmed, and systematically reviewed the literature, conforming to PRISMA guidelines. Two preliminary papers were added from medRxiv.org. The main outcome was the agreement of the digi","2021","07","01","Ophthalmol Ther","Ophthalmology and therapy","Digital health; Mobile health; Remote care; Self-assessment; Telehealth; Telemedicine; VA; Visual acuity; e-Health; m-Health","Imhof","Saskia M","Department of Ophthalmology, University Medical Center Utrecht, Heidelberglaan 100, 3508 GX, Utrecht, The Netherlands",NA
"1820","34169468","10.1007/s40123-021-00360-3","Digital Tools for the Self-Assessment of Visual Acuity: A Systematic Review.","Numerous digital tools to self-assess visual acuity have been introduced. The recent COVID-19 pandemic underlined the need for high-quality remote care. This review gives a current overview of digital tools for remotely assessing visual function and reports on their accuracy. We searched the databases of Embase and Pubmed, and systematically reviewed the literature, conforming to PRISMA guidelines. Two preliminary papers were added from medRxiv.org. The main outcome was the agreement of the digi","2021","07","01","Ophthalmol Ther","Ophthalmology and therapy","Digital health; Mobile health; Remote care; Self-assessment; Telehealth; Telemedicine; VA; Visual acuity; e-Health; m-Health","Wisse","Robert P L","Department of Ophthalmology, University Medical Center Utrecht, Heidelberglaan 100, 3508 GX, Utrecht, The Netherlands",NA
"1821","34169455","10.1007/s12098-021-03833-2","Vertical Transmission of COVID-19.",NA,"2021","07","01","Indian J Pediatr","Indian journal of pediatrics",NA,"Tripathi","Shalini","Department of Pediatrics, King George's Medical University (KGMU), Lucknow, UP, 226003, India. shaliniawasthi@kgmcindia","shaliniawasthi@kgmcindia.edu"
"1822","34169455","10.1007/s12098-021-03833-2","Vertical Transmission of COVID-19.",NA,"2021","07","01","Indian J Pediatr","Indian journal of pediatrics",NA,"Awasthi","Shally","Department of Pediatrics, King George's Medical University (KGMU), Lucknow, UP, 226003, India",NA
"1823","34169455","10.1007/s12098-021-03833-2","Vertical Transmission of COVID-19.",NA,"2021","07","01","Indian J Pediatr","Indian journal of pediatrics",NA,"Singh","S N","Department of Pediatrics, King George's Medical University (KGMU), Lucknow, UP, 226003, India",NA
"1824","34169455","10.1007/s12098-021-03833-2","Vertical Transmission of COVID-19.",NA,"2021","07","01","Indian J Pediatr","Indian journal of pediatrics",NA,"Kumar","Mala","Department of Pediatrics, King George's Medical University (KGMU), Lucknow, UP, 226003, India",NA
"1825","34169450","10.1007/s11030-021-10259-7","New insights into the catalytic mechanism of the SARS-CoV-2 main protease: an ONIOM QM/MM approach.","SARS-CoV-2 M<sup>pro</sup>, also known as the main protease or 3C-like protease, is a key enzyme involved in the replication process of the virus that is causing the COVID-19 pandemic. It is also the most promising antiviral drug target targeting SARS-CoV-2 virus. In this work, the catalytic mechanism of M<sup>pro</sup> was studied using the full model of the enzyme and a computational QM/MM methodology with a 69/72-atoms QM region treated at DLPNO-CCSD(T)/CBS//B3LYP/6-31G(d,p):AMBER level and i","2021","07","01","Mol Divers","Molecular diversity","COVID-19; Catalytic mechanism; Main protease; QM/MM; SARS-CoV-2","Fernandes","Henrique S","UCIBIO@REQUIMTE, BioSIM, Departamento de Biomedicina, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-319, Porto, Portugal",NA
"1826","34169450","10.1007/s11030-021-10259-7","New insights into the catalytic mechanism of the SARS-CoV-2 main protease: an ONIOM QM/MM approach.","SARS-CoV-2 M<sup>pro</sup>, also known as the main protease or 3C-like protease, is a key enzyme involved in the replication process of the virus that is causing the COVID-19 pandemic. It is also the most promising antiviral drug target targeting SARS-CoV-2 virus. In this work, the catalytic mechanism of M<sup>pro</sup> was studied using the full model of the enzyme and a computational QM/MM methodology with a 69/72-atoms QM region treated at DLPNO-CCSD(T)/CBS//B3LYP/6-31G(d,p):AMBER level and i","2021","07","01","Mol Divers","Molecular diversity","COVID-19; Catalytic mechanism; Main protease; QM/MM; SARS-CoV-2","Sousa","Sérgio F","UCIBIO@REQUIMTE, BioSIM, Departamento de Biomedicina, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-319, Porto, Portugal",NA
"1827","34169450","10.1007/s11030-021-10259-7","New insights into the catalytic mechanism of the SARS-CoV-2 main protease: an ONIOM QM/MM approach.","SARS-CoV-2 M<sup>pro</sup>, also known as the main protease or 3C-like protease, is a key enzyme involved in the replication process of the virus that is causing the COVID-19 pandemic. It is also the most promising antiviral drug target targeting SARS-CoV-2 virus. In this work, the catalytic mechanism of M<sup>pro</sup> was studied using the full model of the enzyme and a computational QM/MM methodology with a 69/72-atoms QM region treated at DLPNO-CCSD(T)/CBS//B3LYP/6-31G(d,p):AMBER level and i","2021","07","01","Mol Divers","Molecular diversity","COVID-19; Catalytic mechanism; Main protease; QM/MM; SARS-CoV-2","Cerqueira","Nuno M F S A","UCIBIO@REQUIMTE, BioSIM, Departamento de Biomedicina, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-319, Porto, Portugal. nunoscerqueira@med.up","nunoscerqueira@med.up.pt"
"1828","34169447","10.1007/s40520-021-01914-y","Comorbidity status of deceased COVID-19 in-patients in Italy.","Most COVID-19-related deaths have occurred in older persons with comorbidities. Specific patterns of comorbidities related to COVID-19 deaths have not been investigated. A random sample of 6085 individuals in Italy who died in-hospital with confirmed COVID-19 between February and December 2020 were included. Observed to expected (O/E) ratios of disease pairs were computed and logistic regression models were used to determine the association between disease pairs with O/E values = 1.5. Six pairs ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Chronic disease; Comorbidity; Mortality; Multimorbidity","Vetrano","Davide Liborio","Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Tomatebodavägen 18A, 10th floor17165 Solna, Stockholm, Sweden. davide.vetrano@ki",NA
"1829","34169447","10.1007/s40520-021-01914-y","Comorbidity status of deceased COVID-19 in-patients in Italy.","Most COVID-19-related deaths have occurred in older persons with comorbidities. Specific patterns of comorbidities related to COVID-19 deaths have not been investigated. A random sample of 6085 individuals in Italy who died in-hospital with confirmed COVID-19 between February and December 2020 were included. Observed to expected (O/E) ratios of disease pairs were computed and logistic regression models were used to determine the association between disease pairs with O/E values = 1.5. Six pairs ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Chronic disease; Comorbidity; Mortality; Multimorbidity","Tazzeo","Clare","Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Tomatebodavägen 18A, 10th floor17165 Solna, Stockholm, Sweden",NA
"1830","34169447","10.1007/s40520-021-01914-y","Comorbidity status of deceased COVID-19 in-patients in Italy.","Most COVID-19-related deaths have occurred in older persons with comorbidities. Specific patterns of comorbidities related to COVID-19 deaths have not been investigated. A random sample of 6085 individuals in Italy who died in-hospital with confirmed COVID-19 between February and December 2020 were included. Observed to expected (O/E) ratios of disease pairs were computed and logistic regression models were used to determine the association between disease pairs with O/E values = 1.5. Six pairs ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Chronic disease; Comorbidity; Mortality; Multimorbidity","Palmieri","Luigi","Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Roma, Italy",NA
"1831","34169447","10.1007/s40520-021-01914-y","Comorbidity status of deceased COVID-19 in-patients in Italy.","Most COVID-19-related deaths have occurred in older persons with comorbidities. Specific patterns of comorbidities related to COVID-19 deaths have not been investigated. A random sample of 6085 individuals in Italy who died in-hospital with confirmed COVID-19 between February and December 2020 were included. Observed to expected (O/E) ratios of disease pairs were computed and logistic regression models were used to determine the association between disease pairs with O/E values = 1.5. Six pairs ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Chronic disease; Comorbidity; Mortality; Multimorbidity","Marengoni","Alessandra","Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Tomatebodavägen 18A, 10th floor17165 Solna, Stockholm, Sweden",NA
"1832","34169447","10.1007/s40520-021-01914-y","Comorbidity status of deceased COVID-19 in-patients in Italy.","Most COVID-19-related deaths have occurred in older persons with comorbidities. Specific patterns of comorbidities related to COVID-19 deaths have not been investigated. A random sample of 6085 individuals in Italy who died in-hospital with confirmed COVID-19 between February and December 2020 were included. Observed to expected (O/E) ratios of disease pairs were computed and logistic regression models were used to determine the association between disease pairs with O/E values = 1.5. Six pairs ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Chronic disease; Comorbidity; Mortality; Multimorbidity","Zucchelli","Alberto","Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Tomatebodavägen 18A, 10th floor17165 Solna, Stockholm, Sweden",NA
"1833","34169447","10.1007/s40520-021-01914-y","Comorbidity status of deceased COVID-19 in-patients in Italy.","Most COVID-19-related deaths have occurred in older persons with comorbidities. Specific patterns of comorbidities related to COVID-19 deaths have not been investigated. A random sample of 6085 individuals in Italy who died in-hospital with confirmed COVID-19 between February and December 2020 were included. Observed to expected (O/E) ratios of disease pairs were computed and logistic regression models were used to determine the association between disease pairs with O/E values = 1.5. Six pairs ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Chronic disease; Comorbidity; Mortality; Multimorbidity","Lo Noce","Cinzia","Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Roma, Italy",NA
"1834","34169447","10.1007/s40520-021-01914-y","Comorbidity status of deceased COVID-19 in-patients in Italy.","Most COVID-19-related deaths have occurred in older persons with comorbidities. Specific patterns of comorbidities related to COVID-19 deaths have not been investigated. A random sample of 6085 individuals in Italy who died in-hospital with confirmed COVID-19 between February and December 2020 were included. Observed to expected (O/E) ratios of disease pairs were computed and logistic regression models were used to determine the association between disease pairs with O/E values = 1.5. Six pairs ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Chronic disease; Comorbidity; Mortality; Multimorbidity","Onder","Graziano","Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Roma, Italy",NA
"1835","34169443","10.1007/s12035-021-02450-6","Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.","The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase of public health adversaries and has severely compromised healthcare globally. Early evidence of COVID-19 noted its impact on the pulmonary and cardiovascular functions, while multiple studies in recent time shed light on its substantial neurological complications, though a comprehensive understanding of the cause(s), the mechanism","2021","07","01","Mol Neurobiol","Molecular neurobiology","CNS; COVID-19; COVID-19 pandemic; Neuroinvasion; Neurological complications; PNS; SARS-CoV-2","Dewanjee","Saikat","Advanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India. saikat.dewanjee@jadavpuruniversity","saikat.dewanjee@jadavpuruniversity.in"
"1836","34169443","10.1007/s12035-021-02450-6","Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.","The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase of public health adversaries and has severely compromised healthcare globally. Early evidence of COVID-19 noted its impact on the pulmonary and cardiovascular functions, while multiple studies in recent time shed light on its substantial neurological complications, though a comprehensive understanding of the cause(s), the mechanism","2021","07","01","Mol Neurobiol","Molecular neurobiology","CNS; COVID-19; COVID-19 pandemic; Neuroinvasion; Neurological complications; PNS; SARS-CoV-2","Vallamkondu","Jayalakshmi","National Institute of Technology, Warangal, 506004, Telangana, India",NA
"1837","34169443","10.1007/s12035-021-02450-6","Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.","The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase of public health adversaries and has severely compromised healthcare globally. Early evidence of COVID-19 noted its impact on the pulmonary and cardiovascular functions, while multiple studies in recent time shed light on its substantial neurological complications, though a comprehensive understanding of the cause(s), the mechanism","2021","07","01","Mol Neurobiol","Molecular neurobiology","CNS; COVID-19; COVID-19 pandemic; Neuroinvasion; Neurological complications; PNS; SARS-CoV-2","Kalra","Rajkumar Singh","AIST-INDIA DAILAB, National Institute of Advanced Industrial Science &amp",NA
"1838","34169443","10.1007/s12035-021-02450-6","Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.","The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase of public health adversaries and has severely compromised healthcare globally. Early evidence of COVID-19 noted its impact on the pulmonary and cardiovascular functions, while multiple studies in recent time shed light on its substantial neurological complications, though a comprehensive understanding of the cause(s), the mechanism","2021","07","01","Mol Neurobiol","Molecular neurobiology","CNS; COVID-19; COVID-19 pandemic; Neuroinvasion; Neurological complications; PNS; SARS-CoV-2","Puvvada","Nagaprasad","Applied Biology, CSIR-Indian Institute of Technology, Uppal Road, Tarnaka, Hyderabad, 50000, Telangana, India",NA
"1839","34169443","10.1007/s12035-021-02450-6","Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.","The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase of public health adversaries and has severely compromised healthcare globally. Early evidence of COVID-19 noted its impact on the pulmonary and cardiovascular functions, while multiple studies in recent time shed light on its substantial neurological complications, though a comprehensive understanding of the cause(s), the mechanism","2021","07","01","Mol Neurobiol","Molecular neurobiology","CNS; COVID-19; COVID-19 pandemic; Neuroinvasion; Neurological complications; PNS; SARS-CoV-2","Kandimalla","Ramesh","Applied Biology, CSIR-Indian Institute of Technology, Uppal Road, Tarnaka, Hyderabad, 50000, Telangana, India. ramesh.kandimalla@gmail","ramesh.kandimalla@gmail.com"
"1840","34169443","10.1007/s12035-021-02450-6","Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.","The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase of public health adversaries and has severely compromised healthcare globally. Early evidence of COVID-19 noted its impact on the pulmonary and cardiovascular functions, while multiple studies in recent time shed light on its substantial neurological complications, though a comprehensive understanding of the cause(s), the mechanism","2021","07","01","Mol Neurobiol","Molecular neurobiology","CNS; COVID-19; COVID-19 pandemic; Neuroinvasion; Neurological complications; PNS; SARS-CoV-2","Reddy","P Hemachandra","Texas Tech University Health Sciences Center, Lubbock, TX, USA. hemachandra.reddy@ttuhsc","hemachandra.reddy@ttuhsc.edu"
"1841","34169437","10.1007/s11010-021-04200-7","Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment.","Human SARS Coronavirus-2 (SARS-CoV-2) has infected more than 170 million people worldwide and resulted in more than 3.5 million deaths so far. The infection causes Coronavirus disease (COVID-19) in people of all age groups, notably diabetic and old age people, at a higher risk of infectivity and fatality. Around 35% of the patients who have died of the disease were diabetic. The infection is associated with weakening immune response, chronic inflammation, and potential direct pancreatic impairme","2021","07","01","Mol Cell Biochem","Molecular and cellular biochemistry","Aging; Catechins; Curcumin; Diabetes; Human SARS coronavirus-2; Metformin; Polyphenols and ACE-2; Resveratrol","Chawla","Udeep","Department of Chemistry and Biochemistry, The University of Arizona, Old Chemistry 226, Tucson, AZ, 85721, USA",NA
"1842","34169437","10.1007/s11010-021-04200-7","Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment.","Human SARS Coronavirus-2 (SARS-CoV-2) has infected more than 170 million people worldwide and resulted in more than 3.5 million deaths so far. The infection causes Coronavirus disease (COVID-19) in people of all age groups, notably diabetic and old age people, at a higher risk of infectivity and fatality. Around 35% of the patients who have died of the disease were diabetic. The infection is associated with weakening immune response, chronic inflammation, and potential direct pancreatic impairme","2021","07","01","Mol Cell Biochem","Molecular and cellular biochemistry","Aging; Catechins; Curcumin; Diabetes; Human SARS coronavirus-2; Metformin; Polyphenols and ACE-2; Resveratrol","Kashyap","Manoj Kumar","Amity Stem Cell Institute, Amity Medical School, Amity University Haryana, Amity Education Valley Panchgaon, Manesar (Gurugram), Haryana, India",NA
"1843","34169437","10.1007/s11010-021-04200-7","Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment.","Human SARS Coronavirus-2 (SARS-CoV-2) has infected more than 170 million people worldwide and resulted in more than 3.5 million deaths so far. The infection causes Coronavirus disease (COVID-19) in people of all age groups, notably diabetic and old age people, at a higher risk of infectivity and fatality. Around 35% of the patients who have died of the disease were diabetic. The infection is associated with weakening immune response, chronic inflammation, and potential direct pancreatic impairme","2021","07","01","Mol Cell Biochem","Molecular and cellular biochemistry","Aging; Catechins; Curcumin; Diabetes; Human SARS coronavirus-2; Metformin; Polyphenols and ACE-2; Resveratrol","Husain","Amjad","Centre for Science &amp","husainamjad@gmail.com"
"1844","34169404","10.1007/s12640-021-00389-z","Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.","Aside from the respiratory distress as the predominant clinical presentation of SARS-CoV-2 infection, various neurological complications have been reported with the infection during the ongoing pandemic, some of which cause serious morbidity and mortality. Herein, we gather the latest anatomical evidence of the virus's presence within the central nervous system. We then delve into the possible SARS-CoV-2 entry routes into the neurological tissues, with the hematogenous and the neuronal routes as","2021","07","01","Neurotox Res","Neurotoxicity research","COVID-19; Neurological manifestation; Pathophysiology; SARS-COV-2","Jafari Khaljiri","Helia","Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1845","34169404","10.1007/s12640-021-00389-z","Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.","Aside from the respiratory distress as the predominant clinical presentation of SARS-CoV-2 infection, various neurological complications have been reported with the infection during the ongoing pandemic, some of which cause serious morbidity and mortality. Herein, we gather the latest anatomical evidence of the virus's presence within the central nervous system. We then delve into the possible SARS-CoV-2 entry routes into the neurological tissues, with the hematogenous and the neuronal routes as","2021","07","01","Neurotox Res","Neurotoxicity research","COVID-19; Neurological manifestation; Pathophysiology; SARS-COV-2","Jamalkhah","Monire","Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran",NA
"1846","34169404","10.1007/s12640-021-00389-z","Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.","Aside from the respiratory distress as the predominant clinical presentation of SARS-CoV-2 infection, various neurological complications have been reported with the infection during the ongoing pandemic, some of which cause serious morbidity and mortality. Herein, we gather the latest anatomical evidence of the virus's presence within the central nervous system. We then delve into the possible SARS-CoV-2 entry routes into the neurological tissues, with the hematogenous and the neuronal routes as","2021","07","01","Neurotox Res","Neurotoxicity research","COVID-19; Neurological manifestation; Pathophysiology; SARS-COV-2","Amini Harandi","Ali","Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ali.amini@sbmu.ac","ali.amini@sbmu.ac.ir"
"1847","34169404","10.1007/s12640-021-00389-z","Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.","Aside from the respiratory distress as the predominant clinical presentation of SARS-CoV-2 infection, various neurological complications have been reported with the infection during the ongoing pandemic, some of which cause serious morbidity and mortality. Herein, we gather the latest anatomical evidence of the virus's presence within the central nervous system. We then delve into the possible SARS-CoV-2 entry routes into the neurological tissues, with the hematogenous and the neuronal routes as","2021","07","01","Neurotox Res","Neurotoxicity research","COVID-19; Neurological manifestation; Pathophysiology; SARS-COV-2","Pakdaman","Hossein","Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1848","34169404","10.1007/s12640-021-00389-z","Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.","Aside from the respiratory distress as the predominant clinical presentation of SARS-CoV-2 infection, various neurological complications have been reported with the infection during the ongoing pandemic, some of which cause serious morbidity and mortality. Herein, we gather the latest anatomical evidence of the virus's presence within the central nervous system. We then delve into the possible SARS-CoV-2 entry routes into the neurological tissues, with the hematogenous and the neuronal routes as","2021","07","01","Neurotox Res","Neurotoxicity research","COVID-19; Neurological manifestation; Pathophysiology; SARS-COV-2","Moradi","Milad","Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1849","34169404","10.1007/s12640-021-00389-z","Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.","Aside from the respiratory distress as the predominant clinical presentation of SARS-CoV-2 infection, various neurological complications have been reported with the infection during the ongoing pandemic, some of which cause serious morbidity and mortality. Herein, we gather the latest anatomical evidence of the virus's presence within the central nervous system. We then delve into the possible SARS-CoV-2 entry routes into the neurological tissues, with the hematogenous and the neuronal routes as","2021","07","01","Neurotox Res","Neurotoxicity research","COVID-19; Neurological manifestation; Pathophysiology; SARS-COV-2","Mowla","Ashkan","Division of Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA",NA
"1850","34169390","10.1007/s00894-021-04816-y","Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.","The interaction between SARS-CoV-2 Spike protein and angiotensin-converting enzyme 2 (ACE2) is essential to viral attachment and the subsequent fusion process. Interfering with this event represents an attractive avenue for the development of therapeutics and vaccine development. Here, a hybrid approach of ligand- and structure-based virtual screening techniques were employed to disclose similar analogues of a reported antiviral phytochemical, glycyrrhizin, targeting the blockade of ACE2 interac","2021","07","01","J Mol Model","Journal of molecular modeling","ACE-2; Glycyrrhizin; MMGB/PBSA; SARS-CoV-2; Simulation; Virtual screening; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; Binding Sites; COVID-19; Drug Discovery; Drug Repositioning; Glycyrrhizic Acid; Host-Pathogen Interactions; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Virus Internalization","Ahmad","Sajjad","Department of Health and Biological Sciences, Abasyn University, Peshawar, 25000, Pakistan",NA
"1851","34169390","10.1007/s00894-021-04816-y","Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.","The interaction between SARS-CoV-2 Spike protein and angiotensin-converting enzyme 2 (ACE2) is essential to viral attachment and the subsequent fusion process. Interfering with this event represents an attractive avenue for the development of therapeutics and vaccine development. Here, a hybrid approach of ligand- and structure-based virtual screening techniques were employed to disclose similar analogues of a reported antiviral phytochemical, glycyrrhizin, targeting the blockade of ACE2 interac","2021","07","01","J Mol Model","Journal of molecular modeling","ACE-2; Glycyrrhizin; MMGB/PBSA; SARS-CoV-2; Simulation; Virtual screening; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; Binding Sites; COVID-19; Drug Discovery; Drug Repositioning; Glycyrrhizic Acid; Host-Pathogen Interactions; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Virus Internalization","Waheed","Yasir","Foundation University Medical College, Foundation University Islamabad, DHA-I, Islamabad, 44000, Pakistan. yasir.waheed@fui.edu","yasir.waheed@fui.edu.pk"
"1852","34169390","10.1007/s00894-021-04816-y","Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.","The interaction between SARS-CoV-2 Spike protein and angiotensin-converting enzyme 2 (ACE2) is essential to viral attachment and the subsequent fusion process. Interfering with this event represents an attractive avenue for the development of therapeutics and vaccine development. Here, a hybrid approach of ligand- and structure-based virtual screening techniques were employed to disclose similar analogues of a reported antiviral phytochemical, glycyrrhizin, targeting the blockade of ACE2 interac","2021","07","01","J Mol Model","Journal of molecular modeling","ACE-2; Glycyrrhizin; MMGB/PBSA; SARS-CoV-2; Simulation; Virtual screening; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; Binding Sites; COVID-19; Drug Discovery; Drug Repositioning; Glycyrrhizic Acid; Host-Pathogen Interactions; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Virus Internalization","Abro","Asma","Department of Biotechnology, Faculty of Life Sciences and Informatics, Balochistan University of Information Technology Engineering and Management Sciences, Quetta, Pakistan",NA
"1853","34169390","10.1007/s00894-021-04816-y","Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.","The interaction between SARS-CoV-2 Spike protein and angiotensin-converting enzyme 2 (ACE2) is essential to viral attachment and the subsequent fusion process. Interfering with this event represents an attractive avenue for the development of therapeutics and vaccine development. Here, a hybrid approach of ligand- and structure-based virtual screening techniques were employed to disclose similar analogues of a reported antiviral phytochemical, glycyrrhizin, targeting the blockade of ACE2 interac","2021","07","01","J Mol Model","Journal of molecular modeling","ACE-2; Glycyrrhizin; MMGB/PBSA; SARS-CoV-2; Simulation; Virtual screening; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; Binding Sites; COVID-19; Drug Discovery; Drug Repositioning; Glycyrrhizic Acid; Host-Pathogen Interactions; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Virus Internalization","Abbasi","Sumra Wajid","NUMS Department of Biological Sciences, National University of Medical Sciences, Abid Majeed Rd, The Mall, Rawalpindi, Pakistan",NA
"1854","34169390","10.1007/s00894-021-04816-y","Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.","The interaction between SARS-CoV-2 Spike protein and angiotensin-converting enzyme 2 (ACE2) is essential to viral attachment and the subsequent fusion process. Interfering with this event represents an attractive avenue for the development of therapeutics and vaccine development. Here, a hybrid approach of ligand- and structure-based virtual screening techniques were employed to disclose similar analogues of a reported antiviral phytochemical, glycyrrhizin, targeting the blockade of ACE2 interac","2021","07","01","J Mol Model","Journal of molecular modeling","ACE-2; Glycyrrhizin; MMGB/PBSA; SARS-CoV-2; Simulation; Virtual screening; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; Binding Sites; COVID-19; Drug Discovery; Drug Repositioning; Glycyrrhizic Acid; Host-Pathogen Interactions; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Virus Internalization","Ismail","Saba","NUMS Department of Biological Sciences, National University of Medical Sciences, Abid Majeed Rd, The Mall, Rawalpindi, Pakistan",NA
"1855","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Davidson","Sean M","The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK",NA
"1856","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Lukhna","Kishal","Division of Cardiology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa",NA
"1857","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Gorog","Diana A","Postgraduate Medicine, University of Hertfordshire, UK &amp",NA
"1858","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Salama","Alan D","Department of Renal Medicine, Royal Free Hospital, London, UK",NA
"1859","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Castillo","Alejandro Rosell","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1860","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Giesz","Sara","The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK",NA
"1861","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Golforoush","Pelin","The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK",NA
"1862","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Kalkhoran","Siavash Beikoghli","The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK",NA
"1863","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Lecour","Sandrine","The Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa",NA
"1864","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Imamdin","Aqeela","The Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa",NA
"1865","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","do Carmo","Helison R P","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1866","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Bovi","Ticiane Gonçalez","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1867","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Perroud","Mauricio W","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1868","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Ntsekhe","Mpiko","Division of Cardiology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa",NA
"1869","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Sposito","Andrei C","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1870","34169381","10.1007/s10557-021-07221-y","RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.","Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-CoV-2 can cause a dysregulated inflammatory response known as a cytokine storm, which can progress rapidly to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Suppressing these cytok","2021","07","07","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy","COVID-19; Clinical trial; Cytokines; Endothelial cells; Immunosuppression; Remote ischemic conditioning","Yellon","Derek M","The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK. d.yellon@ucl.ac","d.yellon@ucl.ac.uk"
"1871","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Vigne","Jonathan","Department of Nuclear Medicine, CHU de Caen Normandie, Normandie Université, UNICAEN, 14000, Caen, France. vigne-jo@chu-caen",NA
"1872","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Peyronnet","Damien","Department of Nuclear Medicine, CHU de Caen Normandie, Normandie Université, UNICAEN, 14000, Caen, France",NA
"1873","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Leenhardt","Julien","Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France",NA
"1874","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Dubegny","Constance","Radiopharmacy, Nuclear Medicine Department, CHU de Nantes, 44000, Nantes, France",NA
"1875","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Ardisson","Valérie","Department of Pharmacy, Centre de lutte contre le cancer Eugène Marquis, 35000, Rennes, France",NA
"1876","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Pariscoat","Guillaume","Department of Nuclear Medicine, CHU Bichat, Assistance Publique Hôpitaux de Paris, 75018, Paris, France",NA
"1877","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Bolot","Claire","Radiopharmacy Unit, Pharmacy Department, Groupement Hospitalier Est, Hospices Civils de Lyon, 59 boulevard Pinel, 69677, Bron Cedex, France",NA
"1878","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Rauscher","Aurore","Radiopharmacy, Nuclear Medicine Department, ICO Nantes-Angers, 44800, Saint-Herblain, France",NA
"1879","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Hallouard","François","Radiopharmacy Unit, Pharmacy Department, Groupement Hospitalier Sud, Hospices Civils de Lyon, 165 Chemin du Grand Revoyet, 69310, Pierre-Bénite, France",NA
"1880","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Clave-Darcissac","Caroline","Radiopharmacy Unit, Pharmacy Department, Groupement Hospitalier Sud, Hospices Civils de Lyon, 165 Chemin du Grand Revoyet, 69310, Pierre-Bénite, France",NA
"1881","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Clotagatide","Anthony","Department of Pharmacy, CHU de Saint-Etienne, Hôpital Nord, 42055, Saint-Etienne, France",NA
"1882","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Odouard","Emmanuel","Department of Pharmacy, CHU de Saint-Etienne, Hôpital Nord, 42055, Saint-Etienne, France",NA
"1883","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Faivre-Chauvet","Alain","Radiopharmacy, Nuclear Medicine Department, CHU de Nantes, 44000, Nantes, France",NA
"1884","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Diehl","Justine","Biostatistic and Clinical Research, CHU de Caen Normandie, Normandie Université, UNICAEN, 14000, Caen, France",NA
"1885","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Houdu","Benjamin","Department of Nuclear Medicine, CHU de Caen Normandie, Normandie Université, UNICAEN, 14000, Caen, France",NA
"1886","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Agostini","Denis","Department of Nuclear Medicine, CHU de Caen Normandie, Normandie Université, UNICAEN, 14000, Caen, France",NA
"1887","34169368","10.1007/s00259-021-05361-9","Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.","The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. We retrospectively assessed the volu","2021","07","01","Eur J Nucl Med Mol Imaging","European journal of nuclear medicine and molecular imaging","COVID-19; Lockdown; Nuclear medicine; Public health","Morello","Rémy","Biostatistic and Clinical Research, CHU de Caen Normandie, Normandie Université, UNICAEN, 14000, Caen, France",NA
"1888","34169362","10.1007/s00540-021-02960-6","Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.","In this retrospective study, we compared inhaled sedation with isoflurane to intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute Respiratory Distress Syndrome). Charts of all 20 patients with COVID-19 ARDS admitted to the ICU of a German University Hospital during the first wave of the pandemic between 22/03/2020 and 21/04/2020 were reviewed. Among screened 333 days, isoflurane was used in 97 days, while in 187 days, propofol was used for 12 h or more. The effect and","2021","07","01","J Anesth","Journal of anesthesia","AnaConDa; COVID-19; Critical care; ECMO; Inhaled sedation; Isoflurane","Kermad","Azzeddine","Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany. azzeddine.kermad@uks","azzeddine.kermad@uks.eu"
"1889","34169362","10.1007/s00540-021-02960-6","Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.","In this retrospective study, we compared inhaled sedation with isoflurane to intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute Respiratory Distress Syndrome). Charts of all 20 patients with COVID-19 ARDS admitted to the ICU of a German University Hospital during the first wave of the pandemic between 22/03/2020 and 21/04/2020 were reviewed. Among screened 333 days, isoflurane was used in 97 days, while in 187 days, propofol was used for 12 h or more. The effect and","2021","07","01","J Anesth","Journal of anesthesia","AnaConDa; COVID-19; Critical care; ECMO; Inhaled sedation; Isoflurane","Speltz","Jacques","Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany",NA
"1890","34169362","10.1007/s00540-021-02960-6","Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.","In this retrospective study, we compared inhaled sedation with isoflurane to intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute Respiratory Distress Syndrome). Charts of all 20 patients with COVID-19 ARDS admitted to the ICU of a German University Hospital during the first wave of the pandemic between 22/03/2020 and 21/04/2020 were reviewed. Among screened 333 days, isoflurane was used in 97 days, while in 187 days, propofol was used for 12 h or more. The effect and","2021","07","01","J Anesth","Journal of anesthesia","AnaConDa; COVID-19; Critical care; ECMO; Inhaled sedation; Isoflurane","Danziger","Guy","Department of Internal Medicine V-Pulmonology, Allergology and Intensive Care Medicine, Saarland University Hospital Medical Center, Homburg, Saarland, Germany",NA
"1891","34169362","10.1007/s00540-021-02960-6","Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.","In this retrospective study, we compared inhaled sedation with isoflurane to intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute Respiratory Distress Syndrome). Charts of all 20 patients with COVID-19 ARDS admitted to the ICU of a German University Hospital during the first wave of the pandemic between 22/03/2020 and 21/04/2020 were reviewed. Among screened 333 days, isoflurane was used in 97 days, while in 187 days, propofol was used for 12 h or more. The effect and","2021","07","01","J Anesth","Journal of anesthesia","AnaConDa; COVID-19; Critical care; ECMO; Inhaled sedation; Isoflurane","Mertke","Thilo","Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany",NA
"1892","34169362","10.1007/s00540-021-02960-6","Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.","In this retrospective study, we compared inhaled sedation with isoflurane to intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute Respiratory Distress Syndrome). Charts of all 20 patients with COVID-19 ARDS admitted to the ICU of a German University Hospital during the first wave of the pandemic between 22/03/2020 and 21/04/2020 were reviewed. Among screened 333 days, isoflurane was used in 97 days, while in 187 days, propofol was used for 12 h or more. The effect and","2021","07","01","J Anesth","Journal of anesthesia","AnaConDa; COVID-19; Critical care; ECMO; Inhaled sedation; Isoflurane","Bals","Robert","Department of Internal Medicine V-Pulmonology, Allergology and Intensive Care Medicine, Saarland University Hospital Medical Center, Homburg, Saarland, Germany",NA
"1893","34169362","10.1007/s00540-021-02960-6","Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.","In this retrospective study, we compared inhaled sedation with isoflurane to intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute Respiratory Distress Syndrome). Charts of all 20 patients with COVID-19 ARDS admitted to the ICU of a German University Hospital during the first wave of the pandemic between 22/03/2020 and 21/04/2020 were reviewed. Among screened 333 days, isoflurane was used in 97 days, while in 187 days, propofol was used for 12 h or more. The effect and","2021","07","01","J Anesth","Journal of anesthesia","AnaConDa; COVID-19; Critical care; ECMO; Inhaled sedation; Isoflurane","Volk","Thomas","Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany",NA
"1894","34169362","10.1007/s00540-021-02960-6","Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.","In this retrospective study, we compared inhaled sedation with isoflurane to intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute Respiratory Distress Syndrome). Charts of all 20 patients with COVID-19 ARDS admitted to the ICU of a German University Hospital during the first wave of the pandemic between 22/03/2020 and 21/04/2020 were reviewed. Among screened 333 days, isoflurane was used in 97 days, while in 187 days, propofol was used for 12 h or more. The effect and","2021","07","01","J Anesth","Journal of anesthesia","AnaConDa; COVID-19; Critical care; ECMO; Inhaled sedation; Isoflurane","Lepper","Philipp M","Department of Internal Medicine V-Pulmonology, Allergology and Intensive Care Medicine, Saarland University Hospital Medical Center, Homburg, Saarland, Germany",NA
"1895","34169362","10.1007/s00540-021-02960-6","Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.","In this retrospective study, we compared inhaled sedation with isoflurane to intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute Respiratory Distress Syndrome). Charts of all 20 patients with COVID-19 ARDS admitted to the ICU of a German University Hospital during the first wave of the pandemic between 22/03/2020 and 21/04/2020 were reviewed. Among screened 333 days, isoflurane was used in 97 days, while in 187 days, propofol was used for 12 h or more. The effect and","2021","07","01","J Anesth","Journal of anesthesia","AnaConDa; COVID-19; Critical care; ECMO; Inhaled sedation; Isoflurane","Meiser","Andreas","Department of Anesthesiology, Intensive Care and Pain Medicine, Saarland University Hospital Medical Center, Kirrberger Str. 100, 66421, Homburg, Saarland, Germany",NA
"1896","34169361","10.1007/s00540-021-02965-1","Glucose control using an artificial pancreas in a severe COVID-19 patient on extracorporeal membrane oxygenation: a case report.","The usefulness and safety of continuous glucose monitoring (CGM) systems in adult patients with severe coronavirus disease (COVID-19) have been reported. Using CGM might reduce the exposure patients and healthcare workers to COVID-19 and limit the use of personal protective equipment during the pandemic. CGM devices measure glucose in the subcutaneous interstitial fluid, but the accuracy of this technique has not been established in critically ill patients. The artificial pancreas, STG-55 (Nikki","2021","07","24","J Anesth","Journal of anesthesia","Artificial pancreas; COVID-19; Continuous glucose monitoring; Extracorporeal membrane oxygenation","Hinoue","Takuya","Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan",NA
"1897","34169361","10.1007/s00540-021-02965-1","Glucose control using an artificial pancreas in a severe COVID-19 patient on extracorporeal membrane oxygenation: a case report.","The usefulness and safety of continuous glucose monitoring (CGM) systems in adult patients with severe coronavirus disease (COVID-19) have been reported. Using CGM might reduce the exposure patients and healthcare workers to COVID-19 and limit the use of personal protective equipment during the pandemic. CGM devices measure glucose in the subcutaneous interstitial fluid, but the accuracy of this technique has not been established in critically ill patients. The artificial pancreas, STG-55 (Nikki","2021","07","24","J Anesth","Journal of anesthesia","Artificial pancreas; COVID-19; Continuous glucose monitoring; Extracorporeal membrane oxygenation","Yatabe","Tomoaki","Department of Anesthesiology and Intensive Care Medicine, Nishichita General Hospital, 3-1-1, Nakanoike, Tokai, Aichi, 477-8522, Japan. yatabe.tomoaki@katch.ne","yatabe.tomoaki@katch.ne.jp"
"1898","34169361","10.1007/s00540-021-02965-1","Glucose control using an artificial pancreas in a severe COVID-19 patient on extracorporeal membrane oxygenation: a case report.","The usefulness and safety of continuous glucose monitoring (CGM) systems in adult patients with severe coronavirus disease (COVID-19) have been reported. Using CGM might reduce the exposure patients and healthcare workers to COVID-19 and limit the use of personal protective equipment during the pandemic. CGM devices measure glucose in the subcutaneous interstitial fluid, but the accuracy of this technique has not been established in critically ill patients. The artificial pancreas, STG-55 (Nikki","2021","07","24","J Anesth","Journal of anesthesia","Artificial pancreas; COVID-19; Continuous glucose monitoring; Extracorporeal membrane oxygenation","Fujiwara","Himuro","Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan",NA
"1899","34169361","10.1007/s00540-021-02965-1","Glucose control using an artificial pancreas in a severe COVID-19 patient on extracorporeal membrane oxygenation: a case report.","The usefulness and safety of continuous glucose monitoring (CGM) systems in adult patients with severe coronavirus disease (COVID-19) have been reported. Using CGM might reduce the exposure patients and healthcare workers to COVID-19 and limit the use of personal protective equipment during the pandemic. CGM devices measure glucose in the subcutaneous interstitial fluid, but the accuracy of this technique has not been established in critically ill patients. The artificial pancreas, STG-55 (Nikki","2021","07","24","J Anesth","Journal of anesthesia","Artificial pancreas; COVID-19; Continuous glucose monitoring; Extracorporeal membrane oxygenation","Nishida","Osamu","Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan",NA
"1900","34169328","10.1007/s00520-021-06343-1","Effect of home-based prehabilitation in an enhanced recovery after surgery program for patients undergoing colorectal cancer surgery during the COVID-19 pandemic.","Surgery remains the first curative treatment for colorectal cancer. Prehabilitation seems to attenuate the loss of lean mass in the early postoperative period. However, its long-term role has not been studied. Lockdown due to the COVID-19 pandemic has forced to carry out the prehabilitation program at home. This study aimed to assess the effect of home prehabilitation on body composition, complications, and hospital stay in patients undergoing oncological colorectal surgery. A prospective and ra","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Body composition; COVID-19; Confinement; Lean mass and fat mass; Prehabilitation","López-Rodríguez-Arias","Francisco","Department of General Surgery, Colorectal Unit, Elche University Hospital, Miguel Hernández University, Carrer Almasara 11, 03203, Elche, Alicante, Spain",NA
"1901","34169328","10.1007/s00520-021-06343-1","Effect of home-based prehabilitation in an enhanced recovery after surgery program for patients undergoing colorectal cancer surgery during the COVID-19 pandemic.","Surgery remains the first curative treatment for colorectal cancer. Prehabilitation seems to attenuate the loss of lean mass in the early postoperative period. However, its long-term role has not been studied. Lockdown due to the COVID-19 pandemic has forced to carry out the prehabilitation program at home. This study aimed to assess the effect of home prehabilitation on body composition, complications, and hospital stay in patients undergoing oncological colorectal surgery. A prospective and ra","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Body composition; COVID-19; Confinement; Lean mass and fat mass; Prehabilitation","Sánchez-Guillén","Luis","Department of General Surgery, Colorectal Unit, Elche University Hospital, Miguel Hernández University, Carrer Almasara 11, 03203, Elche, Alicante, Spain. drsanchezguillen@gmail","drsanchezguillen@gmail.com"
"1902","34169328","10.1007/s00520-021-06343-1","Effect of home-based prehabilitation in an enhanced recovery after surgery program for patients undergoing colorectal cancer surgery during the COVID-19 pandemic.","Surgery remains the first curative treatment for colorectal cancer. Prehabilitation seems to attenuate the loss of lean mass in the early postoperative period. However, its long-term role has not been studied. Lockdown due to the COVID-19 pandemic has forced to carry out the prehabilitation program at home. This study aimed to assess the effect of home prehabilitation on body composition, complications, and hospital stay in patients undergoing oncological colorectal surgery. A prospective and ra","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Body composition; COVID-19; Confinement; Lean mass and fat mass; Prehabilitation","Aranaz-Ostáriz","Verónica","Department of General Surgery, Colorectal Unit, Elche University Hospital, Miguel Hernández University, Carrer Almasara 11, 03203, Elche, Alicante, Spain",NA
"1903","34169328","10.1007/s00520-021-06343-1","Effect of home-based prehabilitation in an enhanced recovery after surgery program for patients undergoing colorectal cancer surgery during the COVID-19 pandemic.","Surgery remains the first curative treatment for colorectal cancer. Prehabilitation seems to attenuate the loss of lean mass in the early postoperative period. However, its long-term role has not been studied. Lockdown due to the COVID-19 pandemic has forced to carry out the prehabilitation program at home. This study aimed to assess the effect of home prehabilitation on body composition, complications, and hospital stay in patients undergoing oncological colorectal surgery. A prospective and ra","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Body composition; COVID-19; Confinement; Lean mass and fat mass; Prehabilitation","Triguero-Cánovas","Daniel","Department of General Surgery, Colorectal Unit, Elche University Hospital, Miguel Hernández University, Carrer Almasara 11, 03203, Elche, Alicante, Spain",NA
"1904","34169328","10.1007/s00520-021-06343-1","Effect of home-based prehabilitation in an enhanced recovery after surgery program for patients undergoing colorectal cancer surgery during the COVID-19 pandemic.","Surgery remains the first curative treatment for colorectal cancer. Prehabilitation seems to attenuate the loss of lean mass in the early postoperative period. However, its long-term role has not been studied. Lockdown due to the COVID-19 pandemic has forced to carry out the prehabilitation program at home. This study aimed to assess the effect of home prehabilitation on body composition, complications, and hospital stay in patients undergoing oncological colorectal surgery. A prospective and ra","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Body composition; COVID-19; Confinement; Lean mass and fat mass; Prehabilitation","Lario-Pérez","Sandra","Department of General Surgery, Colorectal Unit, Elche University Hospital, Miguel Hernández University, Carrer Almasara 11, 03203, Elche, Alicante, Spain",NA
"1905","34169328","10.1007/s00520-021-06343-1","Effect of home-based prehabilitation in an enhanced recovery after surgery program for patients undergoing colorectal cancer surgery during the COVID-19 pandemic.","Surgery remains the first curative treatment for colorectal cancer. Prehabilitation seems to attenuate the loss of lean mass in the early postoperative period. However, its long-term role has not been studied. Lockdown due to the COVID-19 pandemic has forced to carry out the prehabilitation program at home. This study aimed to assess the effect of home prehabilitation on body composition, complications, and hospital stay in patients undergoing oncological colorectal surgery. A prospective and ra","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Body composition; COVID-19; Confinement; Lean mass and fat mass; Prehabilitation","Barber-Valles","Xavier","Center for Operations Research, Miguel Hernández University, Elche, Alicante, Spain",NA
"1906","34169328","10.1007/s00520-021-06343-1","Effect of home-based prehabilitation in an enhanced recovery after surgery program for patients undergoing colorectal cancer surgery during the COVID-19 pandemic.","Surgery remains the first curative treatment for colorectal cancer. Prehabilitation seems to attenuate the loss of lean mass in the early postoperative period. However, its long-term role has not been studied. Lockdown due to the COVID-19 pandemic has forced to carry out the prehabilitation program at home. This study aimed to assess the effect of home prehabilitation on body composition, complications, and hospital stay in patients undergoing oncological colorectal surgery. A prospective and ra","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Body composition; COVID-19; Confinement; Lean mass and fat mass; Prehabilitation","Lacueva","Francisco J","Department of General Surgery, Colorectal Unit, Elche University Hospital, Miguel Hernández University, Carrer Almasara 11, 03203, Elche, Alicante, Spain",NA
"1907","34169328","10.1007/s00520-021-06343-1","Effect of home-based prehabilitation in an enhanced recovery after surgery program for patients undergoing colorectal cancer surgery during the COVID-19 pandemic.","Surgery remains the first curative treatment for colorectal cancer. Prehabilitation seems to attenuate the loss of lean mass in the early postoperative period. However, its long-term role has not been studied. Lockdown due to the COVID-19 pandemic has forced to carry out the prehabilitation program at home. This study aimed to assess the effect of home prehabilitation on body composition, complications, and hospital stay in patients undergoing oncological colorectal surgery. A prospective and ra","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Body composition; COVID-19; Confinement; Lean mass and fat mass; Prehabilitation","Ramirez","José M","Department of General Surgery, Colorectal Unit, Lozano Blesa University Clinical Hospital, Zaragoza, Spain",NA
"1908","34169328","10.1007/s00520-021-06343-1","Effect of home-based prehabilitation in an enhanced recovery after surgery program for patients undergoing colorectal cancer surgery during the COVID-19 pandemic.","Surgery remains the first curative treatment for colorectal cancer. Prehabilitation seems to attenuate the loss of lean mass in the early postoperative period. However, its long-term role has not been studied. Lockdown due to the COVID-19 pandemic has forced to carry out the prehabilitation program at home. This study aimed to assess the effect of home prehabilitation on body composition, complications, and hospital stay in patients undergoing oncological colorectal surgery. A prospective and ra","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Body composition; COVID-19; Confinement; Lean mass and fat mass; Prehabilitation","Arroyo","Antonio","Department of General Surgery, Colorectal Unit, Elche University Hospital, Miguel Hernández University, Carrer Almasara 11, 03203, Elche, Alicante, Spain",NA
"1909","34169311","10.1093/bjsopen/zrab051","The quantitative impact of COVID-19 on surgical training in the United Kingdom.","COVID-19 has had a global impact on all aspects of healthcare including surgical training. This study aimed to quantify the impact of COVID-19 on operative case numbers recorded by surgeons in training, and annual review of competency progression (ARCP) outcomes in the UK. Anonymized operative logbook numbers were collated from electronic logbook and ARCP outcome data from the Intercollegiate Surgical Curriculum Programme database for trainees in the 10 surgical specialty training specialties.Op","2021","07","07","BJS Open","BJS open","COVID-19; Clinical Competence; Elective Surgical Procedures; Humans; Pandemics; SARS-CoV-2; Specialties, Surgical; Surgical Procedures, Operative; United Kingdom","Clements","J M","The Association of Surgeons in Training, London, UK",NA
"1910","34169311","10.1093/bjsopen/zrab051","The quantitative impact of COVID-19 on surgical training in the United Kingdom.","COVID-19 has had a global impact on all aspects of healthcare including surgical training. This study aimed to quantify the impact of COVID-19 on operative case numbers recorded by surgeons in training, and annual review of competency progression (ARCP) outcomes in the UK. Anonymized operative logbook numbers were collated from electronic logbook and ARCP outcome data from the Intercollegiate Surgical Curriculum Programme database for trainees in the 10 surgical specialty training specialties.Op","2021","07","07","BJS Open","BJS open","COVID-19; Clinical Competence; Elective Surgical Procedures; Humans; Pandemics; SARS-CoV-2; Specialties, Surgical; Surgical Procedures, Operative; United Kingdom","Burke","J R","The Association of Surgeons in Training, London, UK",NA
"1911","34169311","10.1093/bjsopen/zrab051","The quantitative impact of COVID-19 on surgical training in the United Kingdom.","COVID-19 has had a global impact on all aspects of healthcare including surgical training. This study aimed to quantify the impact of COVID-19 on operative case numbers recorded by surgeons in training, and annual review of competency progression (ARCP) outcomes in the UK. Anonymized operative logbook numbers were collated from electronic logbook and ARCP outcome data from the Intercollegiate Surgical Curriculum Programme database for trainees in the 10 surgical specialty training specialties.Op","2021","07","07","BJS Open","BJS open","COVID-19; Clinical Competence; Elective Surgical Procedures; Humans; Pandemics; SARS-CoV-2; Specialties, Surgical; Surgical Procedures, Operative; United Kingdom","Hope","C","Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital, Derby, UK",NA
"1912","34169311","10.1093/bjsopen/zrab051","The quantitative impact of COVID-19 on surgical training in the United Kingdom.","COVID-19 has had a global impact on all aspects of healthcare including surgical training. This study aimed to quantify the impact of COVID-19 on operative case numbers recorded by surgeons in training, and annual review of competency progression (ARCP) outcomes in the UK. Anonymized operative logbook numbers were collated from electronic logbook and ARCP outcome data from the Intercollegiate Surgical Curriculum Programme database for trainees in the 10 surgical specialty training specialties.Op","2021","07","07","BJS Open","BJS open","COVID-19; Clinical Competence; Elective Surgical Procedures; Humans; Pandemics; SARS-CoV-2; Specialties, Surgical; Surgical Procedures, Operative; United Kingdom","Nally","D M","The Association of Surgeons in Training, London, UK",NA
"1913","34169311","10.1093/bjsopen/zrab051","The quantitative impact of COVID-19 on surgical training in the United Kingdom.","COVID-19 has had a global impact on all aspects of healthcare including surgical training. This study aimed to quantify the impact of COVID-19 on operative case numbers recorded by surgeons in training, and annual review of competency progression (ARCP) outcomes in the UK. Anonymized operative logbook numbers were collated from electronic logbook and ARCP outcome data from the Intercollegiate Surgical Curriculum Programme database for trainees in the 10 surgical specialty training specialties.Op","2021","07","07","BJS Open","BJS open","COVID-19; Clinical Competence; Elective Surgical Procedures; Humans; Pandemics; SARS-CoV-2; Specialties, Surgical; Surgical Procedures, Operative; United Kingdom","Doleman","B","Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital, Derby, UK",NA
"1914","34169311","10.1093/bjsopen/zrab051","The quantitative impact of COVID-19 on surgical training in the United Kingdom.","COVID-19 has had a global impact on all aspects of healthcare including surgical training. This study aimed to quantify the impact of COVID-19 on operative case numbers recorded by surgeons in training, and annual review of competency progression (ARCP) outcomes in the UK. Anonymized operative logbook numbers were collated from electronic logbook and ARCP outcome data from the Intercollegiate Surgical Curriculum Programme database for trainees in the 10 surgical specialty training specialties.Op","2021","07","07","BJS Open","BJS open","COVID-19; Clinical Competence; Elective Surgical Procedures; Humans; Pandemics; SARS-CoV-2; Specialties, Surgical; Surgical Procedures, Operative; United Kingdom","Giwa","L","The Association of Surgeons in Training, London, UK",NA
"1915","34169311","10.1093/bjsopen/zrab051","The quantitative impact of COVID-19 on surgical training in the United Kingdom.","COVID-19 has had a global impact on all aspects of healthcare including surgical training. This study aimed to quantify the impact of COVID-19 on operative case numbers recorded by surgeons in training, and annual review of competency progression (ARCP) outcomes in the UK. Anonymized operative logbook numbers were collated from electronic logbook and ARCP outcome data from the Intercollegiate Surgical Curriculum Programme database for trainees in the 10 surgical specialty training specialties.Op","2021","07","07","BJS Open","BJS open","COVID-19; Clinical Competence; Elective Surgical Procedures; Humans; Pandemics; SARS-CoV-2; Specialties, Surgical; Surgical Procedures, Operative; United Kingdom","Griffiths","G","Joint Committee on Surgical Training, London, UK",NA
"1916","34169311","10.1093/bjsopen/zrab051","The quantitative impact of COVID-19 on surgical training in the United Kingdom.","COVID-19 has had a global impact on all aspects of healthcare including surgical training. This study aimed to quantify the impact of COVID-19 on operative case numbers recorded by surgeons in training, and annual review of competency progression (ARCP) outcomes in the UK. Anonymized operative logbook numbers were collated from electronic logbook and ARCP outcome data from the Intercollegiate Surgical Curriculum Programme database for trainees in the 10 surgical specialty training specialties.Op","2021","07","07","BJS Open","BJS open","COVID-19; Clinical Competence; Elective Surgical Procedures; Humans; Pandemics; SARS-CoV-2; Specialties, Surgical; Surgical Procedures, Operative; United Kingdom","Lund","J N","Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital, Derby, UK",NA
"1917","34169310","10.1093/pm/pnab191","COVID-19 and Project ECHO Driving Innovations in Rural Pain Care &amp; Education.",NA,"2021","06","25","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; Pain; Project ECHO; Rural; Telehealth","Savage","Seddon R","Clinical Associate Professor of Anesthesiology, Geisel School of Medicine at Dartmouth",NA
"1918","34169310","10.1093/pm/pnab191","COVID-19 and Project ECHO Driving Innovations in Rural Pain Care &amp; Education.",NA,"2021","06","25","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; Pain; Project ECHO; Rural; Telehealth","Youngren","Kimberly","Clinical Associate Professor of Anesthesiology, Geisel School of Medicine at Dartmouth",NA
"1919","34169310","10.1093/pm/pnab191","COVID-19 and Project ECHO Driving Innovations in Rural Pain Care &amp; Education.",NA,"2021","06","25","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; Pain; Project ECHO; Rural; Telehealth","Kravic","John","Center for Pain and Spine, Dartmouth Hitchcock Medical Center",NA
"1920","34169310","10.1093/pm/pnab191","COVID-19 and Project ECHO Driving Innovations in Rural Pain Care &amp; Education.",NA,"2021","06","25","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; Pain; Project ECHO; Rural; Telehealth","Olson","Colleen","Assistant Professor of Medicine, Geisel School of Medicine at Dartmouth",NA
"1921","34169310","10.1093/pm/pnab191","COVID-19 and Project ECHO Driving Innovations in Rural Pain Care &amp; Education.",NA,"2021","06","25","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; Pain; Project ECHO; Rural; Telehealth","Pilchik","Dana","Instructor of Psychiatry, Geisel School of Medicine at Dartmouth",NA
"1922","34169310","10.1093/pm/pnab191","COVID-19 and Project ECHO Driving Innovations in Rural Pain Care &amp; Education.",NA,"2021","06","25","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; Pain; Project ECHO; Rural; Telehealth","Broglio","Kathleen","Assistant Professor of Medicine, Geisel School of Medicine at Dartmouth",NA
"1923","34169310","10.1093/pm/pnab191","COVID-19 and Project ECHO Driving Innovations in Rural Pain Care &amp; Education.",NA,"2021","06","25","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; Pain; Project ECHO; Rural; Telehealth","Brackett","Charles","Assistant Professor of Medicine, Geisel School of Medicine at Dartmouth",NA
"1924","34169297","10.1016/j.ahjo.2021.100011","Sex and gender differences in COVID-19: More to be learned!","The COVID-19 pandemic has affected millions of patients across the globe. Multiple studies, national and international governmental data have shown important sex and gender differences in the incidence and outcomes of patients with COVID-19. These differences are not only attributed to the differences in age and comorbid conditions but likely a combination of factors, including hormonal differences, immune response, inflammatory markers and behavioral attitudes, among others. In this review, we ","2021","06","26","Am Heart J Plus","American heart journal plus : cardiology research and practice","COVID-19; Disparities; Gender; Outcomes; Sex","Ya'qoub","Lina","Department of Cardiology, Ochsner-Louisiana State University, Shreveport, LA, USA",NA
"1925","34169297","10.1016/j.ahjo.2021.100011","Sex and gender differences in COVID-19: More to be learned!","The COVID-19 pandemic has affected millions of patients across the globe. Multiple studies, national and international governmental data have shown important sex and gender differences in the incidence and outcomes of patients with COVID-19. These differences are not only attributed to the differences in age and comorbid conditions but likely a combination of factors, including hormonal differences, immune response, inflammatory markers and behavioral attitudes, among others. In this review, we ","2021","06","26","Am Heart J Plus","American heart journal plus : cardiology research and practice","COVID-19; Disparities; Gender; Outcomes; Sex","Elgendy","Islam Y","Department of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar",NA
"1926","34169297","10.1016/j.ahjo.2021.100011","Sex and gender differences in COVID-19: More to be learned!","The COVID-19 pandemic has affected millions of patients across the globe. Multiple studies, national and international governmental data have shown important sex and gender differences in the incidence and outcomes of patients with COVID-19. These differences are not only attributed to the differences in age and comorbid conditions but likely a combination of factors, including hormonal differences, immune response, inflammatory markers and behavioral attitudes, among others. In this review, we ","2021","06","26","Am Heart J Plus","American heart journal plus : cardiology research and practice","COVID-19; Disparities; Gender; Outcomes; Sex","Pepine","Carl J","Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA",NA
"1927","34169281","10.1093/braincomms/fcab118","Gut-brain axis in the neurological comorbidity of COVID-19.",NA,"2021","06","26","Brain Commun","Brain communications",NA,"Chen","Jiezhong","Research Department, Medlab Clinical, Sydney 2015, Australia",NA
"1928","34169281","10.1093/braincomms/fcab118","Gut-brain axis in the neurological comorbidity of COVID-19.",NA,"2021","06","26","Brain Commun","Brain communications",NA,"Vitetta","Luis","Research Department, Medlab Clinical, Sydney 2015, Australia",NA
"1929","34169245","10.1016/j.eclinm.2021.100953","Ethnic inequalities in health: The interplay of racism and COVID-19 in syndemics.",NA,"2021","06","26","EClinicalMedicine","EClinicalMedicine",NA,"Bhui","Kamaldeep","Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, UK",NA
"1930","34169112","10.3389/fsoc.2021.648395","Increased Risk of Death Triggered by Domestic Violence, Hunger, Suicide, Exhausted Health System during COVID-19 Pandemic: Why, How and Solutions.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, just like many other public health emergencies, is a well-established global health burden that has resulted in several changes in routines and lifestyles of people globally. The coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, has directly or indirectly involved in the loss of lives of more than 3.24 million as of 6th May, 2021. The increasing threats posed by this pandemic were subsided by the swift and dras","2021","06","26","Front Sociol","Frontiers in sociology","COVID-19; SARS-CoV-2; death; domestic-violence; hunger; pandemic; suicide","David","Kenneth Bitrus","Hull York Medical School, University of Hull, Heslington, United Kingdom",NA
"1931","34169112","10.3389/fsoc.2021.648395","Increased Risk of Death Triggered by Domestic Violence, Hunger, Suicide, Exhausted Health System during COVID-19 Pandemic: Why, How and Solutions.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, just like many other public health emergencies, is a well-established global health burden that has resulted in several changes in routines and lifestyles of people globally. The coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, has directly or indirectly involved in the loss of lives of more than 3.24 million as of 6th May, 2021. The increasing threats posed by this pandemic were subsided by the swift and dras","2021","06","26","Front Sociol","Frontiers in sociology","COVID-19; SARS-CoV-2; death; domestic-violence; hunger; pandemic; suicide","Aborode","Abdullahi Tunde","Department of Chemistry, University of Ilorin, Ilorin, Nigeria",NA
"1932","34169112","10.3389/fsoc.2021.648395","Increased Risk of Death Triggered by Domestic Violence, Hunger, Suicide, Exhausted Health System during COVID-19 Pandemic: Why, How and Solutions.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, just like many other public health emergencies, is a well-established global health burden that has resulted in several changes in routines and lifestyles of people globally. The coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, has directly or indirectly involved in the loss of lives of more than 3.24 million as of 6th May, 2021. The increasing threats posed by this pandemic were subsided by the swift and dras","2021","06","26","Front Sociol","Frontiers in sociology","COVID-19; SARS-CoV-2; death; domestic-violence; hunger; pandemic; suicide","Olaoye","Damilola Quazeem","Faculty of Pharmacy, University of Ibadan, Oyo, Nigeria",NA
"1933","34169112","10.3389/fsoc.2021.648395","Increased Risk of Death Triggered by Domestic Violence, Hunger, Suicide, Exhausted Health System during COVID-19 Pandemic: Why, How and Solutions.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, just like many other public health emergencies, is a well-established global health burden that has resulted in several changes in routines and lifestyles of people globally. The coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, has directly or indirectly involved in the loss of lives of more than 3.24 million as of 6th May, 2021. The increasing threats posed by this pandemic were subsided by the swift and dras","2021","06","26","Front Sociol","Frontiers in sociology","COVID-19; SARS-CoV-2; death; domestic-violence; hunger; pandemic; suicide","Enang","Ndikpongkeabasi Victor","Faculty of Pharmacy, University of Uyo, Uyo, Nigeria",NA
"1934","34169112","10.3389/fsoc.2021.648395","Increased Risk of Death Triggered by Domestic Violence, Hunger, Suicide, Exhausted Health System during COVID-19 Pandemic: Why, How and Solutions.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, just like many other public health emergencies, is a well-established global health burden that has resulted in several changes in routines and lifestyles of people globally. The coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, has directly or indirectly involved in the loss of lives of more than 3.24 million as of 6th May, 2021. The increasing threats posed by this pandemic were subsided by the swift and dras","2021","06","26","Front Sociol","Frontiers in sociology","COVID-19; SARS-CoV-2; death; domestic-violence; hunger; pandemic; suicide","Oriyomi","Aboaba Kazeem","Department of Agricultural Economics, Federal University of Agriculture, Abeokuta, Nigeria",NA
"1935","34169112","10.3389/fsoc.2021.648395","Increased Risk of Death Triggered by Domestic Violence, Hunger, Suicide, Exhausted Health System during COVID-19 Pandemic: Why, How and Solutions.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, just like many other public health emergencies, is a well-established global health burden that has resulted in several changes in routines and lifestyles of people globally. The coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, has directly or indirectly involved in the loss of lives of more than 3.24 million as of 6th May, 2021. The increasing threats posed by this pandemic were subsided by the swift and dras","2021","06","26","Front Sociol","Frontiers in sociology","COVID-19; SARS-CoV-2; death; domestic-violence; hunger; pandemic; suicide","Yunusa","Ismaeel","Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, SC, United States",NA
"1936","34169110","10.3389/fvets.2021.678595","Community Veterinary Medicine Programs: Pet Owners' Perceptions and Experiences.","Many American pet owners struggle financially, and the COVID-19 pandemic has only exacerbated this problem. Yet, the positive effects that companion animals have in people's lives create the need for supportive systems to ensure that financial limitations, and other barriers, do not preclude pet ownership. To help address these barriers, and reach underserved communities, various forms of community-based veterinary medicine programs have been developed across the country. This study assesses two","2021","06","26","Front Vet Sci","Frontiers in veterinary science","access; community program; disadvantaged pet owners; financial limitations; low-cost veterinary care","Kogan","Lori R","Clinical Sciences Department, Colorado State University, Fort Collins, CO, United States",NA
"1937","34169110","10.3389/fvets.2021.678595","Community Veterinary Medicine Programs: Pet Owners' Perceptions and Experiences.","Many American pet owners struggle financially, and the COVID-19 pandemic has only exacerbated this problem. Yet, the positive effects that companion animals have in people's lives create the need for supportive systems to ensure that financial limitations, and other barriers, do not preclude pet ownership. To help address these barriers, and reach underserved communities, various forms of community-based veterinary medicine programs have been developed across the country. This study assesses two","2021","06","26","Front Vet Sci","Frontiers in veterinary science","access; community program; disadvantaged pet owners; financial limitations; low-cost veterinary care","Accornero","Veronica H","Strategy and Research, The American Society for the Prevention of Cruelty to Animals, New York, NY, United States",NA
"1938","34169110","10.3389/fvets.2021.678595","Community Veterinary Medicine Programs: Pet Owners' Perceptions and Experiences.","Many American pet owners struggle financially, and the COVID-19 pandemic has only exacerbated this problem. Yet, the positive effects that companion animals have in people's lives create the need for supportive systems to ensure that financial limitations, and other barriers, do not preclude pet ownership. To help address these barriers, and reach underserved communities, various forms of community-based veterinary medicine programs have been developed across the country. This study assesses two","2021","06","26","Front Vet Sci","Frontiers in veterinary science","access; community program; disadvantaged pet owners; financial limitations; low-cost veterinary care","Gelb","Emily","Sheltering and Veterinary Services Department, The American Society for the Prevention of Cruelty to Animals, New York, NY, United States",NA
"1939","34169110","10.3389/fvets.2021.678595","Community Veterinary Medicine Programs: Pet Owners' Perceptions and Experiences.","Many American pet owners struggle financially, and the COVID-19 pandemic has only exacerbated this problem. Yet, the positive effects that companion animals have in people's lives create the need for supportive systems to ensure that financial limitations, and other barriers, do not preclude pet ownership. To help address these barriers, and reach underserved communities, various forms of community-based veterinary medicine programs have been developed across the country. This study assesses two","2021","06","26","Front Vet Sci","Frontiers in veterinary science","access; community program; disadvantaged pet owners; financial limitations; low-cost veterinary care","Slater","Margaret R","Strategy and Research, The American Society for the Prevention of Cruelty to Animals, New York, NY, United States",NA
"1940","34169088","10.3389/fnut.2021.680105","Energy Balance-Related Behavior Risk Pattern and Its Correlates During COVID-19 Related Home Confinement.","Self-reported weight gain during the COVID-19 shelter-at-home has raised concerns for weight increases as the pandemic continues. We aimed to investigate the relationship of psychological and health markers with energy balance-related behaviors during the pandemic-related extended home confinement. Ratings for stress, boredom, cravings, sleep, self-control, and beliefs about weight control were collected from 1,609 adults using a questionnaire between April 24th-May 4th, 2020, while COVID-19 ass","2021","06","26","Front Nutr","Frontiers in nutrition","COVID-19; eating behaviors; energy balance; physical activity; psychological factors","Bhutani","Surabhi","School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, United States",NA
"1941","34169088","10.3389/fnut.2021.680105","Energy Balance-Related Behavior Risk Pattern and Its Correlates During COVID-19 Related Home Confinement.","Self-reported weight gain during the COVID-19 shelter-at-home has raised concerns for weight increases as the pandemic continues. We aimed to investigate the relationship of psychological and health markers with energy balance-related behaviors during the pandemic-related extended home confinement. Ratings for stress, boredom, cravings, sleep, self-control, and beliefs about weight control were collected from 1,609 adults using a questionnaire between April 24th-May 4th, 2020, while COVID-19 ass","2021","06","26","Front Nutr","Frontiers in nutrition","COVID-19; eating behaviors; energy balance; physical activity; psychological factors","vanDellen","Michelle R","Department of Psychology, University of Georgia, Athens, GA, United States",NA
"1942","34169088","10.3389/fnut.2021.680105","Energy Balance-Related Behavior Risk Pattern and Its Correlates During COVID-19 Related Home Confinement.","Self-reported weight gain during the COVID-19 shelter-at-home has raised concerns for weight increases as the pandemic continues. We aimed to investigate the relationship of psychological and health markers with energy balance-related behaviors during the pandemic-related extended home confinement. Ratings for stress, boredom, cravings, sleep, self-control, and beliefs about weight control were collected from 1,609 adults using a questionnaire between April 24th-May 4th, 2020, while COVID-19 ass","2021","06","26","Front Nutr","Frontiers in nutrition","COVID-19; eating behaviors; energy balance; physical activity; psychological factors","Haskins","LeeAnn B","Department of Psychology, University of Georgia, Athens, GA, United States",NA
"1943","34169088","10.3389/fnut.2021.680105","Energy Balance-Related Behavior Risk Pattern and Its Correlates During COVID-19 Related Home Confinement.","Self-reported weight gain during the COVID-19 shelter-at-home has raised concerns for weight increases as the pandemic continues. We aimed to investigate the relationship of psychological and health markers with energy balance-related behaviors during the pandemic-related extended home confinement. Ratings for stress, boredom, cravings, sleep, self-control, and beliefs about weight control were collected from 1,609 adults using a questionnaire between April 24th-May 4th, 2020, while COVID-19 ass","2021","06","26","Front Nutr","Frontiers in nutrition","COVID-19; eating behaviors; energy balance; physical activity; psychological factors","Cooper","Jamie A","Department of Foods and Nutrition, University of Georgia, Athens, GA, United States",NA
"1944","34169058","10.3389/fpubh.2021.673208","Workforce Readiness Training: A Comprehensive Training Model That Equips Community Health Workers to Work at the Top of Their Practice and Profession.","Background: Recent reports have recognized that only 20 percent of health outcomes are attributed to clinical care. Environmental conditions, behaviors, and social determinants of health account for 80 percent of overall health outcomes. With shortages of clinical providers stressing an already burdened healthcare system, Community Health Workers (CHWs) can bridge healthcare gaps by addressing these nonmedical factors influencing health. This paper details how a comprehensive train","2021","06","30","Front Public Health","Frontiers in public health","capacity building; competency; model; organizational readiness; skills; training; workforce readiness; COVID-19; Community Health Workers; Humans; Pandemics; SARS-CoV-2; Workforce","Lee","Lily K","Community Health Workers/Promotores Academy, San Manuel Gateway College, Loma Linda University, San Bernardino, CA, United States",NA
"1945","34169058","10.3389/fpubh.2021.673208","Workforce Readiness Training: A Comprehensive Training Model That Equips Community Health Workers to Work at the Top of Their Practice and Profession.","Background: Recent reports have recognized that only 20 percent of health outcomes are attributed to clinical care. Environmental conditions, behaviors, and social determinants of health account for 80 percent of overall health outcomes. With shortages of clinical providers stressing an already burdened healthcare system, Community Health Workers (CHWs) can bridge healthcare gaps by addressing these nonmedical factors influencing health. This paper details how a comprehensive train","2021","06","30","Front Public Health","Frontiers in public health","capacity building; competency; model; organizational readiness; skills; training; workforce readiness; COVID-19; Community Health Workers; Humans; Pandemics; SARS-CoV-2; Workforce","Ruano","Elizabeth","Community Health Workers/Promotores Academy, San Manuel Gateway College, Loma Linda University, San Bernardino, CA, United States",NA
"1946","34169058","10.3389/fpubh.2021.673208","Workforce Readiness Training: A Comprehensive Training Model That Equips Community Health Workers to Work at the Top of Their Practice and Profession.","Background: Recent reports have recognized that only 20 percent of health outcomes are attributed to clinical care. Environmental conditions, behaviors, and social determinants of health account for 80 percent of overall health outcomes. With shortages of clinical providers stressing an already burdened healthcare system, Community Health Workers (CHWs) can bridge healthcare gaps by addressing these nonmedical factors influencing health. This paper details how a comprehensive train","2021","06","30","Front Public Health","Frontiers in public health","capacity building; competency; model; organizational readiness; skills; training; workforce readiness; COVID-19; Community Health Workers; Humans; Pandemics; SARS-CoV-2; Workforce","Fernández","Pamela","Community Health Workers/Promotores Academy, San Manuel Gateway College, Loma Linda University, San Bernardino, CA, United States",NA
"1947","34169058","10.3389/fpubh.2021.673208","Workforce Readiness Training: A Comprehensive Training Model That Equips Community Health Workers to Work at the Top of Their Practice and Profession.","Background: Recent reports have recognized that only 20 percent of health outcomes are attributed to clinical care. Environmental conditions, behaviors, and social determinants of health account for 80 percent of overall health outcomes. With shortages of clinical providers stressing an already burdened healthcare system, Community Health Workers (CHWs) can bridge healthcare gaps by addressing these nonmedical factors influencing health. This paper details how a comprehensive train","2021","06","30","Front Public Health","Frontiers in public health","capacity building; competency; model; organizational readiness; skills; training; workforce readiness; COVID-19; Community Health Workers; Humans; Pandemics; SARS-CoV-2; Workforce","Ortega","Silvia","Community Health Workers/Promotores Academy, San Manuel Gateway College, Loma Linda University, San Bernardino, CA, United States",NA
"1948","34169058","10.3389/fpubh.2021.673208","Workforce Readiness Training: A Comprehensive Training Model That Equips Community Health Workers to Work at the Top of Their Practice and Profession.","Background: Recent reports have recognized that only 20 percent of health outcomes are attributed to clinical care. Environmental conditions, behaviors, and social determinants of health account for 80 percent of overall health outcomes. With shortages of clinical providers stressing an already burdened healthcare system, Community Health Workers (CHWs) can bridge healthcare gaps by addressing these nonmedical factors influencing health. This paper details how a comprehensive train","2021","06","30","Front Public Health","Frontiers in public health","capacity building; competency; model; organizational readiness; skills; training; workforce readiness; COVID-19; Community Health Workers; Humans; Pandemics; SARS-CoV-2; Workforce","Lucas","Carlos","DAP Health, Palm Springs, CA, United States",NA
"1949","34169058","10.3389/fpubh.2021.673208","Workforce Readiness Training: A Comprehensive Training Model That Equips Community Health Workers to Work at the Top of Their Practice and Profession.","Background: Recent reports have recognized that only 20 percent of health outcomes are attributed to clinical care. Environmental conditions, behaviors, and social determinants of health account for 80 percent of overall health outcomes. With shortages of clinical providers stressing an already burdened healthcare system, Community Health Workers (CHWs) can bridge healthcare gaps by addressing these nonmedical factors influencing health. This paper details how a comprehensive train","2021","06","30","Front Public Health","Frontiers in public health","capacity building; competency; model; organizational readiness; skills; training; workforce readiness; COVID-19; Community Health Workers; Humans; Pandemics; SARS-CoV-2; Workforce","Joachim-Célestin","Maud","Community Health Workers/Promotores Academy, San Manuel Gateway College, Loma Linda University, San Bernardino, CA, United States",NA
"1950","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","Cohen","Zsofia P","Laureate Institute for Brain Research, Tulsa, OK, United States",NA
"1951","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","Cosgrove","Kelly T","Laureate Institute for Brain Research, Tulsa, OK, United States",NA
"1952","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","DeVille","Danielle C","Laureate Institute for Brain Research, Tulsa, OK, United States",NA
"1953","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","Akeman","Elisabeth","Laureate Institute for Brain Research, Tulsa, OK, United States",NA
"1954","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","Singh","Manpreet K","Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, United States",NA
"1955","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","White","Evan","Laureate Institute for Brain Research, Tulsa, OK, United States",NA
"1956","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","Stewart","Jennifer L","Laureate Institute for Brain Research, Tulsa, OK, United States",NA
"1957","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","Aupperle","Robin L","Laureate Institute for Brain Research, Tulsa, OK, United States",NA
"1958","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","Paulus","Martin P","Laureate Institute for Brain Research, Tulsa, OK, United States",NA
"1959","34169046","10.3389/fped.2021.622608","The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents.","Background: The COVID-19 pandemic has brought on far-reaching consequences for adolescents. Adolescents with early life stress (ELS) may be at particular risk. We sought to examine how COVID-19 impacted psychological functioning in a sample of healthy and ELS-exposed adolescents during the pandemic. Methods: A total of 24 adolescents (15 healthy, nine ELS) completed self-report measures prior to and during the COVID-19 pandemic. The effect of COVID-19 on symptoms of depression and ","2021","06","26","Front Pediatr","Frontiers in pediatrics","COVID-19; adolescents; anxiety; depression; stress","Kirlic","Namik","Laureate Institute for Brain Research, Tulsa, OK, United States",NA
"1960","34169042","10.47176/mjiri.35.30","Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial.","Background: There is controversy about the efficacy of 5-alpha-reductase inhibitors in COVID-19 patients. Some assumed that finasteride might be a risk factor for deterioration and others proposed it as a possible adjunct treatment for moderate to severe COVID-19 infection in the elderly. Methods: We performed a randomized controlled clinical trial (registration ID IRCT20200505047318N1) on 80 hospitalized male patients aged =50 years diagnosed with COVID-19 pneumonia in a tertiary ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","Adult; COVID-19 Infection; Finasteride; Male; Therapy","Zarehoseinzade","Elham","Department of Infectious Diseases, Clinical Research Development Unit, BouAli Sina Hospital, Qazvin University of Medical of Sciences, Qazvin, Iran",NA
"1961","34169042","10.47176/mjiri.35.30","Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial.","Background: There is controversy about the efficacy of 5-alpha-reductase inhibitors in COVID-19 patients. Some assumed that finasteride might be a risk factor for deterioration and others proposed it as a possible adjunct treatment for moderate to severe COVID-19 infection in the elderly. Methods: We performed a randomized controlled clinical trial (registration ID IRCT20200505047318N1) on 80 hospitalized male patients aged =50 years diagnosed with COVID-19 pneumonia in a tertiary ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","Adult; COVID-19 Infection; Finasteride; Male; Therapy","Allami","Abbas","Department of Infectious Diseases, Clinical Research Development Unit, BouAli Sina Hospital, Qazvin University of Medical of Sciences, Qazvin, Iran",NA
"1962","34169042","10.47176/mjiri.35.30","Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial.","Background: There is controversy about the efficacy of 5-alpha-reductase inhibitors in COVID-19 patients. Some assumed that finasteride might be a risk factor for deterioration and others proposed it as a possible adjunct treatment for moderate to severe COVID-19 infection in the elderly. Methods: We performed a randomized controlled clinical trial (registration ID IRCT20200505047318N1) on 80 hospitalized male patients aged =50 years diagnosed with COVID-19 pneumonia in a tertiary ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","Adult; COVID-19 Infection; Finasteride; Male; Therapy","Ahmadi","Mehrnoosh","Qazvin Blood Transfusion Organization, Qazvin, Iran",NA
"1963","34169042","10.47176/mjiri.35.30","Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial.","Background: There is controversy about the efficacy of 5-alpha-reductase inhibitors in COVID-19 patients. Some assumed that finasteride might be a risk factor for deterioration and others proposed it as a possible adjunct treatment for moderate to severe COVID-19 infection in the elderly. Methods: We performed a randomized controlled clinical trial (registration ID IRCT20200505047318N1) on 80 hospitalized male patients aged =50 years diagnosed with COVID-19 pneumonia in a tertiary ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","Adult; COVID-19 Infection; Finasteride; Male; Therapy","Bijani","Behzad","Department of Infectious Diseases, Clinical Research Development Unit, BouAli Sina Hospital, Qazvin University of Medical of Sciences, Qazvin, Iran",NA
"1964","34169042","10.47176/mjiri.35.30","Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial.","Background: There is controversy about the efficacy of 5-alpha-reductase inhibitors in COVID-19 patients. Some assumed that finasteride might be a risk factor for deterioration and others proposed it as a possible adjunct treatment for moderate to severe COVID-19 infection in the elderly. Methods: We performed a randomized controlled clinical trial (registration ID IRCT20200505047318N1) on 80 hospitalized male patients aged =50 years diagnosed with COVID-19 pneumonia in a tertiary ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","Adult; COVID-19 Infection; Finasteride; Male; Therapy","Mohammadi","Navid","Children Growth Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran",NA
"1965","34169041","10.47176/mjiri.35.29","Performance evaluation of selected decision tree algorithms for COVID-19 diagnosis using routine clinical data.","Background: The novel 2019 Coronavirus disease (COVID-19) poses a great threat to global public health and the economy. The earlier detection of COVID-19 is the key to its treatment and mitigating the transmission of the virus. Given that Machine Learning (ML) could be potentially useful in COVID-19 identification, we compared 7 decision tree (DT) algorithms to select the best clinical diagnostic model. Methods: A hospital-based retrospective dataset was used to train the selected ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","COVID-19; Data Mining; Decision Tree; Machine Learning; Novel Coronavirus","Shanbehzadeh","Mostafa","Department of Health Information Technology, School of Paramedical, Ilam University of Medical Sciences, Ilam, Iran",NA
"1966","34169041","10.47176/mjiri.35.29","Performance evaluation of selected decision tree algorithms for COVID-19 diagnosis using routine clinical data.","Background: The novel 2019 Coronavirus disease (COVID-19) poses a great threat to global public health and the economy. The earlier detection of COVID-19 is the key to its treatment and mitigating the transmission of the virus. Given that Machine Learning (ML) could be potentially useful in COVID-19 identification, we compared 7 decision tree (DT) algorithms to select the best clinical diagnostic model. Methods: A hospital-based retrospective dataset was used to train the selected ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","COVID-19; Data Mining; Decision Tree; Machine Learning; Novel Coronavirus","Kazemi-Arpanahi","Hadi","Department of Health Information Technology, Abadan Faculty of Medical Sciences, Abadan, Iran",NA
"1967","34169041","10.47176/mjiri.35.29","Performance evaluation of selected decision tree algorithms for COVID-19 diagnosis using routine clinical data.","Background: The novel 2019 Coronavirus disease (COVID-19) poses a great threat to global public health and the economy. The earlier detection of COVID-19 is the key to its treatment and mitigating the transmission of the virus. Given that Machine Learning (ML) could be potentially useful in COVID-19 identification, we compared 7 decision tree (DT) algorithms to select the best clinical diagnostic model. Methods: A hospital-based retrospective dataset was used to train the selected ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","COVID-19; Data Mining; Decision Tree; Machine Learning; Novel Coronavirus","Nopour","Raoof","Department of Health Information Technology and Management, School of Paramedical, Tehran University of Medical Sciences, Tehran, Iran",NA
"1968","34169036","10.47176/mjiri.35.24","Iranian researchers' contributions to research on COVID-19: A bibliometric analysis and visualization.","Background: COVID-19 pandemic crisis motivated researchers worldwide to deeply investigate it from different perspectives. As Iran is one of the highly-affected countries by Covid-19, Iranian researchers have focused on studying it. This study aimed at analyzing and visualizing Iranian researchers' papers on COVID-19 from a bibliometric perspective. Methods: By searching MeSH-selected keywords related to COVID-19 in Scopus, Iranian researchers' papers on COVID-19 were extracted in ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","Bibliometrics; COVID-19; Data visualization; Iran; SARS-CoV-2","Saberi","Mohammad Karim","Department of Medical Library and Information Sciences, School of Paramedicine, Hamadan University of Medical Sciences, Hamadan, Iran",NA
"1969","34169036","10.47176/mjiri.35.24","Iranian researchers' contributions to research on COVID-19: A bibliometric analysis and visualization.","Background: COVID-19 pandemic crisis motivated researchers worldwide to deeply investigate it from different perspectives. As Iran is one of the highly-affected countries by Covid-19, Iranian researchers have focused on studying it. This study aimed at analyzing and visualizing Iranian researchers' papers on COVID-19 from a bibliometric perspective. Methods: By searching MeSH-selected keywords related to COVID-19 in Scopus, Iranian researchers' papers on COVID-19 were extracted in ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","Bibliometrics; COVID-19; Data visualization; Iran; SARS-CoV-2","Farhadi","Arezoo","Department of Medical Library and Information Sciences, School of Paramedicine, Hamadan University of Medical Sciences, Hamadan, Iran",NA
"1970","34169036","10.47176/mjiri.35.24","Iranian researchers' contributions to research on COVID-19: A bibliometric analysis and visualization.","Background: COVID-19 pandemic crisis motivated researchers worldwide to deeply investigate it from different perspectives. As Iran is one of the highly-affected countries by Covid-19, Iranian researchers have focused on studying it. This study aimed at analyzing and visualizing Iranian researchers' papers on COVID-19 from a bibliometric perspective. Methods: By searching MeSH-selected keywords related to COVID-19 in Scopus, Iranian researchers' papers on COVID-19 were extracted in ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","Bibliometrics; COVID-19; Data visualization; Iran; SARS-CoV-2","Karami","Samira","Department of Medical Library and Information Sciences, School of Paramedicine, Hamadan University of Medical Sciences, Hamadan, Iran",NA
"1971","34169036","10.47176/mjiri.35.24","Iranian researchers' contributions to research on COVID-19: A bibliometric analysis and visualization.","Background: COVID-19 pandemic crisis motivated researchers worldwide to deeply investigate it from different perspectives. As Iran is one of the highly-affected countries by Covid-19, Iranian researchers have focused on studying it. This study aimed at analyzing and visualizing Iranian researchers' papers on COVID-19 from a bibliometric perspective. Methods: By searching MeSH-selected keywords related to COVID-19 in Scopus, Iranian researchers' papers on COVID-19 were extracted in ","2021","06","26","Med J Islam Repub Iran","Medical journal of the Islamic Republic of Iran","Bibliometrics; COVID-19; Data visualization; Iran; SARS-CoV-2","Mokhtari","Heidar","Department of Library and Information Science, Payame Noor University, Tehran, Iran",NA
"1972","34168972","10.5498/wjp.v11.i6.253","Current global research landscape on COVID-19 and depressive disorders: Bibliometric and visualization analysis.","Coronavirus disease 2019 (COVID-19) has affected daily life globally dramatically over the last year. The impact of the COVID-19 epidemic on mental health is expected to be immense and likely to be long-lasting, raising a range of global problems that need to be addressed accordingly. To analyze the Scopus-based depression research and COVID-19, explain the advancement of research nowadays, and comment on the possible hotspots of depression research and COVID-19 to obtain a more global perspecti","2021","06","26","World J Psychiatry","World journal of psychiatry","Bibliometric; COVID-19; Depression; Psychological distress; Scopus","Al-Jabi","Samah W","Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, West Bank, Palestine. samahjabi@yahoo","samahjabi@yahoo.com"
"1973","34168970","10.5498/wjp.v11.i6.232","COVID-19 impact on high school student's education and mental health: A cohort survey in China.","The ongoing coronavirus disease 2019 (COVID-19) pandemic and the universal implementation of control measures are fundamentally affecting every aspect of our society and daily lives. To evaluate the prevalence of post-traumatic stress disorder symptoms and their associated factors as well as the effects and attitudes towards online education in Chinese high school students. A total of 883 students were included. The first, second and third-year students of a high school in Lanzhou, Gansu provinc","2021","06","26","World J Psychiatry","World journal of psychiatry","COVID-19; China; College entrance examination; Education; Post-traumatic stress disorder; Students","Ma","Zhong-Ren","Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, Gansu Province, China",NA
"1974","34168970","10.5498/wjp.v11.i6.232","COVID-19 impact on high school student's education and mental health: A cohort survey in China.","The ongoing coronavirus disease 2019 (COVID-19) pandemic and the universal implementation of control measures are fundamentally affecting every aspect of our society and daily lives. To evaluate the prevalence of post-traumatic stress disorder symptoms and their associated factors as well as the effects and attitudes towards online education in Chinese high school students. A total of 883 students were included. The first, second and third-year students of a high school in Lanzhou, Gansu provinc","2021","06","26","World J Psychiatry","World journal of psychiatry","COVID-19; China; College entrance examination; Education; Post-traumatic stress disorder; Students","Ma","Wei-Hua","Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, Gansu Province, China",NA
"1975","34168970","10.5498/wjp.v11.i6.232","COVID-19 impact on high school student's education and mental health: A cohort survey in China.","The ongoing coronavirus disease 2019 (COVID-19) pandemic and the universal implementation of control measures are fundamentally affecting every aspect of our society and daily lives. To evaluate the prevalence of post-traumatic stress disorder symptoms and their associated factors as well as the effects and attitudes towards online education in Chinese high school students. A total of 883 students were included. The first, second and third-year students of a high school in Lanzhou, Gansu provinc","2021","06","26","World J Psychiatry","World journal of psychiatry","COVID-19; China; College entrance examination; Education; Post-traumatic stress disorder; Students","Idris","Sakinah","Department of Psychiatry, Faculty of Medicine, Universiti Teknologi MARA, Batu Caves 68100, Selangor, Malaysia",NA
"1976","34168970","10.5498/wjp.v11.i6.232","COVID-19 impact on high school student's education and mental health: A cohort survey in China.","The ongoing coronavirus disease 2019 (COVID-19) pandemic and the universal implementation of control measures are fundamentally affecting every aspect of our society and daily lives. To evaluate the prevalence of post-traumatic stress disorder symptoms and their associated factors as well as the effects and attitudes towards online education in Chinese high school students. A total of 883 students were included. The first, second and third-year students of a high school in Lanzhou, Gansu provinc","2021","06","26","World J Psychiatry","World journal of psychiatry","COVID-19; China; College entrance examination; Education; Post-traumatic stress disorder; Students","Pan","Qiu-Wei","Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, Gansu Province, China",NA
"1977","34168970","10.5498/wjp.v11.i6.232","COVID-19 impact on high school student's education and mental health: A cohort survey in China.","The ongoing coronavirus disease 2019 (COVID-19) pandemic and the universal implementation of control measures are fundamentally affecting every aspect of our society and daily lives. To evaluate the prevalence of post-traumatic stress disorder symptoms and their associated factors as well as the effects and attitudes towards online education in Chinese high school students. A total of 883 students were included. The first, second and third-year students of a high school in Lanzhou, Gansu provinc","2021","06","26","World J Psychiatry","World journal of psychiatry","COVID-19; China; College entrance examination; Education; Post-traumatic stress disorder; Students","Baloch","Zulqarnain","Center for Molecular Medicine in Yunnan Province, Kunming University of Science and Technology, Kunming 650500, Yunnan Province, China. znbalooch@yahoo","znbalooch@yahoo.com"
"1978","34168968","10.5498/wjp.v11.i6.215","Intimate partner violence: A loop of abuse, depression and victimization.","Intimate partner violence has been recognized as a serious public health issue. Exposure to violence contributes to the genesis of, and exacerbates, mental health conditions, and existing mental health problems increase vulnerability to partner violence, a loop that imprisons victims and perpetuates the abuse. A recently described phenomenon is when male violence against females occurs within intimate relationships during youth, and it is termed adolescent or teen dating violence. In this narrat","2021","06","26","World J Psychiatry","World journal of psychiatry","Abuse; COVID-19; Depression; Intimate partner violence; Personalized medicine; Women","Mazza","Marianna","Department of Neurosciences, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome 00168, Italy. mariannamazza@hotmail","mariannamazza@hotmail.com"
"1979","34168968","10.5498/wjp.v11.i6.215","Intimate partner violence: A loop of abuse, depression and victimization.","Intimate partner violence has been recognized as a serious public health issue. Exposure to violence contributes to the genesis of, and exacerbates, mental health conditions, and existing mental health problems increase vulnerability to partner violence, a loop that imprisons victims and perpetuates the abuse. A recently described phenomenon is when male violence against females occurs within intimate relationships during youth, and it is termed adolescent or teen dating violence. In this narrat","2021","06","26","World J Psychiatry","World journal of psychiatry","Abuse; COVID-19; Depression; Intimate partner violence; Personalized medicine; Women","Marano","Giuseppe","Department of Neurosciences, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome 00168, Italy",NA
"1980","34168968","10.5498/wjp.v11.i6.215","Intimate partner violence: A loop of abuse, depression and victimization.","Intimate partner violence has been recognized as a serious public health issue. Exposure to violence contributes to the genesis of, and exacerbates, mental health conditions, and existing mental health problems increase vulnerability to partner violence, a loop that imprisons victims and perpetuates the abuse. A recently described phenomenon is when male violence against females occurs within intimate relationships during youth, and it is termed adolescent or teen dating violence. In this narrat","2021","06","26","World J Psychiatry","World journal of psychiatry","Abuse; COVID-19; Depression; Intimate partner violence; Personalized medicine; Women","Del Castillo","Angela Gonsalez","Service of Clinical Psychology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome 00168, Italy",NA
"1981","34168968","10.5498/wjp.v11.i6.215","Intimate partner violence: A loop of abuse, depression and victimization.","Intimate partner violence has been recognized as a serious public health issue. Exposure to violence contributes to the genesis of, and exacerbates, mental health conditions, and existing mental health problems increase vulnerability to partner violence, a loop that imprisons victims and perpetuates the abuse. A recently described phenomenon is when male violence against females occurs within intimate relationships during youth, and it is termed adolescent or teen dating violence. In this narrat","2021","06","26","World J Psychiatry","World journal of psychiatry","Abuse; COVID-19; Depression; Intimate partner violence; Personalized medicine; Women","Chieffo","Daniela","Service of Clinical Psychology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome 00168, Italy",NA
"1982","34168968","10.5498/wjp.v11.i6.215","Intimate partner violence: A loop of abuse, depression and victimization.","Intimate partner violence has been recognized as a serious public health issue. Exposure to violence contributes to the genesis of, and exacerbates, mental health conditions, and existing mental health problems increase vulnerability to partner violence, a loop that imprisons victims and perpetuates the abuse. A recently described phenomenon is when male violence against females occurs within intimate relationships during youth, and it is termed adolescent or teen dating violence. In this narrat","2021","06","26","World J Psychiatry","World journal of psychiatry","Abuse; COVID-19; Depression; Intimate partner violence; Personalized medicine; Women","Monti","Laura","Service of Clinical Psychology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome 00168, Italy",NA
"1983","34168968","10.5498/wjp.v11.i6.215","Intimate partner violence: A loop of abuse, depression and victimization.","Intimate partner violence has been recognized as a serious public health issue. Exposure to violence contributes to the genesis of, and exacerbates, mental health conditions, and existing mental health problems increase vulnerability to partner violence, a loop that imprisons victims and perpetuates the abuse. A recently described phenomenon is when male violence against females occurs within intimate relationships during youth, and it is termed adolescent or teen dating violence. In this narrat","2021","06","26","World J Psychiatry","World journal of psychiatry","Abuse; COVID-19; Depression; Intimate partner violence; Personalized medicine; Women","Janiri","Delfina","Department of Neurosciences, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome 00168, Italy",NA
"1984","34168968","10.5498/wjp.v11.i6.215","Intimate partner violence: A loop of abuse, depression and victimization.","Intimate partner violence has been recognized as a serious public health issue. Exposure to violence contributes to the genesis of, and exacerbates, mental health conditions, and existing mental health problems increase vulnerability to partner violence, a loop that imprisons victims and perpetuates the abuse. A recently described phenomenon is when male violence against females occurs within intimate relationships during youth, and it is termed adolescent or teen dating violence. In this narrat","2021","06","26","World J Psychiatry","World journal of psychiatry","Abuse; COVID-19; Depression; Intimate partner violence; Personalized medicine; Women","Moccia","Lorenzo","Department of Neurosciences, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome 00168, Italy",NA
"1985","34168968","10.5498/wjp.v11.i6.215","Intimate partner violence: A loop of abuse, depression and victimization.","Intimate partner violence has been recognized as a serious public health issue. Exposure to violence contributes to the genesis of, and exacerbates, mental health conditions, and existing mental health problems increase vulnerability to partner violence, a loop that imprisons victims and perpetuates the abuse. A recently described phenomenon is when male violence against females occurs within intimate relationships during youth, and it is termed adolescent or teen dating violence. In this narrat","2021","06","26","World J Psychiatry","World journal of psychiatry","Abuse; COVID-19; Depression; Intimate partner violence; Personalized medicine; Women","Sani","Gabriele","Department of Neurosciences, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome 00168, Italy",NA
"1986","34168950","10.1016/j.pmedr.2021.101374","The consequential impact of JUUL on youth vaping and the landscape of tobacco products: The state of play in the COVID-19 era.","JUUL is a groundbreaking electronic cigarette (e-cig) and the preeminent vaping product on the market. We present an overview of the rapid and spectacular rise of JUUL and its remarkable fall within the timespan of 2015 - 2020. We highlight JUUL's entering the market in June 2015, becoming the industry leader in mid 2017, and experiencing a litany of setbacks by late 2019 through to early 2020. We address the role played by JUUL in the ongoing epidemic of youth vaping. We also feature competing ","2021","06","26","Prev Med Rep","Preventive medicine reports","ACE2, angiotensin converting enzyme 2; Adolescents; CDC, Centers for Disease Control and Prevention; COVID-19; COVID-19, coronavirus disease 2019; EVALI, e-cig, or vaping, product use-associated lung injury; Electronic cigarettes; Epidemic; FDA, Food and Drug Administration; FTC, Federal Trade Commission; ITC, International Trade Commission; JUUL; NASEM, National Academy of Sciences, Engineering and Medicine NYTS, National Youth Tobacco Survey; NRT, nicotine replacement therapy; Nicotine; PHE, Public Health England; Pandemic; Public health; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; Tobacco; Youth vaping; e-cig, electronic cigarette; nAChR, nicotinic acetylcholine receptor","Besaratinia","Ahmad","Department of Preventive Medicine, USC Keck School of Medicine, University of Southern California, M/C 9603, Los Angeles, CA 90033, USA",NA
"1987","34168950","10.1016/j.pmedr.2021.101374","The consequential impact of JUUL on youth vaping and the landscape of tobacco products: The state of play in the COVID-19 era.","JUUL is a groundbreaking electronic cigarette (e-cig) and the preeminent vaping product on the market. We present an overview of the rapid and spectacular rise of JUUL and its remarkable fall within the timespan of 2015 - 2020. We highlight JUUL's entering the market in June 2015, becoming the industry leader in mid 2017, and experiencing a litany of setbacks by late 2019 through to early 2020. We address the role played by JUUL in the ongoing epidemic of youth vaping. We also feature competing ","2021","06","26","Prev Med Rep","Preventive medicine reports","ACE2, angiotensin converting enzyme 2; Adolescents; CDC, Centers for Disease Control and Prevention; COVID-19; COVID-19, coronavirus disease 2019; EVALI, e-cig, or vaping, product use-associated lung injury; Electronic cigarettes; Epidemic; FDA, Food and Drug Administration; FTC, Federal Trade Commission; ITC, International Trade Commission; JUUL; NASEM, National Academy of Sciences, Engineering and Medicine NYTS, National Youth Tobacco Survey; NRT, nicotine replacement therapy; Nicotine; PHE, Public Health England; Pandemic; Public health; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; Tobacco; Youth vaping; e-cig, electronic cigarette; nAChR, nicotinic acetylcholine receptor","Tommasi","Stella","Department of Preventive Medicine, USC Keck School of Medicine, University of Southern California, M/C 9603, Los Angeles, CA 90033, USA",NA
"1988","34168947","10.1097/GOX.0000000000003686","The Impact of COVID-19 on the Personal Protective Equipment Practices and Preferences of Craniofacial Surgeons.","The COVID-19 pandemic has raised concern about healthcare worker exposure risk. Surgeons operating near the aerodigestive tract are at particularly high risk, given the respiratory spread of SARS-CoV-2. This study examines the practices and opinions of craniofacial surgeons as they adapt to a worldwide epidemic. An electronic survey study was conducted on practicing craniomaxillofacial surgeons regarding their preference of personal protective equipment use before, during, and after the pandemic","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Lee","James C","Department of Plastic Surgery, Southern California Permanente Medical Group, Los Angeles, Calif",NA
"1989","34168947","10.1097/GOX.0000000000003686","The Impact of COVID-19 on the Personal Protective Equipment Practices and Preferences of Craniofacial Surgeons.","The COVID-19 pandemic has raised concern about healthcare worker exposure risk. Surgeons operating near the aerodigestive tract are at particularly high risk, given the respiratory spread of SARS-CoV-2. This study examines the practices and opinions of craniofacial surgeons as they adapt to a worldwide epidemic. An electronic survey study was conducted on practicing craniomaxillofacial surgeons regarding their preference of personal protective equipment use before, during, and after the pandemic","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Ozaki","Ashley","University of Southern California, Los Angeles, Calif",NA
"1990","34168947","10.1097/GOX.0000000000003686","The Impact of COVID-19 on the Personal Protective Equipment Practices and Preferences of Craniofacial Surgeons.","The COVID-19 pandemic has raised concern about healthcare worker exposure risk. Surgeons operating near the aerodigestive tract are at particularly high risk, given the respiratory spread of SARS-CoV-2. This study examines the practices and opinions of craniofacial surgeons as they adapt to a worldwide epidemic. An electronic survey study was conducted on practicing craniomaxillofacial surgeons regarding their preference of personal protective equipment use before, during, and after the pandemic","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Ozaki","Wayne","Los Angeles David Geffen School of Medicine, University of California, Los Angeles, Calif",NA
"1991","34168946","10.1097/GOX.0000000000003658","Perceptions of Saudi Plastic Surgery Residents and Attendings of Online Education during the COVID-19 Pandemic.","The world has faced an unprecedented challenge in controlling the spread of COVID-19-a rapid reshaping of the healthcare system and education was inevitable. Consequently, residency programs adopted e-learning as a social distancing tool for the continuity of the learning process. In this study, we explore the opinions and perspectives of plastic surgery attending doctors and residents on the implications of e-learning. After obtaining ethical approval, this cross-sectional study was conducted e","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Kattan","Abdullah E","Division of Plastic Surgery, Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"1992","34168946","10.1097/GOX.0000000000003658","Perceptions of Saudi Plastic Surgery Residents and Attendings of Online Education during the COVID-19 Pandemic.","The world has faced an unprecedented challenge in controlling the spread of COVID-19-a rapid reshaping of the healthcare system and education was inevitable. Consequently, residency programs adopted e-learning as a social distancing tool for the continuity of the learning process. In this study, we explore the opinions and perspectives of plastic surgery attending doctors and residents on the implications of e-learning. After obtaining ethical approval, this cross-sectional study was conducted e","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Mortada","Hatan","Division of Plastic Surgery, Department of Surgery, King Saud University Medical City, King Saud University and Department of Plastic Surgery &amp",NA
"1993","34168946","10.1097/GOX.0000000000003658","Perceptions of Saudi Plastic Surgery Residents and Attendings of Online Education during the COVID-19 Pandemic.","The world has faced an unprecedented challenge in controlling the spread of COVID-19-a rapid reshaping of the healthcare system and education was inevitable. Consequently, residency programs adopted e-learning as a social distancing tool for the continuity of the learning process. In this study, we explore the opinions and perspectives of plastic surgery attending doctors and residents on the implications of e-learning. After obtaining ethical approval, this cross-sectional study was conducted e","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Alzaidi","Salman","Plastic and Reconstructive Surgery, King Faisal Medical Complex, Taif, Saudi Arabia",NA
"1994","34168946","10.1097/GOX.0000000000003658","Perceptions of Saudi Plastic Surgery Residents and Attendings of Online Education during the COVID-19 Pandemic.","The world has faced an unprecedented challenge in controlling the spread of COVID-19-a rapid reshaping of the healthcare system and education was inevitable. Consequently, residency programs adopted e-learning as a social distancing tool for the continuity of the learning process. In this study, we explore the opinions and perspectives of plastic surgery attending doctors and residents on the implications of e-learning. After obtaining ethical approval, this cross-sectional study was conducted e","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Gelidan","Adnan G","Division of Plastic Surgery, Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"1995","34168945","10.1097/GOX.0000000000003656","Impact of COVID-19 on Elective Cleft Surgery in Low- and Middle-income Countries.","The COVID-19 pandemic disrupted health systems worldwide, including in low- and middle-income countries (LMICs). Many countries limited the delivery of elective surgery. To date, COVID-19's impact on elective surgery in LMICs has been unquantified. We use operative data from a large international non-government cleft organization to compare case volume for 2019 and 2020 to quantify the impact of COVID-19. Smile Train supports a partner network of over 1100 partners globally to deliver treatment ","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Vander Burg","Richard","NGO Strategic Consulting, Norfolk, Va",NA
"1996","34168945","10.1097/GOX.0000000000003656","Impact of COVID-19 on Elective Cleft Surgery in Low- and Middle-income Countries.","The COVID-19 pandemic disrupted health systems worldwide, including in low- and middle-income countries (LMICs). Many countries limited the delivery of elective surgery. To date, COVID-19's impact on elective surgery in LMICs has been unquantified. We use operative data from a large international non-government cleft organization to compare case volume for 2019 and 2020 to quantify the impact of COVID-19. Smile Train supports a partner network of over 1100 partners globally to deliver treatment ","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Agrawal","Karoon","Department of Burns, Plastic &amp",NA
"1997","34168945","10.1097/GOX.0000000000003656","Impact of COVID-19 on Elective Cleft Surgery in Low- and Middle-income Countries.","The COVID-19 pandemic disrupted health systems worldwide, including in low- and middle-income countries (LMICs). Many countries limited the delivery of elective surgery. To date, COVID-19's impact on elective surgery in LMICs has been unquantified. We use operative data from a large international non-government cleft organization to compare case volume for 2019 and 2020 to quantify the impact of COVID-19. Smile Train supports a partner network of over 1100 partners globally to deliver treatment ","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Desai","Priya","Research and Innovation, Smile Train, New York, N",NA
"1998","34168945","10.1097/GOX.0000000000003656","Impact of COVID-19 on Elective Cleft Surgery in Low- and Middle-income Countries.","The COVID-19 pandemic disrupted health systems worldwide, including in low- and middle-income countries (LMICs). Many countries limited the delivery of elective surgery. To date, COVID-19's impact on elective surgery in LMICs has been unquantified. We use operative data from a large international non-government cleft organization to compare case volume for 2019 and 2020 to quantify the impact of COVID-19. Smile Train supports a partner network of over 1100 partners globally to deliver treatment ","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Desalu","Ibironke","Department of Burns, Plastic &amp",NA
"1999","34168945","10.1097/GOX.0000000000003656","Impact of COVID-19 on Elective Cleft Surgery in Low- and Middle-income Countries.","The COVID-19 pandemic disrupted health systems worldwide, including in low- and middle-income countries (LMICs). Many countries limited the delivery of elective surgery. To date, COVID-19's impact on elective surgery in LMICs has been unquantified. We use operative data from a large international non-government cleft organization to compare case volume for 2019 and 2020 to quantify the impact of COVID-19. Smile Train supports a partner network of over 1100 partners globally to deliver treatment ","2021","06","26","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Donkor","Peter","NGO Strategic Consulting, Norfolk, Va",NA
"2000","34168915","10.1063/5.0046574","Nano-layered surface plasmon resonance-based highly sensitive biosensor for virus detection: A theoretical approach to detect SARS-CoV-2.","The outbreak of the coronavirus disease (COVID-19) pandemic has become a worldwide health catastrophe instigated by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Countries are battling to slow the spread of this virus by testing and treating patients, along with other measures such as prohibiting large gatherings, maintaining social distance, and frequent, thorough hand washing, as no vaccines or medicines are available that could effectively treat infected people for different t","2021","06","26","AIP Adv","AIP advances",NA,"Moznuzzaman","Md","Department of Electrical and Electronic Engineering, Jashore University of Science and Technology, Jashore 7408, Bangladesh",NA
"2001","34168915","10.1063/5.0046574","Nano-layered surface plasmon resonance-based highly sensitive biosensor for virus detection: A theoretical approach to detect SARS-CoV-2.","The outbreak of the coronavirus disease (COVID-19) pandemic has become a worldwide health catastrophe instigated by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Countries are battling to slow the spread of this virus by testing and treating patients, along with other measures such as prohibiting large gatherings, maintaining social distance, and frequent, thorough hand washing, as no vaccines or medicines are available that could effectively treat infected people for different t","2021","06","26","AIP Adv","AIP advances",NA,"Khan","Imran","Department of Electrical and Electronic Engineering, Jashore University of Science and Technology, Jashore 7408, Bangladesh",NA
"2002","34168915","10.1063/5.0046574","Nano-layered surface plasmon resonance-based highly sensitive biosensor for virus detection: A theoretical approach to detect SARS-CoV-2.","The outbreak of the coronavirus disease (COVID-19) pandemic has become a worldwide health catastrophe instigated by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Countries are battling to slow the spread of this virus by testing and treating patients, along with other measures such as prohibiting large gatherings, maintaining social distance, and frequent, thorough hand washing, as no vaccines or medicines are available that could effectively treat infected people for different t","2021","06","26","AIP Adv","AIP advances",NA,"Islam","Md Rafiqul","Department of Electrical and Electronic Engineering, Khulna University of Engineering and Technology, Khulna 9203, Bangladesh",NA
"2003","34168899","10.3389/phrs.2021.1604046","Communication With Older Adults in Times of a Pandemic: Practical Suggestions for the Health Care Professionals.","In order to limit the spread of the coronavirus, several protective measures have been put in place in the community, in private and public residences and in health care centers. Some measures have a negative impact on communication. They include physical distancing, the use of face masks and shields as well as the increased use of telephone and videoconferencing for distance communication. The effects of COVID-19 are particularly harsh on older adults. Consequently, older adults, especially tho","2021","06","26","Public Health Rev","Public health reviews","COVID-19; communication; face mask; health care; hearing loss","Pinsonnault-Skvarenina","Alexis","School of Speech-Language Pathology and Audiology, Faculty of Medicine, University of Montreal, Montreal, QC, Canada",NA
"2004","34168899","10.3389/phrs.2021.1604046","Communication With Older Adults in Times of a Pandemic: Practical Suggestions for the Health Care Professionals.","In order to limit the spread of the coronavirus, several protective measures have been put in place in the community, in private and public residences and in health care centers. Some measures have a negative impact on communication. They include physical distancing, the use of face masks and shields as well as the increased use of telephone and videoconferencing for distance communication. The effects of COVID-19 are particularly harsh on older adults. Consequently, older adults, especially tho","2021","06","26","Public Health Rev","Public health reviews","COVID-19; communication; face mask; health care; hearing loss","de Lacerda","Adriana Bender Moreira","School of Speech-Language Pathology and Audiology, Faculty of Medicine, University of Montreal, Montreal, QC, Canada",NA
"2005","34168899","10.3389/phrs.2021.1604046","Communication With Older Adults in Times of a Pandemic: Practical Suggestions for the Health Care Professionals.","In order to limit the spread of the coronavirus, several protective measures have been put in place in the community, in private and public residences and in health care centers. Some measures have a negative impact on communication. They include physical distancing, the use of face masks and shields as well as the increased use of telephone and videoconferencing for distance communication. The effects of COVID-19 are particularly harsh on older adults. Consequently, older adults, especially tho","2021","06","26","Public Health Rev","Public health reviews","COVID-19; communication; face mask; health care; hearing loss","Hotton","Mathieu","School of Rehabilitation, Faculty of Medecine, Université Laval, Québec, QC, Canada",NA
"2006","34168899","10.3389/phrs.2021.1604046","Communication With Older Adults in Times of a Pandemic: Practical Suggestions for the Health Care Professionals.","In order to limit the spread of the coronavirus, several protective measures have been put in place in the community, in private and public residences and in health care centers. Some measures have a negative impact on communication. They include physical distancing, the use of face masks and shields as well as the increased use of telephone and videoconferencing for distance communication. The effects of COVID-19 are particularly harsh on older adults. Consequently, older adults, especially tho","2021","06","26","Public Health Rev","Public health reviews","COVID-19; communication; face mask; health care; hearing loss","Gagné","Jean-Pierre","School of Speech-Language Pathology and Audiology, Faculty of Medicine, University of Montreal, Montreal, QC, Canada",NA
"2007","34168898","10.3389/phrs.2021.1603989","Rebuilding Trust on Routine Immunization in Era of COVID-19 Fear-Role that Civil Society Organizations can Play Hands-in-Hand with Immunization Program.",NA,"2021","06","26","Public Health Rev","Public health reviews","COVID-19; CSOs; demand; improving coverage; routine immunization","Muhammad","Ameer","VITAL Pakistan Trust, Karachi, Pakistan",NA
"2008","34168898","10.3389/phrs.2021.1603989","Rebuilding Trust on Routine Immunization in Era of COVID-19 Fear-Role that Civil Society Organizations can Play Hands-in-Hand with Immunization Program.",NA,"2021","06","26","Public Health Rev","Public health reviews","COVID-19; CSOs; demand; improving coverage; routine immunization","Ahmad","Daniyaal","Medical College, Aga Khan University, Karachi, Pakistan",NA
"2009","34168898","10.3389/phrs.2021.1603989","Rebuilding Trust on Routine Immunization in Era of COVID-19 Fear-Role that Civil Society Organizations can Play Hands-in-Hand with Immunization Program.",NA,"2021","06","26","Public Health Rev","Public health reviews","COVID-19; CSOs; demand; improving coverage; routine immunization","Tariq","Eleze","Medical College, Aga Khan University, Karachi, Pakistan",NA
"2010","34168898","10.3389/phrs.2021.1603989","Rebuilding Trust on Routine Immunization in Era of COVID-19 Fear-Role that Civil Society Organizations can Play Hands-in-Hand with Immunization Program.",NA,"2021","06","26","Public Health Rev","Public health reviews","COVID-19; CSOs; demand; improving coverage; routine immunization","Shafiq","Yasir","VITAL Pakistan Trust, Karachi, Pakistan",NA
"2011","34168892","10.1098/rsos.210467","Reply to comment on Peto <i>et al</i>. (2020): Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic.",NA,"2021","06","26","R Soc Open Sci","Royal Society open science",NA,"Peto","Julian","London School of Hygiene and Tropical Medicine, London, UK",NA
"2012","34168885","10.1098/rsos.201546","Comment: weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic.",NA,"2021","06","26","R Soc Open Sci","Royal Society open science",NA,"Plank","M J","School of Mathematics and Statistics, University of Canterbury, Christchurch, New Zealand",NA
"2013","34168885","10.1098/rsos.201546","Comment: weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic.",NA,"2021","06","26","R Soc Open Sci","Royal Society open science",NA,"James","A","School of Mathematics and Statistics, University of Canterbury, Christchurch, New Zealand",NA
"2014","34168885","10.1098/rsos.201546","Comment: weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic.",NA,"2021","06","26","R Soc Open Sci","Royal Society open science",NA,"Steyn","N","Te Punaha Matatini, Centre of Research Excellence in Complex Systems, New Zealand",NA
"2015","34168876","10.1016/j.amsu.2021.102493","Expectations on online orthopedic course using constructivism theory: A cross-sectional study among medical students.","Medical education in this era has been disturbed by coronavirus disease. Our faculty has quickly adapted the curricula to online formats. The online format seems to be more advantageous in terms of content material and virtual activities, but the results of these adjustments will require subsequent evaluation. The aim of this study was to evaluate medical student expectations of online orthopedics learning that was created based on social constructivism theory. A cross-sectional survey was carri","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Constructivist; Medical student; Online learning; Orthopedic","Suwannaphisit","Sitthiphong","Department of Orthopedics, Faculty of Medicine, Prince of Songkla University, 15 Karnjanavanich Road, Hat Yai, Songkhla, 90110, Thailand",NA
"2016","34168876","10.1016/j.amsu.2021.102493","Expectations on online orthopedic course using constructivism theory: A cross-sectional study among medical students.","Medical education in this era has been disturbed by coronavirus disease. Our faculty has quickly adapted the curricula to online formats. The online format seems to be more advantageous in terms of content material and virtual activities, but the results of these adjustments will require subsequent evaluation. The aim of this study was to evaluate medical student expectations of online orthopedics learning that was created based on social constructivism theory. A cross-sectional survey was carri","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Constructivist; Medical student; Online learning; Orthopedic","Anusitviwat","Chirathit","Department of Orthopedics, Faculty of Medicine, Prince of Songkla University, 15 Karnjanavanich Road, Hat Yai, Songkhla, 90110, Thailand",NA
"2017","34168876","10.1016/j.amsu.2021.102493","Expectations on online orthopedic course using constructivism theory: A cross-sectional study among medical students.","Medical education in this era has been disturbed by coronavirus disease. Our faculty has quickly adapted the curricula to online formats. The online format seems to be more advantageous in terms of content material and virtual activities, but the results of these adjustments will require subsequent evaluation. The aim of this study was to evaluate medical student expectations of online orthopedics learning that was created based on social constructivism theory. A cross-sectional survey was carri","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Constructivist; Medical student; Online learning; Orthopedic","Hongnaparak","Theerawit","Department of Orthopedics, Faculty of Medicine, Prince of Songkla University, 15 Karnjanavanich Road, Hat Yai, Songkhla, 90110, Thailand",NA
"2018","34168876","10.1016/j.amsu.2021.102493","Expectations on online orthopedic course using constructivism theory: A cross-sectional study among medical students.","Medical education in this era has been disturbed by coronavirus disease. Our faculty has quickly adapted the curricula to online formats. The online format seems to be more advantageous in terms of content material and virtual activities, but the results of these adjustments will require subsequent evaluation. The aim of this study was to evaluate medical student expectations of online orthopedics learning that was created based on social constructivism theory. A cross-sectional survey was carri","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Constructivist; Medical student; Online learning; Orthopedic","Bvonpanttarananon","Jongdee","Department of Orthopedics, Faculty of Medicine, Prince of Songkla University, 15 Karnjanavanich Road, Hat Yai, Songkhla, 90110, Thailand",NA
"2019","34168869","10.1016/j.amsu.2021.102466","Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.","There are serious concerns regarding the effectiveness of medical education in its current format during serious crises like the COVID-19 pandemic. To explore academic, financial, psychological, &amp; hygienic impact on medical students. A cross-sectional, questionnaire-based study of students at different medical schools in Jordan. It included both basic and clinical years. There were 415 responses. Females constituted 51.8%. Around 50% of the participants were from the 6th year (n = 194, 46.7%","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19; Health; Jordan; Medical students; Pandemic","Al-Husban","Naser","Obstetrics and Gynecology Department, School of Medicine, The University of Jordan, Amman, Jordan",NA
"2020","34168869","10.1016/j.amsu.2021.102466","Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.","There are serious concerns regarding the effectiveness of medical education in its current format during serious crises like the COVID-19 pandemic. To explore academic, financial, psychological, &amp; hygienic impact on medical students. A cross-sectional, questionnaire-based study of students at different medical schools in Jordan. It included both basic and clinical years. There were 415 responses. Females constituted 51.8%. Around 50% of the participants were from the 6th year (n = 194, 46.7%","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19; Health; Jordan; Medical students; Pandemic","Alkhayat","Aysha","School of Medicine, The University of Jordan, Amman, Jordan",NA
"2021","34168869","10.1016/j.amsu.2021.102466","Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.","There are serious concerns regarding the effectiveness of medical education in its current format during serious crises like the COVID-19 pandemic. To explore academic, financial, psychological, &amp; hygienic impact on medical students. A cross-sectional, questionnaire-based study of students at different medical schools in Jordan. It included both basic and clinical years. There were 415 responses. Females constituted 51.8%. Around 50% of the participants were from the 6th year (n = 194, 46.7%","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19; Health; Jordan; Medical students; Pandemic","Aljweesri","Mariam","School of Medicine, The University of Jordan, Amman, Jordan",NA
"2022","34168869","10.1016/j.amsu.2021.102466","Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.","There are serious concerns regarding the effectiveness of medical education in its current format during serious crises like the COVID-19 pandemic. To explore academic, financial, psychological, &amp; hygienic impact on medical students. A cross-sectional, questionnaire-based study of students at different medical schools in Jordan. It included both basic and clinical years. There were 415 responses. Females constituted 51.8%. Around 50% of the participants were from the 6th year (n = 194, 46.7%","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19; Health; Jordan; Medical students; Pandemic","Alharbi","Reem","School of Medicine, The University of Jordan, Amman, Jordan",NA
"2023","34168869","10.1016/j.amsu.2021.102466","Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.","There are serious concerns regarding the effectiveness of medical education in its current format during serious crises like the COVID-19 pandemic. To explore academic, financial, psychological, &amp; hygienic impact on medical students. A cross-sectional, questionnaire-based study of students at different medical schools in Jordan. It included both basic and clinical years. There were 415 responses. Females constituted 51.8%. Around 50% of the participants were from the 6th year (n = 194, 46.7%","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19; Health; Jordan; Medical students; Pandemic","Aljazzaf","Zahraa","School of Medicine, The University of Jordan, Amman, Jordan",NA
"2024","34168869","10.1016/j.amsu.2021.102466","Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.","There are serious concerns regarding the effectiveness of medical education in its current format during serious crises like the COVID-19 pandemic. To explore academic, financial, psychological, &amp; hygienic impact on medical students. A cross-sectional, questionnaire-based study of students at different medical schools in Jordan. It included both basic and clinical years. There were 415 responses. Females constituted 51.8%. Around 50% of the participants were from the 6th year (n = 194, 46.7%","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19; Health; Jordan; Medical students; Pandemic","Al-Husban","Nehad","Ministry of Justice, Amman, Jordan and external council member, School of Law, Al-Balqa' Applied University, Al-Salt, Jordan",NA
"2025","34168869","10.1016/j.amsu.2021.102466","Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.","There are serious concerns regarding the effectiveness of medical education in its current format during serious crises like the COVID-19 pandemic. To explore academic, financial, psychological, &amp; hygienic impact on medical students. A cross-sectional, questionnaire-based study of students at different medical schools in Jordan. It included both basic and clinical years. There were 415 responses. Females constituted 51.8%. Around 50% of the participants were from the 6th year (n = 194, 46.7%","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19; Health; Jordan; Medical students; Pandemic","Elmuhtaseb","Mohammed S","School of Medicine, The University of Jordan, Amman, Jordan",NA
"2026","34168869","10.1016/j.amsu.2021.102466","Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.","There are serious concerns regarding the effectiveness of medical education in its current format during serious crises like the COVID-19 pandemic. To explore academic, financial, psychological, &amp; hygienic impact on medical students. A cross-sectional, questionnaire-based study of students at different medical schools in Jordan. It included both basic and clinical years. There were 415 responses. Females constituted 51.8%. Around 50% of the participants were from the 6th year (n = 194, 46.7%","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19; Health; Jordan; Medical students; Pandemic","Al Oweidat","Khaled","School of Medicine, The University of Jordan, Amman, Jordan",NA
"2027","34168869","10.1016/j.amsu.2021.102466","Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.","There are serious concerns regarding the effectiveness of medical education in its current format during serious crises like the COVID-19 pandemic. To explore academic, financial, psychological, &amp; hygienic impact on medical students. A cross-sectional, questionnaire-based study of students at different medical schools in Jordan. It included both basic and clinical years. There were 415 responses. Females constituted 51.8%. Around 50% of the participants were from the 6th year (n = 194, 46.7%","2021","06","26","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19; Health; Jordan; Medical students; Pandemic","Obeidat","Nail","School of Medicine, Jordan University of Science and Technology, Irbid, Jordan",NA
"2028","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Jaffrelot Inizan","Théo","Sorbonne Université, LCT, UMR 7616 CNRS Paris France louis.lagardere@sorbonne-universite.fr pierre.monmarche@sorbonne-universite.fr jean-philip.piquemal@sorbonne-universite",NA
"2029","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Célerse","Frédéric","Sorbonne Université, LCT, UMR 7616 CNRS Paris France louis.lagardere@sorbonne-universite.fr pierre.monmarche@sorbonne-universite.fr jean-philip.piquemal@sorbonne-universite",NA
"2030","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Adjoua","Olivier","Sorbonne Université, LCT, UMR 7616 CNRS Paris France louis.lagardere@sorbonne-universite.fr pierre.monmarche@sorbonne-universite.fr jean-philip.piquemal@sorbonne-universite",NA
"2031","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"El Ahdab","Dina","Sorbonne Université, LCT, UMR 7616 CNRS Paris France louis.lagardere@sorbonne-universite.fr pierre.monmarche@sorbonne-universite.fr jean-philip.piquemal@sorbonne-universite",NA
"2032","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Jolly","Luc-Henri","Sorbonne Université, IP2CT, FR 2622 CNRS Paris France",NA
"2033","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Liu","Chengwen","University of Texas at Austin, Department of Biomedical Engineering Texas USA",NA
"2034","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Ren","Pengyu","University of Texas at Austin, Department of Biomedical Engineering Texas USA",NA
"2035","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Montes","Matthieu","Laboratoire GBCM, EA 7528, CNAM, Hésam Université Paris France",NA
"2036","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Lagarde","Nathalie","Laboratoire GBCM, EA 7528, CNAM, Hésam Université Paris France",NA
"2037","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Lagardère","Louis","Sorbonne Université, LCT, UMR 7616 CNRS Paris France louis.lagardere@sorbonne-universite.fr pierre.monmarche@sorbonne-universite.fr jean-philip.piquemal@sorbonne-universite",NA
"2038","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Monmarché","Pierre","Sorbonne Université, LCT, UMR 7616 CNRS Paris France louis.lagardere@sorbonne-universite.fr pierre.monmarche@sorbonne-universite.fr jean-philip.piquemal@sorbonne-universite",NA
"2039","34168762","10.1039/d1sc00145k","High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.","We provide an unsupervised adaptive sampling strategy capable of producing µs-timescale molecular dynamics (MD) simulations of large biosystems using many-body polarizable force fields (PFFs). The global exploration problem is decomposed into a set of separate MD trajectories that can be restarted within a selective process to achieve sufficient phase-space sampling. Accurate statistical properties can be obtained through reweighting. Within this highly parallel setup, the Tinker-HP package can ","2021","06","26","Chem Sci","Chemical science",NA,"Piquemal","Jean-Philip","Sorbonne Université, LCT, UMR 7616 CNRS Paris France louis.lagardere@sorbonne-universite.fr pierre.monmarche@sorbonne-universite.fr jean-philip.piquemal@sorbonne-universite",NA
"2040","34168732","10.4239/wjd.v12.i6.839","New perspectives on angiotensin-converting enzyme 2 and its related diseases.","Since the worldwide outbreak of coronavirus disease 2019, angiotensin-converting enzyme 2 (ACE2) has received widespread attention as the cell receptor of the severe acute respiratory syndrome coronavirus 2 virus. At the same time, as a key enzyme in the renin-angiotensin-system, ACE2 is considered to be an endogenous negative regulator of vasoconstriction, proliferation, fibrosis, and proinflammation caused by the ACE-angiotensin II-angiotensin type 1 receptor axis. ACE2 is now implicated as be","2021","06","26","World J Diabetes","World journal of diabetes","Angiotensin-converting enzyme 2; COVID-19; Diabetes and cardiovascular disease; Renal and lung disease; Renin-angiotensin-system inhibitors; Salt","Liu","Li-Ping","Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, Changsha 410013, Hunan Province, China",NA
"2041","34168732","10.4239/wjd.v12.i6.839","New perspectives on angiotensin-converting enzyme 2 and its related diseases.","Since the worldwide outbreak of coronavirus disease 2019, angiotensin-converting enzyme 2 (ACE2) has received widespread attention as the cell receptor of the severe acute respiratory syndrome coronavirus 2 virus. At the same time, as a key enzyme in the renin-angiotensin-system, ACE2 is considered to be an endogenous negative regulator of vasoconstriction, proliferation, fibrosis, and proinflammation caused by the ACE-angiotensin II-angiotensin type 1 receptor axis. ACE2 is now implicated as be","2021","06","26","World J Diabetes","World journal of diabetes","Angiotensin-converting enzyme 2; COVID-19; Diabetes and cardiovascular disease; Renal and lung disease; Renin-angiotensin-system inhibitors; Salt","Zhang","Xiao-Li","TheFifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, Heidelberg 68135, Baden-Württemberg, Germany",NA
"2042","34168732","10.4239/wjd.v12.i6.839","New perspectives on angiotensin-converting enzyme 2 and its related diseases.","Since the worldwide outbreak of coronavirus disease 2019, angiotensin-converting enzyme 2 (ACE2) has received widespread attention as the cell receptor of the severe acute respiratory syndrome coronavirus 2 virus. At the same time, as a key enzyme in the renin-angiotensin-system, ACE2 is considered to be an endogenous negative regulator of vasoconstriction, proliferation, fibrosis, and proinflammation caused by the ACE-angiotensin II-angiotensin type 1 receptor axis. ACE2 is now implicated as be","2021","06","26","World J Diabetes","World journal of diabetes","Angiotensin-converting enzyme 2; COVID-19; Diabetes and cardiovascular disease; Renal and lung disease; Renin-angiotensin-system inhibitors; Salt","Li","Jian","Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, Changsha 410013, Hunan Province, China. lijianyxy@hunnu.edu","lijianyxy@hunnu.edu.cn"
"2043","34168727","10.4239/wjd.v12.i6.780","Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare.","The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and smart phone apps providing necessary essentials for te","2021","06","26","World J Diabetes","World journal of diabetes","COVID-19; Diabetes management; Diabetes type 1; Telemedicine","Bilic Curcic","Ines","Department of Endocrinology, University Hospital Osijek, Osijek 31000, Croatia",NA
"2044","34168727","10.4239/wjd.v12.i6.780","Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare.","The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and smart phone apps providing necessary essentials for te","2021","06","26","World J Diabetes","World journal of diabetes","COVID-19; Diabetes management; Diabetes type 1; Telemedicine","Cigrovski Berkovic","Maja","Department of Endocrinology, Diabetes, Metabolism and Clinical Pharmacology, University Hospital Dubrava, Zagreb 10000, Croatia",NA
"2045","34168727","10.4239/wjd.v12.i6.780","Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare.","The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and smart phone apps providing necessary essentials for te","2021","06","26","World J Diabetes","World journal of diabetes","COVID-19; Diabetes management; Diabetes type 1; Telemedicine","Kizivat","Tomislav","Clinical Institute of Nuclear Medicine and Radiation Protection, University Hospital Osijek, Osijek 31000, Croatia",NA
"2046","34168727","10.4239/wjd.v12.i6.780","Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare.","The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and smart phone apps providing necessary essentials for te","2021","06","26","World J Diabetes","World journal of diabetes","COVID-19; Diabetes management; Diabetes type 1; Telemedicine","Canecki Varzic","Silvija","Department of Endocrinology, University Hospital Osijek, Osijek 31000, Croatia",NA
"2047","34168727","10.4239/wjd.v12.i6.780","Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare.","The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and smart phone apps providing necessary essentials for te","2021","06","26","World J Diabetes","World journal of diabetes","COVID-19; Diabetes management; Diabetes type 1; Telemedicine","Smolic","Robert","Department of Pathophysiology, Faculty of Medicine Osijek, Osijek 31000, Croatia",NA
"2048","34168727","10.4239/wjd.v12.i6.780","Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare.","The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and smart phone apps providing necessary essentials for te","2021","06","26","World J Diabetes","World journal of diabetes","COVID-19; Diabetes management; Diabetes type 1; Telemedicine","Smolic","Martina","Department of Pharmacology, Faculty of Medicine Osijek, Osijek 31000, Croatia",NA
"2049","34168726","10.4239/wjd.v12.i6.767","Diabetes and inflammatory diseases: An overview from the perspective of Ca<sup>2+</sup>/3'-5'-cyclic adenosine monophosphate signaling.","A large amount of evidence has supported a clinical link between diabetes and inflammatory diseases, e.g., cancer, dementia, and hypertension. In addition, it is also suggested that dysregulations related to Ca<sup>2+</sup> signaling could link these diseases, in addition to 3'-5'-cyclic adenosine monophosphate (cAMP) signaling pathways. Thus, revealing this interplay between diabetes and inflammatory diseases may provide novel insights into the pathogenesis of these diseases. Publication","2021","06","26","World J Diabetes","World journal of diabetes","COVID-19; Ca2+ channel blockers; Ca2+/3'-5'-cyclic adenosine monophosphate signaling; Cancer; Dementia; Diabetes; Hypertension; Neurodegeneration; Pharmacotherapy","Bergantin","Leandro Bueno","Department ofPharmacology, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil. leanbio39@yahoo.com","leanbio39@yahoo.com.br"
"2050","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Rodeles","Luz María","Universidad Nacional del Litoral Santa Fe Argentina Universidad Nacional del Litoral, Santa Fe, Argentina",NA
"2051","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Peverengo","Luz María","Universidad Nacional del Litoral Santa Fe Argentina Universidad Nacional del Litoral, Santa Fe, Argentina",NA
"2052","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Benítez","Romina","Centro de Especialidades Médicas Santa Fe Argentina Centro de Especialidades Médicas, Santa Fe, Argentina",NA
"2053","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Benzaquen","Nadia","Sanatorio Diagnóstico Santa Fe Argentina Sanatorio Diagnóstico, Santa Fe, Argentina",NA
"2054","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Serravalle","Priscila","Centro de Especialidades Médicas Santa Fe Argentina Centro de Especialidades Médicas, Santa Fe, Argentina",NA
"2055","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Long","Ana Karina","Centro de Especialidades Médicas Santa Fe Argentina Centro de Especialidades Médicas, Santa Fe, Argentina",NA
"2056","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Ferreira","Virginia","Centro de Especialidades Médicas Santa Fe Argentina Centro de Especialidades Médicas, Santa Fe, Argentina",NA
"2057","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Benitez","Agostina Daiana","Centro de Especialidades Médicas Santa Fe Argentina Centro de Especialidades Médicas, Santa Fe, Argentina",NA
"2058","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Zunino","Luisina","Centro de Especialidades Médicas Santa Fe Argentina Centro de Especialidades Médicas, Santa Fe, Argentina",NA
"2059","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Lizarraga","Camila","Centro de Especialidades Médicas Santa Fe Argentina Centro de Especialidades Médicas, Santa Fe, Argentina",NA
"2060","34168682","10.26633/RPSP.2021.66","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of ","2021","06","26","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health","Argentina; SARS-CoV-2; Seroprevalence; anosmia; asymptomatic diseases; epidemiology","Vicco","Miguel Hernán","Universidad Nacional del Litoral Santa Fe Argentina Universidad Nacional del Litoral, Santa Fe, Argentina",NA
"2061","34168649","10.3389/fimmu.2021.677027","The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development.","Epstein-Barr virus (EBV) is a human herpesvirus that is common among the global population, causing an enormous disease burden. EBV can directly cause infectious mononucleosis and is also associated with various malignancies and autoimmune diseases. In order to prevent primary infection and subsequent chronic disease, efforts have been made to develop a prophylactic vaccine against EBV in recent years, but there is still no vaccine in clinical use. The outbreak of the COVID-19 pandemic and the g","2021","07","05","Front Immunol","Frontiers in immunology","EpsteinBarr virus; adjuvant; animal model; vaccine; virus immunology; Animals; COVID-19; COVID-19 Vaccines; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Pre-Exposure Prophylaxis; SARS-CoV-2; Viral Vaccines","Sun","Cong","State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China",NA
"2062","34168649","10.3389/fimmu.2021.677027","The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development.","Epstein-Barr virus (EBV) is a human herpesvirus that is common among the global population, causing an enormous disease burden. EBV can directly cause infectious mononucleosis and is also associated with various malignancies and autoimmune diseases. In order to prevent primary infection and subsequent chronic disease, efforts have been made to develop a prophylactic vaccine against EBV in recent years, but there is still no vaccine in clinical use. The outbreak of the COVID-19 pandemic and the g","2021","07","05","Front Immunol","Frontiers in immunology","EpsteinBarr virus; adjuvant; animal model; vaccine; virus immunology; Animals; COVID-19; COVID-19 Vaccines; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Pre-Exposure Prophylaxis; SARS-CoV-2; Viral Vaccines","Chen","Xin-Chun","State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China",NA
"2063","34168649","10.3389/fimmu.2021.677027","The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development.","Epstein-Barr virus (EBV) is a human herpesvirus that is common among the global population, causing an enormous disease burden. EBV can directly cause infectious mononucleosis and is also associated with various malignancies and autoimmune diseases. In order to prevent primary infection and subsequent chronic disease, efforts have been made to develop a prophylactic vaccine against EBV in recent years, but there is still no vaccine in clinical use. The outbreak of the COVID-19 pandemic and the g","2021","07","05","Front Immunol","Frontiers in immunology","EpsteinBarr virus; adjuvant; animal model; vaccine; virus immunology; Animals; COVID-19; COVID-19 Vaccines; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Pre-Exposure Prophylaxis; SARS-CoV-2; Viral Vaccines","Kang","Yin-Feng","State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China",NA
"2064","34168649","10.3389/fimmu.2021.677027","The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development.","Epstein-Barr virus (EBV) is a human herpesvirus that is common among the global population, causing an enormous disease burden. EBV can directly cause infectious mononucleosis and is also associated with various malignancies and autoimmune diseases. In order to prevent primary infection and subsequent chronic disease, efforts have been made to develop a prophylactic vaccine against EBV in recent years, but there is still no vaccine in clinical use. The outbreak of the COVID-19 pandemic and the g","2021","07","05","Front Immunol","Frontiers in immunology","EpsteinBarr virus; adjuvant; animal model; vaccine; virus immunology; Animals; COVID-19; COVID-19 Vaccines; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Pre-Exposure Prophylaxis; SARS-CoV-2; Viral Vaccines","Zeng","Mu-Sheng","State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China",NA
"2065","34168602","10.3389/fpsyg.2021.691498","Dual Stressors and Female Pre-school Teachers' Job Satisfaction During the COVID-19: The Mediation of Work-Family Conflict.","Online education has become a vital weapon to fight against the COVID-19 epidemic in the world. In the home-based online education environment, female pre-school teachers are expected to balance the dual roles of teacher and mother at the same time, which may trigger the work-family conflict. Although previous studies analyzed individual stressors, work-family conflict and its outcomes, there is little research on pre-school teachers' work and parenting experience during major public health emer","2021","06","26","Front Psychol","Frontiers in psychology","job satisfaction; parenting stress; the COVID-19 epidemic; work overload; work-family conflict","Hong","Xiumin","Faculty of Education, Institute of Early Childhood Education, Beijing Normal University, Beijing, China",NA
"2066","34168602","10.3389/fpsyg.2021.691498","Dual Stressors and Female Pre-school Teachers' Job Satisfaction During the COVID-19: The Mediation of Work-Family Conflict.","Online education has become a vital weapon to fight against the COVID-19 epidemic in the world. In the home-based online education environment, female pre-school teachers are expected to balance the dual roles of teacher and mother at the same time, which may trigger the work-family conflict. Although previous studies analyzed individual stressors, work-family conflict and its outcomes, there is little research on pre-school teachers' work and parenting experience during major public health emer","2021","06","26","Front Psychol","Frontiers in psychology","job satisfaction; parenting stress; the COVID-19 epidemic; work overload; work-family conflict","Liu","Qianqian","Faculty of Education, Institute of Early Childhood Education, Beijing Normal University, Beijing, China",NA
"2067","34168602","10.3389/fpsyg.2021.691498","Dual Stressors and Female Pre-school Teachers' Job Satisfaction During the COVID-19: The Mediation of Work-Family Conflict.","Online education has become a vital weapon to fight against the COVID-19 epidemic in the world. In the home-based online education environment, female pre-school teachers are expected to balance the dual roles of teacher and mother at the same time, which may trigger the work-family conflict. Although previous studies analyzed individual stressors, work-family conflict and its outcomes, there is little research on pre-school teachers' work and parenting experience during major public health emer","2021","06","26","Front Psychol","Frontiers in psychology","job satisfaction; parenting stress; the COVID-19 epidemic; work overload; work-family conflict","Zhang","Mingzhu","Faculty of Education, Institute of Early Childhood Education, Beijing Normal University, Beijing, China",NA
"2068","34168595","10.3389/fpsyg.2021.666891","COVID-19 Lockdown: Key Factors in Citizens' Stress.","Background: Confinement due to COVID-19 can have a short- and long-term impact on mental health (increased levels of stress and anxiety and emotional upheaval) and on people's quality of life. Knowing what factors are behind the stress can benefit the development of strategies and resources for future situations of a similar nature. The purpose of this study is to examine the incidence of a series of sociodemographic factors, confinement conditions, and work situation on the stress report","2021","06","26","Front Psychol","Frontiers in psychology","COVID-19; context effects; health and well-being; stress; survey research","Rodríguez","Susana","Departamento de Psicología, Grupo de Investigación en Psicología Educativa (GIPED), University of A Coruña, A Coruña, Spain",NA
"2069","34168595","10.3389/fpsyg.2021.666891","COVID-19 Lockdown: Key Factors in Citizens' Stress.","Background: Confinement due to COVID-19 can have a short- and long-term impact on mental health (increased levels of stress and anxiety and emotional upheaval) and on people's quality of life. Knowing what factors are behind the stress can benefit the development of strategies and resources for future situations of a similar nature. The purpose of this study is to examine the incidence of a series of sociodemographic factors, confinement conditions, and work situation on the stress report","2021","06","26","Front Psychol","Frontiers in psychology","COVID-19; context effects; health and well-being; stress; survey research","Valle","Antonio","Departamento de Psicología, Grupo de Investigación en Psicología Educativa (GIPED), University of A Coruña, A Coruña, Spain",NA
"2070","34168595","10.3389/fpsyg.2021.666891","COVID-19 Lockdown: Key Factors in Citizens' Stress.","Background: Confinement due to COVID-19 can have a short- and long-term impact on mental health (increased levels of stress and anxiety and emotional upheaval) and on people's quality of life. Knowing what factors are behind the stress can benefit the development of strategies and resources for future situations of a similar nature. The purpose of this study is to examine the incidence of a series of sociodemographic factors, confinement conditions, and work situation on the stress report","2021","06","26","Front Psychol","Frontiers in psychology","COVID-19; context effects; health and well-being; stress; survey research","Piñeiro","Isabel","Departamento de Psicología, Grupo de Investigación en Psicología Educativa (GIPED), University of A Coruña, A Coruña, Spain",NA
"2071","34168595","10.3389/fpsyg.2021.666891","COVID-19 Lockdown: Key Factors in Citizens' Stress.","Background: Confinement due to COVID-19 can have a short- and long-term impact on mental health (increased levels of stress and anxiety and emotional upheaval) and on people's quality of life. Knowing what factors are behind the stress can benefit the development of strategies and resources for future situations of a similar nature. The purpose of this study is to examine the incidence of a series of sociodemographic factors, confinement conditions, and work situation on the stress report","2021","06","26","Front Psychol","Frontiers in psychology","COVID-19; context effects; health and well-being; stress; survey research","González-Suárez","Rocío","Departamento de Psicología, Grupo de Investigación en Psicología Educativa (GIPED), University of A Coruña, A Coruña, Spain",NA
"2072","34168595","10.3389/fpsyg.2021.666891","COVID-19 Lockdown: Key Factors in Citizens' Stress.","Background: Confinement due to COVID-19 can have a short- and long-term impact on mental health (increased levels of stress and anxiety and emotional upheaval) and on people's quality of life. Knowing what factors are behind the stress can benefit the development of strategies and resources for future situations of a similar nature. The purpose of this study is to examine the incidence of a series of sociodemographic factors, confinement conditions, and work situation on the stress report","2021","06","26","Front Psychol","Frontiers in psychology","COVID-19; context effects; health and well-being; stress; survey research","Díaz","Fátima M","Departamento de Psicología, Grupo de Investigación en Psicología Educativa (GIPED), University of A Coruña, A Coruña, Spain",NA
"2073","34168595","10.3389/fpsyg.2021.666891","COVID-19 Lockdown: Key Factors in Citizens' Stress.","Background: Confinement due to COVID-19 can have a short- and long-term impact on mental health (increased levels of stress and anxiety and emotional upheaval) and on people's quality of life. Knowing what factors are behind the stress can benefit the development of strategies and resources for future situations of a similar nature. The purpose of this study is to examine the incidence of a series of sociodemographic factors, confinement conditions, and work situation on the stress report","2021","06","26","Front Psychol","Frontiers in psychology","COVID-19; context effects; health and well-being; stress; survey research","Vieites","Tania","Departamento de Psicología, Grupo de Investigación en Psicología Educativa (GIPED), University of A Coruña, A Coruña, Spain",NA
"2074","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Bao","Mei","Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China",NA
"2075","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Yang","Sen","Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China",NA
"2076","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Gale","Robert Peter","Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom",NA
"2077","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Zhang","Yanli","Department of Hematology, Henan Provincial Tumor Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China",NA
"2078","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Liu","Xiaoli","Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China",NA
"2079","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Zhu","Huanling","Department of Hematology, West China Hospital, Sichuan University, Chengdu, China",NA
"2080","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Liang","Rong","Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, China",NA
"2081","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Liu","Bingcheng","State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology, Chinese Academy of Medical Sciences, Tianjin, China",NA
"2082","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Zhou","Li","Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2083","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Li","Zongru","Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China",NA
"2084","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Dou","Xuelin","Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China",NA
"2085","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Shi","Dayu","Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China",NA
"2086","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Wang","Tao","Department of Epidemiology and Biostatistics School of Public Health Peking University Health Science Center, Beijing, China",NA
"2087","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Meng","Li","Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"2088","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Li","Weiming","Department of Hematology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"2089","34168583","10.3389/fpsyt.2021.679932","Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.","Mental health problems in the general population have been reported during the SARS-CoV-2 pandemic; however, there were rare data in persons with chronic myeloid leukemia (CML). Therefore, we performed a cross-sectional study on mental health evaluated using the 9-item Patient Health Questionnaire (PHQ-9; depression), the 7-item Generalized Anxiety Disorder (GAD-7; anxiety), and the 22-item Impact of Event Scale-Revised (IES-R; distress), including subscales of avoidance, intrusion, and hyper-ar","2021","06","26","Front Psychiatry","Frontiers in psychiatry","SARS-CoV-2; anxiety; chronic myeloid leukemia; depression; distress; mental health","Jiang","Qian","Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China",NA
"2090","34168580","10.3389/fpsyt.2021.666588","Impact of the Perceived Mental Stress During the COVID-19 Pandemic on Medical Students' Loneliness Feelings and Future Career Choice: A Preliminary Survey Study.","The outbreak of the COVID-19 epidemic continues to unfold globally, and its negative impact on the public's mental health is starting to reveal. Serving as reserve talents for the healthcare system, medical students are not yet professionally matured enough to face one of the worst global public health crises. This may exert increased mental stress and loneliness feelings, which in turn negatively influence medical students' future career choice. To address the issue, we conducted three online s","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVID-19; career attitude; loneliness; medical students; mental stress","Zheng","Qiuyue","Department of Psychology, School of Health, Fujian Medical University, Fuzhou, China",NA
"2091","34168580","10.3389/fpsyt.2021.666588","Impact of the Perceived Mental Stress During the COVID-19 Pandemic on Medical Students' Loneliness Feelings and Future Career Choice: A Preliminary Survey Study.","The outbreak of the COVID-19 epidemic continues to unfold globally, and its negative impact on the public's mental health is starting to reveal. Serving as reserve talents for the healthcare system, medical students are not yet professionally matured enough to face one of the worst global public health crises. This may exert increased mental stress and loneliness feelings, which in turn negatively influence medical students' future career choice. To address the issue, we conducted three online s","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVID-19; career attitude; loneliness; medical students; mental stress","Lin","Xianhao","Department of Psychology, School of Health, Fujian Medical University, Fuzhou, China",NA
"2092","34168580","10.3389/fpsyt.2021.666588","Impact of the Perceived Mental Stress During the COVID-19 Pandemic on Medical Students' Loneliness Feelings and Future Career Choice: A Preliminary Survey Study.","The outbreak of the COVID-19 epidemic continues to unfold globally, and its negative impact on the public's mental health is starting to reveal. Serving as reserve talents for the healthcare system, medical students are not yet professionally matured enough to face one of the worst global public health crises. This may exert increased mental stress and loneliness feelings, which in turn negatively influence medical students' future career choice. To address the issue, we conducted three online s","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVID-19; career attitude; loneliness; medical students; mental stress","He","Lin","Department of Marketing, School of Management, Zhejiang University, Hangzhou, China",NA
"2093","34168580","10.3389/fpsyt.2021.666588","Impact of the Perceived Mental Stress During the COVID-19 Pandemic on Medical Students' Loneliness Feelings and Future Career Choice: A Preliminary Survey Study.","The outbreak of the COVID-19 epidemic continues to unfold globally, and its negative impact on the public's mental health is starting to reveal. Serving as reserve talents for the healthcare system, medical students are not yet professionally matured enough to face one of the worst global public health crises. This may exert increased mental stress and loneliness feelings, which in turn negatively influence medical students' future career choice. To address the issue, we conducted three online s","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVID-19; career attitude; loneliness; medical students; mental stress","Freudenreich","Thomas","Department of Marketing, School of Management, Zhejiang University, Hangzhou, China",NA
"2094","34168580","10.3389/fpsyt.2021.666588","Impact of the Perceived Mental Stress During the COVID-19 Pandemic on Medical Students' Loneliness Feelings and Future Career Choice: A Preliminary Survey Study.","The outbreak of the COVID-19 epidemic continues to unfold globally, and its negative impact on the public's mental health is starting to reveal. Serving as reserve talents for the healthcare system, medical students are not yet professionally matured enough to face one of the worst global public health crises. This may exert increased mental stress and loneliness feelings, which in turn negatively influence medical students' future career choice. To address the issue, we conducted three online s","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVID-19; career attitude; loneliness; medical students; mental stress","Liu","Tao","Department of Psychology, School of Health, Fujian Medical University, Fuzhou, China",NA
"2095","34168575","10.3389/fpsyt.2021.652356","Based on a Decision Tree Model for Exploring the Risk Factors of Smartphone Addiction Among Children and Adolescents in China During the COVID-19 Pandemic.","Background: Smartphone addiction has emerged as a major concern among children and adolescents over the past few decades and may be heightened by the outbreak of COVID-19, posing a threat to their physical and mental health. Then we aimed to develop a decision tree model as a screening tool for unrecognized smartphone addiction by conducting large sample investigation in mainland China. Methods: The data from cross-sectional investigation of smartphone addiction among children and ","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVD-19; adolescents; children; decision tree model; smartphone addiction","Duan","Li","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China",NA
"2096","34168575","10.3389/fpsyt.2021.652356","Based on a Decision Tree Model for Exploring the Risk Factors of Smartphone Addiction Among Children and Adolescents in China During the COVID-19 Pandemic.","Background: Smartphone addiction has emerged as a major concern among children and adolescents over the past few decades and may be heightened by the outbreak of COVID-19, posing a threat to their physical and mental health. Then we aimed to develop a decision tree model as a screening tool for unrecognized smartphone addiction by conducting large sample investigation in mainland China. Methods: The data from cross-sectional investigation of smartphone addiction among children and ","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVD-19; adolescents; children; decision tree model; smartphone addiction","He","Juan","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China",NA
"2097","34168575","10.3389/fpsyt.2021.652356","Based on a Decision Tree Model for Exploring the Risk Factors of Smartphone Addiction Among Children and Adolescents in China During the COVID-19 Pandemic.","Background: Smartphone addiction has emerged as a major concern among children and adolescents over the past few decades and may be heightened by the outbreak of COVID-19, posing a threat to their physical and mental health. Then we aimed to develop a decision tree model as a screening tool for unrecognized smartphone addiction by conducting large sample investigation in mainland China. Methods: The data from cross-sectional investigation of smartphone addiction among children and ","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVD-19; adolescents; children; decision tree model; smartphone addiction","Li","Min","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China",NA
"2098","34168575","10.3389/fpsyt.2021.652356","Based on a Decision Tree Model for Exploring the Risk Factors of Smartphone Addiction Among Children and Adolescents in China During the COVID-19 Pandemic.","Background: Smartphone addiction has emerged as a major concern among children and adolescents over the past few decades and may be heightened by the outbreak of COVID-19, posing a threat to their physical and mental health. Then we aimed to develop a decision tree model as a screening tool for unrecognized smartphone addiction by conducting large sample investigation in mainland China. Methods: The data from cross-sectional investigation of smartphone addiction among children and ","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVD-19; adolescents; children; decision tree model; smartphone addiction","Dai","Jiali","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China",NA
"2099","34168575","10.3389/fpsyt.2021.652356","Based on a Decision Tree Model for Exploring the Risk Factors of Smartphone Addiction Among Children and Adolescents in China During the COVID-19 Pandemic.","Background: Smartphone addiction has emerged as a major concern among children and adolescents over the past few decades and may be heightened by the outbreak of COVID-19, posing a threat to their physical and mental health. Then we aimed to develop a decision tree model as a screening tool for unrecognized smartphone addiction by conducting large sample investigation in mainland China. Methods: The data from cross-sectional investigation of smartphone addiction among children and ","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVD-19; adolescents; children; decision tree model; smartphone addiction","Zhou","Yurong","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China",NA
"2100","34168575","10.3389/fpsyt.2021.652356","Based on a Decision Tree Model for Exploring the Risk Factors of Smartphone Addiction Among Children and Adolescents in China During the COVID-19 Pandemic.","Background: Smartphone addiction has emerged as a major concern among children and adolescents over the past few decades and may be heightened by the outbreak of COVID-19, posing a threat to their physical and mental health. Then we aimed to develop a decision tree model as a screening tool for unrecognized smartphone addiction by conducting large sample investigation in mainland China. Methods: The data from cross-sectional investigation of smartphone addiction among children and ","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVD-19; adolescents; children; decision tree model; smartphone addiction","Lai","Feiya","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China",NA
"2101","34168575","10.3389/fpsyt.2021.652356","Based on a Decision Tree Model for Exploring the Risk Factors of Smartphone Addiction Among Children and Adolescents in China During the COVID-19 Pandemic.","Background: Smartphone addiction has emerged as a major concern among children and adolescents over the past few decades and may be heightened by the outbreak of COVID-19, posing a threat to their physical and mental health. Then we aimed to develop a decision tree model as a screening tool for unrecognized smartphone addiction by conducting large sample investigation in mainland China. Methods: The data from cross-sectional investigation of smartphone addiction among children and ","2021","06","26","Front Psychiatry","Frontiers in psychiatry","COVD-19; adolescents; children; decision tree model; smartphone addiction","Zhu","Gang","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China",NA
"2102","34168534","10.3389/fnins.2021.564159","Wireless Heart Rate Variability in Assessing Community COVID-19.",NA,"2021","06","26","Front Neurosci","Frontiers in neuroscience","COVID-19 pandemic; Internet of Healthy Things (IoHT); community prevalence; digital epidemiology; heart rate variability; networked hardware/software systems","Drury","Robert L","Canary Systems, Bainbridge Island, WA, United States",NA
"2103","34168534","10.3389/fnins.2021.564159","Wireless Heart Rate Variability in Assessing Community COVID-19.",NA,"2021","06","26","Front Neurosci","Frontiers in neuroscience","COVID-19 pandemic; Internet of Healthy Things (IoHT); community prevalence; digital epidemiology; heart rate variability; networked hardware/software systems","Jarczok","Marc","Clinic for Psychosomatic Medicine and Psychotherapy, University Clinic Ulm, Ulm, Germany",NA
"2104","34168534","10.3389/fnins.2021.564159","Wireless Heart Rate Variability in Assessing Community COVID-19.",NA,"2021","06","26","Front Neurosci","Frontiers in neuroscience","COVID-19 pandemic; Internet of Healthy Things (IoHT); community prevalence; digital epidemiology; heart rate variability; networked hardware/software systems","Owens","Andrew","Department of Old Age Psychiatry, Institute of Psychiatry, Psychology &amp",NA
"2105","34168534","10.3389/fnins.2021.564159","Wireless Heart Rate Variability in Assessing Community COVID-19.",NA,"2021","06","26","Front Neurosci","Frontiers in neuroscience","COVID-19 pandemic; Internet of Healthy Things (IoHT); community prevalence; digital epidemiology; heart rate variability; networked hardware/software systems","Thayer","Julian F","Psychological Sciences Faculty, University of California, Irvine, Irvine, CA, United States",NA
"2106","34168508","10.2147/PRBM.S302729","Could the Associations of Changes in Living Arrangement with Mental Disorders Be Moderated or Mediated During COVID-19 Pandemic?","Changes in living arrangement was one of the most well-established risk factors for mental disorders, but little evidence came from moderating or mediating effect during COVID-19 pandemic. This study aimed to determine whether associations of changes in living arrangement with mental disorders could be moderated or mediated during COVID-19 pandemic. Data were a cross-sectional and international population-based survey data collected as part of theCOVID-19 pandemic. Participants included national","2021","06","26","Psychol Res Behav Manag","Psychology research and behavior management","change in alcohol use; changes in living arrangement; mediators; mental disorders; moderators","Guan","Ming","International Issues Center, Xuchang University, Xuchang, 461000, People's Republic of China",NA
"2107","34168484","10.2147/JIR.S311518","Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.","Most COVID-19 patients are moderate, and fever is the most common clinical manifestation and associated with poorer prognosis. Gut microbiota may also play important roles in COVID-19 pathogenesis. However, the association between gut microbiota and fever in individuals with moderate COVID-19 remains unclear. We compared the clinical features and laboratory results of 187 moderate COVID-19 patients with fever and without fever and identified several inflammatory markers in patients with fever. T","2021","06","26","J Inflamm Res","Journal of inflammation research","epitopes; fever; gut microbiota; moderate COVID-19; shotgun metagenomic sequencing","Zhou","Yaya","Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China",NA
"2108","34168484","10.2147/JIR.S311518","Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.","Most COVID-19 patients are moderate, and fever is the most common clinical manifestation and associated with poorer prognosis. Gut microbiota may also play important roles in COVID-19 pathogenesis. However, the association between gut microbiota and fever in individuals with moderate COVID-19 remains unclear. We compared the clinical features and laboratory results of 187 moderate COVID-19 patients with fever and without fever and identified several inflammatory markers in patients with fever. T","2021","06","26","J Inflamm Res","Journal of inflammation research","epitopes; fever; gut microbiota; moderate COVID-19; shotgun metagenomic sequencing","Shi","Xing","Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, People's Republic of China",NA
"2109","34168484","10.2147/JIR.S311518","Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.","Most COVID-19 patients are moderate, and fever is the most common clinical manifestation and associated with poorer prognosis. Gut microbiota may also play important roles in COVID-19 pathogenesis. However, the association between gut microbiota and fever in individuals with moderate COVID-19 remains unclear. We compared the clinical features and laboratory results of 187 moderate COVID-19 patients with fever and without fever and identified several inflammatory markers in patients with fever. T","2021","06","26","J Inflamm Res","Journal of inflammation research","epitopes; fever; gut microbiota; moderate COVID-19; shotgun metagenomic sequencing","Fu","Wei","Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China",NA
"2110","34168484","10.2147/JIR.S311518","Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.","Most COVID-19 patients are moderate, and fever is the most common clinical manifestation and associated with poorer prognosis. Gut microbiota may also play important roles in COVID-19 pathogenesis. However, the association between gut microbiota and fever in individuals with moderate COVID-19 remains unclear. We compared the clinical features and laboratory results of 187 moderate COVID-19 patients with fever and without fever and identified several inflammatory markers in patients with fever. T","2021","06","26","J Inflamm Res","Journal of inflammation research","epitopes; fever; gut microbiota; moderate COVID-19; shotgun metagenomic sequencing","Xiang","Fei","Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China",NA
"2111","34168484","10.2147/JIR.S311518","Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.","Most COVID-19 patients are moderate, and fever is the most common clinical manifestation and associated with poorer prognosis. Gut microbiota may also play important roles in COVID-19 pathogenesis. However, the association between gut microbiota and fever in individuals with moderate COVID-19 remains unclear. We compared the clinical features and laboratory results of 187 moderate COVID-19 patients with fever and without fever and identified several inflammatory markers in patients with fever. T","2021","06","26","J Inflamm Res","Journal of inflammation research","epitopes; fever; gut microbiota; moderate COVID-19; shotgun metagenomic sequencing","He","Xinliang","Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China",NA
"2112","34168484","10.2147/JIR.S311518","Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.","Most COVID-19 patients are moderate, and fever is the most common clinical manifestation and associated with poorer prognosis. Gut microbiota may also play important roles in COVID-19 pathogenesis. However, the association between gut microbiota and fever in individuals with moderate COVID-19 remains unclear. We compared the clinical features and laboratory results of 187 moderate COVID-19 patients with fever and without fever and identified several inflammatory markers in patients with fever. T","2021","06","26","J Inflamm Res","Journal of inflammation research","epitopes; fever; gut microbiota; moderate COVID-19; shotgun metagenomic sequencing","Yang","Bohan","Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China",NA
"2113","34168484","10.2147/JIR.S311518","Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.","Most COVID-19 patients are moderate, and fever is the most common clinical manifestation and associated with poorer prognosis. Gut microbiota may also play important roles in COVID-19 pathogenesis. However, the association between gut microbiota and fever in individuals with moderate COVID-19 remains unclear. We compared the clinical features and laboratory results of 187 moderate COVID-19 patients with fever and without fever and identified several inflammatory markers in patients with fever. T","2021","06","26","J Inflamm Res","Journal of inflammation research","epitopes; fever; gut microbiota; moderate COVID-19; shotgun metagenomic sequencing","Wang","Xiaorong","Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China",NA
"2114","34168484","10.2147/JIR.S311518","Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.","Most COVID-19 patients are moderate, and fever is the most common clinical manifestation and associated with poorer prognosis. Gut microbiota may also play important roles in COVID-19 pathogenesis. However, the association between gut microbiota and fever in individuals with moderate COVID-19 remains unclear. We compared the clinical features and laboratory results of 187 moderate COVID-19 patients with fever and without fever and identified several inflammatory markers in patients with fever. T","2021","06","26","J Inflamm Res","Journal of inflammation research","epitopes; fever; gut microbiota; moderate COVID-19; shotgun metagenomic sequencing","Ma","Wan-Li","Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China",NA
"2115","34168467","10.2147/IDR.S307238","Geographic Differences on Clinical Manifestations of COVID-19 Infection Between Overseas Chinese and Local Chinese Patients.","The novel coronavirus (COVID-19) has become a global pandemic with sharp rises in the number of confirmed cases and rapid spread across the world. Here, we looked at the effects of geographic differences on clinical manifestations of SARS-CoV-2 infected patients. A total of 114 confirmed COVID-19 patients were included in this study. The epidemiological, demographic, clinical, as well as laboratory findings were extracted from the electronic medical records of these patients. We report the obser","2021","06","26","Infect Drug Resist","Infection and drug resistance","COVID-19 patients; clinical manifestations; geographic differences; inflammatory responses","Liang","Yanhua","Diagnosis and Treatment of Infectious Diseases Research Laboratory, Shenzhen Third People's Hospital, Shenzhen, People's Republic of China",NA
"2116","34168467","10.2147/IDR.S307238","Geographic Differences on Clinical Manifestations of COVID-19 Infection Between Overseas Chinese and Local Chinese Patients.","The novel coronavirus (COVID-19) has become a global pandemic with sharp rises in the number of confirmed cases and rapid spread across the world. Here, we looked at the effects of geographic differences on clinical manifestations of SARS-CoV-2 infected patients. A total of 114 confirmed COVID-19 patients were included in this study. The epidemiological, demographic, clinical, as well as laboratory findings were extracted from the electronic medical records of these patients. We report the obser","2021","06","26","Infect Drug Resist","Infection and drug resistance","COVID-19 patients; clinical manifestations; geographic differences; inflammatory responses","Kou","Shanglong","Diagnosis and Treatment of Infectious Diseases Research Laboratory, Shenzhen Third People's Hospital, Shenzhen, People's Republic of China",NA
"2117","34168467","10.2147/IDR.S307238","Geographic Differences on Clinical Manifestations of COVID-19 Infection Between Overseas Chinese and Local Chinese Patients.","The novel coronavirus (COVID-19) has become a global pandemic with sharp rises in the number of confirmed cases and rapid spread across the world. Here, we looked at the effects of geographic differences on clinical manifestations of SARS-CoV-2 infected patients. A total of 114 confirmed COVID-19 patients were included in this study. The epidemiological, demographic, clinical, as well as laboratory findings were extracted from the electronic medical records of these patients. We report the obser","2021","06","26","Infect Drug Resist","Infection and drug resistance","COVID-19 patients; clinical manifestations; geographic differences; inflammatory responses","Li","Xiaohe","Diagnosis and Treatment of Infectious Diseases Research Laboratory, Shenzhen Third People's Hospital, Shenzhen, People's Republic of China",NA
"2118","34168467","10.2147/IDR.S307238","Geographic Differences on Clinical Manifestations of COVID-19 Infection Between Overseas Chinese and Local Chinese Patients.","The novel coronavirus (COVID-19) has become a global pandemic with sharp rises in the number of confirmed cases and rapid spread across the world. Here, we looked at the effects of geographic differences on clinical manifestations of SARS-CoV-2 infected patients. A total of 114 confirmed COVID-19 patients were included in this study. The epidemiological, demographic, clinical, as well as laboratory findings were extracted from the electronic medical records of these patients. We report the obser","2021","06","26","Infect Drug Resist","Infection and drug resistance","COVID-19 patients; clinical manifestations; geographic differences; inflammatory responses","Ke","Zhiyi","Diagnosis and Treatment of Infectious Diseases Research Laboratory, Shenzhen Third People's Hospital, Shenzhen, People's Republic of China",NA
"2119","34168467","10.2147/IDR.S307238","Geographic Differences on Clinical Manifestations of COVID-19 Infection Between Overseas Chinese and Local Chinese Patients.","The novel coronavirus (COVID-19) has become a global pandemic with sharp rises in the number of confirmed cases and rapid spread across the world. Here, we looked at the effects of geographic differences on clinical manifestations of SARS-CoV-2 infected patients. A total of 114 confirmed COVID-19 patients were included in this study. The epidemiological, demographic, clinical, as well as laboratory findings were extracted from the electronic medical records of these patients. We report the obser","2021","06","26","Infect Drug Resist","Infection and drug resistance","COVID-19 patients; clinical manifestations; geographic differences; inflammatory responses","Zou","Rongrong","Diagnosis and Treatment of Infectious Diseases Research Laboratory, Shenzhen Third People's Hospital, Shenzhen, People's Republic of China",NA
"2120","34168467","10.2147/IDR.S307238","Geographic Differences on Clinical Manifestations of COVID-19 Infection Between Overseas Chinese and Local Chinese Patients.","The novel coronavirus (COVID-19) has become a global pandemic with sharp rises in the number of confirmed cases and rapid spread across the world. Here, we looked at the effects of geographic differences on clinical manifestations of SARS-CoV-2 infected patients. A total of 114 confirmed COVID-19 patients were included in this study. The epidemiological, demographic, clinical, as well as laboratory findings were extracted from the electronic medical records of these patients. We report the obser","2021","06","26","Infect Drug Resist","Infection and drug resistance","COVID-19 patients; clinical manifestations; geographic differences; inflammatory responses","Pan","Yanchao","Diagnosis and Treatment of Infectious Diseases Research Laboratory, Shenzhen Third People's Hospital, Shenzhen, People's Republic of China",NA
"2121","34168467","10.2147/IDR.S307238","Geographic Differences on Clinical Manifestations of COVID-19 Infection Between Overseas Chinese and Local Chinese Patients.","The novel coronavirus (COVID-19) has become a global pandemic with sharp rises in the number of confirmed cases and rapid spread across the world. Here, we looked at the effects of geographic differences on clinical manifestations of SARS-CoV-2 infected patients. A total of 114 confirmed COVID-19 patients were included in this study. The epidemiological, demographic, clinical, as well as laboratory findings were extracted from the electronic medical records of these patients. We report the obser","2021","06","26","Infect Drug Resist","Infection and drug resistance","COVID-19 patients; clinical manifestations; geographic differences; inflammatory responses","Yuan","Jing","Diagnosis and Treatment of Infectious Diseases Research Laboratory, Shenzhen Third People's Hospital, Shenzhen, People's Republic of China",NA
"2122","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Quartuccio","Luca","Rheumatology Clinic, Department of Specialist Medicine, ASUFC, Udine, Italy",NA
"2123","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","De Marchi","Ginevra","Rheumatology Clinic, Department of Specialist Medicine, ASUFC, Udine, Italy",NA
"2124","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Azzolina","Danila","Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiology, Thoracic and Vascular Sciences, University of Padova, Padova, Italy",NA
"2125","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Maresio","Elisabetta","Prochild Onlus, Unit of Psychotherapy and Psychology, Trieste, Italy",NA
"2126","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Colatutto","Donatella","Rheumatology Clinic, Department of Specialist Medicine, ASUFC, Udine, Italy",NA
"2127","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Binutti","Marco","Rheumatology Clinic, Department of Specialist Medicine, ASUFC, Udine, Italy",NA
"2128","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Monte","Marinella","Associazione Malati Reumatici (A.Ma.Re.), Udine, Italy",NA
"2129","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Gallipoli","Silvia","Zeta Research s.r.l., Trieste, Italy",NA
"2130","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Zobec","Federica","Zeta Research s.r.l., Trieste, Italy",NA
"2131","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Lanera","Corrado","Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiology, Thoracic and Vascular Sciences, University of Padova, Padova, Italy",NA
"2132","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Lorenzoni","Giulia","Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiology, Thoracic and Vascular Sciences, University of Padova, Padova, Italy",NA
"2133","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Palese","Alvisa","Department of Medicine (DAME), University of Udine, Udine, Italy",NA
"2134","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Silano","Marco","Unit of Human Nutrition and Health, Department of Food Safety Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, 00161, Italy",NA
"2135","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","De Vita","Salvatore","Rheumatology Clinic, Department of Specialist Medicine, ASUFC, Udine, Italy",NA
"2136","34168460","10.2147/JMDH.S311325","Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.","To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey p","2021","06","26","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; psychological distress; systemic lupus erythematosus","Gregori","Dario","Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiology, Thoracic and Vascular Sciences, University of Padova, Padova, Italy",NA
"2137","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Zerbato","Verena","Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste 34125, Italy",NA
"2138","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Di Bella","Stefano","Infectious Diseases Unit, Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste 34123, Italy. stefano932@gmail","stefano932@gmail.com"
"2139","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Giuffrè","Mauro","Liver Unit, Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste 34127, Italy",NA
"2140","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Jaracz","Anna Wladyslawa","Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste 34125, Italy",NA
"2141","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Gobbo","Ylenia","Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste 34125, Italy",NA
"2142","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Luppino","Diego","Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste 34125, Italy",NA
"2143","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Macor","Paolo","Department of Life Sciences, Trieste University, Trieste 34127, Italy",NA
"2144","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Segat","Ludovica","Department of Hygiene and Public Health Unit, Trieste University Hospital (ASUGI), Trieste 34125, Italy",NA
"2145","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Koncan","Raffaella","Department of Hygiene and Public Health Unit, Trieste University Hospital (ASUGI), Trieste 34125, Italy",NA
"2146","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","D'Agaro","Pierlanfranco","Department of Hygiene and Public Health Unit, Trieste University Hospital (ASUGI), Trieste 34125, Italy",NA
"2147","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Valentini","Michael","Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste 34125, Italy",NA
"2148","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Crocé","Lory Saveria","Liver Unit, Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste 34127, Italy",NA
"2149","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Ruscio","Maurizio","Division of Laboratory Medicine, Trieste University Hospital (ASUGI), Trieste 34125, Italy",NA
"2150","34168414","10.3748/wjg.v27.i22.3130","High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.","One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal inflammation in the general population. To investigate if fecal calprotectin correlates with SARS-CoV-2 intestinal shedding in COVID-19 patients with pneumonia. Patients with SARS-CoV-2 pneumonia admitted to the I","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Fecal calprotectin; Gut; Obesity; SARS-CoV-2; Viral shedding; Adult; COVID-19; Humans; Italy; Leukocyte L1 Antigen Complex; Male; RNA, Viral; SARS-CoV-2","Luzzati","Roberto","Infectious Diseases Unit, Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste 34123, Italy",NA
"2151","34168408","10.3748/wjg.v27.i22.3064","COVID-19 and pediatric fatty liver disease: Is there interplay?","The rapid global spread of coronavirus disease 2019 (COVID-19) infection has become a major health issue with higher morbidity and mortality rates. Besides respiratory symptoms, a growing body of evidence indicates a variety of gastrointestinal manifestations including liver involvement. In this regard, several data supported an association between COVID-19 infection and liver injury in adults, while in children there is compelling but currently limited evidence. In particular, patients with COV","2021","06","28","World J Gastroenterol","World journal of gastroenterology","Adults; COVID-19; Children; Nonalcoholic fatty liver disease; COVID-19; Child; Gastrointestinal Tract; Humans; Liver; Non-alcoholic Fatty Liver Disease; SARS-CoV-2","Di Sessa","Anna","Department of Woman, Child, and General and Specialized Surgery, University of Campania ""Luigi Vanvitelli,"" Naples 80138, Italy. anna.disessa@libero","anna.disessa@libero.it"
"2152","34168408","10.3748/wjg.v27.i22.3064","COVID-19 and pediatric fatty liver disease: Is there interplay?","The rapid global spread of coronavirus disease 2019 (COVID-19) infection has become a major health issue with higher morbidity and mortality rates. Besides respiratory symptoms, a growing body of evidence indicates a variety of gastrointestinal manifestations including liver involvement. In this regard, several data supported an association between COVID-19 infection and liver injury in adults, while in children there is compelling but currently limited evidence. In particular, patients with COV","2021","06","28","World J Gastroenterol","World journal of gastroenterology","Adults; COVID-19; Children; Nonalcoholic fatty liver disease; COVID-19; Child; Gastrointestinal Tract; Humans; Liver; Non-alcoholic Fatty Liver Disease; SARS-CoV-2","Lanzaro","Francesca","Department of Woman, Child, and General and Specialized Surgery, University of Campania ""Luigi Vanvitelli,"" Naples 80138, Italy",NA
"2153","34168408","10.3748/wjg.v27.i22.3064","COVID-19 and pediatric fatty liver disease: Is there interplay?","The rapid global spread of coronavirus disease 2019 (COVID-19) infection has become a major health issue with higher morbidity and mortality rates. Besides respiratory symptoms, a growing body of evidence indicates a variety of gastrointestinal manifestations including liver involvement. In this regard, several data supported an association between COVID-19 infection and liver injury in adults, while in children there is compelling but currently limited evidence. In particular, patients with COV","2021","06","28","World J Gastroenterol","World journal of gastroenterology","Adults; COVID-19; Children; Nonalcoholic fatty liver disease; COVID-19; Child; Gastrointestinal Tract; Humans; Liver; Non-alcoholic Fatty Liver Disease; SARS-CoV-2","Zarrilli","Sarah","Department of Woman, Child, and General and Specialized Surgery, University of Campania ""Luigi Vanvitelli,"" Naples 80138, Italy",NA
"2154","34168408","10.3748/wjg.v27.i22.3064","COVID-19 and pediatric fatty liver disease: Is there interplay?","The rapid global spread of coronavirus disease 2019 (COVID-19) infection has become a major health issue with higher morbidity and mortality rates. Besides respiratory symptoms, a growing body of evidence indicates a variety of gastrointestinal manifestations including liver involvement. In this regard, several data supported an association between COVID-19 infection and liver injury in adults, while in children there is compelling but currently limited evidence. In particular, patients with COV","2021","06","28","World J Gastroenterol","World journal of gastroenterology","Adults; COVID-19; Children; Nonalcoholic fatty liver disease; COVID-19; Child; Gastrointestinal Tract; Humans; Liver; Non-alcoholic Fatty Liver Disease; SARS-CoV-2","Picone","Vittorio","Department of Woman, Child, and General and Specialized Surgery, University of Campania ""Luigi Vanvitelli,"" Naples 80138, Italy",NA
"2155","34168408","10.3748/wjg.v27.i22.3064","COVID-19 and pediatric fatty liver disease: Is there interplay?","The rapid global spread of coronavirus disease 2019 (COVID-19) infection has become a major health issue with higher morbidity and mortality rates. Besides respiratory symptoms, a growing body of evidence indicates a variety of gastrointestinal manifestations including liver involvement. In this regard, several data supported an association between COVID-19 infection and liver injury in adults, while in children there is compelling but currently limited evidence. In particular, patients with COV","2021","06","28","World J Gastroenterol","World journal of gastroenterology","Adults; COVID-19; Children; Nonalcoholic fatty liver disease; COVID-19; Child; Gastrointestinal Tract; Humans; Liver; Non-alcoholic Fatty Liver Disease; SARS-CoV-2","Guarino","Stefano","Department of Woman, Child, and General and Specialized Surgery, University of Campania ""Luigi Vanvitelli,"" Naples 80138, Italy",NA
"2156","34168408","10.3748/wjg.v27.i22.3064","COVID-19 and pediatric fatty liver disease: Is there interplay?","The rapid global spread of coronavirus disease 2019 (COVID-19) infection has become a major health issue with higher morbidity and mortality rates. Besides respiratory symptoms, a growing body of evidence indicates a variety of gastrointestinal manifestations including liver involvement. In this regard, several data supported an association between COVID-19 infection and liver injury in adults, while in children there is compelling but currently limited evidence. In particular, patients with COV","2021","06","28","World J Gastroenterol","World journal of gastroenterology","Adults; COVID-19; Children; Nonalcoholic fatty liver disease; COVID-19; Child; Gastrointestinal Tract; Humans; Liver; Non-alcoholic Fatty Liver Disease; SARS-CoV-2","Miraglia Del Giudice","Emanuele","Department of Woman, Child, and General and Specialized Surgery, University of Campania ""Luigi Vanvitelli,"" Naples 80138, Italy",NA
"2157","34168408","10.3748/wjg.v27.i22.3064","COVID-19 and pediatric fatty liver disease: Is there interplay?","The rapid global spread of coronavirus disease 2019 (COVID-19) infection has become a major health issue with higher morbidity and mortality rates. Besides respiratory symptoms, a growing body of evidence indicates a variety of gastrointestinal manifestations including liver involvement. In this regard, several data supported an association between COVID-19 infection and liver injury in adults, while in children there is compelling but currently limited evidence. In particular, patients with COV","2021","06","28","World J Gastroenterol","World journal of gastroenterology","Adults; COVID-19; Children; Nonalcoholic fatty liver disease; COVID-19; Child; Gastrointestinal Tract; Humans; Liver; Non-alcoholic Fatty Liver Disease; SARS-CoV-2","Marzuillo","Pierluigi","Department of Woman, Child, and General and Specialized Surgery, University of Campania ""Luigi Vanvitelli,"" Naples 80138, Italy",NA
"2158","34168405","10.3748/wjg.v27.i22.3022","Liver injury in COVID-19: Detection, pathogenesis, and treatment.","In the early December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, followed by an outbreak that spread around the world. Numerous studies have shown that liver injury is common in patients with coronavirus disease 2019 (COVID-19), and may aggravate the severity of the disease. However, the exact cause and specific mechanism of COVID-associated liver injury needs to be elucidated further. In this review, we present an analysis","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Clinical features; Liver injury; Potential mechanism; Treatment; COVID-19; China; Disease Outbreaks; Humans; Liver; SARS-CoV-2","Cai","Yue","Key Laboratory of Minimally Invasive Techniques &amp",NA
"2159","34168405","10.3748/wjg.v27.i22.3022","Liver injury in COVID-19: Detection, pathogenesis, and treatment.","In the early December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, followed by an outbreak that spread around the world. Numerous studies have shown that liver injury is common in patients with coronavirus disease 2019 (COVID-19), and may aggravate the severity of the disease. However, the exact cause and specific mechanism of COVID-associated liver injury needs to be elucidated further. In this review, we present an analysis","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Clinical features; Liver injury; Potential mechanism; Treatment; COVID-19; China; Disease Outbreaks; Humans; Liver; SARS-CoV-2","Ye","Li-Ping","Key Laboratory of Minimally Invasive Techniques &amp",NA
"2160","34168405","10.3748/wjg.v27.i22.3022","Liver injury in COVID-19: Detection, pathogenesis, and treatment.","In the early December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, followed by an outbreak that spread around the world. Numerous studies have shown that liver injury is common in patients with coronavirus disease 2019 (COVID-19), and may aggravate the severity of the disease. However, the exact cause and specific mechanism of COVID-associated liver injury needs to be elucidated further. In this review, we present an analysis","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Clinical features; Liver injury; Potential mechanism; Treatment; COVID-19; China; Disease Outbreaks; Humans; Liver; SARS-CoV-2","Song","Ya-Qi","School of Medicine, Zhejiang University, Hangzhou 310000, Zhejiang Province, China",NA
"2161","34168405","10.3748/wjg.v27.i22.3022","Liver injury in COVID-19: Detection, pathogenesis, and treatment.","In the early December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, followed by an outbreak that spread around the world. Numerous studies have shown that liver injury is common in patients with coronavirus disease 2019 (COVID-19), and may aggravate the severity of the disease. However, the exact cause and specific mechanism of COVID-associated liver injury needs to be elucidated further. In this review, we present an analysis","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Clinical features; Liver injury; Potential mechanism; Treatment; COVID-19; China; Disease Outbreaks; Humans; Liver; SARS-CoV-2","Mao","Xin-Li","Key Laboratory of Minimally Invasive Techniques &amp",NA
"2162","34168405","10.3748/wjg.v27.i22.3022","Liver injury in COVID-19: Detection, pathogenesis, and treatment.","In the early December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, followed by an outbreak that spread around the world. Numerous studies have shown that liver injury is common in patients with coronavirus disease 2019 (COVID-19), and may aggravate the severity of the disease. However, the exact cause and specific mechanism of COVID-associated liver injury needs to be elucidated further. In this review, we present an analysis","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Clinical features; Liver injury; Potential mechanism; Treatment; COVID-19; China; Disease Outbreaks; Humans; Liver; SARS-CoV-2","Wang","Li","College of Basic Medicine, Inner Mongolia Medical University, Hohhot 010000, Inner Mongolia Autonomous Region, China",NA
"2163","34168405","10.3748/wjg.v27.i22.3022","Liver injury in COVID-19: Detection, pathogenesis, and treatment.","In the early December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, followed by an outbreak that spread around the world. Numerous studies have shown that liver injury is common in patients with coronavirus disease 2019 (COVID-19), and may aggravate the severity of the disease. However, the exact cause and specific mechanism of COVID-associated liver injury needs to be elucidated further. In this review, we present an analysis","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Clinical features; Liver injury; Potential mechanism; Treatment; COVID-19; China; Disease Outbreaks; Humans; Liver; SARS-CoV-2","Jiang","Yan-Zhi","Department of Gastroenterology and Hepatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China",NA
"2164","34168405","10.3748/wjg.v27.i22.3022","Liver injury in COVID-19: Detection, pathogenesis, and treatment.","In the early December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, followed by an outbreak that spread around the world. Numerous studies have shown that liver injury is common in patients with coronavirus disease 2019 (COVID-19), and may aggravate the severity of the disease. However, the exact cause and specific mechanism of COVID-associated liver injury needs to be elucidated further. In this review, we present an analysis","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Clinical features; Liver injury; Potential mechanism; Treatment; COVID-19; China; Disease Outbreaks; Humans; Liver; SARS-CoV-2","Que","Wei-Tao","Department of Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China",NA
"2165","34168405","10.3748/wjg.v27.i22.3022","Liver injury in COVID-19: Detection, pathogenesis, and treatment.","In the early December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, followed by an outbreak that spread around the world. Numerous studies have shown that liver injury is common in patients with coronavirus disease 2019 (COVID-19), and may aggravate the severity of the disease. However, the exact cause and specific mechanism of COVID-associated liver injury needs to be elucidated further. In this review, we present an analysis","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19; Clinical features; Liver injury; Potential mechanism; Treatment; COVID-19; China; Disease Outbreaks; Humans; Liver; SARS-CoV-2","Li","Shao-Wei","Key Laboratory of Minimally Invasive Techniques &amp",NA
"2166","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Zhu","Dan-Dan","Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China",NA
"2167","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Tan","Xue-Mei","Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China",NA
"2168","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Lu","Li-Qing","Key Laboratory of Cancer proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China",NA
"2169","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Yu","Si-Jia","Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China",NA
"2170","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Jian","Ru-Li","Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China",NA
"2171","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Liang","Xin-Fang","Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China",NA
"2172","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Liao","Yi-Xuan","Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China",NA
"2173","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Fan","Wei","Department of Medicine, Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States",NA
"2174","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Barbier-Torres","Lucíia","Department of Medicine, Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States",NA
"2175","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Yang","Austin","Department of Biology, East Los Angeles College, Los Angeles, CA 91008, United States",NA
"2176","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Yang","He-Ping","Department of Medicine, Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States",NA
"2177","34168400","10.3748/wjg.v27.i22.2944","Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver in","2021","06","28","World J Gastroenterol","World journal of gastroenterology","COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets; COVID-19; Humans; Inflammation Mediators; Liver; NF-E2-Related Factor 2; Oxidative Stress; SARS-CoV-2; Signal Transduction","Liu","Ting","Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China. liuting818@126","liuting818@126.com"
"2178","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Wellner","Alon","Department of Biomedical Engineering, University of California, Irvine, CA, USA",NA
"2179","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"McMahon","Conor","Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA",NA
"2180","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Gilman","Morgan S A","Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA",NA
"2181","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Clements","Jonathan R","Department of Biomedical Engineering, University of California, Irvine, CA, USA",NA
"2182","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Clark","Sarah","Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA",NA
"2183","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Nguyen","Kianna M","Department of Biomedical Engineering, University of California, Irvine, CA, USA",NA
"2184","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Ho","Ming H","Department of Biomedical Engineering, University of California, Irvine, CA, USA",NA
"2185","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Hu","Vincent J","Department of Biomedical Engineering, University of California, Irvine, CA, USA",NA
"2186","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Shin","Jung-Eun","Department of Systems Biology, Harvard Medical School, Boston, MA, USA",NA
"2187","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Feldman","Jared","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA",NA
"2188","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Hauser","Blake M","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA",NA
"2189","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Caradonna","Timothy M","Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA",NA
"2190","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Wingler","Laura M","Department of Medicine, Duke University Medical Center, Durham, NC, USA",NA
"2191","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Schmidt","Aaron G","Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA",NA
"2192","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Marks","Debora S","Department of Systems Biology, Harvard Medical School, Boston, MA, USA",NA
"2193","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Abraham","Jonathan","Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA",NA
"2194","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Kruse","Andrew C","Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. andrew_kruse@hms.harvard","kruse@hms.harvard.edu"
"2195","34168368","10.1038/s41589-021-00832-4","Rapid generation of potent antibodies by autonomous hypermutation in yeast.","The predominant approach for antibody generation remains animal immunization, which can yield exceptionally selective and potent antibody clones owing to the powerful evolutionary process of somatic hypermutation. However, animal immunization is inherently slow, not always accessible and poorly compatible with many antigens. Here, we describe 'autonomous hypermutation yeast surface display' (AHEAD), a synthetic recombinant antibody generation technology that imitates somatic hypermutation inside","2021","07","11","Nat Chem Biol","Nature chemical biology",NA,"Liu","Chang C","Department of Biomedical Engineering, University of California, Irvine, CA, USA. ccl@uci","ccl@uci.edu"
"2196","34168363","10.1038/d41586-021-01731-3","Deleted coronavirus genome sequences trigger scientific intrigue.",NA,"2021","06","26","Nature","Nature","Genomics; SARS-CoV-2; Virology","Callaway","Ewen",NA,NA
"2197","34168348","10.1038/d41586-020-01939-9","How I learnt to love Zoom.",NA,"2021","06","25","Nature","Nature","Careers; Lab life; SARS-CoV-2","Hare","Roseanna",NA,NA
"2198","34168347","10.1038/d41586-020-01898-1","Five ways to tackle PhD research anxieties triggered by COVID-19 lockdowns.",NA,"2021","06","25","Nature","Nature","Careers; Lab life; SARS-CoV-2","Ashton","Paul",NA,NA
"2199","34168347","10.1038/d41586-020-01898-1","Five ways to tackle PhD research anxieties triggered by COVID-19 lockdowns.",NA,"2021","06","25","Nature","Nature","Careers; Lab life; SARS-CoV-2","Pintor-Escobar","Linamaria",NA,NA
"2200","34168345","10.1038/s41577-021-00579-y","Understanding COVID-19 in Africa.",NA,"2021","07","01","Nat Rev Immunol","Nature reviews. Immunology",NA,"Tessema","Sofonias K","Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia",NA
"2201","34168345","10.1038/s41577-021-00579-y","Understanding COVID-19 in Africa.",NA,"2021","07","01","Nat Rev Immunol","Nature reviews. Immunology",NA,"Nkengasong","John N","Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia. nkengasongj@africa-union",NA
"2202","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Menezes","Ana M B","Universidade Federal de Pelotas, Pelotas, Brazil. anamene.epi@gmail","anamene.epi@gmail.com"
"2203","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Victora","Cesar G","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2204","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Hartwig","Fernando P","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2205","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Silveira","Mariângela F","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2206","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Horta","Bernardo L","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2207","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Barros","Aluísio J D","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2208","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Mesenburg","Marilia A","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2209","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Wehrmeister","Fernando C","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2210","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Pellanda","Lúcia C","Fundação Universidade Federal de Ciências de Saúde de Porto Alegre, Porto Alegre, Brazil",NA
"2211","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Dellagostin","Odir A","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2212","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Struchiner","Cláudio J","Fundação Getúlio Vargas, Rio de Janeiro, Brazil",NA
"2213","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Burattini","Marcelo N","Universidade de São Paulo, São Paulo, Brazil",NA
"2214","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Barros","Fernando C","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2215","34168250","10.1038/s41598-021-92775-y","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, number of symptoms and the association with socio-demographic characteristic","2021","07","07","Sci Rep","Scientific reports","Adolescent; Adult; Aged; Antibodies, Viral; Brazil; COVID-19; Carrier State; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Seroepidemiologic Studies; Young Adult","Hallal","Pedro C","Universidade Federal de Pelotas, Pelotas, Brazil",NA
"2216","34168204","10.1038/s41598-021-92605-1","Determining the burden of fungal infections in Zimbabwe.","Zimbabwe currently faces several healthcare challenges, most notably HIV and associated infections including tuberculosis (TB), malaria and recently outbreaks of cholera, typhoid fever and COVID-19. Fungal infections, which are also a major public health threat, receive considerably less attention. Consequently, there is dearth of data regarding the burden of fungal diseases in the country. We estimated the burden of fungal diseases in Zimbabwe based on published literature and 'at-risk' populat","2021","07","07","Sci Rep","Scientific reports","AIDS-Related Opportunistic Infections; Adolescent; Adult; Child; Female; Humans; Incidence; Male; Mycoses; Prevalence; Risk Factors; Zimbabwe","Pfavayi","Lorraine T","Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LG, UK. lorraine.pfavayi@kellogg.ox.ac","lorraine.pfavayi@kellogg.ox.ac.uk"
"2217","34168204","10.1038/s41598-021-92605-1","Determining the burden of fungal infections in Zimbabwe.","Zimbabwe currently faces several healthcare challenges, most notably HIV and associated infections including tuberculosis (TB), malaria and recently outbreaks of cholera, typhoid fever and COVID-19. Fungal infections, which are also a major public health threat, receive considerably less attention. Consequently, there is dearth of data regarding the burden of fungal diseases in the country. We estimated the burden of fungal diseases in Zimbabwe based on published literature and 'at-risk' populat","2021","07","07","Sci Rep","Scientific reports","AIDS-Related Opportunistic Infections; Adolescent; Adult; Child; Female; Humans; Incidence; Male; Mycoses; Prevalence; Risk Factors; Zimbabwe","Denning","David W","Manchester Fungal Infection Group, The University of Manchester and Manchester Academic Health Science Centre, Manchester, UK",NA
"2218","34168204","10.1038/s41598-021-92605-1","Determining the burden of fungal infections in Zimbabwe.","Zimbabwe currently faces several healthcare challenges, most notably HIV and associated infections including tuberculosis (TB), malaria and recently outbreaks of cholera, typhoid fever and COVID-19. Fungal infections, which are also a major public health threat, receive considerably less attention. Consequently, there is dearth of data regarding the burden of fungal diseases in the country. We estimated the burden of fungal diseases in Zimbabwe based on published literature and 'at-risk' populat","2021","07","07","Sci Rep","Scientific reports","AIDS-Related Opportunistic Infections; Adolescent; Adult; Child; Female; Humans; Incidence; Male; Mycoses; Prevalence; Risk Factors; Zimbabwe","Baker","Stephen","University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK",NA
"2219","34168204","10.1038/s41598-021-92605-1","Determining the burden of fungal infections in Zimbabwe.","Zimbabwe currently faces several healthcare challenges, most notably HIV and associated infections including tuberculosis (TB), malaria and recently outbreaks of cholera, typhoid fever and COVID-19. Fungal infections, which are also a major public health threat, receive considerably less attention. Consequently, there is dearth of data regarding the burden of fungal diseases in the country. We estimated the burden of fungal diseases in Zimbabwe based on published literature and 'at-risk' populat","2021","07","07","Sci Rep","Scientific reports","AIDS-Related Opportunistic Infections; Adolescent; Adult; Child; Female; Humans; Incidence; Male; Mycoses; Prevalence; Risk Factors; Zimbabwe","Sibanda","Elopy N","Asthma Allergy and Immunology Clinic, Twin Palms Medical Centre, Harare, Zimbabwe",NA
"2220","34168204","10.1038/s41598-021-92605-1","Determining the burden of fungal infections in Zimbabwe.","Zimbabwe currently faces several healthcare challenges, most notably HIV and associated infections including tuberculosis (TB), malaria and recently outbreaks of cholera, typhoid fever and COVID-19. Fungal infections, which are also a major public health threat, receive considerably less attention. Consequently, there is dearth of data regarding the burden of fungal diseases in the country. We estimated the burden of fungal diseases in Zimbabwe based on published literature and 'at-risk' populat","2021","07","07","Sci Rep","Scientific reports","AIDS-Related Opportunistic Infections; Adolescent; Adult; Child; Female; Humans; Incidence; Male; Mycoses; Prevalence; Risk Factors; Zimbabwe","Mutapi","Francisca","Institute of Immunology and Infection Research, University of Edinburgh, Ashworth Laboratories, King's Buildings, Charlotte Auerbach Road, Edinburgh, EH9 3FL, UK",NA
"2221","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Lichtner","Gregor","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charitéplatz 1, 10117, Berlin, Germany",NA
"2222","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Balzer","Felix","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charitéplatz 1, 10117, Berlin, Germany",NA
"2223","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Haufe","Stefan","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Klinik für Neurologie mit Experimenteller Neurologie, Berlin, Germany",NA
"2224","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Giesa","Niklas","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Medical Informatics, Berlin, Germany",NA
"2225","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Schiefenhövel","Fridtjof","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charitéplatz 1, 10117, Berlin, Germany",NA
"2226","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Schmieding","Malte","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charitéplatz 1, 10117, Berlin, Germany",NA
"2227","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Jurth","Carlo","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charitéplatz 1, 10117, Berlin, Germany",NA
"2228","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Kopp","Wolfgang","Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany",NA
"2229","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Akalin","Altuna","Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany",NA
"2230","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Schaller","Stefan J","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charitéplatz 1, 10117, Berlin, Germany",NA
"2231","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Weber-Carstens","Steffen","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charitéplatz 1, 10117, Berlin, Germany",NA
"2232","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","Spies","Claudia","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charitéplatz 1, 10117, Berlin, Germany",NA
"2233","34168198","10.1038/s41598-021-92475-7","Predicting lethal courses in critically ill COVID-19 patients using a machine learning model trained on patients with non-COVID-19 viral pneumonia.","In a pandemic with a novel disease, disease-specific prognosis models are available only with a delay. To bridge the critical early phase, models built for similar diseases might be applied. To test the accuracy of such a knowledge transfer, we investigated how precise lethal courses in critically ill COVID-19 patients can be predicted by a model trained on critically ill non-COVID-19 viral pneumonia patients. We trained gradient boosted decision tree models on 718 (245 deceased) non-COVID-19 vi","2021","07","07","Sci Rep","Scientific reports","Aged; COVID-19; Critical Illness; Female; Humans; Machine Learning; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Factors","von Dincklage","Falk","Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charitéplatz 1, 10117, Berlin, Germany. falk.von-dincklage@charite","dincklage@charite.de"
"2234","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Redhead","Martin A","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK. mredhead@exscientia.co","mredhead@exscientia.co.uk"
"2235","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Owen","C David","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK",NA
"2236","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Brewitz","Lennart","Department of Chemistry, Chemistry Research Laboratory,, The Ineos Oxford Institute for Antimicrobial Research, 12 Mansfield Road, Oxford, OX1 3TA, UK",NA
"2237","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Collette","Amelia H","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2238","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Lukacik","Petra","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK",NA
"2239","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Strain-Damerell","Claire","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK",NA
"2240","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Robinson","Sean W","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2241","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Collins","Patrick M","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2242","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Schäfer","Philipp","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2243","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Swindells","Mark","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2244","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Radoux","Chris J","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2245","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Hopkins","Iva Navratilova","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2246","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Fearon","Daren","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK",NA
"2247","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Douangamath","Alice","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK",NA
"2248","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","von Delft","Frank","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK",NA
"2249","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Malla","Tika R","Department of Chemistry, Chemistry Research Laboratory,, The Ineos Oxford Institute for Antimicrobial Research, 12 Mansfield Road, Oxford, OX1 3TA, UK",NA
"2250","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Vangeel","Laura","KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, 3000, Leuven, Belgium",NA
"2251","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Vercruysse","Thomas","KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, 3000, Leuven, Belgium",NA
"2252","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Thibaut","Jan","KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, 3000, Leuven, Belgium",NA
"2253","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Leyssen","Pieter","KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, 3000, Leuven, Belgium",NA
"2254","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Nguyen","Tu-Trinh","Calibr, Scripps Research, 11119 N Torrey Pines Road, La Jolla, CA, 92037, USA",NA
"2255","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Hull","Mitchell","Calibr, Scripps Research, 11119 N Torrey Pines Road, La Jolla, CA, 92037, USA",NA
"2256","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Tumber","Anthony","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2257","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Hallett","David J","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2258","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Schofield","Christopher J","Department of Chemistry, Chemistry Research Laboratory,, The Ineos Oxford Institute for Antimicrobial Research, 12 Mansfield Road, Oxford, OX1 3TA, UK",NA
"2259","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Stuart","David I","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK",NA
"2260","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Hopkins","Andrew L","Exscientia, The Schrödinger Building, Oxford Science Park, Oxford, OX4 4GE, UK",NA
"2261","34168183","10.1038/s41598-021-92416-4","Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.","Effective agents to treat coronavirus infection are urgently required, not only to treat COVID-19, but to prepare for future outbreaks. Repurposed anti-virals such as remdesivir and human anti-inflammatories such as barcitinib have received emergency approval but their overall benefits remain unclear. Vaccines are the most promising prospect for COVID-19, but will need to be redeveloped for any future coronavirus outbreak. Protecting against future outbreaks requires the identification of target","2021","07","07","Sci Rep","Scientific reports","Antiviral Agents; COVID-19; Cell Line; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Drug Repositioning; Humans; Oligopeptides; Serpins; Viral Proteins","Walsh","Martin A","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK. martin.walsh@diamond.ac","martin.walsh@diamond.ac.uk"
"2262","34168168","10.1038/s41598-021-92388-5","In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.","The devastating impact of the COVID-19 pandemic caused by SARS-coronavirus 2 (SARS-CoV-2) has raised important questions about its origins and the mechanism of its transfer to humans. A further question was whether companion or commercial animals could act as SARS-CoV-2 vectors, with early data suggesting susceptibility is species specific. To better understand SARS-CoV-2 species susceptibility, we undertook an in silico structural homology modelling, protein-protein docking, and molecular dynam","2021","07","07","Sci Rep","Scientific reports","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Protein Binding; Protein Conformation; Receptors, Virus; Species Specificity; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship","Piplani","Sakshi","College of Medicine and Public Health, Flinders University, Bedford Park, 5046, Australia",NA
"2263","34168168","10.1038/s41598-021-92388-5","In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.","The devastating impact of the COVID-19 pandemic caused by SARS-coronavirus 2 (SARS-CoV-2) has raised important questions about its origins and the mechanism of its transfer to humans. A further question was whether companion or commercial animals could act as SARS-CoV-2 vectors, with early data suggesting susceptibility is species specific. To better understand SARS-CoV-2 species susceptibility, we undertook an in silico structural homology modelling, protein-protein docking, and molecular dynam","2021","07","07","Sci Rep","Scientific reports","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Protein Binding; Protein Conformation; Receptors, Virus; Species Specificity; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship","Singh","Puneet Kumar","Vaxine Pty Ltd, 11 Walkley Avenue, Warradale, 5046, Australia",NA
"2264","34168168","10.1038/s41598-021-92388-5","In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.","The devastating impact of the COVID-19 pandemic caused by SARS-coronavirus 2 (SARS-CoV-2) has raised important questions about its origins and the mechanism of its transfer to humans. A further question was whether companion or commercial animals could act as SARS-CoV-2 vectors, with early data suggesting susceptibility is species specific. To better understand SARS-CoV-2 species susceptibility, we undertook an in silico structural homology modelling, protein-protein docking, and molecular dynam","2021","07","07","Sci Rep","Scientific reports","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Protein Binding; Protein Conformation; Receptors, Virus; Species Specificity; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship","Winkler","David A","Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3086, Australia. d.winkler@latrobe.edu","d.winkler@latrobe.edu.au"
"2265","34168168","10.1038/s41598-021-92388-5","In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.","The devastating impact of the COVID-19 pandemic caused by SARS-coronavirus 2 (SARS-CoV-2) has raised important questions about its origins and the mechanism of its transfer to humans. A further question was whether companion or commercial animals could act as SARS-CoV-2 vectors, with early data suggesting susceptibility is species specific. To better understand SARS-CoV-2 species susceptibility, we undertook an in silico structural homology modelling, protein-protein docking, and molecular dynam","2021","07","07","Sci Rep","Scientific reports","Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Protein Binding; Protein Conformation; Receptors, Virus; Species Specificity; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship","Petrovsky","Nikolai","College of Medicine and Public Health, Flinders University, Bedford Park, 5046, Australia. nikolai.petrovsky@flinders.edu","nikolai.petrovsky@flinders.edu.au"
"2266","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Cao","Changchang","Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"2267","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Cai","Zhaokui","Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"2268","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Xiao","Xia","National Health Commission of the People's Republic of China Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp",NA
"2269","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Rao","Jian","National Health Commission of the People's Republic of China Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp",NA
"2270","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Chen","Juan","Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"2271","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Hu","Naijing","Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"2272","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Yang","Minnan","CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"2273","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Xing","Xiaorui","CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"2274","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Wang","Yongle","CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"2275","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Li","Manman","School of Life Sciences, Henan Normal University, Xinxiang, China",NA
"2276","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Zhou","Bing","State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China",NA
"2277","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Wang","Xiangxi","CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China",NA
"2278","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Wang","Jianwei","National Health Commission of the People's Republic of China Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp","wangjw28@163.com"
"2279","34168138","10.1038/s41467-021-22785-x","The architecture of the SARS-CoV-2 RNA genome inside virion.","SARS-CoV-2 carries the largest single-stranded RNA genome and is the causal pathogen of the ongoing COVID-19 pandemic. How the SARS-CoV-2 RNA genome is folded in the virion remains unknown. To fill the knowledge gap and facilitate structure-based drug development, we develop a virion RNA in situ conformation sequencing technology, named vRIC-seq, for probing viral RNA genome structure unbiasedly. Using vRIC-seq data, we reconstruct the tertiary structure of the SARS-CoV-2 genome and reveal a sur","2021","07","19","Nat Commun","Nature communications","Animals; COVID-19; Cells, Cultured; Chlorocebus aethiops; Genome, Viral; Humans; Nucleic Acid Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, RNA; Virion","Xue","Yuanchao","Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. ycxue@ibp.ac","ycxue@ibp.ac.cn"
"2280","34168111","10.1038/s41387-021-00165-0","Nutrition and immunity: lessons for COVID-19.","The role of the immune system is to protect the individual against pathogenic organisms. Nutrition is one of multiple factors that determines the immune response and good nutrition is important in supporting the immune response. Immunity can be impaired in older people, particularly those who are frail, in those living with obesity, in those who are malnourished and in those with low intakes of micronutrients. The immune impairments associated with nutritional inadequacy increase susceptibility ","2021","07","08","Nutr Diabetes","Nutrition &amp; diabetes","COVID-19; Humans; Immune System; Malnutrition; Micronutrients; Nutritional Status","Calder","Philip C","School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. pcc@soton.ac","pcc@soton.ac.uk"
"2281","34168110","10.1038/s41387-021-00163-2","Diabetes and COVID19: a bidirectional relationship.","The advent and rapid spread of the coronavirus disease-2019 (COVID19) pandemic across the world has focused attention on the relationship of commonly occurring comorbidities such as diabetes on the course and outcomes of this infection. While diabetes does not seem to be associated with an increased risk of COVID19 infection per se, it has been clearly demonstrated that the presence of hyperglycemia of any degree predisposes to worse outcomes, such as more severe respiratory involvement, ICU adm","2021","07","08","Nutr Diabetes","Nutrition &amp; diabetes","Blood Glucose; COVID-19; Communicable Disease Control; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Pandemics","Unnikrishnan","Ranjit","Department of Diabetology, Dr. Mohan's Diabetes Specialities Centre &amp","drranjit@drmohans.com"
"2282","34168110","10.1038/s41387-021-00163-2","Diabetes and COVID19: a bidirectional relationship.","The advent and rapid spread of the coronavirus disease-2019 (COVID19) pandemic across the world has focused attention on the relationship of commonly occurring comorbidities such as diabetes on the course and outcomes of this infection. While diabetes does not seem to be associated with an increased risk of COVID19 infection per se, it has been clearly demonstrated that the presence of hyperglycemia of any degree predisposes to worse outcomes, such as more severe respiratory involvement, ICU adm","2021","07","08","Nutr Diabetes","Nutrition &amp; diabetes","Blood Glucose; COVID-19; Communicable Disease Control; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Pandemics","Misra","Anoop","Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India",NA
"2283","34168100","","Triglyceride regulate ACE2 level through MTHFD1.","Obesity has been followed with interest as a risk factor for COVID-19, with triglycerides as one of four common criteria used to define obesity, which have been used to study the mechanism of obesity. In this study, we showed that angiotensin-converting enzyme-2 (ACE2) is widely expressed in the mouse body, including the kidney, spleen, brain, heart, lung, liver, and testis, and that ACE2 levels increased after a high-fat diet. The ACE2 levels were recorded at 0 days, 3 days, 7 days, and 14 days","2021","06","30","J Biosci","Journal of biosciences","Angiotensin-Converting Enzyme 2; Animals; Biomarkers; COVID-19; Cell Line; Cell Survival; Diet, High-Fat; Formate-Tetrahydrofolate Ligase; Gene Expression Regulation; Humans; Male; Methenyltetrahydrofolate Cyclohydrolase; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mice, Inbred C57BL; Multifunctional Enzymes; Obesity; RNA, Messenger; Risk Factors; SARS-CoV-2; Triglycerides","Ma","Xiaohua","Institute of Neuroscience, Soochow University, Suzhou, China",NA
"2284","34168100","","Triglyceride regulate ACE2 level through MTHFD1.","Obesity has been followed with interest as a risk factor for COVID-19, with triglycerides as one of four common criteria used to define obesity, which have been used to study the mechanism of obesity. In this study, we showed that angiotensin-converting enzyme-2 (ACE2) is widely expressed in the mouse body, including the kidney, spleen, brain, heart, lung, liver, and testis, and that ACE2 levels increased after a high-fat diet. The ACE2 levels were recorded at 0 days, 3 days, 7 days, and 14 days","2021","06","30","J Biosci","Journal of biosciences","Angiotensin-Converting Enzyme 2; Animals; Biomarkers; COVID-19; Cell Line; Cell Survival; Diet, High-Fat; Formate-Tetrahydrofolate Ligase; Gene Expression Regulation; Humans; Male; Methenyltetrahydrofolate Cyclohydrolase; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mice, Inbred C57BL; Multifunctional Enzymes; Obesity; RNA, Messenger; Risk Factors; SARS-CoV-2; Triglycerides","Li","Xiaojing","Institute of Neuroscience, Soochow University, Suzhou, China",NA
"2285","34168100","","Triglyceride regulate ACE2 level through MTHFD1.","Obesity has been followed with interest as a risk factor for COVID-19, with triglycerides as one of four common criteria used to define obesity, which have been used to study the mechanism of obesity. In this study, we showed that angiotensin-converting enzyme-2 (ACE2) is widely expressed in the mouse body, including the kidney, spleen, brain, heart, lung, liver, and testis, and that ACE2 levels increased after a high-fat diet. The ACE2 levels were recorded at 0 days, 3 days, 7 days, and 14 days","2021","06","30","J Biosci","Journal of biosciences","Angiotensin-Converting Enzyme 2; Animals; Biomarkers; COVID-19; Cell Line; Cell Survival; Diet, High-Fat; Formate-Tetrahydrofolate Ligase; Gene Expression Regulation; Humans; Male; Methenyltetrahydrofolate Cyclohydrolase; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mice, Inbred C57BL; Multifunctional Enzymes; Obesity; RNA, Messenger; Risk Factors; SARS-CoV-2; Triglycerides","Wan","B O","Institute of Neuroscience, Soochow University, Suzhou, China",NA
"2286","34168100","","Triglyceride regulate ACE2 level through MTHFD1.","Obesity has been followed with interest as a risk factor for COVID-19, with triglycerides as one of four common criteria used to define obesity, which have been used to study the mechanism of obesity. In this study, we showed that angiotensin-converting enzyme-2 (ACE2) is widely expressed in the mouse body, including the kidney, spleen, brain, heart, lung, liver, and testis, and that ACE2 levels increased after a high-fat diet. The ACE2 levels were recorded at 0 days, 3 days, 7 days, and 14 days","2021","06","30","J Biosci","Journal of biosciences","Angiotensin-Converting Enzyme 2; Animals; Biomarkers; COVID-19; Cell Line; Cell Survival; Diet, High-Fat; Formate-Tetrahydrofolate Ligase; Gene Expression Regulation; Humans; Male; Methenyltetrahydrofolate Cyclohydrolase; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mice, Inbred C57BL; Multifunctional Enzymes; Obesity; RNA, Messenger; Risk Factors; SARS-CoV-2; Triglycerides","Miao","Zhigang","Institute of Neuroscience, Soochow University, Suzhou, China",NA
"2287","34168096","10.18632/aging.203159","<i>In silico</i> analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), and is highly contagious and pathogenic. TMPRSS2 and Neuropilin-1, the key components that facilitate SARS-CoV-2 infection, are potential targets for treatment of COVID-19. Here we performed a comprehensive analysis on NRP1 and TMPRSS2 in lung to provide information for treating comorbidity of COVID-19 with lung cancer. NRP1 is widely expressed across all the human tissues while TMPRSS2 i","2021","07","23","Aging (Albany NY)","Aging","COVID-19; NRP1; SARS-CoV-2; TMPRSS2; immune infiltration; miRNA; Adenocarcinoma of Lung; CD8-Positive T-Lymphocytes; COVID-19; Cancer-Associated Fibroblasts; Computer Simulation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Macrophages; Neuropilin-1; RNA-Seq; SARS-CoV-2; Serine Endopeptidases","Hu","Song","Molecular Cancer Research Center, School of Medicine, Sun Yat-Sen University, Shenzhen 518107, Guangdong, China",NA
"2288","34168096","10.18632/aging.203159","<i>In silico</i> analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), and is highly contagious and pathogenic. TMPRSS2 and Neuropilin-1, the key components that facilitate SARS-CoV-2 infection, are potential targets for treatment of COVID-19. Here we performed a comprehensive analysis on NRP1 and TMPRSS2 in lung to provide information for treating comorbidity of COVID-19 with lung cancer. NRP1 is widely expressed across all the human tissues while TMPRSS2 i","2021","07","23","Aging (Albany NY)","Aging","COVID-19; NRP1; SARS-CoV-2; TMPRSS2; immune infiltration; miRNA; Adenocarcinoma of Lung; CD8-Positive T-Lymphocytes; COVID-19; Cancer-Associated Fibroblasts; Computer Simulation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Macrophages; Neuropilin-1; RNA-Seq; SARS-CoV-2; Serine Endopeptidases","Hu","Zheyu","Molecular Cancer Research Center, School of Medicine, Sun Yat-Sen University, Shenzhen 518107, Guangdong, China",NA
"2289","34168096","10.18632/aging.203159","<i>In silico</i> analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), and is highly contagious and pathogenic. TMPRSS2 and Neuropilin-1, the key components that facilitate SARS-CoV-2 infection, are potential targets for treatment of COVID-19. Here we performed a comprehensive analysis on NRP1 and TMPRSS2 in lung to provide information for treating comorbidity of COVID-19 with lung cancer. NRP1 is widely expressed across all the human tissues while TMPRSS2 i","2021","07","23","Aging (Albany NY)","Aging","COVID-19; NRP1; SARS-CoV-2; TMPRSS2; immune infiltration; miRNA; Adenocarcinoma of Lung; CD8-Positive T-Lymphocytes; COVID-19; Cancer-Associated Fibroblasts; Computer Simulation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Macrophages; Neuropilin-1; RNA-Seq; SARS-CoV-2; Serine Endopeptidases","Qin","Jiajia","Molecular Cancer Research Center, School of Medicine, Sun Yat-Sen University, Shenzhen 518107, Guangdong, China",NA
"2290","34168096","10.18632/aging.203159","<i>In silico</i> analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), and is highly contagious and pathogenic. TMPRSS2 and Neuropilin-1, the key components that facilitate SARS-CoV-2 infection, are potential targets for treatment of COVID-19. Here we performed a comprehensive analysis on NRP1 and TMPRSS2 in lung to provide information for treating comorbidity of COVID-19 with lung cancer. NRP1 is widely expressed across all the human tissues while TMPRSS2 i","2021","07","23","Aging (Albany NY)","Aging","COVID-19; NRP1; SARS-CoV-2; TMPRSS2; immune infiltration; miRNA; Adenocarcinoma of Lung; CD8-Positive T-Lymphocytes; COVID-19; Cancer-Associated Fibroblasts; Computer Simulation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Macrophages; Neuropilin-1; RNA-Seq; SARS-CoV-2; Serine Endopeptidases","Lin","Chuwen","Molecular Cancer Research Center, School of Medicine, Sun Yat-Sen University, Shenzhen 518107, Guangdong, China",NA
"2291","34168096","10.18632/aging.203159","<i>In silico</i> analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), and is highly contagious and pathogenic. TMPRSS2 and Neuropilin-1, the key components that facilitate SARS-CoV-2 infection, are potential targets for treatment of COVID-19. Here we performed a comprehensive analysis on NRP1 and TMPRSS2 in lung to provide information for treating comorbidity of COVID-19 with lung cancer. NRP1 is widely expressed across all the human tissues while TMPRSS2 i","2021","07","23","Aging (Albany NY)","Aging","COVID-19; NRP1; SARS-CoV-2; TMPRSS2; immune infiltration; miRNA; Adenocarcinoma of Lung; CD8-Positive T-Lymphocytes; COVID-19; Cancer-Associated Fibroblasts; Computer Simulation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Macrophages; Neuropilin-1; RNA-Seq; SARS-CoV-2; Serine Endopeptidases","Jiang","Xuan","Molecular Cancer Research Center, School of Medicine, Sun Yat-Sen University, Shenzhen 518107, Guangdong, China",NA
"2292","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Lazari","Lucas Cardoso","Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2293","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Ghilardi","Fabio De Rose","Instituto de Medicina Tropical, University of São Paulo, São Paulo, Brazil",NA
"2294","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Rosa-Fernandes","Livia","Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2295","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Assis","Diego M","Bruker do Brasil, Atibaia, São Paulo, Brazil",NA
"2296","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Nicolau","José Carlos","Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil",NA
"2297","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Santiago","Veronica Feijoli","Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2298","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Dalçóquio","Talia Falcão","Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil",NA
"2299","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Angeli","Claudia B","Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2300","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Bertolin","Adriadne Justi","Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil",NA
"2301","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Marinho","Claudio Rf","Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2302","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Wrenger","Carsten","Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2303","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Durigon","Edison Luiz","Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2304","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Siciliano","Rinaldo Focaccia","Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil",NA
"2305","34168074","10.26508/lsa.202000946","Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.","SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis p","2021","07","19","Life Sci Alliance","Life science alliance","Adult; Aged; Biomarkers; COVID-19; Female; Humans; Machine Learning; Male; Middle Aged; Pandemics; Prognosis; Proteome; Proteomics; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Serum Amyloid A Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","Palmisano","Giuseppe","Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil palmisano.gp@gmail.com palmisano.gp@usp","palmisano.gp@gmail.com"
"2306","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Gobeil","Sophie M-C","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2307","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Janowska","Katarzyna","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2308","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"McDowell","Shana","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2309","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Mansouri","Katayoun","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2310","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Parks","Robert","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2311","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Stalls","Victoria","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2312","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Kopp","Megan F","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2313","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Manne","Kartik","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2314","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Li","Dapeng","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2315","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Wiehe","Kevin","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2316","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Saunders","Kevin O","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2317","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Edwards","Robert J","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2318","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Korber","Bette","Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA",NA
"2319","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Haynes","Barton F","Duke Human Vaccine Institute, Durham, NC 27710, USA",NA
"2320","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Henderson","Rory","Duke Human Vaccine Institute, Durham, NC 27710, USA. rory.henderson@duke.edu priyamvada.acharya@duke","rory.henderson@duke.edu"
"2321","34168071","10.1126/science.abi6226","Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.","SARS-CoV-2 variants with multiple spike mutations enable increased transmission and antibody resistance. Here, we combine cryo-EM, binding and computational analyses to study variant spikes, including one that was involved in transmission between minks and humans, and others that originated and spread in human populations. All variants showed increased ACE2 receptor binding and increased propensity for RBD up states. While adaptation to mink resulted in spike destabilization, the B.1.1.7 (UK) sp","2021","07","07","Science","Science (New York, N.Y.)",NA,"Acharya","Priyamvada","Duke Human Vaccine Institute, Durham, NC 27710, USA. rory.henderson@duke.edu priyamvada.acharya@duke","rory.henderson@duke.edu"
"2322","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Cai","Yongfei","Division of Molecular Medicine, Boston Children's Hospital, 3 Blackfan Street, Boston, MA 02115, USA",NA
"2323","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Zhang","Jun","Division of Molecular Medicine, Boston Children's Hospital, 3 Blackfan Street, Boston, MA 02115, USA",NA
"2324","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Xiao","Tianshu","Division of Molecular Medicine, Boston Children's Hospital, 3 Blackfan Street, Boston, MA 02115, USA",NA
"2325","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Lavine","Christy L","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA",NA
"2326","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Rawson","Shaun","SBGrid Consortium, Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA",NA
"2327","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Peng","Hanqin","Division of Molecular Medicine, Boston Children's Hospital, 3 Blackfan Street, Boston, MA 02115, USA",NA
"2328","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Zhu","Haisun","Institute for Protein Innovation, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115, USA",NA
"2329","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Anand","Krishna","Institute for Protein Innovation, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115, USA",NA
"2330","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Tong","Pei","Division of Allergy and Immunology and Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA",NA
"2331","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Gautam","Avneesh","Division of Allergy and Immunology and Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA",NA
"2332","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Lu","Shen","Codex BioSolutions, Inc., 401 Professional Drive, Gaithersburg, MD 20879, USA",NA
"2333","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Sterling","Sarah M","The Harvard Cryo-EM Center for Structural Biology, Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA",NA
"2334","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Walsh","Richard M","The Harvard Cryo-EM Center for Structural Biology, Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA",NA
"2335","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Rits-Volloch","Sophia","Division of Molecular Medicine, Boston Children's Hospital, 3 Blackfan Street, Boston, MA 02115, USA",NA
"2336","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Lu","Jianming","Codex BioSolutions, Inc., 401 Professional Drive, Gaithersburg, MD 20879, USA",NA
"2337","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Wesemann","Duane R","Division of Allergy and Immunology and Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA",NA
"2338","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Yang","Wei","Institute for Protein Innovation, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115, USA",NA
"2339","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Seaman","Michael S","Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA",NA
"2340","34168070","10.1126/science.abi9745","Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.","Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-convertin","2021","06","29","Science","Science (New York, N.Y.)",NA,"Chen","Bing","Division of Molecular Medicine, Boston Children's Hospital, 3 Blackfan Street, Boston, MA 02115, USA. bchen@crystal.harvard","bchen@crystal.harvard.edu"
"2341","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Tripathi","Sandeep","Children's Hospital of Illinois, OSF Saint Francis Medical Centre, Peoria, Illinois","sandeept@uic.edu"
"2342","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Christison","Amy L","University of Illinois College of Medicine, Peoria, Illinois",NA
"2343","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Levy","Emily","Mayo Clinic, Rochester, Minnesota",NA
"2344","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"McGravery","Jeremy","OSF Saint Francis Medical Centre, Peoria, Illinois",NA
"2345","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Tekin","Aysun","Mayo Clinic, Rochester, Minnesota",NA
"2346","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Bolliger","Dawn","OSF Saint Francis Medical Centre, Peoria, Illinois",NA
"2347","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Kumar","Vishakha K","Society of Critical Care Medicine, Mount Prospect IL",NA
"2348","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Bansal","Vikas","Mayo Clinic, Rochester, Minnesota",NA
"2349","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Chiotos","Kathleen","Children's Hospital of Philadelphia",NA
"2350","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Gist","Katja M","University of Colorado Anschutz Medical Campus",NA
"2351","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Dapul","Heda R","Hassenfeld Children's Hospital at NYU Langone",NA
"2352","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Bhalala","Utpal S","The Children's Hospital of San Antonio, Baylor College of Medicine",NA
"2353","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Gharpure","Varsha P","Advocate Children's Hospital, IL",NA
"2354","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Heneghan","Julia A","University of Minnesota Masonic Children's Hospital",NA
"2355","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Gupta","Neha","University of Oklahoma College of Medicine, OK",NA
"2356","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Bjornstad","Erica C","University of Alabama at Birmingham, AL",NA
"2357","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Montgomery","Vicki L","University of Louisville and Norton Children's Hospital Louisville, KY",NA
"2358","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Walkey","Allan","Boston University School of Public Health, Boston, Massachusetts",NA
"2359","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Kashyap","Rahul","Mayo Clinic, Rochester, Minnesota",NA
"2360","34168067","10.1542/hpeds.2021-006087","The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children with COVID-19.",NA,"2021","06","25","Hosp Pediatr","Hospital pediatrics",NA,"Arteaga","Grace M","Mayo Clinic, Rochester, Minnesota",NA
"2361","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Arrambide","Georgina","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2362","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Llaneza-González","Miguel Ángel","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2363","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Costa-Frossard França","Lucienne","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2364","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Meca-Lallana","Virginia","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona","pmecal@gmail.com"
"2365","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Díaz","Eva Fernández-","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2366","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Moreno-Torres","Irene","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2367","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","García-Domínguez","Jose Manuel","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2368","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Ortega-Suero","Gloria","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2369","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Ayuso-Peralta","Lucía","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2370","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Gómez-Moreno","Mayra","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2371","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Sotoca-Fernández","Javier J","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2372","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Caminero-Rodríguez","Ana Belén","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2373","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Rodríguez de Antonio","Luis A","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2374","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Corujo-Suárez","Marcial","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2375","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Otano-Martínez","María A","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2376","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Pérez-Miralles","Francisco Carlos","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2377","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Reyes-Garrido","Virginia","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2378","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Ayuso-Blanco","Teresa","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2379","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Balseiro-Gómez","José Jesús","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2380","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Muñoz-Pasadas","Mercedes","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2381","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Pérez-Molina","Inmaculada","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2382","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Arnal-García","Carmen","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2383","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Domingo-Santos","Ángela","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2384","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Guijarro-Castro","Cristina","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2385","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Íñiguez-Martínez","Cristina","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2386","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Téllez Lara","Nieves","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2387","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Castellanos-Pinedo","Fernando","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2388","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Castillo-Triviño","Tamara","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2389","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Cerdán-Santacruz","Debora María","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2390","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Pérez-Sempere","Ángel","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2391","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Torres","Berta Sebastián","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2392","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Álvarez de Arcaya","Amaya","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2393","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Costa-Arpín","Eva","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2394","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Durán-Ferreras","Eduardo","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2395","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Fragoso-Martínez","Marta","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2396","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","González-Platas","Montserrat","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2397","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Landete Pascual","Lamberto","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2398","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Millán-Pascual","Jorge","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2399","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Oreja-Guevara","Celia","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona",NA
"2400","34168057","10.1212/NXI.0000000000001024","SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.","To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations between MS characteristics and CO","2021","07","02","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation","Adult; Age Factors; COVID-19; Comorbidity; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurology; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Societies, Medical; Spain","Meca-Lallana","José E","From the Centro de Esclerosis Múltiple de Cataluña (G.A.), (Cemcat), Instituto de Investigación Vall d'Hebron, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona","pmecal@gmail.com"
"2401","34168043","10.1136/bmjgast-2020-000568","Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD).","COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to sup","2021","07","07","BMJ Open Gastroenterol","BMJ open gastroenterology","fatty liver; fibrosis; infectious disease; nonalcoholic steatohepatitis; obesity; COVID-19; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Diet, Healthy; Exercise Therapy; Female; Humans; Male; Non-alcoholic Fatty Liver Disease; Obesity; Pandemics; Physical Distancing; Quarantine; Risk Factors; SARS-CoV-2; Severity of Illness Index","O'Gorman","Philip","School of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland",NA
"2402","34168043","10.1136/bmjgast-2020-000568","Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD).","COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to sup","2021","07","07","BMJ Open Gastroenterol","BMJ open gastroenterology","fatty liver; fibrosis; infectious disease; nonalcoholic steatohepatitis; obesity; COVID-19; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Diet, Healthy; Exercise Therapy; Female; Humans; Male; Non-alcoholic Fatty Liver Disease; Obesity; Pandemics; Physical Distancing; Quarantine; Risk Factors; SARS-CoV-2; Severity of Illness Index","Norris","Suzanne","Department of Hepatology, St James's Hospital, Dublin, Ireland SNorris@stjames","SNorris@stjames.ie"
"2403","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Burgess","Hannah M","Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA",NA
"2404","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Depledge","Daniel P","Department of Medicine, New York University School of Medicine, New York, New York 10016, USA",NA
"2405","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Thompson","Letitia","Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA",NA
"2406","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Srinivas","Kalanghad Puthankalam","Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA",NA
"2407","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Grande","Rebecca C","Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA",NA
"2408","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Vink","Elizabeth I","Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA",NA
"2409","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Abebe","Jonathan S","Department of Medicine, New York University School of Medicine, New York, New York 10016, USA",NA
"2410","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Blackaby","Wesley P","Storm Therapeutics Ltd, Cambridge CB22 3AT, United Kingdom",NA
"2411","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Hendrick","Alan","Storm Therapeutics Ltd, Cambridge CB22 3AT, United Kingdom",NA
"2412","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Albertella","Mark R","Storm Therapeutics Ltd, Cambridge CB22 3AT, United Kingdom",NA
"2413","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Kouzarides","Tony","The Gurdon Institute, Department of Pathology, University of Cambridge, Cambridge CB2 1QN, United Kingdom",NA
"2414","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Stapleford","Kenneth A","Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA",NA
"2415","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Wilson","Angus C","Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA",NA
"2416","34168039","10.1101/gad.348320.121","Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.","N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m<sup>6</sup>A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m<sup>6</sup>A-modified. How the cellular m<sup>6</sup>A modification machinery impacts coronavirus replication, which occurs exclusively in the cytoplasm, is unknow","2021","07","08","Genes Dev","Genes &amp; development","HCoV-OC43; N6-methyladenosine; RNA modification; SARS-CoV-2; coronavirus; direct RNA sequencing; nanopore sequencing; virushost interactions; Adenosine; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Methyltransferases; Nucleocapsid Proteins; RNA Processing, Post-Transcriptional; RNA, Viral; RNA-Binding Proteins; SARS-CoV-2; Virus Replication","Mohr","Ian","Department of Microbiology, New York University School of Medicine, New York, New York 10016, USA",NA
"2417","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Lunney","Meaghan","Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",NA
"2418","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Ronksley","Paul E","Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",NA
"2419","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Weaver","Robert G","Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",NA
"2420","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Barnieh","Lianne","Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",NA
"2421","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Blue","Norman","Office of the Chief Medical Officer of Health, Alberta Health, Government of Alberta, Edmonton, Alberta, Canada",NA
"2422","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Avey","Marc T","Public Health Agency of Canada, Ottawa, Ontario, Canada",NA
"2423","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Rolland-Harris","Elizabeth","Public Health Agency of Canada, Ottawa, Ontario, Canada",NA
"2424","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Khan","Faisal M","Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",NA
"2425","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Pang","Jack X Q","Provincial Population and Public Health, Alberta Health Services, Calgary, Alberta, Canada",NA
"2426","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Rafferty","Ellen","Analytics &amp",NA
"2427","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Scory","Tayler D","Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",NA
"2428","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Svenson","Lawrence W","Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",NA
"2429","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Rodin","Rachel","Public Health Agency of Canada, Ottawa, Ontario, Canada",NA
"2430","34168036","10.1136/bmjopen-2021-050667","COVID-19 infection among international travellers: a prospective analysis.","This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. Prospective analysis of international asymptomatic travellers entering Alberta, Canada. All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarant","2021","06","28","BMJ Open","BMJ open","COVID-19; health policy; public health; Alberta; COVID-19; Humans; Prospective Studies; SARS-CoV-2","Tonelli","Marcello","Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada cello@ucalgary","cello@ucalgary.ca"
"2431","34168031","10.1136/bmjopen-2020-048416","Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.","Evaluation of remdesivir, an RNA polymerase inhibitor, for effectiveness in adults with COVID-19. Electronic search for eligible articles of PubMed, Cochrane Central and clinicaltrials.gov was performed on 20 September 2020. Only randomised controlled trials (RCTs) evaluating efficacy of remdesivir in COVID-19 were included for meta-analysis. Remdesivir was compared with standard of care. Primary outcome was mortality and secondary outcomes were time to clinical improvement and safety outcomes l","2021","06","28","BMJ Open","BMJ open","COVID-19; clinical pharmacology; immunology; respiratory infections; Adenosine Monophosphate; Adult; Alanine; COVID-19; Humans; SARS-CoV-2","Singh","Surjit","Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India",NA
"2432","34168031","10.1136/bmjopen-2020-048416","Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.","Evaluation of remdesivir, an RNA polymerase inhibitor, for effectiveness in adults with COVID-19. Electronic search for eligible articles of PubMed, Cochrane Central and clinicaltrials.gov was performed on 20 September 2020. Only randomised controlled trials (RCTs) evaluating efficacy of remdesivir in COVID-19 were included for meta-analysis. Remdesivir was compared with standard of care. Primary outcome was mortality and secondary outcomes were time to clinical improvement and safety outcomes l","2021","06","28","BMJ Open","BMJ open","COVID-19; clinical pharmacology; immunology; respiratory infections; Adenosine Monophosphate; Adult; Alanine; COVID-19; Humans; SARS-CoV-2","Khera","Daisy","Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India",NA
"2433","34168031","10.1136/bmjopen-2020-048416","Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.","Evaluation of remdesivir, an RNA polymerase inhibitor, for effectiveness in adults with COVID-19. Electronic search for eligible articles of PubMed, Cochrane Central and clinicaltrials.gov was performed on 20 September 2020. Only randomised controlled trials (RCTs) evaluating efficacy of remdesivir in COVID-19 were included for meta-analysis. Remdesivir was compared with standard of care. Primary outcome was mortality and secondary outcomes were time to clinical improvement and safety outcomes l","2021","06","28","BMJ Open","BMJ open","COVID-19; clinical pharmacology; immunology; respiratory infections; Adenosine Monophosphate; Adult; Alanine; COVID-19; Humans; SARS-CoV-2","Chugh","Ankita","Department of Dentistry, All India Institute of Medical Sciences, New Delhi, India ankitamody@gmail","ankitamody@gmail.com"
"2434","34168031","10.1136/bmjopen-2020-048416","Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.","Evaluation of remdesivir, an RNA polymerase inhibitor, for effectiveness in adults with COVID-19. Electronic search for eligible articles of PubMed, Cochrane Central and clinicaltrials.gov was performed on 20 September 2020. Only randomised controlled trials (RCTs) evaluating efficacy of remdesivir in COVID-19 were included for meta-analysis. Remdesivir was compared with standard of care. Primary outcome was mortality and secondary outcomes were time to clinical improvement and safety outcomes l","2021","06","28","BMJ Open","BMJ open","COVID-19; clinical pharmacology; immunology; respiratory infections; Adenosine Monophosphate; Adult; Alanine; COVID-19; Humans; SARS-CoV-2","Khera","Pushpinder Singh","Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, New Delhi, India",NA
"2435","34168031","10.1136/bmjopen-2020-048416","Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.","Evaluation of remdesivir, an RNA polymerase inhibitor, for effectiveness in adults with COVID-19. Electronic search for eligible articles of PubMed, Cochrane Central and clinicaltrials.gov was performed on 20 September 2020. Only randomised controlled trials (RCTs) evaluating efficacy of remdesivir in COVID-19 were included for meta-analysis. Remdesivir was compared with standard of care. Primary outcome was mortality and secondary outcomes were time to clinical improvement and safety outcomes l","2021","06","28","BMJ Open","BMJ open","COVID-19; clinical pharmacology; immunology; respiratory infections; Adenosine Monophosphate; Adult; Alanine; COVID-19; Humans; SARS-CoV-2","Chugh","Vinay Kumar","Department of Dentistry, All India Institute of Medical Sciences, New Delhi, India",NA
"2436","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Wang","Xianglan","Department of Psychiatry, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China",NA
"2437","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Tao","Jiong","Department of Psychiatry, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China",NA
"2438","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Zhu","Qi","Department of Psychiatry, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China",NA
"2439","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Wu","Xiuhua","Department of Psychiatry, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China",NA
"2440","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Li","Tong","Department of Psychiatry, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China",NA
"2441","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Zhao","Chongbang","Department of Psychiatry, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China",NA
"2442","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Yang","Weirui","Department of Psychiatry, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China",NA
"2443","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Wang","Xiaoying","Department of Artificial Intelligence, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China kuwanhong@163.com 18680501034@163","kuwanhong@163.com"
"2444","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Zhang","Jinbei","Department of Psychiatry, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China",NA
"2445","34168028","10.1136/bmjopen-2020-046350","Depression and anxiety symptoms to COVID-19 outbreak among the public, medical staff and patients during the initial phase of the pandemic: an online questionnaire survey by a WeChat Mini Program.","To survey anxiety and depression symptoms to COVID-19 outbreak in the public, medical staff and patients during the initial phase of the pandemic. Cross-sectional online survey administered through WeChat Mini Program using Chinese versions of Zung Self-rating Depression Scale and Zung Self-rating Anxiety Scale. Guangzhou, China. 47 378 public, 1512 medical staff and 125 patients with COVID-19. Higher rates of depression (47.8%) and anxiety symptoms (48.7%) were shown by patients who were screen","2021","06","28","BMJ Open","BMJ open","epidemiology; mental health; psychiatry; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Medical Staff; Pandemics; Prevalence; SARS-CoV-2; Surveys and Questionnaires","Guan","Nianhong","Department of Psychiatry, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China kuwanhong@163.com 18680501034@163","kuwanhong@163.com"
"2446","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","McNamara","Elissa","Department of General Medicine, The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2447","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Saxon","Leanne","Melbourne Academic Centre for Health, Parkville, Victoria, Australia",NA
"2448","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Bond","Katherine","Department of Microbiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2449","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Campbell","Bruce Cv","Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia",NA
"2450","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Douglass","Jo","The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2451","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Dutch","Martin J","Centre for Integrated Critical Care Research, University of Melbourne, Melbourne, Victoria, Australia",NA
"2452","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Grigg","Leeanne","Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2453","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Johnson","Douglas","Department of General Medicine, The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2454","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Knott","Jonathan C","Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia",NA
"2455","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Koye","Digsu N","The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2456","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Putland","Mark","Department of Emergency Medicine, The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2457","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Read","David J","Trauma and Colorectal Units, The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2458","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Smith","Benjamin","Victorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia",NA
"2459","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Thomson","Benjamin Nj","University of Melbourne Department of Surgery, The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2460","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Williamson","Deborah A","Department of Microbiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2461","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Tong","Steven Yc","Victorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia Steven.Tong@mh.org","Steven.Tong@mh.org.au"
"2462","34168026","10.1136/bmjopen-2020-045975","Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.","The threat of a pandemic, over and above the disease itself, may have significant and broad effects on a healthcare system. We aimed to describe the impact of the SARS-CoV-2 pandemic (during a relatively low transmission period) and associated societal restrictions on presentations, admissions and outpatient visits. We compared hospital activity in 2020 with the preceding 5 years, 2015-2019, using a retrospective cohort study design. Quaternary hospital in Melbourne, Australia. Emergency departm","2021","06","28","BMJ Open","BMJ open","COVID-19; health services administration &amp; management; public health; Australia; COVID-19; Emergency Service, Hospital; Humans; Retrospective Studies; SARS-CoV-2; Telemedicine","Fazio","Timothy N","Department of General Medicine, The Royal Melbourne Hospital, Melbourne, Victoria, Australia",NA
"2464","34168002","10.1136/bmj.n1626","Covid-19: Third of people infected have long term symptoms.",NA,"2021","06","28","BMJ","BMJ (Clinical research ed.)",NA,"O'Dowd","Adrian","London",NA
"2465","34167998","10.1136/bcr-2021-244232","Rhino-orbital mucormycosis in a COVID-19 patient.",NA,"2021","06","30","BMJ Case Rep","BMJ case reports","COVID-19; Ear; Nose and throat/otolaryngology; Tropical medicine (infectious disease); COVID-19; Humans; Mucormycosis; Nose Diseases; Orbital Diseases; SARS-CoV-2","Baskar","Harithraa Cheniappangoundar","Department of Otorhinolaryngology &amp",NA
"2466","34167998","10.1136/bcr-2021-244232","Rhino-orbital mucormycosis in a COVID-19 patient.",NA,"2021","06","30","BMJ Case Rep","BMJ case reports","COVID-19; Ear; Nose and throat/otolaryngology; Tropical medicine (infectious disease); COVID-19; Humans; Mucormycosis; Nose Diseases; Orbital Diseases; SARS-CoV-2","Chandran","Aswin","Department of Otorhinolaryngology &amp","ashjipmer@gmail.com"
"2467","34167998","10.1136/bcr-2021-244232","Rhino-orbital mucormycosis in a COVID-19 patient.",NA,"2021","06","30","BMJ Case Rep","BMJ case reports","COVID-19; Ear; Nose and throat/otolaryngology; Tropical medicine (infectious disease); COVID-19; Humans; Mucormycosis; Nose Diseases; Orbital Diseases; SARS-CoV-2","Reddy","Chandra Shekar","Department of Otorhinolaryngology &amp",NA
"2468","34167998","10.1136/bcr-2021-244232","Rhino-orbital mucormycosis in a COVID-19 patient.",NA,"2021","06","30","BMJ Case Rep","BMJ case reports","COVID-19; Ear; Nose and throat/otolaryngology; Tropical medicine (infectious disease); COVID-19; Humans; Mucormycosis; Nose Diseases; Orbital Diseases; SARS-CoV-2","Singh","Shuchita","Department of Otorhinolaryngology &amp",NA
"2469","34167987","10.1136/bcr-2021-243157","Catastrophic bilateral sudden sensorineural hearing loss following COVID-19.","Since December 2019, when it was first detected in Wuhan, the SARS-CoV-2 (COVID-19) has spread across the globe. The pandemic has had an unprecedented impact on the global population with &gt;110 million confirmed cases and 2.5 million deaths. The most common initial symptoms of COVID-19 infection are cough, dyspnoea, fever, malaise and anosmia. Severe clinical manifestations include respiratory compromise, pneumonia, organ failure and death. There have been many other less common symptoms as a ","2021","06","28","BMJ Case Rep","BMJ case reports","COVID-19; ear; neurootology; nose and throat; nose and throat/otolaryngology; otolaryngology / ENT; Aged; COVID-19; Hearing Loss, Bilateral; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; SARS-CoV-2","Edwards","Michael","Department of Otolaryngology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK michael.edwards19@nhs","michael.edwards19@nhs.net"
"2470","34167987","10.1136/bcr-2021-243157","Catastrophic bilateral sudden sensorineural hearing loss following COVID-19.","Since December 2019, when it was first detected in Wuhan, the SARS-CoV-2 (COVID-19) has spread across the globe. The pandemic has had an unprecedented impact on the global population with &gt;110 million confirmed cases and 2.5 million deaths. The most common initial symptoms of COVID-19 infection are cough, dyspnoea, fever, malaise and anosmia. Severe clinical manifestations include respiratory compromise, pneumonia, organ failure and death. There have been many other less common symptoms as a ","2021","06","28","BMJ Case Rep","BMJ case reports","COVID-19; ear; neurootology; nose and throat; nose and throat/otolaryngology; otolaryngology / ENT; Aged; COVID-19; Hearing Loss, Bilateral; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; SARS-CoV-2","Muzaffar","Jameel","Department of Otolaryngology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK",NA
"2471","34167987","10.1136/bcr-2021-243157","Catastrophic bilateral sudden sensorineural hearing loss following COVID-19.","Since December 2019, when it was first detected in Wuhan, the SARS-CoV-2 (COVID-19) has spread across the globe. The pandemic has had an unprecedented impact on the global population with &gt;110 million confirmed cases and 2.5 million deaths. The most common initial symptoms of COVID-19 infection are cough, dyspnoea, fever, malaise and anosmia. Severe clinical manifestations include respiratory compromise, pneumonia, organ failure and death. There have been many other less common symptoms as a ","2021","06","28","BMJ Case Rep","BMJ case reports","COVID-19; ear; neurootology; nose and throat; nose and throat/otolaryngology; otolaryngology / ENT; Aged; COVID-19; Hearing Loss, Bilateral; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; SARS-CoV-2","Naik","Paresh","Department of Otolaryngology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK",NA
"2472","34167987","10.1136/bcr-2021-243157","Catastrophic bilateral sudden sensorineural hearing loss following COVID-19.","Since December 2019, when it was first detected in Wuhan, the SARS-CoV-2 (COVID-19) has spread across the globe. The pandemic has had an unprecedented impact on the global population with &gt;110 million confirmed cases and 2.5 million deaths. The most common initial symptoms of COVID-19 infection are cough, dyspnoea, fever, malaise and anosmia. Severe clinical manifestations include respiratory compromise, pneumonia, organ failure and death. There have been many other less common symptoms as a ","2021","06","28","BMJ Case Rep","BMJ case reports","COVID-19; ear; neurootology; nose and throat; nose and throat/otolaryngology; otolaryngology / ENT; Aged; COVID-19; Hearing Loss, Bilateral; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; SARS-CoV-2","Coulson","Christopher","Department of Otolaryngology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK",NA
"2473","34167963","10.1136/bmjgh-2021-006362","Local manufacturing, local supply chains and health security in Africa: lessons from COVID-19.",NA,"2021","06","30","BMJ Glob Health","BMJ global health","COVID-19; health policies and all other topics; health policy; health systems; public health; Africa; COVID-19; Humans; SARS-CoV-2","Banda","Geoffrey","Science, Technology and Innovation Studies, The University of Edinburgh, School of Social and Political Science, Edinburgh, UK Geoffrey.Banda@ed.ac","Geoffrey.Banda@ed.ac.uk"
"2474","34167963","10.1136/bmjgh-2021-006362","Local manufacturing, local supply chains and health security in Africa: lessons from COVID-19.",NA,"2021","06","30","BMJ Glob Health","BMJ global health","COVID-19; health policies and all other topics; health policy; health systems; public health; Africa; COVID-19; Humans; SARS-CoV-2","Mugwagwa","Julius","Science, Technology, Engineering and Public Policy, University College London, London, UK",NA
"2475","34167963","10.1136/bmjgh-2021-006362","Local manufacturing, local supply chains and health security in Africa: lessons from COVID-19.",NA,"2021","06","30","BMJ Glob Health","BMJ global health","COVID-19; health policies and all other topics; health policy; health systems; public health; Africa; COVID-19; Humans; SARS-CoV-2","Wanjala","Cecilia","Commercial Enterprise Department, KEMRI - Kenyan Medical Research Institute, Nairobi, Kenya",NA
"2476","34167963","10.1136/bmjgh-2021-006362","Local manufacturing, local supply chains and health security in Africa: lessons from COVID-19.",NA,"2021","06","30","BMJ Glob Health","BMJ global health","COVID-19; health policies and all other topics; health policy; health systems; public health; Africa; COVID-19; Humans; SARS-CoV-2","Mackintosh","Maureen","Faculty of Arts and Social Sciences, The Open University, Milton Keynes, UK",NA
"2477","34167963","10.1136/bmjgh-2021-006362","Local manufacturing, local supply chains and health security in Africa: lessons from COVID-19.",NA,"2021","06","30","BMJ Glob Health","BMJ global health","COVID-19; health policies and all other topics; health policy; health systems; public health; Africa; COVID-19; Humans; SARS-CoV-2","Kale","Dinar","Faculty of Arts and Social Sciences, The Open University, Milton Keynes, UK",NA
"2478","34167952","10.1136/bmj.n1635","Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?",NA,"2021","06","28","BMJ","BMJ (Clinical research ed.)",NA,"Wise","Jacqui","Tenterden, Kent",NA
"2479","34167947","10.1136/annrheumdis-2021-220834","Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.",NA,"2021","06","25","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; Methotrexate; Rheumatoid Arthritis; Vaccination","Albach","Fredrik N","Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany",NA
"2480","34167947","10.1136/annrheumdis-2021-220834","Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.",NA,"2021","06","25","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; Methotrexate; Rheumatoid Arthritis; Vaccination","Burmester","Gerd R","Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany",NA
"2481","34167947","10.1136/annrheumdis-2021-220834","Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.",NA,"2021","06","25","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; Methotrexate; Rheumatoid Arthritis; Vaccination","Biesen","Robert","Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany robert.biesen@charite","robert.biesen@charite.de"
"2482","34167945","10.1136/bmj.n1620","Covid-19: How the UK is using lateral flow tests in the pandemic.",NA,"2021","06","25","BMJ","BMJ (Clinical research ed.)",NA,NA,NA,NA,NA
"2483","34167942","10.1136/bmj.n1624","Lateral flow tests cannot rule out SARS-CoV-2 infection.",NA,"2021","06","25","BMJ","BMJ (Clinical research ed.)",NA,NA,NA,NA,NA
"2484","34167924","10.1016/j.rceng.2021.04.002","Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic.","Patients with type 2 diabetes mellitus (T2DM) are at increased risk for severe coronavirus disease 2019 (COVID-19) and related mortality. Glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have significant cardiovascular and renal benefits for patients with T2DM and related comorbidities. Their anti-inflammatory properties could be beneficial in these patients. This work provides less-biased estimates regarding the risk for respiratory tract infections and acute respiratory distress syndrome ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Agonistas del receptor del péptido similar al glucagón tipo 1; COVID-19; Diabetes mellitus tipo 2; Glucagon-like peptide-1 receptor agonists; Infección respiratoria; Neumonía; Pneumonia; Respiratory infection; Type 2 diabetes mellitus","Patoulias","D","Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital ""Hippokration"", Thessaloniki, Greece. Electronic address: dipatoulias@gmail","dipatoulias@gmail.com"
"2485","34167924","10.1016/j.rceng.2021.04.002","Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic.","Patients with type 2 diabetes mellitus (T2DM) are at increased risk for severe coronavirus disease 2019 (COVID-19) and related mortality. Glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have significant cardiovascular and renal benefits for patients with T2DM and related comorbidities. Their anti-inflammatory properties could be beneficial in these patients. This work provides less-biased estimates regarding the risk for respiratory tract infections and acute respiratory distress syndrome ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Agonistas del receptor del péptido similar al glucagón tipo 1; COVID-19; Diabetes mellitus tipo 2; Glucagon-like peptide-1 receptor agonists; Infección respiratoria; Neumonía; Pneumonia; Respiratory infection; Type 2 diabetes mellitus","Boulmpou","A","Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital ""Hippokration"", Thessaloniki, Greece",NA
"2486","34167924","10.1016/j.rceng.2021.04.002","Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic.","Patients with type 2 diabetes mellitus (T2DM) are at increased risk for severe coronavirus disease 2019 (COVID-19) and related mortality. Glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have significant cardiovascular and renal benefits for patients with T2DM and related comorbidities. Their anti-inflammatory properties could be beneficial in these patients. This work provides less-biased estimates regarding the risk for respiratory tract infections and acute respiratory distress syndrome ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Agonistas del receptor del péptido similar al glucagón tipo 1; COVID-19; Diabetes mellitus tipo 2; Glucagon-like peptide-1 receptor agonists; Infección respiratoria; Neumonía; Pneumonia; Respiratory infection; Type 2 diabetes mellitus","Imprialos","K","Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital ""Hippokration"", Thessaloniki, Greece",NA
"2487","34167924","10.1016/j.rceng.2021.04.002","Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic.","Patients with type 2 diabetes mellitus (T2DM) are at increased risk for severe coronavirus disease 2019 (COVID-19) and related mortality. Glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have significant cardiovascular and renal benefits for patients with T2DM and related comorbidities. Their anti-inflammatory properties could be beneficial in these patients. This work provides less-biased estimates regarding the risk for respiratory tract infections and acute respiratory distress syndrome ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Agonistas del receptor del péptido similar al glucagón tipo 1; COVID-19; Diabetes mellitus tipo 2; Glucagon-like peptide-1 receptor agonists; Infección respiratoria; Neumonía; Pneumonia; Respiratory infection; Type 2 diabetes mellitus","Stavropoulos","K","Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital ""Hippokration"", Thessaloniki, Greece",NA
"2488","34167924","10.1016/j.rceng.2021.04.002","Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic.","Patients with type 2 diabetes mellitus (T2DM) are at increased risk for severe coronavirus disease 2019 (COVID-19) and related mortality. Glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have significant cardiovascular and renal benefits for patients with T2DM and related comorbidities. Their anti-inflammatory properties could be beneficial in these patients. This work provides less-biased estimates regarding the risk for respiratory tract infections and acute respiratory distress syndrome ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Agonistas del receptor del péptido similar al glucagón tipo 1; COVID-19; Diabetes mellitus tipo 2; Glucagon-like peptide-1 receptor agonists; Infección respiratoria; Neumonía; Pneumonia; Respiratory infection; Type 2 diabetes mellitus","Papadopoulos","C","Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital ""Hippokration"", Thessaloniki, Greece",NA
"2489","34167924","10.1016/j.rceng.2021.04.002","Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic.","Patients with type 2 diabetes mellitus (T2DM) are at increased risk for severe coronavirus disease 2019 (COVID-19) and related mortality. Glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have significant cardiovascular and renal benefits for patients with T2DM and related comorbidities. Their anti-inflammatory properties could be beneficial in these patients. This work provides less-biased estimates regarding the risk for respiratory tract infections and acute respiratory distress syndrome ","2021","07","01","Rev Clin Esp (Barc)","Revista clinica espanola","Agonistas del receptor del péptido similar al glucagón tipo 1; COVID-19; Diabetes mellitus tipo 2; Glucagon-like peptide-1 receptor agonists; Infección respiratoria; Neumonía; Pneumonia; Respiratory infection; Type 2 diabetes mellitus","Doumas","M","Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital ""Hippokration"", Thessaloniki, Greece",NA
"2490","34167911","10.1016/j.surge.2021.04.005","A tale of three pandemics: Shining a light on a hidden problem.","An ""epidemic"" is an event in which a disease, infectious or non-infectious, is actively spreading within a population and designated area. The term ""pandemic"" is defined as ""an epidemic occurring worldwide, or over a very wide area, crossing international boundaries and usually affecting a large number of people"". The global response to the COVID-19 pandemic has not been seen since the outbreak of Human Immunodeficiency Virus in the early eighties. But there is another unseen pandemic running al","2021","06","25","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Human immunodeficiency virus; Injuries; Pandemic; Trauma","Graham","Simon Matthew","Institute of Population Health, University of Liverpool, Liverpool, UK","S.M.Graham@liverpool.ac.uk"
"2491","34167911","10.1016/j.surge.2021.04.005","A tale of three pandemics: Shining a light on a hidden problem.","An ""epidemic"" is an event in which a disease, infectious or non-infectious, is actively spreading within a population and designated area. The term ""pandemic"" is defined as ""an epidemic occurring worldwide, or over a very wide area, crossing international boundaries and usually affecting a large number of people"". The global response to the COVID-19 pandemic has not been seen since the outbreak of Human Immunodeficiency Virus in the early eighties. But there is another unseen pandemic running al","2021","06","25","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Human immunodeficiency virus; Injuries; Pandemic; Trauma","Laubscher","Maritz","Division of Orthopaedic Surgery, Groote Schuur Hospital, Cape Town, South Africa",NA
"2492","34167911","10.1016/j.surge.2021.04.005","A tale of three pandemics: Shining a light on a hidden problem.","An ""epidemic"" is an event in which a disease, infectious or non-infectious, is actively spreading within a population and designated area. The term ""pandemic"" is defined as ""an epidemic occurring worldwide, or over a very wide area, crossing international boundaries and usually affecting a large number of people"". The global response to the COVID-19 pandemic has not been seen since the outbreak of Human Immunodeficiency Virus in the early eighties. But there is another unseen pandemic running al","2021","06","25","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Human immunodeficiency virus; Injuries; Pandemic; Trauma","Lalloo","David G","Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK",NA
"2493","34167911","10.1016/j.surge.2021.04.005","A tale of three pandemics: Shining a light on a hidden problem.","An ""epidemic"" is an event in which a disease, infectious or non-infectious, is actively spreading within a population and designated area. The term ""pandemic"" is defined as ""an epidemic occurring worldwide, or over a very wide area, crossing international boundaries and usually affecting a large number of people"". The global response to the COVID-19 pandemic has not been seen since the outbreak of Human Immunodeficiency Virus in the early eighties. But there is another unseen pandemic running al","2021","06","25","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Human immunodeficiency virus; Injuries; Pandemic; Trauma","Harrison","William James","Department of Orthopaedic and Trauma Surgery, Countess of Chester Hospital, Chester, UK",NA
"2494","34167911","10.1016/j.surge.2021.04.005","A tale of three pandemics: Shining a light on a hidden problem.","An ""epidemic"" is an event in which a disease, infectious or non-infectious, is actively spreading within a population and designated area. The term ""pandemic"" is defined as ""an epidemic occurring worldwide, or over a very wide area, crossing international boundaries and usually affecting a large number of people"". The global response to the COVID-19 pandemic has not been seen since the outbreak of Human Immunodeficiency Virus in the early eighties. But there is another unseen pandemic running al","2021","06","25","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Human immunodeficiency virus; Injuries; Pandemic; Trauma","Maqungo","Sithombo","Division of Orthopaedic Surgery, Groote Schuur Hospital, Cape Town, South Africa",NA
"2495","34167883","10.1016/j.jadohealth.2021.05.010","Characterizing COVID-19 Content Posted to TikTok: Public Sentiment and Response During the First Phase of the COVID-19 Pandemic.","The purpose of this study was to characterize COVID-19 content posted by users and disseminated via TikTok, a social media platform that has become known largely as an entertainment platform for viral video-sharing. We sought to capture how TikTok videos posted during the initial months of the COVID pandemic changed over time as cases accelerated. This study is an observational analysis of sequential TikTok videos with #coronavirus from January to March 2020. Videos were independently coded to a","2021","07","01","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","COVID-19; Health messaging; Infodemic; Social media; TikTok","Southwick","Lauren","Penn Medicine Center for Digital Health, University of Pennsylvania, Philadelphia, Pennsylvania","lauren.southwick@pennmedicine.upenn.edu"
"2496","34167883","10.1016/j.jadohealth.2021.05.010","Characterizing COVID-19 Content Posted to TikTok: Public Sentiment and Response During the First Phase of the COVID-19 Pandemic.","The purpose of this study was to characterize COVID-19 content posted by users and disseminated via TikTok, a social media platform that has become known largely as an entertainment platform for viral video-sharing. We sought to capture how TikTok videos posted during the initial months of the COVID pandemic changed over time as cases accelerated. This study is an observational analysis of sequential TikTok videos with #coronavirus from January to March 2020. Videos were independently coded to a","2021","07","01","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","COVID-19; Health messaging; Infodemic; Social media; TikTok","Guntuku","Sharath C","Penn Medicine Center for Digital Health, University of Pennsylvania, Philadelphia, Pennsylvania",NA
"2497","34167883","10.1016/j.jadohealth.2021.05.010","Characterizing COVID-19 Content Posted to TikTok: Public Sentiment and Response During the First Phase of the COVID-19 Pandemic.","The purpose of this study was to characterize COVID-19 content posted by users and disseminated via TikTok, a social media platform that has become known largely as an entertainment platform for viral video-sharing. We sought to capture how TikTok videos posted during the initial months of the COVID pandemic changed over time as cases accelerated. This study is an observational analysis of sequential TikTok videos with #coronavirus from January to March 2020. Videos were independently coded to a","2021","07","01","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","COVID-19; Health messaging; Infodemic; Social media; TikTok","Klinger","Elissa V","Penn Medicine Center for Digital Health, University of Pennsylvania, Philadelphia, Pennsylvania",NA
"2498","34167883","10.1016/j.jadohealth.2021.05.010","Characterizing COVID-19 Content Posted to TikTok: Public Sentiment and Response During the First Phase of the COVID-19 Pandemic.","The purpose of this study was to characterize COVID-19 content posted by users and disseminated via TikTok, a social media platform that has become known largely as an entertainment platform for viral video-sharing. We sought to capture how TikTok videos posted during the initial months of the COVID pandemic changed over time as cases accelerated. This study is an observational analysis of sequential TikTok videos with #coronavirus from January to March 2020. Videos were independently coded to a","2021","07","01","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","COVID-19; Health messaging; Infodemic; Social media; TikTok","Seltzer","Emily","Penn Medicine Center for Digital Health, University of Pennsylvania, Philadelphia, Pennsylvania",NA
"2499","34167883","10.1016/j.jadohealth.2021.05.010","Characterizing COVID-19 Content Posted to TikTok: Public Sentiment and Response During the First Phase of the COVID-19 Pandemic.","The purpose of this study was to characterize COVID-19 content posted by users and disseminated via TikTok, a social media platform that has become known largely as an entertainment platform for viral video-sharing. We sought to capture how TikTok videos posted during the initial months of the COVID pandemic changed over time as cases accelerated. This study is an observational analysis of sequential TikTok videos with #coronavirus from January to March 2020. Videos were independently coded to a","2021","07","01","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","COVID-19; Health messaging; Infodemic; Social media; TikTok","McCalpin","Haley J","Penn Medicine Center for Digital Health, University of Pennsylvania, Philadelphia, Pennsylvania",NA
"2500","34167883","10.1016/j.jadohealth.2021.05.010","Characterizing COVID-19 Content Posted to TikTok: Public Sentiment and Response During the First Phase of the COVID-19 Pandemic.","The purpose of this study was to characterize COVID-19 content posted by users and disseminated via TikTok, a social media platform that has become known largely as an entertainment platform for viral video-sharing. We sought to capture how TikTok videos posted during the initial months of the COVID pandemic changed over time as cases accelerated. This study is an observational analysis of sequential TikTok videos with #coronavirus from January to March 2020. Videos were independently coded to a","2021","07","01","J Adolesc Health","The Journal of adolescent health : official publication of the Society for Adolescent Medicine","COVID-19; Health messaging; Infodemic; Social media; TikTok","Merchant","Raina M","Penn Medicine Center for Digital Health, University of Pennsylvania, Philadelphia, Pennsylvania",NA
"2501","34167880","10.1016/j.nut.2021.111347","Vitamin D binding protein: A polymorphic protein with actin-binding capacity in COVID- 19.",NA,"2021","07","01","Nutrition","Nutrition (Burbank, Los Angeles County, Calif.)",NA,"Speeckaert","Marijn M","Department of Nephrology, Ghent University Hospital, Ghent, Belgium",NA
"2502","34167880","10.1016/j.nut.2021.111347","Vitamin D binding protein: A polymorphic protein with actin-binding capacity in COVID- 19.",NA,"2021","07","01","Nutrition","Nutrition (Burbank, Los Angeles County, Calif.)",NA,"Delanghe","Joris R","Department of Diagnostic Sciences, Ghent University, Ghent, Belgium",NA
"2503","34167876","10.1016/j.ejim.2021.06.009","Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.","Single studies support the presence of several post-COVID-19 symptoms; however, no meta-analysis differentiating hospitalized and non-hospitalized patients has been published to date. This meta-analysis analyses the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 . MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to March 15, 2021. Peer-reviewed studies or pre","2021","07","01","Eur J Intern Med","European journal of internal medicine","Covid-19; Dyspnea; Fatigue; Meta-analysis; Prevalence; Symptoms","Fernández-de-Las-Peñas","César","Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos (URJC), Avenida de Atenas s/n, Madrid, Alcorcón 28922 Spain. Electronic address: cesar.fernandez@urjc","cesar.fernandez@urjc.es"
"2504","34167876","10.1016/j.ejim.2021.06.009","Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.","Single studies support the presence of several post-COVID-19 symptoms; however, no meta-analysis differentiating hospitalized and non-hospitalized patients has been published to date. This meta-analysis analyses the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 . MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to March 15, 2021. Peer-reviewed studies or pre","2021","07","01","Eur J Intern Med","European journal of internal medicine","Covid-19; Dyspnea; Fatigue; Meta-analysis; Prevalence; Symptoms","Palacios-Ceña","Domingo","Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos (URJC), Avenida de Atenas s/n, Madrid, Alcorcón 28922 Spain",NA
"2505","34167876","10.1016/j.ejim.2021.06.009","Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.","Single studies support the presence of several post-COVID-19 symptoms; however, no meta-analysis differentiating hospitalized and non-hospitalized patients has been published to date. This meta-analysis analyses the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 . MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to March 15, 2021. Peer-reviewed studies or pre","2021","07","01","Eur J Intern Med","European journal of internal medicine","Covid-19; Dyspnea; Fatigue; Meta-analysis; Prevalence; Symptoms","Gómez-Mayordomo","Víctor","Department of Neurology, Hospital Clínico San Carlos, Madrid, Spain",NA
"2506","34167876","10.1016/j.ejim.2021.06.009","Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.","Single studies support the presence of several post-COVID-19 symptoms; however, no meta-analysis differentiating hospitalized and non-hospitalized patients has been published to date. This meta-analysis analyses the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 . MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to March 15, 2021. Peer-reviewed studies or pre","2021","07","01","Eur J Intern Med","European journal of internal medicine","Covid-19; Dyspnea; Fatigue; Meta-analysis; Prevalence; Symptoms","Florencio","Lidiane L","Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos (URJC), Avenida de Atenas s/n, Madrid, Alcorcón 28922 Spain",NA
"2507","34167876","10.1016/j.ejim.2021.06.009","Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.","Single studies support the presence of several post-COVID-19 symptoms; however, no meta-analysis differentiating hospitalized and non-hospitalized patients has been published to date. This meta-analysis analyses the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 . MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to March 15, 2021. Peer-reviewed studies or pre","2021","07","01","Eur J Intern Med","European journal of internal medicine","Covid-19; Dyspnea; Fatigue; Meta-analysis; Prevalence; Symptoms","Cuadrado","María L","Department of Neurology, Hospital Clínico San Carlos, Madrid, Spain",NA
"2508","34167876","10.1016/j.ejim.2021.06.009","Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.","Single studies support the presence of several post-COVID-19 symptoms; however, no meta-analysis differentiating hospitalized and non-hospitalized patients has been published to date. This meta-analysis analyses the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 . MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to March 15, 2021. Peer-reviewed studies or pre","2021","07","01","Eur J Intern Med","European journal of internal medicine","Covid-19; Dyspnea; Fatigue; Meta-analysis; Prevalence; Symptoms","Plaza-Manzano","Gustavo","Department of Radiology, Rehabilitation and Physiotherapy, Universidad Complutense de Madrid, Madrid, Spain",NA
"2509","34167876","10.1016/j.ejim.2021.06.009","Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.","Single studies support the presence of several post-COVID-19 symptoms; however, no meta-analysis differentiating hospitalized and non-hospitalized patients has been published to date. This meta-analysis analyses the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 . MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to March 15, 2021. Peer-reviewed studies or pre","2021","07","01","Eur J Intern Med","European journal of internal medicine","Covid-19; Dyspnea; Fatigue; Meta-analysis; Prevalence; Symptoms","Navarro-Santana","Marcos","Department of Radiology, Rehabilitation and Physiotherapy, Universidad Complutense de Madrid, Madrid, Spain",NA
"2510","34167874","10.1016/j.jdermsci.2021.06.006","Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.",NA,"2021","07","01","J Dermatol Sci","Journal of dermatological science",NA,"Ohsawa","Risa","Department of Dermatology, Hata Kenmin Hospital, Kochi, Japan",NA
"2511","34167874","10.1016/j.jdermsci.2021.06.006","Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.",NA,"2021","07","01","J Dermatol Sci","Journal of dermatological science",NA,"Sano","Hozumi","Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan",NA
"2512","34167874","10.1016/j.jdermsci.2021.06.006","Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.",NA,"2021","07","01","J Dermatol Sci","Journal of dermatological science",NA,"Ikeda","Mitsunori","Faculty of Nursing and Graduate School of Nursing, and Wellness and Longevity Center, University of Kochi, Kochi, Japan",NA
"2513","34167874","10.1016/j.jdermsci.2021.06.006","Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.",NA,"2021","07","01","J Dermatol Sci","Journal of dermatological science",NA,"Sano","Shigetoshi","Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan. Electronic address: sano.derma@kochi-u.ac",NA
"2514","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Plaza","Vicente","Comité Ejecutivo GEMA, Servicio de Neumología y Alergia, Hospital de la Santa Creu i Sant Pau, Barcelona, España. Electronic address: vplaza@santpau","vplaza@santpau.cat"
"2515","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Alobid","Isam","Sociedad Española de Otorrinolaringología (SEORL), Hospital Clinic, Universidad de Barcelona, Barcelona, España",NA
"2516","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Alvarez","Cesáreo","Sociedad Española de Medicina de Urgencias y Emergencias (SEMES), Hospital de Verín, Orense, España",NA
"2517","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Blanco","Marina","Sociedad Española de Neumología y Cirugía Torácica (SEPAR), Complejo Hospitalario Universitario A Coruña, A Coruña, España",NA
"2518","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Ferreira","Jorge","Sociedad Portuguesa de Pneumologia (SPP), Hospital de São Sebastião - CHEDV, Santa Maria da Feira, Portugal",NA
"2519","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","García","Gabriel","Asociación Latinoamericana del Tórax (ALAT), Hospital Rossi La Plata, Buenos Aires, Argentina",NA
"2520","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Gómez-Outes","Antonio","Sociedad Española de Farmacología Clínica (SEFC), Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Madrid, España",NA
"2521","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Gómez","Fernando","Sociedad Española de Médicos Generales y de Familia (SEMG), Centro de Salud de Bargas, Toledo, España",NA
"2522","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Hidalgo","Antonio","Sociedad Española de Médicos de Atención Primaria (SEMERGEN), Centro de Salud Lucena I. Lucena, Córdoba, España",NA
"2523","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Korta","Javier","Sociedad Española de Neumología Pediátrica (SENP), Hospital Universitario Donostia, Donostia-San Sebastián, España",NA
"2524","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Molina","Jesús","Sociedad Española de Medicina Familiar y Comunitaria (semFYC) y Sociedad de Respiratorio de Atención Primaria (GRAP), Centro de Salud Francia, Fuenlabrada, Dirección Asistencial Oeste, Madrid, España",NA
"2525","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Pellegrini","Francisco Javier","Sociedad Española de Pediatría Extrahospitalaria y Atención Primaria (SEPEAP), Centro de Salud de Pizarrales, Salamanca, España",NA
"2526","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Pérez","Montserrat","Sociedad Española de Farmacia Hospitalaria (SEFH), Hospital Universitario Fundación Alcorcón, Madrid, España",NA
"2527","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Plaza","Javier","Sociedad Española de Farmacia Clínica, Familiar y Comunitaria (SEFAC), Farmacia Dres. Zamora Navarro, Mazarrón, Murcia, España",NA
"2528","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Praena","Manuel","Asociación Española de Pediatría de Atención Primaria (AEPap), Centro de Salud La Candelaria, Sevilla, España",NA
"2529","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Quirce","Santiago","Sociedad Española de Alergia e Inmunología Clínica (SEAIC), Hospital Universitario La Paz, Madrid, España",NA
"2530","34167859","10.1016/j.arbres.2021.05.010","Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.","In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as ","2021","06","25","Arch Bronconeumol","Archivos de bronconeumologia","Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia","Sanz","José","Sociedad Española de Inmunología Clínica-Alergología y Asma Pediátrica (SEICAP), Hospital Católico Universitario Casa de Salud, Valencia, España",NA
"2532","34167838","10.1016/j.vaccine.2021.06.038","COVID-19 vaccination rates vary by community vulnerability: A county-level analysis.","We used the COVID-19 Community Vulnerability Index and 7 theme scores to assess associations between vulnerability and county-level COVID-19 vaccination (n = 2415 counties) through May 25th, 2021. When comparing vaccination rates among quintiles of CCVI scores, Theme 3 (housing type, transportation, household composition, and disability) was associated with the largest disparity, with the least vulnerable counties (Q1) having 33% higher rates of vaccination among individuals aged 18+ (53.5% vs 4","2021","07","09","Vaccine","Vaccine","COVID-19; Equity; SARS-CoV-2; Vaccination; Vulnerability; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; United States; Vaccination","Brown","Clare C","Department of Health Policy and Management, University of Arkansas for Medical Sciences, Fay W Boozman College of Public Health, 4301 West Markham Slot #820, Little Rock, AR 72205, United States. Electronic address: cbrown3@uams","cbrown3@uams.edu"
"2533","34167838","10.1016/j.vaccine.2021.06.038","COVID-19 vaccination rates vary by community vulnerability: A county-level analysis.","We used the COVID-19 Community Vulnerability Index and 7 theme scores to assess associations between vulnerability and county-level COVID-19 vaccination (n = 2415 counties) through May 25th, 2021. When comparing vaccination rates among quintiles of CCVI scores, Theme 3 (housing type, transportation, household composition, and disability) was associated with the largest disparity, with the least vulnerable counties (Q1) having 33% higher rates of vaccination among individuals aged 18+ (53.5% vs 4","2021","07","09","Vaccine","Vaccine","COVID-19; Equity; SARS-CoV-2; Vaccination; Vulnerability; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; United States; Vaccination","Young","Sean G","Department of Environmental and Occupational Health, University of Arkansas for Medical Sciences, Fay W Boozman College of Public Health, 4301 West Markham Slot #820, Little Rock, AR 72205, United States. Electronic address: SGYoung@uams","SGYoung@uams.edu"
"2534","34167838","10.1016/j.vaccine.2021.06.038","COVID-19 vaccination rates vary by community vulnerability: A county-level analysis.","We used the COVID-19 Community Vulnerability Index and 7 theme scores to assess associations between vulnerability and county-level COVID-19 vaccination (n = 2415 counties) through May 25th, 2021. When comparing vaccination rates among quintiles of CCVI scores, Theme 3 (housing type, transportation, household composition, and disability) was associated with the largest disparity, with the least vulnerable counties (Q1) having 33% higher rates of vaccination among individuals aged 18+ (53.5% vs 4","2021","07","09","Vaccine","Vaccine","COVID-19; Equity; SARS-CoV-2; Vaccination; Vulnerability; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; United States; Vaccination","Pro","George C","Department of Health Behavior and Health Education, University of Arkansas for Medical Sciences, Fay W Boozman College of Public Health, 4301 West Markham Slot #820, Little Rock, AR 72205, United States. Electronic address: GCPro@uams","GCPro@uams.edu"
"2535","34167836","10.1016/j.vaccine.2021.06.028","The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.",NA,"2021","07","09","Vaccine","Vaccine","B-cell; COVID-19; Coronavirus; HLA class I; HLA class II; Immune response; Peptide; SARS-CoV-2; T-cell; Universal vaccine; Variant; COVID-19; COVID-19 Vaccines; Epitopes, B-Lymphocyte; Epitopes, T-Lymphocyte; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccines, Subunit; Viral Vaccines","Poland","Gregory A","Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA. Electronic address: poland.gregory@mayo","poland.gregory@mayo.edu"
"2536","34167836","10.1016/j.vaccine.2021.06.028","The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.",NA,"2021","07","09","Vaccine","Vaccine","B-cell; COVID-19; Coronavirus; HLA class I; HLA class II; Immune response; Peptide; SARS-CoV-2; T-cell; Universal vaccine; Variant; COVID-19; COVID-19 Vaccines; Epitopes, B-Lymphocyte; Epitopes, T-Lymphocyte; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccines, Subunit; Viral Vaccines","Ovsyannikova","Inna G","Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA",NA
"2537","34167836","10.1016/j.vaccine.2021.06.028","The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.",NA,"2021","07","09","Vaccine","Vaccine","B-cell; COVID-19; Coronavirus; HLA class I; HLA class II; Immune response; Peptide; SARS-CoV-2; T-cell; Universal vaccine; Variant; COVID-19; COVID-19 Vaccines; Epitopes, B-Lymphocyte; Epitopes, T-Lymphocyte; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccines, Subunit; Viral Vaccines","Kennedy","Richard B","Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA",NA
"2538","34167834","10.1016/j.vaccine.2021.06.037","Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.","The COVID-19 pandemic is causing declines in childhood immunization rates. We examined potential COVID-19-related changes in pediatric 13-valent pneumococcal conjugate vaccine (PCV13) use, subsequent impact on childhood and adult pneumococcal disease rates, and how those changes might affect the favorability of PCV13 use in non-immunocompromised adults aged =65 years. A Markov model estimated pediatric disease resulting from decreased PCV13 use in children aged &lt;5 years; absolute decreases fr","2021","07","09","Vaccine","Vaccine","COVID-19; Cost-effectiveness analysis; Elderly; Pneumococcal vaccination; Aged; COVID-19; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Pandemics; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Vaccination; Vaccines, Conjugate","Smith","Kenneth J","University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. Electronic address: smithkj2@upmc","smithkj2@upmc.edu"
"2539","34167834","10.1016/j.vaccine.2021.06.037","Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.","The COVID-19 pandemic is causing declines in childhood immunization rates. We examined potential COVID-19-related changes in pediatric 13-valent pneumococcal conjugate vaccine (PCV13) use, subsequent impact on childhood and adult pneumococcal disease rates, and how those changes might affect the favorability of PCV13 use in non-immunocompromised adults aged =65 years. A Markov model estimated pediatric disease resulting from decreased PCV13 use in children aged &lt;5 years; absolute decreases fr","2021","07","09","Vaccine","Vaccine","COVID-19; Cost-effectiveness analysis; Elderly; Pneumococcal vaccination; Aged; COVID-19; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Pandemics; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Vaccination; Vaccines, Conjugate","Wateska","Angela R","University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. Electronic address: arw74@pitt","arw74@pitt.edu"
"2540","34167834","10.1016/j.vaccine.2021.06.037","Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.","The COVID-19 pandemic is causing declines in childhood immunization rates. We examined potential COVID-19-related changes in pediatric 13-valent pneumococcal conjugate vaccine (PCV13) use, subsequent impact on childhood and adult pneumococcal disease rates, and how those changes might affect the favorability of PCV13 use in non-immunocompromised adults aged =65 years. A Markov model estimated pediatric disease resulting from decreased PCV13 use in children aged &lt;5 years; absolute decreases fr","2021","07","09","Vaccine","Vaccine","COVID-19; Cost-effectiveness analysis; Elderly; Pneumococcal vaccination; Aged; COVID-19; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Pandemics; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Vaccination; Vaccines, Conjugate","Nowalk","Mary Patricia","University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. Electronic address: tnowalk@pitt","tnowalk@pitt.edu"
"2541","34167834","10.1016/j.vaccine.2021.06.037","Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.","The COVID-19 pandemic is causing declines in childhood immunization rates. We examined potential COVID-19-related changes in pediatric 13-valent pneumococcal conjugate vaccine (PCV13) use, subsequent impact on childhood and adult pneumococcal disease rates, and how those changes might affect the favorability of PCV13 use in non-immunocompromised adults aged =65 years. A Markov model estimated pediatric disease resulting from decreased PCV13 use in children aged &lt;5 years; absolute decreases fr","2021","07","09","Vaccine","Vaccine","COVID-19; Cost-effectiveness analysis; Elderly; Pneumococcal vaccination; Aged; COVID-19; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Pandemics; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Vaccination; Vaccines, Conjugate","Lin","Chyongchiou J","Ohio State University College of Nursing, Columbus, OH, United States. Electronic address: lin.3782@osu","lin.3782@osu.edu"
"2542","34167834","10.1016/j.vaccine.2021.06.037","Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.","The COVID-19 pandemic is causing declines in childhood immunization rates. We examined potential COVID-19-related changes in pediatric 13-valent pneumococcal conjugate vaccine (PCV13) use, subsequent impact on childhood and adult pneumococcal disease rates, and how those changes might affect the favorability of PCV13 use in non-immunocompromised adults aged =65 years. A Markov model estimated pediatric disease resulting from decreased PCV13 use in children aged &lt;5 years; absolute decreases fr","2021","07","09","Vaccine","Vaccine","COVID-19; Cost-effectiveness analysis; Elderly; Pneumococcal vaccination; Aged; COVID-19; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Pandemics; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Vaccination; Vaccines, Conjugate","Harrison","Lee H","University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. Electronic address: lharriso@edc.pitt","lharriso@edc.pitt.edu"
"2543","34167834","10.1016/j.vaccine.2021.06.037","Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.","The COVID-19 pandemic is causing declines in childhood immunization rates. We examined potential COVID-19-related changes in pediatric 13-valent pneumococcal conjugate vaccine (PCV13) use, subsequent impact on childhood and adult pneumococcal disease rates, and how those changes might affect the favorability of PCV13 use in non-immunocompromised adults aged =65 years. A Markov model estimated pediatric disease resulting from decreased PCV13 use in children aged &lt;5 years; absolute decreases fr","2021","07","09","Vaccine","Vaccine","COVID-19; Cost-effectiveness analysis; Elderly; Pneumococcal vaccination; Aged; COVID-19; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Pandemics; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Vaccination; Vaccines, Conjugate","Schaffner","William","Vanderbilt University School of Medicine, Nashville, TN, United States. Electronic address: william.schaffner@vanderbilt","william.schaffner@vanderbilt.edu"
"2544","34167834","10.1016/j.vaccine.2021.06.037","Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.","The COVID-19 pandemic is causing declines in childhood immunization rates. We examined potential COVID-19-related changes in pediatric 13-valent pneumococcal conjugate vaccine (PCV13) use, subsequent impact on childhood and adult pneumococcal disease rates, and how those changes might affect the favorability of PCV13 use in non-immunocompromised adults aged =65 years. A Markov model estimated pediatric disease resulting from decreased PCV13 use in children aged &lt;5 years; absolute decreases fr","2021","07","09","Vaccine","Vaccine","COVID-19; Cost-effectiveness analysis; Elderly; Pneumococcal vaccination; Aged; COVID-19; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Pandemics; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Vaccination; Vaccines, Conjugate","Zimmerman","Richard K","University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. Electronic address: zimmer@pitt","zimmer@pitt.edu"
"2545","34167832","10.1016/j.amjoto.2021.103131","Regarding ""Cranial nerve involvement in COVID-19"".",NA,"2021","07","01","Am J Otolaryngol","American journal of otolaryngology","Deafness; Hearing loss; SARS-CoV-2","Narozny","Waldemar","Department of Otolaryngology, Medical University of Gdansk, Poland",NA
"2546","34167832","10.1016/j.amjoto.2021.103131","Regarding ""Cranial nerve involvement in COVID-19"".",NA,"2021","07","01","Am J Otolaryngol","American journal of otolaryngology","Deafness; Hearing loss; SARS-CoV-2","Tretiakow","Dmitry","Department of Otolaryngology, Medical University of Gdansk, Poland. Electronic address: d.tret@gumed.edu","d.tret@gumed.edu.pl"
"2547","34167832","10.1016/j.amjoto.2021.103131","Regarding ""Cranial nerve involvement in COVID-19"".",NA,"2021","07","01","Am J Otolaryngol","American journal of otolaryngology","Deafness; Hearing loss; SARS-CoV-2","Skorek","Andrzej","Department of Otolaryngology, Medical University of Gdansk, Poland",NA
"2548","34167813","10.1016/j.jtcvs.2021.05.040","Commentary: Rome wasn't built in a day: Learning from initial cohort studies for patients with coronavirus disease receiving extracorporeal membrane oxygenation.",NA,"2021","07","01","J Thorac Cardiovasc Surg","The Journal of thoracic and cardiovascular surgery",NA,"Merritt-Genore","HelenMari","Department of Cardiothoracic Surgery, Heart Consultants, Methodist Physicians' Clinic, Omaha, Neb. Electronic address: helenmari.merritt@gmail","helenmari.merritt@gmail.com"
"2549","34167813","10.1016/j.jtcvs.2021.05.040","Commentary: Rome wasn't built in a day: Learning from initial cohort studies for patients with coronavirus disease receiving extracorporeal membrane oxygenation.",NA,"2021","07","01","J Thorac Cardiovasc Surg","The Journal of thoracic and cardiovascular surgery",NA,"Zavala","Ryan","Division of Perfusion, Nebraska Methodist Hospital, Omaha, Neb",NA
"2550","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Hollenberg","Steven M","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey","Steve.hollenberg@gmail.com"
"2551","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Safi","Lucy","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2552","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Parrillo","Joseph E","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2553","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Fata","Matthew","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2554","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Klinkhammer","Brent","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2555","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Gayed","Noha","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2556","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Glotzer","Taya","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2557","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Go","Ronaldo C","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2558","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Gourna-Paleoudis","Elli","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2559","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Landers","David","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2560","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Jamal","Sameer","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2561","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Shah","Neel","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2562","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Shah","Roshan","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2563","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Tancredi","Jana","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2564","34167784","10.1016/j.amjcard.2021.05.029","Hemodynamic Profiles of Shock in Patients With COVID-19.","Patients with serious COVID infections develop shock frequently. To characterize the hemodynamic profile of this cohort, 156 patients with COVID pneumonia and shock requiring vasopressors had interpretable echocardiography with measurement of ejection fraction (EF) by Simpson's rule and stroke volume (SV) by Doppler. RV systolic pressure (RVSP) was estimated from the tricuspid regurgitation peak velocity. Patients were divided into groups with low or preserved EF (EFL or EFP</sub","2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Turi","Zoltan G","Heart and Vascular Hospital, Hackensack Meridian Health/Hackensack University Medical Center, Hackensack, New Jersey",NA
"2565","34167781","10.1016/j.nefroe.2020.05.006","Is the immune hyporesponsiveness of uraemic patients a protective factor for severe COVID-19 pneumonia?",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","COVID-19; Cytokine Release Syndrome; Humans; Immunity, Cellular; Protective Factors; Renal Insufficiency, Chronic; Renal Replacement Therapy; Spain; Uremia","Florit","Enrique A","Instituto de Nefrología y Urología (ICNU), Hospital Clinic, Barcelona, Spain. Electronic address: kiqueflorit@gmail","kiqueflorit@gmail.com"
"2566","34167781","10.1016/j.nefroe.2020.05.006","Is the immune hyporesponsiveness of uraemic patients a protective factor for severe COVID-19 pneumonia?",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","COVID-19; Cytokine Release Syndrome; Humans; Immunity, Cellular; Protective Factors; Renal Insufficiency, Chronic; Renal Replacement Therapy; Spain; Uremia","Diekmann","Fritz","Instituto de Nefrología y Urología (ICNU), Hospital Clinic, Barcelona, Spain",NA
"2567","34167780","10.1016/j.nefroe.2021.04.001","Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney Transplantation; Male; Patient Readmission; Renal Insufficiency; Tacrolimus; Transplant Recipients","Sánchez Cadena","Abraham David","Servicio de Farmacia, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain. Electronic address: asancad@gmail","asancad@gmail.com"
"2568","34167780","10.1016/j.nefroe.2021.04.001","Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney Transplantation; Male; Patient Readmission; Renal Insufficiency; Tacrolimus; Transplant Recipients","Negreira Caamaño","Martín","Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain",NA
"2569","34167780","10.1016/j.nefroe.2021.04.001","Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney Transplantation; Male; Patient Readmission; Renal Insufficiency; Tacrolimus; Transplant Recipients","Pérez Serrano","Raúl","Servicio de Farmacia, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain",NA
"2570","34167780","10.1016/j.nefroe.2021.04.001","Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney Transplantation; Male; Patient Readmission; Renal Insufficiency; Tacrolimus; Transplant Recipients","Porras Leal","María Lourdes","Servicio de Medicina Interna, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain",NA
"2571","34167779","10.1016/j.nefroe.2021.02.009","Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; Biomarkers; COVID-19; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Seizures; Symptom Assessment","Ho","Kam Sing","Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: kam.ho@mountsinai","kam.ho@mountsinai.org"
"2572","34167779","10.1016/j.nefroe.2021.02.009","Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; Biomarkers; COVID-19; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Seizures; Symptom Assessment","Narasimhan","Bharat","Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2573","34167779","10.1016/j.nefroe.2021.02.009","Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; Biomarkers; COVID-19; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Seizures; Symptom Assessment","Kumar","Aravinth","Institute of Nephrology, Madras Medical College, Chennai, India",NA
"2574","34167779","10.1016/j.nefroe.2021.02.009","Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; Biomarkers; COVID-19; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Seizures; Symptom Assessment","Flynn","Erin","Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2575","34167779","10.1016/j.nefroe.2021.02.009","Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; Biomarkers; COVID-19; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Seizures; Symptom Assessment","Salonia","James","Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2576","34167779","10.1016/j.nefroe.2021.02.009","Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; Biomarkers; COVID-19; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Seizures; Symptom Assessment","El-Hachem","Karim","Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2577","34167779","10.1016/j.nefroe.2021.02.009","Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report.",NA,"2021","07","08","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","Aged; Biomarkers; COVID-19; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Seizures; Symptom Assessment","Mathew","Joseph P","Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2578","34167668","10.1016/j.jfma.2021.06.005","What we have learned from COVID-19 pandemic?",NA,"2021","06","30","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","COVID-19; Humans; Learning; Pandemics; SARS-CoV-2","Chen","Hsiu-Hsi","Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan. Electronic address: chenlin@ntu.edu","chenlin@ntu.edu.tw"
"2579","34167668","10.1016/j.jfma.2021.06.005","What we have learned from COVID-19 pandemic?",NA,"2021","06","30","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","COVID-19; Humans; Learning; Pandemics; SARS-CoV-2","Kao","Jia-Horng","Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan",NA
"2580","34167668","10.1016/j.jfma.2021.06.005","What we have learned from COVID-19 pandemic?",NA,"2021","06","30","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","COVID-19; Humans; Learning; Pandemics; SARS-CoV-2","Chen","Jin-Shing","Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan",NA
"2581","34167668","10.1016/j.jfma.2021.06.005","What we have learned from COVID-19 pandemic?",NA,"2021","06","30","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","COVID-19; Humans; Learning; Pandemics; SARS-CoV-2","Ni","Yen-Hsuan","Department of Pediatrics, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan",NA
"2582","34167612","10.1017/S2045796021000226","The effect of rapidly discharging psychiatric inpatients from Mental Health Act section during COVID-19: a cohort study.","In March 2020, the UK government ordered mental health services to free up bed space to help manage the COVID-19 pandemic. This meant service users detained under the Mental Health Act were discharged at a higher rate than normal. We analysed whether this decision compromised the safety of this vulnerable group of service users. We utilised a cohort study design and allocated service users to either the pre-rapid discharge, rapid discharge or post-rapid discharge group. We conducted a recurrent ","2021","07","16","Epidemiol Psychiatr Sci","Epidemiology and psychiatric sciences","COVID-19; Discharge; Mental Health Act; Psychiatric Inpatient care; Safety; Aftercare; COVID-19; Cohort Studies; Humans; Inpatients; Mental Disorders; Mental Health; Pandemics; Patient Discharge; SARS-CoV-2","Payne-Gill","J","Corporate Psychology &amp",NA
"2583","34167612","10.1017/S2045796021000226","The effect of rapidly discharging psychiatric inpatients from Mental Health Act section during COVID-19: a cohort study.","In March 2020, the UK government ordered mental health services to free up bed space to help manage the COVID-19 pandemic. This meant service users detained under the Mental Health Act were discharged at a higher rate than normal. We analysed whether this decision compromised the safety of this vulnerable group of service users. We utilised a cohort study design and allocated service users to either the pre-rapid discharge, rapid discharge or post-rapid discharge group. We conducted a recurrent ","2021","07","16","Epidemiol Psychiatr Sci","Epidemiology and psychiatric sciences","COVID-19; Discharge; Mental Health Act; Psychiatric Inpatient care; Safety; Aftercare; COVID-19; Cohort Studies; Humans; Inpatients; Mental Disorders; Mental Health; Pandemics; Patient Discharge; SARS-CoV-2","Whitfield","C","Corporate Psychology &amp",NA
"2584","34167612","10.1017/S2045796021000226","The effect of rapidly discharging psychiatric inpatients from Mental Health Act section during COVID-19: a cohort study.","In March 2020, the UK government ordered mental health services to free up bed space to help manage the COVID-19 pandemic. This meant service users detained under the Mental Health Act were discharged at a higher rate than normal. We analysed whether this decision compromised the safety of this vulnerable group of service users. We utilised a cohort study design and allocated service users to either the pre-rapid discharge, rapid discharge or post-rapid discharge group. We conducted a recurrent ","2021","07","16","Epidemiol Psychiatr Sci","Epidemiology and psychiatric sciences","COVID-19; Discharge; Mental Health Act; Psychiatric Inpatient care; Safety; Aftercare; COVID-19; Cohort Studies; Humans; Inpatients; Mental Disorders; Mental Health; Pandemics; Patient Discharge; SARS-CoV-2","Beck","A","Corporate Psychology &amp",NA
"2585","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Knobel","Pablo","Department of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2586","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Serra","Consol","Occupational Health Service, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2587","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Grau","Santiago","Department of Pharmacy, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2588","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Ibañez","Rocio","Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2589","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Diaz","Pilar","Occupational Health Service, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2590","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Ferrández","Olivia","Department of Pharmacy, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2591","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Villar","Rocío","Occupational Health Service, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2592","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Lopez","Alonso Fernando","Occupational Health Service, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2593","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Pujolar","Nuria","Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2594","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Horcajada","Juan Pablo","Service of Infectious Diseases, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2595","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Roman","Marta","Department of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2596","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Comas","Merce","Department of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2597","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Sala","Maria","Department of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2598","34167610","10.1017/ice.2021.287","Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.",NA,"2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Castells","Xavier","Department of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain",NA
"2599","34167608","10.1017/S1368980021002755","Acquisition, mobility and food insecurity: integrated food systems opportunities across urbanicity levels highlighted by COVID-19.","To investigate acquisition and mobility experiences of food-insecure individuals across urbanicity levels (i.e., urban, suburban, rural) in the early months of the COVID-19 pandemic. Cross-sectional study using a nationally representative online panel to measure where food-insecure individuals acquired food, food acquisition barriers and mobility to food sources, which were evaluated across urbanicity levels using chi-squared tests and 95 % CI. USA. 2011 adults (18 years or older). Food insecuri","2021","07","21","Public Health Nutr","Public health nutrition","COVID-19; Food insecurity; Food systems planning; Mobility; Transportation; Urbanicity","Mui","Yeeli","Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD21205, USA",NA
"2600","34167608","10.1017/S1368980021002755","Acquisition, mobility and food insecurity: integrated food systems opportunities across urbanicity levels highlighted by COVID-19.","To investigate acquisition and mobility experiences of food-insecure individuals across urbanicity levels (i.e., urban, suburban, rural) in the early months of the COVID-19 pandemic. Cross-sectional study using a nationally representative online panel to measure where food-insecure individuals acquired food, food acquisition barriers and mobility to food sources, which were evaluated across urbanicity levels using chi-squared tests and 95 % CI. USA. 2011 adults (18 years or older). Food insecuri","2021","07","21","Public Health Nutr","Public health nutrition","COVID-19; Food insecurity; Food systems planning; Mobility; Transportation; Urbanicity","Headrick","Gabby","Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD21205, USA",NA
"2601","34167608","10.1017/S1368980021002755","Acquisition, mobility and food insecurity: integrated food systems opportunities across urbanicity levels highlighted by COVID-19.","To investigate acquisition and mobility experiences of food-insecure individuals across urbanicity levels (i.e., urban, suburban, rural) in the early months of the COVID-19 pandemic. Cross-sectional study using a nationally representative online panel to measure where food-insecure individuals acquired food, food acquisition barriers and mobility to food sources, which were evaluated across urbanicity levels using chi-squared tests and 95 % CI. USA. 2011 adults (18 years or older). Food insecuri","2021","07","21","Public Health Nutr","Public health nutrition","COVID-19; Food insecurity; Food systems planning; Mobility; Transportation; Urbanicity","Raja","Samina","Department of Urban and Regional Planning, University at Buffalo, The State University of New York, Buffalo, NY, USA",NA
"2602","34167608","10.1017/S1368980021002755","Acquisition, mobility and food insecurity: integrated food systems opportunities across urbanicity levels highlighted by COVID-19.","To investigate acquisition and mobility experiences of food-insecure individuals across urbanicity levels (i.e., urban, suburban, rural) in the early months of the COVID-19 pandemic. Cross-sectional study using a nationally representative online panel to measure where food-insecure individuals acquired food, food acquisition barriers and mobility to food sources, which were evaluated across urbanicity levels using chi-squared tests and 95 % CI. USA. 2011 adults (18 years or older). Food insecuri","2021","07","21","Public Health Nutr","Public health nutrition","COVID-19; Food insecurity; Food systems planning; Mobility; Transportation; Urbanicity","Palmer","Anne","Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"2603","34167608","10.1017/S1368980021002755","Acquisition, mobility and food insecurity: integrated food systems opportunities across urbanicity levels highlighted by COVID-19.","To investigate acquisition and mobility experiences of food-insecure individuals across urbanicity levels (i.e., urban, suburban, rural) in the early months of the COVID-19 pandemic. Cross-sectional study using a nationally representative online panel to measure where food-insecure individuals acquired food, food acquisition barriers and mobility to food sources, which were evaluated across urbanicity levels using chi-squared tests and 95 % CI. USA. 2011 adults (18 years or older). Food insecuri","2021","07","21","Public Health Nutr","Public health nutrition","COVID-19; Food insecurity; Food systems planning; Mobility; Transportation; Urbanicity","Ehsani","Johnathon","Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"2604","34167608","10.1017/S1368980021002755","Acquisition, mobility and food insecurity: integrated food systems opportunities across urbanicity levels highlighted by COVID-19.","To investigate acquisition and mobility experiences of food-insecure individuals across urbanicity levels (i.e., urban, suburban, rural) in the early months of the COVID-19 pandemic. Cross-sectional study using a nationally representative online panel to measure where food-insecure individuals acquired food, food acquisition barriers and mobility to food sources, which were evaluated across urbanicity levels using chi-squared tests and 95 % CI. USA. 2011 adults (18 years or older). Food insecuri","2021","07","21","Public Health Nutr","Public health nutrition","COVID-19; Food insecurity; Food systems planning; Mobility; Transportation; Urbanicity","Pollack Porter","Keshia","Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"2605","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Wu","Hsiu","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2606","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Soe","Minn M","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2607","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Konnor","Rebecca","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2608","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Dantes","Raymund","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2609","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Haass","Kathryn","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2610","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Dudeck","Margaret A","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2611","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Gross","Cindy","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2612","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Leaptrot","Denise","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2613","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Sapiano","Mathew R P","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2614","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Allen-Bridson","Katherine","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2615","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Wattenmaker","Lauren","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2616","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Peterson","Kelly","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2617","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Lemoine","Kent","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2618","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Chernetsky Tejedor","Sheri","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2619","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Edwards","Jonathan R","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2620","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Pollock","Daniel","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2621","34167599","10.1017/ice.2021.280","Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27-July 14, 2020.","During March 27-July 14, 2020, the Centers for Disease Control and Prevention's National Healthcare Safety Network extended its surveillance to hospital capacities responding to COVID-19 pandemic. The data showed wide variations across hospitals in case burden, bed occupancies, ventilator usage, and healthcare personnel and supply status. These data were used to inform emergency responses.","2021","07","17","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Benin","Andrea L","Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia",NA
"2622","34167589","10.1186/s40337-021-00427-3","Disordered eating &amp; body image of current and former athletes in a pandemic; a convergent mixed methods study - What can we learn from COVID-19 to support athletes through transitions?","The COVID-19 pandemic has seen worsened mental health as a result of lockdowns, isolation and changes to sociocultural functioning. The postponement of the Tokyo 2020 Olympics is representative of global cancellations of sporting events, reduced facility access and support restrictions that have affected both current and former athlete's psychological wellbeing. This study aimed to determine whether current (n = 93) and former (n = 111) athletes experienced worsened body image, relationship with","2021","07","01","J Eat Disord","Journal of eating disorders","Athlete; Body image; COVID-19; Eating disorder; Retired athlete; Sport","Buckley","Georgina Louise","Department of Nursing and Allied Health, Swinburne University of Technology, John St, Hawthorn, Victoria, 3122, Australia. gbuckley@swin.edu","gbuckley@swin.edu.au"
"2623","34167589","10.1186/s40337-021-00427-3","Disordered eating &amp; body image of current and former athletes in a pandemic; a convergent mixed methods study - What can we learn from COVID-19 to support athletes through transitions?","The COVID-19 pandemic has seen worsened mental health as a result of lockdowns, isolation and changes to sociocultural functioning. The postponement of the Tokyo 2020 Olympics is representative of global cancellations of sporting events, reduced facility access and support restrictions that have affected both current and former athlete's psychological wellbeing. This study aimed to determine whether current (n = 93) and former (n = 111) athletes experienced worsened body image, relationship with","2021","07","01","J Eat Disord","Journal of eating disorders","Athlete; Body image; COVID-19; Eating disorder; Retired athlete; Sport","Hall","Linden Elizabeth","Victorian Institute of Sport, Aughtie Drive, Albert Park, Victoria, 3206, Australia",NA
"2624","34167589","10.1186/s40337-021-00427-3","Disordered eating &amp; body image of current and former athletes in a pandemic; a convergent mixed methods study - What can we learn from COVID-19 to support athletes through transitions?","The COVID-19 pandemic has seen worsened mental health as a result of lockdowns, isolation and changes to sociocultural functioning. The postponement of the Tokyo 2020 Olympics is representative of global cancellations of sporting events, reduced facility access and support restrictions that have affected both current and former athlete's psychological wellbeing. This study aimed to determine whether current (n = 93) and former (n = 111) athletes experienced worsened body image, relationship with","2021","07","01","J Eat Disord","Journal of eating disorders","Athlete; Body image; COVID-19; Eating disorder; Retired athlete; Sport","Lassemillante","Annie-Claude M","Department of Nursing and Allied Health, Swinburne University of Technology, John St, Hawthorn, Victoria, 3122, Australia",NA
"2625","34167589","10.1186/s40337-021-00427-3","Disordered eating &amp; body image of current and former athletes in a pandemic; a convergent mixed methods study - What can we learn from COVID-19 to support athletes through transitions?","The COVID-19 pandemic has seen worsened mental health as a result of lockdowns, isolation and changes to sociocultural functioning. The postponement of the Tokyo 2020 Olympics is representative of global cancellations of sporting events, reduced facility access and support restrictions that have affected both current and former athlete's psychological wellbeing. This study aimed to determine whether current (n = 93) and former (n = 111) athletes experienced worsened body image, relationship with","2021","07","01","J Eat Disord","Journal of eating disorders","Athlete; Body image; COVID-19; Eating disorder; Retired athlete; Sport","Belski","Regina","Department of Nursing and Allied Health, Swinburne University of Technology, John St, Hawthorn, Victoria, 3122, Australia",NA
